Representing term id	Representing term name	Representing term size	Representing term rank	Represented term number	gwas_adolescent_terms_by_significance.txt term rank	gwas_adult_terms_by_significance.txt term rank	gwas_child_terms_by_significance.txt term rank	gwas_elderly_terms_by_significance.txt term rank	gwas_fetus_terms_by_significance.txt term rank	gwas_infant_terms_by_significance.txt term rank	gwas_middle_adult_terms_by_significance.txt term rank	gwas_old_adult_terms_by_significance.txt term rank	gwas_older_adult_terms_by_significance.txt term rank	gwas_young_adult_terms_by_significance.txt term rank	gwas_young_child_terms_by_significance.txt term rank
2023_Skin fluorescence	2023_Skin fluorescence	25	1	1	1	1	23	4	123	1673	3	1032	1	1	4225
1720_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for multivariable)	1720_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for multivariable)	25	1	1	52	71	1	2285	2968	4502	186	4067	112	47	145
3487_Bread type: Wholemeal or wholegrain	3487_Bread type: Wholemeal or wholegrain	25	1	1	4046	355	131	1	2301	697	2053	77	1341	1453	3294
1809_Total power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1809_Total power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	1	1	2176	3231	831	3131	1	1969	3249	4205	4700	1836	666
3063_JAG1 - Protein jagged-1	3063_JAG1 - Protein jagged-1	25	1	1	3663	3772	3947	1665	709	1	4673	1608	3097	2733	3159
86_Lumbar Spine BMD	86_Lumbar Spine BMD	25	1	1	2235	47	515	2	974	2340	1	3	4	462	3363
4543_Gray matter	4543_Gray matter	25	1	1	4580	88	2215	20	2633	4369	7	1	45	196	994
3496_Hair colour (natural, before greying): Red	3496_Hair colour (natural, before greying): Red	25	1	1	1611	1406	2366	14	212	2114	760	20	442	3898	1
2018_Lithium response in Bipolar I patients - Alda Scale of 7 to 8	2018_Lithium response in Bipolar I patients - Alda Scale of 7 to 8	25	2	1	2	16	6	24	1147	3631	320	3458	26	86	1831
3662_Cancer register - Behaviour of cancer tumour: Carcinoma in situ	3662_Cancer register - Behaviour of cancer tumour: Carcinoma in situ	25	2	1	4204	2	2845	455	3959	959	12	189	414	2	656
1033_Neck Section Modulus (GEE, adjusted for age and sex)	1033_Neck Section Modulus (GEE, adjusted for age and sex)	25	2	1	334	3505	2	790	403	3461	1162	707	3425	4564	389
897_Phospholipids in large LDL	897_Phospholipids in large LDL	25	2	1	2623	4733	854	2939	2	2738	4668	2929	643	3735	1855
1087_Age-related Macular Degeneration	1087_Age-related Macular Degeneration	25	2	1	1974	3972	571	774	439	2	3867	2160	4160	1033	1183
3578_Social support - Leisure/social activities: Religious group	3578_Social support - Leisure/social activities: Religious group	25	2	1	717	43	3769	9	3623	3790	2	30	12	319	3217
858_3Lhydroxybutyrate	858_3Lhydroxybutyrate	25	2	1	3863	486	4344	184	982	1163	22	2	5	4394	4549
2026_Baseline positive affect factor score	2026_Baseline positive affect factor score	25	2	1	20	3	680	10	6	3213	9	664	2	3	2883
3904_White blood cell count (three-way meta)	3904_White blood cell count (three-way meta)	25	2	1	4085	889	2062	2423	1576	2019	3499	4144	4095	119	2
4050_Anterior cruciate ligament rupture (fixed effect model)	4050_Anterior cruciate ligament rupture (fixed effect model)	25	3	1	3	4	41	12	46	2395	48	4470	9	52	2016
4605_Right supramarginal	4605_Right supramarginal	25	3	1	13	536	3	2096	2287	4313	535	3102	2062	1562	2699
1926_Lateral ventricular volume (FBAT, adjusted for age and sex)	1926_Lateral ventricular volume (FBAT, adjusted for age and sex)	25	3	1	4694	1056	3967	3	109	2399	1176	19	41	611	639
893_Cholesterol esters in large LDL	893_Cholesterol esters in large LDL	25	3	1	2536	4198	1034	2268	3	2708	4680	2903	898	3801	2526
76_Neovascular disease	76_Neovascular disease	25	3	1	2508	3411	165	704	907	3	4572	3112	3306	1274	989
4499_Right rostral anterior cingulate	4499_Right rostral anterior cingulate	25	3	1	1063	106	1647	79	3191	86	8	61	3	16	970
3868_White blood cell count (two-way meta)	3868_White blood cell count (two-way meta)	25	3	1	3547	972	909	3663	2892	700	4313	3639	3375	96	3
2017_Lithium response in Bipolar I patients - Alda Scale of 6 to 7	2017_Lithium response in Bipolar I patients - Alda Scale of 6 to 7	25	4	1	4	5	446	7	1135	2137	55	4506	10	13	658
4323_Life satisfaction (MA GWAMA)	4323_Life satisfaction (MA GWAMA)	25	4	1	232	151	4	114	2800	2041	796	3380	2912	325	455
3425_Ever smoked	3425_Ever smoked	25	4	1	885	1338	1553	3511	4	3355	3688	3471	1620	2318	2877
2952_ENG - Endoglin	2952_ENG - Endoglin	25	4	1	1683	3145	3284	2494	4084	4	2386	905	2459	4380	1592
4266_Asthma (child-onset)	4266_Asthma (child-onset)	25	4	1	2777	10	3906	1091	2627	2831	4	154	478	68	766
3663_Cancer register - Behaviour of cancer tumour: Malignant, primary site	3663_Cancer register - Behaviour of cancer tumour: Malignant, primary site	25	4	1	1512	6	1748	22	1567	4576	14	4	208	26	1080
2986_CRK - Adapter molecule crk	2986_CRK - Adapter molecule crk	25	4	1	2958	1164	4392	555	64	4177	1140	430	443	4	867
3893_Sum neutrophil eosinophil count (three-way meta)	3893_Sum neutrophil eosinophil count (three-way meta)	25	4	2	3796	1476	1083	4117	3887	1178	3683	4221	3772	121	4
2016_Lithium response in Bipolar I patients - Alda Scale of 5 to 6	2016_Lithium response in Bipolar I patients - Alda Scale of 5 to 6	25	5	1	5	14	598	68	4345	758	435	4301	33	19	1032
1608_Viscosity I (at exam 5, FBAT, adjusted for multivariable)	1608_Viscosity I (at exam 5, FBAT, adjusted for multivariable)	25	5	1	1560	502	5	1499	3523	1854	304	742	1372	465	81
3727_Anxiety - Ever felt worried, tense, or anxious for most of a month or longer	3727_Anxiety - Ever felt worried, tense, or anxious for most of a month or longer	25	5	1	752	1446	80	5	2815	1867	326	2397	52	4023	2584
4755_Sagittal stratum radial diusivities	4755_Sagittal stratum radial diusivities	25	5	1	504	884	428	2107	5	1805	250	3893	510	435	494
43_Social deprivation	43_Social deprivation	25	5	1	4443	3344	2428	1780	1468	5	1756	3583	2199	3096	708
3552_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	3552_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	25	5	2	952	8	1698	259	4245	4414	5	303	3334	7	744
4077_Waist-hip ratio	4077_Waist-hip ratio	25	5	1	4068	1526	1067	242	1728	645	497	5	6	1823	3024
4299_Vitiligo (late onset)	4299_Vitiligo (late onset)	25	5	1	1636	66	2287	830	781	802	76	89	3535	5	136
208_Rheumatoid Arthritis	208_Rheumatoid Arthritis	25	5	1	2639	178	500	4411	83	303	297	562	1065	55	5
2007_Parental transmission distortion	2007_Parental transmission distortion	25	6	1	6	13	34	39	331	997	54	2357	222	70	1637
4051_Anterior cruciate ligament rupture (random effect model)	4051_Anterior cruciate ligament rupture (random effect model)	25	6	1	18	7	65	6	79	1038	60	3769	47	31	1793
74_Age-related Macular Degeneration	74_Age-related Macular Degeneration	25	6	1	2898	3071	116	553	1538	6	4113	2214	3386	1656	1266
4178_White blood cells	4178_White blood cells	25	6	1	954	1721	2021	668	479	906	1141	6	2718	2829	2718
3695_Diagnoses - secondary ICD10: J45 Asthma	3695_Diagnoses - secondary ICD10: J45 Asthma	25	6	1	853	94	2009	988	1317	1544	86	341	4707	6	313
2015_Lithium response in Bipolar I patients - Alda Scale of 4 to 5	2015_Lithium response in Bipolar I patients - Alda Scale of 4 to 5	25	7	1	7	53	449	568	876	1086	1747	1757	155	431	830
2846_PCSK7 - Proprotein convertase subtilisin/kexin type 7	2846_PCSK7 - Proprotein convertase subtilisin/kexin type 7	25	7	1	64	3275	7	1262	3460	436	2441	573	2932	4483	3223
495_Lipid::Fatty acid metabolism (also BCAA metabolism)::propionylcarnitine	495_Lipid::Fatty acid metabolism (also BCAA metabolism)::propionylcarnitine	25	7	1	1913	3860	537	3604	7	163	1746	2084	3356	1967	4394
3848_Lymphocyte count (two-way meta)	3848_Lymphocyte count (two-way meta)	25	7	1	1735	853	1691	4083	1566	7	1457	2884	1104	191	9
998_Monocyte chemotactic protein-1 (CCL2)	998_Monocyte chemotactic protein-1 (CCL2)	25	7	1	4589	323	4689	87	2109	3092	50	7	1613	4407	3693
83_Lumbar Spine BMD	83_Lumbar Spine BMD	25	7	1	2552	96	353	15	766	3749	11	25	7	1634	3352
4018_Systemic Lupus Erythematosus	4018_Systemic Lupus Erythematosus	25	7	1	4023	462	3122	2825	358	1529	1533	2226	2915	179	7
2005_Maternal transmission distortion	2005_Maternal transmission distortion	25	8	1	8	12	42	31	348	410	65	1465	186	95	1355
2791_NUDCD3 - NudC domain-containing protein 3	2791_NUDCD3 - NudC domain-containing protein 3	25	8	1	654	1040	8	4636	2950	4067	388	1163	2286	2682	1843
3825_Osteoarthritis of hip	3825_Osteoarthritis of hip	25	8	1	3099	2846	985	8	3548	149	2297	626	1488	1207	3404
70_Low-density lipoprotein cholesterol	70_Low-density lipoprotein cholesterol	25	8	1	4436	1671	1590	4711	8	382	1280	4672	3081	3035	4541
1633_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for multivariable)	1633_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for multivariable)	25	8	1	1559	1052	2823	4427	2383	8	910	1834	529	1769	432
3544_Mouth/teeth dental problems: Mouth ulcers	3544_Mouth/teeth dental problems: Mouth ulcers	25	8	1	244	34	1062	461	334	616	21	8	1227	190	1219
2019_Lung canger (adjusted for age)	2019_Lung canger (adjusted for age)	25	8	1	335	42	3865	102	226	4664	145	1507	8	399	1568
1202_Rheumatoid Arthritis	1202_Rheumatoid Arthritis	25	8	1	4517	436	1522	3779	175	1520	974	812	1181	193	8
2027_Cryptorchidism (group 1)	2027_Cryptorchidism (group 1)	25	9	1	9	23	100	583	577	2963	671	3496	304	154	1630
1714_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for multivariable)	1714_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for multivariable)	25	9	1	1315	189	9	2360	3325	1844	84	4131	141	2620	270
907_Total cholesterol in LDL	907_Total cholesterol in LDL	25	9	1	1775	4129	1097	2660	9	1690	4612	2351	663	4554	2552
1627_Interleukin 6 (at exam 7, GEE, adjusted for age and sex)	1627_Interleukin 6 (at exam 7, GEE, adjusted for age and sex)	25	9	1	2287	1600	487	3744	3931	9	2283	3600	4162	4227	1015
4644_Gray matter	4644_Gray matter	25	9	1	3761	1287	4099	1917	3841	2614	216	9	103	3961	1797
4267_Asthma (adult-onset)	4267_Asthma (adult-onset)	25	9	1	1420	31	606	960	474	1011	40	169	4655	9	158
2006_Paternal transmission distortion	2006_Paternal transmission distortion	25	10	1	10	15	102	50	516	416	93	1441	237	82	1474
3206_Number of days/week of moderate physical activity 10+ minutes	3206_Number of days/week of moderate physical activity 10+ minutes	25	10	1	243	3196	10	575	555	354	3919	616	3055	4507	396
4347_Coronary artery disease and low-density lipoprotein cholesterol (bivariate)	4347_Coronary artery disease and low-density lipoprotein cholesterol (bivariate)	25	10	1	1909	978	2181	3725	10	435	2690	4455	3604	3216	2293
1950_Visual scanning and motor speed (FBAT, adjusted for multivariable)	1950_Visual scanning and motor speed (FBAT, adjusted for multivariable)	25	10	1	2123	4332	1022	1841	3178	10	2455	1727	2046	2484	875
82_Lumbar Spine BMD (females)	82_Lumbar Spine BMD (females)	25	10	1	3542	168	347	26	854	3091	10	34	25	1002	2276
852_Alanine	852_Alanine	25	10	1	996	1933	4283	1240	407	1634	624	10	2681	1482	4135
4273_Long sleep	4273_Long sleep	25	10	1	160	38	4426	706	1012	2569	966	3319	586	10	2611
3872_Sum basophil neutrophil count (three-way meta)	3872_Sum basophil neutrophil count (three-way meta)	25	10	1	3508	2091	849	4570	3114	2958	3076	3974	4339	212	10
737_::::X-11847	737_::::X-11847	25	11	1	11	4020	167	2514	4072	3161	3000	1863	1257	1676	4304
2770_AKR1A1 - Alcohol dehydrogenase [NADP(+)]	2770_AKR1A1 - Alcohol dehydrogenase [NADP(+)]	25	11	1	4143	11	3586	382	636	704	59	1295	18	11	2139
1369_Total cholesterol (at exam 6, GEE, adjusted for age and sex)	1369_Total cholesterol (at exam 6, GEE, adjusted for age and sex)	25	11	1	2055	2697	11	3433	3696	2014	2966	3489	2743	910	254
2025_10 mg response to amphetamine	2025_10 mg response to amphetamine	25	11	1	19	17	627	11	1195	932	46	480	16	412	2167
1803_Low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1803_Low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	11	1	25	2863	104	2175	11	366	1546	4059	2418	989	57
211_Insomnia (male)	211_Insomnia (male)	25	11	1	2215	2121	3151	2359	4101	11	2058	570	2011	4379	4256
712_::::X-11483	712_::::X-11483	25	11	1	2822	4100	2865	4554	3458	1573	3147	11	650	3456	778
3168_CD27 - CD27 antigen	3168_CD27 - CD27 antigen	24	11	1	592	574	1339	3913	723	1976	465	3934	11	166	3875
4227_Immunosuppressants	4227_Immunosuppressants	25	11	1	3535	247	394	2606	92	1202	159	372	1202	88	11
2795_PFDN5 - Prefoldin subunit 5	2795_PFDN5 - Prefoldin subunit 5	25	12	1	12	2868	1787	509	2954	3857	4101	2187	2604	2501	3321
4234_Antidepressants	4234_Antidepressants	25	12	1	1192	2137	12	1032	3463	1267	2745	1319	1515	3458	2471
920_Phospholipids in medium LDL	920_Phospholipids in medium LDL	25	12	1	2893	1984	2251	3785	12	2155	2749	3283	2156	3656	4078
1823_Inter-trochanteric buckling ratio (GEE, female, adjussted for age)	1823_Inter-trochanteric buckling ratio (GEE, female, adjussted for age)	25	12	1	1386	2483	3159	1087	193	12	3046	2232	2294	1466	202
4204_Estimated glomerular filtration rate	4204_Estimated glomerular filtration rate	25	12	1	1357	1483	4309	741	2534	4335	613	12	740	739	1510
2590_MASP1 - Mannan-binding lectin serine protease 1	2590_MASP1 - Mannan-binding lectin serine protease 1	25	12	1	106	77	925	4453	1962	1353	244	2129	1224	12	1442
3892_Myeloid white cell count (three-way meta)	3892_Myeloid white cell count (three-way meta)	25	12	1	4220	2530	437	4175	4532	1260	2734	3284	1902	205	12
980_Interferon-gamma	980_Interferon-gamma	25	13	1	358	138	13	2123	1220	4315	1966	3990	3446	3779	1422
4436_Herpes simplex virus 1 IgG levels	4436_Herpes simplex virus 1 IgG levels	25	13	1	2819	2800	2000	13	189	3870	3732	362	882	850	699
892_Total cholesterol in large LDL	892_Total cholesterol in large LDL	25	13	2	1642	4541	502	2797	13	2095	4261	2437	655	4223	1736
1604_tPA (at exam 5, FBAT, adjusted for multivariable)	1604_tPA (at exam 5, FBAT, adjusted for multivariable)	25	13	1	3162	3813	3830	2296	4115	13	4503	1554	3843	1591	280
1860_Neck cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	1860_Neck cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	25	13	1	647	208	442	1639	1058	1829	13	3097	61	1398	1236
1598_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for age and sex)	1598_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for age and sex)	25	13	1	3195	1403	274	187	2229	2945	533	13	133	2182	721
2056_Rheumatoid Arthritis	2056_Rheumatoid Arthritis	25	13	1	676	1127	316	1580	2185	2953	185	861	13	38	637
3814_CD8+ T cell level	3814_CD8+ T cell level	25	13	1	3411	1541	359	2759	1716	1318	4707	1231	1786	623	13
1770_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for multivariable)	1770_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for multivariable)	25	14	1	14	2320	54	3542	151	1009	1710	3274	2724	2768	4411
2695_PSMA6 - Proteasome subunit alpha type-6	2695_PSMA6 - Proteasome subunit alpha type-6	25	14	1	63	2931	14	195	2748	3861	4425	347	2223	3153	3401
1807_SDNN HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1807_SDNN HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	14	1	77	541	740	341	453	14	757	1306	845	183	318
3205_Duration of walks	3205_Duration of walks	25	14	1	3573	3167	1145	444	3499	279	4582	14	4242	1049	179
530_Lipid::Lysolipid::1-arachidonoylglycerophosphocholine*	530_Lipid::Lysolipid::1-arachidonoylglycerophosphocholine*	25	14	1	99	126	232	1093	1775	162	36	336	14	250	2957
3238_Exposure to tobacco smoke at home	3238_Exposure to tobacco smoke at home	25	14	1	3321	392	3416	625	2350	4438	829	2528	1615	14	4104
3884_Lymphocyte count (three-way meta)	3884_Lymphocyte count (three-way meta)	25	14	1	2735	833	3302	4480	1764	58	911	3147	1489	269	14
3649_Illnesses of siblings: Stroke	3649_Illnesses of siblings: Stroke	25	15	1	15	1373	1168	4674	671	3497	2546	1332	3874	291	3947
3821_Celiac disease	3821_Celiac disease	25	15	1	3205	492	15	4657	2739	1703	42	105	347	2134	2079
4268_Atrial Fibrillation	4268_Atrial Fibrillation	25	15	1	450	2737	543	1834	15	2282	2706	1309	284	4170	4203
4641_Right accumbens area	4641_Right accumbens area	25	15	1	1356	3025	1839	657	3105	15	4250	4428	3202	1706	26
2049_Periodontal complex trait 4	2049_Periodontal complex trait 4	25	15	1	1570	62	1510	232	1062	1492	15	671	34	168	4059
2513_CDC2 CCNB1 - Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex	2513_CDC2 CCNB1 - Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex	25	15	1	3152	873	2353	2198	4582	1790	289	15	15	614	1413
1871_Shaft average buckling ratio (GEE, female, adjussted for multivariable)	1871_Shaft average buckling ratio (GEE, female, adjussted for multivariable)	25	15	1	2000	302	1030	1753	1865	2234	208	389	185	15	196
4017_Systemic Lupus Erythematosus	4017_Systemic Lupus Erythematosus	25	15	1	1950	368	1583	2771	1188	226	955	1284	2405	177	15
2591_DDR2 - Discoidin domain-containing receptor 2	2591_DDR2 - Discoidin domain-containing receptor 2	25	16	1	16	950	352	3755	4410	3629	3545	2689	2873	304	3411
556_Lipid::Medium chain fatty acid::caproate (6:0)	556_Lipid::Medium chain fatty acid::caproate (6:0)	25	16	1	1059	1188	16	3025	3032	4407	1342	4731	2911	634	1222
3499_Hair colour (natural, before greying): Black	3499_Hair colour (natural, before greying): Black	25	16	1	715	333	242	16	463	3299	264	668	614	978	95
895_Total lipids in large LDL	895_Total lipids in large LDL	25	16	1	2014	4574	1265	3040	16	3477	4599	2899	794	4062	2484
1030_Neck Width (FBAT, adjusted for multivariable)	1030_Neck Width (FBAT, adjusted for multivariable)	25	16	1	4339	4234	478	3360	1408	16	3355	3446	986	3286	2324
3680_Diagnoses - main ICD10: N39 Other disorders of urinary system	3680_Diagnoses - main ICD10: N39 Other disorders of urinary system	25	16	1	1246	181	692	2781	231	1981	16	388	260	1302	4552
4409_Vaginal discharge: Metrorrhagia	4409_Vaginal discharge: Metrorrhagia	25	16	1	888	3243	2328	425	1276	2140	2631	16	1061	1363	3896
3820_Type 1 Diabetes	3820_Type 1 Diabetes	25	16	1	2418	891	2064	2868	121	78	3430	1669	1964	388	16
2022_Fibrotic idiopathic interstitial pneumonias	2022_Fibrotic idiopathic interstitial pneumonias	25	17	1	17	129	160	1978	768	1688	442	3145	351	645	2213
686_::::X-10510	686_::::X-10510	25	17	1	2053	2092	17	1839	3580	4357	1628	499	771	4469	84
1996_MMSE score (at exam 7, FBAT, adjusted for multivariable)	1996_MMSE score (at exam 7, FBAT, adjusted for multivariable)	25	17	1	3908	105	751	17	1613	2745	301	134	241	487	4457
1282_Sagittal diameter by CT (FBAT, adjusted for age, sex, smoking and menopause)	1282_Sagittal diameter by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	17	1	4370	1564	3518	3339	17	4540	3953	3946	2080	1300	559
2956_GOT1 - Aspartate aminotransferase, cytoplasmic	2956_GOT1 - Aspartate aminotransferase, cytoplasmic	25	17	1	4433	2669	3910	3319	913	17	4610	3141	3361	1841	2068
408_Amino acid::Tryptophan metabolism::serotonin (5HT)	408_Amino acid::Tryptophan metabolism::serotonin (5HT)	25	17	1	182	642	603	2637	858	1933	17	1071	401	2630	1709
4024_Excessive hairiness	4024_Excessive hairiness	25	17	1	2079	529	318	86	3498	4084	229	17	98	1172	982
2915_SMPDL3A - Acid sphingomyelinase-like phosphodiesterase 3a	2915_SMPDL3A - Acid sphingomyelinase-like phosphodiesterase 3a	25	17	1	4207	1298	249	2795	1593	3949	211	653	17	855	2848
3832_Vitiligo	3832_Vitiligo	25	17	1	3927	101	766	252	208	3226	222	75	4286	17	60
4300_Vitiligo (early onset)	4300_Vitiligo (early onset)	25	17	1	3849	666	45	428	51	4710	1264	620	2501	23	17
975_Eotaxin (CCL11)	975_Eotaxin (CCL11)	25	18	1	1632	18	1143	3023	3004	2785	95	3016	76	72	2561
502_Lipid::Fatty acid, dicarboxylate::tetradecanedioate	502_Lipid::Fatty acid, dicarboxylate::tetradecanedioate	25	18	1	223	778	18	2008	506	3756	1971	2643	2729	1162	2572
4595_Right pericalcarine	4595_Right pericalcarine	25	18	1	3588	30	2208	18	3736	1668	99	31	87	66	586
919_Concentration of medium LDL particles	919_Concentration of medium LDL particles	25	18	3	1589	2998	1137	2013	18	3729	4127	2320	1583	4698	3039
75_Geographic atrophy	75_Geographic atrophy	25	18	1	2868	4000	164	480	1914	18	4281	1574	4241	1169	1451
4541_Right ventral DC	4541_Right ventral DC	25	18	1	725	113	1598	948	3911	2519	18	109	406	131	3048
4581_Right fusiform	4581_Right fusiform	25	18	1	2094	2554	58	47	1910	3946	308	18	850	4744	4447
1530_Ankle-brachial index (at exam 6, FBAT, adjusted for age and sex)	1530_Ankle-brachial index (at exam 6, FBAT, adjusted for age and sex)	25	18	1	1146	82	4596	800	4239	4569	389	96	962	18	1362
1204_Rheumatoid Arthritis	1204_Rheumatoid Arthritis	25	18	1	1094	2039	146	3205	1621	2359	3506	1657	1299	383	18
2024_Alcohol dependence	2024_Alcohol dependence	25	19	1	59	19	400	143	4549	1473	118	679	38	217	1974
244_CD32 on mDC	244_CD32 on mDC	25	19	1	634	3162	19	3522	3207	2245	4124	2607	4435	1845	634
3991_Mood swings (MOOD)	3991_Mood swings (MOOD)	25	19	1	399	120	4501	19	4318	450	490	395	288	57	3457
2416_FOLH1 - Glutamate carboxypeptidase 2	2416_FOLH1 - Glutamate carboxypeptidase 2	25	19	1	170	1640	3447	1576	19	4083	1353	1537	3817	2886	757
4356_Menstrual cycle length	4356_Menstrual cycle length	25	19	1	2803	720	2039	1381	112	19	730	763	1893	1159	1806
4429_Cytomegalovirus seropositivity	4429_Cytomegalovirus seropositivity	25	19	1	1641	232	3876	1975	3706	4278	19	35	708	621	3208
891_Phospholipids in large HDL	891_Phospholipids in large HDL	25	19	1	2237	2245	1021	1412	1260	1683	1834	1917	19	4491	4438
3823_Systemic Lupus Erythematosus	3823_Systemic Lupus Erythematosus	25	19	1	3852	160	2590	2068	374	951	1221	917	3458	149	19
1856_Neck average buckling ratio (FBAT, male, adjussted for age)	1856_Neck average buckling ratio (FBAT, male, adjussted for age)	25	20	1	512	20	842	120	3818	3330	246	684	85	209	1257
1839_Neck width (GEE, female, adjusted for age)	1839_Neck width (GEE, female, adjusted for age)	25	20	1	299	4319	20	541	2944	3585	3977	1114	4724	944	110
2514_CMA1 - Chymase	2514_CMA1 - Chymase	25	20	1	2346	1943	1976	1921	1747	20	1680	3271	839	4140	89
3540_Reason for glasses/contact lenses: For long-sightedness, i.e. for distance and near, but particularly for near tasks like reading (called 'hypermetropia')	3540_Reason for glasses/contact lenses: For long-sightedness, i.e. for distance and near, but particularly for near tasks like reading (called 'hypermetropia')	25	20	1	310	280	85	2775	1817	1409	20	3394	69	842	1174
176_Waist circumference (male, adjusted for BMI)	176_Waist circumference (male, adjusted for BMI)	25	20	2	2533	514	241	63	4724	1138	937	139	20	1627	2018
205_Microalbuminuria	205_Microalbuminuria	25	20	1	173	261	1046	1026	1094	2926	407	203	121	20	4174
3895_Neutrophil count (three-way meta)	3895_Neutrophil count (three-way meta)	25	20	1	3338	1796	1734	4126	2671	2133	3897	4648	4557	134	20
2858_C3 - Complement C3b	2858_C3 - Complement C3b	25	21	1	21	114	49	803	3292	1990	504	4579	361	99	768
2028_Cryptorchidism (group 2)	2028_Cryptorchidism (group 2)	25	21	1	23	21	371	393	27	3319	88	3796	283	84	2769
4504_Right supramarginal	4504_Right supramarginal	25	21	1	113	1361	21	1386	1318	4116	1672	3497	3059	1324	1901
1494_Remnant lipoprotein triglycerides (at exam 4, FBAT)	1494_Remnant lipoprotein triglycerides (at exam 4, FBAT)	25	21	1	1040	4473	2740	21	2151	1131	3794	846	4429	4614	755
30_Agreablenes (NEO-FFI)	30_Agreablenes (NEO-FFI)	25	21	1	4101	2966	1332	2706	4598	21	1220	2022	2642	1992	585
1688_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for multivariable)	1688_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for multivariable)	25	21	1	4734	1604	3182	3071	1145	40	1833	21	1045	2708	722
2420_ACP5 - Tartrate-resistant acid phosphatase type 5	2420_ACP5 - Tartrate-resistant acid phosphatase type 5	25	21	1	383	1457	702	2163	2705	3854	4642	881	763	21	4442
1203_Rheumatoid Arthritis	1203_Rheumatoid Arthritis	25	21	1	2842	1865	908	3108	904	3224	2582	2238	2202	432	21
4542_Right vessel	4542_Right vessel	25	22	1	22	577	60	1207	936	1390	856	2183	1722	187	1662
2089_GFRA3 - GDNF family receptor alpha-3	2089_GFRA3 - GDNF family receptor alpha-3	25	22	1	1324	22	2559	65	4044	2598	28	527	35	1221	1976
107_Tanner scale	107_Tanner scale	25	22	1	1074	1475	22	3347	4235	2873	71	2118	640	707	4311
694_::::X-11327	694_::::X-11327	25	22	1	970	2272	1487	4691	22	111	255	3397	3532	1539	473
3979_Estimated BMD	3979_Estimated BMD	25	22	1	58	2503	670	1215	970	22	396	2923	3168	2512	2787
4013_Major depressive disorder (ICD-coded)	4013_Major depressive disorder (ICD-coded)	25	22	1	4596	2221	4004	1562	1345	333	2792	22	3191	1792	4504
4064_Estimated glomerular filtration rate based on cystain C	4064_Estimated glomerular filtration rate based on cystain C	25	22	1	2045	195	3597	1089	4004	461	748	744	22	4329	3144
4236_Glucocorticoids	4236_Glucocorticoids	25	22	1	1007	74	2759	2774	673	495	69	613	2922	22	475
3065_AMICA1 - Junctional adhesion molecule-like	3065_AMICA1 - Junctional adhesion molecule-like	25	22	1	2708	4644	1122	3554	3483	244	3927	3421	482	4159	22
2469_CAMK2B - Calcium/calmodulin-dependent protein kinase type II subunit beta	2469_CAMK2B - Calcium/calmodulin-dependent protein kinase type II subunit beta	25	23	1	1947	3305	1922	23	857	3995	4577	500	463	1382	1534
1908_Lateral ventricular volume (FBAT, adjusted for multivariable)	1908_Lateral ventricular volume (FBAT, adjusted for multivariable)	25	23	1	4642	1846	2709	54	23	955	1728	412	302	3989	387
1827_Spine Neck BMD (GEE, female, adjusted for multivariable)	1827_Spine Neck BMD (GEE, female, adjusted for multivariable)	25	23	1	2238	2727	4569	3700	1214	23	1446	4181	2225	3343	4098
3438_Doctor diagnosed asthma	3438_Doctor diagnosed asthma	25	23	1	2764	26	698	451	1996	2424	23	433	4224	33	201
4552_Left inferior temporal	4552_Left inferior temporal	25	23	1	4612	1048	447	521	192	359	949	23	591	2090	1956
2021_Squamous cell (adjusted for age)	2021_Squamous cell (adjusted for age)	25	23	1	70	28	1227	100	310	2401	165	959	23	919	898
1102_High-density lipoprotein - Birth cohorts	1102_High-density lipoprotein - Birth cohorts	25	23	1	3642	2241	150	2197	4524	3810	2910	275	1498	4046	23
3990_Neuroticism sum score	3990_Neuroticism sum score	25	24	1	24	61	3551	233	182	3049	915	836	37	43	3689
3005_EIF4A3 - Eukaryotic initiation factor 4A-III	3005_EIF4A3 - Eukaryotic initiation factor 4A-III	25	24	1	3214	24	3161	732	3916	4557	31	160	102	241	2086
2441_FCGR3B - Low affinity immunoglobulin gamma Fc region receptor III-B	2441_FCGR3B - Low affinity immunoglobulin gamma Fc region receptor III-B	25	24	1	2827	1510	24	1177	4182	1522	4158	1461	2489	4597	2960
2410_METAP1 - Methionine aminopeptidase 1	2410_METAP1 - Methionine aminopeptidase 1	25	24	1	75	2413	721	806	24	315	2969	2158	2061	2089	648
3116_NR1D1 - Nuclear receptor subfamily 1 group D member 1	3116_NR1D1 - Nuclear receptor subfamily 1 group D member 1	25	24	1	359	404	2504	4306	2046	24	3860	68	859	444	528
1628_Interleukin 6 (at exam 7, FBAT, adjusted for multivariable)	1628_Interleukin 6 (at exam 7, FBAT, adjusted for multivariable)	25	24	1	1633	2268	772	1811	2791	1716	24	185	160	747	1120
4507_Cerebellar vermal lobules I V	4507_Cerebellar vermal lobules I V	25	24	1	239	2941	403	1237	1392	501	187	24	2244	4659	2357
2020_Adenocarcinoma (adjusted for age)	2020_Adenocarcinoma (adjusted for age)	25	24	1	119	50	2110	94	468	1744	116	429	24	268	1832
3007_LGALS3BP - Galectin-3-binding protein	3007_LGALS3BP - Galectin-3-binding protein	25	24	1	3669	297	2664	1573	1193	2559	194	497	1133	24	2200
3529_Never eat eggs, dairy, wheat, sugar: Wheat products	3529_Never eat eggs, dairy, wheat, sugar: Wheat products	25	24	1	4453	1393	1635	2277	419	213	4161	4644	736	172	24
4269_Neuroticism general factor	4269_Neuroticism general factor	25	25	1	215	25	4184	639	484	1439	412	703	153	110	3766
1014_Bone Ultrasound Attenuation (FBAT, adjusted for multivariable)	1014_Bone Ultrasound Attenuation (FBAT, adjusted for multivariable)	25	25	1	480	3358	25	4335	1810	4459	2255	3198	3297	4583	144
4508_Cerebellar vermal lobules VI VII	4508_Cerebellar vermal lobules VI VII	25	25	1	1579	316	575	25	3169	1608	1701	180	1380	2407	4087
2683_UFM1 - Ubiquitin-fold modifier 1	2683_UFM1 - Ubiquitin-fold modifier 1	25	25	1	4158	3899	1398	1475	25	2534	3903	3756	4201	2366	140
3660_Cancer register - Histology of cancer tumour: Basal cell carcinoma, NOS	3660_Cancer register - Histology of cancer tumour: Basal cell carcinoma, NOS	25	25	1	4337	497	1331	3541	2688	25	262	218	4016	278	2548
1983_Walking speed (at exam 7, GEE)	1983_Walking speed (at exam 7, GEE)	25	25	1	1242	227	474	3137	3772	1551	25	789	235	557	2488
3191_Number of treatments/medications taken	3191_Number of treatments/medications taken	25	25	1	3806	73	1438	1410	244	1114	132	95	3518	25	37
3815_CD4:CD8 lymphocyte ratio	3815_CD4:CD8 lymphocyte ratio	25	25	1	1195	2135	189	1916	1346	1245	2620	190	3107	259	25
1603_tPA (at exam 5, GEE, adjusted for age and sex)	1603_tPA (at exam 5, GEE, adjusted for age and sex)	25	26	1	26	1082	260	2680	3524	3159	1262	3675	1176	1871	111
360_mDC:%32+	360_mDC:%32+	25	26	1	172	477	26	4222	4226	2879	865	4268	1010	737	3856
4314_Ever smoked regulary	4314_Ever smoked regulary	25	26	1	216	2771	2261	1819	26	3900	2617	4150	2465	3238	2413
2052_Age-related Macular Degeneration	2052_Age-related Macular Degeneration	25	26	1	3215	2172	484	899	1272	26	3022	4261	3011	1134	929
4334_Asthma	4334_Asthma	25	26	1	1319	60	2339	3995	2409	3282	26	615	3777	92	2607
752_::::X-12063	752_::::X-12063	25	26	1	1535	3114	4469	1104	4232	1558	552	26	1154	1765	3235
372_Amino acid::Cysteine, methionine, SAM, taurine metabolism::cysteine	372_Amino acid::Cysteine, methionine, SAM, taurine metabolism::cysteine	25	27	1	27	385	43	4228	579	2909	4585	2302	3974	491	3828
4087_Neuroticism	4087_Neuroticism	24	27	1	694	27	4243	1483	1132	2260	662	1162	157	249	3837
2856_ZAP70 - Tyrosine-protein kinase ZAP-70	2856_ZAP70 - Tyrosine-protein kinase ZAP-70	25	27	1	1711	1799	27	2513	3873	1803	2156	2933	3642	365	1923
3945_HbA1c	3945_HbA1c	25	27	1	3923	952	3419	27	2813	194	471	431	492	3644	2790
1874_Shaft average buckling ratio (FBAT, female, adjussted for age)	1874_Shaft average buckling ratio (FBAT, female, adjussted for age)	25	27	1	3366	4622	1581	2578	3904	27	1752	2940	2379	2539	1505
2610_OLR1 - Oxidized low-density lipoprotein receptor 1	2610_OLR1 - Oxidized low-density lipoprotein receptor 1	25	27	1	165	40	97	1522	1827	3996	27	1810	530	246	2985
1861_Neck cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	1861_Neck cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	25	27	1	2736	1050	619	1100	1311	2083	724	27	43	4631	2064
4600_Right rostral anterior cingulate	4600_Right rostral anterior cingulate	25	27	1	3635	440	4564	924	584	699	352	1766	27	456	2450
3627_Treatment/medication code: paracetamol	3627_Treatment/medication code: paracetamol	25	27	1	584	1417	2351	769	3034	1403	3054	4494	2690	27	1711
2060_C4A C4B - Complement C4b	2060_C4A C4B - Complement C4b	25	27	1	4271	1776	272	3153	842	4406	3517	4580	1651	814	27
148_Body Mass Index (male <= 50 yrs)	148_Body Mass Index (male <= 50 yrs)	25	28	1	28	367	456	3886	2563	2003	1170	3384	2581	1556	42
607_Peptide::gamma-glutamyl::gamma-glutamylthreonine*	607_Peptide::gamma-glutamyl::gamma-glutamylthreonine*	25	28	1	254	1461	28	1308	1611	2241	3655	862	3330	812	2559
4336_Overall activity (conditioning sex and BMI)	4336_Overall activity (conditioning sex and BMI)	25	28	1	1183	191	2100	28	3320	825	2118	629	262	497	1273
1978_Hand grip (at exam 7, FBAT)	1978_Hand grip (at exam 7, FBAT)	25	28	1	3603	925	2556	3516	28	119	3381	1002	3455	1625	1074
3009_MMP14 - Matrix metalloproteinase-14	3009_MMP14 - Matrix metalloproteinase-14	25	28	1	1680	2024	3385	861	1212	28	4563	838	1113	3147	901
1092_Gastric cancer	1092_Gastric cancer	25	28	1	4508	228	3443	599	3795	1431	221	28	106	679	2650
4080_Waist-hip ratio (adjusted for BMI)	4080_Waist-hip ratio (adjusted for BMI)	25	28	1	4720	731	2713	210	4271	1193	1040	161	28	923	1376
93_Birth length	93_Birth length	25	28	1	814	958	3604	1516	4089	3584	2653	2661	3931	28	999
3856_Myeloid white cell count (two-way meta)	3856_Myeloid white cell count (two-way meta)	25	28	1	3833	1306	1946	4207	3684	786	4075	4496	4526	53	28
577_Lipid::Sterol, Steroid::epiandrosterone sulfate	577_Lipid::Sterol, Steroid::epiandrosterone sulfate	25	29	1	29	1001	1078	716	3945	1580	2147	215	3815	152	4382
3417_Neuroticism score	3417_Neuroticism score	25	29	1	37	29	2653	310	1507	2213	633	322	40	48	3989
2453_MATN2 - Matrilin-2	2453_MATN2 - Matrilin-2	25	29	1	2182	4072	29	4110	1935	1749	1188	4719	1705	2448	860
4550_Left fusiform	4550_Left fusiform	25	29	1	4602	374	3366	29	2076	1746	98	877	1253	129	3339
883_Phospholipids in IDL	883_Phospholipids in IDL	25	29	1	1561	3760	2189	3460	29	2194	4597	4628	2008	4175	3623
3119_MAPK9 - Mitogen-activated protein kinase 9	3119_MAPK9 - Mitogen-activated protein kinase 9	25	29	1	1734	4469	1929	3763	2888	29	2280	1220	2414	2695	2845
4235_Adrenergics, inhalants	4235_Adrenergics, inhalants	25	29	1	2589	51	2316	1619	1001	2296	29	328	3902	35	220
510_Lipid::Inositol metabolism::chiro-inositol	510_Lipid::Inositol metabolism::chiro-inositol	25	29	1	747	36	387	1167	2778	975	142	29	233	1122	4491
3911_Cup area	3911_Cup area	25	29	1	1142	678	861	1247	943	1023	1475	3144	29	3370	2156
772_::::X-12405	772_::::X-12405	25	29	1	2433	161	945	2905	2696	243	170	1067	188	29	3206
3315_Use of sun/uv protection	3315_Use of sun/uv protection	25	29	1	500	1936	346	106	1151	3730	1321	1150	1851	3558	29
3572_Pain type(s) experienced in last month: Back pain	3572_Pain type(s) experienced in last month: Back pain	25	30	1	30	660	542	3124	3478	4433	3932	2609	2092	2661	3478
3715_Diagnoses - secondary ICD10: Z92 Personal history of medical treatment	3715_Diagnoses - secondary ICD10: Z92 Personal history of medical treatment	25	30	1	441	872	30	1504	662	2570	1476	4571	2767	3659	3945
3592_Mineral and other dietary supplements: Fish oil (including cod liver oil)	3592_Mineral and other dietary supplements: Fish oil (including cod liver oil)	25	30	1	1682	1051	4449	30	2955	526	266	533	143	4066	2370
3074_NCR1 - Natural cytotoxicity triggering receptor 1	3074_NCR1 - Natural cytotoxicity triggering receptor 1	25	30	1	4060	2469	4234	766	30	938	307	3352	218	4105	682
1579_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	1579_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	25	30	1	139	3836	144	2425	754	30	3958	817	3862	3691	134
4092_Reaction time	4092_Reaction time	25	30	1	4100	398	236	36	4085	725	30	188	1251	56	4515
534_Lipid::Lysolipid::1-eicosadienoylglycerophosphocholine*	534_Lipid::Lysolipid::1-eicosadienoylglycerophosphocholine*	25	30	1	2174	339	972	339	2231	2682	431	1052	30	782	3797
4669_Anterior corona radiata axial diusivities	4669_Anterior corona radiata axial diusivities	25	30	1	914	483	2527	815	1689	3551	1865	2419	420	30	2938
1719_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for age and sex)	1719_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for age and sex)	25	30	1	912	4712	76	4355	3000	466	3962	133	3353	4346	30
4094_Proxy and clinically diagnosed Alzheimer's disease	4094_Proxy and clinically diagnosed Alzheimer's disease	25	31	1	31	2434	784	2187	700	889	1555	4582	1183	1248	156
2035_Central corneal thickness	2035_Central corneal thickness	25	31	1	1664	2254	31	2975	1925	1891	2234	3304	4035	3465	2455
1396_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for multivariable)	1396_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for multivariable)	25	31	1	3415	3097	717	971	31	3304	2366	1424	1798	4674	767
1547_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for age and sex)	1547_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for age and sex)	25	31	1	1393	4004	3519	3608	3340	31	3367	3332	4560	2562	659
888_Free cholesterol in large HDL	888_Free cholesterol in large HDL	25	31	1	1047	1593	805	3476	2752	2526	1898	4087	31	4125	3228
3937_Fucosylation	3937_Fucosylation	25	31	1	3328	4714	839	2977	85	47	4224	4089	318	1971	31
3500_Male-specific factors - Hair/balding pattern: Pattern 1	3500_Male-specific factors - Hair/balding pattern: Pattern 1	25	32	1	32	437	609	3445	4107	1692	3557	4311	3289	347	2974
500_Lipid::Fatty acid, dicarboxylate::hexadecanedioate	500_Lipid::Fatty acid, dicarboxylate::hexadecanedioate	25	32	1	179	32	273	3361	1518	4388	1070	1861	296	864	4663
1962_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for age)	1962_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for age)	25	32	1	1824	4265	32	1749	513	3145	4293	1170	2535	3947	1066
4305_Trunk-trunk fat ratio (male)	4305_Trunk-trunk fat ratio (male)	25	32	1	1553	1036	2966	32	3469	161	206	44	324	2158	497
4112_Sodium	4112_Sodium	25	32	1	2863	2096	2616	1245	32	1992	1791	2812	286	4446	460
4527_Left accumbens area	4527_Left accumbens area	25	32	1	3277	3328	3158	91	942	32	4491	3424	4631	3766	1185
4554_Left lateral occipital	4554_Left lateral occipital	25	32	1	3429	48	4616	2701	2738	941	32	231	65	544	1103
288_CD4:%Treg(39+73+)	288_CD4:%Treg(39+73+)	25	32	1	4308	3533	3864	2740	3875	3659	2397	32	1487	3917	3417
4059_Estimated glomerular filtration rate based on cystain C	4059_Estimated glomerular filtration rate based on cystain C	25	32	1	4290	602	591	499	4384	2313	515	157	32	2464	1766
3679_Diagnoses - main ICD10: M54 Dorsalgia	3679_Diagnoses - main ICD10: M54 Dorsalgia	25	32	1	460	640	2320	1048	583	3197	4422	2711	1477	32	1175
3275_Childhood sunburn occasions	3275_Childhood sunburn occasions	25	32	1	586	967	322	520	1126	4022	716	913	557	3394	32
3633_Illnesses of father: High blood pressure	3633_Illnesses of father: High blood pressure	25	33	1	33	4201	1325	3694	4567	2835	2154	685	2000	4418	3231
2388_CTSS - Cathepsin S	2388_CTSS - Cathepsin S	25	33	1	703	33	38	1066	2089	1392	146	1581	373	397	608
2821_NGF - beta-nerve growth factor	2821_NGF - beta-nerve growth factor	25	33	1	552	2859	33	76	3924	3250	1760	782	1063	1559	2654
3701_Diagnoses - secondary ICD10: M19 Other and unspecified osteoarthritis	3701_Diagnoses - secondary ICD10: M19 Other and unspecified osteoarthritis	25	33	1	847	4145	170	33	1278	4152	2269	3094	3312	1939	1716
3311_Other eye problems	3311_Other eye problems	25	33	1	1510	3741	1207	4287	33	1314	1607	3071	3094	2095	52
4232_Anilides	4232_Anilides	25	33	1	1639	906	1830	4244	759	33	3329	4380	3046	1532	173
2756_SELP - P-Selectin	2756_SELP - P-Selectin	25	33	1	2307	314	3238	99	1388	1121	33	804	891	1032	3280
3651_Illnesses of siblings: High blood pressure	3651_Illnesses of siblings: High blood pressure	25	33	1	2959	1074	4321	369	3397	1485	483	33	1921	808	2029
1689_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for multivariable)	1689_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for multivariable)	25	33	1	4018	1756	2947	1150	118	3479	571	2361	3018	1479	33
531_Lipid::Lysolipid::1-arachidonoylglycerophosphoethanolamine*	531_Lipid::Lysolipid::1-arachidonoylglycerophosphoethanolamine*	25	34	1	34	545	209	2016	2156	2308	944	2518	51	1678	4712
2712_KPNB1 - Importin subunit beta-1	2712_KPNB1 - Importin subunit beta-1	25	34	1	3097	1035	2839	34	2163	4638	2889	1201	517	337	2458
4645_White matter	4645_White matter	25	34	1	2730	1401	2419	1255	34	188	2038	463	421	4576	4345
874_Glycine	874_Glycine	25	34	1	4006	506	4679	4151	902	34	1913	584	474	4270	236
415_Amino acid::Urea cycle; arginine-, proline-, metabolism::N-acetylornithine	415_Amino acid::Urea cycle; arginine-, proline-, metabolism::N-acetylornithine	25	34	1	2082	338	3259	255	2067	1246	34	38	423	724	3126
2742_IL20 - Interleukin-20	2742_IL20 - Interleukin-20	25	34	1	1659	504	2986	795	878	3999	3057	352	314	34	1507
3841_Granulocyte count (two-way meta)	3841_Granulocyte count (two-way meta)	25	34	2	4659	1955	1463	3472	4728	939	3770	4198	3925	161	34
572_Lipid::Sterol, Steroid::androsterone sulfate	572_Lipid::Sterol, Steroid::androsterone sulfate	25	35	1	35	566	576	600	2096	2439	872	625	1819	63	4563
3301_Seen doctor (GP) for nerves, anxiety, tension or depression	3301_Seen doctor (GP) for nerves, anxiety, tension or depression	25	35	1	80	35	3149	243	2904	1044	236	333	187	76	353
3113_IMPDH1 - Inosine-5'-monophosphate dehydrogenase 1	3113_IMPDH1 - Inosine-5'-monophosphate dehydrogenase 1	25	35	1	843	1307	35	4304	3811	3165	97	2005	1618	4318	1488
1600_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for multivariable)	1600_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for multivariable)	25	35	1	1360	1479	956	35	4323	4659	1848	41	78	1988	859
882_Concentration of IDL particles	882_Concentration of IDL particles	25	35	1	1212	2375	2038	2375	35	2372	4132	3930	3251	4634	4260
1045_Bone Ultrasound Speed (GEE, adjusted for multivariable)	1045_Bone Ultrasound Speed (GEE, adjusted for multivariable)	25	35	1	1518	830	2714	1005	3905	35	1474	3895	2607	1574	161
3721_Frequency of memory loss due to drinking alcohol in last year	3721_Frequency of memory loss due to drinking alcohol in last year	25	35	1	1623	165	1478	149	343	4376	35	811	925	1111	4473
3429_Fluid intelligence test - FI6 : conditional arithmetic	3429_Fluid intelligence test - FI6 : conditional arithmetic	25	35	1	135	2126	3522	405	2322	3565	2347	2889	1382	1017	35
2508_BTK - Tyrosine-protein kinase BTK	2508_BTK - Tyrosine-protein kinase BTK	25	36	1	36	659	270	1623	1790	3392	2573	2088	1286	1379	1395
2131_IL2RG - Cytokine receptor common subunit gamma	2131_IL2RG - Cytokine receptor common subunit gamma	25	36	1	117	4217	36	745	3984	3762	1323	62	487	3732	4021
3236_Past tobacco smoking	3236_Past tobacco smoking	25	36	1	692	1234	2501	2969	36	2467	2847	2346	1737	4683	1813
1985_Age at natural menopause (GEE, adjusted for multivariable)	1985_Age at natural menopause (GEE, adjusted for multivariable)	25	36	1	2202	409	2928	2839	2071	36	3244	3067	1117	551	1594
2397_GP6 - Platelet glycoprotein VI	2397_GP6 - Platelet glycoprotein VI	25	36	1	670	580	2097	80	3163	4639	143	36	399	3346	1313
4079_Waist-hip ratio (female)	4079_Waist-hip ratio (female)	25	36	1	2579	829	3525	443	4113	109	729	175	36	884	4645
61_Age at menarche	61_Age at menarche	25	36	1	728	54	1683	160	147	3078	1110	345	430	36	4040
4338_Sleep durataion (conditioning sex and BMI)	4338_Sleep durataion (conditioning sex and BMI)	25	37	1	799	37	1809	264	1776	780	2195	2938	323	77	3681
4182_Low cholesterol lipoprotein	4182_Low cholesterol lipoprotein	25	37	1	218	1780	37	3556	43	235	3033	4259	3111	2152	2025
3728_Anxiety - Ever worried more than most people would in similar situation	3728_Anxiety - Ever worried more than most people would in similar situation	25	37	1	3943	3333	4138	37	3651	1345	2016	1070	1809	3570	760
2855_RPS27A - Ubiquitin	2855_RPS27A - Ubiquitin	25	37	1	3920	1375	1029	1669	37	4602	1882	4066	2435	3094	4726
1701_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for multivariable)	1701_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for multivariable)	25	37	1	622	2463	729	2576	2922	37	567	193	1008	3636	447
634_Xenobiotics::Food component, Plant::quinate	634_Xenobiotics::Food component, Plant::quinate	25	37	1	4627	2560	3389	4728	1189	3490	37	235	346	4424	3839
3254_Salt added to food	3254_Salt added to food	25	37	1	4524	3768	1450	3949	4398	1128	323	37	2565	2705	3398
3797_Depressive affect subcluster	3797_Depressive affect subcluster	25	37	1	341	223	4448	298	4661	3464	521	423	310	37	1705
4143_Diastolic Blood Pressure	4143_Diastolic Blood Pressure	25	38	1	38	1131	1624	4716	4001	2734	1714	2180	1368	595	3077
4362_Acceleration average	4362_Acceleration average	25	38	1	1946	408	1700	38	2333	537	2293	371	91	763	2574
936_Total cholesterol in small LDL	936_Total cholesterol in small LDL	25	38	1	1029	2982	1184	2387	38	2608	4321	1843	1168	3892	3051
4212_Glycine level (male)	4212_Glycine level (male)	25	38	1	1986	337	3412	4697	1881	38	368	65	193	3781	117
867_OmegaL3 fatty acids	867_OmegaL3 fatty acids	25	38	1	4141	4050	2296	1481	4576	2731	38	57	132	1491	3731
655_Amino acid::Polyamine metabolism::X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide	655_Amino acid::Polyamine metabolism::X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide	25	38	1	1571	788	47	374	129	3954	661	46	1395	93	38
3992_Miserableness (MIS)	3992_Miserableness (MIS)	25	39	1	39	56	223	755	2796	3176	173	1964	145	41	1727
2481_ECM1 - Extracellular matrix protein 1	2481_ECM1 - Extracellular matrix protein 1	25	39	1	4576	39	4445	515	2178	1860	681	676	593	1646	4665
1702_Follicle stimulating hormone (at exam 3, FBAT, adjusted for age and sex)	1702_Follicle stimulating hormone (at exam 3, FBAT, adjusted for age and sex)	25	39	1	3848	2427	39	2993	1091	2325	466	2948	3459	3826	795
1811_Very low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1811_Very low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	39	1	3052	4690	2091	189	39	1647	1022	324	1028	1577	170
1329_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	1329_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	25	39	1	2468	4651	3431	1365	2884	39	3950	4550	2030	1488	1953
4229_Drugs affecting bone structure and mineralization	4229_Drugs affecting bone structure and mineralization	25	39	1	4647	218	3922	2109	4165	3046	39	1729	216	106	833
197_Urinary albumin-to-creatinine ratio	197_Urinary albumin-to-creatinine ratio	25	39	1	253	3185	125	2106	947	2165	4211	39	854	4153	3436
538_Lipid::Lysolipid::1-linoleoylglycerophosphoethanolamine*	538_Lipid::Lysolipid::1-linoleoylglycerophosphoethanolamine*	25	39	1	1267	3157	3556	3189	2321	2064	1932	4339	39	1681	2570
1967_MMSE score (at age 65, GEE, adjusted for multivariable)	1967_MMSE score (at age 65, GEE, adjusted for multivariable)	25	39	1	608	803	1423	2320	1640	622	3017	4543	4735	39	2813
1449_Low-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	1449_Low-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	25	39	1	1205	4154	1100	4461	1047	3906	3692	1814	3739	1229	39
1464_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	1464_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	25	40	1	40	1581	106	3278	2334	885	1402	3031	1554	673	837
2141_GDI2 - Rab GDP dissociation inhibitor beta	2141_GDI2 - Rab GDP dissociation inhibitor beta	25	40	1	88	3563	40	2304	2960	3483	4620	3918	4221	4085	2136
3258_Water intake	3258_Water intake	25	40	1	2381	3148	4702	40	4179	3069	181	117	451	4038	674
3623_Treatment/medication code: atorvastatin	3623_Treatment/medication code: atorvastatin	25	40	1	2426	824	731	4488	40	866	608	1365	418	3319	2927
3287_Sensitivity / hurt feelings	3287_Sensitivity / hurt feelings	25	40	1	833	70	2874	55	1148	1220	73	40	70	45	4141
4697_Corticospinal tract mean diusivities	4697_Corticospinal tract mean diusivities	25	40	1	3685	689	3504	119	2596	2546	1095	364	1880	40	573
3824_Celiac disease	3824_Celiac disease	25	40	1	4151	122	943	1095	1832	841	57	236	703	267	40
2159_PLA2G2A - Phospholipase A2, membrane associated	2159_PLA2G2A - Phospholipase A2, membrane associated	25	41	1	41	102	476	2525	1471	1880	200	2337	168	346	4428
405_Amino acid::Tryptophan metabolism::indolelactate	405_Amino acid::Tryptophan metabolism::indolelactate	25	41	1	3157	41	3205	229	2418	2162	128	76	257	244	148
4727_Posterior thalamic radiation (include optic radiation) mode of anisotropy	4727_Posterior thalamic radiation (include optic radiation) mode of anisotropy	25	41	1	4711	806	2152	41	4143	1377	1177	581	2532	566	2901
2207_CCL3L1 - C-C motif chemokine 3-like 1	2207_CCL3L1 - C-C motif chemokine 3-like 1	25	41	1	2972	373	975	1220	41	1699	1145	3423	156	4531	941
1559_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1559_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	41	1	2337	1322	2342	3612	4135	41	3110	3660	4290	1101	115
3965_Gestational weight gain (offspring, total)	3965_Gestational weight gain (offspring, total)	25	41	1	4131	397	3306	108	4725	2473	41	3733	307	3681	3306
3938_Bisecting GlcNAc	3938_Bisecting GlcNAc	25	41	1	4165	4065	404	4460	559	70	2324	4041	59	396	41
4173_Social support - Leisure/social activities: Sports club or gym	4173_Social support - Leisure/social activities: Sports club or gym	25	42	1	42	638	867	1400	4396	327	1964	4186	3364	677	4123
2718_MSLN - Mesothelin	2718_MSLN - Mesothelin	25	42	1	1903	4108	3446	42	848	4199	3917	280	1021	4551	1673
2920_Human-virus - gp41 C34 peptide, HIV	2920_Human-virus - gp41 C34 peptide, HIV	25	42	1	2888	254	1869	1161	42	2246	555	1126	3833	483	128
4046_Rotator cuff injury	4046_Rotator cuff injury	25	42	1	2713	2849	3193	3762	3480	42	2615	4454	2596	3333	1223
4494_Right pericalcarine	4494_Right pericalcarine	25	42	1	4095	184	4284	152	2271	4503	700	42	352	579	1206
4100_Low-density-lipoprotein cholesterol	4100_Low-density-lipoprotein cholesterol	25	42	1	685	118	555	1329	199	2354	514	2200	42	169	2176
1867_Neck-Shaft Angle (GEE, female, adjussted for multivariable)	1867_Neck-Shaft Angle (GEE, female, adjussted for multivariable)	25	42	1	3973	272	2457	984	941	4518	390	4043	1393	42	3762
4640_Right amygdala	4640_Right amygdala	25	43	1	43	1352	557	686	441	822	4604	2295	2600	1050	184
3257_Hot drink temperature	3257_Hot drink temperature	25	43	1	4199	445	3289	43	2368	1957	158	630	125	1806	1942
1581_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	1581_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	25	43	1	115	4089	319	2182	554	43	2860	909	4216	1991	133
1144_Disposition index (adjusted for BMI)	1144_Disposition index (adjusted for BMI)	25	43	1	2965	63	292	3378	3132	1326	43	4345	110	71	1576
3852_Mean corpuscular volume (two-way meta)	3852_Mean corpuscular volume (two-way meta)	25	43	1	3471	2731	1213	3251	2670	1960	4109	43	3404	390	4153
4111_Uric acid	4111_Uric acid	25	43	1	166	4616	826	713	460	120	1636	4596	3956	2204	43
4689_Sagittal stratum axial diusivities	4689_Sagittal stratum axial diusivities	25	44	1	44	183	647	2402	1402	2635	1425	4138	1101	802	2291
2171_EPOR - Erythropoietin receptor	2171_EPOR - Erythropoietin receptor	25	44	1	3083	44	4366	606	3011	1170	392	1152	270	97	2778
2294_AREG - Amphiregulin	2294_AREG - Amphiregulin	25	44	1	579	2075	44	1218	3240	3826	2429	701	303	2197	3050
3671_Diagnoses - main ICD10: K40 Inguinal hernia	3671_Diagnoses - main ICD10: K40 Inguinal hernia	25	44	1	4216	1277	2941	44	605	1537	651	483	251	411	120
3719_Ever had known person concerned about, or recommended reduction of alcohol consumption	3719_Ever had known person concerned about, or recommended reduction of alcohol consumption	25	44	1	830	3129	366	3168	44	1730	1585	4322	2254	2310	3934
1310_Fasting HbA1c (at exam 7, FBAT, adjusted for age and sex)	1310_Fasting HbA1c (at exam 7, FBAT, adjusted for age and sex)	25	44	1	1232	4526	3022	4086	836	44	3787	736	513	3915	303
1672_Bilirubin (at exam 2, FBAT, adjusted for multivariable)	1672_Bilirubin (at exam 2, FBAT, adjusted for multivariable)	25	44	1	1085	185	796	4745	114	1043	44	2677	1362	225	1072
4082_Waist-hip ratio (adjusted for BMI, female)	4082_Waist-hip ratio (adjusted for BMI, female)	25	44	1	1580	827	2472	456	4712	487	1625	359	44	695	3944
3056_IL17RB - interleukin-17 receptor B	3056_IL17RB - interleukin-17 receptor B	25	44	1	1737	706	3098	159	1818	708	2746	2784	647	44	4671
3931_Monogalactosylation	3931_Monogalactosylation	25	44	1	3098	3600	2509	930	2381	2460	742	1200	407	927	44
2800_RAN - GTP-binding nuclear protein Ran	2800_RAN - GTP-binding nuclear protein Ran	25	45	1	45	2573	2137	3045	3942	1120	1329	211	1836	3813	2267
3253_Cereal intake	3253_Cereal intake	25	45	1	137	45	634	383	3429	854	678	3027	315	162	4717
3237_Smoking/smokers in household	3237_Smoking/smokers in household	25	45	1	980	1903	3053	45	4502	4390	2335	924	4493	2115	1964
916_Total cholesterol in medium LDL	916_Total cholesterol in medium LDL	25	45	1	1036	3142	1507	1993	45	3076	4692	2410	590	4567	3166
2572_CD40LG - CD40 ligand	2572_CD40LG - CD40 ligand	25	45	1	3031	1364	2930	1086	355	45	2071	600	1589	2828	3773
4048_Plantar fasciitis	4048_Plantar fasciitis	25	45	1	3810	623	2540	391	3230	3406	45	1695	1069	414	4514
1793_RR interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1793_RR interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	45	1	1774	2830	219	1530	139	1711	1225	45	1000	1041	75
2037_Immunoglobulin A deficiency	2037_Immunoglobulin A deficiency	25	45	1	2917	1451	3006	1242	2149	736	4723	4295	1098	1166	45
4144_Mean arterial pressure	4144_Mean arterial pressure	25	46	1	46	685	2371	1429	959	1475	1459	919	731	335	3726
3241_Salad / raw vegetable intake	3241_Salad / raw vegetable intake	25	46	1	1650	46	1662	237	4442	2495	763	822	220	2609	1379
1441_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	1441_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	25	46	1	51	4013	46	2007	837	395	4578	2742	4065	1348	2550
2366_EDA2R - Tumor necrosis factor receptor superfamily member 27	2366_EDA2R - Tumor necrosis factor receptor superfamily member 27	25	46	1	3753	843	433	46	1045	193	802	130	363	649	2803
574_Lipid::Sterol, Steroid::cortisol	574_Lipid::Sterol, Steroid::cortisol	25	46	1	3010	3875	1314	1863	934	46	260	554	473	3451	3139
2827_IFNL1 - Interferon lambda-1	2827_IFNL1 - Interferon lambda-1	25	46	1	3581	331	1284	332	804	446	321	558	46	1504	822
3310_Age started wearing glasses or contact lenses	3310_Age started wearing glasses or contact lenses	25	46	1	2075	199	1531	251	2384	3170	191	645	436	46	3283
3498_Hair colour (natural, before greying): Dark brown	3498_Hair colour (natural, before greying): Dark brown	25	46	1	203	657	1317	85	107	3426	824	283	232	1915	46
1611_von Willebrand Factor (at exam 5, GEE, adjusted for age and sex)	1611_von Willebrand Factor (at exam 5, GEE, adjusted for age and sex)	25	47	1	47	807	235	1464	3299	413	3482	3173	3392	3963	3320
1276_Sabuctaneous fat by CT (FBAT, adjusted for age and sex)	1276_Sabuctaneous fat by CT (FBAT, adjusted for age and sex)	25	47	1	298	1843	3559	1487	47	254	1206	260	725	4723	896
1955_Similarities raw score (GEE, adjusted for multivariable)	1955_Similarities raw score (GEE, adjusted for multivariable)	25	47	1	1087	55	1636	1519	3635	3317	47	4326	60	135	298
4310_Osteoarthritis of knee	4310_Osteoarthritis of knee	25	47	1	3120	1774	1002	2158	1710	1332	499	47	4725	3703	2543
2285_MMP8 - Neutrophil collagenase	2285_MMP8 - Neutrophil collagenase	25	47	1	3089	192	1103	1360	2269	3486	3237	2597	3997	181	47
3314_Hearing difficulty/problems with background noise	3314_Hearing difficulty/problems with background noise	25	48	1	48	1009	2303	469	2867	4658	2401	2256	901	1052	2952
1231_Usual weekday bedtime (GEE)	1231_Usual weekday bedtime (GEE)	25	48	1	1763	283	48	343	3608	4195	1499	4554	1306	1240	762
3518_How are people in household related to participant: Son and/or daughter (include step-children)	3518_How are people in household related to participant: Son and/or daughter (include step-children)	25	48	1	291	89	3736	48	4691	1393	2983	473	588	91	3216
4539_Right amygdala	4539_Right amygdala	25	48	1	575	2414	1394	1824	48	2521	4072	2450	2601	1316	274
1591_Platelet aggregation to ADP (at exam 5, GEE, adjusted for age and sex)	1591_Platelet aggregation to ADP (at exam 5, GEE, adjusted for age and sex)	25	48	1	4578	1649	443	1801	1178	48	4456	305	1965	603	1407
2166_CCL25 - C-C motif chemokine 25	2166_CCL25 - C-C motif chemokine 25	25	48	1	3024	1371	2999	2038	1955	3564	3092	48	4532	2533	4314
1850_Neck average buckling ratio (FBAT, female, adjussted for multivariable)	1850_Neck average buckling ratio (FBAT, female, adjussted for multivariable)	25	48	1	1236	287	2816	402	4104	499	261	90	48	732	2102
3606_Non-cancer illness code, self-reported: eczema/dermatitis	3606_Non-cancer illness code, self-reported: eczema/dermatitis	25	48	1	3696	3436	4329	2712	4097	2555	817	1584	1920	1414	48
843_::::X-14626	843_::::X-14626	25	49	1	49	1286	824	627	1724	4621	3623	288	2695	4086	4181
3983_Type 2 Diabetes	3983_Type 2 Diabetes	25	49	1	2815	49	4421	1497	4124	3435	459	2839	4073	171	3810
202_Estimated glomerular filtration rate based on cystain C	202_Estimated glomerular filtration rate based on cystain C	25	49	1	2807	110	1443	49	3139	406	750	880	119	896	3475
1343_Resistin (GEE, adjusted for age, sex and BMI)	1343_Resistin (GEE, adjusted for age, sex and BMI)	25	49	1	1949	2103	3548	3081	49	2474	4382	2770	4301	859	2219
1099_C-reactive protein - Birth cohorts	1099_C-reactive protein - Birth cohorts	25	49	1	1328	3058	2882	1689	2500	49	2367	2942	895	3293	3553
2039_Attention function - Orienting - Child	2039_Attention function - Orienting - Child	25	49	1	3168	1089	3450	4178	4103	3450	49	398	809	1822	3444
2461_THBS4 - Thrombospondin-4	2461_THBS4 - Thrombospondin-4	25	49	1	4203	1607	3241	2976	2585	2563	1027	49	266	1311	3804
4197_Waist-hip ratio	4197_Waist-hip ratio	25	49	1	1337	981	3019	531	4623	4654	410	141	49	3541	3383
2565_PRTN3 - Myeloblastin	2565_PRTN3 - Myeloblastin	25	49	1	557	465	2507	3406	4368	4006	1901	2913	788	49	1721
2034_Primary sclerosing cholangitis	2034_Primary sclerosing cholangitis	25	49	1	2331	776	1676	2397	2137	1189	1671	1539	3163	1358	49
156_Hip circumference	156_Hip circumference	25	50	1	50	4059	98	2442	1666	2634	2795	977	1501	2619	129
2321_TSLP - Thymic stromal lymphopoietin	2321_TSLP - Thymic stromal lymphopoietin	25	50	1	1753	1262	50	834	1144	840	303	492	994	933	769
4159_Childhood Absence Epilepsy	4159_Childhood Absence Epilepsy	25	50	1	2250	2206	2668	1376	50	884	3328	2928	3341	1500	63
3289_Nervous feelings	3289_Nervous feelings	25	50	1	1893	3178	2684	633	4339	50	4721	1561	1095	1105	4129
4451_Left inferior temporal	4451_Left inferior temporal	25	50	1	3278	427	1301	132	3100	2750	274	50	215	916	4380
4101_Triglyceride	4101_Triglyceride	25	50	1	1121	1170	1950	3619	3251	1897	1719	1703	50	1794	1924
3586_Types of physical activity in last 4 weeks: Other exercises (eg: swimming, cycling, keep fit, bowling)	3586_Types of physical activity in last 4 weeks: Other exercises (eg: swimming, cycling, keep fit, bowling)	25	50	1	193	1949	1915	230	3529	1820	4704	1569	3856	50	4145
160_Hip circumference (female)	160_Hip circumference (female)	25	50	1	401	1304	659	4448	2103	2500	638	710	411	3121	50
1606_Viscosity I (at exam 5, FBAT, adjusted for age and sex)	1606_Viscosity I (at exam 5, FBAT, adjusted for age and sex)	25	51	1	1971	290	51	218	1215	4225	157	300	1278	369	107
4187_HbA1c	4187_HbA1c	25	51	1	3402	4542	1501	51	1889	981	405	1447	1486	3736	239
1168_HOMA-IR	1168_HOMA-IR	25	51	1	4649	4162	4693	1067	1903	51	3460	2137	2494	3067	3285
4681_Posterior corona radiata axial diusivities	4681_Posterior corona radiata axial diusivities	25	51	1	570	59	995	316	2347	317	51	1478	120	711	568
401_Amino acid::Phenylalanine & tyrosine metabolism::tyrosine	401_Amino acid::Phenylalanine & tyrosine metabolism::tyrosine	25	51	1	657	4248	153	4076	1361	2052	3061	51	3977	2232	3260
3995_Fed-up feelings (FED_UP)	3995_Fed-up feelings (FED_UP)	25	51	1	1689	694	2537	213	4541	4296	1458	1745	1543	51	3052
1341_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age, sex and BMI)	1341_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age, sex and BMI)	24	51	1	3539	2077	529	783	4715	3717	3741	355	1867	3019	51
1712_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for age and sex)	1712_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for age and sex)	25	52	1	510	52	1705	1885	461	4189	640	2300	173	479	226
4720_External capsule mode of anisotropy	4720_External capsule mode of anisotropy	25	52	1	724	2794	52	4438	383	2808	2169	3980	2041	1076	1493
2325_CAST - Calpastatin	2325_CAST - Calpastatin	25	52	1	492	1063	1807	52	2821	1263	443	302	1669	1510	4353
1424_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1424_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	52	1	3888	2290	1949	128	52	4735	4600	1526	4688	4122	1844
1947_Visual memory composite score (GEE, adjusted for multivariable)	1947_Visual memory composite score (GEE, adjusted for multivariable)	25	52	1	1077	3514	3325	2677	1425	52	4483	4017	1106	3183	877
2867_MMP12 - Macrophage metalloelastase	2867_MMP12 - Macrophage metalloelastase	25	52	1	4743	137	3796	3059	2320	3637	52	4133	419	951	2511
2493_PIK3CG - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	2493_PIK3CG - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	25	52	1	1201	3228	3726	2814	922	4003	2513	52	743	3076	1993
4075_Body Mass Index (male)	4075_Body Mass Index (male)	25	53	1	53	2022	666	1595	3660	2554	4256	2112	2186	979	920
1960_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for multivariable)	1960_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for multivariable)	25	53	1	379	1834	53	319	201	3633	3678	614	4137	1198	2117
3017_AK1 - Adenylate kinase isoenzyme 1	3017_AK1 - Adenylate kinase isoenzyme 1	25	53	1	1787	567	4746	53	1603	3667	102	330	83	279	553
3111_PDK1 - [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	3111_PDK1 - [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	25	53	1	1398	4026	691	3270	53	2936	2418	3906	2069	4663	1207
4213_Glycine level (female)	4213_Glycine level (female)	25	53	1	3011	741	3680	3739	716	53	2125	575	801	4033	205
3984_Heart rate increase	3984_Heart rate increase	25	53	1	478	187	874	2869	3474	4339	53	895	416	945	1353
81_Lumbar Spine BMD (males)	81_Lumbar Spine BMD (males)	25	53	1	1388	324	376	240	4154	4611	79	53	224	1944	4279
3316_Frequency of solarium/sunlamp use	3316_Frequency of solarium/sunlamp use	25	53	1	2061	65	2822	1230	4310	3994	85	799	53	98	4346
1747_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for multivariable)	1747_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for multivariable)	25	53	1	2912	2191	213	3210	1546	1096	1454	1113	1500	1788	53
835_Peptide::Dipeptide::X-14208--phenylalanylserine	835_Peptide::Dipeptide::X-14208--phenylalanylserine	25	54	1	54	2394	1295	3379	1890	3907	4457	860	2139	361	3074
4231_Salicylic acid and derivatives	4231_Salicylic acid and derivatives	25	54	1	2609	1619	2043	3248	54	1819	2939	1347	1292	2415	1888
2061_F11 - Coagulation Factor XI	2061_F11 - Coagulation Factor XI	25	54	1	2499	1099	2790	2751	2634	54	2673	807	1240	1727	2459
153_Waist-hip ratio (female > 50 yrs, adjusted for BMI)	153_Waist-hip ratio (female > 50 yrs, adjusted for BMI)	25	54	1	3526	516	3091	300	3620	309	795	54	166	2704	3764
3058_IL22RA2 - Interleukin-22 receptor subunit alpha-2	3058_IL22RA2 - Interleukin-22 receptor subunit alpha-2	25	54	1	4270	1583	2940	482	2802	158	584	2172	54	1467	1785
641_Xenobiotics::Xanthine metabolism::1,7-dimethylurate	641_Xenobiotics::Xanthine metabolism::1,7-dimethylurate	25	54	1	536	148	81	4518	3234	2877	223	984	118	54	2445
1453_Low-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	1453_Low-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	25	54	1	1991	4709	377	958	2116	164	2412	1438	512	1441	54
2223_CD97 - CD97 antigen	2223_CD97 - CD97 antigen	24	55	1	55	1660	149	375	2663	1733	2735	2866	4602	2463	1204
1721_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for multivariable)	1721_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for multivariable)	25	55	1	1266	1973	55	3696	4611	218	4448	459	4521	4732	56
1047_Trochanter BMD (GEE, adjusted for multivariable)	1047_Trochanter BMD (GEE, adjusted for multivariable)	25	55	1	2322	2318	3856	1473	55	2821	4428	3231	4652	1565	2270
2893_PLXNC1 - Plexin-C1	2893_PLXNC1 - Plexin-C1	25	55	1	3227	475	4741	942	2614	55	1020	1822	1086	60	1122
869_OmegaL7 and L9 and saturated fatty acids	869_OmegaL7 and L9 and saturated fatty acids	25	55	1	3955	3293	1855	2482	1172	3917	1697	55	560	4454	800
4072_First PC of the four riskly behaviours	4072_First PC of the four riskly behaviours	25	55	1	241	79	3200	188	235	4118	258	171	55	367	1585
1067_Type 1 Diabetes	1067_Type 1 Diabetes	25	55	1	4724	1801	745	4578	674	688	3513	3195	1014	157	55
2360_IL18BP - Interleukin-18-binding protein	2360_IL18BP - Interleukin-18-binding protein	25	56	1	56	1738	1340	4641	430	3313	4272	2562	2068	720	3132
199_Urinary albumin-to-creatinine ratio (non-diabetic)	199_Urinary albumin-to-creatinine ratio (non-diabetic)	25	56	1	125	4617	56	2292	386	3932	3144	824	2987	3837	2982
4324_Positive affect (MA GWAMA)	4324_Positive affect (MA GWAMA)	25	56	1	4255	3770	992	56	2687	1786	951	1384	1193	4321	891
880_Free cholesterol in IDL	880_Free cholesterol in IDL	25	56	1	686	4195	1934	3457	56	1499	2244	4162	2306	3507	2541
1411_High-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	1411_High-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	25	56	1	3127	4199	4116	4732	1038	56	2489	4204	562	3378	1014
2645_ITGA2B ITGB3 - Integrin alpha-IIb: beta-3 complex	2645_ITGA2B ITGB3 - Integrin alpha-IIb: beta-3 complex	25	56	1	3961	930	1876	1314	2473	1904	56	2218	312	3720	1549
441_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glucose	441_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glucose	25	56	1	4324	2345	1489	3367	2797	3328	2986	56	2660	4734	2098
1294_Diabetes incidence (FBAT, adjusted for age, sex and BMI)	1294_Diabetes incidence (FBAT, adjusted for age, sex and BMI)	25	56	1	1428	1319	1065	670	2842	430	1553	432	56	1149	4042
4070_Ever smoker	4070_Ever smoker	25	57	1	57	632	129	4599	293	1382	4630	3369	1037	1593	2950
4337_Sleep durataion	4337_Sleep durataion	25	57	1	987	57	1877	150	2757	870	2948	2663	397	89	3981
2926_SELL - L-Selectin	2926_SELL - L-Selectin	25	57	1	111	194	57	4689	2494	3294	188	1474	515	1010	1698
1123_Subcutaneous adipose tissue attenuation	1123_Subcutaneous adipose tissue attenuation	25	57	1	599	822	2595	57	2165	4725	702	1525	677	692	942
4225_HMG CoA reductase inhibitors	4225_HMG CoA reductase inhibitors	25	57	1	968	1808	90	2505	57	1467	2811	3889	4323	2468	695
1895_Shaft Section Modulus (GEE, female, adjussted for multivariable)	1895_Shaft Section Modulus (GEE, female, adjussted for multivariable)	25	57	1	2388	4340	3378	1660	2491	57	1180	2888	959	2323	2001
3379_Diastolic Blood Pressure (automated reading)	3379_Diastolic Blood Pressure (automated reading)	25	57	1	1983	816	4311	59	4209	3063	656	116	57	1642	3055
3614_Treatment/medication code: ventolin 100micrograms inhaler	3614_Treatment/medication code: ventolin 100micrograms inhaler	25	58	1	4345	58	1105	2557	2711	2089	64	252	1918	73	217
1021_Neck Cross-Sectional Moment of Inertia (GEE, adjusted for age and sex)	1021_Neck Cross-Sectional Moment of Inertia (GEE, adjusted for age and sex)	25	58	1	1080	985	83	58	552	1513	2672	435	1699	1047	536
1976_Hand grip (at offspring exam 7 cohort exam 27, FBAT)	1976_Hand grip (at offspring exam 7 cohort exam 27, FBAT)	25	58	1	1766	1418	3924	2695	58	296	3559	1323	2789	1817	2044
3418_Fluid intelligence test - Number of fluid intelligence questions attempted within time limit	3418_Fluid intelligence test - Number of fluid intelligence questions attempted within time limit	25	58	1	1136	772	2029	1677	887	3933	58	942	1736	372	1276
4403_Menstruation quality of life impact: Loss of concentration	4403_Menstruation quality of life impact: Loss of concentration	25	58	1	1471	1747	3315	4105	1138	1796	2641	58	1814	3858	2861
889_Total lipids in large HDL	889_Total lipids in large HDL	25	58	1	979	1701	522	2662	1350	3052	1552	4590	58	2989	3397
4694_Body of corpus callosum mean diusivities	4694_Body of corpus callosum mean diusivities	25	58	1	96	707	1197	2413	2655	4604	1513	3532	2845	58	1755
1378_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	1378_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	25	58	1	3606	4647	220	851	2719	286	4507	2591	1517	1723	58
3294_Loneliness, isolation	3294_Loneliness, isolation	25	59	1	1521	4720	59	84	2255	3102	3677	1082	1940	2116	106
4686_Superior corona radiata axial diusivities	4686_Superior corona radiata axial diusivities	24	59	1	3363	3335	3815	435	59	1440	3898	1357	3349	4505	716
4211_Glycine level	4211_Glycine level	25	59	1	2504	1400	3348	3722	1071	59	2408	485	734	4240	155
2534_PDGFRB - Platelet-derived growth factor receptor beta	2534_PDGFRB - Platelet-derived growth factor receptor beta	25	59	1	982	535	2646	867	4625	1524	2385	59	483	628	3534
1187_Parkinson disease	1187_Parkinson disease	25	59	1	62	1503	3798	124	571	2385	3178	2776	108	59	339
3646_Illnesses of mother: Alzheimer's disease/dementia	3646_Illnesses of mother: Alzheimer's disease/dementia	25	59	1	69	4150	184	1019	373	599	3005	4358	3972	2928	59
58_College completion	58_College completion	25	60	1	60	476	3797	2243	2890	4282	2553	4284	2181	1949	3882
1518_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	1518_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	25	60	1	3021	493	3283	60	3754	730	615	493	849	1933	2794
2470_CA6 - Carbonic anhydrase 6	2470_CA6 - Carbonic anhydrase 6	25	60	1	1104	85	1650	491	60	316	810	4706	377	2425	3029
4540_Right accumbens area	4540_Right accumbens area	25	60	1	1408	3709	1772	3076	4211	60	2314	3152	2263	3710	97
3956_Ankle injury (random effect)	3956_Ankle injury (random effect)	25	60	1	161	4159	2462	4731	3881	1619	2246	60	4117	1538	3991
1359_Total cholesterol (at exam 1, GEE, adjusted for age and sex)	1359_Total cholesterol (at exam 1, GEE, adjusted for age and sex)	25	61	1	61	2924	633	652	750	4571	2630	2176	4455	4548	4646
2881_FLRT1 - Leucine-rich repeat transmembrane protein FLRT1	2881_FLRT1 - Leucine-rich repeat transmembrane protein FLRT1	25	61	1	110	119	61	3463	3393	3278	1692	3997	2723	1282	3463
3416_Bipolar and major depression status	3416_Bipolar and major depression status	25	61	1	2116	847	2324	61	3360	3113	3714	4488	2066	2031	1195
1670_Bilirubin (at exam 2, FBAT, adjusted for age and sex)	1670_Bilirubin (at exam 2, FBAT, adjusted for age and sex)	25	61	1	3924	617	4537	809	61	216	161	2360	1171	1433	2020
1297_Adiponectin (GEE, adjusted for age and sex)	1297_Adiponectin (GEE, adjusted for age and sex)	25	61	1	2858	4604	1012	1287	3936	61	3122	1622	4476	3429	1498
4398_Menstruation quality of life impact: Bowel movement	4398_Menstruation quality of life impact: Bowel movement	25	61	1	639	289	2731	1989	1221	4251	61	296	93	90	4147
2033_Cluster headache	2033_Cluster headache	25	61	1	529	1964	1454	4744	4584	4134	787	3962	798	61	1270
3273_Skin colour	3273_Skin colour	25	61	1	247	1266	391	440	249	4532	2079	553	2209	1976	61
2233_MET - Hepatocyte growth factor receptor	2233_MET - Hepatocyte growth factor receptor	25	62	1	589	4503	62	1156	1754	1144	4627	2974	4370	1077	3641
2467_BMP1 - Bone morphogenetic protein 1	2467_BMP1 - Bone morphogenetic protein 1	25	62	1	2410	4144	2431	62	697	1756	2411	1488	415	3742	1715
1185_Low-density lipoprotein cholesterol	1185_Low-density lipoprotein cholesterol	25	62	1	2727	1859	648	1750	62	1611	1712	3701	4249	2458	2581
4437_Herpes simplex virus 2 IgG levels	4437_Herpes simplex virus 2 IgG levels	25	62	1	4120	900	1003	2345	2806	62	1978	2615	2835	4704	204
3302_Seen a psychiatrist for nerves, anxiety, tension or depression	3302_Seen a psychiatrist for nerves, anxiety, tension or depression	25	62	1	3591	1957	1491	146	2540	2638	62	177	509	789	2662
890_Concentration of large HDL particles	890_Concentration of large HDL particles	25	62	1	974	1695	313	2605	505	2872	1501	3694	62	3134	3450
4741_Corticospinal tract radial diusivities	4741_Corticospinal tract radial diusivities	25	62	1	486	1389	535	268	2557	3765	994	865	437	62	3143
1061_Multiple Sclerosis	1061_Multiple Sclerosis	25	62	1	3965	383	558	3133	2003	187	611	1363	4111	185	62
564_Lipid::Monoacylglycerol::1-palmitoylglycerol (1-monopalmitin)	564_Lipid::Monoacylglycerol::1-palmitoylglycerol (1-monopalmitin)	25	63	1	308	1693	63	2565	2342	4098	905	2477	3875	949	1150
2343_PRSS1 - Trypsin-1	2343_PRSS1 - Trypsin-1	25	63	1	640	1443	3905	4678	63	3027	3382	1280	3129	751	2381
4598_Right precentral	4598_Right precentral	25	63	1	2722	2623	3932	2589	1594	63	853	1045	1361	3640	4487
2217_ACVR1B - Activin receptor type-1B	2217_ACVR1B - Activin receptor type-1B	25	63	1	3322	226	1766	409	1905	2553	63	246	198	1834	3084
2734_FGF6 - Fibroblast growth factor 6	2734_FGF6 - Fibroblast growth factor 6	25	63	1	3122	2865	3737	357	647	1972	2037	63	2193	4273	4289
4696_Cingulum (hippocampus) mean diusivities	4696_Cingulum (hippocampus) mean diusivities	25	63	1	2661	994	950	1601	2902	2196	690	198	63	3958	2821
55_Neuroticism	55_Neuroticism	24	64	1	2350	64	4054	2655	3871	2466	1247	978	536	1620	3855
2096_POMC - Beta-endorphin	2096_POMC - Beta-endorphin	25	64	1	158	594	64	3439	3307	4682	569	960	2582	1786	2642
1150_Corrected insulin response (adjusted for insulin sensitivity index)	1150_Corrected insulin response (adjusted for insulin sensitivity index)	25	64	1	4258	965	3013	322	3131	64	643	3687	904	867	927
4723_Genu of corpus callosum mode of anisotropy	4723_Genu of corpus callosum mode of anisotropy	25	64	1	1883	4324	465	722	905	4170	4312	64	2274	4316	4281
2780_EIF4G2 - Eukaryotic translation initiation factor 4 gamma 2	2780_EIF4G2 - Eukaryotic translation initiation factor 4 gamma 2	25	64	1	4428	370	1017	419	2412	2123	960	972	64	523	2660
3511_Reason for reducing amount of alcohol drunk: Other reason	3511_Reason for reducing amount of alcohol drunk: Other reason	25	64	1	825	474	1084	1591	2009	2542	1223	1971	3034	64	3961
1415_High-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	1415_High-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	25	64	1	2696	3911	294	3937	1085	1968	3177	2027	3229	3818	64
3640_Illnesses of mother: Lung cancer	3640_Illnesses of mother: Lung cancer	25	65	1	65	295	389	2501	179	2905	2404	4602	2768	292	3822
1442_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	1442_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	25	65	1	3727	2453	2670	2779	65	2138	2956	4574	2953	3092	267
1819_Inter-trochanteric buckling ratio (GEE, female, adjussted for multivariable)	1819_Inter-trochanteric buckling ratio (GEE, female, adjussted for multivariable)	25	65	1	3406	4681	4621	1441	2605	65	4694	2508	4704	2606	241
3227_Usual side of head for mobile phone use	3227_Usual side of head for mobile phone use	25	65	1	1088	1822	853	636	4607	276	2031	1358	1850	65	3636
2594_ECE1 - Endothelin-converting enzyme 1	2594_ECE1 - Endothelin-converting enzyme 1	25	65	1	3835	3928	1290	1788	738	3310	4655	2820	3521	1078	65
3278_Father still alive	3278_Father still alive	25	66	1	66	888	859	2461	883	2589	1351	4561	2038	311	3254
2743_IL6R - Interleukin-6 receptor subunit alpha	2743_IL6R - Interleukin-6 receptor subunit alpha	25	66	1	2855	4370	66	1299	3814	3505	3502	957	1681	2963	3413
4366_Fraction of accelerations	4366_Fraction of accelerations	25	66	1	916	98	4506	66	3041	3221	2543	1921	273	704	1919
1474_Mean total cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	1474_Mean total cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	25	66	1	2390	1414	1626	4516	66	167	4547	4191	2701	1798	87
2776_HSD17B10 - 3-hydroxyacyl-CoA dehydrogenase type-2	2776_HSD17B10 - 3-hydroxyacyl-CoA dehydrogenase type-2	25	66	1	1026	2923	2203	508	1742	66	3735	1769	3539	1815	3261
3818_Asthma, hay fever or eczema	3818_Asthma, hay fever or eczema	25	66	1	2059	93	2638	2121	2689	2094	66	375	3113	223	2834
2275_CYCS - Cytochrome c	2275_CYCS - Cytochrome c	25	66	1	2234	2383	1542	1432	4199	545	2785	66	906	1366	1392
2355_LGALS3 - Galectin-3	2355_LGALS3 - Galectin-3	25	66	1	453	521	263	2760	3437	4655	1541	3175	66	2678	325
1472_Mean total cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	1472_Mean total cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	25	66	1	3140	4719	1789	4422	108	129	1112	2098	3799	4366	66
3955_Ankle injury (random effect)	3955_Ankle injury (random effect)	25	67	1	67	1173	2175	2777	4053	1849	3736	313	2256	480	4740
63_Age at menarche	63_Age at menarche	25	67	1	1256	67	1733	466	133	3792	998	1297	353	326	3584
1198_Phosphorylated Tau at position 181	1198_Phosphorylated Tau at position 181	25	67	1	459	1225	67	1326	1237	2985	986	2583	384	1138	1620
3751_Traumatic events - Avoided activities or situations because of previous stressful experience in past month	3751_Traumatic events - Avoided activities or situations because of previous stressful experience in past month	25	67	1	2604	2002	1556	67	2057	1614	3791	224	1466	1891	414
1403_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for multivariable)	1403_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for multivariable)	25	67	1	2881	4472	1914	3950	67	3974	822	4627	4566	1068	2100
134_Waist circumference (male, adjusted for BMI)	134_Waist circumference (male, adjusted for BMI)	25	67	1	437	2000	3630	171	3993	67	1356	261	177	4234	1302
4536_Right putamen	4536_Right putamen	25	67	1	1149	87	4484	3897	3211	2903	67	1551	558	105	1659
1904_Hippocampal volume (FBAT, adjusted for multivariable)	1904_Hippocampal volume (FBAT, adjusted for multivariable)	25	67	1	3697	532	3813	294	502	2386	156	67	158	4128	953
877_HDL diameter	877_HDL diameter	25	67	1	1099	1890	884	2122	1723	2452	1900	2857	67	2246	3335
1784_PR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1784_PR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	67	1	328	1347	771	1294	2419	295	3028	939	4294	67	3652
1620_CD40 Ligand serum (at exam 7, FBAT, adjusted for multivariable)	1620_CD40 Ligand serum (at exam 7, FBAT, adjusted for multivariable)	25	67	1	4650	2922	1513	3533	1692	3012	3002	1694	2621	1246	67
399_Amino acid::Phenylalanine & tyrosine metabolism::phenylalanine	399_Amino acid::Phenylalanine & tyrosine metabolism::phenylalanine	25	68	1	68	549	637	3656	4218	2846	754	4212	508	211	1629
1718_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for age and sex)	1718_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for age and sex)	25	68	1	531	68	423	2818	4746	1641	1255	426	1126	852	1365
4410_Vaginal discharge: Smell	4410_Vaginal discharge: Smell	25	68	1	2825	2862	68	3810	2835	3666	2365	1277	1314	1403	3316
3151_CCNB1 - G2/mitotic-specific cyclin-B1	3151_CCNB1 - G2/mitotic-specific cyclin-B1	25	68	1	1462	300	383	3659	68	765	1080	3936	564	2672	2655
3338_Years since last cervical smear test (female)	3338_Years since last cervical smear test (female)	25	68	1	1557	72	3763	1106	4098	68	267	460	101	3034	1674
301_CD4mem:%PD1-R6+	301_CD4mem:%PD1-R6+	25	68	1	1897	1039	3676	1457	2675	3028	68	725	247	1719	2910
3337_Years since last breast cancer screening / mammogram (female)	3337_Years since last breast cancer screening / mammogram (female)	25	68	1	470	1482	621	2232	2702	3444	367	2893	68	848	367
3934_Monosialylation	3934_Monosialylation	25	68	1	3235	2281	2294	2028	897	367	2703	1353	2715	3060	68
3339_Age when periods started (menarche) (female)	3339_Age when periods started (menarche) (female)	25	69	1	681	69	1615	939	243	4711	1564	221	396	366	3466
3096_TGFBR2 - TGF-beta receptor type-2	3096_TGFBR2 - TGF-beta receptor type-2	25	69	1	1513	3264	69	2626	3406	2993	1744	4243	3987	3430	359
1233_Usual weekday bedtime (GEE, adjusted for age, sex and BMI)	1233_Usual weekday bedtime (GEE, adjusted for age, sex and BMI)	25	69	1	1662	172	74	69	4392	2235	480	2448	1141	1317	842
1219_Mean Accumbens	1219_Mean Accumbens	25	69	1	4231	2988	2456	3647	69	2345	3228	2553	2986	3580	4053
576_Lipid::Sterol, Steroid::dehydroisoandrosterone sulfate (DHEA-S)	576_Lipid::Sterol, Steroid::dehydroisoandrosterone sulfate (DHEA-S)	25	69	1	85	503	1247	4073	3168	69	739	477	3433	107	3026
3514_Gas or solid-fuel cooking/heating: A gas fire that you use regularly in winter time	3514_Gas or solid-fuel cooking/heating: A gas fire that you use regularly in winter time	25	69	1	4298	200	1943	95	1107	721	177	69	77	274	4701
2679_PTEN - Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	2679_PTEN - Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	25	69	1	1223	762	2364	2311	786	4081	3317	2314	1818	69	2127
34_Alzheimer's disease	34_Alzheimer's disease	25	69	1	90	2423	2552	4309	790	874	2905	727	2939	3454	69
786_::::X-12627	786_::::X-12627	25	70	1	472	1217	70	4392	994	855	3168	3560	2504	3160	2087
2442_FCGR1A - High affinity immunoglobulin gamma Fc receptor I	2442_FCGR1A - High affinity immunoglobulin gamma Fc receptor I	25	70	1	2278	721	1296	70	3619	4333	4012	2178	2927	1983	714
546_Lipid::Lysolipid::1-stearoylglycerophosphocholine	546_Lipid::Lysolipid::1-stearoylglycerophosphocholine	25	70	1	3883	1363	3413	2203	70	1252	3303	1236	439	2806	548
4532_Right cerebellum exterior	4532_Right cerebellum exterior	25	70	1	3216	1982	3893	3992	807	1292	70	3041	1709	2175	397
639_Xenobiotics::Tobacco metabolite::cotinine	639_Xenobiotics::Tobacco metabolite::cotinine	25	70	1	3049	3783	1776	552	2623	3798	950	70	294	3212	2586
159_Hip circumference (female)	159_Hip circumference (female)	25	70	1	932	2140	1297	3308	2822	2834	1700	1835	947	2865	70
4506_Right insula	4506_Right insula	25	71	1	71	495	646	3266	3278	1466	882	1546	3919	213	882
2379_APP - Amyloid beta A4 protein	2379_APP - Amyloid beta A4 protein	25	71	1	352	3521	71	1777	515	4687	3597	3263	4398	1828	928
2965_AMH - Muellerian-inhibiting factor	2965_AMH - Muellerian-inhibiting factor	25	71	1	3648	273	1351	71	4523	4031	1618	1940	342	364	3774
2963_LYZ - Lysozyme C	2963_LYZ - Lysozyme C	25	71	1	3485	3520	1232	2978	71	3953	1421	2267	1184	1996	2050
4664_Superior corona radiata fractional anisotropy	4664_Superior corona radiata fractional anisotropy	25	71	1	735	2726	1543	392	3667	71	1307	2219	2666	2295	3428
2368_DDX19B - ATP-dependent RNA helicase DDX19B	2368_DDX19B - ATP-dependent RNA helicase DDX19B	25	71	1	3060	1227	3602	981	2413	92	378	71	551	3200	696
1097_Mean Arterial Pressure	1097_Mean Arterial Pressure	25	71	1	4039	637	3213	110	4600	1687	688	136	71	1056	2602
1447_Low-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	1447_Low-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	25	71	1	1274	3807	1053	4508	2223	2777	2571	4442	2963	4464	71
3073_CD200R1 - Cell surface glycoprotein CD200 receptor 1	3073_CD200R1 - Cell surface glycoprotein CD200 receptor 1	25	72	1	72	1980	143	2058	1963	2863	3836	3171	3571	87	1463
2747_CCL13 - C-C motif chemokine 13	2747_CCL13 - C-C motif chemokine 13	25	72	1	304	1861	72	2811	2547	3128	3068	3785	799	2225	368
4368_Cannabis use	4368_Cannabis use	25	72	1	2762	1555	1395	72	4172	4346	2132	325	3778	3256	4080
1877_Shaft average buckling ratio (GEE, male, adjussted for age)	1877_Shaft average buckling ratio (GEE, male, adjussted for age)	25	72	1	1962	1177	2049	1090	72	4258	313	754	604	524	938
1028_Neck Width (FBAT, adjusted for age and sex)	1028_Neck Width (FBAT, adjusted for age and sex)	25	72	1	1793	3800	4712	3386	1654	72	2667	923	1317	2803	3171
720_::::X-11538	720_::::X-11538	25	72	1	3027	586	3747	1672	4376	3504	72	647	138	2274	3082
2051_Periodontal complex trait 5	2051_Periodontal complex trait 5	25	72	1	4657	281	4285	3166	2535	2692	227	72	334	477	3625
218_T:%NKT	218_T:%NKT	25	72	1	3440	279	4534	1945	2994	2131	783	242	72	686	815
3185_Waist circumference	3185_Waist circumference	25	72	1	146	2536	1043	781	2952	334	3384	2703	3124	2453	72
3654_Smoking status: Never	3654_Smoking status: Never	25	73	1	73	2708	941	4589	122	1195	3504	4673	3599	3624	3234
4608_Cerebellar vermal lobules I V	4608_Cerebellar vermal lobules I V	25	73	1	230	3496	73	1953	517	1773	349	184	4164	1895	438
3994_Sensitivity / hurt feelings (HURT)	3994_Sensitivity / hurt feelings (HURT)	25	73	1	319	219	4720	73	600	674	1498	194	504	75	4569
4428_Epstein Barr Virus antigen VCA seropositivity	4428_Epstein Barr Virus antigen VCA seropositivity	25	73	1	4025	4631	2204	3355	73	100	3606	4063	1482	2139	2874
3652_Illnesses of siblings: Diabetes	3652_Illnesses of siblings: Diabetes	25	73	1	763	596	1523	4210	524	73	1551	340	1445	619	96
389_Amino acid::Lysine metabolism::lysine	389_Amino acid::Lysine metabolism::lysine	25	73	1	1010	84	4719	574	3851	3173	1737	73	1231	797	1391
173_Waist circumference (adjusted for BMI)	173_Waist circumference (adjusted for BMI)	25	73	2	400	1081	77	203	3003	642	1520	286	73	3831	2812
1830_Neck length (FBAT, female, adjusted for multivariable)	1830_Neck length (FBAT, female, adjusted for multivariable)	25	73	1	4314	3200	1546	884	312	2329	1098	199	1461	1755	73
3231_Nap during day	3231_Nap during day	25	74	1	74	569	4677	2488	1585	2145	1298	3467	1542	227	3530
2596_FCN1 - Ficolin-1	2596_FCN1 - Ficolin-1	25	74	1	4441	2985	3757	74	4169	312	2270	2706	4500	2243	436
859_CH2 groups in fatty acids	859_CH2 groups in fatty acids	25	74	1	949	3218	460	1373	74	3471	1668	3292	982	1222	951
595_Peptide::Dipeptide::phenylalanylphenylalanine	595_Peptide::Dipeptide::phenylalanylphenylalanine	25	74	1	4708	1912	4118	4186	3884	74	4384	2868	3960	4222	2505
3706_Diagnoses - secondary ICD10: Z53 Persons encntr hlth serv for spec proc & trtmt, not crd out	3706_Diagnoses - secondary ICD10: Z53 Persons encntr hlth serv for spec proc & trtmt, not crd out	25	74	1	967	1162	4736	165	2925	4106	74	138	405	439	1460
2036_Cisplatin-associated ototoxicity	2036_Cisplatin-associated ototoxicity	25	74	1	2451	2388	2416	1297	2526	2557	545	74	440	3113	1627
283_CD4:%Treg(39+73-)	283_CD4:%Treg(39+73-)	25	74	1	156	230	1148	2833	2520	228	2496	4444	1057	74	2496
3494_Coffee type: Ground coffee (include espresso, filter etc)	3494_Coffee type: Ground coffee (include espresso, filter etc)	25	74	1	1769	2534	2257	2080	1404	1135	4366	1372	1206	2785	74
4325_Neuroticism (MA GWAMA)	4325_Neuroticism (MA GWAMA)	24	75	1	1179	75	3982	1668	859	1305	765	856	528	1475	2508
1242_Mean FEV1 from exam 3 and 5 (FBAT, adjusted for multiple covariates)	1242_Mean FEV1 from exam 3 and 5 (FBAT, adjusted for multiple covariates)	25	75	1	1520	4356	75	3011	315	1140	2676	4683	3286	4232	192
3235_Current tobacco smoking	3235_Current tobacco smoking	25	75	1	2206	249	3778	75	127	4625	762	437	1956	482	2638
896_Concentration of large LDL particles	896_Concentration of large LDL particles	25	75	1	1206	4371	1480	2800	75	4501	4629	3069	2010	3496	4119
3996_Nervous feelings (NERV-FEEL)	3996_Nervous feelings (NERV-FEEL)	25	75	1	1674	2142	3702	260	4102	75	4253	546	585	839	3903
2627_IGHG1 IGHG2 IGHG3 IGHG4 IGK@ IGL@ - Immunoglobulin G	2627_IGHG1 IGHG2 IGHG3 IGHG4 IGK@ IGL@ - Immunoglobulin G	25	75	1	3730	116	534	2520	2142	564	75	4176	404	2653	1263
2345_FASLG - Tumor necrosis factor ligand superfamily member 6, soluble form	2345_FASLG - Tumor necrosis factor ligand superfamily member 6, soluble form	25	75	1	790	1367	1961	729	920	2270	184	1030	75	2445	2497
4350_Nonischemic cardiomyopathy	4350_Nonischemic cardiomyopathy	25	76	1	76	585	1885	3879	1749	2653	1757	4052	4374	288	2748
1622_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for age and sex)	1622_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for age and sex)	25	76	1	3523	76	628	2573	863	4699	225	148	167	2132	225
357_earlyB:%27+38-	357_earlyB:%27+38-	25	76	1	1594	4086	690	3062	76	4507	3456	1127	2954	3476	3646
623_Xenobiotics::Drug::4-acetaminophen sulfate	623_Xenobiotics::Drug::4-acetaminophen sulfate	25	76	1	3554	4098	2792	4205	3413	76	2826	1165	1569	3328	850
1015_Bone Ultrasound Attenuation (GEE, adjusted for multivariable)	1015_Bone Ultrasound Attenuation (GEE, adjusted for multivariable)	25	76	1	4455	1758	4703	1183	4302	2518	3686	3562	2309	1472	76
3377_Number of spontaneous miscarriages (female)	3377_Number of spontaneous miscarriages (female)	25	77	1	4586	307	3521	77	4650	1914	511	687	833	727	4704
3003_HPGD - 15-hydroxyprostaglandin dehydrogenase [NAD(+)]	3003_HPGD - 15-hydroxyprostaglandin dehydrogenase [NAD(+)]	25	77	1	971	1873	2104	4416	77	374	3809	3837	2693	3030	4202
2274_ARTN - Artemin	2274_ARTN - Artemin	25	77	1	2883	4399	4015	1098	2424	77	3241	4044	1915	1717	3589
4365_Moderate to vigorous physical activity levels	4365_Moderate to vigorous physical activity levels	25	77	1	3332	258	2681	4025	1944	3913	77	170	2373	648	2080
4424_Hepatitis B HBs antigen seropositivity	4424_Hepatitis B HBs antigen seropositivity	25	77	1	256	3419	2283	2597	3958	3322	4133	3204	4254	3692	77
766_::::X-12231	766_::::X-12231	25	78	1	78	3920	658	2242	2984	4566	3151	4342	2528	3374	2240
1624_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for multivariable)	1624_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for multivariable)	25	78	1	4142	78	2053	1954	867	2242	914	2578	263	646	137
3900_Red blood cell count (three-way meta)	3900_Red blood cell count (three-way meta)	25	78	1	4702	1563	4649	78	4569	1240	2139	4600	2770	3424	3617
881_Total lipids in IDL	881_Total lipids in IDL	25	78	1	2012	2496	3304	3581	78	2181	3563	4079	3424	4404	4161
1281_Sagittal diameter by CT (GEE, adjusted for age and sex)	1281_Sagittal diameter by CT (GEE, adjusted for age and sex)	25	78	1	1424	948	919	1982	2513	701	78	617	1653	206	1031
1004_Macrophage inflammatory protein-1 (CCL4)	1004_Macrophage inflammatory protein-1 (CCL4)	25	78	1	3143	1899	3945	1141	4397	3249	792	78	1119	4452	3683
3263_Average weekly champagne plus white wine intake	3263_Average weekly champagne plus white wine intake	25	78	1	271	499	126	371	3146	3791	585	2401	667	78	3373
2057_Ulcerative colitis	2057_Ulcerative colitis	25	78	1	4722	3426	1500	2132	3718	715	3387	3941	3841	2691	78
121_Obesity class 2	121_Obesity class 2	25	79	1	79	922	1371	4371	4145	2871	3131	3001	2179	1802	4412
3480_Milk type used: Full cream	3480_Milk type used: Full cream	25	79	1	1818	1631	79	720	1998	4504	3627	2058	4627	102	2565
1360_Total cholesterol (at exam 2, FBAT, adjusted for age and sex)	1360_Total cholesterol (at exam 2, FBAT, adjusted for age and sex)	25	79	1	1552	210	3418	4700	624	79	1691	922	2032	305	550
2934_NTRK2 - BDNF/NT-3 growth factors receptor	2934_NTRK2 - BDNF/NT-3 growth factors receptor	25	79	1	2267	2217	1731	3990	3117	4506	560	79	4600	749	2036
567_Lipid::Sphingolipid::palmitoyl sphingomyelin	567_Lipid::Sphingolipid::palmitoyl sphingomyelin	25	79	1	3703	1486	2656	1454	2988	1646	291	353	79	1271	1854
4167_Parkinson disease of sibling pairs (tier 1)	4167_Parkinson disease of sibling pairs (tier 1)	25	79	1	300	2864	3136	434	2552	1735	3619	4291	924	79	2279
1230_Usual weekday bedtime (FBAT)	1230_Usual weekday bedtime (FBAT)	25	79	1	2459	1839	466	2300	1139	4135	3071	2504	1673	1586	79
4453_Left lateral occipital	4453_Left lateral occipital	25	80	1	1896	80	2162	4550	3017	3111	140	214	182	1258	1547
3099_UNC5C - Netrin receptor UNC5C	3099_UNC5C - Netrin receptor UNC5C	25	80	1	2327	3146	3114	3160	80	2126	4332	3389	2824	3111	1070
4175_Heel bone mineral density	4175_Heel bone mineral density	25	80	1	509	3566	2382	295	679	80	595	2486	2815	897	3695
3358_Father's age	3358_Father's age	25	80	1	2367	1116	3311	886	2277	2288	80	1817	107	3226	4577
2925_SFN - 14-3-3 protein sigma	2925_SFN - 14-3-3 protein sigma	25	80	1	4420	912	473	273	1860	3329	924	80	951	1216	1989
886_Total cholesterol in large HDL	886_Total cholesterol in large HDL	25	80	1	502	1512	333	4594	1391	2800	2213	2217	80	2819	2773
3621_Treatment/medication code: metformin	3621_Treatment/medication code: metformin	25	80	1	4073	104	2468	2770	4334	2832	1604	3852	2434	80	848
2252_KAT6A - Histone acetyltransferase KAT6A	2252_KAT6A - Histone acetyltransferase KAT6A	25	80	1	602	3942	519	2919	1540	322	2500	969	1966	4242	80
4377_Resting heart rate	4377_Resting heart rate	25	81	1	81	156	626	279	469	3955	1166	4650	456	398	1118
4321_Neuroticism (univariate)	4321_Neuroticism (univariate)	24	81	1	483	81	4232	849	1858	1297	1056	339	712	773	3910
1614_CD40 Ligand plasma (at exam 7, FBAT, adjusted for age and sex)	1614_CD40 Ligand plasma (at exam 7, FBAT, adjusted for age and sex)	25	81	1	2117	4691	2945	81	787	1574	1061	990	2113	4435	765
2302_ESAM - Endothelial cell-selective adhesion molecule	2302_ESAM - Endothelial cell-selective adhesion molecule	25	81	1	4585	3622	4429	2653	81	97	3571	3201	2774	2513	119
4328_Estimated bone mineral density from heel ultrasounds	4328_Estimated bone mineral density from heel ultrasounds	25	81	1	87	4696	1241	665	890	81	962	2833	3814	2050	4348
3685_Diagnoses - secondary ICD10: E03 Other hypothyroidism	3685_Diagnoses - secondary ICD10: E03 Other hypothyroidism	25	81	1	3562	135	4267	2512	1743	233	81	166	2531	1793	4525
2954_PLA2G1B - Phospholipase A2	2954_PLA2G1B - Phospholipase A2	25	81	1	1826	1041	4671	309	548	103	594	81	201	4540	1084
958_Concentration of very large HDL particles	958_Concentration of very large HDL particles	25	81	1	1941	975	3005	586	962	2983	469	885	81	924	1047
2606_CADM3 - Cell adhesion molecule 3	2606_CADM3 - Cell adhesion molecule 3	25	81	1	2601	162	1410	715	3949	3603	340	4104	256	81	1322
4255_Sleep efficiency	4255_Sleep efficiency	25	82	1	82	3997	244	1897	3713	1715	2958	2255	2416	1709	664
421_Amino acid::Valine, leucine and isoleucine metabolism::2-methylbutyroylcarnitine	421_Amino acid::Valine, leucine and isoleucine metabolism::2-methylbutyroylcarnitine	25	82	1	1037	3494	82	4616	4116	3608	2923	3364	3430	1781	2004
3251_Cheese intake	3251_Cheese intake	25	82	1	2814	3724	1763	82	2394	4319	3636	2392	4360	4213	1377
2941_INS - Insulin	2941_INS - Insulin	25	82	1	2658	1547	4094	2854	82	4235	1958	1607	865	1038	3165
1791_QT interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1791_QT interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	82	1	3095	1030	2352	2275	3610	82	1894	4541	4378	2664	964
4642_Right ventral DC	4642_Right ventral DC	25	82	1	1199	452	1209	1502	553	1889	82	927	1090	293	4273
2894_RSPO2 - R-spondin-2	2894_RSPO2 - R-spondin-2	25	82	1	1198	2699	2332	1398	2673	543	4038	82	2756	3442	3018
1379_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	1379_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	25	82	1	649	198	2226	2234	4518	2781	115	293	82	689	955
3274_Ease of skin tanning	3274_Ease of skin tanning	25	82	1	547	1391	2406	301	145	2007	1859	442	2169	980	82
4091_Proxy and clinically diagnosed Alzheimer's disease	4091_Proxy and clinically diagnosed Alzheimer's disease	25	83	1	83	3964	914	3199	775	1913	3339	2102	1961	1657	420
2902_HIBADH - 3-hydroxyisobutyrate dehydrogenase, mitochondrial	2902_HIBADH - 3-hydroxyisobutyrate dehydrogenase, mitochondrial	25	83	1	4545	83	3365	928	1224	1570	429	739	252	137	2667
4081_Waist-hip ratio (adjusted for BMI, male)	4081_Waist-hip ratio (adjusted for BMI, male)	25	83	1	3417	4141	188	83	3920	2564	4737	2035	1267	644	2119
4242_Rapid automised naming of letters	4242_Rapid automised naming of letters	25	83	1	1257	849	1175	2669	4729	83	707	1631	573	1604	4635
306_CD4mem:%cFTH (2)	306_CD4mem:%cFTH (2)	25	83	1	3762	91	3792	805	1020	4494	83	467	203	182	3154
1042_Shaft Width (FBAT, adjusted for multivariable)	1042_Shaft Width (FBAT, adjusted for multivariable)	25	83	1	4568	457	1549	2199	349	3684	1250	83	1925	2179	2148
3260_Variation in diet	3260_Variation in diet	25	83	1	84	653	1315	381	1734	2751	1010	3076	4453	83	130
3531_Never eat eggs, dairy, wheat, sugar: I eat all of the above	3531_Never eat eggs, dairy, wheat, sugar: I eat all of the above	25	83	1	4665	1344	4668	1920	758	755	2128	2744	1454	1545	83
2434_CNTN2 - Contactin-2	2434_CNTN2 - Contactin-2	25	84	1	1364	670	84	4598	297	2477	3570	1130	3921	1897	739
1280_Sagittal diameter by CT (FBAT, adjusted for age and sex)	1280_Sagittal diameter by CT (FBAT, adjusted for age and sex)	25	84	1	4387	1359	3088	3665	84	4417	3747	3349	3758	997	644
1438_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1438_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	84	1	1014	3910	4112	1862	1118	84	3353	1051	2311	124	2085
815_Lipid::Fatty acid amide::X-13183--stearamide	815_Lipid::Fatty acid amide::X-13183--stearamide	25	84	1	3248	1514	1692	2836	990	1941	3795	84	1327	1477	3718
1165_Fasting glucose	1165_Fasting glucose	25	84	1	565	907	134	2896	2726	2931	419	1798	84	2058	1955
3259_Major dietary changes in the last 5 years	3259_Major dietary changes in the last 5 years	25	85	1	2832	1818	1343	897	3405	85	1084	3711	4575	3747	500
4149_Left ventricular internal dimension in systole	4149_Left ventricular internal dimension in systole	25	85	1	4427	2199	3684	1078	637	3454	3626	85	3323	507	2554
3288_Fed-up feelings	3288_Fed-up feelings	25	85	1	3456	710	1832	304	2628	4583	1883	875	795	85	2298
1267_Residual from predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	1267_Residual from predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	25	85	1	1469	432	315	426	3967	2639	404	3181	359	3271	85
3862_Platelet distribution width (two-way meta)	3862_Platelet distribution width (two-way meta)	25	86	1	86	3407	204	593	1093	4512	1318	334	2680	2077	3248
4359_Biliary atresia	4359_Biliary atresia	25	86	1	746	86	1999	1541	4250	2269	417	1398	1424	510	2303
4001_Loneliness, isolation (LONE)	4001_Loneliness, isolation (LONE)	25	86	1	1449	3479	86	155	1527	2448	3805	1238	2378	4135	453
2221_BCAM - Basal Cell Adhesion Molecule	2221_BCAM - Basal Cell Adhesion Molecule	25	86	1	2603	2051	335	3415	86	4301	3030	796	1207	759	1517
4306_Trunk-trunk fat ratio (female)	4306_Trunk-trunk fat ratio (female)	25	86	1	526	4085	2723	2291	2606	2207	2589	86	1354	3878	1028
204_Urinary albumin-to-creatinine ratio	204_Urinary albumin-to-creatinine ratio	25	86	1	969	214	1829	354	3423	442	488	427	86	703	4113
4089_Maternal history of Alzheimer's disease	4089_Maternal history of Alzheimer's disease	25	86	1	187	3484	281	2464	142	500	3900	1809	4563	4390	86
2945_GCG - Glucagon	2945_GCG - Glucagon	25	87	1	176	109	87	1401	384	1847	178	2246	230	127	210
1958_MMSE score (at exam 5, FBAT, adjusted for multivariable)	1958_MMSE score (at exam 5, FBAT, adjusted for multivariable)	25	87	1	4415	2367	1107	4226	87	4415	3851	2540	4328	1525	312
1436_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1436_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	87	1	2941	2090	2977	1334	292	87	4319	3555	2386	186	2128
4216_Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	4216_Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	25	87	1	3208	182	660	4470	935	3570	87	1790	754	840	1589
4464_Left postcentral	4464_Left postcentral	25	87	1	3556	1820	1460	511	593	2632	284	87	563	2286	408
487_Lipid::Essential fatty acid::dihomo-linolenate (20:3n3 or n6)	487_Lipid::Essential fatty acid::dihomo-linolenate (20:3n3 or n6)	25	88	1	473	4512	88	1785	2258	512	4397	3909	4651	2280	4180
4609_Cerebellar vermal lobules VI VII	4609_Cerebellar vermal lobules VI VII	25	88	1	2838	411	145	88	2253	1072	427	331	1316	2200	3241
3177_PRKCG - Protein kinase C gamma type	3177_PRKCG - Protein kinase C gamma type	25	88	1	4533	3732	4636	3037	88	3291	2384	973	2301	449	1367
380_Amino acid::Glycine, serine and threonine metabolism::glycine	380_Amino acid::Glycine, serine and threonine metabolism::glycine	25	88	1	2527	2005	4713	2713	3759	88	4157	2173	2765	3886	677
4132_Basophil count	4132_Basophil count	25	88	1	4177	425	1861	272	3316	792	491	88	834	1451	2962
2132_LAYN - Layilin	2132_LAYN - Layilin	25	88	1	4605	1248	2271	1902	3832	2823	1395	413	88	2552	4441
347_CD8:%TM (1)	347_CD8:%TM (1)	25	88	1	1131	2129	1001	1962	3420	104	3410	2892	3308	2255	88
3694_Diagnoses - secondary ICD10: I48 Atrial fibrillation and flutter	3694_Diagnoses - secondary ICD10: I48 Atrial fibrillation and flutter	25	89	1	89	3762	398	4100	95	2435	4417	3746	1685	4076	4485
4467_Left precuneus	4467_Left precuneus	25	89	1	2979	3630	89	2136	1582	4130	3072	3246	2433	194	495
1504_Triglycerides (at exam 4, FBAT, adjusted for age and sex)	1504_Triglycerides (at exam 4, FBAT, adjusted for age and sex)	25	89	1	3282	1552	3544	89	3503	3553	1315	247	730	1179	1105
1687_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for age and sex)	1687_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for age and sex)	25	89	1	3053	256	847	476	89	1191	108	2264	1582	537	91
2422_WFIKKN2 - WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2	2422_WFIKKN2 - WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2	25	89	1	4475	1017	2798	922	4208	89	519	327	337	2593	638
785_::::X-12556	785_::::X-12556	25	89	1	3448	1186	554	725	2656	1488	89	357	370	794	321
905_18:2, linoleic acid (LA)	905_18:2, linoleic acid (LA)	25	89	1	1489	902	803	3648	4326	1026	1613	1573	89	2002	2187
3328_Diabetes (diagnosed by doctor)	3328_Diabetes (diagnosed by doctor)	25	90	1	816	90	1273	2609	885	349	281	805	3198	144	304
846_::::X-14662	846_::::X-14662	25	90	1	2019	3648	3044	90	2544	648	3948	2354	2229	4456	979
3725_Frequency of drinking alcohol	3725_Frequency of drinking alcohol	25	90	1	4506	1130	1746	746	90	133	180	377	2363	2994	1360
207_Gout	207_Gout	25	90	1	1825	1886	2554	1051	2041	90	4001	2446	2481	1042	3288
1612_von Willebrand Factor (at exam 5, FBAT, adjusted for multivariable)	1612_von Willebrand Factor (at exam 5, FBAT, adjusted for multivariable)	25	90	1	4197	1264	912	3007	1589	1541	90	3689	501	1465	3015
4680_Inferior fronto-occipital fasciculus axial diusivities	4680_Inferior fronto-occipital fasciculus axial diusivities	25	90	1	294	352	2872	147	1036	2331	2251	718	90	564	783
3836_Sum basophil neutrophil count (two-way meta)	3836_Sum basophil neutrophil count (two-way meta)	25	90	2	2648	2410	1619	3912	3590	1893	3305	2559	3512	512	90
145_Body Mass Index (female)	145_Body Mass Index (female)	25	91	1	91	1279	1467	690	2873	1261	3433	3811	4258	3389	2081
1629_Interleukin 6 (at exam 7, GEE, adjusted for multivariable)	1629_Interleukin 6 (at exam 7, GEE, adjusted for multivariable)	25	91	1	1619	4737	91	2178	2230	229	3723	2760	3023	3832	227
545_Lipid::Lysolipid::1-palmitoylglycerophosphoinositol*	545_Lipid::Lysolipid::1-palmitoylglycerophosphoinositol*	25	91	1	3491	4727	4121	2301	91	3797	1157	4004	1691	4351	4659
3885_Lymphocyte percentage of white cells (three-way meta)	3885_Lymphocyte percentage of white cells (three-way meta)	25	91	1	488	2584	615	1570	3261	91	4643	1553	3683	1695	1769
1484_Mean triglycerides from exam 1-7 (FBAT, adjusted for multivariable)	1484_Mean triglycerides from exam 1-7 (FBAT, adjusted for multivariable)	25	91	1	3889	1325	2077	4085	1190	873	91	4489	4722	1290	2388
2555_CXCL6 - C-X-C motif chemokine 6	2555_CXCL6 - C-X-C motif chemokine 6	25	91	1	1475	3111	1415	2416	3554	1464	2662	91	4385	2890	937
2048_Periodontal complex trait 3 - Aa trait	2048_Periodontal complex trait 3 - Aa trait	25	92	1	92	609	491	118	4229	3880	988	3108	4484	2863	685
3319_Wheeze or whistling in the chest in last year	3319_Wheeze or whistling in the chest in last year	25	92	1	4214	92	3951	1770	4173	4429	239	1492	4276	378	1682
2432_CD5L - CD5 antigen-like	2432_CD5L - CD5 antigen-like	25	92	1	3595	2944	92	125	1864	4162	2009	814	1665	2148	2137
2419_SEMA3A - Semaphorin-3A	2419_SEMA3A - Semaphorin-3A	25	92	1	3118	121	1005	92	4454	249	967	416	572	252	838
3045_CRTAM - Cytotoxic and regulatory T-cell molecule	3045_CRTAM - Cytotoxic and regulatory T-cell molecule	25	92	1	4632	1218	182	3624	1748	2301	92	1759	1599	2047	1141
3011_MAPK12 - Mitogen-activated protein kinase 12	3011_MAPK12 - Mitogen-activated protein kinase 12	25	92	1	2460	747	4155	399	816	1073	1309	92	1213	972	3480
3184_Esophageal squamous cell carcinoma	3184_Esophageal squamous cell carcinoma	25	92	1	4418	568	2534	1884	3846	3829	574	1728	92	165	1647
1988_Age at death (FBAT, adjusted for multivariable)	1988_Age at death (FBAT, adjusted for multivariable)	25	92	1	1844	3934	1278	2067	2667	1007	3830	867	2648	2113	92
3448_Impedance measures - Impedance of leg (right)	3448_Impedance measures - Impedance of leg (right)	25	93	1	93	4049	742	1115	792	1871	1975	704	365	3052	4011
2544_PRSS3 - Trypsin-3	2544_PRSS3 - Trypsin-3	25	93	1	245	3056	93	2830	3225	3768	1169	4721	759	2802	776
4270_Anxiety/tension factors	4270_Anxiety/tension factors	25	93	2	2638	1397	2451	93	3761	1032	658	1177	2087	2014	2115
1847_Neck Section Modulus (GEE, female, adjusted for age)	1847_Neck Section Modulus (GEE, female, adjusted for age)	25	93	1	1665	1487	2288	3145	93	3118	1423	3585	1647	1099	286
2192_FGF18 - Fibroblast growth factor 18	2192_FGF18 - Fibroblast growth factor 18	25	93	1	1157	4041	2302	1976	1284	93	1200	2992	3652	3437	150
2876_CLU - Clusterin	2876_CLU - Clusterin	25	93	1	2549	3357	276	1074	3296	2393	3864	93	2340	273	2211
1090_Alcohol dependence	1090_Alcohol dependence	25	94	1	94	4411	1372	1963	2198	2826	726	424	3655	3395	1049
947_Sphingomyelins	947_Sphingomyelins	25	94	1	1097	3452	94	4385	811	3734	2126	4664	3896	2421	1435
2212_SOD1 - Superoxide dismutase [Cu-Zn]	2212_SOD1 - Superoxide dismutase [Cu-Zn]	25	94	1	3498	2120	3824	459	94	974	3323	2149	379	2202	302
1321_Adiponectin (GEE, adjusted for age, sex and BMI)	1321_Adiponectin (GEE, adjusted for age, sex and BMI)	25	94	1	3871	4167	1573	4289	1782	94	1074	2624	3996	2371	782
3348_Age when last used oral contraceptive pill (female)	3348_Age when last used oral contraceptive pill (female)	25	94	1	2513	224	2721	153	3133	238	94	2662	292	1460	1532
4163_Generalized epilepsy with tonic-clonic seizures	4163_Generalized epilepsy with tonic-clonic seizures	25	94	1	4093	2353	2542	1232	3306	2847	941	94	808	3297	1903
2337_MRC2 - C-type mannose receptor 2	2337_MRC2 - C-type mannose receptor 2	25	94	1	2289	423	3661	98	573	425	318	474	94	3103	1251
4309_Osteoarthritis of hip	4309_Osteoarthritis of hip	25	94	1	4146	2561	1874	239	4247	3151	1554	2111	1633	94	3160
130_Hip circumference (male, adjusted for BMI)	130_Hip circumference (male, adjusted for BMI)	25	94	1	3748	3363	2312	762	2574	1321	2862	97	341	375	94
2246_MAPK3 - Mitogen-activated protein kinase 3	2246_MAPK3 - Mitogen-activated protein kinase 3	25	95	1	95	2225	250	3429	2374	3817	4290	332	967	4643	3698
4302_Arms-arm fat ratio (female)	4302_Arms-arm fat ratio (female)	25	95	1	4070	95	1667	289	2982	4367	169	263	426	3317	1885
1238_Rate of decline FEF25-75 (FBAT, adjusted for multiple covariates)	1238_Rate of decline FEF25-75 (FBAT, adjusted for multiple covariates)	25	95	1	3604	2608	95	4037	1169	3160	805	1059	4088	358	1704
2428_CA10 - Carbonic anhydrase-related protein 10	2428_CA10 - Carbonic anhydrase-related protein 10	25	95	1	4286	2710	3078	752	1014	95	2357	2408	1088	3275	723
183_Waist-hip ratio (female)	183_Waist-hip ratio (female)	25	95	1	3921	857	4589	407	4123	620	101	466	95	569	2530
2808_TPI1 - Triosephosphate isomerase	2808_TPI1 - Triosephosphate isomerase	25	96	1	408	3921	96	140	3557	2427	2277	1256	957	3879	2076
3000_GRN - Granulins	3000_GRN - Granulins	25	96	1	3550	3037	2864	956	96	358	2972	2698	4256	488	4553
1017_Femoral BMD (GEE, adjusted for multivariable)	1017_Femoral BMD (GEE, adjusted for multivariable)	25	96	1	3787	3943	1541	2213	507	96	4295	4016	4711	2045	2241
1653_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for multivariable)	1653_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for multivariable)	25	96	1	1747	1157	2258	1082	3238	898	96	1499	1452	1252	595
2910_PPIB - Peptidyl-prolyl cis-trans isomerase B	2910_PPIB - Peptidyl-prolyl cis-trans isomerase B	25	96	1	1654	248	498	2105	871	643	234	4479	96	207	3811
3285_Miserableness	3285_Miserableness	25	97	1	97	661	2633	822	4119	3219	2192	1298	749	342	3986
2719_NAGK - N-acetyl-D-glucosamine kinase	2719_NAGK - N-acetyl-D-glucosamine kinase	25	97	1	3729	97	4350	430	4561	2426	636	1849	149	702	2732
1933_Parietal brain volume (GEE, adjusted for age and sex)	1933_Parietal brain volume (GEE, adjusted for age and sex)	25	97	1	3649	1399	3344	97	4534	1299	1208	165	214	4061	1618
820_::::X-13477	820_::::X-13477	25	97	1	3210	1343	3336	1134	97	3993	1863	4487	2773	990	2755
3631_Illnesses of father: Bowel cancer	3631_Illnesses of father: Bowel cancer	25	97	1	2439	1345	2207	3908	499	1322	4413	3463	97	2859	4705
3307_Overall health rating	3307_Overall health rating	25	98	1	98	4528	2756	3242	3471	3839	4106	1927	4042	771	1577
1440_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	1440_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	25	98	1	2954	2510	4532	796	98	412	4480	4533	3619	1079	552
2896_SLITRK5 - SLIT and NTRK-like protein 5	2896_SLITRK5 - SLIT and NTRK-like protein 5	25	98	1	4099	1763	2818	635	1096	98	1387	3368	1923	3448	3041
1686_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for age and sex)	1686_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for age and sex)	25	98	1	4677	2158	790	3259	1245	275	3020	98	1661	2290	258
1371_Total cholesterol (at exam 7, GEE, adjusted for age and sex)	1371_Total cholesterol (at exam 7, GEE, adjusted for age and sex)	25	98	1	3613	593	693	2083	3737	408	931	771	1125	2056	98
885_Isoleucine	885_Isoleucine	25	99	1	313	99	951	2145	851	3100	4494	1187	796	696	2221
2172_CSF3R - Granulocyte colony-stimulating factor receptor	2172_CSF3R - Granulocyte colony-stimulating factor receptor	25	99	1	637	369	99	222	1801	4324	2380	2056	2005	1003	4249
2255_RAD51 - DNA repair protein RAD51 homolog 1	2255_RAD51 - DNA repair protein RAD51 homolog 1	25	99	1	2408	3822	1166	3403	99	127	315	4395	4261	1708	858
4623_Left caudate	4623_Left caudate	25	99	1	615	2698	3234	1007	2202	99	4520	2134	3994	3061	135
4399_Menstruation quality of life impact: Depression	4399_Menstruation quality of life impact: Depression	25	99	1	1270	2314	2620	2265	645	808	732	99	1645	4588	1963
3542_Reason for glasses/contact lenses: For 'astigmatism'	3542_Reason for glasses/contact lenses: For 'astigmatism'	25	99	1	1833	1187	3071	178	3200	3357	1256	618	99	2457	2305
2498_STAB2 - Stabilin-2	2498_STAB2 - Stabilin-2	25	99	1	4332	2666	588	1693	1060	1207	4174	933	2968	348	99
1755_Cancer (GEE, adjusted for age and sex)	1755_Cancer (GEE, adjusted for age and sex)	25	100	1	100	4474	1457	656	420	1210	554	2343	926	501	2893
2859_C4A C4B - Complement C4	2859_C4A C4B - Complement C4	25	100	1	3383	100	4684	2270	197	1181	559	2004	3904	420	123
1356_Total cholesterol (at exam 1, FBAT, multivariate adjusted)	1356_Total cholesterol (at exam 1, FBAT, multivariate adjusted)	25	100	1	1861	4741	2772	4290	100	2770	2233	3780	3183	940	3179
1006_Regulated on Activation, Normal T Cell Expressed and Secreted (CCL5)	1006_Regulated on Activation, Normal T Cell Expressed and Secreted (CCL5)	25	100	1	2037	139	2373	308	4187	1015	100	2844	1011	504	1548
2104_PRL - Prolactin	2104_PRL - Prolactin	25	100	1	329	3914	257	2473	808	1476	3032	100	1963	3885	3612
2451_LRP8 - Low-density lipoprotein receptor-related protein 8	2451_LRP8 - Low-density lipoprotein receptor-related protein 8	25	100	1	2738	146	264	565	4283	3074	196	297	100	508	2042
2793_PON1 - Serum paraoxonase/arylesterase 1	2793_PON1 - Serum paraoxonase/arylesterase 1	25	100	1	144	190	1672	3286	1380	3048	2077	1034	613	100	2810
3933_Galactosylation	3933_Galactosylation	25	100	1	3558	631	1192	1500	545	169	2202	3798	1237	4053	100
1070_Familial Parkinson Disease	1070_Familial Parkinson Disease	25	101	1	101	1497	4206	868	4554	3571	3348	4160	867	519	2961
1885_Shaft Width (GEE, female, adjussted for multivariable)	1885_Shaft Width (GEE, female, adjussted for multivariable)	25	101	1	4248	4022	101	2612	450	1627	4358	3794	3911	1016	2074
787_::::X-12644	787_::::X-12644	25	101	1	2436	2610	4742	101	832	1945	2695	3846	4161	1564	1958
3688_Diagnoses - secondary ICD10: E78 Disorders of lipoprotein metabolism and other lipidemias	3688_Diagnoses - secondary ICD10: E78 Disorders of lipoprotein metabolism and other lipidemias	25	101	1	2102	1951	1760	4230	101	681	4311	3344	3520	3310	3657
685_::::X-10506	685_::::X-10506	25	101	1	3726	1858	2912	2340	1129	101	4145	941	1593	3123	1733
3947_11q deletion neuroblastoma	3947_11q deletion neuroblastoma	25	101	1	2386	4149	481	4129	588	4056	1216	101	2320	4238	1019
3545_Mouth/teeth dental problems: Painful gums	3545_Mouth/teeth dental problems: Painful gums	25	101	1	353	1435	1268	394	4423	196	2457	3385	1287	101	1403
4613_Brain stem	4613_Brain stem	25	101	1	1928	3434	3825	613	2080	857	399	2259	4716	2826	101
3041_CD274 - Programmed cell death 1 ligand 1	3041_CD274 - Programmed cell death 1 ligand 1	25	102	1	102	1986	114	3853	3551	2928	3440	2558	3266	3252	1914
1561_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1561_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	102	1	1990	3614	4236	1870	102	744	3959	1885	1979	2145	952
1615_CD40 Ligand plasma (at exam 7, GEE, adjusted for age and sex)	1615_CD40 Ligand plasma (at exam 7, GEE, adjusted for age and sex)	25	102	1	4741	2230	2240	4213	3453	102	4178	2910	4320	4712	2289
1391_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	1391_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	25	102	1	4633	961	885	1111	3910	773	3156	102	628	2386	925
1434_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	1434_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	25	102	1	776	4708	905	2404	271	1331	3661	1621	3585	1715	102
4692_Anterior limb of internal capsule mean diusivities	4692_Anterior limb of internal capsule mean diusivities	25	103	1	103	1031	2712	772	4203	3105	3941	2993	2148	538	2140
3291_Tense / 'highly strung'	3291_Tense / 'highly strung'	25	103	1	1365	103	1951	523	3322	728	148	803	325	844	3777
3077_NOTCH1 - Neurogenic locus notch homolog protein 1	3077_NOTCH1 - Neurogenic locus notch homolog protein 1	25	103	1	4322	3337	103	4078	2226	2060	1948	2736	3507	3115	1686
3754_Traumatic events - Felt very upset when reminded of stressful expresince in past month	3754_Traumatic events - Felt very upset when reminded of stressful expresince in past month	25	103	1	1912	2696	644	103	1170	4550	4615	248	3586	3708	2040
1692_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for multivariable)	1692_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for multivariable)	25	103	1	1400	3391	3117	2395	103	1010	1594	4382	2421	3032	2003
3922_Heart rate variability (SDNN)	3922_Heart rate variability (SDNN)	25	103	1	2950	154	2224	349	4612	258	103	1211	550	650	2021
3753_Traumatic events - Repeated disturbing thoughts of stressful experience in past month	3753_Traumatic events - Repeated disturbing thoughts of stressful experience in past month	25	103	1	3273	124	499	131	1497	3620	835	103	223	1905	4416
568_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 1*	568_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 1*	25	103	1	936	797	2033	4075	1615	738	1987	2080	1969	103	4502
4380_Phltrium width	4380_Phltrium width	25	103	1	812	779	1391	1395	376	4418	288	2714	883	713	103
2701_TPT1 - Translationally-controlled tumor protein	2701_TPT1 - Translationally-controlled tumor protein	25	104	1	104	690	840	1769	1182	3806	3884	1351	825	1585	2002
2537_RPS6KA3 - Ribosomal protein S6 kinase alpha-3	2537_RPS6KA3 - Ribosomal protein S6 kinase alpha-3	25	104	1	3564	2209	2859	104	1378	2446	3336	4195	114	998	1134
986_Interleukin-18	986_Interleukin-18	25	104	1	2483	3406	1363	3102	104	757	2928	1852	931	3139	1465
4528_Left ventral DC	4528_Left ventral DC	25	104	1	4381	365	118	560	2189	2911	104	238	2739	332	2591
1007_Stem cell factor	1007_Stem cell factor	25	104	1	4486	4267	1526	431	1059	3245	1195	104	1463	3905	3250
953_VLDL diameter	953_VLDL diameter	25	104	1	3878	1795	1477	1554	2679	860	421	557	104	3985	3975
699_Nucleotide::Purine metabolism, (hypo)xanthine/inosine containing::X-11422--xanthine	699_Nucleotide::Purine metabolism, (hypo)xanthine/inosine containing::X-11422--xanthine	25	104	1	1000	159	4517	1817	4275	3670	3595	3644	3148	104	3955
1409_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for age and sex)	1409_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for age and sex)	25	104	1	1884	1635	584	2720	2042	2597	322	3255	3122	1779	104
287_CD4:%Treg(73+)	287_CD4:%Treg(73+)	25	105	1	105	430	2216	3280	1703	4392	312	3938	1190	878	1695
2219_ANGPT1 - Angiopoietin-1	2219_ANGPT1 - Angiopoietin-1	25	105	1	545	4184	105	1968	481	746	3346	4074	3658	1824	215
4731_Superior fronto-occipital fasciculus mode of anisotropy	4731_Superior fronto-occipital fasciculus mode of anisotropy	25	105	1	2869	2056	2035	105	4128	4487	1217	2008	2664	2736	1558
409_Amino acid::Tryptophan metabolism::tryptophan	409_Amino acid::Tryptophan metabolism::tryptophan	25	105	1	644	203	1096	4090	105	3414	463	3611	921	753	3868
152_Waist-hip ratio (male <= 50 yrs, adjusted for BMI)	152_Waist-hip ratio (male <= 50 yrs, adjusted for BMI)	25	105	1	419	4347	773	4219	4595	105	2622	2837	3435	1340	1559
652_::::X-02269	652_::::X-02269	25	105	1	3401	1895	1592	1003	1972	3892	105	2766	171	3815	2551
1915_Parietal brain volume (GEE, adjusted for multivariable)	1915_Parietal brain volume (GEE, adjusted for multivariable)	25	105	1	2357	942	1077	123	2764	1863	287	113	105	2649	1494
1317_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age and sex)	1317_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age and sex)	24	105	1	4007	1881	1428	1796	3124	2837	4236	3080	3583	2150	105
4003_Juvenile idiopathic arthritis with vs without uveitis	4003_Juvenile idiopathic arthritis with vs without uveitis	25	106	1	1975	1321	1238	3005	106	1433	3930	3844	1527	2283	388
4572_Left superior parietal	4572_Left superior parietal	25	106	1	3293	2837	1177	3979	4293	106	4243	3568	4529	3752	672
934_Concentration of small HDL particles	934_Concentration of small HDL particles	25	106	1	919	1750	2705	328	2493	3272	106	210	678	1269	281
232_mDC (2):%CD1c+	232_mDC (2):%CD1c+	25	106	1	3192	2559	4600	3880	3760	4222	564	106	2298	642	3679
4343_Sleep sedentary	4343_Sleep sedentary	25	107	1	107	825	652	3295	4451	636	248	2575	587	2447	1588
3805_Platelet count	3805_Platelet count	25	107	1	1717	107	1326	4520	2448	4585	385	539	313	407	3106
4568_Left precuneus	4568_Left precuneus	25	107	1	3211	2565	107	4482	1873	3703	1645	3121	2314	3619	483
4685_Splenium of corpus callosum axial diusivities	4685_Splenium of corpus callosum axial diusivities	25	107	1	1965	651	3862	107	1739	4221	1822	1197	3339	1621	1363
1815_Femoral Neck BMD (GEE, female, adjusted for multivariable)	1815_Femoral Neck BMD (GEE, female, adjusted for multivariable)	25	107	1	650	4160	2268	4668	400	107	4645	4385	1936	2997	1636
1283_Sagittal diameter by CT (GEE, adjusted for age, sex, smoking and menopause)	1283_Sagittal diameter by CT (GEE, adjusted for age, sex, smoking and menopause)	25	107	1	1372	1010	997	1626	4042	800	107	1292	1938	112	1075
464_Lipid::Bile acid metabolism::cholate	464_Lipid::Bile acid metabolism::cholate	25	107	1	4725	4412	3379	4047	1445	1184	4195	107	4295	2096	703
2785_PKM2 - Pyruvate kinase PKM	2785_PKM2 - Pyruvate kinase PKM	25	108	1	108	1930	504	792	1753	3967	3580	2932	2162	2978	1621
2549_FGF1 - Fibroblast growth factor 1	2549_FGF1 - Fibroblast growth factor 1	25	108	1	4514	108	1239	471	314	2502	373	1756	1806	2771	840
1974_Morbidity-free survival (at age 65, FBAT, adjusted for birth-cohort)	1974_Morbidity-free survival (at age 65, FBAT, adjusted for birth-cohort)	25	108	1	1538	2844	108	4012	2045	3480	735	1659	3608	2104	371
3668_Diagnoses - main ICD10: I25 Chronic ischemic heart disease	3668_Diagnoses - main ICD10: I25 Chronic ischemic heart disease	25	108	1	4049	3197	4454	3962	4381	108	2730	3879	3344	1296	2093
3655_Smoking status: Previous vs Current	3655_Smoking status: Previous vs Current	25	108	1	3259	2160	3458	1008	1491	2585	2819	108	2134	4356	3430
1562_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1562_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	108	1	1752	2436	2348	910	2571	3719	4439	3293	2524	108	406
2030_Ulcerative colitis	2030_Ulcerative colitis	25	108	1	4110	3204	140	4466	1848	1333	3201	1770	375	607	108
1748_Urinary albumin excertion (at exam 6, FBAT, adjusted for multivariable)	1748_Urinary albumin excertion (at exam 6, FBAT, adjusted for multivariable)	25	109	1	109	4638	205	4568	1365	118	4361	2520	2827	3162	245
1172_Heart rate	1172_Heart rate	25	109	1	295	212	109	361	283	4075	283	3823	212	589	3438
4252_Number of sleep episodes	4252_Number of sleep episodes	25	109	1	2351	264	2148	109	3948	1495	1480	1577	462	151	3924
3335_Light smokers, at least 100 smokes in lifetime	3335_Light smokers, at least 100 smokes in lifetime	25	109	1	4698	724	1080	3408	459	267	109	1407	702	490	472
3023_PRDX6 - Peroxiredoxin-6	3023_PRDX6 - Peroxiredoxin-6	25	109	1	3913	1112	3102	2194	3417	1302	603	665	109	2262	1470
2229_KLK11 - Kallikrein-11	2229_KLK11 - Kallikrein-11	25	109	1	1706	1120	818	764	614	2428	713	2799	1110	109	1036
3108_GCKR - Glucokinase regulatory protein	3108_GCKR - Glucokinase regulatory protein	25	109	1	2763	4479	596	1512	4358	3836	4110	2557	2964	871	109
637_Xenobiotics::Food component, Plant::thymol sulfate	637_Xenobiotics::Food component, Plant::thymol sulfate	25	110	1	321	3690	110	518	1789	4017	583	1227	1825	1518	2917
748_::::X-12038	748_::::X-12038	25	110	1	4226	3794	4607	2403	110	482	4497	2848	3873	4024	730
387_Amino acid::Histidine metabolism::histidine	387_Amino acid::Histidine metabolism::histidine	25	110	1	931	1595	3574	4064	1670	110	4685	4189	1656	3840	2944
4394_Heavy vaginal discharge	4394_Heavy vaginal discharge	25	110	1	3413	691	2560	1810	4513	2972	110	2381	320	1415	3495
1875_Shaft average buckling ratio (GEE, female, adjussted for age)	1875_Shaft average buckling ratio (GEE, female, adjussted for age)	25	110	1	2872	472	2002	111	286	720	294	110	123	197	341
3667_Diagnoses - main ICD10: H26 Other cataract	3667_Diagnoses - main ICD10: H26 Other cataract	25	111	1	3179	111	4625	532	2701	1559	1705	580	2413	203	2885
1305_Fasting insulin (at exam 7, GEE, adjusted for age and sex)	1305_Fasting insulin (at exam 7, GEE, adjusted for age and sex)	25	111	1	4621	4359	111	1448	658	4262	3082	3782	1033	2073	3162
1768_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for age and sex)	1768_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for age and sex)	25	111	1	262	4360	259	4400	111	1108	1101	1887	2925	4204	3552
3407_Number of older siblings	3407_Number of older siblings	25	111	1	3074	1174	3142	544	1206	1258	111	1915	176	540	2243
3817_CD56+ NK cell level	3817_CD56+ NK cell level	25	111	1	3528	2239	2213	1185	347	1296	418	111	2665	3625	3146
1184_High-density lipoprotein cholesterol	1184_High-density lipoprotein cholesterol	25	111	1	2686	621	1256	2772	2208	4180	3176	1271	111	4403	4492
3865_Red cell distribution width (two-way meta)	3865_Red cell distribution width (two-way meta)	25	111	1	2518	2052	2636	4308	2919	3745	2183	383	2979	111	2467
4679_Genu of corpus callosum axial diusivities	4679_Genu of corpus callosum axial diusivities	25	112	1	112	4225	3989	2362	4587	392	4017	552	1410	959	3305
4344_Sleep sedentary (conditioning sex and BMI)	4344_Sleep sedentary (conditioning sex and BMI)	25	112	1	438	112	4193	4390	3430	3910	891	1985	519	2616	4559
3549_Mouth/teeth dental problems: Dentures	3549_Mouth/teeth dental problems: Dentures	25	112	1	257	180	112	1960	4360	3440	947	131	179	4359	3097
4335_Overall activity	4335_Overall activity	25	112	1	1643	349	1485	112	847	3408	2224	380	402	1020	2191
3061_LILRB1 - Leukocyte immunoglobulin-like receptor subfamily B member 1	3061_LILRB1 - Leukocyte immunoglobulin-like receptor subfamily B member 1	25	112	1	2709	3124	2361	757	277	112	1763	3736	441	1733	4638
3532_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault to yourself	3532_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault to yourself	25	112	1	1429	748	305	3578	143	2264	112	4294	131	1226	1484
2599_IL22RA1 - Interleukin-22 receptor subunit alpha-1	2599_IL22RA1 - Interleukin-22 receptor subunit alpha-1	25	112	1	1832	2425	4098	1165	923	3094	1631	112	495	1352	1179
4582_Right inferior parietal	4582_Right inferior parietal	25	112	1	3608	3549	3699	2726	375	274	2764	1738	4304	2795	112
4118_Zinc sulfate turbidity test	4118_Zinc sulfate turbidity test	25	113	1	141	3652	113	1970	1418	2944	1829	2610	3855	159	2296
2425_TGFBI - Transforming growth factor-beta-induced protein ig-h3	2425_TGFBI - Transforming growth factor-beta-induced protein ig-h3	25	113	1	2908	2642	570	113	3069	1980	727	156	1094	1112	2454
865_Esterified cholesterol	865_Esterified cholesterol	25	113	1	1259	2393	3171	4443	113	1689	2628	3061	3376	3413	3643
1648_P-selectin (at exam 7, FBAT, adjusted formultivariable)	1648_P-selectin (at exam 7, FBAT, adjusted formultivariable)	25	113	1	3926	3681	4663	1136	465	113	4657	1060	4132	2776	1849
3437_Doctor diagnosed hayfever or allergic rhinitis	3437_Doctor diagnosed hayfever or allergic rhinitis	25	113	1	1119	973	2575	4454	686	3758	113	535	4712	1580	3368
887_Cholesterol esters in large HDL	887_Cholesterol esters in large HDL	25	113	1	990	1577	686	4276	743	4337	2423	3287	113	2797	2920
3808_Lymphocyte count	3808_Lymphocyte count	25	113	1	1696	850	4544	4625	3342	443	1148	1010	2540	113	374
1056_Systemic Lupus Erythematosus	1056_Systemic Lupus Erythematosus	25	113	1	1171	2196	510	848	3371	2002	3929	3680	2598	499	113
3326_Number of children fathered (male)	3326_Number of children fathered (male)	25	114	1	114	2304	2125	3012	3426	1585	4297	847	2694	717	1614
1385_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	1385_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	25	114	1	4283	2330	4018	4077	2417	114	1408	1994	4525	4543	3107
2444_GFRA1 - GDNF family receptor alpha-1	2444_GFRA1 - GDNF family receptor alpha-1	25	114	1	4171	693	3847	4299	3800	2523	114	1132	316	1177	3539
2526_IL18R1 - Interleukin-18 receptor 1	2526_IL18R1 - Interleukin-18 receptor 1	25	114	1	4247	813	1930	1191	4484	2388	141	114	221	3591	4456
2885_HS6ST1 - Heparan-sulfate 6-O-sulfotransferase 1	2885_HS6ST1 - Heparan-sulfate 6-O-sulfotransferase 1	25	114	1	1264	3731	2235	1080	470	989	3310	3789	3536	114	1374
4217_Drugs used in diabetes	4217_Drugs used in diabetes	25	114	1	482	257	539	4031	216	431	477	695	4218	232	114
3601_Non-cancer illness code, self-reported: diabetes	3601_Non-cancer illness code, self-reported: diabetes	25	115	1	819	115	907	2798	436	338	325	465	3058	180	167
2745_CXCL10 - C-X-C motif chemokine 10	2745_CXCL10 - C-X-C motif chemokine 10	25	115	1	1339	804	115	3802	1116	4181	839	349	1020	3004	4112
3509_Reason for reducing amount of alcohol drunk: Illness or ill health	3509_Reason for reducing amount of alcohol drunk: Illness or ill health	25	115	1	2554	442	3082	115	1653	1389	189	213	305	1335	3621
3613_Treatment/medication code: simvastatin	3613_Treatment/medication code: simvastatin	25	115	1	1908	3059	823	4439	115	2146	3554	4073	3578	2144	932
3822_Primary biliary cirrhosis	3822_Primary biliary cirrhosis	25	115	1	834	3417	4635	2763	660	115	2515	4238	345	2230	259
3819_Multiple Sclerosis	3819_Multiple Sclerosis	25	115	1	787	4711	3181	4483	311	191	2694	115	3508	2326	342
4701_Genu of corpus callosum mean diusivities	4701_Genu of corpus callosum mean diusivities	25	115	1	1349	826	2901	336	609	657	263	205	115	139	865
1491_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for age and sex)	1491_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for age and sex)	25	115	1	1039	487	3870	4310	3324	234	2445	3839	3128	115	934
4052_25-Hydroxyvitamin D level	4052_25-Hydroxyvitamin D level	25	116	1	116	4588	1584	621	4254	352	734	659	1777	3360	435
1395_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for age and sex)	1395_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for age and sex)	25	116	1	3995	2409	2744	116	823	1568	182	1649	467	2167	775
54_Subjective well being	54_Subjective well being	25	116	1	4606	4447	162	675	116	3914	2866	2781	3212	3578	1833
2284_CGA LHB - Luteinizing hormone	2284_CGA LHB - Luteinizing hormone	25	116	1	2531	3812	1386	2820	731	116	2260	1388	4264	4393	1333
184_Waist-hip ratio (female)	184_Waist-hip ratio (female)	25	116	1	4091	2043	3277	211	4618	795	232	318	116	1437	2840
1467_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	1467_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	25	116	1	3153	334	4386	4621	1042	339	890	878	477	116	2236
1618_CD40 Ligand serum (at exam 7, FBAT, adjusted for age and sex)	1618_CD40 Ligand serum (at exam 7, FBAT, adjusted for age and sex)	25	116	1	3147	4171	2277	4677	3276	3402	1122	851	4587	3341	116
402_Amino acid::Tryptophan metabolism::3-indoxyl sulfate	402_Amino acid::Tryptophan metabolism::3-indoxyl sulfate	25	117	1	433	117	511	4633	2499	4267	240	3728	726	1025	2783
1888_Shaft Width (FBAT, female, adjussted for age)	1888_Shaft Width (FBAT, female, adjussted for age)	25	117	1	867	1034	117	2515	2907	3998	904	2851	531	458	193
2639_SCT - Secretin	2639_SCT - Secretin	25	117	1	4707	389	4296	117	623	930	667	1597	322	188	2677
3266_Average weekly fortified wine intake	3266_Average weekly fortified wine intake	25	117	1	587	1018	3000	3400	117	1812	1266	2636	3395	847	4430
1893_Shaft Section Modulus (GEE, adjussted for multivariable)	1893_Shaft Section Modulus (GEE, adjussted for multivariable)	25	117	1	2188	4609	684	2128	621	117	4609	1327	2674	3685	159
1383_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	1383_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	25	117	1	4349	2602	1684	2510	708	518	117	2443	2167	1729	1640
2655_CA9 - Carbonic anhydrase 9	2655_CA9 - Carbonic anhydrase 9	25	117	1	2840	599	2358	193	1232	3868	406	825	117	1293	2847
1026_Femoral Neck Length (FBAT, adjusted for multivariable)	1026_Femoral Neck Length (FBAT, adjusted for multivariable)	25	117	1	1902	3440	336	4001	4741	769	2261	4465	1073	117	207
243_CXCR3 on CD4n	243_CXCR3 on CD4n	25	118	1	118	564	930	292	4420	3148	1669	1670	1209	393	3138
327_CD4mem:%Th9	327_CD4mem:%Th9	25	118	1	2208	3679	4141	478	3915	3345	120	118	343	4362	1666
4256_Sleep midpoint	4256_Sleep midpoint	25	118	1	3900	240	3467	2809	4656	684	1030	3252	1794	118	2329
1247_Mean FEV1/FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	1247_Mean FEV1/FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	25	118	1	454	2812	343	2625	739	881	1283	1253	3365	2930	118
4041_Schizophrenia vs Bipolar disorder	4041_Schizophrenia vs Bipolar disorder	25	119	1	727	4655	119	1493	1719	2642	2974	2089	3935	3738	2621
3026_PPA1 - Inorganic pyrophosphatase	3026_PPA1 - Inorganic pyrophosphatase	25	119	1	2257	3925	3759	698	119	1017	2111	285	1983	3614	1522
1586_Factor VII (at exam 5, FBAT, adjusted for age and sex)	1586_Factor VII (at exam 5, FBAT, adjusted for age and sex)	25	119	1	2836	2307	4245	411	4639	1208	119	513	568	4550	2451
4237_Antihistamines for systemic use	4237_Antihistamines for systemic use	25	119	1	986	464	3618	2702	345	4027	269	119	2787	263	2822
150_Body Mass Index (female <= 50 yrs)	150_Body Mass Index (female <= 50 yrs)	25	120	1	120	2914	2105	4709	2079	2703	2312	1215	3503	3154	3409
3349_Ever used hormone-replacement therapy (HRT) (female)	3349_Ever used hormone-replacement therapy (HRT) (female)	25	120	1	178	3544	120	196	1983	469	3874	766	2513	1633	4117
2460_THBS2 - Thrombospondin-2	2460_THBS2 - Thrombospondin-2	25	120	1	2975	1433	4474	959	120	1931	1121	317	783	1881	542
4177_C-reactive protein	4177_C-reactive protein	25	120	1	3942	4223	4683	3362	1441	3243	2953	120	2515	3058	2056
1564_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1564_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	120	1	3877	2542	3970	449	1410	2961	2851	4676	3567	120	377
3139_F9 - Coagulation factor IXab	3139_F9 - Coagulation factor IXab	25	121	1	121	2744	187	2081	1201	2013	1972	3860	4153	2627	1433
4223_Calcium channel blockers	4223_Calcium channel blockers	25	121	1	428	841	121	2378	4404	1093	2222	3735	3725	823	2503
990_Interleukin-2 receptor, alpha subunit	990_Interleukin-2 receptor, alpha subunit	25	121	1	2700	3355	2003	121	625	4743	717	1919	723	1934	1224
3692_Diagnoses - secondary ICD10: I20 Angina pectoris	3692_Diagnoses - secondary ICD10: I20 Angina pectoris	25	121	1	2837	665	3894	2353	1192	121	1190	3096	1861	787	3277
4165_Juvenile Myoclonic Epilepsy (JME)	4165_Juvenile Myoclonic Epilepsy (JME)	25	121	1	2097	1200	1770	1002	4040	4094	121	173	1370	153	816
3772_Depression - Recent feelings of tiredness or low enery	3772_Depression - Recent feelings of tiredness or low enery	25	121	1	1254	592	898	2745	4262	3971	790	121	134	130	3003
2426_BGN - Biglycan	2426_BGN - Biglycan	25	121	1	171	1948	1058	2517	1217	308	2528	2293	4508	4246	121
3244_Oily fish intake	3244_Oily fish intake	25	122	1	122	3240	1822	3194	2463	4649	4201	3398	812	1732	484
2449_IL24 - Interleukin-24	2449_IL24 - Interleukin-24	25	122	1	1105	534	122	4605	2408	576	2348	4668	3320	4319	2361
3085_ROBO2 - Roundabout homolog 2	3085_ROBO2 - Roundabout homolog 2	25	122	1	3403	3948	382	122	2170	1355	1432	454	1639	2304	4030
3060_IL7R - Interleukin-7 receptor subunit alpha	3060_IL7R - Interleukin-7 receptor subunit alpha	25	122	1	2699	3453	1464	247	776	122	2623	501	540	3383	3389
3625_Treatment/medication code: levothyroxine sodium	3625_Treatment/medication code: levothyroxine sodium	25	122	1	4245	128	4146	2500	2855	273	122	823	3566	3641	2749
3174_CST1 - Cystatin-SN	3174_CST1 - Cystatin-SN	25	122	1	3546	509	2995	3702	4207	4231	1667	122	1358	1581	3034
4677_Fornix (column and body of fornix) axial diusivities	4677_Fornix (column and body of fornix) axial diusivities	25	122	1	2343	1062	3324	302	3925	1239	845	346	122	1552	4686
1226_Intracranial Volume	1226_Intracranial Volume	25	122	1	1921	901	3095	1880	3520	3716	1769	1856	1318	122	4558
2515_CSNK2A1 - Casein kinase II subunit alpha	2515_CSNK2A1 - Casein kinase II subunit alpha	25	122	1	2023	3393	1665	2208	2897	364	2774	588	3466	3245	122
3576_Social support - Leisure/social activities: Sports club or gym	3576_Social support - Leisure/social activities: Sports club or gym	25	123	1	123	1232	2758	2293	2190	567	2039	3543	3665	670	3129
2032_Prognosis in Crohn's Disease	2032_Prognosis in Crohn's Disease	25	123	1	3477	123	2737	743	3088	812	2309	1773	2461	516	314
4635_Right thalamus proper	4635_Right thalamus proper	25	123	1	3713	4581	123	1304	149	2020	2930	1588	580	3609	1042
445_Carbohydrate::Nucleotide sugars, pentose metabolism::arabinose	445_Carbohydrate::Nucleotide sugars, pentose metabolism::arabinose	25	123	1	2319	1111	1108	902	3449	123	1514	2265	2029	416	1676
548_Lipid::Lysolipid::1-stearoylglycerophosphoinositol	548_Lipid::Lysolipid::1-stearoylglycerophosphoinositol	25	123	1	1874	878	1965	3636	2949	3467	123	3904	466	226	3965
928_MonoLunsaturated fatty acids	928_MonoLunsaturated fatty acids	25	123	1	4450	2480	3370	3084	1574	3178	2305	123	1298	4633	1747
3381_Prospective memory test - Time to answer	3381_Prospective memory test - Time to answer	25	123	1	1298	548	3995	829	3384	3525	3670	1653	2676	123	2396
3402_Fluid intelligence test - FI3 : word interpolation	3402_Fluid intelligence test - FI3 : word interpolation	25	124	1	124	2725	3398	3655	3129	4606	3112	1464	602	925	1538
1285_Visceral fat by CT (GEE, adjusted for age and sex)	1285_Visceral fat by CT (GEE, adjusted for age and sex)	25	124	1	3637	4484	124	3774	2580	733	2648	4113	3454	3724	692
1707_Luteinizing hormone (at exam 3, GEE, adjusted for age and sex)	1707_Luteinizing hormone (at exam 3, GEE, adjusted for age and sex)	25	124	1	3812	2266	3721	802	124	4531	542	2220	1792	1868	1461
1311_Fasting HbA1c (at exam 7, GEE, adjusted for age and sex)	1311_Fasting HbA1c (at exam 7, GEE, adjusted for age and sex)	25	124	1	3941	2964	3844	318	2482	124	2007	3288	4407	2807	180
189_Waist-hip ratio (female, adjusted for BMI)	189_Waist-hip ratio (female, adjusted for BMI)	25	124	2	3990	1615	2355	162	4636	2170	124	471	129	2515	3384
1897_Shaft Section Modulus (GEE, male, adjussted for multivariable)	1897_Shaft Section Modulus (GEE, male, adjussted for multivariable)	25	124	1	1814	4323	1262	1295	2020	156	830	124	4173	4315	2209
2375_CD33 - Myeloid cell surface antigen CD33	2375_CD33 - Myeloid cell surface antigen CD33	25	124	1	1024	4663	3697	1615	2090	4207	4056	2216	124	2658	2669
69_Ulcerative Colitis	69_Ulcerative Colitis	25	124	1	4564	1117	230	2882	2899	2115	2188	1137	319	303	124
718_::::X-11530	718_::::X-11530	25	125	1	251	125	2085	4007	745	2766	1470	4667	1598	931	2292
938_Concentration of small LDL particles	938_Concentration of small LDL particles	25	125	1	2065	2498	3469	4743	125	1793	3023	4387	3071	2882	4178
4285_PEF	4285_PEF	25	125	1	4113	1941	3206	3971	4445	125	1100	4741	522	2642	2858
1924_Hippocampal volume (FBAT, adjusted for age and sex)	1924_Hippocampal volume (FBAT, adjusted for age and sex)	25	125	1	2732	928	3177	377	2404	4702	125	1221	428	4282	1872
4511_Right basal forebrain	4511_Right basal forebrain	25	125	1	4029	4451	4498	1649	3232	4129	4621	125	4733	2821	2490
170_Waist circumference (male)	170_Waist circumference (male)	25	125	1	1395	3353	2195	2902	1823	424	2416	1789	1926	2699	125
4601_Right rostral middle frontal	4601_Right rostral middle frontal	25	126	1	126	625	2698	3777	1073	1177	3083	3429	4139	2809	1760
659_::::X-04494	659_::::X-04494	25	126	1	1968	4519	2621	126	3444	415	1052	937	3644	1839	3167
2702_TPO - Thyroid peroxidase	2702_TPO - Thyroid peroxidase	25	126	1	2633	2188	3408	3489	126	3034	2625	2688	4075	3697	2703
1991_Age at death (GEE, adjusted for birth-cohort)	1991_Age at death (GEE, adjusted for birth-cohort)	25	126	1	3380	4094	3391	3268	1016	126	3785	1131	3138	4401	320
4650_Body of corpus callosum fractional anisotropy	4650_Body of corpus callosum fractional anisotropy	25	126	1	550	765	494	1315	248	2848	126	1454	1715	426	126
3850_Mean corpuscular hemoglobin concentration (two-way meta)	3850_Mean corpuscular hemoglobin concentration (two-way meta)	25	126	1	1563	4227	2716	2064	4559	4364	3306	126	1733	520	2888
422_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxobutyrate	422_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxobutyrate	25	126	1	691	225	2083	2326	3890	3738	134	132	126	264	3067
1073_Parkinson disease	1073_Parkinson disease	25	126	1	1573	1651	3706	1644	3616	3362	4191	3752	2355	126	2959
4166_Body Mass Index	4166_Body Mass Index	25	127	1	127	627	2045	1355	3273	1219	3166	4443	2551	2862	1998
3637_Illnesses of father: Prostate cancer	3637_Illnesses of father: Prostate cancer	25	127	1	3641	127	3579	3844	2921	4077	2991	4027	2700	344	2973
3521_Current employment status: Looking after home and/or family	3521_Current employment status: Looking after home and/or family	25	127	1	671	4448	127	421	2217	1223	2828	1895	2119	1805	984
4388_Epithelial ovarian cancer (Endometrioid)	4388_Epithelial ovarian cancer (Endometrioid)	25	127	1	4518	4627	323	127	4205	3212	2318	2606	4143	3143	4723
2210_MMP7 - Matrilysin	2210_MMP7 - Matrilysin	25	127	1	2793	387	2426	139	1974	784	127	561	144	4400	2109
1195_Asthma (male)	1195_Asthma (male)	25	127	1	1808	4109	4463	3430	2643	4713	4387	127	3765	3110	4392
956_Free cholesterol in very large HDL	956_Free cholesterol in very large HDL	25	127	1	1726	805	3438	674	1064	3912	203	870	127	620	2680
1257_Percent predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	1257_Percent predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	25	127	1	2161	588	300	473	3341	2197	494	3268	435	4347	127
2825_FGF16 - Fibroblast growth factor 16	2825_FGF16 - Fibroblast growth factor 16	25	128	1	128	3475	904	754	881	3115	2776	912	1136	3916	2448
2775_EPS15L1 - Epidermal growth factor receptor substrate 15-like 1	2775_EPS15L1 - Epidermal growth factor receptor substrate 15-like 1	25	128	1	1350	3668	128	4170	2591	1950	2646	3942	2105	3948	2112
2504_BCL2 - Apoptosis regulator Bcl-2	2504_BCL2 - Apoptosis regulator Bcl-2	25	128	1	1486	1981	1400	878	128	2772	2647	1493	393	985	831
3829_Posterior cortical atrophy	3829_Posterior cortical atrophy	25	128	1	1092	3683	1075	365	3787	128	1976	3612	4636	3278	3902
458_Energy::Krebs cycle::alpha-ketoglutarate	458_Energy::Krebs cycle::alpha-ketoglutarate	25	128	1	3164	2869	2804	1253	3974	4057	1165	128	279	3990	3620
179_Waist-hip ratio	179_Waist-hip ratio	25	128	1	534	2740	379	327	4195	479	517	918	128	3302	3274
1332_Fasting HbA1c (at exam 5, FBAT, adjusted for age, sex and BMI)	1332_Fasting HbA1c (at exam 5, FBAT, adjusted for age, sex and BMI)	25	128	1	2517	454	2631	3749	2316	4232	130	4539	866	128	3812
2938_F9 - Coagulation factor IX	2938_F9 - Coagulation factor IX	25	129	1	129	2207	166	2453	1203	729	860	2780	2519	2147	2341
1110_Subcutaneous adipose tissue volume (female)	1110_Subcutaneous adipose tissue volume (female)	25	129	1	1025	992	2168	129	2203	3834	346	986	2009	2036	4002
2253_PRKCD - Protein kinase C delta type	2253_PRKCD - Protein kinase C delta type	25	129	1	4259	1201	4735	148	4409	1760	129	425	281	200	450
1857_Neck average buckling ratio (GEE, male, adjussted for age)	1857_Neck average buckling ratio (GEE, male, adjussted for age)	25	129	1	474	4501	1693	3342	3162	2743	2613	129	1389	2773	3573
1478_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	1478_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	25	130	1	130	1072	1214	3514	1428	2112	3786	4471	2172	236	4215
2031_Inflammatory Bowel Disease	2031_Inflammatory Bowel Disease	25	130	1	2882	130	3621	3989	1676	1645	402	1252	2124	735	199
2560_HAMP - Hepcidin	2560_HAMP - Hepcidin	25	130	1	1341	699	130	4152	3073	3452	639	3480	666	2534	915
3284_Mood swings	3284_Mood swings	25	130	1	336	149	4053	130	4196	1014	755	567	328	253	2648
2713_ING1 - Inhibitor of growth protein 1	2713_ING1 - Inhibitor of growth protein 1	25	130	1	1537	3621	2159	1050	130	2810	4414	2278	1246	2804	260
3368_Chest pain or discomfort walking normally	3368_Chest pain or discomfort walking normally	25	130	1	4002	325	1608	556	1636	130	354	1572	1626	1535	3754
4379_BRCA1/2-negative breast cancer	4379_BRCA1/2-negative breast cancer	25	131	1	131	4662	2520	231	3051	460	2999	3111	1351	889	2161
1374_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for age and sex)	1374_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for age and sex)	25	131	1	2371	131	4122	892	2492	2919	468	399	142	133	1096
3036_TPM1 - Tropomyosin alpha-1 chain	3036_TPM1 - Tropomyosin alpha-1 chain	25	131	1	3481	2303	3423	4220	131	2803	3223	1600	2203	3588	2946
1593_Log ADP platelet aggregation (at exam 5, GEE, adjusted for multivariable)	1593_Log ADP platelet aggregation (at exam 5, GEE, adjusted for multivariable)	25	131	1	4704	1867	420	4420	1329	131	2727	542	2685	2861	910
1716_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for multivariable)	1716_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for multivariable)	25	131	1	2143	471	828	2541	717	2795	1449	1149	1004	2223	131
2276_CYP3A4 - Cytochrome P450 3A4	2276_CYP3A4 - Cytochrome P450 3A4	25	132	1	132	3213	4153	1927	1328	3334	3611	1154	3845	2737	3224
1975_Morbidity-free survival (at age 65, GEE, adjusted for birth-cohort)	1975_Morbidity-free survival (at age 65, GEE, adjusted for birth-cohort)	25	132	1	789	132	1660	265	523	2683	566	3167	571	370	489
1972_Morbidity-free survival (at age 65, FBAT, adjusted for multivariable)	1972_Morbidity-free survival (at age 65, FBAT, adjusted for multivariable)	25	132	1	1374	4570	132	1563	1375	4721	2184	2979	2111	2258	733
3920_Total cholesterol	3920_Total cholesterol	25	132	1	175	1100	155	1898	132	532	3283	2871	1455	2379	3585
2669_IL11RA - Interleukin-11 receptor subunit alpha	2669_IL11RA - Interleukin-11 receptor subunit alpha	25	132	1	653	2030	608	3321	779	132	3016	3677	3627	2652	1668
126_Height (male)	126_Height (male)	25	132	1	1391	3657	1110	2154	4081	2157	673	4381	2377	132	930
1455_Low-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	1455_Low-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	25	132	1	2275	4137	1799	4660	687	151	2827	3256	4502	2211	132
4378_High blood pressure	4378_High blood pressure	25	133	1	133	1760	3472	962	4648	4334	1918	2319	1201	3560	3013
263_DNT:%CD127+TEF	263_DNT:%CD127+TEF	25	133	1	340	133	4191	342	843	2524	457	2316	1255	245	4417
2_Attention deficit hyperactivity disorder	2_Attention deficit hyperactivity disorder	25	133	1	1009	1817	133	3328	3847	4286	1487	4416	2829	1267	1307
1658_Alkaline phosphatase (at exam 2, FBAT, adjusted for age and sex)	1658_Alkaline phosphatase (at exam 2, FBAT, adjusted for age and sex)	25	133	1	4434	3374	4571	133	1261	3424	1181	174	1773	2454	1544
2836_COLEC11 - Collectin-11	2836_COLEC11 - Collectin-11	25	133	1	4254	844	1642	2142	2336	4627	133	2148	2408	592	1483
3558_Medication for pain relief, constipation, heartburn: Ibuprofen (e.g. Nurofen)	3558_Medication for pain relief, constipation, heartburn: Ibuprofen (e.g. Nurofen)	25	134	1	134	4385	2108	3627	3803	2717	4061	4733	1555	243	1208
3246_Processed meat intake	3246_Processed meat intake	25	134	1	2024	134	1171	448	2389	369	347	3620	3450	1663	4242
4110_Estimated glomerular filtration rate	4110_Estimated glomerular filtration rate	25	134	1	411	376	548	134	1709	1483	2431	3343	3726	1473	4378
4711_Sagittal stratum mean diusivities	4711_Sagittal stratum mean diusivities	25	134	1	2670	3532	4641	3708	134	2971	4041	4559	3564	552	4594
4570_Left rostral middle frontal	4570_Left rostral middle frontal	25	134	1	1089	4241	936	1488	4264	134	4579	1450	3394	2731	3112
2211_PPBP - Neutrophil-activating peptide 2	2211_PPBP - Neutrophil-activating peptide 2	25	135	1	4213	3649	135	1807	1415	4348	1129	2391	623	4290	3219
3018_CLIC1 - Chloride intracellular channel protein 1	3018_CLIC1 - Chloride intracellular channel protein 1	25	135	1	896	4628	3294	135	2996	2584	452	153	301	4150	332
1854_Neck average buckling ratio (FBAT, female, adjussted for age)	1854_Neck average buckling ratio (FBAT, female, adjussted for age)	25	135	1	4697	946	1552	1470	135	4726	575	1515	1153	2507	2300
1631_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for age and sex)	1631_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for age and sex)	25	135	1	667	2919	3430	3162	1904	135	3578	1850	4744	1046	176
2213_ALPL - Alkaline phosphatase, tissue-nonspecific isozyme	2213_ALPL - Alkaline phosphatase, tissue-nonspecific isozyme	25	135	1	856	3659	317	2406	3513	3183	135	266	231	4433	1217
1394_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for age and sex)	1394_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	135	1	3404	2514	2696	761	3701	4133	881	135	3475	3654	1002
2688_GAPDH - Glyceraldehyde-3-phosphate dehydrogenase	2688_GAPDH - Glyceraldehyde-3-phosphate dehydrogenase	25	135	1	2137	2224	2167	980	3517	3280	1817	498	135	1323	1085
3551_Vascular/heart problems diagnosed by doctor: High blood pressure	3551_Vascular/heart problems diagnosed by doctor: High blood pressure	25	136	1	136	2360	1291	1520	2035	3747	3698	4142	719	3986	1641
4065_Gait speed	4065_Gait speed	24	136	1	1722	136	283	1922	2878	2880	256	964	161	766	347
1508_Triglycerides (at exam 6, FBAT, adjusted for age and sex)	1508_Triglycerides (at exam 6, FBAT, adjusted for age and sex)	25	136	1	576	2472	136	1961	2181	3084	3631	4236	4731	2844	2088
3070_LAG3 - Lymphocyte activation gene 3 protein	3070_LAG3 - Lymphocyte activation gene 3 protein	25	136	1	3884	3803	459	136	1017	547	1051	571	4271	1962	263
1373_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	1373_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	25	136	1	227	1203	1998	1393	136	172	1813	2432	2161	1253	331
4544_White matter	4544_White matter	25	136	1	848	2649	1707	1629	162	136	1621	504	366	4636	4633
4303_Legs-leg fat ratio (male)	4303_Legs-leg fat ratio (male)	25	136	1	1417	1622	2663	320	2776	579	136	292	204	3725	1699
85_Femoral Neck BMD	85_Femoral Neck BMD	25	136	1	1427	1463	911	533	2906	2894	215	1831	136	1007	2197
4505_Right transverse temporal	4505_Right transverse temporal	25	136	1	423	1630	3427	1212	4620	3720	1215	1556	1801	136	2549
3365_Back pain for 3+ months	3365_Back pain for 3+ months	25	137	1	1187	734	137	3788	3047	2431	2697	1633	1875	1799	3237
3180_STIP1 - Stress-induced-phosphoprotein 1	3180_STIP1 - Stress-induced-phosphoprotein 1	25	137	1	548	4524	538	137	1372	2830	1365	810	219	4451	2181
4658_Inferior fronto-occipital fasciculus fractional anisotropy	4658_Inferior fronto-occipital fasciculus fractional anisotropy	25	137	1	3964	620	3185	2458	137	1479	1745	212	3648	3221	1670
706_::::X-11444	706_::::X-11444	25	137	1	2140	746	3305	2298	1583	137	3605	2076	4527	1421	1788
4512_Brain stem	4512_Brain stem	25	137	1	4354	2645	4093	1062	4111	1165	137	1855	1438	2834	338
3871_Basophil percentage of granulocytes (three-way meta)	3871_Basophil percentage of granulocytes (three-way meta)	25	137	1	2320	239	1483	2698	3779	1498	382	137	4475	2628	4189
780_::::X-12456	780_::::X-12456	25	137	1	4446	1022	2156	4286	4249	1346	493	4714	137	608	1839
2631_PLG - Angiostatin	2631_PLG - Angiostatin	25	138	1	138	1415	171	3442	3594	2798	2674	1078	1840	1937	3527
2122_IL6ST - Interleukin-6 receptor subunit beta	2122_IL6ST - Interleukin-6 receptor subunit beta	25	138	1	1004	450	138	3246	3786	4586	220	2621	2960	362	1012
3730_Depression - Age at last episode of depression	3730_Depression - Age at last episode of depression	25	138	1	2355	481	2434	138	2439	2066	4151	1955	278	310	3891
1886_Shaft Width (FBAT, male, adjussted for multivariable)	1886_Shaft Width (FBAT, male, adjussted for multivariable)	25	138	1	4155	555	1418	964	138	4642	2166	4713	1909	265	1172
2277_NBL1 - Neuroblastoma suppressor of tumorigenicity 1	2277_NBL1 - Neuroblastoma suppressor of tumorigenicity 1	25	138	1	1827	1206	4566	4381	1588	138	3267	1681	3831	1523	4741
601_Peptide::gamma-glutamyl::gamma-glutamylglutamate	601_Peptide::gamma-glutamyl::gamma-glutamylglutamate	25	138	1	4715	491	2535	1490	4671	4066	138	237	190	1144	4452
3232_Sleeplessness / insomnia	3232_Sleeplessness / insomnia	25	138	1	190	366	868	1363	4414	4719	1352	3247	2125	138	2060
1143_Acute insulin response (adjusted for BMI)	1143_Acute insulin response (adjusted for BMI)	25	138	1	1210	3067	685	2184	2999	4219	3904	3009	3456	3631	138
2300_EDAR - Tumor necrosis factor receptor superfamily member EDAR	2300_EDAR - Tumor necrosis factor receptor superfamily member EDAR	25	139	1	662	4032	139	4714	2777	1717	654	253	772	604	1752
2946_C3 - C3a anaphylatoxin	2946_C3 - C3a anaphylatoxin	25	139	1	1930	3512	2677	3146	791	139	4511	1775	984	2637	856
1384_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	1384_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	25	139	1	798	147	2417	236	3372	934	139	282	394	2015	3768
2180_SIGLEC6 - Sialic acid-binding Ig-like lectin 6	2180_SIGLEC6 - Sialic acid-binding Ig-like lectin 6	25	139	1	2953	998	3473	3740	2805	2398	1493	3006	139	453	2596
1068_Bipolar disorder	1068_Bipolar disorder	25	139	1	495	1154	984	999	3145	2719	176	2739	1473	3386	139
133_Waist circumference (female)	133_Waist circumference (female)	25	140	1	140	1189	4328	2704	1285	4184	3952	3483	3294	1573	3717
2279_CFD - Complement factor D	2279_CFD - Complement factor D	25	140	1	3625	140	2641	528	4536	3343	1214	4473	1793	4007	1570
4751_Splenium of corpus callosum radial diusivities	4751_Splenium of corpus callosum radial diusivities	25	140	1	4305	1075	1778	1540	140	2787	3496	2003	4113	2209	911
2865_IL12B IL23A - Interleukin-23	2865_IL12B IL23A - Interleukin-23	25	140	1	3536	4002	3900	4421	3452	140	4675	3550	3102	4637	268
2333_IL19 - Interleukin-19	2333_IL19 - Interleukin-19	25	140	1	558	730	3170	946	1028	832	460	140	635	218	973
935_Triglycerides in small HDL	935_Triglycerides in small HDL	25	140	1	3092	2709	3069	3410	3121	3376	2720	3636	140	4657	2067
1024_Femoral Neck Length (FBAT, adjusted for age and sex)	1024_Femoral Neck Length (FBAT, adjusted for age and sex)	25	140	1	2711	3518	959	1440	1131	3065	1509	4278	905	140	238
2177_NANOG - Homeobox protein NANOG	2177_NANOG - Homeobox protein NANOG	25	141	1	2570	141	267	1132	3359	1119	1292	4525	1510	216	1252
2807_TKT - Transketolase	2807_TKT - Transketolase	25	141	1	489	4386	141	180	3382	3654	1755	639	199	3140	1635
1794_RR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1794_RR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	141	1	1185	1166	4130	141	1492	3199	2018	4617	2207	3468	4213
2790_NME1 - Nucleoside diphosphate kinase A	2790_NME1 - Nucleoside diphosphate kinase A	25	141	1	3971	2853	2465	1270	141	3702	3831	3258	3793	3534	3898
3167_CDH15 - Cadherin-15	3167_CDH15 - Cadherin-15	25	141	1	721	663	2354	1983	2918	141	523	4708	1100	657	4647
4691_Anterior corona radiata mean diusivities	4691_Anterior corona radiata mean diusivities	25	141	1	1576	695	3649	1678	1121	2316	1116	1318	806	141	1952
1952_Boston Naming Test score without cues (FBAT, adjusted for multivariable)	1952_Boston Naming Test score without cues (FBAT, adjusted for multivariable)	25	141	1	1394	3674	3470	3524	3639	666	3389	3491	4382	3295	141
4607_Right insula	4607_Right insula	25	142	1	142	274	1854	4552	4350	558	348	3647	2261	231	469
3860_Neutrophil percentage of white cells (two-way meta)	3860_Neutrophil percentage of white cells (two-way meta)	25	142	1	3155	142	638	2212	3877	3127	1357	4196	3317	447	2469
1147_Ratio of AUC insulin to AUC glucose	1147_Ratio of AUC insulin to AUC glucose	25	142	1	757	4037	142	4087	639	1001	3121	4599	1431	3291	1418
336_NKeff:%2-158a+	336_NKeff:%2-158a+	25	142	1	1784	3759	1539	142	1853	3167	2656	3125	3103	3205	4342
1529_Remnant lipoprotein cholesterol (at exam 4, GEE)	1529_Remnant lipoprotein cholesterol (at exam 4, GEE)	25	142	1	4163	2795	3731	1225	276	142	1380	2145	1210	3531	1781
3468_Impedance measures - Trunk fat percentage	3468_Impedance measures - Trunk fat percentage	25	142	1	1598	320	3495	4377	2651	652	637	382	476	142	623
3190_Number of self-reported non-cancer illnesses	3190_Number of self-reported non-cancer illnesses	25	142	1	2368	876	1328	3449	3253	871	752	667	1116	1057	142
3795_Neuroticism	3795_Neuroticism	25	143	1	143	238	2454	941	1283	1002	4246	414	471	545	4017
3645_Illnesses of mother: Diabetes	3645_Illnesses of mother: Diabetes	25	143	1	2424	143	2739	3277	2685	3901	2266	1279	4689	341	1696
1617_CD40 Ligand plasma (at exam 7, GEE, adjusted for multivariable)	1617_CD40 Ligand plasma (at exam 7, GEE, adjusted for multivariable)	25	143	1	3497	3356	3251	3588	3512	143	4561	3018	4228	2876	1265
438_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannose	438_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannose	25	143	1	876	1140	2256	2343	215	1168	150	143	4396	1830	2887
3439_Tobacco smoking	3439_Tobacco smoking	25	143	1	2401	250	2267	1482	447	4114	1374	2142	1145	143	2652
3755_Mental distress - Ever sought or received professional help for mental distress	3755_Mental distress - Ever sought or received professional help for mental distress	25	143	1	2352	1488	3328	3273	167	3657	4458	1415	2270	683	143
4721_Fornix (column and body of fornix) mode of anisotropy	4721_Fornix (column and body of fornix) mode of anisotropy	25	144	1	546	144	1967	3431	3300	1471	235	2348	2764	559	3919
621_Xenobiotics::Drug::2-methoxyacetaminophen sulfate*	621_Xenobiotics::Drug::2-methoxyacetaminophen sulfate*	25	144	1	3875	940	4396	144	2708	4327	1852	1704	3004	2099	3038
1401_High-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	1401_High-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	25	144	1	4031	1180	152	791	144	155	714	444	1714	685	194
4659_Posterior corona radiata fractional anisotropy	4659_Posterior corona radiata fractional anisotropy	25	144	1	2398	2201	1465	3941	3255	144	2355	3355	2115	2663	2311
2331_LGALS2 - Galectin-2	2331_LGALS2 - Galectin-2	25	144	1	4439	2502	2640	3346	3280	878	144	3370	1590	4500	3776
4538_Right hippocampus	4538_Right hippocampus	25	144	1	3284	1626	880	536	2722	752	3172	144	3483	2553	1431
2497_PTPN11 - Tyrosine-protein phosphatase non-receptor type 11	2497_PTPN11 - Tyrosine-protein phosphatase non-receptor type 11	25	145	1	145	4003	163	2697	1575	1994	3625	2113	2259	2403	4160
3932_Digalactosylation	3932_Digalactosylation	25	145	1	1443	145	2578	992	3579	1587	561	2244	289	1275	1443
665_::::X-05907	665_::::X-05907	25	145	1	3752	1121	3859	145	3198	4072	1053	445	429	868	2046
1575_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	1575_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	25	145	1	4622	3675	2349	2532	2313	145	3875	3261	3709	2135	1043
4053_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	4053_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	25	145	1	2036	956	3104	1394	1788	549	786	145	624	1908	4255
4329_Fractures	4329_Fractures	25	145	1	1490	505	4336	597	3434	3616	1659	3383	581	145	4309
1764_Heart failure (free of MI, FBAT, adjusted for age and sex)	1764_Heart failure (free of MI, FBAT, adjusted for age and sex)	25	146	1	4393	3994	3288	3808	146	3726	2025	4161	909	3670	444
4370_Thyroid-stimulating hormone (male)	4370_Thyroid-stimulating hormone (male)	25	146	1	2503	3541	2483	4610	777	146	4464	2082	1295	3265	1335
2725_UBE2N - Ubiquitin-conjugating enzyme E2 N	2725_UBE2N - Ubiquitin-conjugating enzyme E2 N	25	146	1	222	2403	730	168	2741	3903	540	146	244	748	1934
925_Concentration of medium VLDL particles	925_Concentration of medium VLDL particles	25	146	1	4489	3181	1287	3769	1648	2059	989	1484	146	2984	3033
4728_Retrolenticular part of internal capsule mode of anisotropy	4728_Retrolenticular part of internal capsule mode of anisotropy	25	146	1	773	393	2243	331	744	4210	683	360	1630	146	1536
1066_Multiple Sclerosis	1066_Multiple Sclerosis	25	146	1	4268	4745	2609	4533	3907	789	3199	4551	1307	4026	146
3672_Diagnoses - main ICD10: K52 Other and unsp noninfective gastroenteritis and colitis	3672_Diagnoses - main ICD10: K52 Other and unsp noninfective gastroenteritis and colitis	25	147	1	147	929	1824	3580	1021	268	2627	3240	1312	1459	754
313_CD4nv:%TFH (1)	313_CD4nv:%TFH (1)	25	147	1	661	4652	147	1370	4449	1397	3278	3932	3616	2495	2981
3214_Frequency of light DIY in last 4 weeks	3214_Frequency of light DIY in last 4 weeks	25	147	1	1176	2682	3128	2521	4198	147	3047	4685	4410	2818	3600
702_::::X-11438	702_::::X-11438	25	147	1	3601	863	1335	1047	4324	1894	147	1961	780	1713	3342
642_Xenobiotics::Xanthine metabolism::1-methylurate	642_Xenobiotics::Xanthine metabolism::1-methylurate	25	147	1	3626	310	2221	4563	1099	2323	476	147	1702	3206	3687
3044_CD300C - CMRF35-like molecule 6	3044_CD300C - CMRF35-like molecule 6	25	147	1	2362	242	2598	1351	4674	3794	807	1741	147	1175	828
2059_Type 2 Diabetes	2059_Type 2 Diabetes	25	147	1	1572	2406	662	3631	4701	2694	3358	1014	3920	147	2405
1786_QT interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1786_QT interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	147	1	2733	2048	1260	2681	2531	1461	2512	652	3117	922	147
2165_TNFRSF13B - Tumor necrosis factor receptor superfamily member 13B	2165_TNFRSF13B - Tumor necrosis factor receptor superfamily member 13B	25	148	1	148	2229	1484	925	2351	298	3813	3553	2135	2478	3847
838_Peptide::Dipeptide::X-14450--phenylalanylleucine	838_Peptide::Dipeptide::X-14450--phenylalanylleucine	25	148	1	382	3398	148	759	1335	2857	2446	873	3040	3268	3099
3554_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Cholesterol lowering medication	3554_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Cholesterol lowering medication	25	148	1	2486	2921	293	3149	148	1951	2836	3508	3542	3309	704
3915_Disc area	3915_Disc area	25	148	1	1334	934	1643	4682	184	148	635	2081	2430	294	629
4207_Blood urea nitrogen	4207_Blood urea nitrogen	25	148	1	1511	966	3340	283	3007	1378	2227	200	148	1584	4476
989_Interleukin-2	989_Interleukin-2	25	148	1	2889	696	1141	4487	1002	3563	1078	394	4553	148	3337
4500_Right rostral middle frontal	4500_Right rostral middle frontal	25	149	1	149	3635	814	3815	1455	1494	1637	4202	3492	4162	4536
684_::::X-10500	684_::::X-10500	25	149	1	4123	982	4038	1618	3339	1449	149	908	3905	4096	4230
2147_TNFRSF17 - Tumor necrosis factor receptor superfamily member 17	2147_TNFRSF17 - Tumor necrosis factor receptor superfamily member 17	25	149	1	3938	418	2126	2086	2144	3830	591	149	534	587	2489
1262_Residual from predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	1262_Residual from predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	25	149	1	1294	4539	413	2164	689	1750	1383	1946	417	3474	149
46_Baldness	46_Baldness	25	150	1	150	655	1622	2374	3279	1080	4445	2287	1083	494	4543
3008_SCGB2A1 - Mammaglobin-B	3008_SCGB2A1 - Mammaglobin-B	25	150	1	740	150	2662	3525	2939	4731	2810	521	911	4678	4227
2648_PROC - Activated Protein C	2648_PROC - Activated Protein C	25	150	1	3639	646	2099	1773	150	994	4492	4157	2688	4176	4323
683_::::X-10429	683_::::X-10429	25	150	1	1803	2540	2774	4383	3164	150	3644	4565	3016	2033	4033
3389_Friendships satisfaction	3389_Friendships satisfaction	25	150	1	4242	704	1081	450	3614	4192	852	150	971	1418	2380
1252_Percent predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	1252_Percent predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	25	150	1	1601	1742	222	2050	397	1075	254	1320	150	3512	308
2404_KLK5 - Kallikrein-5	2404_KLK5 - Kallikrein-5	25	150	1	1116	196	4104	903	3731	1578	874	3002	842	150	3602
2417_RET - Proto-oncogene tyrosine-protein kinase receptor Ret	2417_RET - Proto-oncogene tyrosine-protein kinase receptor Ret	25	151	1	151	202	604	735	840	4411	1403	259	3606	214	2180
2541_MPL - Thrombopoietin Receptor	2541_MPL - Thrombopoietin Receptor	25	151	1	673	2143	151	2757	557	2723	3491	1144	1758	1137	222
3977_Lean body mass (whole body)	3977_Lean body mass (whole body)	25	151	1	2219	479	3317	151	2803	678	1136	301	869	625	4300
3332_Taking other prescription medications	3332_Taking other prescription medications	25	151	1	4119	243	4365	3252	353	583	151	1012	3088	170	233
3916_Disc area	3916_Disc area	25	151	1	4173	3441	738	569	1645	2457	2443	151	1215	4594	4640
3420_Pairs matching test - Number of incorrect matches in round	3420_Pairs matching test - Number of incorrect matches in round	25	151	1	4333	382	2781	2997	2951	3592	917	4623	151	4431	2504
169_Waist circumference (male)	169_Waist circumference (male)	25	151	1	2268	3511	2310	3729	783	1249	2789	2344	1892	2954	151
3989_Heart rate recovery at 50 secnds	3989_Heart rate recovery at 50 secnds	25	152	1	152	2965	514	926	1953	3179	2084	4432	2541	1811	4434
1366_Total cholesterol (at exam 5, FBAT, adjusted for age and sex)	1366_Total cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	152	1	3206	152	661	358	194	668	381	1904	381	2012	410
1081_Alzheimer's disease	1081_Alzheimer's disease	25	152	1	877	767	1847	4196	152	1517	3211	1344	3092	419	1106
2098_IGFBP2 - Insulin-like growth factor-binding protein 2	2098_IGFBP2 - Insulin-like growth factor-binding protein 2	25	152	1	2472	3396	1872	1388	4531	152	400	2731	4001	4248	4298
4519_Left cerebellum exterior	4519_Left cerebellum exterior	25	152	1	4426	2590	2992	1072	2114	1714	152	1011	3580	4651	1213
446_Carbohydrate::Nucleotide sugars, pentose metabolism::threitol	446_Carbohydrate::Nucleotide sugars, pentose metabolism::threitol	25	152	1	4066	2187	3675	839	2967	1255	553	152	2567	4714	1979
4098_Total cholesterol	4098_Total cholesterol	25	152	1	392	1038	159	4404	405	2142	1784	2236	152	3926	2195
4576_Left insula	4576_Left insula	25	152	1	872	1700	1755	2034	3792	677	1805	650	4624	2356	152
4475_Left insula	4475_Left insula	25	153	1	153	2306	879	1456	2561	491	4047	1056	4456	1053	742
351_gdT:%CM (2)	351_gdT:%CM (2)	25	153	1	1544	153	891	2477	4537	4237	604	2190	682	286	3653
2528_INSR - Insulin receptor	2528_INSR - Insulin receptor	25	153	1	3474	2735	4451	2144	153	3108	319	2291	1985	2520	4241
1605_tPA (at exam 5, GEE, adjusted for multivariable)	1605_tPA (at exam 5, GEE, adjusted for multivariable)	25	153	1	2555	2686	2225	4388	3414	153	1619	2952	1843	3427	197
3388_Family relationship satisfaction	3388_Family relationship satisfaction	25	153	1	2168	2385	1774	974	4710	1722	153	1190	537	4028	1454
4643_Right vessel	4643_Right vessel	25	153	1	272	2398	374	2815	1153	660	1426	609	4106	845	153
2842_HNRNPAB - Heterogeneous nuclear ribonucleoprotein A/B	2842_HNRNPAB - Heterogeneous nuclear ribonucleoprotein A/B	25	154	1	154	4297	2047	2084	1845	872	2057	3278	3177	4727	2371
1245_Mean FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	1245_Mean FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	25	154	1	2297	4329	154	4352	3421	4481	2476	163	3666	3520	570
3988_Heart rate recovery at 40 secnds	3988_Heart rate recovery at 40 secnds	25	154	1	155	3710	492	154	2836	2824	4123	2767	1066	4527	4738
1465_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	1465_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	25	154	1	4411	1723	4246	4473	154	958	2340	2451	1271	1245	1563
1446_Low-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	1446_Low-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	25	154	1	3656	1061	3835	3221	2359	154	4463	4606	3689	2634	963
1175_Excessive daytime sleepness	1175_Excessive daytime sleepness	25	154	1	3506	723	4001	3218	1968	1909	154	3749	3887	941	1393
3449_Impedance measures - Impedance of leg (left)	3449_Impedance measures - Impedance of leg (left)	25	154	1	794	3086	1356	758	1481	2128	679	1419	154	2912	4294
3413_Fluid intelligence score	3413_Fluid intelligence score	25	154	1	455	2605	3242	1805	2357	942	3632	2491	1804	3334	154
3968_Asthma (fixed effect model)	3968_Asthma (fixed effect model)	25	155	1	2614	155	883	1899	1235	1176	224	1383	3414	285	386
62_Age at menopause	62_Age at menopause	25	155	1	4398	761	3002	1099	155	3689	3769	661	1476	1570	3943
4633_Right cerebellum exterior	4633_Right cerebellum exterior	25	155	1	3236	2524	4202	4318	1074	1160	155	3883	3171	1614	330
3553_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	3553_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	25	155	1	1290	1190	4440	870	1076	3819	386	155	1128	588	4679
3605_Non-cancer illness code, self-reported: hayfever/allergic rhinitis	3605_Non-cancer illness code, self-reported: hayfever/allergic rhinitis	25	155	1	2723	252	2041	794	1204	2937	167	624	4145	155	352
3849_Lymphocyte percentage of white cells (two-way meta)	3849_Lymphocyte percentage of white cells (two-way meta)	25	156	1	638	2151	156	488	2645	183	1940	2325	3694	1840	1301
2503_UFC1 - Ubiquitin-fold modifier-conjugating enzyme 1	2503_UFC1 - Ubiquitin-fold modifier-conjugating enzyme 1	25	156	1	2867	2945	3290	156	810	1848	1549	2497	899	4697	2373
4749_Posterior thalamic radiation (include optic radiation) radial diusivities	4749_Posterior thalamic radiation (include optic radiation) radial diusivities	25	156	1	4108	2238	4441	4401	156	4220	2800	2962	4376	1837	1638
547_Lipid::Lysolipid::1-stearoylglycerophosphoethanolamine	547_Lipid::Lysolipid::1-stearoylglycerophosphoethanolamine	25	156	1	1027	1184	2471	2240	3424	2443	3681	2584	4157	156	3483
599_Peptide::Fibrinogen cleavage peptide::ADSGEGDFXAEGGGVR*	599_Peptide::Fibrinogen cleavage peptide::ADSGEGDFXAEGGGVR*	25	157	1	157	2597	2017	4622	3528	3168	4581	3323	3443	2983	1853
2336_CCL3 - C-C motif chemokine 3	2336_CCL3 - C-C motif chemokine 3	25	157	1	394	157	585	2004	2883	4331	1055	4495	209	658	3230
3569_Why stopped smoking: Financial reasons	3569_Why stopped smoking: Financial reasons	25	157	1	206	1862	157	4679	3733	594	1792	829	660	1000	2841
3709_Diagnoses - secondary ICD10: Z82 Family history of certain disabilities and chronic diseases (leading to disablement)	3709_Diagnoses - secondary ICD10: Z82 Family history of certain disabilities and chronic diseases (leading to disablement)	25	157	1	1336	4262	2821	157	3030	1272	3277	373	1711	762	2943
4114_Chloride	4114_Chloride	25	157	1	4733	4259	2612	1443	157	2706	4590	2951	4169	4108	1427
1639_Myeloperoxidase (at exam 7, GEE, adjusted for age and sex)	1639_Myeloperoxidase (at exam 7, GEE, adjusted for age and sex)	25	157	1	3207	4063	1528	3988	615	157	1951	4258	2206	2633	2024
1062_Psoriasis	1062_Psoriasis	25	157	1	4189	2208	3138	3679	1300	4700	2505	1125	4694	1228	157
828_::::X-13741	828_::::X-13741	25	158	1	3035	158	4212	2574	1620	3209	2605	2686	1521	547	3836
491_Lipid::Essential fatty acid::linoleate (18:2n6)	491_Lipid::Essential fatty acid::linoleate (18:2n6)	25	158	1	607	1729	158	3591	1683	2550	3522	4715	4133	3055	4530
3293_Suffer from 'nerves'	3293_Suffer from 'nerves'	25	158	1	2487	3220	2715	158	1690	1327	3780	1747	1167	2624	1373
45_Self-reported tiredness	45_Self-reported tiredness	25	158	1	4124	3416	643	847	158	3109	3582	3249	4343	1480	1164
971_Phospholipids in chylomicrons and extremely large VLDL	971_Phospholipids in chylomicrons and extremely large VLDL	25	158	1	1093	2319	2467	1744	2957	1106	705	158	724	2558	2463
1887_Shaft Width (GEE, male, adjussted for multivariable)	1887_Shaft Width (GEE, male, adjussted for multivariable)	25	158	1	4520	836	1694	3046	3258	2637	3596	2386	2480	158	978
3515_Gas or solid-fuel cooking/heating: An open solid fuel fire that you use regularly in winter time	3515_Gas or solid-fuel cooking/heating: An open solid fuel fire that you use regularly in winter time	25	159	1	159	754	1821	3359	1524	3264	2890	225	847	2910	2456
1766_Heart failure (free of MI, FBAT, adjusted for multivariable)	1766_Heart failure (free of MI, FBAT, adjusted for multivariable)	25	159	1	3746	3894	1182	3872	159	3020	4148	4318	2566	2638	1107
2457_RGMB - RGM domain family member B	2457_RGMB - RGM domain family member B	25	159	1	2615	2109	1851	1864	1673	159	1944	3688	3555	3255	3500
4198_Waist-hip ratio (male)	4198_Waist-hip ratio (male)	25	159	1	521	2829	3460	858	2943	1172	3286	159	3838	4593	3066
4208_Blood urea nitrogen	4208_Blood urea nitrogen	25	159	1	2455	1409	4300	1022	3857	2447	2940	1819	159	3488	1859
1963_Mean MMSE score for exam 5 and 7 (GEE, adjusted for age)	1963_Mean MMSE score for exam 5 and 7 (GEE, adjusted for age)	25	160	1	2364	2195	1390	2103	160	1732	2232	1967	1591	4559	3043
3055_IL1RAPL2 - X-linked interleukin-1 receptor accessory protein-like 2	3055_IL1RAPL2 - X-linked interleukin-1 receptor accessory protein-like 2	25	160	1	2122	999	350	1529	3611	160	3853	2387	1428	3821	250
839_::::X-14473	839_::::X-14473	25	160	1	1720	434	2305	3536	1644	440	160	2850	311	714	4692
3430_Fluid intelligence test - FI8 : chained arithmetic	3430_Fluid intelligence test - FI8 : chained arithmetic	25	160	1	756	745	1367	1307	4660	569	2360	1107	469	160	1143
2071_APOE - Apolipoprotein E	2071_APOE - Apolipoprotein E	25	160	1	4350	4006	3554	1321	4723	1453	3425	2730	1790	2332	160
1430_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1430_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	161	1	3006	1381	161	2603	3254	1736	369	1898	376	4646	1023
3582_Types of transport used (excluding work): Walk	3582_Types of transport used (excluding work): Walk	25	161	1	3473	3151	2180	161	3617	4352	2562	1173	3480	2657	4667
2849_SIGLEC1 - Sialoadhesin	2849_SIGLEC1 - Sialoadhesin	25	161	1	2782	2237	417	270	161	3252	1510	722	671	3493	1811
4397_Menstruation quality of life impact: Increased appetite	4397_Menstruation quality of life impact: Increased appetite	25	162	1	162	634	2121	4586	3025	3812	4616	1262	2343	2527	4424
1909_Lateral ventricular volume (GEE, adjusted for multivariable)	1909_Lateral ventricular volume (GEE, adjusted for multivariable)	25	162	1	4404	716	1185	1382	3184	4474	162	992	1401	1508	265
759_::::X-12188	759_::::X-12188	25	162	1	1283	4405	1975	1143	3293	2382	3045	162	4412	4001	2070
4361_Atrial fibrillation	4361_Atrial fibrillation	25	162	1	344	1280	760	2228	433	4001	1686	2845	162	2617	4699
1582_D-dimer (at exam 6, FBAT, adjusted for age and sex)	1582_D-dimer (at exam 6, FBAT, adjusted for age and sex)	25	162	1	3370	1779	3067	4111	1769	294	4203	284	4213	1968	162
4653_Corticospinal tract fractional anisotropy	4653_Corticospinal tract fractional anisotropy	25	163	1	163	1224	234	2737	4529	1899	2448	3648	4136	4013	2412
3626_Treatment/medication code: bendroflumethiazide	3626_Treatment/medication code: bendroflumethiazide	25	163	1	815	163	239	841	3019	2843	864	1626	1576	380	2576
1053_Neuroblastoma	1053_Neuroblastoma	25	163	1	4320	2947	4529	163	1878	3828	1717	1480	4543	240	4709
3743_Depression - Feelings of worthlessness during worst period of depression	3743_Depression - Feelings of worthlessness during worst period of depression	25	163	1	4145	438	1445	1157	163	3193	2744	1889	805	394	1590
933_Total lipids in small HDL	933_Total lipids in small HDL	25	163	1	226	544	2410	418	926	4141	163	728	254	715	740
3363_Age started hormone-replacement therapy (HRT) (female)	3363_Age started hormone-replacement therapy (HRT) (female)	25	163	1	1963	173	2935	3083	4539	2976	2593	4172	163	1489	4164
1772_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for age and sex)	1772_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for age and sex)	25	163	1	4193	1410	1347	4734	592	2025	3552	3134	4282	4251	163
1669_Aspartate aminotransferase (at exam 2, GEE, adjusted for multivariable)	1669_Aspartate aminotransferase (at exam 2, GEE, adjusted for multivariable)	25	164	1	164	1380	211	2673	1363	4496	1400	2551	2290	981	2228
4174_Social support - Leisure/social activities: Religious group	4174_Social support - Leisure/social activities: Religious group	25	164	1	683	164	1897	547	4251	2654	179	244	432	316	4364
1961_Mean MMSE score for exam 5 and 7 (GEE, adjusted for multivariable)	1961_Mean MMSE score for exam 5 and 7 (GEE, adjusted for multivariable)	25	164	1	3249	837	2481	4430	164	740	2062	3686	2055	329	4262
137_Weight (female)	137_Weight (female)	25	164	1	3470	380	2807	2874	3689	2975	164	549	1232	3376	2681
2435_CNTN4 - Contactin-4	2435_CNTN4 - Contactin-4	25	164	1	2685	518	1231	254	1341	1884	699	164	918	1018	3239
2492_PIK3CA PIK3R1 - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform:Phosphatidylinositol 3-kinase regulatory subunit alpha complex	2492_PIK3CA PIK3R1 - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform:Phosphatidylinositol 3-kinase regulatory subunit alpha complex	25	164	1	3799	926	4200	3333	4713	2320	1489	599	164	2376	4591
4718_Cingulum (hippocampus) mode of anisotropy	4718_Cingulum (hippocampus) mode of anisotropy	25	164	1	4556	448	3632	1054	240	2959	510	186	2741	164	3232
4621_Left cerebellum white matter	4621_Left cerebellum white matter	25	164	1	3181	1315	2402	1671	3950	1928	1574	2898	1741	1582	164
2283_IGF1 - Insulin-like growth factor I	2283_IGF1 - Insulin-like growth factor I	25	165	1	1637	4732	1717	1170	165	1454	3777	2796	4446	4411	1349
677_::::X-09026	677_::::X-09026	25	165	1	2761	1288	2059	4402	3368	165	1685	2728	1695	3769	4183
71_High-density lipoprotein cholesterol	71_High-density lipoprotein cholesterol	25	165	1	4249	4492	2365	3289	2457	2935	3971	1677	165	1978	615
1429_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1429_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	165	1	2276	3715	3879	610	2913	632	3638	3672	4350	3745	165
2715_LDHB - L-lactate dehydrogenase B chain	2715_LDHB - L-lactate dehydrogenase B chain	25	166	1	2422	166	3510	4139	4619	2536	384	3781	541	1434	2779
4628_Left accumbens area	4628_Left accumbens area	25	166	1	2064	3538	3773	166	4059	735	4186	802	3992	1449	515
937_Total lipids in small LDL	937_Total lipids in small LDL	25	166	1	2158	2183	2672	3690	166	4063	3616	2869	1493	2334	3551
4374_Free thyroxine (FT4, female)	4374_Free thyroxine (FT4, female)	25	166	1	3632	682	3432	1893	4385	166	479	1328	1942	730	4315
203_Chronic kidney disease	203_Chronic kidney disease	25	166	1	4468	575	3301	1312	617	1242	166	1263	172	2097	1610
2175_MICA - MHC class I polypeptide-related sequence A	2175_MICA - MHC class I polypeptide-related sequence A	25	166	1	3831	1678	3983	4201	1216	1771	4603	3642	2858	2554	166
723_::::X-11550	723_::::X-11550	25	167	1	167	2750	820	1229	2885	4349	2377	1620	3852	3819	651
486_Lipid::Carnitine metabolism::stearoylcarnitine	486_Lipid::Carnitine metabolism::stearoylcarnitine	25	167	1	1447	167	4201	1452	721	2483	1386	278	274	3415	3974
3128_PDE5A - cGMP-specific 3',5'-cyclic phosphodiesterase	3128_PDE5A - cGMP-specific 3',5'-cyclic phosphodiesterase	25	167	1	2003	3443	3628	167	572	521	4591	4148	692	3576	427
1089_Alcohol dependence	1089_Alcohol dependence	25	167	1	2323	1197	2055	1144	1533	262	528	167	391	1189	724
4_Autism spectrum disorder	4_Autism spectrum disorder	25	167	1	2924	3713	4557	4296	3108	2759	1893	3210	1826	167	4641
4433_Mumps IgG levels	4433_Mumps IgG levels	25	168	1	168	801	296	3129	2298	2902	2815	2125	2509	1766	4676
1287_Visceral fat by CT (GEE, adjusted for age, sex, smoking, menopause)	1287_Visceral fat by CT (GEE, adjusted for age, sex, smoking, menopause)	25	168	1	3785	4313	168	4004	2597	418	2456	3727	3273	3016	491
2394_GAS1 - Growth arrest-specific protein 1	2394_GAS1 - Growth arrest-specific protein 1	25	168	1	1096	3562	1183	596	168	882	3514	449	1539	2722	4489
2540_BIRC5 - Baculoviral IAP repeat-containing protein 5	2540_BIRC5 - Baculoviral IAP repeat-containing protein 5	25	168	1	252	1753	2470	573	262	168	3398	3136	2429	3809	4404
1054_Amyotrophic lateral sclerosis	1054_Amyotrophic lateral sclerosis	25	168	1	3242	533	3116	871	1607	1890	168	2512	1124	2288	2753
1818_Inter-trochanteric buckling ratio (FBAT, female, adjussted for multivariable)	1818_Inter-trochanteric buckling ratio (FBAT, female, adjussted for multivariable)	25	168	1	1700	399	4563	507	895	1335	1437	168	180	1190	3489
4520_Left cerebellum white matter	4520_Left cerebellum white matter	25	168	1	4643	968	4384	1528	1330	2758	879	3357	1074	799	168
1107_Blond hair in Solomon Islanders	1107_Blond hair in Solomon Islanders	25	169	1	169	527	1118	3634	2268	1663	330	3556	2746	509	3800
3495_Hair colour (natural, before greying): Blonde	3495_Hair colour (natural, before greying): Blonde	25	169	1	496	169	1397	961	2970	767	1809	3315	625	1073	1807
1223_Mean Pallidum	1223_Mean Pallidum	25	169	1	905	2954	169	3948	1868	4401	4196	2001	3476	2568	208
4000_Suffer from 'nerves' (SUF-NERV)	4000_Suffer from 'nerves' (SUF-NERV)	25	169	1	3701	2461	1159	169	1894	868	4181	4055	3526	1998	2705
3493_Coffee type: Instant coffee	3493_Coffee type: Instant coffee	25	169	1	1387	3605	2244	2794	169	1190	3944	3632	917	3617	2555
180_Waist-hip ratio	180_Waist-hip ratio	25	169	1	1332	2247	561	325	3705	225	770	929	169	1001	3181
4104_Total protein	4104_Total protein	25	169	1	4097	4693	2568	2195	190	1947	1082	3275	1166	4705	169
3410_Interpolated Year when non-cancer illness first diagnosed	3410_Interpolated Year when non-cancer illness first diagnosed	25	170	2	1618	170	2685	1881	1482	3801	280	1381	1002	743	734
4480_Right fusiform	4480_Right fusiform	25	170	1	4388	2046	412	170	2112	2221	1726	589	1957	4054	4475
608_Peptide::gamma-glutamyl::gamma-glutamyltyrosine	608_Peptide::gamma-glutamyl::gamma-glutamyltyrosine	25	170	1	1695	2439	870	1876	170	2768	1338	1396	2019	474	2092
1327_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	1327_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	25	170	1	4676	3401	1440	1291	1161	170	3699	1829	3407	3190	292
615_Xenobiotics::Benzoate metabolism::4-vinylphenol sulfate	615_Xenobiotics::Benzoate metabolism::4-vinylphenol sulfate	25	170	1	3395	2258	756	1944	4308	2763	3185	1616	170	3711	2461
2348_IL4R - Interleukin-4 receptor subunit alpha	2348_IL4R - Interleukin-4 receptor subunit alpha	25	171	1	3247	171	4290	4727	4659	4215	2034	4364	892	698	4324
1576_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	1576_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	25	171	1	1464	782	4669	4114	171	4200	1929	1005	1301	952	3396
3207_Duration of moderate activity	3207_Duration of moderate activity	25	171	1	432	2989	1274	366	1883	171	2048	222	2085	2479	701
2269_PCNA - Proliferating cell nuclear antigen	2269_PCNA - Proliferating cell nuclear antigen	25	171	1	4130	1098	3546	2443	3593	437	171	1842	2426	3497	1231
674_::::X-08402	674_::::X-08402	25	171	1	4030	2551	582	4120	1456	3163	1959	4458	4507	2357	171
3555_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Blood pressure medication	3555_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Blood pressure medication	25	172	1	197	4470	172	2877	2895	3679	4532	1178	2368	3119	912
3391_Ever depressed for a whole week	3391_Ever depressed for a whole week	25	172	1	4700	1556	1764	172	4543	3442	4035	2887	923	1397	4222
945_Serum total cholesterol	945_Serum total cholesterol	25	172	1	720	2127	2617	1605	172	2462	4689	4362	4579	4210	3697
2643_CTSH - Cathepsin H	2643_CTSH - Cathepsin H	25	172	1	4592	649	590	2201	329	2028	172	1654	1435	4198	1247
4036_Alcohol dependency (unrelated genotyped individuals)	4036_Alcohol dependency (unrelated genotyped individuals)	25	172	1	1054	1703	4183	3926	1043	2949	3587	172	4670	3595	2312
168_Waist circumference	168_Waist circumference	25	172	1	350	4044	752	3767	3250	2845	2311	1668	2003	1704	172
1234_Usual weekday sleep duration (FBAT)	1234_Usual weekday sleep duration (FBAT)	25	173	1	2728	2572	173	3683	2037	2582	1999	4061	1157	2270	262
4606_Right transverse temporal	4606_Right transverse temporal	25	173	1	3534	4425	2491	173	4010	498	2987	1338	4309	874	4599
855_ApoB	855_ApoB	25	173	1	1227	1086	1229	2909	173	2135	3708	3970	3162	2867	3049
3032_FAP - Seprase	3032_FAP - Seprase	25	173	1	1958	4454	3735	4262	692	173	2144	1278	3711	632	1521
4745_Genu of corpus callosum radial diusivities	4745_Genu of corpus callosum radial diusivities	25	173	1	594	845	2596	835	457	2285	446	943	174	173	405
1199_Epilepsy	1199_Epilepsy	25	174	1	174	1028	4685	653	3241	3984	1566	1423	2973	1412	2015
3340_Had menopause (female)	3340_Had menopause (female)	25	174	1	938	174	1603	492	1503	2852	3748	187	3240	1886	1448
305_CD4mem:%cFTH (1)	305_CD4mem:%cFTH (1)	25	174	1	236	3430	174	3455	1628	2053	3722	4375	4129	3690	1098
4135_Red blood cell count	4135_Red blood cell count	25	174	1	380	332	827	174	3843	2940	1131	4453	400	1725	2811
3029_RB1 - Retinoblastoma-associated protein	3029_RB1 - Retinoblastoma-associated protein	25	174	1	1926	2570	1585	2454	174	3671	1089	3595	4082	3397	4431
1025_Femoral Neck Length (GEE, adjusted for age and sex)	1025_Femoral Neck Length (GEE, adjusted for age and sex)	25	174	1	3280	2504	1431	807	2285	174	1567	4445	1540	2756	174
2500_PTPN2 - Tyrosine-protein phosphatase non-receptor type 2	2500_PTPN2 - Tyrosine-protein phosphatase non-receptor type 2	25	174	1	4616	687	3526	1092	546	1349	174	931	518	1388	1848
1979_Hand grip (at exam 7, GEE)	1979_Hand grip (at exam 7, GEE)	25	174	1	2249	496	3191	1378	1354	2184	275	2708	690	174	510
506_Lipid::Glycerolipid metabolism::choline	506_Lipid::Glycerolipid metabolism::choline	25	175	1	249	3260	175	711	4604	4672	2766	311	1035	1576	572
2823_DHH - Desert hedgehog protein N-product	2823_DHH - Desert hedgehog protein N-product	25	175	1	726	1878	501	175	3375	2596	1679	3564	2184	3385	1050
2201_IL10 - Interleukin-10	2201_IL10 - Interleukin-10	25	175	1	2009	1122	753	3614	4560	175	1832	216	2672	2591	1243
592_Peptide::Dipeptide::cyclo(leu-pro)	592_Peptide::Dipeptide::cyclo(leu-pro)	25	175	1	4541	1066	4185	3219	678	3263	175	2811	770	3428	2608
1388_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	1388_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	25	175	1	2676	267	4037	977	1867	1789	391	2433	175	318	1020
358_earlyB:%27+	358_earlyB:%27+	25	175	1	961	498	4593	2314	3496	2802	2831	3279	3206	175	3350
1335_Fasting HbA1c (at exam 7, GEE, adjusted for age, sex and BMI)	1335_Fasting HbA1c (at exam 7, GEE, adjusted for age, sex and BMI)	25	175	1	2690	2112	1358	1309	1727	396	2307	4013	2339	1863	175
3634_Illnesses of father: Diabetes	3634_Illnesses of father: Diabetes	25	176	1	655	176	2292	256	3658	3922	212	230	2870	820	4054
1364_Total cholesterol (at exam 4, FBAT, adjusted for age and sex)	1364_Total cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	176	1	3070	3956	176	1569	3983	455	4605	4626	4595	4610	2125
1884_Shaft Width (FBAT, female, adjussted for multivariable)	1884_Shaft Width (FBAT, female, adjussted for multivariable)	25	176	1	4488	435	2773	176	1522	4186	908	343	246	1364	652
3210_Usual walking pace	3210_Usual walking pace	25	176	1	966	4255	2570	697	176	3970	3624	1960	3029	804	741
831_::::X-14057	831_::::X-14057	25	176	1	983	1841	2510	3224	3817	176	2198	273	3534	1692	2930
4193_PR interval	4193_PR interval	25	176	1	1799	809	3108	372	780	2147	1213	176	545	793	2641
3886_Mean corpuscular hemoglobin concentration (three-way meta)	3886_Mean corpuscular hemoglobin concentration (three-way meta)	25	176	1	2716	2334	3011	3401	1290	3831	3149	635	3942	176	3536
3691_Diagnoses - secondary ICD10: I10 Essential (primary) hypertension	3691_Diagnoses - secondary ICD10: I10 Essential (primary) hypertension	25	177	1	177	2916	564	1126	1614	3014	1600	509	2278	2440	3453
1064_Bipolar disorder	1064_Bipolar disorder	25	177	1	1301	177	2630	1346	3922	4587	484	2303	395	178	2870
1625_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for multivariable)	1625_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for multivariable)	25	177	1	3217	1692	177	1599	3188	1754	3572	1264	2530	3630	2556
2616_TLR4 LY96 - Toll-like receptor 4:Lymphocyte antigen 96 complex	2616_TLR4 LY96 - Toll-like receptor 4:Lymphocyte antigen 96 complex	25	177	1	184	3594	2118	177	489	923	1922	1467	2569	3540	2956
741_::::X-11858	741_::::X-11858	25	177	1	1780	2124	3891	496	177	3443	1447	4018	3854	1404	4139
1149_Corrected insulin response	1149_Corrected insulin response	25	177	1	4521	466	1288	889	2814	177	1855	3774	3218	410	700
2831_SFTPD - Pulmonary surfactant-associated protein D	2831_SFTPD - Pulmonary surfactant-associated protein D	25	177	1	1180	3676	2655	3070	2366	3122	3432	2818	2342	3791	177
298_CD4mem:%preTh17 (2)	298_CD4mem:%preTh17 (2)	25	178	1	2454	4389	178	2552	3343	2801	2158	3958	2556	3687	2544
4746_Inferior fronto-occipital fasciculus radial diusivities	4746_Inferior fronto-occipital fasciculus radial diusivities	25	178	1	3287	3349	3359	1764	178	3822	1289	3861	1259	4490	3749
532_Lipid::Lysolipid::1-arachidonoylglycerophosphoinositol*	532_Lipid::Lysolipid::1-arachidonoylglycerophosphoinositol*	25	178	1	2564	955	1518	2940	3813	178	2944	4509	3047	339	2675
3942_HbA1c	3942_HbA1c	25	178	1	3525	2766	1384	3822	4689	754	1590	178	3065	3193	4032
968_Triglycerides in very small VLDL	968_Triglycerides in very small VLDL	25	178	1	3442	2292	1364	3750	4083	621	3974	3230	178	3933	3767
2928_EPHA2 - Ephrin type-A receptor 2	2928_EPHA2 - Ephrin type-A receptor 2	25	178	1	2595	2167	1068	3024	3176	1983	3213	3986	2638	3888	178
3199_Distance between home and job workplace	3199_Distance between home and job workplace	25	179	1	1910	179	3821	1243	3091	2496	1616	2211	1411	580	4482
2547_AGT - Angiotensinogen	2547_AGT - Angiotensinogen	25	179	1	4628	2055	179	4665	3027	3541	1919	2900	4480	4458	3275
4668_Uncinate fasciculus fractional anisotropy	4668_Uncinate fasciculus fractional anisotropy	25	179	1	1979	3805	3089	179	2257	3256	3828	1439	3235	1813	4697
1646_P-selectin (at exam 7, FBAT, adjusted for age and sex)	1646_P-selectin (at exam 7, FBAT, adjusted for age and sex)	25	179	1	1494	4463	1833	2619	535	179	1965	826	2302	2717	2172
3971_Total body BMD	3971_Total body BMD	25	179	1	684	1087	2494	542	4364	4434	467	179	524	3214	4037
4142_Systolic Blood Pressure	4142_Systolic Blood Pressure	25	180	1	180	551	3851	1036	616	1113	1946	2012	1188	898	2846
1301_Fasting plasma glucose (at exam 7, GEE, adjusted for age and sex)	1301_Fasting plasma glucose (at exam 7, GEE, adjusted for age and sex)	24	180	1	2043	3961	180	3318	2431	4044	4376	2849	3090	3549	660
4275_Glycine level	4275_Glycine level	25	180	1	4342	1442	3131	2968	180	239	1059	385	1852	4340	326
995_Interleukin-8 (CXCL8)	995_Interleukin-8 (CXCL8)	25	180	1	3086	3015	1858	452	865	180	395	2309	1507	1329	790
3520_Current employment status: Retired	3520_Current employment status: Retired	25	181	1	181	1855	902	3230	2310	3920	2524	2438	374	2174	3879
3383_Prospective memory test - Number of attempts	3383_Prospective memory test - Number of attempts	25	181	1	3846	4327	181	831	1696	3838	3136	3855	3677	1301	4474
2768_PGD - 6-phosphogluconate dehydrogenase, decarboxylating	2768_PGD - 6-phosphogluconate dehydrogenase, decarboxylating	25	181	1	891	2057	3909	181	1165	3085	877	323	3043	3923	661
3745_Happiness and subjective well-being - General happiness	3745_Happiness and subjective well-being - General happiness	25	181	1	1240	1788	1904	2916	181	1599	3515	4684	2195	2249	2255
1433_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	1433_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	25	181	1	3241	991	1815	1635	264	181	526	2935	3357	1866	2626
3962_Gestational weight gain (maternal, late)	3962_Gestational weight gain (maternal, late)	25	181	1	2646	2068	1492	439	2914	4287	2268	181	952	1624	2410
709_::::X-11469	709_::::X-11469	25	181	1	234	441	186	671	2153	3627	334	4141	181	3501	2649
47_Age at first birth	47_Age at first birth	25	181	1	424	1994	3425	417	3725	2475	2376	2495	4380	301	181
3323_Ever had prostate specific antigen (PSA) test	3323_Ever had prostate specific antigen (PSA) test	25	182	1	849	2086	268	182	1053	2581	1617	690	2498	1844	3147
4241_Rapid alternating stimulus test for letters/numbers	4241_Rapid alternating stimulus test for letters/numbers	25	182	1	3033	654	1938	1272	2747	182	1019	1800	598	4695	2285
2278_ESR1 - Estrogen receptor	2278_ESR1 - Estrogen receptor	25	182	1	616	927	3818	618	1821	2700	209	182	1091	2305	4102
3684_Diagnoses - main ICD10: R31 Hematuria	3684_Diagnoses - main ICD10: R31 Hematuria	25	182	1	1967	1096	3111	1418	2212	2776	1620	1093	2888	215	182
3898_Platelet distribution width (three-way meta)	3898_Platelet distribution width (three-way meta)	25	183	1	183	3488	218	546	1238	3431	572	1218	2318	2645	3369
1115_Visceral sdipose tissue volume (adjusted for BMI, male)	1115_Visceral sdipose tissue volume (adjusted for BMI, male)	25	183	1	516	2688	183	1029	1458	3336	3856	1736	2991	4157	3559
2576_SERPINA1 - Alpha-1-antitrypsin	2576_SERPINA1 - Alpha-1-antitrypsin	25	183	1	2427	784	4014	183	650	4445	2098	3714	3669	1168	3692
1318_Resistin (FBAT, adjusted for age and sex)	1318_Resistin (FBAT, adjusted for age and sex)	25	183	1	2862	4676	3308	2983	183	383	1650	602	468	1773	1710
3534_Mental health - Illness, injury, bereavement, stress in last 2 years: Death of a close relative	3534_Mental health - Illness, injury, bereavement, stress in last 2 years: Death of a close relative	25	183	1	4640	1284	4274	1426	1559	3835	183	879	455	2666	1540
40_Reaction time	40_Reaction time	25	183	1	3868	362	781	1153	4401	3871	854	183	3431	630	3799
4137_Hematocrit	4137_Hematocrit	25	183	1	2133	402	3113	2586	1296	4244	2817	3206	183	4508	4422
4127_Lactate dehydrogenase	4127_Lactate dehydrogenase	25	183	1	2768	715	770	2843	799	3347	4334	1523	2625	1743	183
2575_ADIPOQ - Adiponectin	2575_ADIPOQ - Adiponectin	25	184	1	2382	3546	1200	303	1381	184	4461	3983	2867	2220	4587
78_Femoral Neck BMD (males)	78_Femoral Neck BMD (males)	25	184	1	3030	1146	4301	1967	1478	3820	616	1122	184	4275	4234
2774_DCTN2 - Dynactin subunit 2	2774_DCTN2 - Dynactin subunit 2	25	184	1	1660	2641	4360	1564	1697	3000	2518	3179	1997	184	2420
1269_Epworth Sleepiness Scale (GEE)	1269_Epworth Sleepiness Scale (GEE)	25	185	1	185	1354	846	4558	2765	1373	3316	2057	4232	2239	1065
3101_PDE7A - High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	3101_PDE7A - High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	25	185	1	1366	3002	185	4587	2318	2775	3899	2516	1882	701	2362
4055_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	4055_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	25	185	1	351	1900	901	185	533	936	3210	1104	3489	3646	2734
967_Phospholipids in very small VLDL	967_Phospholipids in very small VLDL	25	185	1	3668	3103	3007	2412	185	1370	4248	4735	3821	3983	3751
1695_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for age and sex)	1695_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for age and sex)	25	185	1	3036	2317	402	4433	1387	185	2740	1746	2149	3971	895
3256_Coffee intake	3256_Coffee intake	25	185	1	2376	3623	1152	1837	4100	2995	1086	3052	2034	1181	185
3188_Pulse rate (automated reading)	3188_Pulse rate (automated reading)	25	186	1	186	353	195	963	1226	3375	722	1753	815	570	3927
1882_Shaft cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	1882_Shaft cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	25	186	1	894	186	3490	1544	2073	3964	1875	2193	766	381	1165
2699_SEZ6L2 - Seizure 6-like protein 2	2699_SEZ6L2 - Seizure 6-like protein 2	25	186	1	3757	2087	2987	186	3063	1978	1134	611	447	811	1158
1201_Focal epilepsy	1201_Focal epilepsy	25	186	1	2749	3703	3454	3469	186	1446	3462	3797	3101	3535	1983
3914_Disc area	3914_Disc area	25	186	1	3618	1618	2576	3824	232	186	1067	2519	3354	765	900
67_Inflammatory Bowel Disease	67_Inflammatory Bowel Disease	25	186	1	3409	211	2815	3791	2245	3031	649	830	1903	515	186
1235_Usual weekday sleep duration (GEE)	1235_Usual weekday sleep duration (GEE)	25	187	1	3901	4619	900	2546	187	2224	1397	3718	3075	1280	3381
1749_Urinary albumin excertion (at exam 6, GEE, adjusted for multivariable)	1749_Urinary albumin excertion (at exam 6, GEE, adjusted for multivariable)	25	187	1	217	664	3028	3566	3387	1956	2208	4171	1866	1095	187
3133_CALR - Calreticulin	3133_CALR - Calreticulin	25	188	1	188	304	231	4566	2910	555	1303	3775	1577	586	1508
4425_Hepatitis B HBc antigen seropositivity	4425_Hepatitis B HBc antigen seropositivity	25	188	1	656	188	2727	1853	2876	1251	1222	3402	1182	542	4395
879_Total cholesterol in IDL	879_Total cholesterol in IDL	25	188	1	1003	2341	2993	4428	188	1233	4085	3477	4102	4161	4628
2076_CXCL16 - C-X-C motif chemokine 16	2076_CXCL16 - C-X-C motif chemokine 16	25	188	1	4637	3083	4398	1189	972	3126	3102	4275	2847	1887	188
31_Conscientiousness (NEO-FFI)	31_Conscientiousness (NEO-FFI)	25	189	1	189	346	810	950	2684	4386	338	272	827	1452	728
1380_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	1380_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	25	189	1	3977	1267	1511	2807	1704	189	4388	1405	3276	2194	1970
2634_CDKN1B - Cyclin-dependent kinase inhibitor 1B	2634_CDKN1B - Cyclin-dependent kinase inhibitor 1B	25	189	1	1258	2486	327	4451	3564	2912	3378	3085	189	2493	698
2115_EIF5 - Eukaryotic translation initiation factor 5	2115_EIF5 - Eukaryotic translation initiation factor 5	25	189	1	485	485	2245	2696	4570	4483	1275	673	4247	189	3487
300_CD4mem:%Th1* (3)	300_CD4mem:%Th1* (3)	25	189	1	1453	2981	4489	3198	2848	1876	1920	1778	2828	3375	189
4203_End stage renal disease	4203_End stage renal disease	25	190	1	1191	4703	190	2391	764	1662	1128	4612	2328	3618	523
3689_Diagnoses - secondary ICD10: F17 Nicotine dependence	3689_Diagnoses - secondary ICD10: F17 Nicotine dependence	25	190	1	3922	3279	4275	190	1677	2377	1720	666	4138	2010	4085
1832_Neck length (FBAT, male, adjusted for multivariable)	1832_Neck length (FBAT, male, adjusted for multivariable)	25	190	1	4673	1681	2285	1113	1509	190	1739	2879	2428	4718	230
3124_IMPDH2 - Inosine-5'-monophosphate dehydrogenase 2	3124_IMPDH2 - Inosine-5'-monophosphate dehydrogenase 2	25	190	1	3325	852	987	3267	3913	1419	190	4255	392	4623	781
1473_Mean total cholesterol from exam 1-7 (GEE, adjusted for multivariable)	1473_Mean total cholesterol from exam 1-7 (GEE, adjusted for multivariable)	25	190	1	4315	1963	4181	3492	633	1661	827	3808	3470	2222	190
3591_Medication for cholesterol, blood pressure or diabetes: Blood pressure medication	3591_Medication for cholesterol, blood pressure or diabetes: Blood pressure medication	25	191	1	191	1605	226	1250	3494	2471	912	3336	1556	3949	887
1248_Percent predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	1248_Percent predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	25	191	1	1237	2839	191	2664	3960	1548	3230	2819	2877	3015	457
3791_Ease of getting up in the morning	3791_Ease of getting up in the morning	25	191	1	4515	2118	1350	191	3465	901	1926	967	3519	2333	1221
4693_Average across all tracts mean diusivities	4693_Average across all tracts mean diusivities	25	191	1	381	2405	3642	2801	191	2183	1028	1777	2277	517	4291
2961_ITGAV ITGB5 - Integrin alpha-V: beta-5 complex	2961_ITGAV ITGB5 - Integrin alpha-V: beta-5 complex	25	191	1	3822	3503	2192	2985	4708	3923	897	191	2031	4082	454
1212_Type 2 Diabetes	1212_Type 2 Diabetes	25	191	1	1495	236	3046	2115	2788	329	1815	4620	191	296	620
1743_Urinary albumin excertion (at exam 6, GEE, adjusted for age and sex)	1743_Urinary albumin excertion (at exam 6, GEE, adjusted for age and sex)	25	191	1	998	2154	3741	2981	3714	1763	1362	4701	3639	2692	191
3954_Ankle injury (fixed effect)	3954_Ankle injury (fixed effect)	25	192	1	192	2616	1098	2860	2621	2987	2967	245	3962	1231	3032
1435_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	1435_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	25	192	1	2015	3825	192	4009	1796	451	1032	2263	2772	1540	1078
2053_Advanced adenoma	2053_Advanced adenoma	25	192	1	1989	3509	2973	192	3802	3095	3749	2638	4466	4669	1496
1563_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1563_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	192	1	2937	1155	569	1027	1434	192	2869	735	3999	230	293
3361_Neck/shoulder pain for 3+ months	3361_Neck/shoulder pain for 3+ months	25	192	1	2669	318	2505	3147	1327	2730	192	1962	2047	2117	4067
4479_Right entorhinal	4479_Right entorhinal	25	192	1	2846	980	1648	502	3502	1503	918	192	371	1100	4683
514_Lipid::Long chain fatty acid::10-heptadecenoate (17:1n7)	514_Lipid::Long chain fatty acid::10-heptadecenoate (17:1n7)	25	192	1	326	1596	882	1878	4496	2626	659	3625	192	3178	4500
1355_Plasma Apolipoprotein C3 level (GEE, adjusted for age and sex)	1355_Plasma Apolipoprotein C3 level (GEE, adjusted for age and sex)	25	192	1	2687	3045	3539	385	4446	2341	1496	2225	1853	192	2104
4045_Type 2 Diabetes	4045_Type 2 Diabetes	25	193	1	4656	193	4170	1257	4726	4458	1163	2045	2788	1139	4290
736_::::X-11845	736_::::X-11845	25	193	1	664	4295	193	4526	2762	2891	982	4426	2851	4694	922
604_Peptide::gamma-glutamyl::gamma-glutamylleucine	604_Peptide::gamma-glutamyl::gamma-glutamylleucine	25	193	1	224	1208	1534	701	3247	779	193	3807	2246	728	4186
1666_Aspartate aminotransferase (at exam 2, FBAT, adjusted for age and sex)	1666_Aspartate aminotransferase (at exam 2, FBAT, adjusted for age and sex)	25	194	1	194	1168	418	3957	1721	2299	1285	3176	210	1045	913
2978_ERAP1 - Endoplasmic reticulum aminopeptidase 1	2978_ERAP1 - Endoplasmic reticulum aminopeptidase 1	25	194	1	497	3334	194	4080	4468	846	2823	4038	3912	4376	1650
3035_SSRP1 - FACT complex subunit SSRP1	3035_SSRP1 - FACT complex subunit SSRP1	25	194	1	4583	645	2093	194	1981	4409	358	484	265	429	801
3097_HAVCR2 - Hepatitis A virus cellular receptor 2	3097_HAVCR2 - Hepatitis A virus cellular receptor 2	25	194	1	2530	2706	4715	2685	3602	3087	1412	1594	194	1660	4508
3434_Numeric memory test - Maximum digits remembered correctly	3434_Numeric memory test - Maximum digits remembered correctly	25	195	1	195	524	2603	1318	3605	2547	4348	3655	4593	424	2934
4073_General risk tolerance	4073_General risk tolerance	25	195	1	3345	4345	1565	4399	195	998	562	4179	2165	201	356
1868_Neck-Shaft Angle (FBAT, male, adjussted for multivariable)	1868_Neck-Shaft Angle (FBAT, male, adjussted for multivariable)	25	195	1	3295	1118	4108	1728	4139	195	1837	2321	3337	641	2521
3183_SNRPF - Small nuclear ribonucleoprotein F	3183_SNRPF - Small nuclear ribonucleoprotein F	25	195	1	2875	1226	1124	348	4435	631	195	2640	2580	1986	4736
1389_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	1389_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	25	195	1	797	1680	2652	4414	1141	739	1826	195	1350	584	1405
1486_Mean triglycerides from exam 1-7 (FBAT, adjusted for age and sex)	1486_Mean triglycerides from exam 1-7 (FBAT, adjusted for age and sex)	25	195	1	4074	879	4701	663	2539	1198	1491	1324	195	3402	2103
2074_C8A C8B C8G - Complement component C8	2074_C8A C8B C8G - Complement component C8	25	195	1	2707	4578	1393	2654	1542	3189	2870	2691	2063	195	613
2907_HSD17B1 - Estradiol 17-beta-dehydrogenase 1	2907_HSD17B1 - Estradiol 17-beta-dehydrogenase 1	25	195	1	1906	1424	340	3980	993	4428	1037	1690	3127	1974	195
4057_Estimated glomerular filtration rate based on serum creatinine	4057_Estimated glomerular filtration rate based on serum creatinine	25	196	1	196	814	1261	228	1505	375	1687	1444	3033	3836	3537
3630_Illnesses of father: Lung cancer	3630_Illnesses of father: Lung cancer	25	196	1	1984	2489	196	2113	361	581	3844	2772	2707	3010	614
344_NKearly:%335+314-	344_NKearly:%335+314-	25	196	1	3880	2107	3583	1221	196	2078	4515	2248	1355	1027	4134
3320_Chest pain or discomfort	3320_Chest pain or discomfort	25	196	1	2626	611	594	634	2343	869	590	196	629	1885	1328
1094_Systolic Blood Pressure	1094_Systolic Blood Pressure	25	196	1	3309	2607	2699	223	2169	3491	806	1287	196	824	1272
479_Lipid::Carnitine metabolism::cis-4-decenoyl carnitine	479_Lipid::Carnitine metabolism::cis-4-decenoyl carnitine	25	197	1	699	197	2318	1286	2484	1698	2591	1811	741	451	2540
1534_Ankle-brachial index (at exam 7, FBAT, adjusted for age and sex)	1534_Ankle-brachial index (at exam 7, FBAT, adjusted for age and sex)	25	197	1	1988	1916	197	4510	2436	242	3088	3850	4452	2626	612
2864_IL11 - Interleukin-11	2864_IL11 - Interleukin-11	25	197	1	2057	2886	1991	197	2195	2024	1990	1006	661	3431	2282
1656_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for multivariable)	1656_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for multivariable)	25	197	1	4167	1302	3347	3642	4677	197	2861	678	1172	3048	2605
2632_CKB CKM - Creatine kinase M-type:Creatine kinase B-type heterodimer	2632_CKB CKM - Creatine kinase M-type:Creatine kinase B-type heterodimer	25	197	1	674	570	1434	1158	1876	706	197	1796	2138	1448	1054
3888_Mean corpuscular volume (three-way meta)	3888_Mean corpuscular volume (three-way meta)	25	197	1	3549	4224	2182	3819	3572	1839	1681	197	4534	756	3083
17_Anorexia nervosa	17_Anorexia nervosa	25	197	1	519	3839	700	2663	3497	2572	4214	4726	197	2560	2263
53_Educational attainment	53_Educational attainment	25	198	1	198	3578	4072	2562	2594	911	3370	1630	3631	503	587
1662_Alanine transaminase (at exam 2, FBAT, adjusted for age and sex)	1662_Alanine transaminase (at exam 2, FBAT, adjusted for age and sex)	25	198	1	1281	1212	198	1081	3152	1719	4626	2785	3840	2911	531
471_Lipid::Bile acid metabolism::taurocholate	471_Lipid::Bile acid metabolism::taurocholate	25	198	1	4150	662	1280	198	2278	4093	481	947	2332	3936	3148
811_::::X-12851	811_::::X-12851	25	198	1	1381	4299	1102	1759	198	3528	2833	3379	4630	2964	1306
4421_Herpes simplex virus 1 seropositivity	4421_Herpes simplex virus 1 seropositivity	25	198	1	2809	4636	1346	4127	918	198	1786	4354	3170	4262	3904
3926_Total-body less head BMD	3926_Total-body less head BMD	25	198	1	1670	2609	2897	2348	3078	1908	198	3160	1272	2655	3721
591_Peptide::Dipeptide::aspartylphenylalanine	591_Peptide::Dipeptide::aspartylphenylalanine	25	198	1	1233	558	339	4612	4329	2690	445	3813	942	198	1634
836_Peptide::Dipeptide::X-14304--leucylalanine	836_Peptide::Dipeptide::X-14304--leucylalanine	25	198	1	889	1427	2123	4050	1577	3613	657	2195	1043	3127	198
1125_Subcutaneous adipose tissue attenuation (female)	1125_Subcutaneous adipose tissue attenuation (female)	25	199	1	199	447	3609	1939	3412	2166	1935	3015	762	3743	2516
1421_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1421_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	199	1	1613	4675	199	3077	4127	2661	2152	774	2992	1906	1445
3941_Body Mass Index (female)	3941_Body Mass Index (female)	25	199	1	1060	2193	881	199	2887	3033	1530	1119	2859	576	2322
4471_Left superior parietal	4471_Left superior parietal	25	199	1	1842	1768	2955	3667	2840	199	3500	4194	3653	1750	1706
4523_Left putamen	4523_Left putamen	25	199	1	758	584	1810	2643	2475	2487	199	1342	1282	1195	1798
4265_Ankylosing spondylitis	4265_Ankylosing spondylitis	25	199	1	1286	234	1843	2657	653	2177	1138	358	1270	199	894
1398_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for age and sex)	1398_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	200	1	200	500	2341	2496	646	4564	4380	1120	3175	256	4088
3870_Basophil percentage of white cells (three-way meta)	3870_Basophil percentage of white cells (three-way meta)	25	200	1	1723	769	200	4164	2295	661	502	310	3274	3945	2945
842_::::X-14625	842_::::X-14625	25	200	1	3072	1339	3180	200	4459	3982	992	3922	2406	870	4359
1898_Troch Neck BMD (FBAT, female, adjussted for multivariable)	1898_Troch Neck BMD (FBAT, female, adjussted for multivariable)	25	200	1	3079	597	3799	324	200	1330	743	337	499	2443	803
1711_Thyroid stimulation hormone (at exam 3, GEE, adjusted for age and sex)	1711_Thyroid stimulation hormone (at exam 3, GEE, adjusted for age and sex)	25	200	1	4608	1231	2660	4358	2692	200	1847	410	856	1313	847
4147_Posterior wall thickness	4147_Posterior wall thickness	25	200	1	2746	3870	623	1001	2288	634	1465	4315	200	4460	1119
3155_KRT18 - Keratin, type I cytoskeletal 18	3155_KRT18 - Keratin, type I cytoskeletal 18	25	200	1	1276	2309	2948	2699	1364	689	2933	1953	2823	4221	200
2139_PRKCA - Protein kinase C alpha type	2139_PRKCA - Protein kinase C alpha type	25	201	1	201	3589	926	2349	4109	2098	2019	1346	991	2424	3392
2427_C1R - Complement C1r subcomponent	2427_C1R - Complement C1r subcomponent	25	201	1	2835	201	2166	765	1745	2049	251	350	1595	1705	3971
2458_HFE2 - Hemojuvelin	2458_HFE2 - Hemojuvelin	25	201	1	3081	4304	201	682	2120	2488	4060	4597	3748	2001	4682
2682_TLR2 - Toll-like receptor 2	2682_TLR2 - Toll-like receptor 2	25	201	1	624	1465	1486	201	4681	344	901	1195	2326	904	897
1699_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for age and sex)	1699_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for age and sex)	25	201	1	2181	2804	3086	2803	351	201	1575	3270	4172	2518	1123
1940_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	1940_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	25	201	1	2149	335	1881	1182	1804	4634	201	3544	238	3547	885
3602_Non-cancer illness code, self-reported: hypothyroidism/myxoedema	3602_Non-cancer illness code, self-reported: hypothyroidism/myxoedema	25	201	1	3224	262	3854	2844	4352	265	210	201	3626	2788	3801
2933_BMPR2 - Bone morphogenetic protein receptor type-2	2933_BMPR2 - Bone morphogenetic protein receptor type-2	25	202	1	202	4515	373	3573	2576	2307	2888	1739	2187	3453	3315
4748_Posterior limb of internal capsule radial diusivities	4748_Posterior limb of internal capsule radial diusivities	25	202	1	2280	3074	202	4282	699	2867	247	506	3806	3381	333
3589_Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding, lawn mowing, carpentry, digging)	3589_Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding, lawn mowing, carpentry, digging)	25	202	1	362	3644	4025	202	1661	255	2333	2222	3358	3151	3554
520_Lipid::Long chain fatty acid::margarate (17:0)	520_Lipid::Long chain fatty acid::margarate (17:0)	25	202	1	1733	4078	3832	4268	202	1998	3313	4404	338	546	3117
3798_Worry subcluster	3798_Worry subcluster	25	202	1	2110	3123	3375	748	3666	202	3942	907	1041	942	2728
423_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxovalerate	423_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxovalerate	25	202	1	2540	351	2755	1557	4511	208	202	406	3634	817	2199
3722_Frequency of feeling guilt or remorse after drinking alcohol in last year	3722_Frequency of feeling guilt or remorse after drinking alcohol in last year	25	202	1	3728	312	3279	3632	663	2617	424	202	1160	582	3150
1919_Total cerebral brain volume (GEE, adjusted for multivariable)	1919_Total cerebral brain volume (GEE, adjusted for multivariable)	25	202	1	3856	3459	3984	4496	567	2628	1113	2726	202	4565	2253
4661_Posterior thalamic radiation (include optic radiation) fractional anisotropy	4661_Posterior thalamic radiation (include optic radiation) fractional anisotropy	25	202	1	2144	1285	4437	2079	296	2139	849	3221	1564	202	1197
206_Serum Urate	206_Serum Urate	25	203	1	360	2929	203	628	2466	2356	695	3415	606	828	3425
3608_Non-cancer illness code, self-reported: high cholesterol	3608_Non-cancer illness code, self-reported: high cholesterol	25	203	1	3674	2450	1252	3869	203	1013	1866	4635	4680	4200	3809
3392_Longest period of depression	3392_Longest period of depression	25	203	1	3032	1509	4697	2722	2091	203	4162	2721	3393	2380	3360
3744_Cannabis use - Ever taken cannabis	3744_Cannabis use - Ever taken cannabis	25	203	1	1504	2959	4579	250	3961	1071	2378	3282	3147	4000	203
860_CH2 groups to double bonds ratio	860_CH2 groups to double bonds ratio	25	204	1	204	4660	253	1460	477	3700	2015	2543	2945	726	579
3459_Impedance measures - Leg predicted mass (left)	3459_Impedance measures - Leg predicted mass (left)	25	204	2	4243	204	4572	740	3935	1543	600	3043	3961	3230	1436
2412_NID1 - Nidogen-1	2412_NID1 - Nidogen-1	25	204	1	415	4046	4560	204	2214	3754	2575	1900	4349	857	4605
2099_IGFBP3 - Insulin-like growth factor-binding protein 3	2099_IGFBP3 - Insulin-like growth factor-binding protein 3	25	204	1	4264	2505	4266	2907	204	628	1155	4705	2411	3776	1081
3716_Diagnoses - secondary ICD10: Z95 Presence of cardiac and vascular implants and grafts	3716_Diagnoses - secondary ICD10: Z95 Presence of cardiac and vascular implants and grafts	25	204	1	2806	4460	4630	3543	4563	204	2809	2476	2021	2190	4721
3974_Total body BMD (30-45 years old)	3974_Total body BMD (30-45 years old)	25	204	1	2523	604	4578	423	1500	3002	204	1159	818	1776	3476
4510_Left basal forebrain	4510_Left basal forebrain	25	204	1	1020	1341	1086	484	3094	4650	492	204	651	4189	4611
4317_Drinks per day	4317_Drinks per day	25	204	1	561	269	3132	1325	3143	1034	306	2485	261	204	4231
2937_C3 - Complement C3d fragment	2937_C3 - Complement C3d fragment	25	205	1	205	3119	452	4093	492	4303	2984	2502	1811	2988	609
3086_ROBO3 - Roundabout homolog 3	3086_ROBO3 - Roundabout homolog 3	25	205	1	1406	3354	3540	205	1506	2087	1775	421	2300	4700	3529
1820_Inter-trochanteric buckling ratio (FBAT, male, adjussted for multivariable)	1820_Inter-trochanteric buckling ratio (FBAT, male, adjussted for multivariable)	25	205	1	4669	1370	3765	3118	205	796	3940	4285	4127	1669	1656
3460_Impedance measures - Arm fat percentage (right)	3460_Impedance measures - Arm fat percentage (right)	25	205	1	2313	4597	2892	1171	3102	205	4469	4082	4451	1153	965
1876_Shaft average buckling ratio (FBAT, male, adjussted for age)	1876_Shaft average buckling ratio (FBAT, male, adjussted for age)	25	205	1	3230	1836	952	2190	655	3201	205	220	2636	3185	2514
2289_PTHLH - Parathyroid hormone-related protein	2289_PTHLH - Parathyroid hormone-related protein	25	205	1	771	1328	2582	465	4136	2057	719	4417	205	392	4729
703_::::X-11440	703_::::X-11440	25	206	1	296	206	1136	3726	2044	844	1204	1575	403	4071	729
988_Interleukin-1 receptor antagonist	988_Interleukin-1 receptor antagonist	25	206	1	260	2072	206	696	2826	625	1097	3062	1378	2229	2168
114_Waist-hip ratio (adjusted for BMI)	114_Waist-hip ratio (adjusted for BMI)	25	206	1	2332	4707	4495	4417	206	1581	4344	3420	3869	4520	508
4438_Helicobacter pylori IgG levels	4438_Helicobacter pylori IgG levels	25	206	1	1190	3843	3118	4546	2290	206	4194	3787	1336	3049	1745
4141_Platelet count	4141_Platelet count	25	206	1	4267	4686	1537	1052	3679	3596	4370	206	2350	593	3385
2478_CSK - Tyrosine-protein kinase CSK	2478_CSK - Tyrosine-protein kinase CSK	25	206	1	1345	4493	2073	1322	3096	2882	1525	1134	206	2961	1151
1873_Shaft average buckling ratio (GEE, male, adjussted for multivariable)	1873_Shaft average buckling ratio (GEE, male, adjussted for multivariable)	25	206	1	3832	1528	1126	3343	390	1064	1936	1329	1663	1322	206
3497_Hair colour (natural, before greying): Light brown	3497_Hair colour (natural, before greying): Light brown	25	207	1	207	954	1820	287	428	1342	2550	1983	1769	2068	1387
1987_Age at natural menopause (GEE)	1987_Age at natural menopause (GEE)	25	207	1	784	207	3764	1722	223	1126	1415	1517	4190	1289	2402
830_::::X-14056	830_::::X-14056	25	207	1	311	3425	207	1625	1052	257	2168	2481	1803	1409	3229
2362_PGF - Placenta growth factor	2362_PGF - Placenta growth factor	25	207	1	518	3767	769	207	826	4651	4421	2166	4399	3616	4250
1708_Luteinizing hormone (at exam 3, FBAT, adjusted for multivariable)	1708_Luteinizing hormone (at exam 3, FBAT, adjusted for multivariable)	25	207	1	4542	4416	4598	3965	207	288	2541	1443	2714	2540	2194
1742_Urinary albumin excertion (at exam 6, FBAT, adjusted for age and sex)	1742_Urinary albumin excertion (at exam 6, FBAT, adjusted for age and sex)	25	207	1	466	4424	360	3200	718	207	2981	3869	1898	3772	796
770_::::X-12261	770_::::X-12261	25	207	1	2370	530	2307	712	1266	2988	207	1604	1007	671	4076
4259_Facial attractiveness (female-coder, male samples)	4259_Facial attractiveness (female-coder, male samples)	25	207	1	4563	1793	3772	4185	3862	3950	3862	207	4706	3701	3400
3356_Number of unsuccessful stop-smoking attempts	3356_Number of unsuccessful stop-smoking attempts	25	207	1	682	215	1737	2030	2175	3316	531	3291	207	1065	1624
2997_FGG - Fibrinogen gamma chain	2997_FGG - Fibrinogen gamma chain	25	208	1	208	671	2438	3385	675	3192	2772	2569	496	229	3842
1649_P-selectin (at exam 7, GEE, adjusted for multivariable)	1649_P-selectin (at exam 7, GEE, adjusted for multivariable)	25	208	1	1566	2746	208	4123	3282	641	1440	1395	1430	1631	276
1009_Stromal cell-derived factor-1 alpha (CXCL12)	1009_Stromal cell-derived factor-1 alpha (CXCL12)	25	208	1	3443	562	3081	208	4662	3573	612	1105	2075	1795	4143
1568_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for multivariable)	1568_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for multivariable)	25	208	1	2378	1408	4291	3917	4300	2667	4490	208	811	1622	3562
3341_Number of live births (female)	3341_Number of live births (female)	25	208	1	1691	3771	3094	1616	3656	1278	4324	4060	4325	208	3826
2258_UBE2I - SUMO-conjugating enzyme UBC9	2258_UBE2I - SUMO-conjugating enzyme UBC9	25	209	1	209	2887	4241	1648	379	2644	3647	2937	2658	4556	694
2552_CNTF - Ciliary Neurotrophic Factor	2552_CNTF - Ciliary Neurotrophic Factor	25	209	1	4588	209	3319	1658	3156	611	1094	3965	2121	4745	747
555_Lipid::Medium chain fatty acid::caprate (10:0)	555_Lipid::Medium chain fatty acid::caprate (10:0)	25	209	1	3445	818	3925	209	1219	3530	3742	3395	3428	558	1756
2908_APOD - Apolipoprotein D	2908_APOD - Apolipoprotein D	25	209	1	4648	4043	838	2316	209	3473	3653	4609	3554	4207	1340
1339_HOMA-IR (at exam 7, GEE, adjusted for age, sex and BMI)	1339_HOMA-IR (at exam 7, GEE, adjusted for age, sex and BMI)	25	209	1	1819	2518	1846	1097	2893	209	2609	1008	3693	4095	687
3565_Vitamin and mineral supplements: Vitamin E	3565_Vitamin and mineral supplements: Vitamin E	25	209	1	4338	3585	4064	2206	1970	3624	4270	209	1262	3598	3255
2901_IL6 - Interleukin-6	2901_IL6 - Interleukin-6	25	209	1	1853	1069	737	3022	3089	980	4398	4419	3417	535	209
1521_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	1521_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	25	210	1	210	1883	1281	990	2211	892	226	4402	2735	4253	2852
1117_Pericardial adipose tissue volume	1117_Pericardial adipose tissue volume	25	210	1	410	3854	210	1416	4366	2957	4369	4424	3001	3345	2227
2267_MDK - Midkine	2267_MDK - Midkine	25	210	1	4200	1153	4590	4528	210	3919	3287	2311	3044	2814	4391
3308_Long-standing illness, disability or infirmity	3308_Long-standing illness, disability or infirmity	25	210	1	2573	449	3494	3082	309	210	686	938	675	532	789
4739_Cingulum (cingulate gyrus) radial diusivities	4739_Cingulum (cingulate gyrus) radial diusivities	25	210	1	2811	2262	3655	1699	485	2920	310	528	609	210	4494
3503_Male-specific factors - Hair/balding pattern: Pattern 4	3503_Male-specific factors - Hair/balding pattern: Pattern 4	25	211	1	211	579	1796	4534	2961	1659	3896	4012	1807	734	4540
1843_Neck Section Modulus (GEE, female, adjusted for multivariable)	1843_Neck Section Modulus (GEE, female, adjusted for multivariable)	25	211	1	2404	1736	3073	2758	211	4032	1986	564	3105	2967	1516
1537_Ankle-brachial index (at exam 7, GEE, adjusted for multivariable)	1537_Ankle-brachial index (at exam 7, GEE, adjusted for multivariable)	25	211	1	503	1237	3615	3693	3093	211	1072	2735	4180	2125	1248
226_B Mem:%IgG	226_B Mem:%IgG	25	211	1	3204	763	3249	879	1310	3498	365	751	211	2858	3958
3936_Sialylation	3936_Sialylation	25	211	1	2612	675	4133	1362	346	999	721	1873	2053	4690	211
80_Femoral Neck BMD	80_Femoral Neck BMD	25	212	1	212	1466	1504	1129	4016	3147	1024	507	485	2873	4219
3855_Mean platelet volume (two-way meta)	3855_Mean platelet volume (two-way meta)	25	212	1	1414	2774	212	3643	2430	2169	2011	2333	4419	2924	1861
3010_MAPK11 - Mitogen-activated protein kinase 11	3010_MAPK11 - Mitogen-activated protein kinase 11	25	212	1	276	3793	1681	212	3804	2657	2000	950	452	4152	4745
1817_Femoral Neck BMD (GEE, male, adjusted for multivariable)	1817_Femoral Neck BMD (GEE, male, adjusted for multivariable)	25	212	1	3910	3149	3404	3684	4695	212	3797	4058	2468	4019	540
3528_Never eat eggs, dairy, wheat, sugar: Eggs or foods containing eggs	3528_Never eat eggs, dairy, wheat, sugar: Eggs or foods containing eggs	25	212	1	2419	414	2489	1795	3265	2986	978	2980	3262	805	212
558_Lipid::Medium chain fatty acid::heptanoate (7:0)	558_Lipid::Medium chain fatty acid::heptanoate (7:0)	25	213	1	213	4088	320	1789	4304	4644	3406	491	2012	4018	916
143_Body Mass Index	143_Body Mass Index	25	213	1	235	213	1671	1028	2889	2980	1573	3681	1323	2841	1957
461_Energy::Krebs cycle::succinylcarnitine	461_Energy::Krebs cycle::succinylcarnitine	25	213	1	2816	469	3677	855	213	1369	4476	1314	3169	729	2378
4634_Right cerebellum white matter	4634_Right cerebellum white matter	25	213	1	4319	3995	4352	2054	2056	2677	213	928	3784	3414	295
42_Self-rated health	42_Self-rated health	25	213	1	2178	511	4662	4038	1758	1531	973	1048	213	4261	399
2667_FCN3 - Ficolin-3	2667_FCN3 - Ficolin-3	25	213	1	3306	3454	2276	3559	3071	2453	2372	3083	2375	1094	213
2307_IFNG - Interferon gamma	2307_IFNG - Interferon gamma	25	214	1	214	1156	673	3203	4092	2788	4587	3372	4192	3292	1218
2788_NME2 - Nucleoside diphosphate kinase B	2788_NME2 - Nucleoside diphosphate kinase B	25	214	1	373	4680	214	780	3545	2901	2120	1325	855	1914	2564
201_Estimated glomerular filtration rate based on serum creatinine	201_Estimated glomerular filtration rate based on serum creatinine	25	214	1	1778	4742	1685	214	838	644	1808	1938	3391	4177	3205
979_Hepatocyte growth factor	979_Hepatocyte growth factor	25	214	1	1894	4273	3403	4328	214	1920	1970	1377	2548	3382	1648
2111_TNFRSF8 - Tumor necrosis factor receptor superfamily member 8	2111_TNFRSF8 - Tumor necrosis factor receptor superfamily member 8	25	214	1	462	1694	410	2768	2611	214	2382	576	4379	2925	252
97_Height SDS (male at age 12)	97_Height SDS (male at age 12)	25	214	1	3830	4238	1354	1056	2898	801	214	585	3031	4439	3561
1171_Body fat percentage	1171_Body fat percentage	25	214	1	2576	2582	3997	4246	4340	1929	2475	4344	802	594	214
1229_Parkinson Disease	1229_Parkinson Disease	25	215	1	864	405	215	4032	1291	4744	278	3682	1504	258	2274
1010_Tumor necrosis factor alpha	1010_Tumor necrosis factor alpha	25	215	1	479	4398	325	215	1616	3216	4168	392	1339	1361	1073
49_Age at first birth (male)	49_Age at first birth (male)	25	215	1	2790	1602	3944	891	1629	215	4726	4072	2077	2088	962
3393_Number of depression episodes	3393_Number of depression episodes	25	216	1	2171	216	1187	3366	2934	4336	744	2423	1744	1529	1779
4105_Albumin	4105_Albumin	25	216	1	1402	388	216	350	1159	2491	4586	1053	4209	1630	619
1292_Diabetes incidence (FBAT, adjusted for age and sex)	1292_Diabetes incidence (FBAT, adjusted for age and sex)	25	216	1	367	2552	1508	216	401	1561	2959	1786	460	3664	2249
155_Hip circumference	155_Hip circumference	25	216	1	231	3236	397	3557	1686	2442	3143	1367	2248	2855	216
1890_Shaft Width (FBAT, male, adjussted for age)	1890_Shaft Width (FBAT, male, adjussted for age)	25	217	1	1439	217	4500	545	1493	1615	1360	1260	1886	436	490
1787_QT interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1787_QT interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	217	1	2091	417	217	535	1760	971	529	644	378	1507	841
4358_Diverticular disease	4358_Diverticular disease	25	217	1	3327	1160	2515	217	4425	637	899	612	744	2906	1850
1574_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	1574_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	25	217	1	1292	1536	3488	4675	217	4739	3146	1945	2345	1004	3542
909_Leucine	909_Leucine	25	217	1	3159	1470	3517	691	3729	217	2336	951	2004	860	3869
4591_Right paracentral	4591_Right paracentral	25	217	1	4625	484	2422	4539	1018	775	217	1243	972	2059	4210
1717_Thyroid stimulation hormone (at exam 4, GEE, adjusted for multivariable)	1717_Thyroid stimulation hormone (at exam 4, GEE, adjusted for multivariable)	25	217	1	1858	444	954	1903	2654	1875	317	217	1019	2213	1506
1083_Hemoglobin A1C level in intensive treatment group	1083_Hemoglobin A1C level in intensive treatment group	25	217	1	3897	1863	3855	2401	3443	1102	2033	4099	217	2016	1160
4042_Obsessive compulsive disorder	4042_Obsessive compulsive disorder	25	218	1	2270	1171	3244	3087	218	991	798	1976	1369	3924	1515
4708_Superior corona radiata mean diusivities	4708_Superior corona radiata mean diusivities	25	218	1	4723	244	1984	4729	3308	2070	218	2034	1109	2694	4355
4440_Hepatitis B HBc antigen IgG levels	4440_Hepatitis B HBc antigen IgG levels	25	218	1	573	2646	291	4629	478	3886	4718	4378	3132	3107	218
1594_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for age and sex)	1594_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for age and sex)	25	219	1	219	4064	1191	1717	1241	1490	3049	2272	4057	4267	1671
1740_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for multivariable)	1740_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for multivariable)	25	219	1	263	4544	4407	219	2022	4645	3639	3455	4086	281	3007
1675_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for age and sex)	1675_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for age and sex)	25	219	1	3219	2012	3272	2492	219	3305	4485	2966	1959	4417	1437
1387_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	1387_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	25	219	1	4523	2250	3966	3780	4456	219	3448	2095	4135	2590	2201
807_::::X-12833	807_::::X-12833	25	219	1	3359	882	2627	739	366	2054	219	2532	1566	282	3424
1400_High-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	1400_High-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	25	219	1	514	1416	3033	651	464	944	1062	219	269	3914	676
3_Attention deficit hyperactivity disorder	3_Attention deficit hyperactivity disorder	25	219	1	698	1627	817	3398	1383	2925	2217	4632	2998	219	3157
1194_Ulcerative colitis	1194_Ulcerative colitis	25	219	1	2668	1067	689	3901	1472	1592	1367	747	706	1136	219
3502_Male-specific factors - Hair/balding pattern: Pattern 3	3502_Male-specific factors - Hair/balding pattern: Pattern 3	25	220	1	220	1444	1906	2347	2294	3869	2032	4054	2967	3350	2720
4004_Juvenile idiopathic arthritis with vs without uveitis	4004_Juvenile idiopathic arthritis with vs without uveitis	25	220	1	3146	220	2025	2675	4705	2006	709	3475	1631	653	2163
1357_Total cholesterol (at exam 1, GEE, multivariate adjusted)	1357_Total cholesterol (at exam 1, GEE, multivariate adjusted)	25	220	1	568	361	2145	220	1179	4042	509	1806	1097	1069	3647
856_Ratio of bisLallylic bonds to double bonds in lipids	856_Ratio of bisLallylic bonds to double bonds in lipids	25	220	1	1467	3829	656	1552	220	1530	1390	4366	2407	261	893
1641_Myeloperoxidase (at exam 7, GEE, adjusted for multivariable)	1641_Myeloperoxidase (at exam 7, GEE, adjusted for multivariable)	25	220	1	3156	3282	3377	2456	1815	220	1873	1598	2595	2643	3900
1206_Longevity (>= 90 yrs vs < 65 yrs)	1206_Longevity (>= 90 yrs vs < 65 yrs)	25	220	1	953	1727	4515	4561	4628	4603	2516	2404	3423	220	3808
4109_Serum creatinine	4109_Serum creatinine	25	221	1	221	539	829	234	2480	2684	2296	2053	2178	1185	2000
2796_GPI - Glucose-6-phosphate isomerase	2796_GPI - Glucose-6-phosphate isomerase	25	221	1	1073	221	2079	4029	354	3217	441	1648	722	1260	726
1872_Shaft average buckling ratio (FBAT, male, adjussted for multivariable)	1872_Shaft average buckling ratio (FBAT, male, adjussted for multivariable)	25	221	1	593	3609	221	4391	1525	1303	1736	930	1916	1356	562
2010_High-density lipoprotein cholesterol	2010_High-density lipoprotein cholesterol	25	221	1	690	1938	2080	221	4465	1623	3203	3299	746	2235	3338
2611_LRPAP1 - alpha-2-macroglobulin receptor-associated protein	2611_LRPAP1 - alpha-2-macroglobulin receptor-associated protein	25	221	1	4445	831	4608	1505	221	3210	1041	550	3717	306	479
768_Peptide::Dipeptide::X-12244--N-acetylcarnosine	768_Peptide::Dipeptide::X-12244--N-acetylcarnosine	25	221	1	4709	3550	2280	3540	1702	221	4141	1916	2812	3494	3802
4580_Right entorhinal	4580_Right entorhinal	25	221	1	2048	712	2870	1285	442	1527	1592	2970	707	221	2998
3588_Types of physical activity in last 4 weeks: Light DIY (eg: pruning, watering the lawn)	3588_Types of physical activity in last 4 weeks: Light DIY (eg: pruning, watering the lawn)	25	221	1	831	3736	2750	2042	1414	2869	3477	1941	1862	3426	221
2711_HINT1 - Histidine triad nucleotide-binding protein 1	2711_HINT1 - Histidine triad nucleotide-binding protein 1	25	222	1	2301	222	2832	770	2469	2071	539	523	1584	1030	1543
740_::::X-11852	740_::::X-11852	25	222	1	792	3327	3201	2796	222	1192	4092	3820	4078	3849	2294
4710_Superior longitudinal fasciculus mean diusivities	4710_Superior longitudinal fasciculus mean diusivities	25	222	1	1692	561	1695	1466	306	222	791	2169	3926	4042	3555
4509_Cerebellar vermal lobules VIII X	4509_Cerebellar vermal lobules VIII X	25	222	1	4663	3939	1867	3830	2243	1116	2863	2442	3802	222	583
1836_Neck width (FBAT, male, adjusted for multivariable)	1836_Neck width (FBAT, male, adjusted for multivariable)	25	223	1	2939	648	2769	1274	2542	223	1324	453	2380	3987	3433
4713_Anterior corona radiata mode of anisotropy	4713_Anterior corona radiata mode of anisotropy	25	223	1	3793	658	4692	376	1097	1125	1232	223	2816	640	3345
2365_ULBP2 - NKG2D ligand 2	2365_ULBP2 - NKG2D ligand 2	25	223	1	2199	2298	1132	3302	1034	1725	4729	2978	3053	4113	223
523_Lipid::Long chain fatty acid::nonadecanoate (19:0)	523_Lipid::Long chain fatty acid::nonadecanoate (19:0)	25	224	1	333	357	224	1866	2272	4029	1860	3552	3776	1549	3169
1560_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1560_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	224	1	3358	2326	3275	224	2444	3645	3184	3360	1828	266	446
3683_Diagnoses - main ICD10: R19 Oth symptoms and signs involving the dgstv sys and abdomen	3683_Diagnoses - main ICD10: R19 Oth symptoms and signs involving the dgstv sys and abdomen	25	224	1	4543	3604	2642	1667	224	3066	3521	3530	3021	1796	3817
3787_Insomnia (male)	3787_Insomnia (male)	25	224	1	2220	3636	2674	623	2289	224	2470	2870	4506	3612	2331
2512_TNFSF8 - Tumor necrosis factor ligand superfamily member 8	2512_TNFSF8 - Tumor necrosis factor ligand superfamily member 8	25	224	1	751	412	2866	2346	2799	3500	371	2444	940	224	1875
1892_Shaft Section Modulus (FBAT, adjussted for multivariable)	1892_Shaft Section Modulus (FBAT, adjussted for multivariable)	25	224	1	1652	2278	2119	3091	1122	2539	862	1827	603	401	224
3176_PRKCB - Protein kinase C beta type (splice variant beta-II)	3176_PRKCB - Protein kinase C beta type (splice variant beta-II)	25	225	1	225	1219	560	3904	2995	3587	1503	4035	3187	2289	1911
1309_Fasting HbA1c (at exam 5, GEE, adjusted for age and sex)	1309_Fasting HbA1c (at exam 5, GEE, adjusted for age and sex)	25	225	1	2046	3656	225	1123	2620	3024	1891	997	2455	4640	756
4687_Superior fronto-occipital fasciculus axial diusivities	4687_Superior fronto-occipital fasciculus axial diusivities	25	225	1	1976	1119	2571	225	4480	1917	1504	762	611	234	2744
2078_FGF8 - Fibroblast growth factor 8 isoform B	2078_FGF8 - Fibroblast growth factor 8 isoform B	25	225	1	2330	4336	3883	2778	225	3234	3519	1414	1375	4237	2364
3421_Pairs matching test - Time to complete round	3421_Pairs matching test - Time to complete round	25	225	1	3283	1092	3902	4498	4200	4085	1527	1101	225	1304	3211
647_Xenobiotics::Xanthine metabolism::paraxanthine	647_Xenobiotics::Xanthine metabolism::paraxanthine	25	226	1	4144	2984	4186	226	3672	1975	1231	2009	1268	4294	2155
2862_IL3RA - Interleukin-3 receptor subunit alpha	2862_IL3RA - Interleukin-3 receptor subunit alpha	25	226	1	3788	3136	4364	2533	1693	4100	1878	226	735	2667	670
1210_FEV1/FCV	1210_FEV1/FCV	25	226	1	4742	1748	2238	2724	1920	4549	620	1576	226	3089	3678
1483_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for age and sex)	1483_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for age and sex)	25	227	1	1348	546	227	1776	954	3976	377	1808	1754	4441	363
2564_CCL15 - C-C motif chemokine 15	2564_CCL15 - C-C motif chemokine 15	25	227	1	619	2905	1971	227	1137	4666	893	251	767	1959	4507
4180_Platelets	4180_Platelets	25	227	1	2864	1305	551	3122	227	2315	2897	3493	1855	3044	4657
1249_Percent predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	1249_Percent predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	25	227	1	1868	3904	622	3936	1230	227	3344	1866	4664	4630	248
1736_Serum phosphorus (at exam 2, FBAT, adjusted for multivariable)	1736_Serum phosphorus (at exam 2, FBAT, adjusted for multivariable)	25	227	1	3265	2620	2842	590	246	2100	1931	227	1696	3746	3367
3921_Triglycerides cholesterol	3921_Triglycerides cholesterol	25	227	1	3493	3906	4530	3942	4732	2825	2159	2242	227	3479	3794
1372_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	1372_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	25	228	1	228	1623	600	1477	3264	2698	3400	1853	250	1597	2808
2248_HAT1 - Histone acetyltransferase type B catalytic subunit	2248_HAT1 - Histone acetyltransferase type B catalytic subunit	25	228	1	4614	1712	228	1356	2062	4306	2075	1528	2313	879	1928
4146_Interventricular septum thickness	4146_Interventricular septum thickness	25	228	1	2101	4467	1069	2658	228	888	1977	2704	2800	2709	1936
1370_Total cholesterol (at exam 7, FBAT, adjusted for age and sex)	1370_Total cholesterol (at exam 7, FBAT, adjusted for age and sex)	25	228	1	4634	1880	2692	505	3519	1640	228	1614	2630	1650	881
3998_Tense / 'highly strung' (TENSE)	3998_Tense / 'highly strung' (TENSE)	25	228	1	4195	552	4314	793	4021	2784	495	228	674	4047	3470
4348_Coronary artery disease and high-density lipoprotein cholesterol (bivariate)	4348_Coronary artery disease and high-density lipoprotein cholesterol (bivariate)	25	228	1	2072	2535	2949	3811	1639	1586	4190	3581	228	4206	3014
4391_Dysmenorrhea (quality of life impact)	4391_Dysmenorrhea (quality of life impact)	25	228	1	755	1474	2847	1620	1800	1274	2472	1389	2622	228	1102
1837_Neck width (GEE, male, adjusted for multivariable)	1837_Neck width (GEE, male, adjusted for multivariable)	25	228	1	3936	1104	3355	1739	2668	4073	2936	1237	3562	1202	228
3322_Most recent bowel cancer screening	3322_Most recent bowel cancer screening	25	229	1	229	3121	2011	2636	1911	1307	2403	1408	3670	2086	2978
2677_PAK6 - Serine/threonine-protein kinase PAK 6	2677_PAK6 - Serine/threonine-protein kinase PAK 6	25	229	1	3243	229	4249	1103	1785	4050	1862	925	3154	2066	4656
4423_Helicobacter pylori seropositivity	4423_Helicobacter pylori seropositivity	25	229	1	947	4403	229	611	2932	3543	2466	3601	1241	2199	855
2892_PLCG1 - 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	2892_PLCG1 - 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	25	229	1	4325	1764	4007	3652	229	929	1389	740	1217	2774	1126
3536_Mental health - Illness, injury, bereavement, stress in last 2 years: Financial difficulties	3536_Mental health - Illness, injury, bereavement, stress in last 2 years: Financial difficulties	25	229	1	1397	1816	1768	865	989	742	2323	229	356	492	1971
2561_LTA LTB - Lymphotoxin alpha1:beta2	2561_LTA LTB - Lymphotoxin alpha1:beta2	25	229	1	3907	1996	2448	457	2560	1236	2778	512	229	3675	4090
4371_Thyroid-stimulating hormone (female)	4371_Thyroid-stimulating hormone (female)	25	229	1	2218	2770	4408	817	2391	248	2022	3509	784	4311	229
3279_Father's age at death	3279_Father's age at death	25	230	1	3709	4075	3339	4275	230	3412	1979	1557	2686	3902	2683
2505_BCL2A1 - Bcl-2-related protein A1	2505_BCL2A1 - Bcl-2-related protein A1	25	230	1	4353	4699	1782	1583	4013	230	883	3948	4633	2600	794
2939_F10 - Coagulation Factor X	2939_F10 - Coagulation Factor X	25	230	1	507	458	2848	1702	892	1456	230	2087	253	2685	3861
89_Infant head circumference	89_Infant head circumference	25	231	1	2292	231	4654	662	2709	3866	314	2336	1570	1463	1773
679_::::X-09706	679_::::X-09706	25	231	1	2245	2240	1054	4405	1777	231	2856	2416	3813	4295	4254
2196_GDF11 - Growth/differentiation factor 11	2196_GDF11 - Growth/differentiation factor 11	25	231	1	2446	1314	1254	2813	2081	332	231	738	894	3956	2138
1587_Factor VII (at exam 5, GEE, adjusted for age and sex)	1587_Factor VII (at exam 5, GEE, adjusted for age and sex)	25	231	1	2344	4173	4548	3172	4260	251	2313	1054	4673	3655	231
717_::::X-11529	717_::::X-11529	25	232	1	275	515	2459	4493	402	232	1277	2279	601	1496	3648
2863_IL5RA - Interleukin-5 receptor subunit alpha	2863_IL5RA - Interleukin-5 receptor subunit alpha	25	232	1	3708	2983	3716	853	3902	3511	1416	232	681	693	3196
1777_Heart failure (censored at interval MI, GEE, adjusted for age and sex)	1777_Heart failure (censored at interval MI, GEE, adjusted for age and sex)	25	232	1	533	3474	750	2134	740	2652	4460	3435	1134	3817	232
3395_Ever highly irritable/argumentative for 2 days	3395_Ever highly irritable/argumentative for 2 days	25	233	1	233	4104	3429	2862	3895	2333	4709	971	1762	2532	4390
24_Attention deficit hyperactivity disorder	24_Attention deficit hyperactivity disorder	25	233	1	911	233	1311	2059	1945	703	503	1707	327	816	1791
1333_Fasting HbA1c (at exam 5, GEE, adjusted for age, sex and BMI)	1333_Fasting HbA1c (at exam 5, GEE, adjusted for age, sex and BMI)	25	233	1	1144	2248	233	1894	1938	3963	2064	1146	3645	2791	506
1661_Alkaline phosphatase (at exam 2, GEE, adjusted for multivariable)	1661_Alkaline phosphatase (at exam 2, GEE, adjusted for multivariable)	25	233	1	1362	4166	1429	1827	233	1963	2394	4343	1216	4627	2175
4274_Short sleep	4274_Short sleep	25	233	1	4413	1429	3960	4676	501	1457	233	1089	1409	2306	1519
1163_Hemoglobin A1C	1163_Hemoglobin A1C	25	233	1	4581	3765	2726	3196	3778	4107	1706	233	3205	1519	2936
4462_Left pars triangularis	4462_Left pars triangularis	25	233	1	1293	1006	3543	2396	1627	1408	2337	1451	2394	233	4418
4264_Ankylosing spondylitis	4264_Ankylosing spondylitis	25	234	1	2054	1471	4546	3513	234	2267	3782	4535	3884	302	273
2303_LGALS4 - Galectin-4	2303_LGALS4 - Galectin-4	25	234	1	4094	1551	4063	1890	4439	4019	4350	234	919	2402	2480
255_CD3 on 127+DN T	255_CD3 on 127+DN T	25	234	1	1122	547	3015	3716	2735	2715	698	815	234	4736	4725
3768_Anxiety - Recent trouble relaxing	3768_Anxiety - Recent trouble relaxing	25	234	1	3304	4568	528	1397	4615	1857	3758	417	2358	1380	234
1846_Neck Section Modulus (FBAT, female, adjusted for age)	1846_Neck Section Modulus (FBAT, female, adjusted for age)	25	235	1	2049	235	1704	2266	2695	716	1364	1401	1079	334	2449
3243_Dried fruit intake	3243_Dried fruit intake	25	235	1	1083	1449	4142	235	3209	1090	848	1920	4406	3338	2831
32_Neuroticism (IRT)	32_Neuroticism (IRT)	25	235	1	1709	3501	4039	1449	4378	496	4556	3266	1643	235	2113
3255_Tea intake	3255_Tea intake	25	235	1	3784	1313	2234	1105	3764	1436	470	2806	774	3464	235
1482_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for age and sex)	1482_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for age and sex)	25	236	1	1955	1253	3943	3503	236	401	4071	1192	4310	1351	407
239_CD24 on IgA+ B	239_CD24 on IgA+ B	25	236	1	3904	1175	4399	4208	3989	236	1782	3137	2902	322	1820
884_Triglycerides in IDL	884_Triglycerides in IDL	25	236	1	2098	1643	1509	4618	299	826	3858	2549	236	3177	2905
2809_DCTPP1 - dCTP pyrophosphatase 1	2809_DCTPP1 - dCTP pyrophosphatase 1	25	237	1	237	3140	915	420	3775	2505	4508	3107	4637	1775	4363
3967_Asthma (random effect model)	3967_Asthma (random effect model)	25	237	1	3695	237	386	1727	2828	1209	642	1722	4517	970	593
3891_Mean platelet volume (three-way meta)	3891_Mean platelet volume (three-way meta)	25	237	1	2154	2729	237	2556	1967	1291	2091	2669	4342	1913	1499
1307_Insulin sensitivity (GEE, adjusted for age and sex)	1307_Insulin sensitivity (GEE, adjusted for age and sex)	25	237	1	3580	1258	2174	2255	237	560	723	610	240	2700	4532
1410_High-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	1410_High-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	25	237	1	246	3091	2308	3461	497	237	1982	3026	2305	471	3664
4426_Epstein Barr Virus antigen EA seropositivity	4426_Epstein Barr Virus antigen EA seropositivity	25	237	1	3815	531	1208	3075	1649	511	237	4088	2002	484	3736
4412_Total IgM levels	4412_Total IgM levels	25	237	1	1892	1755	247	3695	2647	1282	1980	2394	1594	237	834
1835_Neck width (GEE, female, adjusted for multivariable)	1835_Neck width (GEE, female, adjusted for multivariable)	25	237	1	4077	4649	310	4324	1571	1030	606	4689	1750	4117	237
2110_CD80 - T-lymphocyte activation antigen CD80	2110_CD80 - T-lymphocyte activation antigen CD80	25	238	1	238	4326	1793	1084	3365	2733	3109	1641	4568	2389	802
4122_Gamma-glutamyl transferase	4122_Gamma-glutamyl transferase	25	238	1	4005	1283	238	3158	3358	2946	3771	760	1056	3954	3956
2446_SERPIND1 - Heparin cofactor 2	2446_SERPIND1 - Heparin cofactor 2	25	238	1	3666	275	1658	238	3722	4398	1483	356	636	2242	3276
3094_TNFRSF19 - Tumor necrosis factor receptor superfamily member 19	3094_TNFRSF19 - Tumor necrosis factor receptor superfamily member 19	25	238	1	4111	3038	835	2388	238	4693	4054	2324	4146	3632	1140
1428_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1428_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	238	1	4497	463	741	857	3698	1932	238	1390	1040	1684	466
3925_Coronary artery disease (SOFT definition including angina)	3925_Coronary artery disease (SOFT definition including angina)	25	238	1	2644	468	3774	4059	1685	814	1211	2262	2234	238	2302
1889_Shaft Width (GEE, female, adjussted for age)	1889_Shaft Width (GEE, female, adjussted for age)	25	239	1	633	2067	4095	4348	239	2206	1540	3410	2698	1595	3778
2834_CHST2 - Carbohydrate sulfotransferase 2	2834_CHST2 - Carbohydrate sulfotransferase 2	25	239	1	2420	3392	2526	659	2619	690	837	239	673	4415	2788
1095_Diastolic Blood Pressure	1095_Diastolic Blood Pressure	25	239	1	2852	1310	3547	351	4011	2251	1135	858	239	2472	1986
1193_Crohn's Disease	1193_Crohn's Disease	25	239	1	2613	246	2669	3462	2602	2741	1175	2281	764	239	743
543_Lipid::Lysolipid::1-palmitoylglycerophosphocholine	543_Lipid::Lysolipid::1-palmitoylglycerophosphocholine	25	240	1	240	4434	1954	1856	509	3552	4115	946	4359	498	3504
2783_LCMT1 - Leucine carboxyl methyltransferase 1	2783_LCMT1 - Leucine carboxyl methyltransferase 1	25	240	1	541	4564	240	3981	4365	1310	3089	3413	3056	3677	2731
2045_Primary angle closure glaucoma	2045_Primary angle closure glaucoma	25	240	1	2224	858	4503	824	2216	240	720	262	554	1842	521
1509_Triglycerides (at exam 6, GEE, adjusted for age and sex)	1509_Triglycerides (at exam 6, GEE, adjusted for age and sex)	25	240	1	4501	1438	2133	4239	4683	3344	2172	240	1602	3749	1800
3216_Frequency of friend/family visits	3216_Frequency of friend/family visits	25	240	1	4735	1815	2281	2665	2244	4076	3239	4245	3159	1825	240
2832_ADAM12 - Disintegrin and metalloproteinase domain-containing protein 12	2832_ADAM12 - Disintegrin and metalloproteinase domain-containing protein 12	25	241	1	242	241	243	3236	4649	3655	2458	1157	2438	297	4062
3648_Illnesses of siblings: Heart disease	3648_Illnesses of siblings: Heart disease	25	241	1	4265	1553	593	241	308	3681	1398	1009	4079	1469	2623
3806_White blood cell count	3806_White blood cell count	25	241	1	3080	2312	3449	3876	241	1175	2621	863	1697	862	376
2384_CA4 - Carbonic anhydrase 4	2384_CA4 - Carbonic anhydrase 4	24	241	1	3836	298	2929	2165	393	241	925	2121	652	1950	3738
1_Attention deficit hyperactivity disorder	1_Attention deficit hyperactivity disorder	25	241	1	1416	2759	4613	3537	3543	4197	241	806	2056	3775	4713
1549_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for multivariable)	1549_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for multivariable)	25	241	1	2645	1802	3550	2614	3252	1500	2733	241	1611	3204	2986
1312_HOMA-IR (at exam 5, FBAT, adjusted for age and sex)	1312_HOMA-IR (at exam 5, FBAT, adjusted for age and sex)	25	242	1	1607	3781	1649	688	242	1253	2451	2834	1444	3825	2682
728_::::X-11792	728_::::X-11792	25	242	1	4224	2023	1605	1331	1110	1549	242	2856	2505	1801	3928
2329_FTH1 FTL - Ferritin	2329_FTH1 FTL - Ferritin	25	242	1	1019	916	2577	2684	3289	4635	451	965	242	577	2418
4131_Eosinophil count	4131_Eosinophil count	25	242	1	484	760	2117	1650	1844	1269	731	478	987	242	4445
3030_RPS3 - 40S ribosomal protein S3	3030_RPS3 - 40S ribosomal protein S3	25	242	1	3630	3841	2628	821	1098	2720	3715	2100	2463	617	242
3774_Traumatic events - Been in aconfiding relationship as an adult	3774_Traumatic events - Been in aconfiding relationship as an adult	25	243	1	3465	643	1591	972	1400	2191	243	1412	3953	674	549
1337_HOMA-IR (at exam 5, GEE, adjusted for age, sex and BMI)	1337_HOMA-IR (at exam 5, GEE, adjusted for age, sex and BMI)	25	243	1	4257	4186	2247	1317	1200	1497	1532	243	1767	3508	518
2047_Periodontal complex trait 2	2047_Periodontal complex trait 2	25	243	1	2042	893	3931	396	2028	848	1420	767	243	830	2057
1507_Triglycerides (at exam 5, GEE, adjusted for age and sex)	1507_Triglycerides (at exam 5, GEE, adjusted for age and sex)	25	243	1	1055	2842	3568	2229	3678	444	1741	2634	2170	4573	243
1758_Breast cancer (FBAT, adjusted for age)	1758_Breast cancer (FBAT, adjusted for age)	25	244	1	2073	1296	2048	244	688	3813	869	3516	960	1662	1372
2456_PGLYRP1 - Peptidoglycan recognition protein 1	2456_PGLYRP1 - Peptidoglycan recognition protein 1	25	244	1	854	1611	767	856	1049	4240	1282	2011	2088	3627	244
4551_Left inferior parietal	4551_Left inferior parietal	25	245	1	2068	245	3329	683	4589	1211	2444	4662	1451	1350	3639
779_::::X-12450	779_::::X-12450	25	245	1	4016	1809	429	245	3659	3389	4262	3143	1708	4388	2924
1916_Temporal brain volume (FBAT, adjusted for multivariable)	1916_Temporal brain volume (FBAT, adjusted for multivariable)	25	245	1	2938	2670	983	3675	245	2930	764	1115	4505	4471	1658
1704_Follicle stimulating hormone (at exam 3, FBAT, adjusted for multivariable)	1704_Follicle stimulating hormone (at exam 3, FBAT, adjusted for multivariable)	25	245	1	270	2825	4574	1506	3956	245	2282	1767	3964	555	1562
2530_KLK6 - Kallikrein-6	2530_KLK6 - Kallikrein-6	25	245	1	3879	415	4533	837	4730	4399	245	1084	1449	496	2239
714_::::X-11491	714_::::X-11491	25	245	1	1496	860	3520	1407	3064	1835	1434	1118	245	2781	3370
662_Amino acid::Butanoate metabolism::X-04499--3,4-dihydroxybutyrate	662_Amino acid::Butanoate metabolism::X-04499--3,4-dihydroxybutyrate	25	246	1	1730	2419	246	3478	3436	3731	1325	3935	3387	1387	2130
636_Xenobiotics::Food component, Plant::stachydrine	636_Xenobiotics::Food component, Plant::stachydrine	25	246	1	2567	4258	577	246	443	1443	1828	3178	3051	1385	4746
3464_Impedance measures - Arm fat percentage (left)	3464_Impedance measures - Arm fat percentage (left)	25	246	1	2431	3100	4223	2656	4076	246	2616	3412	3190	290	2268
1300_Fasting plasma glucose (at exam 7, FBAT, adjusted for age and sex)	1300_Fasting plasma glucose (at exam 7, FBAT, adjusted for age and sex)	25	246	1	852	4555	3434	1018	822	4535	1723	3033	1934	4587	246
453_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::biliverdin	453_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::biliverdin	25	247	1	4384	3315	3651	3915	247	3862	3781	1628	1731	4428	3666
3826_Osteoarthritis of knee	3826_Osteoarthritis of knee	25	247	1	4655	2509	3197	3705	1293	247	3540	2482	4371	638	949
569_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 2*	569_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 2*	25	247	1	3592	3113	855	1188	3845	1481	1469	1881	639	247	1735
3072_MICB - MHC class I polypeptide-related sequence B	3072_MICB - MHC class I polypeptide-related sequence B	25	247	1	3512	4239	2602	2251	1862	384	4036	3745	2705	4292	247
633_Xenobiotics::Food component, Plant::piperine	633_Xenobiotics::Food component, Plant::piperine	25	248	1	248	1441	1414	4065	4105	3915	543	4429	1718	3372	3168
2996_FGFR4 - Fibroblast growth factor receptor 4	2996_FGFR4 - Fibroblast growth factor receptor 4	25	248	1	1262	4191	248	337	4522	3075	1606	669	4266	801	2878
1769_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for age and sex)	1769_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for age and sex)	25	248	1	2664	915	2374	248	4633	1622	1461	335	605	2053	655
3617_Treatment/medication code: atenolol	3617_Treatment/medication code: atenolol	25	248	1	978	1842	4650	314	839	1764	892	489	248	4596	1930
4442_Epstein Barr Virus antigen EBNA IgG levels	4442_Epstein Barr Virus antigen EBNA IgG levels	25	248	1	3847	2101	472	4354	1937	1681	4316	2131	2127	248	564
1217_Alcohol consumption (dichotomous, male)	1217_Alcohol consumption (dichotomous, male)	25	249	1	4126	1807	3965	249	2905	3377	3556	4118	4742	4545	2047
4726_Posterior limb of internal capsule mode of anisotropy	4726_Posterior limb of internal capsule mode of anisotropy	25	249	1	3254	1610	2820	727	4433	4670	249	457	4439	915	3950
2118_ERBB2 - Receptor tyrosine-protein kinase erbB-2	2118_ERBB2 - Receptor tyrosine-protein kinase erbB-2	25	249	1	3151	2259	4510	1423	1442	3501	1485	249	1575	3999	4096
3813_CD4+ T cell level	3813_CD4+ T cell level	25	249	1	3094	1835	4433	3329	586	3275	738	4584	249	360	607
3317_Falls in the last year	3317_Falls in the last year	25	249	1	2187	1346	978	1102	1394	2186	2829	316	2384	3539	249
4224_Agents acting on the renin-angiotensin system	4224_Agents acting on the renin-angiotensin system	25	250	1	250	1531	1319	1422	3235	2322	3175	2159	1291	4363	957
444_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::pyruvate	444_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::pyruvate	25	250	1	3869	2928	4732	2564	250	3586	1821	4729	4253	1283	4490
447_Cofactors and vitamins::Ascorbate and aldarate metabolism::ascorbate (Vitamin C)	447_Cofactors and vitamins::Ascorbate and aldarate metabolism::ascorbate (Vitamin C)	25	250	1	2203	2898	3810	3891	3311	250	1892	1513	3514	1497	1805
3973_Total body BMD (45-60 years old)	3973_Total body BMD (45-60 years old)	25	250	1	2083	918	1515	775	3218	3987	580	250	280	3307	2656
1973_Morbidity-free survival (at age 65, GEE, adjusted for multivariable)	1973_Morbidity-free survival (at age 65, GEE, adjusted for multivariable)	25	251	1	267	251	3219	570	668	3513	1096	2524	1437	430	1064
3882_High light scatter reticulocyte count (three-way meta)	3882_High light scatter reticulocyte count (three-way meta)	25	251	1	1758	3626	251	3142	1759	2130	4574	1321	3197	4737	2288
23_Major depressive disorder (females)	23_Major depressive disorder (females)	25	251	1	1222	1365	2232	1664	251	1129	4569	2185	1385	3561	1578
734_::::X-11820	734_::::X-11820	25	251	1	2166	3290	4725	1559	2250	2579	1733	4466	3916	251	3462
525_Lipid::Long chain fatty acid::palmitate (16:0)	525_Lipid::Long chain fatty acid::palmitate (16:0)	25	251	1	1127	3571	1134	2327	2700	1873	2637	2803	3184	1954	251
2670_IL12RB2 - Interleukin-12 receptor subunit beta-2	2670_IL12RB2 - Interleukin-12 receptor subunit beta-2	25	252	1	2510	2122	252	3706	1655	3962	3416	3157	1944	3373	588
2532_LYN - Tyrosine-protein kinase Lyn	2532_LYN - Tyrosine-protein kinase Lyn	25	252	1	879	1274	3805	965	252	4455	2205	1680	358	976	2825
1306_Insulin sensitivity (FBAT, adjusted for age and sex)	1306_Insulin sensitivity (FBAT, adjusted for age and sex)	25	252	1	549	728	804	589	1681	252	761	3916	727	1955	584
2372_CD4 - T-cell surface glycoprotein CD4	2372_CD4 - T-cell surface glycoprotein CD4	25	252	1	3412	674	4097	823	4307	3298	252	578	790	478	2082
3366_Age at menopause (last menstrual period) (female)	3366_Age at menopause (last menstrual period) (female)	25	253	1	2818	253	1786	2497	4269	1593	1538	2765	938	635	4018
4670_Anterior limb of internal capsule axial diusivities	4670_Anterior limb of internal capsule axial diusivities	25	253	1	829	1707	2562	253	3305	1664	3486	4313	1544	605	2440
746_::::X-12013	746_::::X-12013	25	253	1	2848	3796	4196	2972	253	2107	1857	446	2937	4203	3932
1724_Serum calcium (at exam 2, FBAT, adjusted for age, sex and serum creatinine)	1724_Serum calcium (at exam 2, FBAT, adjusted for age, sex and serum creatinine)	25	253	1	2484	478	792	2062	2946	253	1392	2699	3775	1230	4517
9_Schizophrenia	9_Schizophrenia	25	253	1	564	1505	712	1738	3248	2578	253	1832	4151	2385	4350
2077_FGF10 - Fibroblast growth factor 10	2077_FGF10 - Fibroblast growth factor 10	25	253	1	563	4556	407	2480	3037	960	4660	4730	4008	4492	253
3581_Types of transport used (excluding work): Car/motor vehicle	3581_Types of transport used (excluding work): Car/motor vehicle	25	254	1	4712	3470	254	472	735	3782	2624	1865	332	3485	3769
3130_TYK2 - Non-receptor tyrosine-protein kinase TYK2	3130_TYK2 - Non-receptor tyrosine-protein kinase TYK2	25	254	1	3947	2662	3154	2799	254	1877	4343	4122	2126	4164	4235
3811_Basophil count	3811_Basophil count	25	254	1	4440	2149	4628	1560	4535	4174	1695	254	1342	600	451
1489_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for multivariable)	1489_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for multivariable)	25	254	1	4729	1073	4028	2769	1082	831	2696	4136	3938	254	1623
528_Lipid::Long chain fatty acid::stearate (18:0)	528_Lipid::Long chain fatty acid::stearate (18:0)	25	255	1	255	647	553	3435	2989	4722	4442	4273	3066	2602	3816
2951_FGA FGB FGG - D-dimer	2951_FGA FGB FGG - D-dimer	25	255	1	416	255	3665	4735	2315	1450	793	2897	1732	351	4495
2218_ADAMTS4 - A disintegrin and metalloproteinase with thrombospondin motifs 4	2218_ADAMTS4 - A disintegrin and metalloproteinase with thrombospondin motifs 4	25	255	1	3446	1311	255	2962	539	3303	1864	2968	1860	2238	4265
2009_Hypertriglyceridemia	2009_Hypertriglyceridemia	25	255	1	3670	614	3593	2022	255	983	3123	1988	1797	3673	4195
1192_Refractive error	1192_Refractive error	25	255	1	1707	1679	4477	1925	4210	2866	846	255	696	3051	3061
2081_IL12A IL12B - Interleukin-12	2081_IL12A IL12B - Interleukin-12	25	255	1	1459	2115	1666	2032	2038	539	482	1308	255	1644	1938
4360_Biliary atresia	4360_Biliary atresia	25	255	1	386	1178	572	1891	1324	2865	1201	3845	3498	255	3494
1799_High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1799_High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	255	1	451	4404	338	3852	1908	376	2997	4206	4499	1731	255
4189_Fasting glucose	4189_Fasting glucose	25	256	1	1587	1919	256	2782	3833	3449	380	2576	2921	877	2971
1224_Mean Putamen	1224_Mean Putamen	25	256	1	4483	1269	2188	3864	256	2753	1994	3353	4107	1291	4690
3082_CD200 - OX-2 membrane glycoprotein	3082_CD200 - OX-2 membrane glycoprotein	25	256	1	2135	1666	1785	4267	2330	256	2047	2109	3756	1061	1169
2381_NAAA - N-acylethanolamine-hydrolyzing acid amidase	2381_NAAA - N-acylethanolamine-hydrolyzing acid amidase	25	256	1	3388	3777	2933	1640	1117	1638	1295	256	2853	2525	501
3186_Hip circumference	3186_Hip circumference	25	256	1	775	1792	1514	4146	1990	419	2226	1102	1796	3492	256
1679_Atrial natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	1679_Atrial natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	25	257	1	3953	2033	1611	257	3219	2981	3465	3460	2769	486	626
250_CD39 on CD4 T	250_CD39 on CD4 T	25	257	1	4260	1538	2592	2793	257	3821	1039	1066	329	846	4432
1228_Parkinson Disease (additive model)	1228_Parkinson Disease (additive model)	25	257	1	2698	513	426	2524	2008	4695	257	447	368	946	1189
4332_Erectile dysfunction	4332_Erectile dysfunction	25	257	1	4044	1195	4447	2302	2377	1795	1011	257	577	4168	4688
4263_Ankylosing spondylitis	4263_Ankylosing spondylitis	25	257	1	1498	433	4341	2566	352	2716	1419	1586	2452	257	417
1694_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for age and sex)	1694_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for age and sex)	25	257	1	3104	2162	562	299	2844	798	3281	3814	3969	4120	257
2102_MMP9 - Matrix metalloproteinase-9	2102_MMP9 - Matrix metalloproteinase-9	25	258	1	258	669	563	3921	2123	4261	675	641	3988	1778	4268
3290_Worrier / anxious feelings	3290_Worrier / anxious feelings	25	258	1	862	851	258	1831	4400	4310	1008	752	498	1791	1770
4449_Left fusiform	4449_Left fusiform	25	258	1	3109	3619	3598	258	3505	1826	376	828	1310	2322	3201
281_CD8:%Act(25+38+RO+)	281_CD8:%Act(25+38+RO+)	25	258	1	2039	4300	802	3713	258	3038	3038	2390	2312	4167	711
3943_HbA1c	3943_HbA1c	25	258	1	3263	2532	2564	4046	4506	880	1584	258	4091	2405	4229
3344_Age at last live birth (female)	3344_Age at last live birth (female)	25	258	1	596	3252	477	2057	1114	2339	4144	1549	258	460	346
2622_CFHR5 - Complement factor H-related protein 5	2622_CFHR5 - Complement factor H-related protein 5	25	259	1	259	601	2557	1404	4129	749	2440	1205	1478	2127	4607
127_Height (female)	127_Height (female)	25	259	1	2521	259	4135	4160	773	3889	682	3022	2696	2131	329
851_Acetate	851_Acetate	25	259	1	3062	700	3281	2120	259	4509	3194	2729	3351	3957	2206
1891_Shaft Width (GEE, male, adjussted for age)	1891_Shaft Width (GEE, male, adjussted for age)	25	259	1	4316	4408	1719	3517	1173	259	990	3105	3795	443	1041
4005_Osteoarthritis (self reported)	4005_Osteoarthritis (self reported)	25	259	1	2328	868	3987	614	2030	3939	259	1793	3250	1827	4056
39_Memory	39_Memory	25	259	1	1220	439	3958	585	4616	4203	602	741	259	612	3770
2752_PLG - Plasmin	2752_PLG - Plasmin	25	260	1	2829	260	1121	2335	3626	477	394	3817	3126	4332	1977
632_Xenobiotics::Food component, Plant::N-(2-furoyl)glycine	632_Xenobiotics::Food component, Plant::N-(2-furoyl)glycine	25	260	1	2964	4602	2075	2220	260	301	1957	1679	1250	2237	2991
449_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,E)*	449_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,E)*	25	260	1	710	811	4203	4154	4305	260	4454	2468	3607	3354	4700
849_::::X-18601	849_::::X-18601	25	260	1	1193	2667	1835	2130	3681	4102	3912	1409	2522	260	4258
3597_Non-cancer illness code, self-reported: hypertension	3597_Non-cancer illness code, self-reported: hypertension	25	261	1	261	3258	1448	1745	4377	2319	3960	4028	1360	2603	981
4503_Right superior temporal	4503_Right superior temporal	25	261	1	3527	3835	261	1277	1569	407	3296	1360	1787	3062	2419
1063_Schizophrenia	1063_Schizophrenia	25	261	1	1821	2231	3850	261	4440	3935	4024	4247	4427	4136	4031
3212_Frequency of walking for pleasure in last 4 weeks	3212_Frequency of walking for pleasure in last 4 weeks	25	261	1	284	909	1853	3193	261	3421	948	3596	1518	861	3323
1404_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for age and sex)	1404_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	261	1	4593	4624	1992	2886	833	261	4580	4100	2201	4360	1198
2522_GZMA - Granzyme A	2522_GZMA - Granzyme A	25	261	1	4000	328	1607	1661	4512	4561	1354	1449	2852	374	261
1121_Pericardial adipose tissue volume (adjusted for height and weight, male)	1121_Pericardial adipose tissue volume (adjusted for height and weight, male)	25	262	1	1178	4363	262	2422	1813	4740	2387	4011	3239	4617	470
1703_Follicle stimulating hormone (at exam 3, GEE, adjusted for age and sex)	1703_Follicle stimulating hormone (at exam 3, GEE, adjusted for age and sex)	25	262	1	4105	4500	1852	262	1315	4488	3756	1991	2103	3524	1429
1659_Alkaline phosphatase (at exam 2, GEE, adjusted for age and sex)	1659_Alkaline phosphatase (at exam 2, GEE, adjusted for age and sex)	25	262	1	1353	1888	4123	1421	4008	3233	3652	4388	1364	262	3081
4637_Right putamen	4637_Right putamen	25	263	1	397	263	2206	3241	4573	2163	359	845	1340	495	1287
2789_NSFL1C - NSFL1 cofactor p47	2789_NSFL1C - NSFL1 cofactor p47	25	263	1	3640	1182	3271	263	2742	2793	2121	1596	555	2069	1156
4121_Alkaline phosphatase	4121_Alkaline phosphatase	25	263	1	1995	4420	3941	1930	263	4592	3707	510	1483	1416	400
1330_Insulin sensitivity (FBAT, adjusted for age, sex and BMI)	1330_Insulin sensitivity (FBAT, adjusted for age, sex and BMI)	25	263	1	4546	939	3505	1224	3582	263	843	2199	755	2026	1877
1035_Neck Section Modulus (GEE, adjusted for multivariable)	1035_Neck Section Modulus (GEE, adjusted for multivariable)	25	264	1	264	3471	1190	4690	4497	4630	4407	1106	1788	4647	1339
3248_Beef intake	3248_Beef intake	25	264	1	3141	540	4605	1083	2064	264	1194	3976	4434	1029	3136
2898_PPY - Pancreatic hormone	2898_PPY - Pancreatic hormone	25	264	1	1071	345	1334	1820	587	1738	415	264	1236	312	3063
3639_Illnesses of mother: Stroke	3639_Illnesses of mother: Stroke	25	264	1	886	4600	3783	895	665	4110	4307	4699	264	2541	936
2487_PRKCI - Protein kinase C iota type	2487_PRKCI - Protein kinase C iota type	25	264	1	2389	2622	2587	1444	862	1143	1928	3949	2689	3931	264
4556_Left lingual	4556_Left lingual	25	265	1	265	2454	395	3958	4610	3614	2651	1638	3859	710	1173
51_Number of children ever born (female)	51_Number of children ever born (female)	25	265	1	2148	265	4678	3323	1048	3308	3738	1485	1629	1182	2403
1265_Residual from predicted FVC for latest exam (GEE, adjusted for multiple covariates)	1265_Residual from predicted FVC for latest exam (GEE, adjusted for multiple covariates)	25	265	1	2739	2466	265	1223	4470	2833	4114	970	2848	2418	2686
1458_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1458_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	265	1	1901	429	1595	3731	265	1727	2249	4086	2655	2281	4100
616_Xenobiotics::Benzoate metabolism::benzoate	616_Xenobiotics::Benzoate metabolism::benzoate	25	265	1	4128	736	4681	275	1282	3634	265	697	879	2783	2152
3230_Morning/evening person (chronotype)	3230_Morning/evening person (chronotype)	25	265	1	2067	676	2098	788	4177	1630	938	265	1018	2027	1402
2940_GDF2 - Growth/differentiation factor 2	2940_GDF2 - Growth/differentiation factor 2	25	266	1	266	2892	4287	4098	3418	1550	1764	2880	2637	2566	2558
3033_SIRT2 - NAD-dependent protein deacetylase sirtuin-2	3033_SIRT2 - NAD-dependent protein deacetylase sirtuin-2	25	266	1	4065	266	2883	4397	2369	2689	708	1072	1034	1273	3544
1948_Visuospatial memory and organization (FBAT, adjusted for multivariable)	1948_Visuospatial memory and organization (FBAT, adjusted for multivariable)	25	266	1	4205	1825	266	1612	414	924	1187	4232	1497	4272	323
2067_TIMP2 - Metalloproteinase inhibitor 2	2067_TIMP2 - Metalloproteinase inhibitor 2	25	266	1	4654	4729	4442	1151	266	4734	2499	991	3584	705	971
1368_Total cholesterol (at exam 6, FBAT, adjusted for age and sex)	1368_Total cholesterol (at exam 6, FBAT, adjusted for age and sex)	25	266	1	4615	3340	4012	395	1929	266	3743	3979	4366	3473	1026
2448_IGFBP7 - Insulin-like growth factor-binding protein 7	2448_IGFBP7 - Insulin-like growth factor-binding protein 7	25	266	1	4058	2772	1195	2934	2980	3859	2219	314	481	2382	266
3999_Worry too long after embarrassment (WORR-EMB)	3999_Worry too long after embarrassment (WORR-EMB)	25	267	1	1584	865	1244	267	4313	4463	2841	1547	3682	3406	443
676_::::X-08988	676_::::X-08988	25	267	1	331	1934	422	4351	267	2278	2945	1153	4639	2908	3938
932_Pyruvate	932_Pyruvate	25	267	1	1421	4648	2921	3850	3898	1304	2354	267	4570	4729	3883
2103_MPO - Myeloperoxidase	2103_MPO - Myeloperoxidase	25	267	1	3372	792	3063	904	3451	3383	1735	1285	267	610	2724
167_Waist circumference	167_Waist circumference	25	268	1	268	4459	2404	4092	4051	3229	2274	2389	2424	1936	1016
1822_Inter-trochanteric buckling ratio (FBAT, female, adjussted for age)	1822_Inter-trochanteric buckling ratio (FBAT, female, adjussted for age)	25	268	1	621	268	850	612	1143	2613	342	3381	2303	1782	1440
3573_Pain type(s) experienced in last month: Stomach or abdominal pain	3573_Pain type(s) experienced in last month: Stomach or abdominal pain	25	268	1	2526	2460	3401	603	268	4466	1724	3522	4433	2948	4518
2662_EPHA5 - Ephrin type-A receptor 5	2662_EPHA5 - Ephrin type-A receptor 5	25	268	1	3679	732	4369	1515	2031	2771	268	3169	584	1846	4063
1100_Diastolic Blood Pressure - Birth cohorts	1100_Diastolic Blood Pressure - Birth cohorts	25	268	1	1069	2400	3032	1818	1379	3195	3664	268	2830	2091	4182
3147_CASP10 - Caspase-10	3147_CASP10 - Caspase-10	25	268	1	1886	4035	328	687	3917	3325	2960	1172	268	1784	3547
2536_PRKACA - cAMP-dependent protein kinase catalytic subunit alpha	2536_PRKACA - cAMP-dependent protein kinase catalytic subunit alpha	25	269	1	269	3169	3636	1589	782	3599	4470	1068	2152	3276	1751
2260_SERPINA3 - Alpha-1-antichymotrypsin	2260_SERPINA3 - Alpha-1-antichymotrypsin	25	269	1	3068	2736	269	3111	2335	1878	4436	408	1376	1225	1492
2137_PAFAH1B2 - Platelet-activating factor acetylhydrolase IB subunit beta	2137_PAFAH1B2 - Platelet-activating factor acetylhydrolase IB subunit beta	25	269	1	2701	3153	3260	269	3048	2783	2716	1750	1212	3533	1775
1510_Triglycerides (at exam 7, FBAT, adjusted for age and sex)	1510_Triglycerides (at exam 7, FBAT, adjusted for age and sex)	25	269	1	4405	3868	1604	1607	269	1650	4377	4629	1051	2956	592
1796_RR interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1796_RR interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	269	1	2986	4679	3685	4572	1499	269	1835	1862	3436	1619	1153
3890_Monocyte percentage of white cells (three-way meta)	3890_Monocyte percentage of white cells (three-way meta)	25	269	1	3698	1484	3744	4601	418	386	3097	269	3685	441	1004
1044_Bone Ultrasound Speed (FBAT, adjusted for multivariable)	1044_Bone Ultrasound Speed (FBAT, adjusted for multivariable)	25	269	1	3579	3862	1322	1273	4631	548	3604	4210	4027	1208	269
2386_CTSA - Lysosomal protective protein	2386_CTSA - Lysosomal protective protein	25	270	1	4461	270	3297	2100	2379	662	4661	518	3736	1940	4453
3550_Vascular/heart problems diagnosed by doctor: Angina	3550_Vascular/heart problems diagnosed by doctor: Angina	25	270	1	2440	1020	4597	2331	270	2397	907	4546	4472	2397	1746
1833_Neck length (GEE, male, adjusted for multivariable)	1833_Neck length (GEE, male, adjusted for multivariable)	25	270	1	3165	3918	2289	3369	3892	270	3013	1417	3497	4243	2359
3422_Trail making test - Duration to complete numeric path (trail #1)	3422_Trail making test - Duration to complete numeric path (trail #1)	25	270	1	1715	947	314	4199	2759	2079	270	1097	875	1209	401
213_Lymph:%CD4	213_Lymph:%CD4	25	270	1	1248	1392	2748	424	1246	2762	556	270	543	636	3427
2011_Remission following treatment of MDD subjects	2011_Remission following treatment of MDD subjects	25	270	1	1367	2592	1850	1455	3284	4691	4443	3191	2516	270	2692
4616_4th ventricle	4616_4th ventricle	25	271	1	4020	271	1327	3978	3373	3606	3436	4158	3049	328	563
617_Xenobiotics::Benzoate metabolism::catechol sulfate	617_Xenobiotics::Benzoate metabolism::catechol sulfate	25	271	1	1296	1966	271	4168	1684	1629	2699	2749	4440	1355	650
3720_Frequency of failure to fulfil normal expectations fue to drinking alcohol in last year	3720_Frequency of failure to fulfil normal expectations fue to drinking alcohol in last year	25	271	1	1851	2274	4105	271	4287	3253	1556	2411	2574	2526	1432
1450_Low-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	1450_Low-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	271	1	2282	401	4043	3212	3783	271	756	3363	2618	4195	3889
1930_Occipital brain volume (FBAT, adjusted for age and sex)	1930_Occipital brain volume (FBAT, adjusted for age and sex)	25	271	1	4484	3826	3255	2966	360	3860	271	1345	4279	4141	1001
2273_APOE - Apolipoprotein E (isoform E4)	2273_APOE - Apolipoprotein E (isoform E4)	25	271	1	2787	2549	1908	2048	2637	3611	434	271	308	4586	1058
864_22:6, docosahexaenoic acid (DHA)	864_22:6, docosahexaenoic acid (DHA)	25	271	1	2124	1374	843	4128	3649	2067	1404	1656	271	356	2929
4717_Cingulum (cingulate gyrus) mode of anisotropy	4717_Cingulum (cingulate gyrus) mode of anisotropy	25	271	1	946	3460	3596	1259	1510	3888	2438	3358	915	271	632
4293_Depression	4293_Depression	25	271	1	2694	1436	4197	3178	396	1655	3640	3960	4194	2934	271
1319_Resistin (GEE, adjusted for age and sex)	1319_Resistin (GEE, adjusted for age and sex)	25	272	1	1663	2297	2544	4044	272	3515	3275	4560	3798	930	2170
3739_Depression - Ever had prolonged feelings of sadness or depression	3739_Depression - Ever had prolonged feelings of sadness or depression	25	272	1	2177	974	3624	3279	3901	272	618	1721	1858	1085	477
2966_MMP1 - Interstitial collagenase	2966_MMP1 - Interstitial collagenase	25	272	1	3952	2361	2384	1271	3896	3713	272	391	2611	1265	4376
927_Triglycerides in medium VLDL	927_Triglycerides in medium VLDL	25	272	1	4691	2999	1055	3377	4303	1626	803	2413	272	2837	4480
3076_NOTCH2 - Neurogenic locus notch homolog protein 2	3076_NOTCH2 - Neurogenic locus notch homolog protein 2	25	272	1	4152	3634	337	2432	3886	3567	4094	1784	2780	272	1738
4431_Toxoplasmosis IgG levels	4431_Toxoplasmosis IgG levels	25	272	1	1533	4153	1406	2861	1580	4522	3889	2909	3210	4553	272
171_Waist circumference (female)	171_Waist circumference (female)	25	273	1	273	4440	2274	4344	3404	4575	2957	4207	4037	2605	872
3731_Depression - Difficulty concentrating during worst ddepression	3731_Depression - Difficulty concentrating during worst ddepression	25	273	1	1595	686	3296	1061	273	3721	1844	1749	646	1055	1286
3593_Mineral and other dietary supplements: Glucosamine	3593_Mineral and other dietary supplements: Glucosamine	25	273	1	1112	1500	3481	494	2129	3517	273	3409	1821	1336	2205
3304_Age first had sexual intercourse	3304_Age first had sexual intercourse	25	274	1	274	3864	1779	4571	1349	3628	1660	1394	817	528	4295
2629_A2M - Alpha-2-macroglobulin	2629_A2M - Alpha-2-macroglobulin	25	274	1	4425	1517	393	274	2474	1097	4260	3390	3084	2896	3508
110_Coronary artery disease	110_Coronary artery disease	25	274	1	3173	2346	2919	3854	274	4579	4678	1135	2706	795	4571
1771_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for multivariable)	1771_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for multivariable)	25	274	1	4732	3127	2743	724	3283	4430	3665	274	1713	3289	2332
745_::::X-12007	745_::::X-12007	25	275	1	842	3080	275	4635	630	1169	2076	3418	1185	1456	3984
2216_ACE2 - Angiotensin-converting enzyme 2	2216_ACE2 - Angiotensin-converting enzyme 2	25	275	1	2490	1819	1856	797	275	2498	773	2633	680	3674	2095
924_Total lipids in medium VLDL	924_Total lipids in medium VLDL	25	275	1	3611	2593	1724	4006	3183	1842	984	1463	275	3897	3931
4353_Tuberculosis	4353_Tuberculosis	25	275	1	1318	1084	4362	2508	2210	4329	789	2498	362	275	2462
2462_ABL1 - Tyrosine-protein kinase ABL1	2462_ABL1 - Tyrosine-protein kinase ABL1	25	275	1	2543	2526	440	3262	563	328	3827	1643	2651	688	275
4039_Bipolar disorder	4039_Bipolar disorder	25	276	1	680	276	3816	335	4176	4320	813	1619	449	2074	1645
750_::::X-12040	750_::::X-12040	25	276	1	3789	1845	2785	276	1837	3022	1885	1714	1441	1110	3197
4574_Left supramarginal	4574_Left supramarginal	25	276	1	3333	2588	2980	1656	3192	1214	276	1016	387	1023	2313
4339_Walking	4339_Walking	25	276	1	2680	1108	3886	608	906	1601	968	276	1531	3751	4410
277_CD8:%Act(25+)	277_CD8:%Act(25+)	25	276	1	2794	342	2580	846	3182	4079	1168	1312	276	440	1935
3462_Impedance measures - Arm fat-free mass (right)	3462_Impedance measures - Arm fat-free mass (right)	25	276	2	551	4525	651	2252	4317	3270	2271	3495	1392	276	522
4108_Blood urea nitrogen	4108_Blood urea nitrogen	25	277	1	277	2148	1966	1427	4041	1949	3368	1452	2496	3065	3079
4186_Coffee cups per day	4186_Coffee cups per day	25	277	1	3739	277	4730	719	2465	2520	478	522	626	3057	1557
4290_Frequent insomnia symptoms	4290_Frequent insomnia symptoms	25	277	1	436	1525	277	1647	4606	1110	3107	1183	3447	521	2354
2753_PLG - Plasminogen	2753_PLG - Plasminogen	25	277	1	3939	786	4640	277	4544	4070	2762	3673	295	1368	3256
1577_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	1577_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	25	277	1	4685	3655	2531	2900	1893	277	3359	4480	4721	2049	1527
812_::::X-12855	812_::::X-12855	25	277	1	4469	301	4545	548	3780	1817	277	448	638	1396	1511
240_CD27 on IgG+B	240_CD27 on IgG+B	25	277	1	1646	4018	1109	4018	3793	2010	1161	277	2744	3757	3824
1191_PGC cross disorder	1191_PGC cross disorder	25	277	1	2625	4021	2733	874	969	793	4523	3170	277	1512	1652
1589_Factor VII (at exam 5, GEE, adjusted for multivariable)	1589_Factor VII (at exam 5, GEE, adjusted for multivariable)	25	277	1	4229	3022	3243	3846	518	867	1889	2420	3300	2251	277
2383_ADAMTS13 - A disintegrin and metalloproteinase with thrombospondin motifs 13	2383_ADAMTS13 - A disintegrin and metalloproteinase with thrombospondin motifs 13	25	278	1	278	1167	2400	4557	2433	834	1497	2695	1768	838	3912
3799_Red blood cell count	3799_Red blood cell count	25	278	1	3246	278	4619	733	3826	2432	1241	4024	884	583	1471
3834_Basophil percentage of white cells (two-way meta)	3834_Basophil percentage of white cells (two-way meta)	25	278	1	3065	1691	278	1924	1256	513	2598	1859	2778	1698	2712
848_Xenobiotics::Food component/Plant::X-14977--vanillin	848_Xenobiotics::Food component/Plant::X-14977--vanillin	25	278	1	3777	396	2957	278	4443	2040	2687	2138	569	384	2756
870_Free cholesterol	870_Free cholesterol	25	278	1	1750	2358	3935	3972	278	2538	3252	3982	2970	3152	4601
3946_HbA1c	3946_HbA1c	25	278	1	3988	2073	3222	4115	4160	278	1872	3074	2042	363	3596
2205_LTF - Lactotransferrin	2205_LTF - Lactotransferrin	25	278	1	3048	2685	1535	3806	3244	4690	2300	1931	1972	3100	278
4164_Juvenile Absence Epilepsy (JAE)	4164_Juvenile Absence Epilepsy (JAE)	25	279	1	279	2015	1599	1655	1152	3532	3909	3924	2782	1440	2017
2382_ADAMTS1 - A disintegrin and metalloproteinase with thrombospondin motifs 1	2382_ADAMTS1 - A disintegrin and metalloproteinase with thrombospondin motifs 1	25	279	1	1933	3916	279	1145	3475	1965	2807	4461	2807	511	1309
2817_CRP - C-reactive protein	2817_CRP - C-reactive protein	25	279	1	2584	624	2297	840	279	3177	2023	2527	3513	4534	4535
649_Xenobiotics::Xanthine metabolism::theophylline	649_Xenobiotics::Xanthine metabolism::theophylline	25	279	1	2796	1135	1008	3261	1223	3733	279	719	1739	1683	4433
1544_White matter hyperintensity volume (FBAT, adjusted for multivariable)	1544_White matter hyperintensity volume (FBAT, adjusted for multivariable)	25	279	1	4562	2963	1036	2052	3521	420	3589	279	3493	4322	1455
4620_Left cerebellum exterior	4620_Left cerebellum exterior	25	279	1	3791	3036	2858	3994	574	3881	1035	4036	3713	1554	279
4363_Strenuous sports or other exercises	4363_Strenuous sports or other exercises	25	280	1	280	3225	4261	3039	1087	2366	2259	4518	3948	560	4366
3775_Traumatic events - Able to pay rent/morgage as an adult	3775_Traumatic events - Able to pay rent/morgage as an adult	25	280	1	992	1603	280	2828	560	771	2239	999	1703	3294	1135
4651_Cingulum (cingulate gyrus) fractional anisotropy	4651_Cingulum (cingulate gyrus) fractional anisotropy	25	280	1	3967	3814	2647	280	3059	2908	1085	1799	3768	1423	3759
2378_METAP2 - Methionine aminopeptidase 2	2378_METAP2 - Methionine aminopeptidase 2	25	280	1	1627	2822	3869	1666	280	4342	4089	312	1625	2949	372
2764_H2AFZ - Histone H2A.z	2764_H2AFZ - Histone H2A.z	25	280	1	1801	4036	2894	4340	2769	280	4530	1336	3982	4003	2061
4140_Mean corpuscular hemoglobin concentration	4140_Mean corpuscular hemoglobin concentration	25	280	1	3707	3704	3755	2678	2638	3187	922	2807	1399	280	3429
120_Obesity class 1	120_Obesity class 1	25	281	1	281	3559	3459	3465	4125	4038	4633	3816	4007	3040	3047
3336_Ever had breast cancer screening / mammogram (female)	3336_Ever had breast cancer screening / mammogram (female)	25	281	1	3823	413	1887	281	4503	3785	2567	1007	896	530	2797
2347_HP - Haptoglobin	2347_HP - Haptoglobin	25	281	1	4294	3343	4718	1713	281	2392	4488	643	1032	4345	2474
4571_Left superior frontal	4571_Left superior frontal	25	281	1	2222	880	2898	1652	4062	281	1438	2140	2409	3020	4027
2698_SBDS - Ribosome maturation protein SBDS	2698_SBDS - Ribosome maturation protein SBDS	25	281	1	1526	1468	1365	679	3173	1118	3330	281	595	2398	462
731_::::X-11799	731_::::X-11799	25	282	1	282	3271	419	580	2051	2293	3480	402	3057	3155	3667
146_Body Mass Index	146_Body Mass Index	25	282	1	926	282	3079	1042	3702	2646	2450	2602	2356	4512	3333
2082_CCL20 - C-C motif chemokine 20	2082_CCL20 - C-C motif chemokine 20	25	282	1	2655	2095	282	4519	1805	4020	2199	1632	4685	2842	812
3224_Weekly usage of mobile phone in last 3 months	3224_Weekly usage of mobile phone in last 3 months	25	282	1	3128	363	2934	282	3109	4647	586	692	2983	1132	3188
451_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (Z,Z)	451_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (Z,Z)	25	282	1	3818	2513	4295	592	282	1552	4390	1050	980	948	1583
1448_Low-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	1448_Low-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	282	1	1492	2098	1052	4644	2629	282	2522	4175	2794	905	1191
2751_PDGFB - Platelet-derived growth factor subunit B	2751_PDGFB - Platelet-derived growth factor subunit B	25	282	1	4310	2219	1449	4255	1942	613	282	4688	835	3895	4403
959_Phospholipids in very large HDL	959_Phospholipids in very large HDL	25	282	1	1800	1824	2965	694	1544	3321	888	1251	282	996	1790
2615_TEC - Tyrosine-protein kinase Tec	2615_TEC - Tyrosine-protein kinase Tec	25	282	1	4234	2894	1696	987	3801	4061	3204	1897	4524	1670	282
2931_IL1A - Interleukin-1 alpha	2931_IL1A - Interleukin-1 alpha	25	283	1	283	4401	3959	3486	1504	1938	3531	2827	4511	3438	4465
4673_Cingulum (cingulate gyrus) axial diusivities	4673_Cingulum (cingulate gyrus) axial diusivities	25	283	1	2744	3099	903	513	2124	283	3236	1970	1960	2895	3834
3816_CD19+ B cell level	3816_CD19+ B cell level	25	283	1	2901	4033	3607	1333	3738	3523	3891	2670	3932	283	1312
1162_Fasting proinsulin (adjusted for fasting insulin, age and sex)	1162_Fasting proinsulin (adjusted for fasting insulin, age and sex)	25	283	1	3020	1568	2808	477	1477	2210	4450	2247	2538	2022	283
3117_PPIE - Peptidyl-prolyl cis-trans isomerase E	3117_PPIE - Peptidyl-prolyl cis-trans isomerase E	25	284	1	2621	284	2649	1980	747	4461	2237	4304	2446	3237	854
2143_PLAUR - Urokinase plasminogen activator surface receptor	2143_PLAUR - Urokinase plasminogen activator surface receptor	25	284	1	1351	3931	284	2846	1274	3978	4391	4169	2916	1170	3497
2332_GFAP - Glial fibrillary acidic protein	2332_GFAP - Glial fibrillary acidic protein	25	284	1	445	932	1401	284	4391	1410	2067	3836	1635	2670	1035
537_Lipid::Lysolipid::1-linoleoylglycerophosphocholine	537_Lipid::Lysolipid::1-linoleoylglycerophosphocholine	25	284	1	1751	3557	3690	285	284	1547	3326	3367	810	4165	3780
3827_Osteoarthritis of hip and/or knee	3827_Osteoarthritis of hip and/or knee	25	284	1	3600	4593	1101	957	3576	284	3231	4403	1506	3132	4075
536_Lipid::Lysolipid::1-heptadecanoylglycerophosphocholine	536_Lipid::Lysolipid::1-heptadecanoylglycerophosphocholine	25	284	1	2002	2391	1575	1514	395	4049	3890	3772	3343	284	4283
1397_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for multivariable)	1397_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for multivariable)	25	284	1	4599	2715	1533	2998	4335	402	2760	1625	2941	4008	284
3037_PRSS2 - Trypsin-2	3037_PRSS2 - Trypsin-2	25	285	1	285	3873	1900	3187	1344	2889	4598	4621	4569	993	4483
4071_Number of sexual partners	4071_Number of sexual partners	25	285	1	560	285	3913	607	1228	1755	3035	2270	2141	964	683
1208_FEV1	1208_FEV1	25	285	1	461	461	285	3458	3045	2091	3372	3795	1163	4011	1966
2064_TIMP1 - Metalloproteinase inhibitor 1	2064_TIMP1 - Metalloproteinase inhibitor 1	25	285	1	972	3186	2745	3292	285	3138	3129	4545	1939	1990	1394
8_Major depressive disorder	8_Major depressive disorder	25	285	1	4225	517	2466	2810	3021	285	1915	4425	1868	3713	2814
1640_Myeloperoxidase (at exam 7, FBAT, adjusted for multivariable)	1640_Myeloperoxidase (at exam 7, FBAT, adjusted for multivariable)	25	285	1	3809	3766	799	2994	933	588	285	1239	4424	4093	1985
1128_Visceral adipose tissue sttenutation (female)	1128_Visceral adipose tissue sttenutation (female)	25	285	1	4329	2637	3889	1911	4654	3516	3099	3738	285	4193	3899
1841_Neck width (GEE, male, adjusted for age)	1841_Neck width (GEE, male, adjusted for age)	25	285	1	1581	4614	1151	3311	2428	639	3469	4595	3345	3087	285
2359_IL13 - Interleukin-13	2359_IL13 - Interleukin-13	25	286	1	286	1954	4017	3099	2665	464	3396	2250	2469	943	4547
3296_Risk taking	3296_Risk taking	25	286	1	1578	286	2186	468	3662	3896	1534	775	698	4106	1783
1497_Triglycerides (at exam 1, GEE, adjusted for multivariable)	1497_Triglycerides (at exam 1, GEE, adjusted for multivariable)	25	286	1	4047	4011	286	3231	4483	557	3268	4677	3548	3526	1814
2923_ITIH4 - Inter-alpha-trypsin inhibitor heavy chain H4	2923_ITIH4 - Inter-alpha-trypsin inhibitor heavy chain H4	25	286	1	1272	4577	541	286	303	4236	1884	1640	1516	4381	4597
769_::::X-12253	769_::::X-12253	25	286	1	3864	375	3858	588	2860	4404	286	628	1436	2110	2188
1613_von Willebrand Factor (at exam 5, GEE, adjusted for multivariable)	1613_von Willebrand Factor (at exam 5, GEE, adjusted for multivariable)	25	287	1	287	4268	1475	3034	1965	462	1947	2007	1200	4215	4060
2511_CA13 - Carbonic anhydrase 13	2511_CA13 - Carbonic anhydrase 13	25	287	1	3166	3959	287	2428	3438	2805	2874	2114	2571	3336	557
2781_IGF1R - Insulin-like growth factor 1 receptor	2781_IGF1R - Insulin-like growth factor 1 receptor	25	287	1	3513	667	344	3049	287	1850	444	1650	946	1342	1868
1512_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	1512_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	25	287	1	1657	1460	2860	2400	3347	287	969	4307	383	1762	2622
4700_Fornix (cres) / Stria terminalis mean diusivities	4700_Fornix (cres) / Stria terminalis mean diusivities	25	287	1	995	2136	4527	4688	2467	2093	3399	287	2834	3117	3464
2369_MAPK1 - Mitogen-activated protein kinase 1	2369_MAPK1 - Mitogen-activated protein kinase 1	25	287	1	343	3598	937	1060	2160	2349	2544	319	287	3637	892
4054_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	4054_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	25	287	1	2032	595	1233	968	3539	2647	3060	587	1059	287	918
1858_Neck cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	1858_Neck cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	25	287	1	2106	3799	4624	4325	3120	1747	2410	4503	3069	3782	287
2567_CPB2 - Carboxypeptidase B2	2567_CPB2 - Carboxypeptidase B2	25	288	1	288	2288	813	1349	3823	1150	2191	1043	2546	1344	574
1840_Neck width (FBAT, male, adjusted for age)	1840_Neck width (FBAT, male, adjusted for age)	25	288	1	2501	288	2453	344	2309	426	821	1675	424	1285	4321
1752_Cystatin C (at exam 7, FBAT, adjusted for multivariable)	1752_Cystatin C (at exam 7, FBAT, adjusted for multivariable)	25	288	1	2074	3861	288	1179	1590	1018	4351	2536	3681	2762	334
3571_Pain type(s) experienced in last month: Neck or shoulder pain	3571_Pain type(s) experienced in last month: Neck or shoulder pain	25	288	1	4061	1196	3545	288	1949	4515	2428	2506	981	3729	2569
3043_CD226 - CD226 antigen	3043_CD226 - CD226 antigen	25	288	1	2600	2402	2567	3340	288	4610	1589	1158	3350	3790	2597
3579_Social support - Leisure/social activities: Adult education class	3579_Social support - Leisure/social activities: Adult education class	25	288	1	1152	3789	2706	4741	2476	2381	4647	1274	582	561	288
4221_Diuretics	4221_Diuretics	25	289	1	289	4213	2490	684	2852	1660	2254	1429	3823	299	4537
4492_Right pars orbitalis	4492_Right pars orbitalis	25	289	1	395	1739	289	2744	3797	2688	861	3187	3039	1310	1113
1855_Neck average buckling ratio (GEE, female, adjussted for age)	1855_Neck average buckling ratio (GEE, female, adjussted for age)	25	289	1	3255	1905	2976	2511	289	2056	663	1047	1320	1203	464
1969_MMSE score (at age 65, GEE, adjusted for birth-cohort)	1969_MMSE score (at age 65, GEE, adjusted for birth-cohort)	25	289	1	583	3273	4672	3446	741	289	4624	1933	4219	2576	2933
596_Peptide::Dipeptide::pro-hydroxy-pro	596_Peptide::Dipeptide::pro-hydroxy-pro	25	289	1	2535	802	1425	1085	2317	4475	889	289	2758	4051	3662
2562_LTA LTB - Lymphotoxin alpha2:beta1	2562_LTA LTB - Lymphotoxin alpha2:beta1	25	289	1	1768	489	4062	4145	3044	2258	2607	3676	4302	289	1910
4610_Cerebellar vermal lobules VIII X	4610_Cerebellar vermal lobules VIII X	25	289	1	3331	4358	1089	2462	1680	1775	4263	3875	3314	379	289
1227_Life span	1227_Life span	25	290	1	290	3342	1149	1025	1495	2499	2971	1359	1822	4312	2386
1291_Waist circumference by CT (GEE, adjusted for age, sex, smoking and menopause)	1291_Waist circumference by CT (GEE, adjusted for age, sex, smoking and menopause)	25	290	1	1028	1674	290	4303	2783	2111	653	4738	3753	1021	1255
3202_Job involves shift work	3202_Job involves shift work	25	290	1	4008	633	3657	290	3992	2178	704	2987	1048	2374	2909
4315_Cigarettes per day	4315_Cigarettes per day	25	290	1	3851	3367	3373	2310	290	4400	336	1979	4421	4228	2925
3615_Treatment/medication code: lansoprazole	3615_Treatment/medication code: lansoprazole	25	290	1	4471	4027	3575	4565	3532	290	4184	1092	2896	2444	4498
653_::::X-02973	653_::::X-02973	25	290	1	1820	390	2259	2679	3338	517	290	1911	1859	500	1717
957_Total lipids in very large HDL	957_Total lipids in very large HDL	25	290	1	2731	2026	4349	537	1130	3124	527	764	290	1054	2657
3367_Ever had hysterectomy (womb removed) (female)	3367_Ever had hysterectomy (womb removed) (female)	25	290	1	2448	2776	1153	4722	4627	1271	4589	3764	1911	4337	290
87_Asthma	87_Asthma	25	291	1	3434	291	2177	1419	3661	3097	362	1087	872	355	862
2735_FN1 - Fibronectin	2735_FN1 - Fibronectin	25	291	1	1181	2085	2242	291	4188	3351	4676	3199	3696	3522	2429
2363_RARRES2 - Retinoic acid receptor responder protein 2	2363_RARRES2 - Retinoic acid receptor responder protein 2	25	291	1	2926	347	2266	2215	291	3073	4170	1797	1102	920	3395
4566_Left posterior cingulate	4566_Left posterior cingulate	25	291	1	1017	2197	1788	664	3495	291	2878	1061	3900	1516	3247
2523_GSK3A GSK3B - Glycogen synthase kinase-3 alpha/beta	2523_GSK3A GSK3B - Glycogen synthase kinase-3 alpha/beta	25	291	1	471	2125	1868	1172	4720	3386	4487	291	2222	2299	328
974_Cutaneous T-cell attracting (CCL27)	974_Cutaneous T-cell attracting (CCL27)	25	291	1	4402	3057	2967	3840	1828	1347	393	2969	291	4662	1147
544_Lipid::Lysolipid::1-palmitoylglycerophosphoethanolamine	544_Lipid::Lysolipid::1-palmitoylglycerophosphoethanolamine	25	291	1	963	2282	4357	3916	824	3155	647	3843	3172	1238	291
551_Lipid::Lysolipid::2-palmitoylglycerophosphocholine*	551_Lipid::Lysolipid::2-palmitoylglycerophosphocholine*	25	292	1	292	1876	1146	4174	1005	3942	1429	2191	3747	529	4566
3760_Depression - Recent feelings of inadequacy	3760_Depression - Recent feelings of inadequacy	25	292	1	3378	292	4124	630	664	1103	1467	2563	1904	1610	4055
3371_Chest pain or discomfort when walking uphill or hurrying	3371_Chest pain or discomfort when walking uphill or hurrying	25	292	1	2396	4226	4490	2333	2819	292	2577	2826	4048	4263	2256
391_Amino acid::Phenylalanine & tyrosine metabolism::3-(3-hydroxyphenyl)propionate	391_Amino acid::Phenylalanine & tyrosine metabolism::3-(3-hydroxyphenyl)propionate	25	293	1	293	2368	330	2923	2403	4452	1257	3954	4003	775	1887
3270_Comparative body size at age 10	3270_Comparative body size at age 10	25	293	1	3614	293	3722	952	1839	4018	4188	832	3565	343	2524
2296_CD36 - Platelet glycoprotein 4	2296_CD36 - Platelet glycoprotein 4	25	293	1	2994	854	3541	293	3654	4370	513	1293	380	2121	3603
3469_Impedance measures - Trunk fat mass	3469_Impedance measures - Trunk fat mass	25	293	1	913	3399	1993	1228	1142	293	4703	1055	3797	3525	551
433_Amino acid::Valine, leucine and isoleucine metabolism::valine	433_Amino acid::Valine, leucine and isoleucine metabolism::valine	25	293	1	3559	3801	4343	2196	4426	4551	293	726	685	3667	2976
485_Lipid::Carnitine metabolism::palmitoylcarnitine	485_Lipid::Carnitine metabolism::palmitoylcarnitine	25	293	1	3617	386	4733	2248	1100	1039	4715	3106	293	1550	4137
4272_Sleep duration	4272_Sleep duration	25	294	1	2488	294	2813	2848	1106	907	458	3269	1766	1200	1683
3539_Reason for glasses/contact lenses: For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia')	3539_Reason for glasses/contact lenses: For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia')	25	294	1	4272	4560	3939	3960	294	397	3635	2128	3108	556	2360
2964_CCL19 - C-C motif chemokine 19	2964_CCL19 - C-C motif chemokine 19	25	294	1	4238	777	2061	1825	2131	2506	438	294	1799	1767	3135
269_CD4:%TM (2)	269_CD4:%TM (2)	25	294	1	364	1939	4591	2872	4099	3555	2138	1065	459	3880	294
261_CD8:%SCM	261_CD8:%SCM	25	295	1	2925	3372	295	966	4527	3086	1904	1310	2490	2160	4680
4090_Family history of Alzheimer's disease	4090_Family history of Alzheimer's disease	25	295	1	1072	3318	531	2728	295	3286	4728	4121	4154	3596	465
2156_IGFBP5 - Insulin-like growth factor-binding protein 5	2156_IGFBP5 - Insulin-like growth factor-binding protein 5	25	295	1	3655	406	1795	1244	3575	1201	295	1903	535	909	4479
2190_C3 - C3a anaphylatoxin des Arginine	2190_C3 - C3a anaphylatoxin des Arginine	25	295	1	3425	2499	1859	2894	802	3041	3976	295	670	1672	3298
1757_Cancer (GEE, adjusted for multivariable)	1757_Cancer (GEE, adjusted for multivariable)	25	295	1	505	2182	3842	2853	2179	1363	1802	4557	3355	295	1159
1159_Fasting insulin main effect	1159_Fasting insulin main effect	25	296	1	3718	296	3029	1352	1598	584	2871	3737	2013	4142	3210
3088_SEMA6A - Semaphorin-6A	3088_SEMA6A - Semaphorin-6A	25	296	1	1358	717	1228	296	866	2600	1941	839	1671	3800	1214
2299_DSG1 - Desmoglein-1	2299_DSG1 - Desmoglein-1	25	296	1	4269	861	3880	1617	3603	4385	296	3445	2464	4448	824
994_Interleukin-7	994_Interleukin-7	25	296	1	1762	3651	1006	4725	1191	4615	1050	1100	3194	578	296
624_Xenobiotics::Drug::hydroquinone sulfate	624_Xenobiotics::Drug::hydroquinone sulfate	25	297	1	297	4245	1757	1031	3467	1194	674	366	484	2585	1681
2577_AHSG - Alpha-2-HS-glycoprotein	2577_AHSG - Alpha-2-HS-glycoprotein	25	297	1	723	3517	297	1258	3763	4578	2898	1580	1256	4616	2472
3681_Diagnoses - main ICD10: R07 Pain in throat and chest	3681_Diagnoses - main ICD10: R07 Pain in throat and chest	25	297	1	1108	1044	3101	297	3535	2151	1638	2672	4255	2494	4711
2839_ENTPD5 - Ectonucleoside triphosphate diphosphohydrolase 5	2839_ENTPD5 - Ectonucleoside triphosphate diphosphohydrolase 5	25	297	1	897	3288	2783	4489	1978	297	4048	3533	3561	4497	391
1200_Genetic generalized epilepsy	1200_Genetic generalized epilepsy	25	297	1	1649	1308	965	2119	3897	914	360	711	297	829	4066
1681_Atrial natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	1681_Atrial natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	25	297	1	1745	2500	425	323	2683	4024	4649	4143	4265	1710	297
4597_Right posterior cingulate	4597_Right posterior cingulate	25	298	1	3258	4230	298	1020	435	2237	1758	2101	1423	3321	2727
4754_Superior longitudinal fasciculus radial diusivities	4754_Superior longitudinal fasciculus radial diusivities	25	298	1	2466	2511	3135	707	298	1885	1515	2838	4051	2907	1566
4703_Posterior corona radiata mean diusivities	4703_Posterior corona radiata mean diusivities	25	298	1	3004	572	2389	1588	1595	745	298	1717	1402	3363	2863
1964_MMSE score (at exam 5, FBAT, adjusted for age)	1964_MMSE score (at exam 5, FBAT, adjusted for age)	25	298	1	1211	628	4615	913	3866	577	2701	298	360	776	1401
1111_Visceral sdipose tissue volume	1111_Visceral sdipose tissue volume	25	298	1	2688	718	3090	403	1183	3618	587	781	298	470	884
267_CD4:%Exhausted	267_CD4:%Exhausted	25	298	1	3749	635	2920	3263	550	1707	1995	2072	4690	298	3818
4044_Body Mass Index	4044_Body Mass Index	25	299	1	1522	299	2363	485	4389	2939	547	543	1309	1306	1180
503_Lipid::Fatty acid, ester::n-Butyl Oleate	503_Lipid::Fatty acid, ester::n-Butyl Oleate	25	299	1	3475	1165	299	1347	912	3482	3789	2603	1194	2542	3583
3913_Cup area	3913_Cup area	25	299	1	855	1782	1212	693	2927	299	2030	1952	737	4310	1816
2224_COMMD7 - COMM domain-containing protein 7	2224_COMMD7 - COMM domain-containing protein 7	25	299	1	2300	313	4434	4212	1797	2337	299	1017	1907	1997	3959
4525_Left hippocampus	4525_Left hippocampus	25	299	1	1624	2938	1203	1790	2260	2364	4706	299	2757	3727	1045
3723_Frequency of needing morning drink of alcohol after heavy drinking session in last year	3723_Frequency of needing morning drink of alcohol after heavy drinking session in last year	25	299	1	2228	1961	1178	1797	3670	2813	1081	956	299	4355	2142
1308_Fasting HbA1c (at exam 5, FBAT, adjusted for age and sex)	1308_Fasting HbA1c (at exam 5, FBAT, adjusted for age and sex)	25	299	1	705	4229	844	4079	3595	3561	655	1509	2437	3955	299
742_::::X-11859	742_::::X-11859	25	300	1	2801	1628	894	2131	300	2185	2767	2040	3426	3551	2902
3233_Snoring	3233_Snoring	25	300	2	1940	1854	2604	1758	2923	300	2256	1276	1785	1578	1458
1776_Heart failure (censored at interval MI, FBAT, adjusted for age and sex)	1776_Heart failure (censored at interval MI, FBAT, adjusted for age and sex)	25	300	1	1530	838	1066	4331	2286	362	300	1691	813	722	657
926_Phospholipids in medium VLDL	926_Phospholipids in medium VLDL	25	300	1	2775	4079	1342	2995	1247	1652	1299	2461	300	3997	1883
273_CD8:%SCM	273_CD8:%SCM	25	300	1	393	344	610	2405	1625	2109	833	3743	2935	300	1069
3261_Alcohol intake frequency	3261_Alcohol intake frequency	25	300	1	4466	887	3714	1313	1946	2816	2893	456	4104	3846	300
4168_Open-angle glaucoma (fixed-effect model)	4168_Open-angle glaucoma (fixed-effect model)	25	301	1	301	1383	550	818	3682	346	3171	2949	1779	4202	3556
3866_Reticulocyte count (two-way meta)	3866_Reticulocyte count (two-way meta)	25	301	1	2340	3871	301	2829	1427	363	1456	3250	3755	4171	829
1232_Usual weekday bedtime (FBAT, adjusted for age, sex and BMI)	1232_Usual weekday bedtime (FBAT, adjusted for age, sex and BMI)	25	301	1	1412	1838	3493	4706	301	1298	4608	3824	1006	1376	820
1363_Total cholesterol (at exam 3, GEE, adjusted for age and sex)	1363_Total cholesterol (at exam 3, GEE, adjusted for age and sex)	25	301	1	2577	4317	3030	2851	3326	4173	3374	3961	1876	3994	301
2810_PTPN6 - Tyrosine-protein phosphatase non-receptor type 6	2810_PTPN6 - Tyrosine-protein phosphatase non-receptor type 6	25	302	1	302	3445	3942	3848	1104	4125	4501	4009	3986	4091	1385
2042_Attention function - Standard error of hit reaction time - Child	2042_Attention function - Standard error of hit reaction time - Child	25	302	1	2044	812	302	1919	2468	3983	413	3536	500	352	3359
362_1c+mDC:%32+	362_1c+mDC:%32+	25	302	1	2928	2762	1249	4718	302	3943	3219	4324	1407	3342	3310
4489_Right parahippocampal	4489_Right parahippocampal	25	302	1	2084	1297	3394	4553	3079	302	711	2135	1511	3240	488
2371_VEGFC - Vascular endothelial growth factor C	2371_VEGFC - Vascular endothelial growth factor C	25	302	1	4680	2184	2092	4157	4462	3437	302	1678	3340	1401	4572
2728_HSPA1A - Heat shock 70 kDa protein 1A/1B	2728_HSPA1A - Heat shock 70 kDa protein 1A/1B	25	303	1	303	3847	1369	4131	3065	1540	4365	3828	2475	3082	1101
1729_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for multivariable)	1729_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for multivariable)	25	303	1	3276	303	3753	845	1591	2640	544	2338	1024	423	4051
2603_MMEL1 - Membrane metallo-endopeptidase-like 1	2603_MMEL1 - Membrane metallo-endopeptidase-like 1	25	303	1	4027	2911	303	3932	1154	695	1017	2500	2989	2178	3760
2084_KIT - Mast/stem cell growth factor receptor Kit	2084_KIT - Mast/stem cell growth factor receptor Kit	25	304	1	689	2322	304	771	1304	2814	4613	452	3025	2296	923
3194_Number of vehicles in household	3194_Number of vehicles in household	25	304	1	4160	2277	3919	4091	304	596	4029	2407	3182	3198	533
2107_TNFRSF9 - Tumor necrosis factor receptor superfamily member 9	2107_TNFRSF9 - Tumor necrosis factor receptor superfamily member 9	25	304	1	3750	1647	2981	4413	1438	304	2215	3566	2608	784	3829
2157_IGFBP6 - Insulin-like growth factor-binding protein 6	2157_IGFBP6 - Insulin-like growth factor-binding protein 6	25	304	1	3426	4164	2666	3878	3076	753	4614	304	1612	1730	591
172_Waist circumference (female)	172_Waist circumference (female)	25	305	1	305	4042	2583	4099	3485	4122	3098	3731	3742	2481	452
2921_LPO - Lactoperoxidase	2921_LPO - Lactoperoxidase	25	305	1	1401	305	2834	877	2616	1785	1615	3407	1496	2883	4127
2225_EDA - Ectodysplasin-A, secreted form	2225_EDA - Ectodysplasin-A, secreted form	25	305	1	3951	1421	4728	305	1901	1059	609	985	1016	1763	3523
2689_DNAJB1 - DnaJ homolog subfamily B member 1	2689_DNAJB1 - DnaJ homolog subfamily B member 1	25	305	1	2462	2956	4475	3190	305	1964	1191	833	697	3229	445
4281_PEF	4281_PEF	25	305	1	3373	1698	3852	3394	3971	305	870	4023	713	2986	3876
1864_Neck cross-sectional moment of inertia (FBAT, male, adjussted for age)	1864_Neck cross-sectional moment of inertia (FBAT, male, adjussted for age)	25	305	1	4380	2520	1682	2611	608	1588	305	4469	2321	3891	4071
3401_Loud music exposure frequency	3401_Loud music exposure frequency	25	305	1	4459	4456	743	975	2143	3687	2304	2466	2792	2497	305
570_Lipid::Sterol, Steroid::5alpha-androstan-3beta,17beta-diol disulfate	570_Lipid::Sterol, Steroid::5alpha-androstan-3beta,17beta-diol disulfate	25	306	1	306	4383	1381	2842	1875	1281	4331	1446	4178	810	4562
1838_Neck width (FBAT, female, adjusted for age)	1838_Neck width (FBAT, female, adjusted for age)	25	306	1	4479	306	3121	1149	1502	3936	1609	995	1831	2284	1902
2209_MMP3 - Stromelysin-1	2209_MMP3 - Stromelysin-1	25	306	1	765	4264	306	1492	3215	3013	3001	2600	3326	1751	764
3985_Heart rate recovery at 10 secnds	3985_Heart rate recovery at 10 secnds	25	306	1	861	4545	367	306	3060	4011	2884	3342	2523	4212	4344
866_Fatty acid length	866_Fatty acid length	25	306	1	1804	2703	4656	346	2207	306	409	1116	2957	2757	4220
381_Amino acid::Glycine, serine and threonine metabolism::N-acetylglycine	381_Amino acid::Glycine, serine and threonine metabolism::N-acetylglycine	25	306	1	4687	4468	4400	876	2246	3103	2714	306	1329	3249	4718
1485_Mean triglycerides from exam 1-7 (GEE, adjusted for multivariable)	1485_Mean triglycerides from exam 1-7 (GEE, adjusted for multivariable)	25	306	1	3533	2020	1007	2582	3796	2244	2281	1764	306	3552	1178
2443_FCN2 - Ficolin-2	2443_FCN2 - Ficolin-2	25	306	1	2173	3188	488	4387	1000	3958	1840	2810	2365	4710	306
459_Energy::Krebs cycle::citrate	459_Energy::Krebs cycle::citrate	25	307	1	307	3466	578	577	2555	3686	3667	2568	4183	4080	3149
4251_M10 timing	4251_M10 timing	25	307	1	3275	2847	307	1021	4183	756	2087	840	3133	4472	878
1660_Alkaline phosphatase (at exam 2, FBAT, adjusted for multivariable)	1660_Alkaline phosphatase (at exam 2, FBAT, adjusted for multivariable)	25	307	1	2568	3451	1378	307	458	1088	2601	748	1676	4739	774
1760_Breast cancer (FBAT, adjusted for age and BMI)	1760_Breast cancer (FBAT, adjusted for age and BMI)	25	307	1	1972	2294	1302	526	307	2035	2017	4156	1765	2118	926
364_Amino acid::Alanine and aspartate metabolism::alanine	364_Amino acid::Alanine and aspartate metabolism::alanine	25	307	1	1871	2909	2446	4600	4194	307	2747	565	1757	1853	3665
2609_OCIAD1 - OCIA domain-containing protein 1	2609_OCIAD1 - OCIA domain-containing protein 1	25	307	1	355	4406	354	506	3531	3481	4682	307	3119	4118	4237
1266_Residual from predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	1266_Residual from predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	307	1	4403	1326	3664	842	2507	587	3119	2228	4604	307	3192
1913_Occipital brain volume (GEE, adjusted for multivariable)	1913_Occipital brain volume (GEE, adjusted for multivariable)	25	307	1	4598	2356	427	2996	3446	3007	1663	2483	4047	1613	307
4327_Well-being spectrum	4327_Well-being spectrum	25	308	1	1407	308	4320	525	909	2248	1879	3502	2050	550	1233
722_::::X-11546	722_::::X-11546	25	308	1	1507	4569	308	3121	3352	1859	2632	4002	3511	4266	3850
4226_Thyroid preparations	4226_Thyroid preparations	25	308	1	1867	446	2031	644	1436	787	1125	308	4203	769	1068
3312_Electronic device use - Plays computer games	3312_Electronic device use - Plays computer games	25	308	1	828	490	4228	692	3155	2525	2692	3998	479	308	4606
193_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	193_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	25	309	1	309	3173	1577	501	1026	3492	4140	1109	4352	3682	4564
3286_Irritability	3286_Irritability	25	309	1	605	309	1072	2176	2004	4636	2693	1234	553	377	4744
1805_PNN50 HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1805_PNN50 HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	309	1	1444	4673	309	3562	1473	4446	4306	3638	2197	4398	344
3763_Depression - Recent feelings of depression	3763_Depression - Recent feelings of depression	25	309	1	4307	394	2623	1396	4094	2862	309	1948	1239	647	3550
868_OmegaL6 fatty acids	868_OmegaL6 fatty acids	25	309	1	1161	668	3452	2826	3683	979	1260	1870	309	1048	4360
3062_LILRB2 - Leukocyte immunoglobulin-like receptor subfamily B member 2	3062_LILRB2 - Leukocyte immunoglobulin-like receptor subfamily B member 2	25	309	1	810	3919	899	4481	1469	3463	3973	813	4270	309	2108
3242_Fresh fruit intake	3242_Fresh fruit intake	25	309	1	1075	2638	3811	584	755	3194	4453	1169	2545	4230	309
3867_Reticulocyte fraction of red cells (two-way meta)	3867_Reticulocyte fraction of red cells (two-way meta)	25	310	1	3827	3229	363	2014	945	310	896	4743	3721	3315	481
1745_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for age and sex)	1745_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for age and sex)	25	310	1	4358	2371	2019	2273	566	325	2753	1406	1474	2972	310
1896_Shaft Section Modulus (FBAT, male, adjussted for multivariable)	1896_Shaft Section Modulus (FBAT, male, adjussted for multivariable)	25	311	1	3992	311	4499	2380	1262	4391	3347	3047	3496	888	3650
2962_LIFR - Leukemia inhibitory factor receptor	2962_LIFR - Leukemia inhibitory factor receptor	25	311	1	1779	4716	311	2688	4219	1016	4095	3570	1279	3982	944
4074_Body Mass Index	4074_Body Mass Index	25	311	1	976	1245	1189	311	3768	1774	1580	2862	2650	938	3357
981_Interleukin-10	981_Interleukin-10	25	311	1	1742	3984	2158	2369	3116	4272	311	4707	1946	1305	4107
1261_Residual from predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	1261_Residual from predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	25	311	1	2550	1530	3400	2705	2036	538	2179	1555	3933	1174	311
4357_Albuminuria	4357_Albuminuria	25	312	1	312	2589	3042	2283	1985	4328	4308	2926	4660	854	2424
3661_Cancer register - Histology of cancer tumour: Adenocarcinoma, NOS	3661_Cancer register - Histology of cancer tumour: Adenocarcinoma, NOS	25	312	1	1061	1445	312	1828	1671	4423	4459	4587	2224	3838	544
2969_STC1 - Stanniocalcin-1	2969_STC1 - Stanniocalcin-1	25	312	1	733	4130	2309	312	4064	586	919	876	596	2575	4022
4419_Measles seropositivity	4419_Measles seropositivity	25	313	1	4253	2752	1545	313	576	2765	2635	681	1039	3248	4698
3024_UCHL1 - Ubiquitin carboxyl-terminal hydrolase isozyme L1	3024_UCHL1 - Ubiquitin carboxyl-terminal hydrolase isozyme L1	25	313	1	4303	3007	2414	2506	313	441	4592	4742	1467	3706	2035
154_Waist-hip ratio (female <= 50 yrs, adjusted for BMI)	154_Waist-hip ratio (female <= 50 yrs, adjusted for BMI)	25	313	1	4304	350	1307	390	1316	313	629	2593	608	652	3795
131_Hip circumference (female, adjusted for BMI)	131_Hip circumference (female, adjusted for BMI)	25	313	1	3786	400	4508	2584	3196	2450	3356	3972	2529	313	646
2857_SERPING1 - Plasma protease C1 inhibitor	2857_SERPING1 - Plasma protease C1 inhibitor	25	314	1	314	443	713	2364	1288	3751	2263	1639	3560	457	2819
1647_P-selectin (at exam 7, GEE, adjusted for age and sex)	1647_P-selectin (at exam 7, GEE, adjusted for age and sex)	25	314	1	1628	4058	370	1912	929	314	3420	3019	2370	4632	482
3584_Types of transport used (excluding work): Cycle	3584_Types of transport used (excluding work): Cycle	25	314	1	527	1402	4353	605	2631	928	2979	2369	2255	314	1157
216_NKT:%4-8-	216_NKT:%4-8-	25	315	1	315	1757	4082	638	2353	3309	610	4178	425	4549	3025
3106_PPID - Peptidyl-prolyl cis-trans isomerase D	3106_PPID - Peptidyl-prolyl cis-trans isomerase D	25	315	1	959	315	923	2735	1767	2075	335	3587	2799	408	1110
1690_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for age and sex)	1690_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for age and sex)	25	315	1	1959	2175	348	315	1075	1087	2737	1112	2583	3532	1170
1759_Breast cancer (GEE, adjusted for age)	1759_Breast cancer (GEE, adjusted for age)	25	315	1	3202	2687	3903	2560	2767	2232	4346	315	4609	893	1845
2716_MBD4 - Methyl-CpG-binding domain protein 4	2716_MBD4 - Methyl-CpG-binding domain protein 4	25	315	1	2056	990	1243	3117	3035	1445	3434	4396	1331	315	2995
3442_Impedance measures - Whole body fat mass	3442_Impedance measures - Whole body fat mass	25	315	1	538	3410	2006	1527	2127	561	3990	1914	3211	4384	315
79_Femoral Neck BMD (females)	79_Femoral Neck BMD (females)	25	316	1	316	2198	1980	1572	1351	4619	894	850	889	4126	4169
4395_Menstruation quality of life impact: Acne	4395_Menstruation quality of life impact: Acne	25	316	1	2423	3642	3670	3421	316	4341	2978	4276	3149	3149	2222
2477_CHRDL1 - Chordin-like protein 1	2477_CHRDL1 - Chordin-like protein 1	25	316	1	3221	354	2606	1301	691	864	316	670	1937	534	628
1244_Mean FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	1244_Mean FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	25	316	1	2812	3442	540	2817	520	4105	4028	3561	3589	4372	316
4058_Estimated glomerular filtration rate based on serum creatinine	4058_Estimated glomerular filtration rate based on serum creatinine	25	317	1	317	3068	512	4459	852	2362	1210	649	4414	2269	3878
1511_Triglycerides (at exam 7, GEE, adjusted for age and sex)	1511_Triglycerides (at exam 7, GEE, adjusted for age and sex)	25	317	1	3039	317	1958	3412	1309	2384	2655	3219	2226	1392	1968
3229_Getting up in morning	3229_Getting up in morning	25	317	1	3779	2517	1571	317	2082	2704	3263	658	1610	2969	2030
2860_C5 C6 - Complement C5b-C6 complex	2860_C5 C6 - Complement C5b-C6 complex	25	317	1	1396	2363	2982	4672	317	1533	2816	2335	4504	1785	3293
3570_Pain type(s) experienced in last month: Headache	3570_Pain type(s) experienced in last month: Headache	25	317	1	1836	565	3961	463	4022	990	867	2036	317	742	2853
798_::::X-12734	798_::::X-12734	25	317	1	2103	2787	3637	887	3657	698	345	1355	2106	317	1949
397_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetate	397_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetate	25	317	1	1782	4177	1201	4356	3366	1656	3198	1683	1971	2727	317
3568_Why stopped smoking: Health precaution	3568_Why stopped smoking: Health precaution	25	318	1	318	3834	545	2888	1277	3488	3982	4267	1470	1718	478
4120_Alanine aminotransferase	4120_Alanine aminotransferase	25	318	1	2566	2701	1045	2865	318	2910	2069	1761	1001	3585	2126
1680_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	1680_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	25	318	1	4087	1979	2915	3548	3978	318	775	419	979	4111	4278
194_Estimated glomerular filtration rate based on cystain C	194_Estimated glomerular filtration rate based on cystain C	25	319	1	922	319	664	1159	4388	428	857	848	357	3822	4149
3522_Current employment status: Unable to work because of sickness or disability	3522_Current employment status: Unable to work because of sickness or disability	25	319	1	2844	451	3107	4562	319	2332	592	2122	600	3869	2983
4134_Lymphocyte count	4134_Lymphocyte count	25	319	1	1873	4275	631	524	2068	319	1001	3754	4292	3700	2072
481_Lipid::Carnitine metabolism::hexanoylcarnitine	481_Lipid::Carnitine metabolism::hexanoylcarnitine	25	319	1	4285	3420	989	2736	4504	1005	2177	2768	4303	4068	319
744_::::X-11905	744_::::X-11905	25	320	1	320	2548	566	1748	4682	3223	2395	1966	3897	4367	3651
280_CD8:%DR+73+39-25-	280_CD8:%DR+73+39-25-	25	320	1	4217	3525	4259	1197	320	4422	4652	911	4550	2206	1417
3215_Duration of light DIY	3215_Duration of light DIY	25	320	1	3720	1215	1630	1096	3516	320	1522	1905	3500	4124	1763
2671_PRKCQ - Protein kinase C theta type	2671_PRKCQ - Protein kinase C theta type	25	320	1	1796	4071	1446	1815	1270	1339	3450	320	2575	2391	1163
4563_Left pars triangularis	4563_Left pars triangularis	25	320	1	785	977	2333	1867	2694	2324	2497	709	2323	320	3485
2663_FGF23 - Fibroblast growth factor 23	2663_FGF23 - Fibroblast growth factor 23	25	321	1	3959	321	2500	699	3026	1200	814	699	1480	718	3491
2502_TPSG1 - Tryptase gamma	2502_TPSG1 - Tryptase gamma	25	321	1	2085	4485	321	3615	2348	791	548	2550	3379	2079	1841
3102_PRKAA1 PRKAB1  PRKAG1 - AMP Kinase (alpha1beta1gamma1)	3102_PRKAA1 PRKAB1  PRKAG1 - AMP Kinase (alpha1beta1gamma1)	25	321	1	4595	3133	3415	321	3574	673	902	1846	2633	4570	3324
4684_Retrolenticular part of internal capsule axial diusivities	4684_Retrolenticular part of internal capsule axial diusivities	25	321	1	4212	372	1621	4030	321	3420	1109	4056	913	1902	3163
1535_Ankle-brachial index (at exam 7, GEE, adjusted for age and sex)	1535_Ankle-brachial index (at exam 7, GEE, adjusted for age and sex)	25	321	1	465	4626	1408	4045	1412	321	4595	1929	3719	750	413
3208_Number of days/week of vigorous physical activity 10+ minutes	3208_Number of days/week of vigorous physical activity 10+ minutes	25	321	1	3107	4736	4211	2499	3441	2415	1349	321	2795	4178	1808
921_Total cholesterol in medium VLDL	921_Total cholesterol in medium VLDL	25	321	1	3742	3183	963	2875	1657	1279	1468	3128	321	4675	1913
4629_Left ventral DC	4629_Left ventral DC	25	321	1	2229	1520	436	389	462	3924	634	538	3453	321	4069
2580_BMP10 - Bone morphogenetic protein 10	2580_BMP10 - Bone morphogenetic protein 10	25	322	1	322	4592	3648	2466	4494	3082	3719	3898	3342	3911	4710
2387_CTSD - Cathepsin D	2387_CTSD - Cathepsin D	25	322	1	1204	322	3892	1608	1987	654	4330	1375	841	1072	636
2164_PROS1 - Vitamin K-dependent protein S	2164_PROS1 - Vitamin K-dependent protein S	25	322	1	2677	3572	482	4285	322	4062	4335	1662	4438	1537	904
4066_Educational attainment	4066_Educational attainment	25	322	1	612	3101	4199	1786	1474	1916	1924	2099	3167	345	322
668_::::X-06246	668_::::X-06246	25	323	1	323	2955	3442	3803	3808	1421	1869	4199	3829	3515	799
3384_Non-accidental death in close genetic family	3384_Non-accidental death in close genetic family	25	323	1	2399	2336	1505	3026	323	4381	2317	4657	1606	963	3344
1443_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	1443_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	24	323	1	387	1837	614	2932	2551	323	2150	3235	2351	2529	1154
1599_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for age and sex)	1599_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for age and sex)	25	323	1	543	987	2344	810	2086	3526	3041	4700	4149	323	3680
3149_CKAP2 - Cytoskeleton-associated protein 2	3149_CKAP2 - Cytoskeleton-associated protein 2	25	324	1	324	2050	2624	2628	1646	4068	4429	1142	4515	3041	3994
1132_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI)	1132_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI)	25	324	1	741	1181	324	1994	2132	4260	2097	2426	3549	928	2994
1810_Very low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1810_Very low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	324	1	2077	3858	1703	4440	324	1577	1867	2097	3955	3391	1267
1079_Prostate cancer	1079_Prostate cancer	25	324	1	4080	3859	4644	3710	1907	324	4209	982	1050	3244	4271
4008_Osteoarthritis of knee (hospital diagnosed)	4008_Osteoarthritis of knee (hospital diagnosed)	25	324	1	3731	3586	3224	4024	3383	3927	324	4483	4322	1601	1962
1258_Residual from predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	1258_Residual from predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	25	324	1	2047	1573	467	3303	4148	675	1677	4681	4658	324	1277
3343_Age at first live birth (female)	3343_Age at first live birth (female)	25	324	1	1208	2063	2548	4119	977	2306	3256	2060	525	659	324
2792_PA2G4 - Proliferation-associated protein 2G4	2792_PA2G4 - Proliferation-associated protein 2G4	25	325	1	325	2044	455	2161	2400	4314	2691	1544	3668	4370	1537
693_::::X-11317	693_::::X-11317	25	325	1	3455	3717	3372	4431	325	1868	2670	4355	1269	3950	3580
142_Height	142_Height	25	326	1	3689	326	4189	3073	702	3572	512	3651	2752	3142	1622
1003_Macrophage inflammatory protein-1 (CCL3)	1003_Macrophage inflammatory protein-1 (CCL3)	25	326	1	2225	3909	326	1710	3461	3755	3740	2905	3545	1161	4419
4632_Right inferior lateral ventricle	4632_Right inferior lateral ventricle	25	326	1	1765	832	3727	326	1397	2118	2258	1349	4448	1829	3189
4316_Smoking cessation	4316_Smoking cessation	25	326	1	4577	456	694	587	326	947	448	2124	769	663	1818
2314_LSAMP - Limbic system-associated membrane protein	2314_LSAMP - Limbic system-associated membrane protein	25	326	1	2876	1860	3669	2502	1490	326	1644	1025	733	2390	1457
2874_CBX5 - Chromobox protein homolog 5	2874_CBX5 - Chromobox protein homolog 5	25	326	1	865	3821	974	3646	1155	1105	3271	326	3870	1740	1292
929_Other polyunsaturated fatty acids than 18:2	929_Other polyunsaturated fatty acids than 18:2	25	326	1	440	3695	2911	4270	1077	3269	2642	2941	326	3452	2169
2008_Dapsone hypersensitivity syndrome	2008_Dapsone hypersensitivity syndrome	25	327	1	327	4306	2697	408	1231	3682	3503	2927	2231	4621	2523
2551_CAT - Catalase	2551_CAT - Catalase	25	327	1	2532	327	2337	3272	3636	2254	3452	4151	1574	336	3474
4707_Splenium of corpus callosum mean diusivities	4707_Splenium of corpus callosum mean diusivities	25	327	1	2285	2792	953	3097	327	1697	379	2589	3865	1402	736
1118_Pericardial adipose tissue volume (male)	1118_Pericardial adipose tissue volume (male)	25	327	1	2266	410	1715	1063	1023	3711	327	1270	857	796	654
1946_Visual memory composite score (FBAT, adjusted for multivariable)	1946_Visual memory composite score (FBAT, adjusted for multivariable)	25	327	1	2405	340	3732	2433	1936	478	607	663	1127	327	2587
4194_Systolic Blood Pressure	4194_Systolic Blood Pressure	25	327	1	2569	2805	3435	3290	813	4720	4727	2873	4477	818	327
2323_SERPINF2 - Alpha-2-antiplasmin	2323_SERPINF2 - Alpha-2-antiplasmin	25	328	1	1340	1228	4081	1118	328	3205	3532	607	1458	745	3615
1977_Hand grip (at offspring exam 7 cohort exam 27, GEE)	1977_Hand grip (at offspring exam 7 cohort exam 27, GEE)	25	328	1	566	590	1385	860	1931	827	328	1906	1446	459	529
1869_Neck-Shaft Angle (GEE, male, adjussted for multivariable)	1869_Neck-Shaft Angle (GEE, male, adjussted for multivariable)	25	329	1	4181	329	3461	885	3381	2809	630	2258	2155	2210	2722
3759_Anxiety - Reccent feelings or nervousness or anxiety	3759_Anxiety - Reccent feelings or nervousness or anxiety	25	329	1	1310	2773	329	3704	3170	627	2506	1627	2491	851	1572
1457_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1457_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	329	1	4532	1141	4278	329	2979	447	1130	1743	1442	3188	2859
3385_Happiness	3385_Happiness	25	329	1	1777	1340	2541	373	4452	1137	329	603	1129	1471	2132
3952_Amyotrophic lateral sclerosis (logistic)	3952_Amyotrophic lateral sclerosis (logistic)	25	329	1	3665	794	4453	4069	561	2361	1996	329	3185	4084	3113
4304_Legs-leg fat ratio (female)	4304_Legs-leg fat ratio (female)	25	330	1	330	2564	2124	3051	3331	2404	2977	2021	4409	2943	3668
609_Peptide::gamma-glutamyl::gamma-glutamylvaline	609_Peptide::gamma-glutamyl::gamma-glutamylvaline	25	330	1	1053	330	816	2700	1103	1295	2464	4005	1922	3564	524
3415_Reaction time test - Mean time to correctly identify matches	3415_Reaction time test - Mean time to correctly identify matches	25	330	1	2617	4200	1032	330	1770	4060	3403	1337	3729	4219	1253
4318_Anti-Mullerian hormone	4318_Anti-Mullerian hormone	25	330	1	1934	371	601	3903	330	2017	1009	2212	1932	409	3720
643_Xenobiotics::Xanthine metabolism::1-methylxanthine	643_Xenobiotics::Xanthine metabolism::1-methylxanthine	25	330	1	772	2665	4609	2414	2717	330	1381	3668	1280	1904	1382
923_Free cholesterol in medium VLDL	923_Free cholesterol in medium VLDL	25	330	1	2952	4209	1582	3373	1809	982	2042	3439	330	4331	2397
1477_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for multivariable)	1477_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for multivariable)	25	330	1	4477	1210	1627	1941	1954	1226	3289	852	814	330	576
2519_FN1 - Fibronectin Fragment 4	2519_FN1 - Fibronectin Fragment 4	25	331	1	4122	3492	331	3036	2002	2073	2927	2875	1856	1114	3022
803_::::X-12786	803_::::X-12786	25	331	1	4296	3013	2572	2224	4698	331	4129	3130	4497	2477	1725
4244_Rapid automised naming and rapid alternating stimulus test performance	4244_Rapid automised naming and rapid alternating stimulus test performance	25	331	1	2971	1481	1355	4511	1244	2932	331	4229	2040	4703	3240
295_CD4mem:%Th17	295_CD4mem:%Th17	25	331	1	2632	3976	1849	1567	3328	4283	472	1442	331	1790	3796
2903_FABP3 - Fatty acid-binding protein, heart	2903_FABP3 - Fatty acid-binding protein, heart	25	331	1	3078	1492	3650	2137	2303	1448	579	4511	1546	331	948
1213_Alcohol consumption	1213_Alcohol consumption	25	332	1	332	3245	1925	4740	3819	3938	3255	2153	4217	3009	4614
651_::::X-02249	651_::::X-02249	25	332	1	3866	1105	332	1663	1252	4486	1126	4040	1716	3765	582
2944_POMC - Corticotropin	2944_POMC - Corticotropin	25	332	1	1261	4124	489	3345	332	3776	1335	2652	2448	3883	2577
4326_Depressive symptoms (MA GWAMA)	4326_Depressive symptoms (MA GWAMA)	25	332	1	1125	2671	1403	4102	3746	915	332	3186	2933	3443	857
2710_EIF5A - Eukaryotic translation initiation factor 5A-1	2710_EIF5A - Eukaryotic translation initiation factor 5A-1	25	333	1	4476	2630	4614	333	695	1737	4631	3951	1003	1087	738
209_Intelligence	209_Intelligence	25	333	1	2281	3819	392	2281	333	2992	4403	3722	3012	4524	1750
334_NKeff:%Kir (1)	334_NKeff:%Kir (1)	25	333	1	4565	1499	4522	1486	1007	4255	333	749	1397	1920	1988
2772_CFL1 - Cofilin-1	2772_CFL1 - Cofilin-1	25	333	1	3034	1958	3760	710	4133	2108	1091	468	333	2654	1018
3374_Headaches for 3+ months	3374_Headaches for 3+ months	25	333	1	1980	1579	2473	2859	4266	3289	768	4132	1247	333	2492
3250_Pork intake	3250_Pork intake	25	334	1	1952	1124	334	1424	4403	4104	2990	3232	433	3223	3727
4312_White matter hyperintensities	4312_White matter hyperintensities	25	334	1	4739	2233	3252	334	1251	3918	3476	3704	2118	4664	1600
1390_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	1390_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	25	335	1	4530	3491	3719	3906	335	4601	4180	3166	3348	2375	1804
2003_Plasma Lipoprotein A level	2003_Plasma Lipoprotein A level	25	335	1	3047	1724	1455	3397	3370	335	558	1254	2315	2024	2506
2948_CASP2 - Caspase-2	2948_CASP2 - Caspase-2	25	335	1	1789	1683	2768	1366	4578	4277	703	2251	335	1546	4245
3406_Fluid intelligence test - FI8 : chained arithmetic	3406_Fluid intelligence test - FI8 : chained arithmetic	25	335	1	3944	1003	2991	951	3410	1145	486	4329	546	2065	335
2202_IL16 - Interleukin-16	2202_IL16 - Interleukin-16	25	336	1	1126	336	657	4034	3107	3852	341	3182	2466	1328	2266
4345_Coronary artery disease and total cholesterol (bivariate)	4345_Coronary artery disease and total cholesterol (bivariate)	25	336	1	1376	1356	2618	4116	336	748	3426	4697	2037	3077	3871
1813_Biologic age by osseographic scoring system (GEE, adjusted for multivariable)	1813_Biologic age by osseographic scoring system (GEE, adjusted for multivariable)	25	336	1	4331	1159	856	4250	4455	336	2914	2912	2096	2995	732
898_Total cholesterol in large VLDL	898_Total cholesterol in large VLDL	25	336	1	3385	4082	917	3495	784	2303	868	1720	336	4209	1678
3221_Time spent driving	3221_Time spent driving	25	336	1	2553	3949	2543	4713	3456	2180	3659	4497	1285	3410	336
1723_Serum calcium (at exam 2, GEE, adjusted for age and sex)	1723_Serum calcium (at exam 2, GEE, adjusted for age and sex)	25	337	1	337	1240	3926	3090	1452	4074	1912	1248	2543	2294	1030
462_Energy::Oxidative phosphorylation::acetylphosphate	462_Energy::Oxidative phosphorylation::acetylphosphate	25	337	1	2489	874	4280	1130	337	4300	3413	4558	3809	1648	3694
1713_Thyroid stimulation hormone (at exam 4, GEE, adjusted for age and sex)	1713_Thyroid stimulation hormone (at exam 4, GEE, adjusted for age and sex)	25	337	1	3013	673	4276	1501	2936	337	489	1585	2861	2052	1380
1865_Neck cross-sectional moment of inertia (GEE, male, adjussted for age)	1865_Neck cross-sectional moment of inertia (GEE, male, adjussted for age)	25	337	1	4276	890	1011	1049	2215	3651	337	655	542	3653	988
3461_Impedance measures - Arm fat mass (right)	3461_Impedance measures - Arm fat mass (right)	25	337	2	368	3216	1427	1991	2395	691	3957	2716	2589	4426	337
4367_Coronary artery disease in diabetes	4367_Coronary artery disease in diabetes	25	338	1	338	1794	1380	4398	488	3382	487	404	983	3335	1509
2043_Bipolar disorder	2043_Bipolar disorder	25	338	1	2492	4435	2330	338	3724	3789	3280	1026	1958	2550	567
2595_EPHB4 - Ephrin type-B receptor 4	2595_EPHB4 - Ephrin type-B receptor 4	25	338	1	4335	4206	3478	2077	338	1643	3766	3305	3637	1444	3121
262_CD8:%Naive	262_CD8:%Naive	25	338	1	581	1394	1085	2341	4509	1813	1240	338	662	571	961
3533_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault of a close relative	3533_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault of a close relative	25	338	1	1629	997	3299	3727	4380	4555	4562	3298	4599	338	3601
4712_Uncinate fasciculus mean diusivities	4712_Uncinate fasciculus mean diusivities	25	339	1	339	1207	1218	3563	2007	1682	2926	1928	2624	1889	1375
1619_CD40 Ligand serum (at exam 7, GEE, adjusted for age and sex)	1619_CD40 Ligand serum (at exam 7, GEE, adjusted for age and sex)	25	339	1	3837	3592	2087	4626	339	1215	1748	2756	1357	485	3271
1922_Hippocampal volume (FBAT, adjusted for age and sex)	1922_Hippocampal volume (FBAT, adjusted for age and sex)	25	339	1	2635	1805	3407	516	931	3763	339	1702	434	3929	844
493_Lipid::Fatty acid metabolism::isovalerate	493_Lipid::Fatty acid metabolism::isovalerate	25	339	1	1473	1114	3381	1662	3522	4096	632	1763	339	1331	4497
3297_Frequency of depressed mood in last 2 weeks	3297_Frequency of depressed mood in last 2 weeks	25	340	1	3288	3304	1242	340	874	1521	4392	2719	2190	2203	924
931_Phenylalanine	931_Phenylalanine	25	340	1	3102	1496	3287	4266	340	4188	1582	4357	490	2866	2443
4279_FVC	4279_FVC	25	340	1	2163	4119	1383	550	3865	340	4651	3584	4150	1319	1420
3844_Hemoglobin concentration (two-way meta)	3844_Hemoglobin concentration (two-way meta)	25	340	1	1369	1893	4675	3151	3147	4489	622	1233	340	3972	4528
3781_Depression - Trouble falling asleep	3781_Depression - Trouble falling asleep	25	340	1	2593	2180	4312	2112	1923	1053	2501	3702	3582	340	3268
1022_Neck Cross-Sectional Moment of Inertia (FBAT)	1022_Neck Cross-Sectional Moment of Inertia (FBAT)	25	340	1	2911	1123	1932	2734	1267	1993	1115	2377	1887	929	340
3477_Own or rent accommodation lived in: Own with a mortgage	3477_Own or rent accommodation lived in: Own with a mortgage	25	341	1	2231	341	3671	2834	1909	3425	1172	2000	3166	567	3346
4390_Dysmenorrhea pain severity	4390_Dysmenorrhea pain severity	25	341	1	669	1870	341	918	2034	3015	4533	688	2488	1851	4466
818_Lipid::Carnitine metabolism::X-13431--nonanoylcarnitine*	818_Lipid::Carnitine metabolism::X-13431--nonanoylcarnitine*	25	341	1	4052	1216	3853	4505	341	4121	1331	720	3152	1492	4284
135_Waist circumference (female, adjusted for BMI)	135_Waist circumference (female, adjusted for BMI)	25	341	1	895	2968	1563	1406	3262	341	4121	4682	4114	2942	4626
191_Estimated glomerular filtration rate based on serum creatinine	191_Estimated glomerular filtration rate based on serum creatinine	25	342	1	342	4466	1263	447	651	2764	4684	2168	3773	4197	3775
346_NKearly:%337+335+2-	346_NKearly:%337+335+2-	25	342	1	3376	3341	342	1296	4230	4254	3997	4057	578	2947	4612
4565_Left postcentral	4565_Left postcentral	25	342	1	3112	2714	2275	2885	342	4088	794	1267	4615	3793	541
3737_Depression - Ever had prolonged loss of interest in normal activities	3737_Depression - Ever had prolonged loss of interest in normal activities	25	342	1	540	3352	2958	4437	4574	342	1950	2535	695	2651	2264
2282_IGFBP4 - Insulin-like growth factor-binding protein 4	2282_IGFBP4 - Insulin-like growth factor-binding protein 4	25	342	1	4096	2531	1953	2216	3126	1312	2083	342	2745	3620	4303
4218_Antithrombotic agents	4218_Antithrombotic agents	25	343	1	883	343	439	4654	719	1705	2578	4601	694	403	1846
2346_FLT3LG - Fms-related tyrosine kinase 3 ligand	2346_FLT3LG - Fms-related tyrosine kinase 3 ligand	25	343	1	3862	1725	521	1509	1667	343	2719	1664	3389	2231	4252
332_NKeff:%Act(335+)	332_NKeff:%Act(335+)	25	343	1	4525	1719	4496	799	4151	2436	343	800	1652	1102	4073
3079_NRCAM - Neuronal cell adhesion molecule	3079_NRCAM - Neuronal cell adhesion molecule	25	343	1	1543	2692	361	2489	404	2918	2012	2317	3123	4568	343
1271_Epworth Sleepiness Scale (GEE, adjusted for age, sex and BMI)	1271_Epworth Sleepiness Scale (GEE, adjusted for age, sex and BMI)	25	344	1	413	815	1300	4142	344	2811	4498	2534	2956	1051	1961
1981_Walking speed (at offspring exam 7 cohort exam 27, GEE)	1981_Walking speed (at offspring exam 7 cohort exam 27, GEE)	25	344	1	2363	519	777	1558	4727	1417	344	1858	1082	1141	4192
727_::::X-11787	727_::::X-11787	25	344	1	4392	3132	1112	3781	706	4198	2519	344	1782	2878	2953
948_Total fatty acids	948_Total fatty acids	25	344	1	2974	2854	1808	3999	1663	3775	753	559	344	4648	2689
1853_Neck average buckling ratio (GEE, male, adjussted for multivariable)	1853_Neck average buckling ratio (GEE, male, adjussted for multivariable)	25	345	1	345	2147	3190	3416	2225	2603	2452	1189	2189	2816	3935
3724_Frequency of inability to cease drinking in last year	3724_Frequency of inability to cease drinking in last year	25	345	1	934	870	345	2585	4413	2678	999	3569	1982	2725	392
4392_Menstrual pain medicine use	4392_Menstrual pain medicine use	25	345	1	871	4601	809	345	1109	3931	1711	1046	1986	2408	4545
2295_BMP7 - Bone morphogenetic protein 7	2295_BMP7 - Bone morphogenetic protein 7	25	345	1	2038	3694	1131	2709	2305	345	4111	4569	4643	3676	1786
2697_RPS6KA5 - Ribosomal protein S6 kinase alpha-5	2697_RPS6KA5 - Ribosomal protein S6 kinase alpha-5	25	345	1	3839	1915	3165	3381	746	727	2731	2683	4464	4247	345
4709_Superior fronto-occipital fasciculus mean diusivities	4709_Superior fronto-occipital fasciculus mean diusivities	25	346	1	346	3545	2968	2553	3839	2933	1641	1925	3406	1043	2485
1826_Spine Neck BMD (FBAT, female, adjusted for multivariable)	1826_Spine Neck BMD (FBAT, female, adjusted for multivariable)	25	347	1	347	1448	1521	3555	3914	1350	3365	3791	1046	455	1111
4579_Right cuneus	4579_Right cuneus	25	347	1	2109	683	2163	347	1822	1359	2908	733	2128	1187	1414
794_::::X-12719	794_::::X-12719	25	347	1	4360	2738	4319	1844	4744	347	4021	898	2308	3763	3017
214_NK:%Term	214_NK:%Term	25	348	1	348	2430	3562	3800	2761	4132	741	3539	885	1850	4496
1091_Alcohol dependence	1091_Alcohol dependence	25	348	1	4504	348	2738	2930	3481	4737	1133	2943	3290	2373	2975
4465_Left posterior cingulate	4465_Left posterior cingulate	25	348	1	677	1458	1617	1114	4077	348	628	750	3014	1243	2326
800_::::X-12749	800_::::X-12749	25	348	1	2909	2097	3045	4298	3687	4242	1414	348	3060	2044	1061
2199_CCL1 - C-C motif chemokine 1	2199_CCL1 - C-C motif chemokine 1	25	348	1	1528	2047	1516	4187	4328	4097	2820	793	348	2885	2671
1763_Prostate cancer (GEE, adjusted for age)	1763_Prostate cancer (GEE, adjusted for age)	25	348	1	1865	3187	3137	3531	1089	2481	3343	2395	1427	2748	348
4562_Left pars orbitalis	4562_Left pars orbitalis	25	349	1	349	1710	438	2947	3727	1387	4519	910	2558	3944	2049
1286_Visceral fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	1286_Visceral fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	349	1	3361	1294	349	436	1871	1111	3792	3035	4013	4658	1501
3912_Cup area	3912_Cup area	25	349	1	1078	3175	746	4215	1411	726	3392	3405	349	4287	2212
2187_GDF5 - Growth/differentiation factor 5	2187_GDF5 - Growth/differentiation factor 5	25	349	1	4274	384	1836	1341	2449	3358	1029	2085	2324	349	2522
4228_Anti-inflammatory and antirheumatic products, non-steroids	4228_Anti-inflammatory and antirheumatic products, non-steroids	25	349	1	1046	3408	3168	1798	3690	492	2658	3634	2657	1022	349
2339_SPARC - SPARC	2339_SPARC - SPARC	25	350	1	3551	3744	2004	3068	350	2312	2238	4269	2563	2991	1489
1982_Walking speed (at exam 7, FBAT)	1982_Walking speed (at exam 7, FBAT)	25	350	1	3702	2855	1845	4066	3349	350	1565	3073	4668	1571	1723
2691_NACA - Nascent polypeptide-associated complex subunit alpha	2691_NACA - Nascent polypeptide-associated complex subunit alpha	25	350	1	4347	622	4140	2884	3769	4545	350	3362	3221	3581	3200
2176_POR - NADPH--cytochrome P450 reductase	2176_POR - NADPH--cytochrome P450 reductase	25	350	1	2583	360	3777	1674	4138	2464	1090	1209	350	395	4155
1584_D-dimer (at exam 6, FBAT, adjusted for multivariable)	1584_D-dimer (at exam 6, FBAT, adjusted for multivariable)	25	350	1	1110	431	3341	1319	2843	2670	832	1362	2668	350	977
4095_Atrial Fibrillation	4095_Atrial Fibrillation	25	351	1	1081	2659	351	3825	899	1685	710	4552	4116	2746	3522
2990_PI3 - Elafin	2990_PI3 - Elafin	25	351	1	2169	3446	2086	900	2427	351	1806	486	1881	3102	3299
1781_Artial fibrillation (GEE, adjusted for age and sex)	1781_Artial fibrillation (GEE, adjusted for age and sex)	25	351	1	2239	962	4430	3539	3194	3311	351	1049	1075	1237	4259
382_Amino acid::Glycine, serine and threonine metabolism::N-acetylthreonine	382_Amino acid::Glycine, serine and threonine metabolism::N-acetylthreonine	25	351	1	1828	2222	2319	801	2470	4169	3675	351	1996	2340	496
2569_TGFB3 - Transforming growth factor beta-3	2569_TGFB3 - Transforming growth factor beta-3	25	351	1	718	4438	595	3520	964	2643	4230	4095	4014	2327	351
1519_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	1519_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	25	352	1	3279	2927	3822	352	4411	4543	1372	2044	3786	2713	2233
3292_Worry too long after embarrassment	3292_Worry too long after embarrassment	25	353	1	1617	1540	1292	353	3806	4542	3680	1987	3811	3758	393
340_NKeff:%2+337-R7-	340_NKeff:%2+337-R7-	25	353	1	1915	1749	2857	3426	3390	353	3872	2150	2942	2874	441
2341_PTN - Pleiotrophin	2341_PTN - Pleiotrophin	25	353	1	1113	2350	2626	2263	3558	3011	353	1303	2479	4733	2178
749_::::X-12039	749_::::X-12039	25	353	1	1115	3524	715	2831	2697	4041	3128	2577	3085	353	3712
1554_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1554_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	354	1	354	1453	3267	4407	4291	811	2113	1340	1394	1965	1707
1074_Serum levels of soluble E-selectin with T1D	1074_Serum levels of soluble E-selectin with T1D	25	354	1	2416	3202	2869	1609	4309	2150	3911	354	4222	2632	2408
946_Serum total triglycerides	946_Serum total triglycerides	25	354	1	3530	4392	1138	3943	1167	2156	1271	1965	354	2706	2717
508_Lipid::Glycerolipid metabolism::glycerol 3-phosphate (G3P)	508_Lipid::Glycerolipid metabolism::glycerol 3-phosphate (G3P)	25	354	1	3949	3194	1023	3222	440	3208	3724	3925	3757	354	3913
2953_LGALS8 - Galectin-8	2953_LGALS8 - Galectin-8	25	354	1	3519	4125	1723	1248	4669	3268	1993	2436	1817	3298	354
4427_Epstein Barr Virus antigen EBNA seropositivity	4427_Epstein Barr Virus antigen EBNA seropositivity	25	355	1	1529	1759	355	2155	4214	1940	3067	2645	3754	1629	4193
2309_IL17RA - Interleukin-17 receptor A	2309_IL17RA - Interleukin-17 receptor A	25	355	1	4645	4069	1041	355	382	966	1811	461	2060	1964	4216
4704_Posterior limb of internal capsule mean diusivities	4704_Posterior limb of internal capsule mean diusivities	25	355	1	448	2904	1461	2339	1088	355	2563	3193	2946	1211	3238
602_Peptide::gamma-glutamyl::gamma-glutamylglutamine	602_Peptide::gamma-glutamyl::gamma-glutamylglutamine	25	355	1	3349	1672	3866	3672	3363	3542	355	682	2347	1205	4446
3880_Hemoglobin concentration (three-way meta)	3880_Hemoglobin concentration (three-way meta)	25	355	1	1011	839	3977	3341	4338	3685	597	932	355	3450	3545
541_Lipid::Lysolipid::1-oleoylglycerophosphoethanolamine	541_Lipid::Lysolipid::1-oleoylglycerophosphoethanolamine	25	355	1	2754	4270	1512	367	3482	965	2748	1902	2447	1064	355
3756_Mental distress - Ever suffered mental distress preventing usual activities	3756_Mental distress - Ever suffered mental distress preventing usual activities	25	356	1	356	2116	2298	3453	4236	3057	1548	4520	1120	1764	3872
2866_KNG1 - Kininogen-1	2866_KNG1 - Kininogen-1	25	356	1	418	356	1193	4724	4441	2540	1182	3189	672	965	4000
432_Amino acid::Valine, leucine and isoleucine metabolism::levulinate (4-oxovalerate)	432_Amino acid::Valine, leucine and isoleucine metabolism::levulinate (4-oxovalerate)	25	356	1	2041	4615	356	4477	3962	4201	363	2761	4068	3597	3521
2344_VWF - von Willebrand factor	2344_VWF - von Willebrand factor	25	356	1	4159	2946	4710	356	3419	3433	2640	422	3193	3207	2473
2506_BMX - Cytoplasmic tyrosine-protein kinase BMX	2506_BMX - Cytoplasmic tyrosine-protein kinase BMX	25	356	1	2125	1539	3878	1787	356	3802	3881	4478	4436	1688	2771
2605_CDC42BPB - Serine/threonine-protein kinase MRCK beta	2605_CDC42BPB - Serine/threonine-protein kinase MRCK beta	25	356	1	3993	4240	3969	3477	3994	356	4695	3046	2892	3894	2545
845_::::X-14658	845_::::X-14658	25	356	1	1455	2635	2444	1732	2337	2164	356	1530	2771	1716	4204
3090_SIGLEC14 - Sialic acid-binding Ig-like lectin 14	3090_SIGLEC14 - Sialic acid-binding Ig-like lectin 14	25	357	1	357	3740	480	1075	937	3395	2176	1386	1968	3868	2525
814_::::X-13069	814_::::X-13069	25	357	1	569	1831	357	3417	729	3373	3690	455	1883	1227	1948
1354_Plasma Apolipoprotein C3 level (FBAT, adjusted for age and sex)	1354_Plasma Apolipoprotein C3 level (FBAT, adjusted for age and sex)	25	357	1	4299	1690	1279	2233	357	3134	4286	3351	4326	1241	759
2392_CRISP3 - Cysteine-rich secretory protein 3	2392_CRISP3 - Cysteine-rich secretory protein 3	25	357	1	4613	4060	3146	4195	4095	357	3118	2308	1346	2359	605
844_::::X-14632	844_::::X-14632	25	357	1	997	644	812	3135	2375	3548	357	3577	620	2348	1008
435_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::erythrose	435_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::erythrose	25	357	1	457	2431	733	2445	2291	2061	1568	3034	3203	357	2077
4322_Depressive symptoms (univariate)	4322_Depressive symptoms (univariate)	25	357	1	3350	2178	3569	4670	2319	3926	2040	1366	3847	1852	357
4260_Facial attractiveness (female-coder)	4260_Facial attractiveness (female-coder)	25	358	1	2551	358	464	2937	4122	2615	701	2759	2886	2775	3953
4139_Mean corpuscular hemoglobin	4139_Mean corpuscular hemoglobin	25	358	1	2766	2011	358	3596	3668	2314	4719	2821	2310	865	3109
1375_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for age and sex)	1375_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for age and sex)	25	358	1	620	4509	4582	4200	855	456	2358	3618	2390	3218	358
1970_MMSE score (at exam 7, FBAT, adjusted for age)	1970_MMSE score (at exam 7, FBAT, adjusted for age)	25	359	1	2976	359	2023	3752	1440	2609	1424	2038	832	4160	1504
3501_Male-specific factors - Hair/balding pattern: Pattern 2	3501_Male-specific factors - Hair/balding pattern: Pattern 2	25	359	1	3133	4548	4161	359	1738	1927	1455	2883	1419	733	2531
2592_DKK3 - Dickkopf-related protein 3	2592_DKK3 - Dickkopf-related protein 3	25	359	1	3228	4498	4696	3100	359	3640	3474	3748	2895	4358	3445
598_Peptide::Fibrinogen cleavage peptide::ADpSGEGDFXAEGGGVR*	598_Peptide::Fibrinogen cleavage peptide::ADpSGEGDFXAEGGGVR*	25	359	1	2783	933	385	1044	2820	4697	1012	4083	3479	359	2026
1295_Diabetes incidence (GEE, adjusted for age, sex and BMI)	1295_Diabetes incidence (GEE, adjusted for age, sex and BMI)	25	360	1	2255	4014	2304	360	4108	1325	4688	409	843	4009	431
1565_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1565_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	360	1	4309	3370	1308	3114	591	360	3417	2611	2797	2778	1550
1651_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for age and sex)	1651_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for age and sex)	25	360	1	4147	3302	3767	4061	2502	490	815	1378	4450	2613	360
3786_Insomnia	3786_Insomnia	25	361	1	361	739	2905	3235	4734	973	1709	656	653	549	2350
1423_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1423_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	361	1	4012	4352	1628	1101	690	361	4318	3944	2539	1878	1539
2759_F2 - Thrombin	2759_F2 - Thrombin	25	361	1	1383	1911	2173	2338	4233	1434	361	2515	516	3138	1310
383_Amino acid::Glycine, serine and threonine metabolism::serine	383_Amino acid::Glycine, serine and threonine metabolism::serine	25	361	1	2780	2359	3406	1389	4347	3805	1721	361	4702	2188	4580
4161_Focal Epilepsy, lesion negative	4161_Focal Epilepsy, lesion negative	25	361	1	1466	914	2022	3163	3201	835	1430	3215	1897	3396	361
1439_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1439_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	362	1	748	3685	362	3621	3401	3680	1652	3943	3161	3797	1490
813_Lipid::Essential fatty acid::X-12990--docosapentaenoic acid (n6-DPA)	813_Lipid::Essential fatty acid::X-12990--docosapentaenoic acid (n6-DPA)	25	362	1	1756	3395	3807	362	3427	3577	1099	496	1752	1598	2958
219_Lymph:%CD8	219_Lymph:%CD8	25	362	1	1942	2243	3530	2878	362	890	3691	4107	3636	2020	1039
3156_TNFSF14 - Tumor necrosis factor ligand superfamily member 14	3156_TNFSF14 - Tumor necrosis factor ligand superfamily member 14	25	362	1	2672	1097	1412	3232	3049	4416	2988	3346	1302	1611	362
1250_Percent predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	1250_Percent predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	363	1	363	2539	568	934	2511	3391	3113	1982	4226	1674	1743
2803_SPHK1 - Sphingosine kinase 1	2803_SPHK1 - Sphingosine kinase 1	25	363	1	2233	3257	3980	363	2818	3374	4669	4001	488	4386	852
630_Xenobiotics::Food component, Plant::ergothioneine	630_Xenobiotics::Food component, Plant::ergothioneine	25	363	1	3245	3272	4106	3893	363	4622	1347	3891	4649	1639	1500
4154_Ejection fraction	4154_Ejection fraction	25	363	1	3874	3645	3155	1338	4031	1300	462	363	2089	4444	4524
610_Peptide::Polypeptide::bradykinin, des-arg(9)	610_Peptide::Polypeptide::bradykinin, des-arg(9)	25	364	1	3238	364	3286	2479	2284	1398	374	1356	4215	752	2721
3966_Asthma (fixed effect model)	3966_Asthma (fixed effect model)	25	364	1	3290	460	364	1690	2523	2148	500	1942	4422	822	725
3986_Heart rate recovery at 20 secnds	3986_Heart rate recovery at 20 secnds	25	364	1	714	3688	2360	364	1031	3770	2963	3806	1196	4088	4462
2133_LTBR - Tumor necrosis factor receptor superfamily member 3	2133_LTBR - Tumor necrosis factor receptor superfamily member 3	25	364	1	4282	2029	2397	1793	364	4375	3970	3126	2846	4192	3490
1906_Hippocampal volume (FBAT, adjusted for multivariable)	1906_Hippocampal volume (FBAT, adjusted for multivariable)	25	364	1	4092	753	3846	1631	3717	3281	364	1466	444	4406	2376
2929_CSF3 - Granulocyte colony-stimulating factor	2929_CSF3 - Granulocyte colony-stimulating factor	25	364	1	3462	1827	4113	386	753	2036	2995	1242	364	2923	4170
1516_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	1516_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	25	364	1	4223	2563	3590	2906	4457	836	1849	3156	385	4510	364
2054_Percentage improvement after 12 weeks of antidepressant treatment in MDD	2054_Percentage improvement after 12 weeks of antidepressant treatment in MDD	25	365	1	365	970	1257	4719	1711	747	2994	1259	728	3203	2595
3678_Diagnoses - main ICD10: M23 Internal derangement of knee	3678_Diagnoses - main ICD10: M23 Internal derangement of knee	25	365	1	1463	2449	365	2207	483	4493	3905	2415	2654	1091	3948
1326_Fasting insulin (at exam 5, FBAT, adjusted for age, sex and BMI)	1326_Fasting insulin (at exam 5, FBAT, adjusted for age, sex and BMI)	25	365	1	4531	2702	1792	2732	365	2342	2932	3897	1093	3425	886
3268_Alcohol intake versus 10 years previously	3268_Alcohol intake versus 10 years previously	25	365	1	988	3522	1888	3603	3844	365	2325	2664	1096	1685	1582
2970_F3 - Tissue Factor	2970_F3 - Tissue Factor	25	365	1	2726	2516	3999	888	534	649	437	365	3820	4300	1299
195_Chronic kidney disease	195_Chronic kidney disease	25	365	1	4448	1869	2876	2261	2522	3977	965	2174	930	3626	365
660_::::X-04495	660_::::X-04495	25	366	1	366	1332	586	2990	1578	4705	614	4514	2467	1682	3302
3373_Knee pain for 3+ months	3373_Knee pain for 3+ months	25	366	1	1516	4443	4242	3561	3237	3767	366	3449	1388	2648	3111
3747_Happiness and subjective well-being - Belief that own life is meaningfull	3747_Happiness and subjective well-being - Belief that own life is meaningfull	25	366	1	3430	4439	559	1203	1355	3267	4479	3138	1557	3233	366
260_CD8:%TE	260_CD8:%TE	25	367	1	781	2891	2030	2290	367	4228	1512	1487	2860	3398	3269
2750_PAPPA - Pappalysin-1	2750_PAPPA - Pappalysin-1	25	367	1	2284	3226	639	2847	629	1104	1569	367	2893	3368	2271
583_Nucleotide::Purine metabolism, adenine containing::N1-methyladenosine	583_Nucleotide::Purine metabolism, adenine containing::N1-methyladenosine	25	367	1	4462	2114	2579	1682	1618	1394	1794	1272	367	2894	4624
695_::::X-11334	695_::::X-11334	25	368	1	493	1875	368	3983	4432	3891	3811	3443	4696	2392	4282
3757_Mania - Ever had period extreme irritability	3757_Mania - Ever had period extreme irritability	25	368	1	1644	4491	916	368	1838	2022	3270	1682	3686	1432	3301
1480_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for multivariable)	1480_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for multivariable)	25	368	1	3928	3667	2841	3592	368	510	2468	1023	4245	3232	602
2765_TG - Thyroglobulin	2765_TG - Thyroglobulin	25	368	1	1188	2943	4257	3881	3889	368	1286	1623	2993	1129	4351
215_NK:%Eff	215_NK:%Eff	25	368	1	1731	3567	4156	1548	3428	1164	2722	368	969	4517	4649
1352_Plasma Apolipoprotein C3 level (FBAT, multivariate adjusted)	1352_Plasma Apolipoprotein C3 level (FBAT, multivariate adjusted)	25	368	1	3577	3880	2185	1900	1515	1576	3610	4515	4202	368	1667
388_Amino acid::Lysine metabolism::glutaroyl carnitine	388_Amino acid::Lysine metabolism::glutaroyl carnitine	25	369	1	369	2236	1940	1714	789	2250	2060	948	3484	731	2333
517_Lipid::Long chain fatty acid::arachidonate (20:4n6)	517_Lipid::Long chain fatty acid::arachidonate (20:4n6)	25	369	1	1322	3945	369	1549	1373	3218	1294	1719	1440	1277	2776
1845_Neck Section Modulus (GEE, male, adjusted for multivariable)	1845_Neck Section Modulus (GEE, male, adjusted for multivariable)	25	369	1	4206	2512	2614	3000	369	2069	2131	2165	3803	4645	2147
3019_NCK1 - Cytoplasmic protein NCK1	3019_NCK1 - Cytoplasmic protein NCK1	25	369	1	2129	2808	3293	2417	2798	693	1557	369	4677	3759	2415
2455_NTN4 - Netrin-4	2455_NTN4 - Netrin-4	25	369	1	1781	3721	3555	2101	1385	2876	1272	874	369	4184	3608
4476_Right caudal anterior cingulate	4476_Right caudal anterior cingulate	25	369	1	3824	2707	3501	4702	500	509	811	488	2215	2430	369
2046_Periodontal complex trait 1 - Socransky trait	2046_Periodontal complex trait 1 - Socransky trait	25	370	1	2606	391	3674	370	1919	3781	866	440	710	1167	3977
628_Xenobiotics::Drug::salicylate	628_Xenobiotics::Drug::salicylate	25	370	1	3876	2487	3849	1675	370	473	2790	3917	2928	2277	4622
1109_Subcutaneous adipose tissue volume (male)	1109_Subcutaneous adipose tissue volume (male)	25	370	1	3838	3489	2532	4300	2617	370	1523	975	2719	2955	4046
4725_Posterior corona radiata mode of anisotropy	4725_Posterior corona radiata mode of anisotropy	25	370	1	2720	3447	1907	1323	3377	705	370	1133	1248	4470	3432
3690_Diagnoses - secondary ICD10: F32 Major depressive disorder, single episode	3690_Diagnoses - secondary ICD10: F32 Major depressive disorder, single episode	25	370	1	2724	2428	714	2319	3930	1185	1654	370	1800	2460	3594
264_CD4:%SCM	264_CD4:%SCM	25	370	1	4162	2880	1664	4581	3151	1238	1071	1624	480	4324	370
4516_Optic chiasm	4516_Optic chiasm	25	371	1	371	2432	821	4241	3256	4519	961	3589	2687	2492	1863
4441_Epstein Barr Virus antigen EA IgG levels	4441_Epstein Barr Virus antigen EA IgG levels	25	371	1	929	3582	1917	1842	371	1040	4223	3664	2996	1893	3484
4740_Cingulum (hippocampus) radial diusivities	4740_Cingulum (hippocampus) radial diusivities	25	371	1	3452	4365	2336	3173	544	371	2477	2696	1780	4032	2051
732_::::X-11805	732_::::X-11805	25	371	1	1375	2066	1095	2141	3245	762	1953	3643	2712	371	4574
4381_Epithelial ovarian cancer (all invasive)	4381_Epithelial ovarian cancer (all invasive)	25	372	1	372	988	526	2723	1004	1222	4493	1949	2640	1566	3354
4308_Osteoarthritis of hit or knee	4308_Osteoarthritis of hit or knee	25	372	1	3781	866	372	3274	4242	883	1336	3427	3556	4353	1350
417_Amino acid::Urea cycle; arginine-, proline-, metabolism::proline	417_Amino acid::Urea cycle; arginine-, proline-, metabolism::proline	25	372	1	614	679	958	2278	372	2732	3788	4647	1842	1312	2908
2981_CAPG - Macrophage-capping protein	2981_CAPG - Macrophage-capping protein	25	372	1	2961	587	4066	1380	2626	372	3628	1410	4314	2354	843
3050_EPHA10 - Ephrin type-A receptor 10	3050_EPHA10 - Ephrin type-A receptor 10	25	372	1	2906	1989	2315	1480	2618	2622	372	2658	2544	4539	2096
3896_Neutrophil percentage of white cells (three-way meta)	3896_Neutrophil percentage of white cells (three-way meta)	25	372	1	2874	3206	1013	631	4341	4584	3161	963	372	1272	1087
1778_Heart failure (censored at interval MI, FBAT, adjusted for multivariable)	1778_Heart failure (censored at interval MI, FBAT, adjusted for multivariable)	25	373	1	2861	1926	819	3534	3422	373	450	1473	787	1232	967
2436_CNTN5 - Contactin-5	2436_CNTN5 - Contactin-5	25	373	1	3307	729	1742	4016	3965	1149	2223	1228	1989	373	4217
2573_DKK1 - Dickkopf-related protein 1	2573_DKK1 - Dickkopf-related protein 1	25	373	1	4672	3384	624	4232	2945	3709	1923	3214	1869	2720	373
276_CD4:%RTE	276_CD4:%RTE	25	374	1	374	905	1087	1774	2784	1695	1076	3760	874	2702	3691
3387_Health satisfaction	3387_Health satisfaction	25	374	1	1163	2031	4488	4472	2039	4437	1708	374	465	2409	3597
4031_Alcohol dependency (discovery)	4031_Alcohol dependency (discovery)	25	375	1	375	1813	2090	1651	3954	4120	3562	3963	1945	4592	3880
1610_von Willebrand Factor (at exam 5, FBAT, adjusted for age and sex)	1610_von Willebrand Factor (at exam 5, FBAT, adjusted for age and sex)	25	375	1	3414	4483	375	2329	2723	2236	3264	3546	4177	3241	2775
404_Amino acid::Tryptophan metabolism::indoleacetate	404_Amino acid::Tryptophan metabolism::indoleacetate	25	375	1	2164	3268	3300	4136	4596	3867	375	3154	2371	4145	4057
468_Lipid::Bile acid metabolism::glycodeoxycholate	468_Lipid::Bile acid metabolism::glycodeoxycholate	25	375	1	3393	787	3693	4512	3074	2422	844	2976	1042	4741	375
823_::::X-13549	823_::::X-13549	25	376	1	376	2009	632	1430	1320	582	2934	1496	1211	3498	3355
1609_Viscosity I (at exam 5, GEE, adjusted for multivariable)	1609_Viscosity I (at exam 5, GEE, adjusted for multivariable)	25	376	1	3529	1786	2136	881	939	3335	3866	376	2805	3666	1464
1664_Alanine transaminase (at exam 2, FBAT, adjusted for multivariable)	1664_Alanine transaminase (at exam 2, FBAT, adjusted for multivariable)	25	376	1	1413	1713	4461	1037	3403	4053	2351	2720	1337	376	4068
2063_COL18A1 - Endostatin	2063_COL18A1 - Endostatin	25	377	1	377	2555	448	3812	3464	1865	2295	4125	3794	1013	668
2548_B2M - Beta-2-microglobulin	2548_B2M - Beta-2-microglobulin	25	377	1	1030	377	761	2451	1558	2565	668	2680	1905	2154	3728
1751_Cystatin C (at exam 7, GEE, adjusted for age and sex)	1751_Cystatin C (at exam 7, GEE, adjusted for age and sex)	25	377	1	4555	2824	836	820	377	2686	3916	2692	2627	2555	780
2168_TNFSF18 - Tumor necrosis factor ligand superfamily member 18	2168_TNFSF18 - Tumor necrosis factor ligand superfamily member 18	25	377	1	4250	4657	1972	3929	2026	377	1734	2151	3779	2396	3787
2814_KLK3 - Prostate-specific antigen	2814_KLK3 - Prostate-specific antigen	25	378	1	378	1007	1871	2890	2471	2604	3933	2277	4347	1171	2979
2310_IL18RAP - Interleukin-18 receptor accessory protein	2310_IL18RAP - Interleukin-18 receptor accessory protein	25	378	1	2479	378	4486	4656	4087	2630	2093	1206	390	2491	3890
4201_Body Mass Index	4201_Body Mass Index	25	378	1	1057	453	378	2269	4175	1845	1690	3244	1265	778	3115
2040_Attention function - Excutive function - Child	2040_Attention function - Excutive function - Child	25	378	1	2413	3913	2511	378	2750	845	3229	4739	2001	1655	4427
3141_APOE - Apolipoprotein E (isoform E2)	3141_APOE - Apolipoprotein E (isoform E2)	25	378	1	3003	3981	1725	4607	378	4128	2688	809	4181	4566	4238
2326_CCL23 - Ck-beta-8-1	2326_CCL23 - Ck-beta-8-1	25	378	1	2060	3360	4432	4650	1977	378	3087	819	1900	2017	3957
1773_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for age and sex)	1773_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for age and sex)	25	378	1	3517	1898	3560	530	2363	1832	836	378	2415	4338	1320
1382_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	1382_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	25	378	1	2684	2690	649	4547	1393	3462	4525	1369	3026	1481	378
3299_Frequency of tenseness / restlessness in last 2 weeks	3299_Frequency of tenseness / restlessness in last 2 weeks	25	379	1	554	379	962	4378	3012	4395	4120	2860	2267	476	4586
2927_TNFRSF10A - Tumor necrosis factor receptor superfamily member 10A	2927_TNFRSF10A - Tumor necrosis factor receptor superfamily member 10A	25	379	1	4510	1209	1899	379	2508	4178	1238	642	988	2042	3492
270_CD4:%Naive	270_CD4:%Naive	25	379	1	409	4311	1697	2596	946	379	903	3048	1549	3227	2918
4069_Drinks per week	4069_Drinks per week	25	379	1	3664	2819	3489	604	475	3609	582	379	955	651	1423
165_Hip circumference (female, adjusted for BMI)	165_Hip circumference (female, adjusted for BMI)	25	379	1	2380	3093	3915	2124	1337	2577	2210	1663	4004	3056	379
1190_Mitral annular calcification	1190_Mitral annular calcification	25	380	1	2377	4271	380	2666	1994	1808	4399	4051	3559	3128	3684
394_Amino acid::Phenylalanine & tyrosine metabolism::3-phenylpropionate (hydrocinnamate)	394_Amino acid::Phenylalanine & tyrosine metabolism::3-phenylpropionate (hydrocinnamate)	25	380	1	3511	743	4611	380	4557	470	2275	2133	996	3629	2344
2079_PLA2G2E - Group IIE secretory phospholipase A2	2079_PLA2G2E - Group IIE secretory phospholipase A2	25	380	1	3422	4610	2961	4063	380	2676	3011	4348	1137	4482	3814
4730_Superior corona radiata mode of anisotropy	4730_Superior corona radiata mode of anisotropy	25	380	1	930	3313	755	4396	3028	380	1558	2382	1363	3705	3622
1673_Bilirubin (at exam 2, GEE, adjusted for multivariable)	1673_Bilirubin (at exam 2, GEE, adjusted for multivariable)	25	380	1	3257	3980	739	3064	4342	2458	1452	3183	3993	2185	380
4195_Diastolic Blood Pressure	4195_Diastolic Blood Pressure	25	381	1	3449	381	4714	2924	1146	2576	804	525	1029	890	3386
3376_Number of stillbirths (female)	3376_Number of stillbirths (female)	25	381	1	679	2681	381	723	2150	1174	1278	574	1064	629	758
151_Waist-hip ratio (male > 50 yrs, adjusted for BMI)	151_Waist-hip ratio (male > 50 yrs, adjusted for BMI)	25	381	1	3887	1301	3056	4021	381	2968	3293	2778	1573	2665	1092
4060_Estimated glomerular filtration rate based on cystain C	4060_Estimated glomerular filtration rate based on cystain C	25	381	1	2652	2785	3441	2929	3789	381	3091	434	1105	882	2383
3803_Mean corpuscular hemoglobin	3803_Mean corpuscular hemoglobin	25	381	1	1597	3597	699	3288	4738	1286	3492	381	3769	2887	2579
1683_Brain natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	1683_Brain natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	25	381	1	4730	4293	4567	487	444	984	1797	2231	3876	1522	381
908_LDL diameter	908_LDL diameter	25	382	1	4566	3104	3124	4662	3732	1356	3561	715	382	4174	3059
3635_Illnesses of father: Alzheimer's disease/dementia	3635_Illnesses of father: Alzheimer's disease/dementia	25	382	1	1023	1076	4002	4224	2517	2409	1388	4456	936	382	4578
386_Amino acid::Histidine metabolism::3-methylhistidine	386_Amino acid::Histidine metabolism::3-methylhistidine	25	382	1	1156	4367	444	1654	2104	619	3120	783	2219	1583	382
2630_GPT - Alanine aminotransferase 1	2630_GPT - Alanine aminotransferase 1	25	383	1	4491	1434	4723	1117	4144	778	383	944	592	2625	3548
2476_CD207 - C-type lectin domain family 4 member K	2476_CD207 - C-type lectin domain family 4 member K	25	383	1	890	3999	4647	4023	1171	2900	2660	2312	1688	2411	383
2423_ACAN - Aggrecan core protein	2423_ACAN - Aggrecan core protein	25	384	1	384	4409	2695	2632	1916	2459	1174	1674	2273	4685	4527
3604_Non-cancer illness code, self-reported: depression	3604_Non-cancer illness code, self-reported: depression	25	384	1	1505	1569	384	1704	4126	2687	2106	2846	1078	3908	1531
4297_Extreme obesity (childhood)	4297_Extreme obesity (childhood)	25	384	1	1347	1697	2622	384	2509	2724	3544	3826	3284	2601	2900
3280_Mother still alive	3280_Mother still alive	25	384	1	2081	3077	830	558	2787	1012	4568	384	3568	2674	1234
587_Nucleotide::Purine metabolism, urate metabolism::allantoin	587_Nucleotide::Purine metabolism, urate metabolism::allantoin	25	384	1	425	1490	4076	2599	3622	4330	485	569	1421	1389	384
253_CD123 on 11c+123+DC	253_CD123 on 11c+123+DC	25	385	1	385	1425	1451	1268	2065	3905	557	1217	1679	902	3640
1273_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI and usual sleep duration)	1273_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI and usual sleep duration)	25	385	1	430	1299	869	3063	385	4589	3490	4405	3891	1658	2229
2818_ICAM1 - Intercellular adhesion molecule 1	2818_ICAM1 - Intercellular adhesion molecule 1	25	385	1	2967	4407	2701	1972	1781	385	1762	765	2603	4743	3356
3516_Heating type(s) in home: Gas central heating	3516_Heating type(s) in home: Gas central heating	25	385	1	4154	1659	2879	4010	3243	4161	536	3940	2412	385	4115
1290_Waist circumference by CT (FBAT, adjusted for age, sex, smoking and menopause)	1290_Waist circumference by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	385	1	1359	2308	3972	2056	761	2951	4548	3966	4491	660	385
4030_Alcohol dependency (bayesian effect  for unrelated genotyped individuals)	4030_Alcohol dependency (bayesian effect  for unrelated genotyped individuals)	25	386	1	1788	4520	4173	2444	1733	1542	3643	386	2975	2103	2123
900_Free cholesterol in large VLDL	900_Free cholesterol in large VLDL	25	386	1	1964	4242	1687	2536	1164	2097	1013	784	386	4402	2592
2531_LCK - Tyrosine-protein kinase Lck	2531_LCK - Tyrosine-protein kinase Lck	25	386	1	1282	1675	2140	2126	2965	1667	2415	896	928	386	2058
1197_Cerebrospinal fluid levels of amyloid-beta 1-42	1197_Cerebrospinal fluid levels of amyloid-beta 1-42	25	387	1	1410	4410	1113	387	4023	3809	3550	2644	2157	2080	2742
1342_Resistin (FBAT, adjusted for age, sex and BMI)	1342_Resistin (FBAT, adjusted for age, sex and BMI)	25	387	1	2312	4351	3179	1999	387	1792	1345	1096	2140	2217	772
4443_Epstein Barr Virus antigen VCA IgG levels	4443_Epstein Barr Virus antigen VCA IgG levels	25	387	1	3681	426	4416	3002	2556	387	3321	755	4269	1019	4152
3355_Ever stopped smoking for 6+ months	3355_Ever stopped smoking for 6+ months	25	387	1	2314	1609	4698	3072	530	2348	387	2289	2236	1487	2406
1829_Spine Neck BMD (GEE, male, adjusted for multivariable)	1829_Spine Neck BMD (GEE, male, adjusted for multivariable)	25	387	1	4028	3844	4558	1575	3392	2875	1490	387	1026	3189	1900
4311_Diverticular disease	4311_Diverticular disease	25	387	1	2480	3049	3276	4585	1487	2747	3888	1615	3990	387	2216
1471_Lipoprotein A (at exam 3, GEE, adjusted for age and sex)	1471_Lipoprotein A (at exam 3, GEE, adjusted for age and sex)	25	388	1	388	1145	3998	4490	2331	3956	3242	961	1962	935	4320
2203_IL17F - Interleukin-17F	2203_IL17F - Interleukin-17F	25	388	1	2983	923	388	3484	3157	2551	2162	4111	3091	452	3272
185_Waist-hip ratio (adjusted for BMI)	185_Waist-hip ratio (adjusted for BMI)	25	388	2	1120	4632	1076	388	1596	1033	3501	1370	1453	1548	3259
1157_Fasting glucose main effect (adjusted for BMI)	1157_Fasting glucose main effect (adjusted for BMI)	25	388	1	3487	4495	981	3041	388	4656	1279	2431	2423	4078	2741
2861_FGF7 - Fibroblast growth factor 7	2861_FGF7 - Fibroblast growth factor 7	25	388	1	950	2335	1497	2093	3990	388	2503	1688	2849	4442	1104
3220_Time spent using computer	3220_Time spent using computer	25	388	1	2445	1571	508	1585	953	2510	1054	3010	388	4196	1482
4007_Osteoarthritis of hip (hospital diagnosed)	4007_Osteoarthritis of hip (hospital diagnosed)	25	389	1	389	2474	2008	1792	3849	4377	3312	3285	4023	2721	2829
603_Peptide::gamma-glutamyl::gamma-glutamylisoleucine*	603_Peptide::gamma-glutamyl::gamma-glutamylisoleucine*	25	389	1	2984	1682	797	2707	389	409	2319	2804	2211	1689	2702
4671_Average across all tracts axial diusivities	4671_Average across all tracts axial diusivities	25	389	1	439	1952	2990	2385	556	389	2001	2252	1559	563	2573
3972_Total body BMD (60 or older)	3972_Total body BMD (60 or older)	25	389	1	3028	1588	2924	3031	3957	2674	506	1179	389	2469	3785
411_Amino acid::Urea cycle; arginine-, proline-, metabolism::arginine	411_Amino acid::Urea cycle; arginine-, proline-, metabolism::arginine	25	389	1	3337	1327	2780	4367	2510	1939	1102	1077	1587	389	4148
1923_Hippocampal volume (GEE, adjusted for age and sex)	1923_Hippocampal volume (GEE, adjusted for age and sex)	25	390	1	390	3096	607	3940	2201	2127	2508	3205	3411	4365	3456
1808_Total power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1808_Total power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	390	1	1503	3414	390	1875	4429	1122	4233	3391	3086	4600	3859
3040_AMHR2 - Anti-Muellerian hormone type-2 receptor	3040_AMHR2 - Anti-Muellerian hormone type-2 receptor	25	390	1	1482	1987	3335	3838	3591	390	4546	4384	3646	1218	2495
618_Xenobiotics::Benzoate metabolism::hippurate	618_Xenobiotics::Benzoate metabolism::hippurate	25	390	1	2273	507	2200	3447	1741	3568	2371	390	3672	1251	3568
2413_NRP1 - Neuropilin-1	2413_NRP1 - Neuropilin-1	25	390	1	2334	4076	4150	1581	3298	3569	1259	2904	2391	2595	390
4068_Automobile speeding propensity	4068_Automobile speeding propensity	25	391	1	391	1868	1413	3707	2218	1153	3111	2622	4306	4343	1447
291_CD4:%Act(DR+38+)	291_CD4:%Act(DR+38+)	25	391	1	1215	2465	3975	1613	391	2612	4205	3020	1730	4063	1227
3693_Diagnoses - secondary ICD10: I25 Chronic ischemic heart disease	3693_Diagnoses - secondary ICD10: I25 Chronic ischemic heart disease	25	391	1	3357	3476	4335	982	1765	391	2812	2347	2296	4317	2517
1567_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for age and sex)	1567_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for age and sex)	25	391	1	3583	3261	1668	1239	3711	2691	2985	1666	792	391	1523
2919_CMPK1 - UMP-CMP kinase	2919_CMPK1 - UMP-CMP kinase	25	392	1	4280	3917	4052	1700	392	4536	2837	4134	3222	2965	2575
4185_Cigarettes per day (excluding nonsmokers)	4185_Cigarettes per day (excluding nonsmokers)	25	393	1	1540	3021	4160	4305	1494	393	3744	1080	3501	2565	3472
3620_Treatment/medication code: amlodipine	3620_Treatment/medication code: amlodipine	25	393	1	3172	3689	2024	2908	1971	4124	4317	393	4022	4344	1472
2843_LRRTM1 - Leucine-rich repeat transmembrane neuronal protein 1	2843_LRRTM1 - Leucine-rich repeat transmembrane neuronal protein 1	25	394	1	1815	2062	3210	2945	394	4660	3923	2771	2163	4017	797
4461_Left pars orbitalis	4461_Left pars orbitalis	25	394	1	1130	1575	927	859	4547	394	3308	3572	4229	2822	3992
4011_Broad depression	4011_Broad depression	25	394	1	3893	937	3733	2108	3750	1386	4025	2924	2233	1697	394
1220_Mean Amygdala	1220_Mean Amygdala	25	395	1	2115	395	2071	1293	1536	4365	692	3765	642	754	4623
1263_Residual from predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	1263_Residual from predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	25	395	1	3132	1183	470	1462	3573	4293	565	1491	2150	1263	395
467_Lipid::Bile acid metabolism::glycocholate	467_Lipid::Bile acid metabolism::glycocholate	25	396	1	396	3316	1828	1730	4356	1834	4623	2863	3005	2921	4458
3919_Low-density lipoprotein cholesterol	3919_Low-density lipoprotein cholesterol	25	396	1	1441	1243	396	3836	632	1460	1547	3905	1266	3266	3599
452_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::heme*	452_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::heme*	25	396	1	4430	3248	636	2440	1123	4089	522	396	968	2536	1712
2635_TNF - Tumor necrosis factor	2635_TNF - Tumor necrosis factor	25	397	1	2464	4175	878	397	4110	1000	2052	3135	2492	2311	3329
1939_Hippocampal volume (GEE, adjusted for multivariable with APOE)	1939_Hippocampal volume (GEE, adjusted for multivariable with APOE)	25	397	1	1091	3090	2217	4639	3056	4142	397	849	2995	2399	2805
2604_MAP2K2 - Dual specificity mitogen-activated protein kinase kinase 2	2604_MAP2K2 - Dual specificity mitogen-activated protein kinase kinase 2	25	397	1	3984	1976	3270	3832	3876	2420	4226	397	2781	2577	4472
4222_Beta blocking agents	4222_Beta blocking agents	25	398	1	398	1718	3723	2147	2101	4454	1486	2254	2024	4190	2658
3736_Depression - Impact of normal roles during worst period of depression	3736_Depression - Impact of normal roles during worst period of depression	25	398	1	4182	3008	4682	398	3838	563	3261	1042	4520	2755	1424
3807_Neutrophil count	3807_Neutrophil count	25	398	1	1862	3624	1128	2390	398	1572	2231	2954	2793	4016	1835
754_::::X-12093	754_::::X-12093	25	398	1	2217	598	525	3553	3277	398	3393	4015	4387	1742	4708
663_::::X-04500	663_::::X-04500	25	398	1	2305	616	2346	2465	3953	2974	398	3327	2275	1341	4425
3669_Diagnoses - main ICD10: K21 Gastro-esophageal reflux disease	3669_Diagnoses - main ICD10: K21 Gastro-esophageal reflux disease	25	398	1	3998	3888	495	718	2364	4071	4447	3927	398	3478	3362
480_Lipid::Carnitine metabolism::decanoylcarnitine	480_Lipid::Carnitine metabolism::decanoylcarnitine	25	398	1	779	4008	2849	1761	3334	2727	4699	1226	3007	1092	398
2597_GNS - N-acetylglucosamine-6-sulfatase	2597_GNS - N-acetylglucosamine-6-sulfatase	25	399	1	3484	3064	399	4681	595	2357	2786	4504	3226	3778	3348
2312_JAM2 - Junctional adhesion molecule B	2312_JAM2 - Junctional adhesion molecule B	25	399	1	1169	3612	2777	4532	399	1425	3765	3448	4551	3807	4669
4481_Right inferior parietal	4481_Right inferior parietal	25	399	1	2539	4174	4055	2956	2581	399	3145	3058	4281	3827	516
3658_Cancer register - Type of cancer: ICD10: C44 Other and unspecified malignant neoplasm of skin	3658_Cancer register - Type of cancer: ICD10: C44 Other and unspecified malignant neoplasm of skin	25	400	1	2936	3515	2139	1577	1880	400	2825	3996	1720	3018	1139
2499_TBK1 - Serine/threonine-protein kinase TBK1	2499_TBK1 - Serine/threonine-protein kinase TBK1	25	400	1	1460	2287	2455	2866	2587	4123	1633	400	2736	2847	945
4702_Inferior fronto-occipital fasciculus mean diusivities	4702_Inferior fronto-occipital fasciculus mean diusivities	25	400	1	788	2111	1679	742	525	4308	4077	4411	3181	400	1011
854_ApoA1	854_ApoA1	25	401	1	1008	4373	401	3407	4590	4558	4583	4096	786	4154	1352
1096_Pulse pressure	1096_Pulse pressure	25	401	1	2725	4061	3658	401	3350	1157	3516	3303	4746	4628	2739
3978_Lean body mass (appendicular)	3978_Lean body mass (appendicular)	25	401	1	4548	1502	4381	2021	4526	3890	401	537	2051	1249	485
4626_Left hippocampus	4626_Left hippocampus	25	401	1	3510	2838	1409	1409	3148	1525	4084	401	3372	2992	995
522_Lipid::Long chain fatty acid::myristoleate (14:1n5)	522_Lipid::Long chain fatty acid::myristoleate (14:1n5)	25	402	1	873	482	2412	4703	2352	3727	474	3576	689	402	2999
3491_Cereal type: Muesli	3491_Cereal type: Muesli	25	402	1	1671	3865	4182	2692	1514	682	4213	1397	2874	4453	402
1240_Rate of decline of FEV1 (FBAT, adjusted for multiple covariates)	1240_Rate of decline of FEV1 (FBAT, adjusted for multiple covariates)	25	403	1	403	742	1589	3297	3587	783	873	1794	2295	2162	3843
497_Lipid::Fatty acid, dicarboxylate::2-hydroxyglutarate	497_Lipid::Fatty acid, dicarboxylate::2-hydroxyglutarate	25	403	1	1155	403	889	4263	635	3698	1193	2359	438	2285	3730
3567_Why stopped smoking: Illness or ill health	3567_Why stopped smoking: Illness or ill health	25	403	1	836	1914	4115	2600	963	403	3588	1110	4592	2884	2560
258_CD8mem:%CD31+	258_CD8mem:%CD31+	25	403	1	734	1687	430	3951	4621	504	403	1117	3199	1458	1653
4156_Epilepsy	4156_Epilepsy	25	403	1	3714	3815	961	1227	3583	1907	1750	403	4237	3093	2977
1367_Total cholesterol (at exam 5, GEE, adjusted for age and sex)	1367_Total cholesterol (at exam 5, GEE, adjusted for age and sex)	25	403	1	3076	1107	3096	4634	1700	1693	920	1661	2228	4194	403
1552_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1552_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	404	1	404	846	3148	2897	3016	4609	1036	3259	1701	1528	1530
1153_Insulin response to glucose duing the first 30 min (adjusted for BMI)	1153_Insulin response to glucose duing the first 30 min (adjusted for BMI)	25	404	1	1954	1689	1294	404	1265	3937	4416	3884	3236	2686	3510
1966_MMSE score (at age 65, FBAT, adjusted for multivariable)	1966_MMSE score (at age 65, FBAT, adjusted for multivariable)	25	404	1	4394	2754	1989	2914	1756	404	1779	4282	4623	2353	785
1065_Schizophrenia	1065_Schizophrenia	25	404	1	3935	2038	4194	2808	4635	4279	3302	4415	4674	404	3862
3426_Fluid intelligence test - FI3 : word interpolation	3426_Fluid intelligence test - FI3 : word interpolation	25	404	1	3568	4284	3584	3807	2974	1262	1656	2375	3008	2320	404
605_Peptide::gamma-glutamyl::gamma-glutamylmethionine*	605_Peptide::gamma-glutamyl::gamma-glutamylmethionine*	25	405	1	405	4260	4163	2313	1386	3090	3224	2141	4681	3412	3498
3333_Frequency of heavy DIY in last 4 weeks	3333_Frequency of heavy DIY in last 4 weeks	25	405	1	903	4552	405	2437	2373	4467	3155	4437	3474	2267	2993
3699_Diagnoses - secondary ICD10: K57 Diverticular disease of intestine	3699_Diagnoses - secondary ICD10: K57 Diverticular disease of intestine	25	405	1	1864	4074	1210	2379	2306	405	4244	4183	934	1907	2158
428_Amino acid::Valine, leucine and isoleucine metabolism::isobutyrylcarnitine	428_Amino acid::Valine, leucine and isoleucine metabolism::isobutyrylcarnitine	25	405	1	3503	3276	2856	4292	415	1401	2186	405	1648	2905	1242
719_::::X-11537	719_::::X-11537	25	405	1	1621	2070	2942	1594	3536	1385	3495	3945	3750	405	3933
788_::::X-12645	788_::::X-12645	25	406	1	406	3450	3691	678	1286	2965	831	4368	2594	3663	3073
3881_High light scatter percentage of red cells (three-way meta)	3881_High light scatter percentage of red cells (three-way meta)	25	406	1	2666	3730	406	2567	4255	2277	2666	953	3486	2055	2948
3607_Non-cancer illness code, self-reported: osteoarthritis	3607_Non-cancer illness code, self-reported: osteoarthritis	25	406	1	2186	3568	2193	406	4438	3064	589	1511	4386	1390	3598
2385_CTSC - Dipeptidyl peptidase 1	2385_CTSC - Dipeptidyl peptidase 1	25	406	1	807	4361	725	1311	406	3246	3081	1289	3249	3583	1825
41_Educational attainment	41_Educational attainment	25	406	1	832	3924	2233	4161	1401	1092	4160	420	1627	406	1744
2241_WIF1 - Wnt inhibitory factor 1	2241_WIF1 - Wnt inhibitory factor 1	25	407	1	407	3198	475	3247	3549	3641	1311	1244	3359	2072	1740
2558_IL17B - Interleukin-17B	2558_IL17B - Interleukin-17B	25	407	1	704	407	2408	3265	3050	575	619	1033	683	562	2031
2170_AIMP1 - Endothelial monocyte-activating polypeptide 2	2170_AIMP1 - Endothelial monocyte-activating polypeptide 2	25	407	1	1044	4643	2855	1140	1824	1635	2614	407	1526	2433	2987
140_Waist-hip ratio (male, adjusted for BMI)	140_Waist-hip ratio (male, adjusted for BMI)	25	408	1	1961	2119	408	1524	1236	2229	1058	4658	1846	2662	1973
3804_Mean corpuscular hemoglobin concentration	3804_Mean corpuscular hemoglobin concentration	25	408	1	1304	2351	1494	4182	408	3427	1930	3257	3396	2832	2691
2490_PAK7 - Serine/threonine-protein kinase PAK 7	2490_PAK7 - Serine/threonine-protein kinase PAK 7	25	408	1	3678	1437	1057	2371	3127	2897	408	1140	777	2996	4585
256_CD32 on 11c+123+DC	256_CD32 on 11c+123+DC	25	408	1	1280	4210	1282	1598	3317	3214	1602	2327	408	3874	3752
12_Schizophrenia/Bipolar disorder	12_Schizophrenia/Bipolar disorder	25	409	1	590	3087	409	985	2962	612	3114	3768	4640	2571	2054
1685_Brain natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	1685_Brain natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	25	409	1	2759	4281	4695	1836	409	2744	3994	1709	3301	1476	1560
3644_Illnesses of mother: High blood pressure	3644_Illnesses of mother: High blood pressure	25	409	1	1098	4486	938	3747	3411	3847	3764	3724	409	2916	3763
2029_Crohn's Disease	2029_Crohn's Disease	25	409	1	2325	4620	3212	1622	4027	1109	4664	1995	4331	1309	409
2738_HBEGF - Heparin-binding EGF-like growth factor	2738_HBEGF - Heparin-binding EGF-like growth factor	25	410	1	2673	600	4385	410	4030	3398	1218	1647	3463	3274	3756
2563_CCL22 - C-C motif chemokine 22	2563_CCL22 - C-C motif chemokine 22	25	410	1	4696	2700	4317	2094	410	4112	550	582	1070	4285	2884
4162_Focal Epilepsy, other lesion	4162_Focal Epilepsy, other lesion	25	410	1	4004	2803	2763	4573	1336	920	3243	2831	410	4342	4464
2266_IL4 - Interleukin-4	2266_IL4 - Interleukin-4	25	411	1	1082	2144	411	3390	2849	2631	2814	3194	1499	1602	1587
1997_MMSE score (at exam 7, GEE, adjusted for multivariable)	1997_MMSE score (at exam 7, GEE, adjusted for multivariable)	25	411	1	1810	2396	3327	650	411	4248	3042	1186	4539	3432	1513
1929_Temporal horn volume (GEE, adjusted for age and sex)	1929_Temporal horn volume (GEE, adjusted for age and sex)	25	411	1	3392	2969	3008	695	4640	411	933	4031	618	1945	1408
2100_LEP - Leptin	2100_LEP - Leptin	25	411	1	4636	986	4125	1390	1280	1935	411	2213	4069	2618	4257
4683_Posterior thalamic radiation (include optic radiation) axial diusivities	4683_Posterior thalamic radiation (include optic radiation) axial diusivities	25	411	1	1945	3857	3100	4582	2010	3154	2107	411	3083	3669	1611
1520_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	1520_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	25	411	1	2274	1395	1079	2189	2881	1624	3010	721	445	1847	411
2311_IL1RL2 - Interleukin-1 receptor-like 2	2311_IL1RL2 - Interleukin-1 receptor-like 2	25	412	1	412	3168	1240	2591	3927	2262	1539	2069	2905	3545	1685
4615_3rd ventricle	4615_3rd ventricle	25	412	1	2559	4654	4455	412	3946	2418	1313	619	3610	1542	2772
950_Tyrosine	950_Tyrosine	25	412	1	2791	4630	1944	1233	412	925	1263	1522	2837	421	2906
1513_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	1513_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	25	412	1	2244	2653	678	2904	1841	1057	2708	3222	412	1931	3064
4522_Left caudate	4522_Left caudate	25	412	1	764	3640	3938	624	3206	672	2066	3265	4635	3101	412
2088_CDH1 - Cadherin-1	2088_CDH1 - Cadherin-1	25	413	1	1343	2910	2741	413	472	893	2248	2464	4324	3460	4576
3490_Cereal type: Oat cereal (e.g. Ready Brek, porridge)	3490_Cereal type: Oat cereal (e.g. Ready Brek, porridge)	25	413	1	4740	4256	1236	4680	413	624	2096	2592	1998	3548	3133
2539_STK16 - Serine/threonine-protein kinase 16	2539_STK16 - Serine/threonine-protein kinase 16	25	413	1	2475	1972	3167	642	1927	2705	532	4498	413	768	3723
284_CD4:%Act(38+)	284_CD4:%Act(38+)	25	413	1	4635	1268	1304	2210	3111	3350	2965	2787	2145	413	2947
2494_AKT1 AKT2 AKT3 - Protein kinase B alpha/beta/gamma	2494_AKT1 AKT2 AKT3 - Protein kinase B alpha/beta/gamma	25	414	1	414	3134	2246	1405	1551	992	2161	1044	2999	1014	1535
2484_HCK - Tyrosine-protein kinase HCK	2484_HCK - Tyrosine-protein kinase HCK	25	414	1	957	2481	414	4336	2365	3701	2626	2733	2352	1413	2782
789_::::X-12680	789_::::X-12680	25	414	1	2702	1281	966	414	1390	3636	1666	4078	1131	1429	3565
2974_ANXA1 - Annexin A1	2974_ANXA1 - Annexin A1	25	414	1	4610	2562	2231	3998	2172	414	2043	1744	4458	1367	4734
993_Interleukin-6	993_Interleukin-6	25	414	1	2262	1080	1127	3776	981	3617	414	3082	974	1808	4722
1156_Fasting glucose main effect	1156_Fasting glucose main effect	25	415	1	2447	4331	415	2426	1024	4332	1327	2233	900	4099	2457
3735_Depression - Frequency of depressed days during worst episode of depression	3735_Depression - Frequency of depressed days during worst episode of depression	25	415	1	4355	2429	4174	415	3859	4574	4282	2396	2401	2696	2684
4714_Anterior limb of internal capsule mode of anisotropy	4714_Anterior limb of internal capsule mode of anisotropy	25	415	1	2537	2732	2802	543	992	3981	808	415	2926	415	3885
4533_Right cerebellum white matter	4533_Right cerebellum white matter	25	415	1	3531	1616	2799	880	2265	3099	1047	4439	1848	3046	415
3454_Impedance measures - Leg fat-free mass (right)	3454_Impedance measures - Leg fat-free mass (right)	25	416	2	3286	416	2960	470	3560	1161	525	2598	3914	4496	4272
3666_Diagnoses - main ICD10: D12 Benign neoplasm of colon, rectum, anus and anal canal	3666_Diagnoses - main ICD10: D12 Benign neoplasm of colon, rectum, anus and anal canal	25	416	1	2223	526	416	2153	4745	2979	4210	3911	861	1572	2903
3486_Bread type: Brown	3486_Bread type: Brown	25	416	1	1746	1220	3057	416	3952	2271	4268	4594	3827	2414	1477
196_Estimated glomerular filtration rate based on serum creatinine	196_Estimated glomerular filtration rate based on serum creatinine	25	416	1	4364	1884	2153	2955	416	3744	2331	4625	4629	1714	3065
4038_Schizophrenia	4038_Schizophrenia	25	416	1	2131	672	4008	2023	4592	2549	416	2882	4092	843	4184
2947_PPP3CA PPP3R1 - Calcineurin	2947_PPP3CA PPP3R1 - Calcineurin	25	416	1	4278	3201	3888	1435	2579	1380	2798	4718	953	3557	416
4169_Open-angle glaucoma (random-effect model)	4169_Open-angle glaucoma (random-effect model)	25	417	1	417	768	1910	2226	772	665	1998	3937	1107	3518	4212
390_Amino acid::Lysine metabolism::pipecolate	390_Amino acid::Lysine metabolism::pipecolate	25	417	1	3336	2656	2171	4584	417	4000	4257	3478	3462	690	3626
4383_Epithelial ovarian cancer (high-grade serous)	4383_Epithelial ovarian cancer (high-grade serous)	25	417	1	4692	4105	2747	4281	1443	417	3505	4025	2587	1993	1982
2761_CFH - Complement factor H	2761_CFH - Complement factor H	25	417	1	1738	2753	1488	4425	894	2711	4031	4369	1976	417	866
4340_Walking (conditioning sex and BMI)	4340_Walking (conditioning sex and BMI)	25	418	1	2021	2418	775	1928	3903	1822	1198	418	829	3126	3792
2149_CAPN1 CAPNS1 - Calpain I	2149_CAPN1 CAPNS1 - Calpain I	25	418	1	1681	738	1049	2247	1976	1925	1442	3671	1054	418	4551
2352_C9 - Complement component C9	2352_C9 - Complement component C9	25	418	1	1783	3311	2065	2601	2236	3307	2917	1143	3791	4462	418
2415_SERPINE2 - Glia-derived nexin	2415_SERPINE2 - Glia-derived nexin	25	419	1	501	419	1091	2017	1367	3026	2681	3000	2876	1422	1406
4573_Left superior temporal	4573_Left superior temporal	25	419	1	3628	821	2219	1372	3400	1268	4495	1951	4147	655	419
2707_CDC37 - Hsp90 co-chaperone Cdc37	2707_CDC37 - Hsp90 co-chaperone Cdc37	25	420	1	420	2841	2278	3661	2613	2042	3086	4190	3158	2570	966
3650_Illnesses of siblings: Breast cancer	3650_Illnesses of siblings: Breast cancer	25	420	1	1792	921	1875	2887	749	3037	420	646	494	2598	2663
4215_Estimated glomerular filtration rate	4215_Estimated glomerular filtration rate	25	421	1	421	840	1743	2323	809	3722	943	1935	2200	2293	3184
3136_SHC1 - SHC-transforming protein 1	3136_SHC1 - SHC-transforming protein 1	25	421	1	2236	421	4147	3743	1460	4559	520	2434	3557	1410	3996
4171_Loneliness	4171_Loneliness	25	421	1	2628	1770	421	721	4000	593	4356	2510	3195	1744	679
2488_LYN - Tyrosine-protein kinase Lyn, isoform B	2488_LYN - Tyrosine-protein kinase Lyn, isoform B	25	421	1	1677	2693	4738	3078	421	2870	4411	4359	2554	3621	1479
969_Total lipids in chylomicrons and extremely large VLDL	969_Total lipids in chylomicrons and extremely large VLDL	25	421	1	2461	1999	1000	2526	896	421	1252	1479	454	1286	1761
2822_INHBA INHBB - Inhibin beta A chain:Inhibin beta B chain heterodimer	2822_INHBA INHBB - Inhibin beta A chain:Inhibin beta B chain heterodimer	25	421	1	3023	1608	2420	503	3606	3198	1108	1434	2143	1756	421
611_Peptide::Polypeptide::HWESASXX*	611_Peptide::Polypeptide::HWESASXX*	25	422	1	422	4444	2101	2138	1814	531	3955	2494	4277	3628	2184
10_Schizophrenia	10_Schizophrenia	25	422	1	3507	422	2359	4272	3486	2172	2029	3615	3327	1924	3579
2380_ARSB - Arylsulfatase B	2380_ARSB - Arylsulfatase B	25	422	1	2008	2790	2499	422	1715	1052	863	1591	2810	1445	4481
2675_MATK - Megakaryocyte-associated tyrosine-protein kinase	2675_MATK - Megakaryocyte-associated tyrosine-protein kinase	25	422	1	2931	3658	4260	812	422	520	4139	1975	4361	1928	4400
1138_Mother's age at death	1138_Mother's age at death	25	422	1	3346	3126	3187	3969	971	422	3455	3959	4357	4399	2830
3629_Illnesses of father: Stroke	3629_Illnesses of father: Stroke	25	422	1	3802	1798	2255	4507	2817	4025	422	3778	840	2549	4312
1023_Neck Cross-Sectional Moment of Inertia (GEE)	1023_Neck Cross-Sectional Moment of Inertia (GEE)	25	422	1	759	1785	696	517	795	2129	665	1038	422	3553	3710
1275_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	1275_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	25	422	1	532	943	620	2231	2866	4450	1838	1558	4395	422	1703
2091_GFRA2 - GDNF family receptor alpha-2	2091_GFRA2 - GDNF family receptor alpha-2	25	422	1	4132	2889	3742	2061	538	1280	4378	2179	4555	1770	422
2733_CFB - Complement factor B	2733_CFB - Complement factor B	25	423	1	1305	1358	2779	2075	423	3545	1699	3524	1138	4481	2774
4022_Eyebrows	4022_Eyebrows	25	423	1	4465	4613	1104	3909	1032	423	3459	3296	3420	4434	2538
374_Amino acid::Glutamate metabolism::glutamate	374_Amino acid::Glutamate metabolism::glutamate	25	423	1	3974	4081	2480	1327	3939	790	423	3064	1571	3441	4460
1345_Plasma Apolipoprotein A-I level (GEE, multivariate adjusted)	1345_Plasma Apolipoprotein A-I level (GEE, multivariate adjusted)	25	423	1	1829	1109	3257	3918	730	542	3048	3696	3971	633	423
359_mDC:%64-274-	359_mDC:%64-274-	25	424	1	2442	424	3875	2318	3969	1591	1466	4021	1987	4440	3854
448_Cofactors and vitamins::Ascorbate and aldarate metabolism::threonate	448_Cofactors and vitamins::Ascorbate and aldarate metabolism::threonate	25	424	1	708	1705	424	3374	4739	1628	3868	2271	3082	481	4727
2270_TNFSF11 - Tumor necrosis factor ligand superfamily member 11	2270_TNFSF11 - Tumor necrosis factor ligand superfamily member 11	25	424	1	702	4571	2643	4535	424	4273	4003	2989	2691	3842	1215
3969_Asthma (random effect model)	3969_Asthma (random effect model)	25	424	1	3734	680	486	3452	1570	650	758	1997	3464	764	424
1264_Residual from predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	1264_Residual from predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	25	425	1	943	1950	4450	540	425	1912	785	3815	3248	1641	1226
4738_Body of corpus callosum radial diusivities	4738_Body of corpus callosum radial diusivities	25	425	1	1314	4301	3037	3467	1872	1824	425	3432	3950	3509	665
119_Extreme Waist-hip ratio (adjusted for BMI)	119_Extreme Waist-hip ratio (adjusted for BMI)	25	425	1	1303	2340	1382	3019	2496	3676	3446	4690	2372	425	2192
1741_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for multivariable)	1741_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for multivariable)	25	425	1	4221	1242	2969	1187	1982	568	782	954	457	1952	425
3472_Age at cancer diagnosis	3472_Age at cancer diagnosis	25	426	1	426	1214	2837	1687	1630	3601	3428	2617	3352	1157	1951
4518_Left inferior lateral ventricle	4518_Left inferior lateral ventricle	25	426	1	1137	1349	2600	1146	426	2330	2391	2639	2626	3260	3365
4400_Menstruation quality of life impact: Edema	4400_Menstruation quality of life impact: Edema	25	426	1	1848	2234	4180	3411	562	2374	426	902	3155	1354	2315
1098_Body Mass Index - Birth cohorts	1098_Body Mass Index - Birth cohorts	25	426	1	3427	1252	2399	3275	1806	1413	1230	621	1347	1330	426
1180_Insomnia (female)	1180_Insomnia (female)	25	427	1	427	4426	1708	2162	2825	4187	3269	4459	3131	3611	1690
580_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::hypoxanthine	580_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::hypoxanthine	25	427	1	2296	2415	1780	427	2641	2672	4008	4225	2451	2615	2598
2409_MEPE - Matrix extracellular phosphoglycoprotein	2409_MEPE - Matrix extracellular phosphoglycoprotein	25	427	1	3963	2491	3877	3677	427	3441	4339	4694	4426	2271	2512
14_Posttraumatic stress disorder	14_Posttraumatic stress disorder	25	427	1	498	1143	3396	3922	3327	427	693	1471	1563	2098	1881
4346_Coronary artery disease and triglyceride (bivariate)	4346_Coronary artery disease and triglyceride (bivariate)	25	427	1	3576	3898	1812	4476	2901	679	650	3165	427	3565	3412
3935_Disialylation	3935_Disialylation	25	427	1	1732	4437	4409	2495	944	2749	1306	1255	2791	427	1370
4287_FVC	4287_FVC	25	428	1	1432	428	789	3651	2293	3560	3366	4249	1319	2233	2260
1425_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1425_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	428	1	4330	3660	1670	1511	2429	2005	428	1470	2100	1381	611
3746_Happiness and subjective well-being - General happiness with own health	3746_Happiness and subjective well-being - General happiness with own health	25	428	1	4686	4685	1366	3048	1258	2950	980	428	3504	4557	3016
2189_C3 - Complement C3	2189_C3 - Complement C3	25	428	1	860	2133	845	1998	2023	2259	1804	4440	1294	428	1857
2328_CLEC4M - C-type lectin domain family 4 member M	2328_CLEC4M - C-type lectin domain family 4 member M	25	428	1	2831	1247	674	1016	877	1046	1803	1139	3690	2153	428
626_Xenobiotics::Drug::metoprolol acid metabolite*	626_Xenobiotics::Drug::metoprolol acid metabolite*	25	429	1	429	1263	3514	3666	2804	3447	2495	2305	4333	1109	4454
1151_Disposition index	1151_Disposition index	25	429	1	1551	1535	2130	429	4314	1031	1825	3614	4070	1295	4287
1105_Systolic Blood Pressure - Birth cohorts	1105_Systolic Blood Pressure - Birth cohorts	25	429	1	3842	2877	4137	2419	429	4212	2920	3164	3600	3463	2568
3917_Adiponectin	3917_Adiponectin	25	429	1	921	4346	935	753	4241	429	3189	853	2331	3739	3976
1481_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for multivariable)	1481_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for multivariable)	25	429	1	4209	510	1155	3741	1641	3496	455	3314	1805	3090	429
1051_Parkinson disease (tier 2b)	1051_Parkinson disease (tier 2b)	25	430	1	1450	1205	1765	2504	3867	3961	430	1399	1888	4304	1341
3172_NPPA - Atrial natriuretic factor	3172_NPPA - Atrial natriuretic factor	25	430	1	2089	3380	1164	4608	884	2709	3117	2802	1738	1206	430
3240_Cooked vegetable intake	3240_Cooked vegetable intake	25	431	1	431	1677	1402	1532	4164	4247	1508	2026	1164	575	2688
1630_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for age and sex)	1630_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for age and sex)	25	431	1	985	3882	431	2571	3538	2121	3908	1998	3516	3610	1146
4715_Average across all tracts mode of anisotropy	4715_Average across all tracts mode of anisotropy	25	431	1	1823	1828	2269	4072	431	4479	2901	2717	489	678	737
4657_Genu of corpus callosum fractional anisotropy	4657_Genu of corpus callosum fractional anisotropy	25	431	1	4701	607	2143	1845	870	1493	433	888	431	738	1282
2624_KLK14 - Kallikrein-14	2624_KLK14 - Kallikrein-14	25	432	1	3266	4190	432	3202	2447	3390	3337	2996	2349	3756	2475
3616_Treatment/medication code: omeprazole	3616_Treatment/medication code: omeprazole	25	432	1	3662	1029	4478	432	1523	3470	776	1430	2883	2112	1131
431_Amino acid::Valine, leucine and isoleucine metabolism::leucine	431_Amino acid::Valine, leucine and isoleucine metabolism::leucine	25	432	1	3201	2321	3743	2925	432	1665	3727	3771	2897	3444	3716
777_Lipid::Long chain fatty acid::X-12442--5,8-tetradecadienoate	777_Lipid::Long chain fatty acid::X-12442--5,8-tetradecadienoate	25	432	1	3612	4016	2027	3911	2795	432	4472	2814	3282	3762	959
2877_COL23A1 - Collagen alpha-1(XXIII) chain	2877_COL23A1 - Collagen alpha-1(XXIII) chain	25	432	1	1370	1658	4726	756	3753	3512	432	1882	2285	2184	2890
2582_CDH6 - Cadherin-6	2582_CDH6 - Cadherin-6	25	433	1	3315	4580	1926	433	1958	3989	4039	3604	4461	2650	4196
3598_Non-cancer illness code, self-reported: angina	3598_Non-cancer illness code, self-reported: angina	25	433	1	4584	1667	3077	2049	694	433	3510	2530	2525	2108	2580
4575_Left transverse temporal	4575_Left transverse temporal	25	433	1	1546	1645	2435	2537	2862	1594	3576	3422	3886	433	1880
1542_White matter hyperintensity volume (FBAT, adjusted for age and sex)	1542_White matter hyperintensity volume (FBAT, adjusted for age and sex)	25	433	1	3479	2585	1557	1034	3181	1229	4360	1560	3427	4123	433
1469_Lipoprotein A (at exam 3, GEE, adjusted for multivariable)	1469_Lipoprotein A (at exam 3, GEE, adjusted for multivariable)	25	434	1	434	1085	4657	3105	1761	3338	1627	4434	1030	994	3888
2297_CNTN1 - Contactin-1	2297_CNTN1 - Contactin-1	25	434	1	3418	4251	434	1152	1268	2885	3709	4422	3324	932	3311
1779_Heart failure (censored at interval MI, GEE, adjusted for multivariable)	1779_Heart failure (censored at interval MI, GEE, adjusted for multivariable)	25	434	1	1612	1720	2396	1420	434	1244	3009	2573	2239	2155	662
2474_CDK8 CCNC - Cyclin-dependent kinase 8:Cyclin-C complex	2474_CDK8 CCNC - Cyclin-dependent kinase 8:Cyclin-C complex	25	434	1	4233	3421	2078	3765	3057	434	3885	1001	3469	1858	1060
88_Type 2 Diabetes	88_Type 2 Diabetes	25	434	1	4040	755	1224	3384	2693	1724	2070	4237	3048	434	2515
1316_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age and sex)	1316_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age and sex)	25	434	1	1165	1777	3611	1013	986	1265	4408	2147	2227	987	434
2769_AKR7A2 - Aflatoxin B1 aldehyde reductase member 2	2769_AKR7A2 - Aflatoxin B1 aldehyde reductase member 2	25	435	1	435	4030	3162	2006	3937	3277	4183	2230	2537	2792	3291
2878_PPBP - Connective tissue-activating peptide III	2878_PPBP - Connective tissue-activating peptide III	25	435	1	1620	3786	435	3427	1921	4491	2486	4745	2220	3814	2393
3587_Types of physical activity in last 4 weeks: Strenuous sports	3587_Types of physical activity in last 4 weeks: Strenuous sports	25	436	1	2183	1634	3634	512	2545	3315	436	3827	2400	2631	3056
141_Waist-hip ratio (female, adjusted for BMI)	141_Waist-hip ratio (female, adjusted for BMI)	25	436	1	3486	1507	3964	2549	1242	3364	2160	436	599	2361	1130
1814_Femoral Neck BMD (FBAT, female, adjusted for multivariable)	1814_Femoral Neck BMD (FBAT, female, adjusted for multivariable)	25	437	1	3125	2404	1025	437	853	2369	2061	593	1586	2502	4421
875_Glycoprotein acetyls, mainly a1Lacid glycoprotein	875_Glycoprotein acetyls, mainly a1Lacid glycoprotein	25	437	1	2013	3324	2943	3136	437	1869	3174	903	686	1987	4013
4577_Right caudal anterior cingulate	4577_Right caudal anterior cingulate	25	437	1	1289	1576	2764	3148	3820	2451	1542	1091	1013	437	3273
48_Age at first birth (female)	48_Age at first birth (female)	25	437	1	1255	3376	3687	681	2349	2923	3442	2430	2520	2325	437
4470_Left superior frontal	4470_Left superior frontal	25	438	1	3615	1348	3041	438	3609	2311	1938	901	2091	1563	4616
2479_CTSV - Cathepsin L2	2479_CTSV - Cathepsin L2	25	438	1	2290	1740	1964	2356	438	2149	2904	657	2137	1279	1389
978_Growth regulated oncogene (CXCL1)	978_Growth regulated oncogene (CXCL1)	25	438	1	2444	3967	1919	3599	932	438	2534	753	4468	2735	4349
2136_MST1R - Macrophage-stimulating protein receptor	2136_MST1R - Macrophage-stimulating protein receptor	25	438	1	3026	4579	4655	2104	1897	1723	4108	438	3416	2730	633
1376_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	1376_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	25	438	1	4745	1014	3948	3179	4478	1691	3077	3447	2855	438	1486
3835_Basophil percentage of granulocytes (two-way meta)	3835_Basophil percentage of granulocytes (two-way meta)	25	439	1	4048	1172	483	2899	2100	439	1722	1411	3597	2378	3284
251_CD27 on CD8 T	251_CD27 on CD8 T	25	439	1	4674	963	4581	2936	4141	2484	439	4007	4699	2372	1729
2066_PROK1 - Prokineticin-1	2066_PROK1 - Prokineticin-1	25	439	1	1554	3079	1161	1458	2206	2695	2332	439	4142	3059	1774
2094_HMGB1 - High mobility group protein B1	2094_HMGB1 - High mobility group protein B1	25	439	1	1418	2777	671	3719	2715	4153	1798	2203	1565	1666	439
400_Amino acid::Phenylalanine & tyrosine metabolism::phenyllactate (PLA)	400_Amino acid::Phenylalanine & tyrosine metabolism::phenyllactate (PLA)	25	440	1	3352	1055	2704	3095	767	713	440	2459	3189	2641	2709
3960_Gestational weight gain (maternal, total)	3960_Gestational weight gain (maternal, total)	25	440	1	2944	2799	709	598	1407	1838	2600	3770	3270	3246	440
3504_Non-butter spread type details: Flora Pro-Active or Benecol	3504_Non-butter spread type details: Flora Pro-Active or Benecol	25	441	1	770	1871	441	4271	1449	3574	942	2939	1017	4070	4531
2153_HGF - Hepatocyte growth factor	2153_HGF - Hepatocyte growth factor	25	441	1	2995	2677	3218	441	3652	1584	2216	3557	4134	1603	2063
2144_MAPT - Microtubule-associated protein tau	2144_MAPT - Microtubule-associated protein tau	25	441	1	4495	1592	3035	3975	2176	2298	1049	441	4053	3457	3998
3546_Mouth/teeth dental problems: Bleeding gums	3546_Mouth/teeth dental problems: Bleeding gums	25	442	1	442	877	4473	1510	1037	2681	648	3799	619	2093	4111
2672_MAPKAPK2 - MAP kinase-activated protein kinase 2	2672_MAPKAPK2 - MAP kinase-activated protein kinase 2	25	442	1	2750	3940	1435	442	2592	1117	3139	586	597	1526	1142
355_IgG+B:%27+	355_IgG+B:%27+	25	442	1	3071	571	4561	1935	2283	2050	2485	2096	1345	442	4239
1626_Interleukin 6 (at exam 7, FBAT, adjusted for age and sex)	1626_Interleukin 6 (at exam 7, FBAT, adjusted for age and sex)	25	442	1	2502	2652	1942	836	3798	2209	1559	2496	893	1254	442
3696_Diagnoses - secondary ICD10: K21 Gastro-esophageal reflux disease	3696_Diagnoses - secondary ICD10: K21 Gastro-esophageal reflux disease	25	443	1	443	3552	3106	2357	2443	571	772	693	1649	1438	4207
3249_Lamb/mutton intake	3249_Lamb/mutton intake	25	443	1	729	2997	1379	3877	2564	2878	1693	443	3872	2697	1425
4258_Facial attractiveness (male-coder, male samples)	4258_Facial attractiveness (male-coder, male samples)	25	444	1	444	2093	2282	1545	1735	1934	3447	2612	2477	1320	3131
3364_Age last used hormone-replacement therapy (HRT) (female)	3364_Age last used hormone-replacement therapy (HRT) (female)	25	445	1	4015	2810	445	562	4234	1285	3234	3565	1870	2891	2208
2875_CDON - Cell adhesion molecule-related/down-regulated by oncogenes	2875_CDON - Cell adhesion molecule-related/down-regulated by oncogenes	25	445	1	658	1420	4164	445	1600	2016	3910	4130	1551	2254	1899
188_Waist-hip ratio (male, adjusted for BMI)	188_Waist-hip ratio (male, adjusted for BMI)	25	445	1	2582	3019	2313	1359	445	1821	4716	2146	1579	1119	4620
1377_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	1377_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	25	445	1	3379	3161	2632	2415	1652	445	3444	3149	2142	1831	2327
1018_Lumbar Spine BMD (FBAT, adjusted for multivariable)	1018_Lumbar Spine BMD (FBAT, adjusted for multivariable)	25	445	1	3198	945	523	784	1250	493	4571	1740	838	445	1171
3510_Reason for reducing amount of alcohol drunk: Health precaution	3510_Reason for reducing amount of alcohol drunk: Health precaution	25	446	1	446	606	454	3156	4653	2713	1463	2475	3140	1774	2182
3864_Red blood cell count (two-way meta)	3864_Red blood cell count (two-way meta)	25	446	1	4481	1351	2211	446	4673	2552	2008	4661	2641	2939	1713
1254_Percent predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	1254_Percent predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	25	446	1	1727	3761	3508	813	446	2669	1288	1086	1835	3881	1646
1402_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for multivariable)	1402_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for multivariable)	25	446	1	1993	910	1890	2989	504	810	1118	1888	446	1652	1186
3901_Red cell distribution width (three-way meta)	3901_Red cell distribution width (three-way meta)	25	446	1	3253	3297	4286	3797	4033	3771	1269	780	3906	446	2045
3380_Systolic Blood Pressure (automated reading)	3380_Systolic Blood Pressure (automated reading)	25	447	1	447	3647	2619	2337	2858	3557	4292	3382	1839	2538	2452
1218_Alcohol consumption (dichotomous, female)	1218_Alcohol consumption (dichotomous, female)	25	447	1	544	3555	786	4225	4711	1858	447	3805	3141	1070	2533
4667_Sagittal stratum fractional anisotropy	4667_Sagittal stratum fractional anisotropy	25	448	1	3054	3602	1941	1364	448	3254	987	4286	1759	1365	1230
289_CD4:%Act(25+127+)	289_CD4:%Act(25+127+)	25	448	1	2902	1013	3405	1038	585	448	3682	3401	1863	3006	1005
221_T:%Vg9+Vd2-low	221_T:%Vg9+Vd2-low	25	448	1	535	3809	2102	4695	889	2633	2698	2965	448	4477	2323
3012_MAPK13 - Mitogen-activated protein kinase 13	3012_MAPK13 - Mitogen-activated protein kinase 13	25	448	1	2978	1019	2522	4002	2521	3514	1787	2792	2266	448	2166
2802_NAPA - Alpha-soluble NSF attachment protein	2802_NAPA - Alpha-soluble NSF attachment protein	25	448	1	553	4683	4523	493	4014	3009	1642	2318	1384	1930	448
3313_Hearing difficulty/problems	3313_Hearing difficulty/problems	25	449	1	449	4477	3795	1476	841	759	1233	4076	1344	2128	1009
1638_Myeloperoxidase (at exam 7, FBAT, adjusted for age and sex)	1638_Myeloperoxidase (at exam 7, FBAT, adjusted for age and sex)	25	449	1	3671	2835	832	2150	449	1797	1916	4585	3531	3109	2183
899_Cholesterol esters in large VLDL	899_Cholesterol esters in large VLDL	25	449	1	3374	1524	516	2174	2857	449	2530	3923	738	4473	2369
3812_CD3+ T cell level	3812_CD3+ T cell level	25	449	1	1524	557	1517	2192	4424	3169	449	1129	3096	541	4121
2587_CHL1 - Neural cell adhesion molecule L1-like protein	2587_CHL1 - Neural cell adhesion molecule L1-like protein	25	449	1	4328	4625	1047	1992	677	2822	4744	2710	1456	2787	449
4376_Hypothyroidism	4376_Hypothyroidism	25	450	1	892	3247	450	2613	2199	2999	2895	2743	4288	2673	4012
4262_Facial attractiveness (female-coder, female samples)	4262_Facial attractiveness (female-coder, female samples)	25	450	1	1767	869	1285	986	2503	1273	963	450	549	1618	4714
2668_FYN - Tyrosine-protein kinase Fyn	2668_FYN - Tyrosine-protein kinase Fyn	25	450	1	571	2936	4514	3928	2307	2587	4040	2014	450	4067	3740
2262_CTF1 - Cardiotrophin-1	2262_CTF1 - Cardiotrophin-1	25	450	1	845	3010	1865	462	788	3507	3725	4702	1023	450	3496
2935_VEGFA - Vascular endothelial growth factor A, isoform 121	2935_VEGFA - Vascular endothelial growth factor A, isoform 121	25	451	1	1600	740	451	4293	4463	3368	676	1230	912	3500	1024
2370_DIABLO - Diablo homolog, mitochondrial	2370_DIABLO - Diablo homolog, mitochondrial	25	451	1	2857	2613	2326	3176	451	2358	1605	3551	3288	3086	2665
4295_Morning person (binary)	4295_Morning person (binary)	25	451	1	4457	1376	1204	1415	4447	1197	2153	451	4481	1892	1013
1080_Prostate cancer	1080_Prostate cancer	25	452	1	452	1037	1167	3055	3943	2789	4217	841	3618	939	1449
1934_Temporal brain volume (FBAT, adjusted for age and sex)	1934_Temporal brain volume (FBAT, adjusted for age and sex)	25	452	1	3476	3383	544	2315	452	2921	970	651	4346	4730	805
3622_Treatment/medication code: cod liver oil capsule	3622_Treatment/medication code: cod liver oil capsule	25	452	1	3399	2494	3962	2205	2459	452	3422	2737	3880	4244	504
2124_Human-virus - Protein E7_HPV16	2124_Human-virus - Protein E7_HPV16	25	453	1	3858	931	453	4446	2248	2468	1571	1512	886	4314	2603
600_Peptide::Fibrinogen cleavage peptide::DSGEGDFXAEGGGVR*	600_Peptide::Fibrinogen cleavage peptide::DSGEGDFXAEGGGVR*	25	453	1	1998	2377	2809	453	2650	4091	1945	4128	2804	3411	2941
1444_Low-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	1444_Low-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	25	453	1	1539	4335	4382	3628	4651	453	4254	2196	2766	2676	2566
1831_Neck length (GEE, female, adjusted for multivariable)	1831_Neck length (GEE, female, adjusted for multivariable)	25	453	1	3983	2538	2877	3703	1186	3130	453	2070	4115	531	4440
944_Triglycerides in small VLDL	944_Triglycerides in small VLDL	25	453	1	2773	4523	2135	4137	2691	1814	2197	3341	453	2546	3027
1209_FVC	1209_FVC	25	454	1	3312	3554	3758	454	3226	3434	4451	3859	2632	4676	2287
1315_HOMA-IR (at exam 7, GEE, adjusted for age and sex)	1315_HOMA-IR (at exam 7, GEE, adjusted for age and sex)	25	454	1	3763	3833	944	3238	454	2794	4553	3849	4469	1234	1256
68_Crohn's Disease	68_Crohn's Disease	25	454	1	2246	2216	2996	2322	3688	454	1314	778	3451	767	1364
4560_Left paracentral	4560_Left paracentral	25	454	1	2387	1455	2394	1234	661	1898	454	1167	1333	2336	4014
4129_White blood cell count	4129_White blood cell count	25	454	1	4689	2263	1587	4311	2108	1180	4305	4449	3945	454	2996
1008_Stem cell growth factor beta	1008_Stem cell growth factor beta	25	455	1	1148	455	2558	777	1516	1669	2322	1658	785	3071	1579
2065_PLAT - Tissue-type plasminogen activator	2065_PLAT - Tissue-type plasminogen activator	25	455	1	610	2802	1150	2060	455	2433	1034	3386	2635	4738	3312
4617_Optic chiasm	4617_Optic chiasm	25	456	1	456	3306	3051	4112	1187	3642	2686	1890	4348	2120	2817
1127_Visceral adipose tissue sttenutation (male)	1127_Visceral adipose tissue sttenutation (male)	25	456	1	1331	2546	1298	3056	456	1631	3894	1787	1954	574	3053
91_Childhood obesity	91_Childhood obesity	25	456	1	1170	3784	2555	2448	2069	3068	456	798	1238	1703	4044
4230_Opioids	4230_Opioids	25	456	1	2823	1291	3390	3816	4369	1216	3309	1400	464	4709	456
2705_ASGR1 - Asialoglycoprotein receptor 1	2705_ASGR1 - Asialoglycoprotein receptor 1	25	457	1	1914	2801	457	3140	3708	2756	4022	4547	1601	4258	2034
132_Waist circumference (male)	132_Waist circumference (male)	25	457	1	475	2244	3705	911	4047	457	3541	4222	3009	3671	807
4276_Carpal tunnel syndrome	4276_Carpal tunnel syndrome	25	458	1	458	3523	2209	4452	2416	3106	2649	3049	4535	1294	2617
2924_TXNDC12 - Thioredoxin domain-containing protein 12	2924_TXNDC12 - Thioredoxin domain-containing protein 12	25	458	1	2384	3989	458	2090	3440	2994	1451	2414	688	3013	4706
3330_Fractured/broken bones in last 5 years	3330_Fractured/broken bones in last 5 years	25	458	1	4406	951	4471	458	1243	3056	1048	2840	2280	1587	3755
3773_Anxiety - Recent worrying too much about different things	3773_Anxiety - Recent worrying too much about different things	25	458	1	2450	3748	1338	1046	3447	458	3877	868	1085	4146	2736
2729_AGER - Advanced glycosylation end product-specific receptor, soluble	2729_AGER - Advanced glycosylation end product-specific receptor, soluble	25	458	1	3723	3381	2036	1280	2370	1970	1291	458	3412	3384	992
1500_Triglycerides (at exam 2, FBAT, adjusted for age and sex)	1500_Triglycerides (at exam 2, FBAT, adjusted for age and sex)	25	458	1	1250	550	4686	920	1984	3925	2375	1095	458	522	1575
2391_C2 - Complement C2	2391_C2 - Complement C2	25	458	1	1333	2445	3313	1461	3213	483	4202	2454	1561	3648	458
2250_KPNA2 - Importin subunit alpha-1	2250_KPNA2 - Importin subunit alpha-1	25	459	1	2509	459	683	3271	2554	2990	3859	2816	2562	1568	653
3559_Medication for pain relief, constipation, heartburn: Paracetamol	3559_Medication for pain relief, constipation, heartburn: Paracetamol	25	459	1	880	3035	4737	983	1511	459	4255	4299	1891	656	1128
2162_PSPN - Persephin	2162_PSPN - Persephin	25	459	1	3432	2102	1945	2312	2823	614	3225	3490	2703	1131	459
2280_GHR - Growth hormone receptor	2280_GHR - Growth hormone receptor	25	460	1	1186	3941	2325	460	3457	3238	3843	479	4089	3047	1275
3997_Worrier / anxious feelings (WORRY)	3997_Worrier / anxious feelings (WORRY)	25	461	1	738	1506	461	2617	4215	4304	1312	1063	846	2751	2990
463_Energy::Oxidative phosphorylation::phosphate	463_Energy::Oxidative phosphorylation::phosphate	25	461	1	1291	2192	1031	2593	1906	2663	461	4220	2260	4590	2695
4682_Posterior limb of internal capsule axial diusivities	4682_Posterior limb of internal capsule axial diusivities	25	461	1	3826	3326	1891	1014	1798	3778	3823	2858	461	4509	4429
3878_Granulocyte percentage of myeloid white cells (three-way meta)	3878_Granulocyte percentage of myeloid white cells (three-way meta)	25	461	1	2316	1149	1469	3896	1638	2480	3579	899	3650	461	3435
3404_Fluid intelligence test - FI6 : conditional arithmetic	3404_Fluid intelligence test - FI6 : conditional arithmetic	25	461	1	3178	3118	3368	2970	1834	3899	2787	2596	2007	1980	461
1710_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for age and sex)	1710_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for age and sex)	25	462	1	2226	1545	462	4733	2200	2851	1529	4173	547	869	823
2854_TPM2 - Tropomyosin beta chain	2854_TPM2 - Tropomyosin beta chain	25	462	1	2556	871	2611	1610	4602	2058	1643	462	1192	1373	2828
1596_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for multivariable)	1596_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for multivariable)	25	463	1	463	4671	4481	661	1898	1567	2599	2243	3258	2765	1017
606_Peptide::gamma-glutamyl::gamma-glutamylphenylalanine	606_Peptide::gamma-glutamyl::gamma-glutamylphenylalanine	25	463	1	4718	781	463	1186	3615	2353	1799	866	956	786	3973
33_Extraversion (IRT)	33_Extraversion (IRT)	25	463	1	1863	3078	4535	1645	684	463	4628	3819	2647	466	1196
1405_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for age and sex)	1405_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for age and sex)	25	463	1	1151	3506	3123	3963	685	2892	2006	2363	4052	463	1467
3264_Average weekly beer plus cider intake	3264_Average weekly beer plus cider intake	25	463	1	2477	795	1482	2852	1772	4234	2487	4431	4492	3039	463
3686_Diagnoses - secondary ICD10: E11 Type 2 diabetes mellitus	3686_Diagnoses - secondary ICD10: E11 Type 2 diabetes mellitus	25	464	1	464	697	1502	3616	1766	468	3666	1804	4185	807	940
4678_Fornix (cres) / Stria terminalis axial diusivities	4678_Fornix (cres) / Stria terminalis axial diusivities	25	464	1	3222	4494	2484	464	3398	2360	4328	4530	1857	891	4116
550_Lipid::Lysolipid::2-oleoylglycerophosphocholine*	550_Lipid::Lysolipid::2-oleoylglycerophosphocholine*	25	464	1	3691	520	3993	1138	3894	3244	464	3218	929	565	3252
3178_SLAMF7 - SLAM family member 7	3178_SLAMF7 - SLAM family member 7	25	464	1	678	1969	3074	1997	2256	2023	2346	464	1159	3615	3225
3324_Relative age of first facial hair (male)	3324_Relative age of first facial hair (male)	25	464	1	1164	2253	4391	4623	849	2562	1868	4671	2918	464	4377
3118_MAP2K4 - Dual specificity mitogen-activated protein kinase kinase 4	3118_MAP2K4 - Dual specificity mitogen-activated protein kinase kinase 4	25	465	1	1114	2264	2492	641	715	465	1394	835	4363	2701	1882
2389_ENTPD1 - Ectonucleoside triphosphate diphosphohydrolase 1	2389_ENTPD1 - Ectonucleoside triphosphate diphosphohydrolase 1	25	466	1	1676	1565	4378	4542	466	1704	4234	1886	4029	1468	3558
3170_TNNI2 - Troponin I, fast skeletal muscle	3170_TNNI2 - Troponin I, fast skeletal muscle	25	467	1	467	4376	2871	2095	4430	3067	2780	3459	4686	3145	3108
90_Body Mass Index - Child	90_Body Mass Index - Child	25	467	1	2251	467	1711	2460	1196	2998	2903	2418	3649	883	3520
2130_IL13RA1 - Interleukin-13 receptor subunit alpha-1	2130_IL13RA1 - Interleukin-13 receptor subunit alpha-1	25	467	1	795	2275	841	467	4267	2455	2982	2452	3706	806	3741
2350_WISP1 - WNT1-inducible-signaling pathway protein 1	2350_WISP1 - WNT1-inducible-signaling pathway protein 1	25	467	1	4661	2643	2056	4312	467	4158	1184	3984	2337	2136	2583
2483_GZMH - Granzyme H	2483_GZMH - Granzyme H	25	467	1	2432	2053	3828	3804	2682	467	501	2472	2944	4608	720
4138_Mean corpuscular volume	4138_Mean corpuscular volume	25	467	1	801	4678	857	4624	3869	3114	2178	2186	3744	467	4693
339_NKeff:%Kir+ (4)	339_NKeff:%Kir+ (4)	25	467	1	1562	4228	1870	1275	3744	2205	3621	605	3530	3543	467
1709_Luteinizing hormone (at exam 3, GEE, adjusted for multivariable)	1709_Luteinizing hormone (at exam 3, GEE, adjusted for multivariable)	25	468	1	468	3255	991	2191	3374	4013	2014	2106	3740	1820	3793
3595_Mineral and other dietary supplements: Zinc	3595_Mineral and other dietary supplements: Zinc	25	468	1	3516	2424	468	3301	3500	4151	2081	2103	4577	2028	1452
1046_Trochanter BMD (FBAT, adjusted for multivariable)	1046_Trochanter BMD (FBAT, adjusted for multivariable)	25	468	1	2651	3338	3130	3382	503	969	3431	3302	950	468	4399
2815_CLEC1B - C-type lectin domain family 1 member B	2815_CLEC1B - C-type lectin domain family 1 member B	25	468	1	578	3990	4067	2570	1101	4495	1684	1532	1273	1734	468
3561_Medication for pain relief, constipation, heartburn: Laxatives (e.g. Dulcolax, Senokot)	3561_Medication for pain relief, constipation, heartburn: Laxatives (e.g. Dulcolax, Senokot)	25	469	1	469	681	793	2365	4498	3394	921	4317	4445	1737	2630
1925_Hippocampal volume (GEE, adjusted for multivariable)	1925_Hippocampal volume (GEE, adjusted for multivariable)	25	469	1	850	3565	469	3454	2792	514	1718	743	3291	4532	3853
3673_Diagnoses - main ICD10: K57 Diverticular disease of intestine	3673_Diagnoses - main ICD10: K57 Diverticular disease of intestine	25	469	1	3045	2362	2334	4590	4045	3714	2212	469	2593	2483	1071
1256_Percent predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	1256_Percent predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	469	1	4371	1625	3503	564	3227	1264	3412	1416	3808	469	4302
2050_Periodontal complex trait 5 - Pg trait	2050_Periodontal complex trait 5 - Pg trait	25	470	1	878	470	1283	3650	4015	2621	4167	2997	4616	602	3408
26_Agression	26_Agression	25	470	1	2620	2170	1654	1621	4231	4692	2556	470	4693	1374	3967
4119_Aspartate aminotransferase	4119_Aspartate aminotransferase	25	470	1	572	2289	4417	1077	2527	1532	4057	3025	470	2168	788
535_Lipid::Lysolipid::1-eicosatrienoylglycerophosphocholine*	535_Lipid::Lysolipid::1-eicosatrienoylglycerophosphocholine*	25	471	1	4287	3232	471	3490	797	3673	1586	1241	1943	4004	4728
2557_IL17A - Interleukin-17A	2557_IL17A - Interleukin-17A	25	471	1	3915	4656	3841	833	471	978	3737	1568	1910	3960	2615
2994_PTK2 - Focal adhesion kinase 1	2994_PTK2 - Focal adhesion kinase 1	25	471	1	2366	1459	4599	4462	4357	471	2100	2294	1321	1938	2582
1259_Residual from predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	1259_Residual from predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	25	471	1	3419	3269	1600	3772	1882	1416	4112	3907	4025	3440	471
2120_ERBB4 - Receptor tyrosine-protein kinase erbB-4	2120_ERBB4 - Receptor tyrosine-protein kinase erbB-4	25	472	1	3050	1125	4252	2029	844	472	3037	1249	575	3419	2066
29_Openness to Experience (NEO-FFI)	29_Openness to Experience (NEO-FFI)	25	472	1	904	2961	2356	3644	3092	2153	1578	472	2623	1963	3739
4455_Left lingual	4455_Left lingual	25	472	1	803	656	4085	519	1746	4051	4357	2370	472	777	3364
136_Weight (male)	136_Weight (male)	25	472	1	1924	3477	1116	2961	3080	2247	4686	4316	3188	472	4016
3031_CD163 - Scavenger receptor cysteine-rich type 1 protein M130	3031_CD163 - Scavenger receptor cysteine-rich type 1 protein M130	25	473	1	3520	473	2916	4315	3878	2176	1984	1742	3553	2282	1478
1040_Shaft Width (FBAT, adjusted for age and sex)	1040_Shaft Width (FBAT, adjusted for age and sex)	25	473	1	4662	1090	4555	3714	473	659	1899	2284	2357	654	569
407_Amino acid::Tryptophan metabolism::kynurenine	407_Amino acid::Tryptophan metabolism::kynurenine	25	473	1	4414	2165	2220	4108	1358	1986	473	2283	2889	3893	4720
111_Coronary artery disease	111_Coronary artery disease	25	473	1	4188	892	778	2527	925	4612	1502	2734	627	473	2696
4497_Right precentral	4497_Right precentral	25	474	1	2982	1191	2432	4509	1980	474	2036	1184	2114	3528	4365
4170_Loneliness (MTAG)	4170_Loneliness (MTAG)	25	474	1	3764	1959	579	717	4476	1523	3254	1371	3315	950	474
2263_CCL28 - C-C motif chemokine 28	2263_CCL28 - C-C motif chemokine 28	25	475	1	3918	3072	2295	475	3217	2201	2555	1339	3413	2401	2392
3192_Length of time at current address	3192_Length of time at current address	25	475	1	3347	1318	1939	3185	1299	475	1856	1024	1417	2314	3502
2167_SERPINA7 - Thyroxine-Binding Globulin	2167_SERPINA7 - Thyroxine-Binding Globulin	25	475	1	4116	3432	3817	609	1462	1206	475	1281	4531	3001	1127
3481_Milk type used: Semi-skimmed	3481_Milk type used: Semi-skimmed	25	475	1	4416	3076	4587	3139	4082	1319	4444	1989	475	2004	1325
3195_Average total household income before tax	3195_Average total household income before tax	25	475	1	2295	3320	4169	1855	4436	1915	3842	1771	1403	475	1187
1169_Leptin	1169_Leptin	25	476	1	476	4504	976	2667	1687	1006	3717	3534	3662	2596	1430
4663_Splenium of corpus callosum fractional anisotropy	4663_Splenium of corpus callosum fractional anisotropy	25	476	1	3232	856	3635	2429	476	1982	3132	3146	4204	2877	1051
3078_NOTCH3 - Neurogenic locus notch homolog protein 3	3078_NOTCH3 - Neurogenic locus notch homolog protein 3	25	476	1	3545	2618	3638	3480	3172	476	1492	1587	3502	2759	663
2897_SORCS2 - VPS10 domain-containing receptor SorCS2	2897_SORCS2 - VPS10 domain-containing receptor SorCS2	25	476	1	2751	2821	3709	2951	3743	3284	2704	476	3853	3723	2501
2116_EFNA4 - Ephrin-A4	2116_EFNA4 - Ephrin-A4	25	476	1	4275	4721	1718	4699	3022	1800	2507	1160	4291	4307	476
3526_Transport type for commuting to job workplace: Public transport	3526_Transport type for commuting to job workplace: Public transport	25	477	1	477	2448	4233	3165	2824	4362	4265	3123	4583	1616	2062
4084_Type 2 Diabetes (adjusted for BMI)	4084_Type 2 Diabetes (adjusted for BMI)	25	479	1	736	798	479	676	2146	2085	3603	2908	2073	2933	3092
1546_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for age and sex)	1546_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for age and sex)	25	479	1	1638	3325	2665	479	527	2532	4473	2650	3143	1943	2620
1733_Chronic kidney disease (at exam 7, GEE, adjusted for multivariable)	1733_Chronic kidney disease (at exam 7, GEE, adjusted for multivariable)	25	480	1	3396	480	2689	2317	1722	2136	2056	1583	999	2476	1842
1468_Lipoprotein A (at exam 3, FBAT, adjusted for multivariable)	1468_Lipoprotein A (at exam 3, FBAT, adjusted for multivariable)	25	480	1	4535	751	4727	3870	480	1906	3133	3810	4208	2687	691
2732_CCL24 - C-C motif chemokine 24	2732_CCL24 - C-C motif chemokine 24	25	480	1	4292	790	3528	2730	2061	480	508	3848	3032	3844	545
1103_Insulin - Birth cohorts	1103_Insulin - Birth cohorts	25	480	1	4175	3581	2521	2325	1207	601	3182	777	2822	4058	480
1700_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for multivariable)	1700_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for multivariable)	25	481	1	481	4247	2477	4359	2437	2594	3360	4477	4653	4689	1663
3577_Social support - Leisure/social activities: Pub or social club	3577_Social support - Leisure/social activities: Pub or social club	25	481	1	2132	3431	1286	481	1063	2915	2163	1222	617	2622	914
4529_Left vessel	4529_Left vessel	25	481	1	2497	3190	3666	1533	1389	481	2721	3887	1884	3072	2411
664_::::X-05426	664_::::X-05426	25	481	1	3421	2252	2585	3035	703	3837	3985	481	914	4622	2218
4179_Mean corpuscular hemoglobin concentration	4179_Mean corpuscular hemoglobin concentration	25	482	1	1508	3779	1712	814	482	4148	1300	2783	4564	4151	512
4735_Anterior corona radiata radial diusivities	4735_Anterior corona radiata radial diusivities	25	482	1	4494	4476	3953	3933	1128	3071	2308	482	2015	4112	2704
3025_PGK1 - Phosphoglycerate kinase 1	3025_PGK1 - Phosphoglycerate kinase 1	25	483	1	4395	1454	1783	483	3665	3579	4500	4314	3732	961	1631
4386_Epithelial ovarian cancer (Borderline serous and mucinous)	4386_Epithelial ovarian cancer (Borderline serous and mucinous)	25	484	1	524	4123	580	3977	2029	484	3259	4154	1748	1406	3297
4586_Right lateral orbitofrontal	4586_Right lateral orbitofrontal	25	485	1	783	1126	485	811	1995	1154	3593	2855	1514	858	1545
2678_PDGFC - Platelet-derived growth factor C	2678_PDGFC - Platelet-derived growth factor C	25	485	1	3885	2628	4339	1358	1699	485	1725	1035	4683	2219	4114
3427_Fluid intelligence test - FI4 : positional arithmetic	3427_Fluid intelligence test - FI4 : positional arithmetic	25	486	1	3114	4429	1761	486	4644	2202	1154	1393	3734	2840	2365
1432_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	1432_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	25	486	1	1168	3892	1597	4471	486	606	3585	1872	3890	2823	2856
2155_C3 - Complement C3b, inactivated	2155_C3 - Complement C3b, inactivated	25	486	1	1882	4029	3143	3420	4495	486	4489	3159	701	4499	3941
501_Lipid::Fatty acid, dicarboxylate::octadecanedioate	501_Lipid::Fatty acid, dicarboxylate::octadecanedioate	25	486	1	3269	2442	1996	3150	3637	987	1066	4421	486	1989	1434
2533_POSTN - Periostin	2533_POSTN - Periostin	25	486	1	2548	3610	1639	3255	2135	2021	2679	1880	4214	4478	486
1828_Spine Neck BMD (FBAT, male, adjusted for multivariable)	1828_Spine Neck BMD (FBAT, male, adjusted for multivariable)	25	487	1	487	4290	815	1877	2072	1130	4336	3153	2683	3466	832
1550_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1550_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	487	1	1877	2338	3663	3479	487	1616	3409	4302	2518	3270	825
847_::::X-14745	847_::::X-14745	25	487	1	1568	1079	2931	1469	1366	2346	809	487	1365	1196	3566
2995_FCAR - Immunoglobulin alpha Fc receptor	2995_FCAR - Immunoglobulin alpha Fc receptor	25	487	1	4502	3014	2018	2407	3023	3800	2089	1803	4671	3590	487
1350_Plasma Apolipoprotein B level (FBAT, adjusted for age and sex)	1350_Plasma Apolipoprotein B level (FBAT, adjusted for age and sex)	25	488	1	2417	488	517	1751	2903	3644	2510	583	877	1896	2202
349_CD8:%TM (2)	349_CD8:%TM (2)	25	488	1	1773	2920	4528	4237	3836	488	4083	3956	1662	4486	543
613_Xenobiotics::Benzoate metabolism::4-ethylphenylsulfate	613_Xenobiotics::Benzoate metabolism::4-ethylphenylsulfate	25	489	1	2138	2958	3216	489	4276	3107	1696	3312	3142	3835	4579
939_Total cholesterol in small VLDL	939_Total cholesterol in small VLDL	25	489	1	4239	1983	2291	4647	978	489	2570	3093	1933	4681	3242
4469_Left rostral middle frontal	4469_Left rostral middle frontal	25	489	1	1872	1501	3991	1800	4663	1470	1033	2484	716	489	4550
1949_Visuospatial memory and organization (GEE, adjusted for multivariable)	1949_Visuospatial memory and organization (GEE, adjusted for multivariable)	25	490	1	490	2987	2409	4248	4422	4383	1355	3281	2831	3480	1331
1993_Survival past average life expectancy (GEE, adjusted for multivariable)	1993_Survival past average life expectancy (GEE, adjusted for multivariable)	25	490	1	1109	3747	490	1803	3932	3359	3767	3011	3369	2487	1281
3761_Depression - Recent trouble concentrating on things	3761_Depression - Recent trouble concentrating on things	25	490	1	3196	1730	2918	490	1561	732	2606	801	4275	2511	3322
1824_Inter-trochanteric buckling ratio (FBAT, male, adjussted for age)	1824_Inter-trochanteric buckling ratio (FBAT, male, adjussted for age)	25	490	1	1214	3485	2844	3939	490	592	2436	4655	4726	4375	1946
1643_Osteoprotegerin (at exam 7, GEE, adjusted for age and sex)	1643_Osteoprotegerin (at exam 7, GEE, adjusted for age and sex)	25	490	1	2146	3537	4729	4403	3562	3181	2844	490	1523	2083	2477
2644_CSF1 - Macrophage colony-stimulating factor 1	2644_CSF1 - Macrophage colony-stimulating factor 1	25	491	1	491	1138	1781	4150	3204	3283	859	2647	3013	1191	3031
4490_Right paracentral	4490_Right paracentral	25	491	1	2339	1744	1596	4580	491	1042	913	2105	1400	3081	2801
2254_RAC1 - Ras-related C3 botulinum toxin substrate 1	2254_RAC1 - Ras-related C3 botulinum toxin substrate 1	25	491	1	2458	2040	4673	1219	1339	4623	909	1698	491	2081	821
1392_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for multivariable)	1392_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for multivariable)	25	492	1	3574	2993	1226	1417	4221	4059	4588	1947	1434	1503	492
3137_SLC25A18 - Mitochondrial glutamate carrier 2	3137_SLC25A18 - Mitochondrial glutamate carrier 2	25	493	1	4496	3952	493	3316	2578	4113	4482	3506	2832	1151	621
578_Lipid::Sterol, Steroid::estrone 3-sulfate	578_Lipid::Sterol, Steroid::estrone 3-sulfate	25	493	1	3482	3415	4323	1445	493	3314	3300	3665	3628	2586	1931
904_Triglycerides in large VLDL	904_Triglycerides in large VLDL	25	493	1	1592	4028	1948	2633	1112	2373	932	945	493	4217	2777
96_Height SDS (female at age 10)	96_Height SDS (female at age 10)	25	493	1	627	1515	3316	2592	1669	515	1842	921	1381	493	3110
3748_Traumatic events - Felt loved as child	3748_Traumatic events - Felt loved as child	25	493	1	3308	3551	4602	2449	2192	2113	930	2745	2720	2900	493
4351_Male pattern baldness (BOLT LMM infinitesimal mixed model)	4351_Male pattern baldness (BOLT LMM infinitesimal mixed model)	25	494	1	494	4538	1960	1065	2414	1212	1985	2049	1332	4437	4436
2237_ICAM2 - Intercellular adhesion molecule 2	2237_ICAM2 - Intercellular adhesion molecule 2	25	494	1	1234	494	672	3931	1420	916	934	4279	2947	1084	1184
3110_CSNK2A2 CSNK2B - Casein kinase II 2-alpha':2-beta heterotetramer	3110_CSNK2A2 CSNK2B - Casein kinase II 2-alpha':2-beta heterotetramer	25	494	1	3270	2529	3779	619	494	3185	4206	4412	4488	4414	839
1166_Fasting insulin	1166_Fasting insulin	25	494	1	3817	4508	4023	2498	2781	494	1326	3177	916	3862	4548
2766_YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,SFN - 14-3-3 protein family	2766_YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,SFN - 14-3-3 protein family	25	494	1	687	4254	4637	3376	2166	3354	672	494	1226	3050	2242
991_Interleukin-4	991_Interleukin-4	25	495	1	2880	4566	4306	495	2171	3295	4535	1913	4243	2750	4125
2649_PTGS2 - Prostaglandin G/H synthase 2	2649_PTGS2 - Prostaglandin G/H synthase 2	25	495	1	4067	4400	4078	1814	495	3018	3774	4298	3680	1838	1864
3160_PIM1 - Serine/threonine-protein kinase pim-1	3160_PIM1 - Serine/threonine-protein kinase pim-1	25	495	1	1702	684	1749	2539	1050	1061	1320	495	548	3366	2124
1522_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	1522_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	25	496	1	811	1598	496	3721	4091	2664	1431	2930	654	1647	2135
747_::::X-12029	747_::::X-12029	25	496	1	3368	3946	1883	3074	496	3851	3193	4215	2166	4320	4670
104_Late pubertal growth	104_Late pubertal growth	25	496	1	2715	1684	2411	2694	3310	4668	496	2828	700	974	3637
3741_Depression - Professional informed about depression	3741_Depression - Professional informed about depression	25	497	1	1260	4661	497	1068	4025	2009	2369	4213	4061	3037	1879
1775_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for multivariable)	1775_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for multivariable)	25	497	1	3712	4461	2805	497	2055	1892	3642	1754	4547	4036	1731
3742_Depression - Feelings of tiredness during worst episode of depression	3742_Depression - Feelings of tiredness during worst episode of depression	25	497	1	749	1257	1271	3595	1713	497	3183	3607	1558	1176	2951
758_::::X-12116	758_::::X-12116	25	497	1	520	711	837	4474	4073	3882	959	2896	497	4436	3341
3530_Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	3530_Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	25	498	1	3563	3237	3021	498	2261	553	985	3234	3738	4563	3538
2358_IL2 - Interleukin-2	2358_IL2 - Interleukin-2	25	498	1	3814	4455	4298	2088	498	1672	4672	3337	2291	2946	2693
1445_Low-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	1445_Low-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	25	498	1	4062	3214	2861	1479	1634	2807	498	2177	2802	1758	1772
2664_FGFR2 - Fibroblast growth factor receptor 2	2664_FGFR2 - Fibroblast growth factor receptor 2	25	498	1	2748	3219	4588	4323	3082	1491	2732	788	3524	3698	498
4292_Asthma	4292_Asthma	25	499	1	499	3033	768	3509	2986	2907	4134	1477	2043	4672	3789
2813_BOC - Brother of CDO	2813_BOC - Brother of CDO	25	499	1	2788	1549	3715	2733	2612	2714	1674	3272	3382	2252	499
585_Nucleotide::Purine metabolism, guanine containing::guanosine	585_Nucleotide::Purine metabolism, guanine containing::guanosine	25	500	1	2544	722	1720	500	3165	2850	1183	1435	3209	876	1114
2138_CDH3 - Cadherin-3	2138_CDH3 - Cadherin-3	25	501	1	2095	501	1651	1981	3553	3453	4711	4397	1845	1140	2725
2527_CXCL8 - Interleukin-8	2527_CXCL8 - Interleukin-8	25	502	1	2157	1670	1741	832	4354	502	3130	4500	2790	2011	2234
3535_Mental health - Illness, injury, bereavement, stress in last 2 years: Marital separation/divorce	3535_Mental health - Illness, injury, bereavement, stress in last 2 years: Marital separation/divorce	25	502	1	4383	2743	2825	3404	2724	1509	3322	502	1433	1264	561
1324_Fasting plasma glucose (at exam 7, FBAT, adjusted for age, sex and BMI)	1324_Fasting plasma glucose (at exam 7, FBAT, adjusted for age, sex and BMI)	25	502	1	3645	1058	1826	1335	1369	1047	826	4386	502	3852	590
1086_Pancreatic cancer	1086_Pancreatic cancer	25	502	1	2011	708	2028	4015	3824	3845	2082	3340	1520	502	4340
825_::::X-13619	825_::::X-13619	25	502	1	937	3573	1452	1949	1068	1546	4143	3428	3745	3329	502
245_CD34 on Stem	245_CD34 on Stem	25	503	1	3341	2080	1911	2776	2033	503	2700	2340	3550	1759	2864
1515_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	1515_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	24	503	1	4681	1852	3350	3923	3302	2561	1836	503	1484	2716	709
4569_Left rostral anterior cingulate	4569_Left rostral anterior cingulate	25	503	1	2394	4279	2923	4529	1751	3458	2793	1004	503	2161	1672
1698_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for age and sex)	1698_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for age and sex)	25	503	1	4412	1624	2676	1073	3288	2522	823	820	1624	1919	503
3906_Intraocular pressure	3906_Intraocular pressure	25	504	1	899	1548	2654	504	4461	2204	3819	3761	1326	2680	2033
3483_Milk type used: Soya	3483_Milk type used: Soya	25	505	1	940	1803	505	1578	3588	4354	2882	4581	1717	4147	2534
3042_ICOSLG - ICOS ligand	3042_ICOSLG - ICOS ligand	25	505	1	3085	2246	4248	1354	4079	505	2225	1699	4010	4245	3832
961_Total lipids in very large VLDL	961_Total lipids in very large VLDL	25	505	1	3616	3811	1310	1431	1835	751	505	958	576	3074	4593
3372_Age hay fever, rhinitis or eczema diagnosed	3372_Age hay fever, rhinitis or eczema diagnosed	25	505	1	3821	1663	4387	3357	4664	3258	876	505	4667	4050	3942
930_Phosphatidylcholine and other cholines	930_Phosphatidylcholine and other cholines	25	505	1	2374	2302	1245	4441	4579	3200	4746	4091	505	4726	2336
2482_FETUB - Fetuin-B	2482_FETUB - Fetuin-B	25	505	1	3343	2459	3567	1137	2220	2648	3206	4723	1465	505	3087
1951_Visual scanning and motor speed (GEE, adjusted for multivariable)	1951_Visual scanning and motor speed (GEE, adjusted for multivariable)	25	505	1	2997	3886	1727	1965	4029	3399	3876	2809	4054	2032	505
586_Nucleotide::Purine metabolism, guanine containing::N2,N2-dimethylguanosine	586_Nucleotide::Purine metabolism, guanine containing::N2,N2-dimethylguanosine	25	506	1	506	1766	2487	2559	4018	2417	507	680	1080	892	931
106_Tanner scale (male)	106_Tanner scale (male)	25	506	1	3055	3752	506	2468	760	4456	2913	4145	1165	2899	2198
4530_Right lateral ventricle	4530_Right lateral ventricle	25	506	1	955	1650	897	2789	3224	506	1368	3545	2919	1103	3123
903_Phospholipids in large VLDL	903_Phospholipids in large VLDL	25	506	1	2525	4534	1160	3171	1488	2887	898	1003	506	4271	2320
1569_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for multivariable)	1569_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for multivariable)	25	506	1	3768	2185	4056	3125	2810	4227	3801	2328	1802	506	1884
2542_THBS1 - Thrombospondin-1	2542_THBS1 - Thrombospondin-1	25	507	1	2860	3011	507	2982	1674	1099	3285	3955	2785	4579	2928
1821_Inter-trochanteric buckling ratio (GEE, male, adjussted for multivariable)	1821_Inter-trochanteric buckling ratio (GEE, male, adjussted for multivariable)	25	507	1	2329	4513	1896	2244	1294	507	2359	4438	2796	3799	3533
406_Amino acid::Tryptophan metabolism::indolepropionate	406_Amino acid::Tryptophan metabolism::indolepropionate	25	507	1	1606	3463	3881	1205	4261	3123	1629	1723	507	3462	2879
775_::::X-12435	775_::::X-12435	25	507	1	1721	2704	1901	4320	1489	1758	3584	2061	3936	1375	507
2880_EMR2 - EGF-like module-containing mucin-like hormone receptor-like 2	2880_EMR2 - EGF-like module-containing mucin-like hormone receptor-like 2	25	508	1	508	2390	1987	3717	2652	4028	3820	577	3515	2114	3531
4037_Autism spectrum disorder	4037_Autism spectrum disorder	25	508	1	2195	508	2817	2358	704	4499	4296	3623	2591	3064	3972
1451_Low-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	1451_Low-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	25	508	1	1694	1045	2502	1641	508	4460	801	1486	1308	2715	806
4280_FEV1/FVC ratio	4280_FEV1/FVC ratio	25	508	1	1679	3661	4542	3547	875	508	2330	2554	2899	4166	2922
2741_IL25 - Interleukin-25	2741_IL25 - Interleukin-25	25	508	1	1885	1832	1560	2328	3570	3814	1494	508	2054	4235	1321
4126_Creatine kinase	4126_Creatine kinase	25	509	1	2179	1527	509	898	3450	895	1396	4126	1198	1728	4520
1365_Total cholesterol (at exam 4, GEE, adjusted for age and sex)	1365_Total cholesterol (at exam 4, GEE, adjusted for age and sex)	25	509	1	2465	1932	986	2755	1675	3538	1014	3087	927	2732	509
1616_CD40 Ligand plasma (at exam 7, FBAT, adjusted for multivariable)	1616_CD40 Ligand plasma (at exam 7, FBAT, adjusted for multivariable)	25	510	1	3658	2619	4272	510	2966	1806	3613	4323	4465	1426	527
365_Amino acid::Alanine and aspartate metabolism::asparagine	365_Amino acid::Alanine and aspartate metabolism::asparagine	25	510	1	4699	2348	3682	2941	510	905	524	2865	4315	4279	3969
4614_CSF	4614_CSF	25	511	1	511	2525	1576	2139	3630	2380	2757	2654	1060	2530	826
2105_ROR1 - Tyrosine-protein kinase transmembrane receptor ROR1	2105_ROR1 - Tyrosine-protein kinase transmembrane receptor ROR1	25	511	1	3250	3593	4526	3856	511	2300	2290	3574	1334	4241	1200
297_CD4mem:%Th22	297_CD4mem:%Th22	25	511	1	3226	3388	2290	2867	4193	4363	2289	511	993	669	2532
4023_Hair (Straight/curly)	4023_Hair (Straight/curly)	25	511	1	2336	4670	3258	1213	4680	4662	797	1402	511	2344	598
2195_FGF9 - Fibroblast growth factor 9	2195_FGF9 - Fibroblast growth factor 9	25	511	1	3381	2324	4622	4041	2582	2268	4468	4528	4299	2245	511
72_Triglycerides cholesterol	72_Triglycerides cholesterol	25	512	1	2001	512	4157	3866	669	1152	3137	988	2180	1074	1939
3698_Diagnoses - secondary ICD10: K44 Diaphragmatic hernia	3698_Diagnoses - secondary ICD10: K44 Diaphragmatic hernia	25	512	1	2256	1754	4575	3668	512	918	3920	3751	4574	2838	2873
2140_PRKCZ - Protein kinase C zeta type	2140_PRKCZ - Protein kinase C zeta type	25	513	1	513	4481	1407	4314	537	1402	4078	4185	4071	4541	3282
4457_Left middle temporal	4457_Left middle temporal	25	513	1	3509	4097	513	1374	1072	3872	3612	729	2506	2207	2012
806_::::X-12830	806_::::X-12830	25	513	1	1616	1489	520	2920	1631	4196	3134	1103	2098	513	2349
3252_Bread intake	3252_Bread intake	25	513	1	2511	2473	2107	3260	3596	1700	3761	3541	1525	3875	513
4063_Estimated glomerular filtration rate based on serum creatinine	4063_Estimated glomerular filtration rate based on serum creatinine	25	514	1	629	4536	852	514	2745	1357	4347	1996	4411	4077	4544
970_Concentration of chylomicrons and extremely large VLDL particles	970_Concentration of chylomicrons and extremely large VLDL particles	25	514	1	2112	2202	2299	2001	514	2328	1139	548	1118	4092	2277
2771_ANP32B - Acidic leucine-rich nuclear phosphoprotein 32 family member B	2771_ANP32B - Acidic leucine-rich nuclear phosphoprotein 32 family member B	25	514	1	1384	1023	1437	3375	3979	4716	2437	514	3200	1116	1188
3726_Frequency of consuming six or more units of alcohol	3726_Frequency of consuming six or more units of alcohol	25	514	1	636	1495	4376	1950	2438	1162	2149	4665	514	1011	1724
764_::::X-12217	764_::::X-12217	25	514	1	4437	4415	2761	3736	2755	1708	769	2350	3547	514	2375
2754_KLKB1 - Plasma kallikrein	2754_KLKB1 - Plasma kallikrein	25	514	1	3408	1814	665	3688	2530	4541	3335	2712	1978	4735	514
3713_Diagnoses - secondary ICD10: Z88 Allergy status to drug/meds/biol subst	3713_Diagnoses - secondary ICD10: Z88 Allergy status to drug/meds/biol subst	25	515	1	515	1810	629	1611	3921	3117	2517	1193	3410	1090	4269
3628_Illnesses of father: Heart disease	3628_Illnesses of father: Heart disease	25	515	1	3902	3075	2728	1282	3928	1426	4742	515	4485	2740	3467
1278_Sabuctaneous fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	1278_Sabuctaneous fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	516	1	617	1811	4420	1679	536	516	1160	632	1180	4680	1274
3903_Reticulocyte fraction of red cells (three-way meta)	3903_Reticulocyte fraction of red cells (three-way meta)	25	516	1	2674	2648	1417	2227	1343	1776	516	4716	2402	2509	2037
271_CD4:%CD244+ Nave	271_CD4:%CD244+ Nave	25	516	1	3733	2488	4225	4179	1157	3225	2659	516	4207	4438	2862
4485_Right lateral orbitofrontal	4485_Right lateral orbitofrontal	25	517	1	517	2018	630	947	4474	2470	3793	1847	1636	947	2398
99_Pubertal growth (female)	99_Pubertal growth (female)	25	517	1	2574	3499	3409	2074	596	2504	3029	517	2064	4291	1605
166_Hip circumference (female, adjusted for BMI)	166_Hip circumference (female, adjusted for BMI)	25	517	1	2824	2550	3068	2952	642	4157	1754	1501	3544	3805	517
3845_High light scatter percentage of red cells (two-way meta)	3845_High light scatter percentage of red cells (two-way meta)	25	518	1	1306	2293	518	4465	1175	1649	3266	1334	4112	3392	2992
4102_Blood sugar	4102_Blood sugar	25	518	1	722	903	1520	3204	1940	4202	518	3320	1087	1972	3471
3687_Diagnoses - secondary ICD10: E66 Overweight and obesity	3687_Diagnoses - secondary ICD10: E66 Overweight and obesity	25	519	1	4528	1272	1042	2408	519	3875	4549	4320	4200	3225	1232
2447_HTRA2 - Serine protease HTRA2, mitochondrial	2447_HTRA2 - Serine protease HTRA2, mitochondrial	25	519	1	4284	4710	3681	1791	1111	519	1092	871	1678	2621	2043
4021_Double eyelid	4021_Double eyelid	25	519	1	4129	3746	3845	1888	1732	2509	3160	519	3699	2247	1326
3271_Comparative height size at age 10	3271_Comparative height size at age 10	25	519	1	4084	713	3235	3223	2242	3356	1751	2582	3095	953	519
2883_FUT5 - Alpha-(1,3)-fucosyltransferase 5	2883_FUT5 - Alpha-(1,3)-fucosyltransferase 5	25	520	1	3783	4188	1462	1571	2479	4185	4564	520	2840	3469	2428
2904_CSF2 - Granulocyte-macrophage colony-stimulating factor	2904_CSF2 - Granulocyte-macrophage colony-stimulating factor	25	520	1	1380	1423	4458	843	1592	1376	1800	705	520	1156	3501
1072_Systemic Lupus Erythematosus	1072_Systemic Lupus Erythematosus	25	520	1	1103	4103	3411	1847	2498	3131	3345	3359	720	2952	520
2976_CDNF - Cerebral dopamine neurotrophic factor	2976_CDNF - Cerebral dopamine neurotrophic factor	25	521	1	750	4236	795	4475	521	3735	3498	940	4028	2417	624
379_Amino acid::Glycine, serine and threonine metabolism::betaine	379_Amino acid::Glycine, serine and threonine metabolism::betaine	25	521	1	3223	576	2851	4653	2872	2668	1228	1368	521	1154	4484
1917_Temporal brain volume (GEE, adjusted for multivariable)	1917_Temporal brain volume (GEE, adjusted for multivariable)	25	522	1	522	1407	2496	2410	4564	1141	3935	3494	1469	4530	2824
483_Lipid::Carnitine metabolism::octanoylcarnitine	483_Lipid::Carnitine metabolism::octanoylcarnitine	25	522	1	1684	522	4377	979	2734	4547	1229	3831	1666	835	580
4636_Right caudate	4636_Right caudate	25	522	1	1217	1065	3793	522	4431	3339	1448	2509	533	2510	4163
1862_Neck cross-sectional moment of inertia (FBAT, female, adjussted for age)	1862_Neck cross-sectional moment of inertia (FBAT, female, adjussted for age)	25	522	1	2361	2061	1747	4726	522	1679	4338	1990	3700	2316	1168
873_Glycerol	873_Glycerol	25	522	1	3169	2767	2896	4353	2094	522	3676	3853	2341	4679	4333
2687_ETHE1 - Persulfide dioxygenase ETHE1, mitochondrial	2687_ETHE1 - Persulfide dioxygenase ETHE1, mitochondrial	25	523	1	523	688	3479	3654	3680	565	1422	2513	939	3174	1642
3247_Poultry intake	3247_Poultry intake	25	523	1	920	523	3992	1043	1446	3688	670	1815	4021	2317	4043
2949_COTL1 - Coactosin-like protein	2949_COTL1 - Coactosin-like protein	25	523	1	1565	2017	1962	4249	4024	523	1441	2031	4017	4465	3204
3218_Time spent outdoors in winter	3218_Time spent outdoors in winter	25	523	1	3176	703	1419	1543	3364	3422	1488	3520	523	2572	4660
3846_High light scatter reticulocyte count (two-way meta)	3846_High light scatter reticulocyte count (two-way meta)	25	524	1	2821	3753	524	3216	3066	1518	2739	1918	2776	3272	3317
2151_TDGF1 - Teratocarcinoma-derived growth factor 1	2151_TDGF1 - Teratocarcinoma-derived growth factor 1	25	524	1	1849	3456	1051	3354	908	524	4431	1099	758	2416	4322
1536_Ankle-brachial index (at exam 7, FBAT, adjusted for multivariable)	1536_Ankle-brachial index (at exam 7, FBAT, adjusted for multivariable)	25	524	1	3719	1223	536	2125	4460	4426	4136	524	1795	2195	3570
1762_Prostate cancer (FBAT, adjusted for age)	1762_Prostate cancer (FBAT, adjusted for age)	25	525	1	525	4599	2214	3211	2567	4396	1505	1286	4045	2846	2989
2749_NTF4 - Neurotrophin-4	2749_NTF4 - Neurotrophin-4	25	525	1	4458	976	4576	760	2699	525	3779	3473	1632	4606	681
2942_CCL7 - C-C motif chemokine 7	2942_CCL7 - C-C motif chemokine 7	25	525	1	2379	3060	1936	4193	2736	741	4169	1999	2483	525	2259
1538_White matter hyperintensity volume (FBAT, adjusted for age and sex)	1538_White matter hyperintensity volume (FBAT, adjusted for age and sex)	25	525	1	3505	2372	1564	3201	4617	2444	4172	1374	3790	4220	525
3051_EPHB2 - Ephrin type-B receptor 2	3051_EPHB2 - Ephrin type-B receptor 2	25	526	1	666	2599	4088	3814	526	4729	1535	1315	3002	2018	3936
1693_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for multivariable)	1693_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for multivariable)	25	526	1	4684	3927	3198	1996	2497	2943	996	526	876	3734	2409
2740_IL17D - Interleukin-17D	2740_IL17D - Interleukin-17D	25	526	1	4190	789	1368	1030	3923	2389	1877	1124	526	1333	3507
3765_Anxiety - Recent feelings of foreboding	3765_Anxiety - Recent feelings of foreboding	25	526	1	2914	862	2518	3970	4270	3457	1839	3200	4152	526	4162
2847_PDPK1 - 3-phosphoinositide-dependent protein kinase 1	2847_PDPK1 - 3-phosphoinositide-dependent protein kinase 1	25	526	1	1970	2820	1188	4155	4624	1937	2481	3567	2842	1262	526
2525_IL15RA - Interleukin-15 receptor subunit alpha	2525_IL15RA - Interleukin-15 receptor subunit alpha	25	527	1	1519	2883	527	862	3087	4738	2207	1956	2938	4397	4602
246_CD56 on NK eff	246_CD56 on NK eff	25	527	1	2797	1261	1690	527	4719	1902	2724	1210	4182	2071	2798
2912_TFF3 - Trefoil factor 3	2912_TFF3 - Trefoil factor 3	25	527	1	4438	3182	2625	3858	2240	527	2907	4115	2856	3702	1327
2778_SYNCRIP - Heterogeneous nuclear ribonucleoprotein Q	2778_SYNCRIP - Heterogeneous nuclear ribonucleoprotein Q	25	527	1	3747	578	3930	2111	2197	4537	1026	2458	527	4115	2032
2142_ICAM3 - Intercellular adhesion molecule 3	2142_ICAM3 - Intercellular adhesion molecule 3	25	527	1	2675	757	3496	3065	1079	2004	979	2239	3237	527	1300
1905_Hippocampal volume (GEE, adjusted for multivariable)	1905_Hippocampal volume (GEE, adjusted for multivariable)	25	528	1	528	3707	1913	4455	2329	3529	577	1307	2990	2926	2988
4288_FEV1/FVC ratio	4288_FEV1/FVC ratio	25	528	1	1342	528	1798	4609	3734	1511	2065	1495	2213	4041	3982
1801_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1801_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	528	1	3855	2506	4046	4632	528	1728	4512	2682	4692	2451	943
265_CD8:%RTE	265_CD8:%RTE	25	528	1	3022	4134	785	2069	1426	528	3693	1508	4417	3269	3849
622_Xenobiotics::Drug::3-(cystein-S-yl)acetaminophen*	622_Xenobiotics::Drug::3-(cystein-S-yl)acetaminophen*	25	529	1	2935	1985	4205	529	1601	824	1949	3309	2410	1961	3287
3277_Maternal smoking around birth	3277_Maternal smoking around birth	25	529	1	1229	2624	4129	3396	529	4661	2633	2441	4124	1865	3353
4313_Age of initiation of regular smoking	4313_Age of initiation of regular smoking	25	529	1	2299	3806	3531	3234	590	529	3839	4408	2760	3890	1182
2721_PDXP - Pyridoxal phosphate phosphatase	2721_PDXP - Pyridoxal phosphate phosphatase	25	529	1	606	2355	1655	3600	3395	4508	1906	529	2955	3771	2286
571_Lipid::Sterol, Steroid::7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca)	571_Lipid::Sterol, Steroid::7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca)	25	530	1	530	3189	886	2719	2472	4150	2566	3184	1522	736	3120
3958_Antisocial behavior (male)	3958_Antisocial behavior (male)	25	530	1	2232	4414	530	1883	1791	1768	3710	2266	1475	4025	2431
2125_Human-virus - Protein E7_HPV18	2125_Human-virus - Protein E7_HPV18	25	530	1	2516	3553	1990	3253	4244	530	2109	4159	3366	1428	1990
2612_RBP4 - Retinol-binding protein 4	2612_RBP4 - Retinol-binding protein 4	25	530	1	3090	3957	1432	2459	3712	3951	2865	530	903	2351	2441
3146_S100A9 - Protein S100-A9	3146_S100A9 - Protein S100-A9	25	531	1	1288	1885	3708	3098	531	1900	2919	2051	2364	1431	4469
3851_Mean corpuscular hemoglobin (two-way meta)	3851_Mean corpuscular hemoglobin (two-way meta)	25	531	1	2850	3791	888	4257	2992	3370	3629	531	4251	536	3784
3488_Cereal type: Bran cereal (e.g. All Bran, Branflakes)	3488_Cereal type: Bran cereal (e.g. All Bran, Branflakes)	25	532	1	737	1012	532	1168	814	1399	4554	2790	4562	2198	751
2117_EFNA5 - Ephrin-A5	2117_EFNA5 - Ephrin-A5	25	532	1	2608	3804	3247	2545	532	4317	1954	714	3215	3011	2589
2816_SAA1 - Serum amyloid A-1 protein	2816_SAA1 - Serum amyloid A-1 protein	25	532	1	672	3239	719	1269	4448	2842	3195	532	3279	4301	791
4033_Alcohol dependency (unrelated genotyped individuals)	4033_Alcohol dependency (unrelated genotyped individuals)	25	532	1	1484	1271	4338	1659	1486	4482	2363	1823	532	901	2752
4590_Right parahippocampal	4590_Right parahippocampal	25	532	1	1541	2826	4518	3593	2075	2530	3008	4508	2072	4656	532
1148_AUC insulin	1148_AUC insulin	25	533	1	2198	1638	533	3169	901	3232	1341	2921	2737	2335	3391
4450_Left inferior parietal	4450_Left inferior parietal	25	533	1	2507	1193	3229	1590	4112	533	3052	3375	4581	1590	2527
292_CD4:%Act(PD1+)	292_CD4:%Act(PD1+)	25	533	1	4503	1992	3250	3450	4170	1882	4179	4693	2507	533	1565
1215_Alcohol consumption (female)	1215_Alcohol consumption (female)	25	534	1	2252	2014	2729	534	1969	3988	4540	595	1813	2671	3569
4015_Central corneal thickness	4015_Central corneal thickness	25	534	1	3780	2025	3362	3079	2698	534	4239	2269	3621	2094	3908
713_::::X-11485	713_::::X-11485	25	534	1	2678	1913	3093	3228	3716	2281	534	4200	3234	1362	3823
1325_Fasting plasma glucose (at exam 7, GEE, adjusted for age, sex and BMI)	1325_Fasting plasma glucose (at exam 7, GEE, adjusted for age, sex and BMI)	24	534	1	3124	2079	726	3626	3571	2081	1816	534	2709	2508	575
1027_Femoral Neck Length (GEE, adjusted for multivariable)	1027_Femoral Neck Length (GEE, adjusted for multivariable)	25	534	1	3082	3345	1633	2604	3175	927	3116	3627	1693	3634	534
1237_Usual weekday sleep duration (GEE, adjusted for age, sex and BMI)	1237_Usual weekday sleep duration (GEE, adjusted for age, sex and BMI)	25	535	1	2689	4442	3039	2855	2772	535	3739	3437	4720	2221	3119
19_Ever versus never beeing a regular smoker	19_Ever versus never beeing a regular smoker	25	535	1	2755	3397	2160	1737	2453	2008	1820	2024	3099	3367	535
2794_PES1 - Pescadillo homolog	2794_PES1 - Pescadillo homolog	25	536	1	4219	4562	906	4548	850	536	3338	3741	2550	2428	1006
2406_LTA4H - Leukotriene A-4 hydrolase	2406_LTA4H - Leukotriene A-4 hydrolase	25	536	1	4727	1601	1014	4097	4036	2449	596	536	3537	2216	1702
2286_EHMT2 - Histone-lysine N-methyltransferase EHMT2	2286_EHMT2 - Histone-lysine N-methyltransferase EHMT2	25	537	1	537	3254	1318	2639	2000	2545	2886	4356	3467	958	3005
398_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetylglutamine	398_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetylglutamine	25	537	1	701	537	1957	2967	967	3276	2273	1290	2288	819	3588
678_::::X-09108	678_::::X-09108	25	537	1	4127	4565	1866	3413	4450	2773	537	3333	4675	3356	1945
2727_FGF4 - Fibroblast growth factor 4	2727_FGF4 - Fibroblast growth factor 4	25	537	1	4538	1709	1225	2948	547	3743	991	4468	902	836	537
1935_Temporal brain volume (GEE, adjusted for age and sex)	1935_Temporal brain volume (GEE, adjusted for age and sex)	25	538	1	887	538	4424	3042	3632	2309	2115	4611	3310	2488	1602
4736_Anterior limb of internal capsule radial diusivities	4736_Anterior limb of internal capsule radial diusivities	25	538	1	706	4342	4620	538	3568	3112	2072	2181	2387	2703	3526
3054_GPNMB - Transmembrane glycoprotein NMB	3054_GPNMB - Transmembrane glycoprotein NMB	25	538	1	766	2850	3112	4643	3036	1329	538	893	2099	2140	1100
2641_TNFRSF4 - Tumor necrosis factor receptor superfamily member 4	2641_TNFRSF4 - Tumor necrosis factor receptor superfamily member 4	25	538	1	2200	3965	1559	2792	815	1852	2454	3045	538	1873	3058
2228_IL27 EBI3 - Interleukin-27	2228_IL27 EBI3 - Interleukin-27	25	538	1	2586	2990	2753	1122	2718	897	2027	883	2751	2186	538
2709_EEF1B2 - Elongation factor 1-beta	2709_EEF1B2 - Elongation factor 1-beta	25	539	1	539	2420	1754	4183	805	4217	4477	1275	4625	3467	1525
4319_Life satisfaction (univariate)	4319_Life satisfaction (univariate)	25	539	1	2743	2527	3417	539	2232	3142	1332	854	1089	4087	2225
1571_Mean abdominal aortic calcification - Agatston score  (at exam 7, GEE, adjusted for age and sex)	1571_Mean abdominal aortic calcification - Agatston score  (at exam 7, GEE, adjusted for age and sex)	25	539	1	4487	897	2335	4233	610	1600	841	1326	539	613	1730
4202_Chronic kidney disease	4202_Chronic kidney disease	25	539	1	1079	626	2514	2987	3242	2286	3466	4394	1275	539	1823
3583_Types of transport used (excluding work): Public transport	3583_Types of transport used (excluding work): Public transport	25	539	1	2498	4402	1313	4591	1808	4701	2117	3350	3419	3506	539
985_Interleukin-17	985_Interleukin-17	25	540	1	1002	3528	3979	1045	540	1315	4352	2656	3245	1345	3821
802_::::X-12776	802_::::X-12776	25	540	1	3772	3884	968	3014	1255	540	3180	4576	3871	4289	4444
1942_White matter hyperintensity volume (FBAT, adjusted for multivariable with APOE)	1942_White matter hyperintensity volume (FBAT, adjusted for multivariable with APOE)	25	540	1	4539	4237	1337	3598	3439	1923	4235	540	3110	2812	2697
4584_Right isthmus cingulate	4584_Right isthmus cingulate	25	541	1	3898	1772	2658	3195	541	4497	1391	3192	4090	2122	1177
3441_Impedance measures - Body fat percentage	3441_Impedance measures - Body fat percentage	25	541	1	1390	3321	3471	2116	3333	541	2877	1380	2354	1789	868
2900_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 38	2900_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 38	25	541	1	1330	1901	1496	1266	2371	4605	541	1845	3272	4602	3035
2913_AFM - Afamin	2913_AFM - Afamin	25	541	1	2920	2010	2250	3368	2875	1886	3325	541	3957	3870	2759
3171_TNNI3 - Troponin I, cardiac muscle	3171_TNNI3 - Troponin I, cardiac muscle	25	542	1	542	2305	3465	632	3860	1911	3053	3692	4365	1447	2751
3512_Type of tobacco previously smoked: Manufactured cigarettes	3512_Type of tobacco previously smoked: Manufactured cigarettes	25	542	1	851	542	1422	3681	4012	2211	1063	1731	992	2005	4478
3580_Social support - Leisure/social activities: Other group activity	3580_Social support - Leisure/social activities: Other group activity	25	542	1	713	774	3464	2903	542	3876	1819	3239	1195	2347	3220
3143_CD70 - CD70 antigen	3143_CD70 - CD70 antigen	25	543	1	3843	543	2013	4003	1846	2106	2707	3241	3973	661	2251
1910_Temporal horn volume (FBAT, adjusted for multivariable)	1910_Temporal horn volume (FBAT, adjusted for multivariable)	25	543	1	1299	1920	3072	4191	543	2655	3100	1535	565	3780	1260
1595_Platelet aggregation to collagen (at exam 5, GEE, adjusted for age and sex)	1595_Platelet aggregation to collagen (at exam 5, GEE, adjusted for age and sex)	25	543	1	2741	1907	748	907	2662	1414	3713	2083	3927	543	4106
4548_Left cuneus	4548_Left cuneus	25	544	1	1847	2169	757	915	2833	544	3539	3921	2235	3740	3374
3327_Had major operations	3327_Had major operations	25	544	1	3766	3638	3527	1384	3138	4246	2915	544	822	1513	4173
942_Concentration of small VLDL particles	942_Concentration of small VLDL particles	25	544	1	2770	4743	1388	3504	2021	1364	2629	4253	544	4030	1817
2787_L1CAM - Neural cell adhesion molecule L1	2787_L1CAM - Neural cell adhesion molecule L1	25	545	1	1514	4543	1004	1627	3673	2212	828	545	3106	2102	1181
1419_High-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	1419_High-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	25	546	1	2927	3347	546	3192	3664	2082	2045	4260	4024	2985	1616
4124_Prothrombin time	4124_Prothrombin time	25	546	1	1278	4641	2766	4040	1370	546	3284	864	2602	4626	4371
4660_Posterior limb of internal capsule fractional anisotropy	4660_Posterior limb of internal capsule fractional anisotropy	25	546	1	4719	4294	3688	3282	1124	3934	546	1305	3701	4725	2802
1938_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	1938_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	25	546	1	3682	935	3376	1058	710	1455	842	2958	973	4721	546
4734_Uncinate fasciculus mode of anisotropy	4734_Uncinate fasciculus mode of anisotropy	25	547	1	3233	3171	547	4619	3221	2233	4353	2164	583	1876	1941
2315_MBL2 - Mannose-binding protein C	2315_MBL2 - Mannose-binding protein C	25	547	1	2653	2173	3589	4056	4034	3215	3705	547	4441	4182	3185
1251_Percent predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	1251_Percent predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	25	547	1	4174	2045	1680	4645	3703	609	2782	2234	3888	3026	547
2618_BMPER - BMP-binding endothelial regulator protein	2618_BMPER - BMP-binding endothelial regulator protein	25	548	1	3149	702	2413	1833	1439	3739	1202	2533	3054	548	1528
4604_Right superior temporal	4604_Right superior temporal	25	549	1	4470	1317	549	1391	1877	891	1776	2791	1189	2745	4449
753_::::X-12092	753_::::X-12092	25	549	1	1645	3088	3009	549	3627	2819	627	920	1084	2824	3917
1393_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for multivariable)	1393_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for multivariable)	25	549	1	2069	4039	848	2974	549	1362	2873	4712	3913	2902	1259
575_Lipid::Sterol, Steroid::cortisone	575_Lipid::Sterol, Steroid::cortisone	25	549	1	2261	3301	1333	2431	2164	3047	549	3090	1315	2187	2869
672_::::X-06351	672_::::X-06351	25	550	1	2412	1537	4415	2548	4407	550	3096	4680	3118	3608	1991
149_Body Mass Index (female > 50 yrs)	149_Body Mass Index (female > 50 yrs)	25	551	1	631	1185	2613	551	1794	3101	1179	3417	2863	4480	3963
4705_Posterior thalamic radiation (include optic radiation) mean diusivities	4705_Posterior thalamic radiation (include optic radiation) mean diusivities	25	551	1	4478	554	3838	4597	551	1836	1296	601	3959	4328	3075
2119_ERBB3 - Receptor tyrosine-protein kinase erbB-3	2119_ERBB3 - Receptor tyrosine-protein kinase erbB-3	25	551	1	3919	3727	964	3428	3473	551	3257	4184	3408	2569	3499
56_Depressive symptoms	56_Depressive symptoms	25	551	1	1937	2380	1442	2943	1535	4361	551	1867	4610	2535	1628
3677_Diagnoses - main ICD10: M17 Osteoarthritis of knee	3677_Diagnoses - main ICD10: M17 Osteoarthritis of knee	25	551	1	760	3267	2146	4203	770	1802	1069	551	1233	1266	4542
2197_HPX - Hemopexin	2197_HPX - Hemopexin	25	552	1	3428	2831	552	708	2249	1428	4030	1783	1447	2893	560
3923_Heart rate variability (RMSSD)	3923_Heart rate variability (RMSSD)	25	552	1	1230	3246	4629	3239	4473	552	2262	2202	4490	2133	2949
915_Phospholipids in medium HDL	915_Phospholipids in medium HDL	25	552	1	2474	2949	1567	3481	2751	2192	1065	1180	552	4072	4386
285_CD4:%Treg(39+)	285_CD4:%Treg(39+)	25	553	1	1564	553	3364	3283	1988	2840	578	1022	873	833	4310
217_NKT:%4+R5-	217_NKT:%4+R5-	25	553	1	4261	2130	4333	3834	771	608	2876	1505	2984	553	1237
4531_Right inferior lateral ventricle	4531_Right inferior lateral ventricle	25	554	1	4236	3092	3318	554	1342	1779	4300	821	2549	2798	4511
3375_Time since last prostate specific antigen (PSA) test	3375_Time since last prostate specific antigen (PSA) test	25	554	1	4527	2721	4073	649	1659	554	1333	1520	3715	788	1617
315_CD8mem:%PD1+R6+	315_CD8mem:%PD1+R6+	25	554	1	4057	2271	4646	654	4096	2893	3371	1755	1502	554	4653
1475_Mean total cholesterol from exam 1-7 (GEE, adjusted for age and sex)	1475_Mean total cholesterol from exam 1-7 (GEE, adjusted for age and sex)	25	554	1	4288	4052	3729	2000	1708	3508	2291	1923	3214	3080	554
751_::::X-12056	751_::::X-12056	25	555	1	4529	639	3614	1433	3479	3503	645	555	1311	666	3699
3013_MAPK14 - Mitogen-activated protein kinase 14	3013_MAPK14 - Mitogen-activated protein kinase 14	25	555	1	4447	1702	3410	1155	2672	676	3165	1232	1313	911	555
3831_Amyotrophic lateral sclerosis (linear mixed model)	3831_Amyotrophic lateral sclerosis (linear mixed model)	25	556	1	556	3831	1860	4279	2355	4511	2612	2189	3867	3792	1346
2763_TF - Serotransferrin	2763_TF - Serotransferrin	25	556	1	2992	556	2922	1438	4500	4280	1846	2207	1984	3263	4406
1912_Occipital brain volume (FBAT, adjusted for multivariable)	1912_Occipital brain volume (FBAT, adjusted for multivariable)	25	556	1	1969	4521	556	3605	1326	1505	697	857	4368	4641	1099
268_CD4:%TM (1)	268_CD4:%TM (1)	25	556	1	965	2189	3711	3826	4593	556	2968	4164	1398	2749	2529
1725_Serum calcium (at exam 2, GEE, adjusted for age, sex and serum creatinine)	1725_Serum calcium (at exam 2, GEE, adjusted for age, sex and serum creatinine)	25	556	1	1189	4232	3863	1139	1295	3140	4088	556	3908	4677	779
341_NKeff:%314-R7-	341_NKeff:%314-R7-	25	556	1	3845	2343	3245	1196	4263	2351	2756	2641	556	2767	4637
2524_HIPK3 - Homeodomain-interacting protein kinase 3	2524_HIPK3 - Homeodomain-interacting protein kinase 3	25	556	1	3820	1255	723	2642	1922	623	4107	4711	4011	1735	556
2377_IDUA - alpha-L-iduronidase	2377_IDUA - alpha-L-iduronidase	25	557	1	4241	1473	3534	557	2630	3612	1159	2625	4195	3716	4200
1412_High-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	1412_High-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	558	1	3627	3755	3573	3622	558	3446	4204	3098	1743	2881	3807
1334_Fasting HbA1c (at exam 7, FBAT, adjusted for age, sex and BMI)	1334_Fasting HbA1c (at exam 7, FBAT, adjusted for age, sex and BMI)	25	558	1	3213	1965	1644	2256	2426	597	1203	2934	4171	3718	558
4086_Type 2 Diabetes (adjusted for BMI)	4086_Type 2 Diabetes (adjusted for BMI)	25	559	1	559	2212	4218	2764	4647	3737	4619	2864	3954	1671	3488
3749_Traumatic events - Someone to take to doctor when needed as a child	3749_Traumatic events - Someone to take to doctor when needed as a child	25	559	1	3743	559	779	4294	3991	3083	935	3700	1672	4081	3266
3049_TNFRSF25 - Tumor necrosis factor receptor superfamily member 25	3049_TNFRSF25 - Tumor necrosis factor receptor superfamily member 25	25	559	1	2005	3278	3619	559	3697	2039	1500	1020	1261	957	3852
940_Free cholesterol in small VLDL	940_Free cholesterol in small VLDL	25	559	1	4377	3241	998	3515	3118	559	4309	3549	1585	2688	2645
4675_Corticospinal tract axial diusivities	4675_Corticospinal tract axial diusivities	25	559	1	3721	573	4395	2071	1695	2152	1511	3044	559	2212	4276
3162_SET - Protein SET	3162_SET - Protein SET	25	560	1	2354	560	2852	854	2168	4253	3327	3311	1152	1063	1262
2520_FLT3 - Receptor-type tyrosine-protein kinase FLT3	2520_FLT3 - Receptor-type tyrosine-protein kinase FLT3	25	560	1	1981	2811	2831	1708	1459	1921	993	560	3943	1424	4035
4010_Amyotrophic lateral sclerosis	4010_Amyotrophic lateral sclerosis	25	561	1	3867	1800	2111	561	1556	4628	3124	1247	1391	573	3008
2272_APOE - Apolipoprotein E (isoform E3)	2272_APOE - Apolipoprotein E (isoform E3)	25	561	1	1295	1752	3266	2065	1319	4143	737	2425	561	1256	1481
1078_Serum Iron concentration	1078_Serum Iron concentration	25	562	1	562	1956	2765	3363	1057	2666	2539	3196	2237	4205	4166
2535_BCAN - Brevican core protein	2535_BCAN - Brevican core protein	25	562	1	3069	2276	4612	2889	2145	562	4090	3095	2649	3962	727
117_Extreme Body Mass Index	117_Extreme Body Mass Index	25	563	1	1608	563	1857	1088	4550	4238	1038	3150	819	4670	2131
2584_CASP3 - Caspase-3	2584_CASP3 - Caspase-3	25	563	1	4600	1378	2014	563	2455	1134	4019	4048	2818	2040	1865
3125_PDE11A - Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	3125_PDE11A - Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	25	563	1	1268	756	1701	3687	4167	2387	563	2440	958	3158	4437
100_Pubertal growth (male)	100_Pubertal growth (male)	25	563	1	3945	2633	3840	1278	1678	1028	1632	563	2221	3967	4387
2373_IL2RA - Interleukin-2 receptor subunit alpha	2373_IL2RA - Interleukin-2 receptor subunit alpha	25	564	1	2197	2426	3885	2439	564	610	1611	4139	3517	2528	3069
178_Waist circumference (female, adjusted for BMI)	178_Waist circumference (female, adjusted for BMI)	25	565	2	1487	3738	565	826	599	2240	1560	855	1199	3308	1819
3083_PRLR - Prolactin receptor	3083_PRLR - Prolactin receptor	25	565	1	643	2663	2888	2286	565	4326	2755	3406	2882	2263	4731
3638_Illnesses of mother: Heart disease	3638_Illnesses of mother: Heart disease	25	565	1	1101	1238	2497	4054	4453	2228	3138	683	3136	1299	565
3788_Insomnia (female)	3788_Insomnia (female)	25	566	1	1022	1654	4107	566	3466	3349	599	1876	1373	1749	2416
1414_High-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	1414_High-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	566	1	2201	3409	3174	1108	3788	566	4537	1335	2218	3946	1687
3305_Lifetime number of sexual partners	3305_Lifetime number of sexual partners	25	566	1	2254	2088	2187	1059	2152	2171	2525	566	2869	3737	1211
4099_High-density-lipoprotein cholesterol	4099_High-density-lipoprotein cholesterol	25	566	1	4172	4312	3444	3402	2440	3740	728	2462	566	3717	2800
1041_Shaft Width (GEE, adjusted for age and sex)	1041_Shaft Width (GEE, adjusted for age and sex)	25	566	1	4183	1840	1119	4576	2005	2566	1224	2891	4663	598	566
1655_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for age and sex)	1655_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for age and sex)	25	567	1	567	692	3237	3240	2126	3110	2432	1448	1719	1108	2737
1634_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for age and sex)	1634_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for age and sex)	25	567	1	3451	4388	567	4206	3510	1480	4618	4435	3292	3834	1314
3517_How are people in household related to participant: Husband, wife or partner	3517_How are people in household related to participant: Husband, wife or partner	25	567	1	1653	4193	1063	567	3996	4539	1267	787	1710	4350	4370
2354_FGF5 - Fibroblast growth factor 5	2354_FGF5 - Fibroblast growth factor 5	25	567	1	942	919	1848	3792	4321	1293	4740	1354	567	1224	993
3193_Number in household	3193_Number in household	25	568	1	3489	1830	2954	1498	568	4015	928	1196	852	4103	1526
3095_IL27RA - Interleukin-27 receptor subunit alpha	3095_IL27RA - Interleukin-27 receptor subunit alpha	25	568	1	2470	2986	655	2072	2267	3985	568	634	4252	2531	2366
1506_Triglycerides (at exam 5, FBAT, adjusted for age and sex)	1506_Triglycerides (at exam 5, FBAT, adjusted for age and sex)	25	568	1	1354	1091	2106	2455	4120	1422	2298	568	751	3808	972
3103_KRAS - GTPase KRas	3103_KRAS - GTPase KRas	25	568	1	3126	1518	2917	3783	2280	896	2221	2042	4098	568	889
3166_TNFRSF21 - Tumor necrosis factor receptor superfamily member 21	3166_TNFRSF21 - Tumor necrosis factor receptor superfamily member 21	25	569	1	2915	4550	3253	3066	569	1171	3056	4389	2044	2456	2743
3854_Monocyte percentage of white cells (two-way meta)	3854_Monocyte percentage of white cells (two-way meta)	25	570	1	4374	2647	3867	3827	570	970	4237	834	4536	783	1456
2598_HGFAC - Hepatocyte growth factor activator	2598_HGFAC - Hepatocyte growth factor activator	25	570	1	3937	4182	2586	3925	1374	570	1716	4376	4713	1420	2969
2737_GZMB - Granzyme B	2737_GZMB - Granzyme B	25	570	1	2856	2113	676	3766	3655	828	570	2479	1686	3867	1795
2583_CAMK1 - Calcium/calmodulin-dependent protein kinase type 1	2583_CAMK1 - Calcium/calmodulin-dependent protein kinase type 1	25	570	1	2066	2834	1324	3440	3515	669	3803	1171	570	2087	1604
2871_ADAMTS15 - A disintegrin and metalloproteinase with thrombospondin motifs 15	2871_ADAMTS15 - A disintegrin and metalloproteinase with thrombospondin motifs 15	25	571	1	2025	959	4435	571	1784	3975	1962	713	1746	2253	3851
1928_Temporal horn volume (FBAT, adjusted for age and sex)	1928_Temporal horn volume (FBAT, adjusted for age and sex)	25	571	1	1084	4724	1632	2708	1537	3279	4570	3115	1412	2524	571
730_::::X-11795	730_::::X-11795	25	572	1	4218	3137	2937	572	988	3844	2315	4727	709	2743	719
3902_Reticulocyte count (three-way meta)	3902_Reticulocyte count (three-way meta)	25	572	1	3185	2013	706	2140	928	572	847	4572	2168	3180	890
1715_Thyroid stimulation hormone (at exam 3, GEE, adjusted for multivariable)	1715_Thyroid stimulation hormone (at exam 3, GEE, adjusted for multivariable)	25	572	1	4279	4695	2034	3483	4197	646	3235	572	2552	3748	980
698_::::X-11412	698_::::X-11412	25	572	1	675	1652	2827	1125	575	1241	1767	648	3863	572	2230
2198_Human-virus - Protein Rev_HV2BE	2198_Human-virus - Protein Rev_HV2BE	25	573	1	3260	1995	4559	3138	2054	573	2855	3403	2517	1383	1675
1136_Parents' age at death	1136_Parents' age at death	25	573	1	1515	1673	1978	2027	3275	2419	573	2623	1682	712	4609
3114_HMGCR - 3-hydroxy-3-methylglutaryl-coenzyme A reductase	3114_HMGCR - 3-hydroxy-3-methylglutaryl-coenzyme A reductase	25	574	1	574	1711	1071	1913	976	3643	1004	4675	4669	622	3758
992_Interleukin-5	992_Interleukin-5	25	574	1	1932	3874	574	2971	955	2978	3379	3168	2669	1506	968
4752_Superior corona radiata radial diusivities	4752_Superior corona radiata radial diusivities	25	574	1	1953	3751	3949	2295	3879	574	4314	1899	4729	1932	4020
3729_Depression - Age at first episode of depression	3729_Depression - Age at first episode of depression	25	574	1	818	3519	811	1468	3618	1462	1880	1018	574	2813	600
2975_ANXA2 - Annexin A2	2975_ANXA2 - Annexin A2	25	576	1	2310	3540	1548	576	3067	4374	2220	1225	1929	2766	2052
384_Amino acid::Glycine, serine and threonine metabolism::threonine	384_Amino acid::Glycine, serine and threonine metabolism::threonine	25	576	1	3997	2978	3360	3120	1308	4698	576	2362	1245	3033	4629
519_Lipid::Long chain fatty acid::eicosenoate (20:1n9 or 11)	519_Lipid::Long chain fatty acid::eicosenoate (20:1n9 or 11)	25	577	1	577	1336	645	4240	4379	2485	3871	4192	2801	3912	2653
1479_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for age and sex)	1479_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for age and sex)	25	577	1	869	2583	1305	4035	728	3591	4385	1791	4026	599	577
4452_Left isthmus cingulate	4452_Left isthmus cingulate	25	578	1	1154	896	2691	578	2756	1833	759	4347	1490	1726	3377
3647_Illnesses of mother: Severe depression	3647_Illnesses of mother: Severe depression	25	578	1	2980	3105	3785	3671	578	1977	2326	1772	4260	4308	3006
1347_Plasma Apolipoprotein A-I level (GEE, adjusted for age and sex)	1347_Plasma Apolipoprotein A-I level (GEE, adjusted for age and sex)	25	578	1	2865	920	3188	932	2311	578	4521	3056	4618	684	1239
1298_Fasting plasma glucose (at exam 5, FBAT, adjusted for age and sex)	1298_Fasting plasma glucose (at exam 5, FBAT, adjusted for age and sex)	25	578	1	1440	2007	3040	1521	3214	4694	4373	694	2027	682	578
3527_Transport type for commuting to job workplace: Cycle	3527_Transport type for commuting to job workplace: Cycle	25	579	1	4646	3502	4374	579	821	4562	3319	4447	4278	4389	2785
212_Insomnia (female)	212_Insomnia (female)	25	579	1	3633	2657	4032	1265	4156	2748	1963	579	1820	4607	1891
469_Lipid::Bile acid metabolism::hyodeoxycholate	469_Lipid::Bile acid metabolism::hyodeoxycholate	25	579	1	2321	2273	3605	3180	3137	3293	3918	1456	579	2782	4009
4282_FEV1	4282_FEV1	25	580	1	580	4047	4340	2114	2266	4182	4426	4241	3434	1966	3724
781_::::X-12465	781_::::X-12465	25	580	1	2348	4554	1674	4504	580	1427	3295	1074	4528	3231	3191
1941_Hippocampal volume (GEE, adjusted for multivariable with APOE)	1941_Hippocampal volume (GEE, adjusted for multivariable with APOE)	25	580	1	1759	2658	1968	3789	3752	580	3865	4645	4545	3124	3564
4249_Diurnal inactivity duration	4249_Diurnal inactivity duration	25	581	1	2303	581	2378	601	1771	734	2051	3464	1642	2726	4666
3556_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Hormone replacement therapy	3556_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Hormone replacement therapy	25	581	1	2230	4092	581	1729	4565	2527	2529	1972	2033	1638	1194
1032_Neck Section Modulus (FBAT, adjusted for age and sex)	1032_Neck Section Modulus (FBAT, adjusted for age and sex)	25	581	1	3466	1953	3616	581	1521	3921	1601	1498	1519	4413	2612
966_Concentration of very small VLDL particles	966_Concentration of very small VLDL particles	25	581	1	1760	1309	2959	3673	581	2077	2175	2041	718	4119	2283
2550_CXCL13 - C-X-C motif chemokine 13	2550_CXCL13 - C-X-C motif chemokine 13	25	581	1	3829	1289	3326	1718	3693	4356	581	4037	3857	2499	3970
872_Glutamine	872_Glutamine	25	581	1	2040	3265	710	2672	2099	1609	4081	1504	2599	581	2557
1944_Total cerebral brain volume (FBAT, adjusted for multivariable with APOE)	1944_Total cerebral brain volume (FBAT, adjusted for multivariable with APOE)	25	581	1	4574	4136	4419	1634	827	903	2498	3821	3275	2067	581
1566_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for age and sex)	1566_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for age and sex)	25	582	1	582	3439	2962	1353	4416	3883	3463	4330	2962	1654	3937
790_::::X-12696	790_::::X-12696	25	582	1	1506	582	3125	4395	4499	4316	1785	2964	630	757	1688
3665_Diagnoses - main ICD10: C44 Other and unspecified malignant neoplasm of skin	3665_Diagnoses - main ICD10: C44 Other and unspecified malignant neoplasm of skin	25	582	1	2662	3973	2956	582	3790	899	3411	3450	4710	3607	1485
4349_Heart failure	4349_Heart failure	25	582	1	2277	4066	1217	3096	582	638	2840	3685	3230	3816	1176
2845_MFGE8 - Lactadherin	2845_MFGE8 - Lactadherin	25	583	1	4034	583	993	3867	628	3369	2112	3710	2754	3586	3479
949_Total phosphoglycerides	949_Total phosphoglycerides	25	583	1	1068	3850	583	1076	3509	953	3914	3103	1324	4037	4590
4622_Left thalamus proper	4622_Left thalamus proper	25	585	1	585	1368	3775	3080	1054	1139	2961	4335	3313	770	836
2887_IL34 - Interleukin-34	2887_IL34 - Interleukin-34	25	585	1	2311	2369	4497	4687	2704	585	3019	3507	3763	4538	849
122_Obesity class 3	122_Obesity class 3	25	585	1	1881	1139	3936	969	3625	2629	1788	3301	2171	585	4131
2614_DKKL1 - Dickkopf-like protein 1	2614_DKKL1 - Dickkopf-like protein 1	25	587	1	1834	2365	587	3300	2636	4037	3454	1824	4140	3988	3940
4019_Age spot	4019_Age spot	25	588	1	588	3527	1880	3527	3747	3136	1967	3989	4728	3083	2224
2703_UBE2L3 - Ubiquitin-conjugating enzyme E2 L3	2703_UBE2L3 - Ubiquitin-conjugating enzyme E2 L3	25	588	1	693	2515	2971	2299	2753	4312	588	1676	797	2109	4214
3940_Body Mass Index (male)	3940_Body Mass Index (male)	25	589	1	1712	589	3439	3335	3537	1973	4736	3324	4244	746	2265
3930_N-glycosylation	3930_N-glycosylation	25	589	1	1032	719	589	1657	1891	595	2531	2618	910	4519	589
4558_Left middle temporal	4558_Left middle temporal	25	589	1	2403	2378	2512	4048	589	2780	4164	3726	2713	1926	3674
3068_KIR3DS1 - Killer cell immunoglobulin-like receptor 3DS1	3068_KIR3DS1 - Killer cell immunoglobulin-like receptor 3DS1	25	589	1	1389	3006	825	2076	2239	589	2683	2800	4273	1711	3886
2757_TNC - Tenascin	2757_TNC - Tenascin	25	589	1	4601	2873	3620	1914	2174	2216	1450	2469	589	2712	3781
3034_SPTAN1 - Spectrin alpha chain, non-erythrocytic 1	3034_SPTAN1 - Spectrin alpha chain, non-erythrocytic 1	25	590	1	1569	3444	2191	4005	3647	590	1827	4564	3614	2793	2809
4514_3rd ventricle	4514_3rd ventricle	25	590	1	3661	3697	2650	672	2728	2092	2585	590	4240	1400	4522
4459_Left paracentral	4459_Left paracentral	25	590	1	1167	603	4491	640	4658	4745	725	2465	1374	590	2980
2002_Serum YKL-40 level	2002_Serum YKL-40 level	25	591	1	591	3599	3273	4555	3425	3188	3649	3078	4405	2938	3072
286_CD4:%Treg(39-73+)	286_CD4:%Treg(39-73+)	25	591	1	826	591	3921	1614	3158	3411	855	3890	2431	1104	2578
4115_Calcium	4115_Calcium	25	591	1	1051	3281	2210	591	2085	1309	3216	2991	4428	3316	2904
1911_Temporal horn volume (GEE, adjusted for multivariable)	1911_Temporal horn volume (GEE, adjusted for multivariable)	25	591	1	2114	3926	3740	3337	4577	591	1413	4234	1052	3974	2816
4364_Vigorous physical activity	4364_Vigorous physical activity	25	591	1	2905	2408	2265	1826	3362	4524	981	591	3465	4699	4608
101_Pubertal growth	101_Pubertal growth	25	591	1	2947	1005	4179	1375	3332	4577	2230	3462	3405	591	3440
367_Amino acid::Alanine and aspartate metabolism::N-acetylalanine	367_Amino acid::Alanine and aspartate metabolism::N-acetylalanine	25	592	1	2495	2797	592	1910	886	2658	601	3881	2154	626	3999
4753_Superior fronto-occipital fasciculus radial diusivities	4753_Superior fronto-occipital fasciculus radial diusivities	25	592	1	793	2660	3453	3938	3402	2970	1655	592	3309	3273	1062
561_Lipid::Medium chain fatty acid::undecanoate (11:0)	561_Lipid::Medium chain fatty acid::undecanoate (11:0)	25	593	1	1812	2791	1801	954	3448	3133	593	3392	976	1118	3399
3382_Prospective memory test - Duration screen displayed	3382_Prospective memory test - Duration screen displayed	25	594	1	994	3996	1090	594	2972	4350	3821	2531	4337	2313	2353
490_Lipid::Essential fatty acid::eicosapentaenoate (EPA; 20:5n3)	490_Lipid::Essential fatty acid::eicosapentaenoate (EPA; 20:5n3)	25	594	1	4382	3423	1375	4543	594	4014	2189	4607	791	4089	2674
3619_Treatment/medication code: ibuprofen	3619_Treatment/medication code: ibuprofen	25	594	1	2578	4421	3361	1320	1757	2037	3824	594	1242	2693	3178
4289_PEF	4289_PEF	25	594	1	3437	726	4372	875	3791	1058	997	1570	594	2503	2248
3762_Anxiety - Recent inability to stop or control worying	3762_Anxiety - Recent inability to stop or control worying	25	594	1	1458	3929	2932	2393	1530	2575	4156	2574	2445	700	594
539_Lipid::Lysolipid::1-myristoylglycerophosphocholine	539_Lipid::Lysolipid::1-myristoylglycerophosphocholine	25	595	1	595	2545	1481	4615	4469	4424	3637	1164	920	4029	3609
3039_TNFAIP6 - Tumor necrosis factor-inducible gene 6 protein	3039_TNFAIP6 - Tumor necrosis factor-inducible gene 6 protein	25	595	1	2968	3210	3662	595	2847	2934	3921	4019	3613	3314	2629
3357_Likelihood of resuming smoking	3357_Likelihood of resuming smoking	25	596	1	3570	883	4013	3154	3707	2272	1876	596	2740	3326	4206
3792_Daytime napping	3792_Daytime napping	25	596	1	731	1761	2212	2127	2610	4431	4584	2971	1274	596	3524
3776_Traumatic events - Been in serious accident believed to be life-threatening	3776_Traumatic events - Been in serious accident believed to be life-threatening	25	596	1	4076	3433	1740	3589	2969	3647	2665	4006	3861	4199	596
2214_FGA FGB FGG - Fibrinogen	2214_FGA FGB FGG - Fibrinogen	25	597	1	597	1094	4302	2418	2327	1979	3468	1156	3591	3125	1734
274_CD8:%TEM	274_CD8:%TEM	25	597	1	767	2675	597	1174	4471	4617	2808	859	2817	2589	3153
2491_SERPINA5 - Plasma serine protease inhibitor	2491_SERPINA5 - Plasma serine protease inhibitor	25	597	1	3686	2476	2070	4124	597	1930	1173	3224	2836	2070	3164
2507_IBSP - Bone sialoprotein 2	2507_IBSP - Bone sialoprotein 2	25	597	1	2189	4208	2081	1765	868	1415	3301	597	932	4130	3327
1322_Fasting plasma glucose (at exam 5, FBAT, adjusted for age, sex and BMI)	1322_Fasting plasma glucose (at exam 5, FBAT, adjusted for age, sex and BMI)	25	597	1	2630	1773	2197	4393	4585	4033	3986	3238	705	597	1446
1931_Occipital brain volume (GEE, adjusted for age and sex)	1931_Occipital brain volume (GEE, adjusted for age and sex)	25	597	1	4102	4664	653	2959	1461	4292	2770	2779	2396	2429	597
392_Amino acid::Phenylalanine & tyrosine metabolism::3-(4-hydroxyphenyl)lactate	392_Amino acid::Phenylalanine & tyrosine metabolism::3-(4-hydroxyphenyl)lactate	25	598	1	598	3696	2637	1756	4284	1308	4671	3273	2361	1969	1601
304_CD4mem:%Th1* (5)	304_CD4mem:%Th1* (5)	25	598	1	2247	4419	3790	2555	598	3753	2361	2374	4012	4506	4305
1060_Breast cancer	1060_Breast cancer	25	598	1	4713	4587	4044	1861	1553	598	3215	1425	2820	1700	969
2174_LAMA1 LAMB1  LAMC1 - Laminin	2174_LAMA1 LAMB1  LAMC1 - Laminin	25	598	1	739	2455	4467	1628	2850	4599	598	2798	4495	3860	845
333_NKeff:%337+	333_NKeff:%337+	25	598	1	3044	3221	3667	1692	3379	4345	3467	598	1837	3327	1369
1116_Visceral sdipose tissue volume (adjusted for BMI, female)	1116_Visceral sdipose tissue volume (adjusted for BMI, female)	25	599	1	1761	4489	599	4260	4257	3582	3075	1879	4586	1609	1384
1470_Lipoprotein A (at exam 3, FBAT, adjusted for age and sex)	1470_Lipoprotein A (at exam 3, FBAT, adjusted for age and sex)	25	599	1	3891	1422	4036	1865	762	922	3024	3939	3487	2437	599
2319_SIGLEC9 - Sialic acid-binding Ig-like lectin 9	2319_SIGLEC9 - Sialic acid-binding Ig-like lectin 9	25	600	1	600	4277	834	1195	3926	3692	2110	2260	2366	2728	4468
2890_BIRC7 - Baculoviral IAP repeat-containing protein 7 Isoform beta	2890_BIRC7 - Baculoviral IAP repeat-containing protein 7 Isoform beta	25	600	1	3369	2632	3371	1012	3977	600	1064	1701	4698	2594	3060
1205_Serum Thyroid-stimulating hormone level	1205_Serum Thyroid-stimulating hormone level	25	601	1	601	2979	2392	2762	2162	3367	1344	1589	2819	1442	4510
1570_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	1570_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	25	601	1	4603	4286	3134	3670	601	833	4049	4567	4317	3078	1552
3476_Own or rent accommodation lived in: Own outright (by you or someone in your household)	3476_Own or rent accommodation lived in: Own outright (by you or someone in your household)	25	601	1	2099	2059	3985	737	2577	2881	2405	2473	3910	601	3613
2188_C1QA C1QB  C1QC - Complement C1q subcomponent	2188_C1QA C1QB  C1QC - Complement C1q subcomponent	25	601	1	2022	4549	4660	4646	1842	3646	4076	2066	2971	716	601
1635_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for age and sex)	1635_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for age and sex)	25	602	1	1066	1849	602	3312	4273	1235	4528	3501	2188	1498	2510
2722_PSMD7 - 26S proteasome non-ATPase regulatory subunit 7	2722_PSMD7 - 26S proteasome non-ATPase regulatory subunit 7	25	602	1	1582	4692	1714	602	3304	1959	2935	4129	2670	4711	4538
3134_GRAP2 - GRB2-related adapter protein 2	3134_GRAP2 - GRB2-related adapter protein 2	25	602	1	2932	3778	3513	4022	602	2255	884	3162	1992	4468	4101
862_Creatinine	862_Creatinine	25	602	1	3436	1355	2150	2146	4558	602	680	2488	1742	3148	3907
242_PD1 on CD4mem	242_PD1 on CD4mem	25	603	1	603	1864	822	916	4299	1961	4566	3841	2230	2612	3737
963_Phospholipids in very large VLDL	963_Phospholipids in very large VLDL	25	603	1	1308	1016	2703	3009	603	1903	2247	633	2108	2808	2892
1825_Inter-trochanteric buckling ratio (GEE, male, adjussted for age)	1825_Inter-trochanteric buckling ratio (GEE, male, adjussted for age)	25	603	1	1648	2881	3652	637	1166	603	691	1780	781	4716	2915
590_Nucleotide::Pyrimidine metabolism, uracil containing::uridine	590_Nucleotide::Pyrimidine metabolism, uracil containing::uridine	25	603	1	1226	2598	2112	4283	3246	709	4449	1974	2018	1419	603
2984_CTSZ - Cathepsin Z	2984_CTSZ - Cathepsin Z	25	604	1	604	4278	1566	3859	801	1395	623	3591	4298	4612	1330
1181_Sleep duration	1181_Sleep duration	25	604	1	2996	2332	4289	4469	604	2317	3895	4094	4267	4604	2075
2581_C1S - Complement C1s subcomponent	2581_C1S - Complement C1s subcomponent	25	604	1	2119	4394	2797	1871	2648	604	2584	1427	3368	2462	1762
3303_Able to confide	3303_Able to confide	25	604	1	4480	2786	4215	1907	1610	4517	2329	604	2958	3371	1533
293_CD4:%Act(PD1+127+39-73-)	293_CD4:%Act(PD1+127+39-73-)	25	604	1	3001	2204	808	2254	3771	2174	1246	2961	4425	2582	604
1990_Age at death (FBAT, adjusted for birth-cohort)	1990_Age at death (FBAT, adjusted for birth-cohort)	25	605	1	3115	605	4401	2822	2483	1217	2883	2257	2929	665	635
1130_Ratio of visceral-tosubcutaneous adipose tissue volume (male)	1130_Ratio of visceral-tosubcutaneous adipose tissue volume (male)	25	605	1	1635	2867	605	700	2049	4163	1444	1288	964	1941	3390
4742_External capsule radial diusivities	4742_External capsule radial diusivities	25	605	1	3555	4387	4022	3309	1902	605	1587	3695	2733	3168	1847
4662_Retrolenticular part of internal capsule fractional anisotropy	4662_Retrolenticular part of internal capsule fractional anisotropy	25	605	1	3057	3944	1404	2802	2807	2440	605	1472	4544	2181	2355
4160_Focal Epilepsy, hippocampal sclerosis (HS)	4160_Focal Epilepsy, hippocampal sclerosis (HS)	25	606	1	2415	800	2229	1531	1547	3146	1144	606	3924	1921	4130
2411_ASAH2 - Neutral ceramidase	2411_ASAH2 - Neutral ceramidase	25	606	1	2640	1584	4294	1494	3726	1680	3012	4401	1608	606	4413
2058_Psoriasis	2058_Psoriasis	25	606	1	3424	1741	2760	4361	2856	850	2424	1734	3333	1239	606
361_mDCL%274+	361_mDCL%274+	25	607	1	2443	1342	3809	4243	607	2105	1639	4026	3844	3012	3104
1146_Peak insulin response (adjusted for BMI)	1146_Peak insulin response (adjusted for BMI)	25	607	1	1703	2971	1181	2450	2985	607	4705	2919	2783	3254	880
791_::::X-12704	791_::::X-12704	25	607	1	2742	1523	1831	4707	3323	1050	3577	2422	607	2473	1828
1140_Type 2 Diabetes (Dominance deviation model)	1140_Type 2 Diabetes (Dominance deviation model)	25	608	1	3144	608	4493	2321	1360	2141	2028	3679	4338	906	3827
3225_Hands-free device/speakerphone use with mobile phone in last 3 month	3225_Hands-free device/speakerphone use with mobile phone in last 3 month	25	608	1	2016	1889	4680	940	2589	670	2565	608	3770	1326	2177
3456_Impedance measures - Leg fat percentage (left)	3456_Impedance measures - Leg fat percentage (left)	25	609	1	609	2301	2597	1582	3986	1254	3591	3705	3575	2061	3422
3161_SEMA3E - Semaphorin-3E	3161_SEMA3E - Semaphorin-3E	25	609	1	4376	3143	1196	994	2768	805	1673	1705	2742	609	2700
338_NKeff:%Kir+ (3)	338_NKeff:%Kir+ (3)	25	610	1	3188	610	3558	908	961	4453	2504	3127	1158	4387	2850
3924_Heart rate variability (pvRSA/HF)	3924_Heart rate variability (pvRSA/HF)	25	610	1	2765	641	833	680	3641	1094	1242	968	610	2412	2345
2773_VTA1 - Vacuolar protein sorting-associated protein VTA1 homolog	2773_VTA1 - Vacuolar protein sorting-associated protein VTA1 homolog	25	610	1	778	2134	1879	3629	4505	2544	2752	4678	3525	3529	610
767_::::X-12236	767_::::X-12236	25	611	1	611	3653	969	1724	4054	1388	3972	3872	2283	4595	2165
1437_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1437_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	611	1	761	2875	611	2519	3530	3825	1519	2920	3546	4333	2186
3069_KLRF1 - Killer cell lectin-like receptor subfamily F member 1	3069_KLRF1 - Killer cell lectin-like receptor subfamily F member 1	25	611	1	2100	4478	3827	2181	611	2739	3472	1579	3749	2543	4208
3793_Sleep duration	3793_Sleep duration	25	612	1	4072	612	3010	1176	1198	2203	706	2478	1727	917	1319
2400_IDE - Insulin-degrading enzyme	2400_IDE - Insulin-degrading enzyme	25	612	1	2718	924	612	953	622	4567	4499	708	4588	960	853
1122_Pericardial adipose tissue volume (adjusted for height and weight, female)	1122_Pericardial adipose tissue volume (adjusted for height and weight, female)	25	612	1	2033	4517	1272	2738	612	1563	3581	2280	4603	2007	4264
3182_SPOCK2 - Testican-2	3182_SPOCK2 - Testican-2	25	612	1	3200	1717	1838	4297	4019	2416	2101	3802	612	3358	3654
4153_Fractional shortening	4153_Fractional shortening	25	613	1	613	2962	2421	3061	818	1864	886	2037	3967	2909	3378
796_::::X-12728	796_::::X-12728	25	613	1	4043	613	1952	2534	1090	1607	1007	1062	1928	1917	3825
4184_Total cholesterol	4184_Total cholesterol	25	613	1	4179	2832	613	2324	998	2438	2925	3040	3098	2711	2114
4722_Fornix (cres) / Stria terminalis mode of anisotropy	4722_Fornix (cres) / Stria terminalis mode of anisotropy	25	613	1	3499	3808	695	1624	613	3432	2652	3613	3429	4536	3461
1505_Triglycerides (at exam 4, GEE, adjusted for age and sex)	1505_Triglycerides (at exam 4, GEE, adjusted for age and sex)	25	615	1	3710	615	3578	4138	2488	3410	1563	3365	1325	725	1381
4535_Right caudate	4535_Right caudate	25	615	1	744	1469	3264	615	4405	4297	1603	3254	1220	1555	4296
2317_PDCD1LG2 - Programmed cell death 1 ligand 2	2317_PDCD1LG2 - Programmed cell death 1 ligand 2	25	615	1	1631	3018	2401	3770	1275	615	2044	2439	3598	618	1378
3281_Mother's age	3281_Mother's age	25	615	1	2248	2401	3507	3905	2460	2407	3594	1644	615	1062	777
3524_Transport type for commuting to job workplace: Car/motor vehicle	3524_Transport type for commuting to job workplace: Car/motor vehicle	25	615	1	2191	3437	776	1040	4580	3610	2675	1893	2994	615	3402
1682_Brain natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	1682_Brain natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	25	616	1	3077	4266	616	1517	4224	837	2004	3619	3422	1371	1053
4205_Estimated glomerular filtration rate	4205_Estimated glomerular filtration rate	25	616	1	881	4001	1223	616	2599	1674	4267	1519	4128	3239	4081
4183_Triglyceride	4183_Triglyceride	25	616	1	3108	3840	1205	3331	1783	2423	1411	3310	616	2485	1295
310_CD4nv:%preTh17	310_CD4nv:%preTh17	25	616	1	2242	1144	2113	4104	3220	3404	4644	3888	3228	616	4379
4103_Hemoglobin A1c	4103_Hemoglobin A1c	25	616	1	4567	2995	2752	2752	1356	830	3886	889	3766	3542	616
2182_SHH - Sonic hedgehog protein	2182_SHH - Sonic hedgehog protein	25	617	1	4317	2728	617	4313	2193	3438	2559	3347	2732	1664	3447
3400_Noisy workplace	3400_Noisy workplace	25	617	1	3770	4735	4480	617	1160	1089	4252	3338	4101	1346	3331
1806_SDNN HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1806_SDNN HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	617	1	3294	3629	2362	1568	957	617	2511	3488	4607	2486	2483
724_::::X-11552	724_::::X-11552	25	617	1	2704	1254	4648	2915	3068	1101	617	1141	693	826	1896
2850_SPARCL1 - SPARC-like protein 1	2850_SPARCL1 - SPARC-like protein 1	25	617	1	915	1467	1447	1553	1928	2230	4154	1246	4430	856	617
4729_Splenium of corpus callosum mode of anisotropy	4729_Splenium of corpus callosum mode of anisotropy	25	618	1	618	652	3950	3568	4292	4103	3352	2406	4060	675	3516
4559_Left parahippocampal	4559_Left parahippocampal	25	618	1	4313	618	3843	1204	1127	3980	2941	2975	2389	792	702
4446_Left caudal middle frontal	4446_Left caudal middle frontal	25	618	1	3088	3722	618	2870	757	4478	1914	4336	3438	3650	1580
762_::::X-12212	762_::::X-12212	25	618	1	3272	1783	4080	3432	618	3522	1006	1825	4737	3830	3644
4631_Right lateral ventricle	4631_Right lateral ventricle	25	618	1	2402	3798	3248	1276	3144	618	2718	2748	3660	2999	3541
2038_Attention function - Alerting - Child	2038_Attention function - Alerting - Child	25	618	1	918	3780	2997	1812	3179	2853	4434	1737	2059	3761	618
2950_F5 - Coagulation Factor V	2950_F5 - Coagulation Factor V	25	619	1	2747	619	1312	1832	2981	2294	3438	3331	2094	3182	1719
4123_Activated partial thromboplastin time	4123_Activated partial thromboplastin time	25	619	1	2071	4642	641	4408	619	993	3574	4529	837	2977	627
2001_Height	2001_Height	25	620	1	3896	3375	3761	620	4714	3190	2581	827	3346	3088	3407
198_Urinary albumin-to-creatinine ratio (diabetes positive)	198_Urinary albumin-to-creatinine ratio (diabetes positive)	25	620	1	4363	3428	2476	2928	620	4732	4745	2981	3125	2614	1921
4220_Antihypertensives	4220_Antihypertensives	25	621	1	4170	1570	3524	1775	3270	2611	3601	4216	621	2013	2876
4239_Latent naming speed	4239_Latent naming speed	25	622	1	2400	1975	2828	622	2586	4302	669	3715	3563	2461	3719
2087_ANGPT4 - Angiopoietin-4	2087_ANGPT4 - Angiopoietin-4	25	622	1	2973	3144	4190	923	3396	2503	3369	622	3196	4528	1082
1113_Visceral sdipose tissue volume (female)	1113_Visceral sdipose tissue volume (female)	25	622	1	4550	1866	4368	747	3864	2618	4197	2755	622	2307	3820
1879_Shaft cross-sectional moment of inertia (GEE, adjussted for multivariable)	1879_Shaft cross-sectional moment of inertia (GEE, adjussted for multivariable)	25	622	1	3716	4621	3955	927	1180	737	3618	1333	1827	4558	622
2313_JAM3 - Junctional adhesion molecule C	2313_JAM3 - Junctional adhesion molecule C	25	623	1	623	1636	1114	1646	3314	3723	3006	1258	3403	4731	2942
1085_Behcet disease	1085_Behcet disease	25	623	1	2795	1567	4552	1300	4327	829	2794	623	1177	791	1399
1328_Fasting insulin (at exam 7, FBAT, adjusted for age, sex and BMI)	1328_Fasting insulin (at exam 7, FBAT, adjusted for age, sex and BMI)	25	624	1	1835	1850	3516	3016	1376	4556	2523	966	4591	624	4286
2882_FUT3 - Galactoside 3(4)-L-fucosyltransferase	2882_FUT3 - Galactoside 3(4)-L-fucosyltransferase	25	625	1	625	2544	3523	2237	1416	2390	1729	2170	3810	3405	1094
3809_Monocyte count	3809_Monocyte count	25	625	1	2692	2328	625	3796	4551	685	4639	2613	4612	3574	4636
4688_Superior longitudinal fasciculus axial diusivities	4688_Superior longitudinal fasciculus axial diusivities	25	625	1	742	2879	1716	4523	3140	4229	625	3525	3573	3210	2911
113_Height	113_Height	25	625	1	3771	2349	2387	2047	1483	1840	771	3609	4646	988	625
2760_PLAU - Urokinase-type plasminogen activator	2760_PLAU - Urokinase-type plasminogen activator	25	626	1	626	4274	2749	2876	707	2124	3397	2487	1667	1557	2513
3566_Vitamin and mineral supplements: Multivitamins +/- minerals	3566_Vitamin and mineral supplements: Multivitamins +/- minerals	25	626	1	3676	1735	4100	626	1957	1311	1536	3866	2071	2384	3459
4534_Right thalamus proper	4534_Right thalamus proper	25	626	1	1686	3530	1033	3305	626	2656	3592	1926	3363	1741	1444
3126_PDE3A - cGMP-inhibited 3',5'-cyclic phosphodiesterase A	3126_PDE3A - cGMP-inhibited 3',5'-cyclic phosphodiesterase A	25	626	1	3956	4221	3278	2791	4282	626	4279	3104	4223	1668	1909
910_Total cholesterol in medium HDL	910_Total cholesterol in medium HDL	25	626	1	960	1337	3701	852	2398	4596	626	1782	2403	755	4408
16_Posttraumatic stress disorder	16_Posttraumatic stress disorder	25	627	1	1041	3977	864	1726	627	3206	2173	3804	1263	2467	3952
2706_CAMKK1 - Calcium/calmodulin-dependent protein kinase kinase 1	2706_CAMKK1 - Calcium/calmodulin-dependent protein kinase kinase 1	25	627	1	993	2161	3561	3735	3312	4223	3159	627	3995	4660	954
3959_Antisocial behavior (female)	3959_Antisocial behavior (female)	25	627	1	3330	2816	1959	3571	1869	1944	916	797	2367	627	1654
1668_Aspartate aminotransferase (at exam 2, FBAT, adjusted for multivariable)	1668_Aspartate aminotransferase (at exam 2, FBAT, adjusted for multivariable)	25	628	1	628	3947	948	3304	3272	1115	4696	2852	1425	2078	1193
15_Posttraumatic stress disorder	15_Posttraumatic stress disorder	25	629	1	2913	629	1321	4060	3455	4689	715	4152	2560	1040	1010
2298_CTGF - Connective tissue growth factor	2298_CTGF - Connective tissue growth factor	25	629	1	1656	2874	2863	629	2716	1257	2586	1462	2074	3975	1651
4253_Sleep duration (mean)	4253_Sleep duration (mean)	25	629	1	2241	1617	794	1752	968	629	4713	3470	3940	2054	1205
524_Lipid::Long chain fatty acid::oleate (18:1n9)	524_Lipid::Long chain fatty acid::oleate (18:1n9)	25	630	1	630	1331	2588	2294	634	4190	1088	1028	1356	1946	3326
230_mDC:%X-Presenting	230_mDC:%X-Presenting	25	630	1	1371	630	3594	3389	1884	3675	3685	3060	2454	631	4604
1937_Total cerebral brain volume (GEE, adjusted for age and sex)	1937_Total cerebral brain volume (GEE, adjusted for age and sex)	25	630	1	1327	3547	4139	4701	2058	630	3773	4654	2330	2849	3443
1585_D-dimer (at exam 6, GEE, adjusted for multivariable)	1585_D-dimer (at exam 6, GEE, adjusted for multivariable)	25	630	1	1045	2249	640	3103	2423	863	1481	3987	3093	3014	630
549_Lipid::Lysolipid::2-linoleoylglycerophosphocholine*	549_Lipid::Lysolipid::2-linoleoylglycerophosphocholine*	25	631	1	4210	1790	3549	2381	631	2742	2717	4436	3723	3416	1984
4496_Right posterior cingulate	4496_Right posterior cingulate	25	631	1	4721	1918	2486	2806	2194	2125	631	3910	1148	2048	4172
715_::::X-11497	715_::::X-11497	25	631	1	4560	1211	2812	4166	3827	3948	895	631	2176	2950	3379
3354_Age stopped smoking	3354_Age stopped smoking	25	631	1	4591	796	3782	645	4142	4527	718	979	631	4252	3020
2955_GSTP1 - Glutathione S-transferase P	2955_GSTP1 - Glutathione S-transferase P	25	631	1	3314	1241	2796	1781	2827	2962	1670	4452	2338	3085	631
474_Lipid::Bile acid metabolism::ursodeoxycholate	474_Lipid::Bile acid metabolism::ursodeoxycholate	25	632	1	632	3936	932	3545	2196	1535	2980	1992	1156	1349	3372
902_Concentration of large VLDL particles	902_Concentration of large VLDL particles	25	632	1	3410	4303	1125	2616	1292	1818	1290	1860	632	2343	3376
416_Amino acid::Urea cycle; arginine-, proline-, metabolism::ornithine	416_Amino acid::Urea cycle; arginine-, proline-, metabolism::ornithine	25	633	1	858	1202	2979	2092	1006	633	2240	4634	2129	1250	1297
465_Lipid::Bile acid metabolism::deoxycholate	465_Lipid::Bile acid metabolism::deoxycholate	25	633	1	4559	2724	1629	1593	643	3846	1824	1805	633	2587	2281
2989_DSC3 - Desmocollin-3	2989_DSC3 - Desmocollin-3	25	634	1	1714	1988	754	2631	4679	1324	2680	2310	634	1435	2865
658_::::X-04357	658_::::X-04357	25	635	1	635	2860	2657	2832	3354	3997	3461	2071	3318	3446	4205
475_Lipid::Carnitine metabolism::2-tetradecenoyl carnitine	475_Lipid::Carnitine metabolism::2-tetradecenoyl carnitine	25	635	1	984	4334	635	2812	2024	2735	1073	4248	750	2394	4596
2628_ALB - Serum albumin	2628_ALB - Serum albumin	25	635	1	1610	2601	4034	1725	2338	635	4559	3063	3818	1860	2039
1075_Leprosy	1075_Leprosy	25	636	1	4573	636	3581	4486	4050	1084	4052	4242	1416	676	3628
559_Lipid::Medium chain fatty acid::laurate (12:0)	559_Lipid::Medium chain fatty acid::laurate (12:0)	25	636	1	1593	2747	1133	2073	1431	1294	3984	636	3836	3657	1908
482_Lipid::Carnitine metabolism::laurylcarnitine	482_Lipid::Carnitine metabolism::laurylcarnitine	25	637	1	4368	3115	1618	4169	1508	1637	2196	637	4030	3721	4383
906_Lactate	906_Lactate	25	637	1	4081	750	1348	1636	4501	4590	2292	776	637	4055	3733
3105_PDE9A - High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	3105_PDE9A - High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	25	637	1	1609	3745	1202	2551	4489	1051	1297	915	1284	637	2628
84_Forearm BMD	84_Forearm BMD	25	638	1	4540	2587	4405	3050	638	4440	2750	2842	2212	1165	2340
2521_FSTL3 - Follistatin-related protein 3	2521_FSTL3 - Follistatin-related protein 3	25	638	1	2326	3986	3164	1413	1149	2261	4298	638	1894	3409	817
1288_Waist circumference by CT (FBAT, adjusted for age and sex)	1288_Waist circumference by CT (FBAT, adjusted for age and sex)	25	639	1	1446	2041	3358	1642	861	3588	4510	3652	4163	639	793
2516_EPHA1 - Ephrin type-A receptor 1	2516_EPHA1 - Ephrin type-A receptor 1	25	640	1	3644	4717	3734	2727	640	3990	3949	4666	2976	1192	4240
50_Number of children ever born	50_Number of children ever born	25	640	1	4572	1882	3256	1743	1718	640	2777	2861	3805	1958	2308
1413_High-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	1413_High-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	25	640	1	3803	3702	1495	1973	1040	4439	747	640	2755	2966	864
3135_MMP16 - Matrix metalloproteinase-16	3135_MMP16 - Matrix metalloproteinase-16	25	640	1	2127	4025	3996	4319	4202	1469	2590	4523	4340	3770	640
2466_ADRBK1 - beta-adrenergic receptor kinase 1	2466_ADRBK1 - beta-adrenergic receptor kinase 1	25	641	1	641	2049	996	901	1396	3348	3863	1128	687	1653	1858
4113_Potassium	4113_Potassium	25	641	1	1920	2684	2058	714	641	3510	2480	2701	2276	2936	3663
2694_PSMA1 - Proteasome subunit alpha type-1	2694_PSMA1 - Proteasome subunit alpha type-1	25	641	1	3899	898	1825	2434	2228	4191	641	2155	793	4339	1268
1583_D-dimer (at exam 6, GEE, adjusted for age and sex)	1583_D-dimer (at exam 6, GEE, adjusted for age and sex)	25	641	1	3320	3262	3751	1039	2088	3297	1239	1214	641	3281	3517
4515_4th ventricle	4515_4th ventricle	25	641	1	2308	885	887	2652	4325	4036	3806	1057	3247	672	641
328_CD4mem:%preTh17 (3)	328_CD4mem:%preTh17 (3)	25	642	1	642	1715	3928	3613	1307	2283	4635	1684	4168	4269	3203
4014_Major depressive disorder	4014_Major depressive disorder	25	642	1	651	766	642	1988	3263	3098	694	2724	1186	1060	1597
1462_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1462_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	642	1	2820	1974	2088	4278	927	972	1593	1884	3574	1493	642
2755_SERPINA3 - alpha-1-antichymotrypsin complex	2755_SERPINA3 - alpha-1-antichymotrypsin complex	25	643	1	4552	4540	3312	643	4286	4012	1379	4163	2265	4149	1869
710_::::X-11470	710_::::X-11470	25	643	1	1531	1644	4050	3092	3577	2217	954	3243	3397	643	1044
2559_ITGA1 ITGB1 - Integrin alpha-I: beta-1 complex	2559_ITGA1 ITGB1 - Integrin alpha-I: beta-1 complex	25	643	1	4083	2674	1416	1507	2102	1823	3812	4197	2083	1780	643
3842_Granulocyte percentage of myeloid white cells (two-way meta)	3842_Granulocyte percentage of myeloid white cells (two-way meta)	25	644	1	4609	3743	3062	2168	644	1504	3818	1667	3064	912	1316
4331_Postburn scar height	4331_Postburn scar height	25	644	1	3239	1716	3456	1236	4253	1458	644	1037	1734	1142	3361
589_Nucleotide::Pyrimidine metabolism, uracil containing::pseudouridine	589_Nucleotide::Pyrimidine metabolism, uracil containing::pseudouridine	25	644	1	3958	3664	2273	1596	3321	1598	4617	1521	644	2574	4328
4028_Alcohol dependency (fixed effect model for unrelated genotyped individuals)	4028_Alcohol dependency (fixed effect model for unrelated genotyped individuals)	25	645	1	645	3332	2607	2386	2607	4149	4381	4610	4362	4408	1758
943_Phospholipids in small VLDL	943_Phospholipids in small VLDL	25	645	1	2697	4107	1602	4227	3646	1351	2306	3763	645	3603	2404
3409_Education - Qualifications	3409_Education - Qualifications	25	645	1	745	2991	1759	3254	2785	3413	3524	2763	1775	918	645
1753_Cystatin C (at exam 7, GEE, adjusted for multivariable)	1753_Cystatin C (at exam 7, GEE, adjusted for multivariable)	25	646	1	646	1026	4502	4177	1222	3153	3651	2237	3321	1081	908
4301_Arms-arm fat ratio (male)	4301_Arms-arm fat ratio (male)	25	646	1	813	1472	1988	646	2537	3725	3222	4034	1053	2427	1261
2646_IL5 - Interleukin-5	2646_IL5 - Interleukin-5	25	646	1	3042	2625	2254	3709	4731	3748	646	2835	800	2268	3655
2475_CHEK2 - Serine/threonine-protein kinase Chk2	2475_CHEK2 - Serine/threonine-protein kinase Chk2	25	647	1	3634	3852	2103	647	1218	1231	4355	3900	3062	1009	3923
669_::::X-06267	669_::::X-06267	25	647	1	1690	1542	1219	2912	3794	2291	4276	3588	3139	3789	647
1466_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	1466_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	25	648	1	648	2251	863	2352	1281	2321	3869	1302	3946	1533	1264
4206_Estimated glomerular filtration rate	4206_Estimated glomerular filtration rate	25	648	1	700	4730	877	648	3052	1827	4245	2285	4046	3652	4079
2869_PDGFA - Platelet-derived growth factor subunit A	2869_PDGFA - Platelet-derived growth factor subunit A	25	648	1	3364	3147	3334	3215	648	1482	2459	4290	2317	4148	3964
1173_Chronotype (continuous)	1173_Chronotype (continuous)	25	648	1	3281	2576	2806	4259	1560	3827	4173	3371	648	3390	3894
2438_CST6 - Cystatin-M	2438_CST6 - Cystatin-M	25	649	1	3751	979	895	798	649	707	3939	3434	836	3704	1573
3398_Leg pain on walking	3398_Leg pain on walking	25	649	1	4611	2462	4580	3348	4594	3741	3703	1696	649	4535	1121
2496_REN - Renin	2496_REN - Renin	25	649	1	3468	4261	1921	2857	1470	3605	2080	3871	4000	3407	649
94_Birth weight	94_Birth weight	25	650	1	2126	650	3934	1990	917	3062	1789	4097	3704	2564	3590
2353_CTSB - Cathepsin B	2353_CTSB - Cathepsin B	25	650	1	2411	1572	650	4107	1934	4168	3599	1833	745	1236	1366
4417_Rubella seropositivity	4417_Rubella seropositivity	25	651	1	1586	3885	3668	3973	1997	651	3961	4070	2191	3120	863
2762_MMP2 - 72 kDa type IV collagenase	2762_MMP2 - 72 kDa type IV collagenase	25	652	1	652	4395	1399	2946	2964	3088	2460	2616	4401	1977	2261
2607_NID2 - Nidogen-2	2607_NID2 - Nidogen-2	25	652	1	4710	1714	3049	2767	652	4373	4402	4306	2775	3202	2886
3414_Birth weight	3414_Birth weight	25	652	1	4569	4689	1129	2804	2583	3010	652	2261	3595	2953	1057
1034_Neck Section Modulus (FBAT, adjusted for multivariable)	1034_Neck Section Modulus (FBAT, adjusted for multivariable)	25	653	1	3575	1917	4030	2289	1886	653	834	2175	1289	3258	2889
1804_PNN50 HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1804_PNN50 HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	654	1	3522	3620	654	1746	3433	2641	3992	3072	4590	1890	1304
2335_CXCL11 - C-X-C motif chemokine 11	2335_CXCL11 - C-X-C motif chemokine 11	25	654	1	3113	2467	2155	1119	654	2044	2426	717	828	4045	2162
3828_Primary biliary cirrhosis	3828_Primary biliary cirrhosis	25	654	1	3458	1781	4238	2898	1454	3902	2085	654	2673	2275	2754
2824_FGF12 - Fibroblast growth factor 12	2824_FGF12 - Fibroblast growth factor 12	25	655	1	4386	4591	980	655	2441	2854	4299	1440	3418	4155	946
697_::::X-11381	697_::::X-11381	25	655	1	1038	1083	1255	1600	2078	655	1689	3540	748	3731	4613
2318_PTPN1 - Tyrosine-protein phosphatase non-receptor type 1	2318_PTPN1 - Tyrosine-protein phosphatase non-receptor type 1	25	656	1	3946	2163	1362	1339	656	656	4606	4441	3293	2292	1692
1002_Monokine induced by interferon-gamma (CXCL9)	1002_Monokine induced by interferon-gamma (CXCL9)	25	656	1	4240	4728	4428	3986	3335	945	3226	2017	656	3787	3156
1358_Total cholesterol (at exam 1, FBAT, adjusted for age and sex)	1358_Total cholesterol (at exam 1, FBAT, adjusted for age and sex)	25	657	1	2859	3643	4550	1267	657	2249	2494	4507	3022	1146	2055
581_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::inosine	581_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::inosine	25	657	1	4644	773	3421	3159	3758	3783	1871	2460	657	1261	4091
3796_Depressive symptoms	3796_Depressive symptoms	25	658	1	2779	3003	2357	658	1213	2707	4681	1828	4408	2580	933
1422_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1422_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	658	1	1160	2493	3351	3021	2773	658	4044	3431	4540	4044	1619
2454_CADM1 - Cell adhesion molecule 1	2454_CADM1 - Cell adhesion molecule 1	25	658	1	4726	4121	2367	1742	1115	1720	4046	2064	658	3296	1701
2700_SGTA - Small glutamine-rich tetratricopeptide repeat-containing protein alpha	2700_SGTA - Small glutamine-rich tetratricopeptide repeat-containing protein alpha	25	659	1	659	749	3641	2892	1055	1429	3441	4374	3402	3137	697
252_CD3 on CD8 T	252_CD3 on CD8 T	25	659	1	1509	1806	3644	4538	659	1320	4200	2881	3951	885	1827
573_Lipid::Sterol, Steroid::cholesterol	573_Lipid::Sterol, Steroid::cholesterol	25	660	1	660	2827	3613	3606	1406	1091	3883	1518	2570	3300	1613
1735_Serum phosphorus (at exam 2, GEE, adjusted for age and sex)	1735_Serum phosphorus (at exam 2, GEE, adjusted for age and sex)	25	660	2	4051	3081	4525	660	1829	3600	4002	1166	2006	4598	1741
3789_Morningness	3789_Morningness	25	660	1	2070	1276	1525	1719	4007	1372	1664	660	1740	3660	1318
822_::::X-13548	822_::::X-13548	25	662	1	2546	4106	4744	1971	3361	856	2791	662	1524	2489	4367
4240_Latent naming speed	4240_Latent naming speed	25	662	1	4194	3070	3332	1956	1698	807	1678	3894	3253	662	3137
115_Variability of Body Mass Index	115_Variability of Body Mass Index	25	663	1	663	1198	3800	905	3995	1179	3979	4251	1994	956	2307
4369_Thyroid-stimulating hormone	4369_Thyroid-stimulating hormone	25	663	1	2341	4344	3323	1254	3098	663	2046	4166	1228	4057	2121
4155_E/A ratio	4155_E/A ratio	25	664	1	2884	3107	3064	3756	2362	664	4687	4109	4650	1699	2214
1427_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1427_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	664	1	3160	3830	1026	2436	1637	1872	664	2517	2710	3095	874
3564_Vitamin and mineral supplements: Vitamin D	3564_Vitamin and mineral supplements: Vitamin D	25	664	1	1433	1935	732	1538	1532	1148	995	1891	664	4229	4687
1134_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, female)	1134_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, female)	25	664	1	2681	2081	4592	3968	4066	2996	2041	2620	1952	664	2795
4151_Left ventricular mass index	4151_Left ventricular mass index	25	665	1	665	1923	3480	1823	2915	931	1150	4427	4131	1219	2760
795_::::X-12726	795_::::X-12726	25	665	1	3121	4207	3092	2686	2001	2790	1626	1665	665	2171	3419
2891_NXPH1 - Neurexophilin-1	2891_NXPH1 - Neurexophilin-1	25	666	1	3433	2100	3608	666	4743	710	3861	2424	3439	3301	4285
4247_Ambidextrousness	4247_Ambidextrousness	25	666	1	3318	1239	3269	2821	666	2956	1234	2400	2806	1357	3233
2126_HSP90AA1 HSP90AB1 - Heat shock protein HSP 90-alpha/beta	2126_HSP90AA1 HSP90AB1 - Heat shock protein HSP 90-alpha/beta	25	666	1	958	4436	1863	2873	2608	4047	666	1304	1132	3475	2609
466_Lipid::Bile acid metabolism::glycochenodeoxycholate	466_Lipid::Bile acid metabolism::glycochenodeoxycholate	25	667	1	2029	4697	667	1428	1736	1085	1581	4390	2174	1875	1728
1548_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for multivariable)	1548_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for multivariable)	25	667	1	1478	4558	2230	1926	667	3969	3650	4085	3255	1288	3592
4382_Epithelial ovarian cancer (high -grade and low-grade serous)	4382_Epithelial ovarian cancer (high -grade and low-grade serous)	25	667	1	3954	4307	4162	3330	1651	667	1284	4482	2120	1626	3540
279_CD8:%39+	279_CD8:%39+	25	667	1	1567	996	1817	4696	3442	1078	2250	4155	2450	667	3632
4210_Chronic kidney disease	4210_Chronic kidney disease	25	667	1	1111	4276	791	3119	3982	3697	2253	4686	2175	3719	667
542_Lipid::Lysolipid::1-palmitoleoylglycerophosphocholine*	542_Lipid::Lysolipid::1-palmitoleoylglycerophosphocholine*	25	668	1	668	2215	1147	1782	3294	1753	2709	3505	2943	3937	1890
1621_CD40 Ligand serum (at exam 7, GEE, adjusted for multivariable)	1621_CD40 Ligand serum (at exam 7, GEE, adjusted for multivariable)	25	668	1	1326	3560	668	2355	727	908	1801	1552	949	1596	1491
3325_Relative age voice broke (male)	3325_Relative age voice broke (male)	25	668	1	4372	989	946	1986	701	3947	4641	2982	668	2107	3571
1452_Low-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	1452_Low-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	25	668	1	2264	983	3872	1241	1176	1809	2278	4112	1600	668	2898
827_::::X-13671	827_::::X-13671	25	669	1	786	1043	669	3307	4106	2516	4471	3203	3850	1255	3725
105_Tanner scale (female)	105_Tanner scale (female)	25	669	1	4401	4215	1569	669	4237	1841	4650	1601	4442	3672	1897
3879_Hematocrit (three-way meta)	3879_Hematocrit (three-way meta)	25	669	1	1434	1587	2089	4649	3870	1077	2482	4622	669	4560	3873
4676_External capsule axial diusivities	4676_External capsule axial diusivities	25	669	1	1542	3303	928	1453	3998	4477	1407	3708	4191	1760	669
2593_DPP7 - Dipeptidyl peptidase 2	2593_DPP7 - Dipeptidyl peptidase 2	25	670	1	2610	2568	4659	2509	670	4172	3567	737	1980	4056	4702
1454_Low-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	1454_Low-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	25	671	1	2957	3526	4707	1226	2070	671	4137	4352	1406	3991	1308
2617_KDR - Vascular endothelial growth factor receptor 2	2617_KDR - Vascular endothelial growth factor receptor 2	25	671	1	2866	3330	3766	3558	1424	1811	3173	1550	1383	3353	671
2959_HBA1 HBB - Hemoglobin	2959_HBA1 HBB - Hemoglobin	25	672	1	3231	4497	2331	1754	672	3419	3633	1877	3079	4691	4099
2179_NOV - Protein NOV homolog	2179_NOV - Protein NOV homolog	25	672	1	3705	3691	3280	1931	2763	1926	3590	672	1062	2030	2006
52_Number of children ever born (male)	52_Number of children ever born (male)	25	673	1	4482	941	1306	673	1740	2120	3945	3901	3477	3027	712
1642_Osteoprotegerin (at exam 7, FBAT, adjusted for age and sex)	1642_Osteoprotegerin (at exam 7, FBAT, adjusted for age and sex)	25	673	1	4157	4427	787	2271	4180	3204	4192	2813	2487	2193	673
231_mDC (2):%CD1c-	231_mDC (2):%CD1c-	25	674	1	2456	4611	3724	3256	3975	3784	1359	674	4043	1818	2352
3140_ELANE - Neutrophil elastase	3140_ELANE - Neutrophil elastase	25	675	1	2175	1879	675	4596	4599	1004	2922	2292	1824	3741	1288
3944_HbA1c	3944_HbA1c	25	675	1	3256	1771	3566	4652	4146	4156	1482	675	3269	1560	2868
511_Lipid::Inositol metabolism::myo-inositol	511_Lipid::Inositol metabolism::myo-inositol	25	675	1	3619	908	1663	3471	4281	1081	1248	1724	1912	1474	675
2998_GP1BA - Platelet glycoprotein Ib alpha chain	2998_GP1BA - Platelet glycoprotein Ib alpha chain	25	676	1	2134	2828	1466	3863	676	4624	4349	4325	2761	1377	4426
436_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::fructose	436_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::fructose	25	676	1	1838	3199	862	3817	1793	2859	2902	3092	676	4687	1117
4553_Left isthmus cingulate	4553_Left isthmus cingulate	25	677	1	4037	677	4269	689	2845	1991	1119	4640	3120	1005	4664
3006_JAK2 - Tyrosine-protein kinase JAK2	3006_JAK2 - Tyrosine-protein kinase JAK2	25	677	1	2599	2636	677	917	1208	2425	745	2676	1690	3730	4402
4656_Fornix (cres) / Stria terminalis fractional anisotropy	4656_Fornix (cres) / Stria terminalis fractional anisotropy	25	677	1	1517	2783	4235	677	2464	2284	4166	1420	2210	4107	3645
4130_Neutrophil count	4130_Neutrophil count	25	677	1	4407	1726	2893	2045	1271	2412	677	1726	1552	1417	3227
3858_Neutrophil percentage of granulocytes (two-way meta)	3858_Neutrophil percentage of granulocytes (two-way meta)	25	677	1	1419	3227	2300	4301	4548	4321	1334	677	1772	4515	4041
1774_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for multivariable)	1774_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for multivariable)	25	678	1	1309	758	4521	1169	1009	2441	2321	3345	3612	1117	678
3163_TNFRSF13C - Tumor necrosis factor receptor superfamily member 13C	3163_TNFRSF13C - Tumor necrosis factor receptor superfamily member 13C	25	679	1	1956	3982	679	2053	4646	2806	2964	4651	4335	831	1348
962_Concentration of very large VLDL particles	962_Concentration of very large VLDL particles	25	679	1	3355	4607	940	1779	3388	1066	1371	2276	679	2839	3735
2127_IL1RAP - Interleukin-1 Receptor accessory protein	2127_IL1RAP - Interleukin-1 Receptor accessory protein	25	680	1	1655	2807	3196	3991	680	4573	4522	2945	4170	3855	2646
4199_Waist-hip ratio (female)	4199_Waist-hip ratio (female)	25	680	1	3504	3486	929	2788	1650	680	3248	2143	2813	3029	4684
2992_ESD - S-formylglutathione hydrolase	2992_ESD - S-formylglutathione hydrolase	25	680	1	4737	2470	2178	3209	1780	3296	2663	4319	2704	680	4368
2724_SNX4 - Sorting nexin-4	2724_SNX4 - Sorting nexin-4	25	680	1	1224	799	3024	2486	3508	1566	4315	4305	1459	2504	680
2334_IL1B - Interleukin-1 beta	2334_IL1B - Interleukin-1 beta	25	681	1	2090	2668	681	1904	4121	2607	2561	3021	1545	2272	4681
2414_PIGR - Polymeric immunoglobulin receptor	2414_PIGR - Polymeric immunoglobulin receptor	25	681	1	948	1450	2253	3961	681	4347	1770	2435	3643	1012	2588
4148_Left ventricular internal dimension in diastole	4148_Left ventricular internal dimension in diastole	25	681	1	3480	1452	722	1683	2677	4371	3340	1645	2262	681	3587
2914_OLFM4 - Olfactomedin-4	2914_OLFM4 - Olfactomedin-4	25	682	1	4251	2650	682	3144	4158	1987	1853	4481	3377	4635	2245
808_::::X-12844	808_::::X-12844	25	682	1	4344	3424	3265	4435	682	2273	4455	3851	2533	1757	3658
1674_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for age and sex)	1674_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for age and sex)	25	683	1	3794	1856	3059	3564	683	917	825	3142	2482	4502	1669
314_CD4nv:%TFH (2)	314_CD4nv:%TFH (2)	25	683	1	2890	3400	1924	3560	1895	683	2552	1802	3617	2025	1967
2999_GPC5 - Glypican-5	2999_GPC5 - Glypican-5	25	684	1	4334	3625	4721	1696	2339	4095	684	3300	2307	3668	3080
4625_Left pallidum	4625_Left pallidum	25	684	1	2528	1823	3227	4028	1602	4484	3494	769	684	1360	3314
1407_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for multivariable)	1407_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for multivariable)	25	684	1	2663	3708	890	4368	4686	4294	800	3280	4334	3568	684
3541_Reason for glasses/contact lenses: For just reading/near work as you are getting older (called 'presbyopia')	3541_Reason for glasses/contact lenses: For just reading/near work as you are getting older (called 'presbyopia')	25	685	1	1174	2299	913	685	2385	2665	3763	3608	1950	825	1294
4649_Average across all tracts fractional anisotropy	4649_Average across all tracts fractional anisotropy	25	685	1	1577	3350	999	3882	2727	1710	685	2353	3186	3977	1244
1980_Walking speed (at offspring exam 7 cohort exam 27, FBAT)	1980_Walking speed (at offspring exam 7 cohort exam 27, FBAT)	25	686	1	2515	4725	1673	1383	4161	686	3841	4050	2453	1720	1283
4128_C-reactive protein	4128_C-reactive protein	25	686	1	3139	3953	3981	1859	3908	2573	3533	686	3678	3538	2144
3104_NMT1 - Glycylpeptide N-tetradecanoyltransferase 1	3104_NMT1 - Glycylpeptide N-tetradecanoyltransferase 1	25	686	1	1992	1922	2222	2544	2111	838	2379	4214	3978	2981	686
3482_Milk type used: Skimmed	3482_Milk type used: Skimmed	25	687	1	2897	949	687	785	2393	2068	964	1108	3866	1173	2723
4502_Right superior parietal	4502_Right superior parietal	25	687	1	3240	969	4709	4052	2486	687	2579	2998	2247	2974	3920
792_::::X-12712	792_::::X-12712	25	687	1	4561	2631	3183	2284	2380	3196	687	872	2910	1739	4138
671_::::X-06350	671_::::X-06350	25	687	1	1275	2296	3175	2221	1322	4285	2685	4710	2734	687	1466
3038_TYMS - Thymidylate synthase	3038_TYMS - Thymidylate synthase	25	688	1	688	2329	2889	2097	751	3929	4251	1718	1229	3693	713
2367_AURKA - Aurora kinase A	2367_AURKA - Aurora kinase A	25	688	1	3091	3711	688	3352	3142	2917	3334	3830	1776	2383	1132
4652_Cingulum (hippocampus) fractional anisotropy	4652_Cingulum (hippocampus) fractional anisotropy	25	688	1	2667	1256	982	3728	1950	894	2801	2224	824	4163	688
1050_Parkinson disease of unrelated individuals (tier 2a)	1050_Parkinson disease of unrelated individuals (tier 2a)	25	689	1	1231	2775	4606	4106	2882	4340	689	1437	3017	3764	731
496_Lipid::Fatty acid, branched::15-methylpalmitate (isobar with 2-methylpalmitate)	496_Lipid::Fatty acid, branched::15-methylpalmitate (isobar with 2-methylpalmitate)	25	689	1	1064	2654	4722	1193	1887	4233	766	689	3010	798	4407
1994_Survival past average life expectancy (FBAT, adjusted for birth-cohort)	1994_Survival past average life expectancy (FBAT, adjusted for birth-cohort)	25	689	1	3356	3907	1544	2200	769	1404	1151	3666	2082	1814	689
832_::::X-14086	832_::::X-14086	25	690	1	1135	3095	2835	4628	4280	2343	2845	2235	2398	1661	690
3840_Eosinophil percentage of granulocytes (two-way meta)	3840_Eosinophil percentage of granulocytes (two-way meta)	25	691	1	2981	2176	3115	4478	3533	3823	1251	691	2555	4618	3893
2723_SKP1 - S-phase kinase-associated protein 1	2723_SKP1 - S-phase kinase-associated protein 1	25	691	1	2318	2422	1169	1955	983	2895	2715	2029	691	1696	2231
2501_TPSB2 - Tryptase beta-2	2501_TPSB2 - Tryptase beta-2	25	691	1	1822	1101	2010	2641	1979	1313	1328	955	1144	691	1040
1420_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1420_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	692	1	1361	2270	780	1467	3542	692	2049	4379	2474	1194	1419
3609_Treatment/medication code: omega-3/fish oil supplement	3609_Treatment/medication code: omega-3/fish oil supplement	25	693	1	3724	3029	3557	1835	693	2898	2103	3788	3623	1408	3405
2805_TK1 - Thymidine kinase, cytosolic	2805_TK1 - Thymidine kinase, cytosolic	25	693	1	3933	4704	3109	2958	903	2855	2535	3512	2177	2008	693
1020_Neck Cross-Sectional Moment of Inertia (FBAT, adjusted for age and sex)	1020_Neck Cross-Sectional Moment of Inertia (FBAT, adjusted for age and sex)	25	694	1	2999	1743	4487	3809	4063	694	2677	4208	1596	4250	2111
2194_FGF20 - Fibroblast growth factor 20	2194_FGF20 - Fibroblast growth factor 20	25	694	1	839	1516	2493	3047	4351	1861	2954	3919	3019	694	1639
1998_Body Mass Index	1998_Body Mass Index	25	695	1	695	1997	892	4522	1092	4353	4327	1261	4413	2764	3790
1800_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1800_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	696	1	696	1230	4057	1821	2184	4046	3458	2555	4307	4138	1851
1802_Low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1802_Low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	696	1	1404	3627	2237	1957	696	1538	2765	3399	2697	1649	1898
952_Valine	952_Valine	25	696	1	3905	3616	1614	4559	2241	4147	696	1213	2432	3527	1780
2717_MED1 - Mediator of RNA polymerase II transcription subunit 1	2717_MED1 - Mediator of RNA polymerase II transcription subunit 1	25	696	1	2575	2446	4168	2135	793	1853	3115	696	3213	3941	1748
95_Birth weight	95_Birth weight	25	697	1	697	828	3215	3535	763	3972	3126	2393	4420	3806	4334
4214_Type 2 Diabetes	4214_Type 2 Diabetes	25	697	1	1500	2069	697	825	4316	4266	2218	2514	2476	2718	2226
3471_Impedance measures - Trunk predicted mass	3471_Impedance measures - Trunk predicted mass	25	697	1	1172	3677	1634	2973	4134	2161	1610	3251	1677	697	1809
1456_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1456_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	698	1	4137	698	2109	2992	979	1337	887	2388	1068	2062	3930
771_::::X-12329	771_::::X-12329	25	698	1	1277	4343	2424	2469	698	4183	3164	843	862	2261	3670
4624_Left putamen	4624_Left putamen	25	698	1	1501	1641	3026	1408	2270	3602	1237	698	3692	2021	1886
3883_Immature fraction of reticulocytes (three-way meta)	3883_Immature fraction of reticulocytes (three-way meta)	25	699	1	1816	835	1777	3174	4507	1765	3078	2184	699	1659	2601
3159_OMD - Osteomodulin	3159_OMD - Osteomodulin	25	699	1	3567	3461	1246	4264	1799	2927	3726	2775	1578	699	3578
3433_Symbol digit substitution test - Duration to entering value	3433_Symbol digit substitution test - Duration to entering value	25	700	1	2682	881	3654	3485	2731	2977	1688	700	2289	1184	2880
3234_Daytime dozing / sleeping (narcolepsy)	3234_Daytime dozing / sleeping (narcolepsy)	25	701	1	1015	701	3884	2953	2077	3893	2422	4383	1999	2227	4144
1734_Serum phosphorus (at exam 2, FBAT, adjusted for age and sex)	1734_Serum phosphorus (at exam 2, FBAT, adjusted for age and sex)	25	701	1	1321	3131	701	3334	1019	1676	4102	2687	3267	4552	3303
3217_Time spend outdoors in summer	3217_Time spend outdoors in summer	25	702	1	4473	3027	4059	702	2115	3664	3294	3510	3849	2830	3980
1399_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for age and sex)	1399_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for age and sex)	25	702	1	791	4559	2076	1736	1253	702	3451	3267	4727	3843	1411
3961_Gestational weight gain (maternal, early)	3961_Gestational weight gain (maternal, early)	25	702	1	2359	2749	2084	1116	1966	4325	4163	702	3041	4006	2399
635_Xenobiotics::Food component, Plant::saccharin	635_Xenobiotics::Food component, Plant::saccharin	25	703	1	2358	2569	703	3875	4655	3003	3967	1331	998	3909	1821
1314_HOMA-IR (at exam 7, FBAT, adjusted for age and sex)	1314_HOMA-IR (at exam 7, FBAT, adjusted for age and sex)	25	703	1	4166	3824	2906	703	2812	2355	3663	882	1812	2869	1694
3197_Length of working week for main job	3197_Length of working week for main job	25	704	1	907	3866	704	2382	4696	2960	3362	2773	4005	1754	2023
819_::::X-13435	819_::::X-13435	25	704	1	4500	4368	1645	1673	4157	2015	3497	4137	704	4611	3761
192_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	192_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	25	705	1	4549	705	1842	4221	4717	1831	1197	2154	3651	4214	4034
3059_IL23R - Interleukin-23 receptor	3059_IL23R - Interleukin-23 receptor	25	705	1	1978	4603	705	2003	3356	3527	3015	3260	4648	3925	1152
1346_Plasma Apolipoprotein A-I level (FBAT, adjusted for age and sex)	1346_Plasma Apolipoprotein A-I level (FBAT, adjusted for age and sex)	25	705	1	4716	3138	4361	705	1476	4035	2063	916	2609	1901	4005
2777_FER - Tyrosine-protein kinase Fer	2777_FER - Tyrosine-protein kinase Fer	25	705	1	962	848	3908	1860	705	3418	1243	4485	1935	3108	3591
3265_Average weekly spirits intake	3265_Average weekly spirits intake	25	705	1	2139	2479	2523	2384	4002	940	3852	2774	3930	3264	705
2183_CRLF2 - Cytokine receptor-like factor 2	2183_CRLF2 - Cytokine receptor-like factor 2	25	706	1	3774	1688	3047	997	1457	4671	1343	706	804	2146	3753
4061_Urinary albumin-to-creatinine ratio	4061_Urinary albumin-to-creatinine ratio	25	706	1	2338	4431	4144	2979	4009	3696	2912	4218	3296	706	3914
2240_RPS27A - Ubiquitin+1, truncated mutation for UbB	2240_RPS27A - Ubiquitin+1, truncated mutation for UbB	25	706	1	1699	4458	4626	1328	4488	766	3778	2030	1293	2917	706
2473_CDK5 CDK5R1 - Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex	2473_CDK5 CDK5R1 - Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex	24	707	1	707	3500	727	4158	1885	2463	1732	2565	2536	3863	4038
312_CD4nv:%Th1	312_CD4nv:%Th1	25	707	1	2598	3672	707	1908	4678	1067	3085	2117	2586	2604	4277
1795_RR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1795_RR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	707	1	2062	3464	3804	1216	1158	3023	3978	2560	3671	4134	707
1260_Residual from predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	1260_Residual from predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	708	1	1536	3901	708	2435	4312	2469	2806	3264	2643	1075	2304
837_::::X-14374	837_::::X-14374	25	708	1	3300	1447	4427	4484	1679	3885	2035	3868	853	708	3351
1667_Aspartate aminotransferase (at exam 2, GEE, adjusted for age and sex)	1667_Aspartate aminotransferase (at exam 2, GEE, adjusted for age and sex)	25	709	1	709	2634	2001	3993	958	4683	4517	731	2679	2085	3949
2518_FN1 - Fibronectin Fragment 3	2518_FN1 - Fibronectin Fragment 3	25	709	1	2160	709	4264	1923	1405	1247	4354	1563	2116	2868	1037
4097_Colorectal cancer	4097_Colorectal cancer	25	709	1	3680	1857	4165	709	800	823	4575	4646	4565	4129	1388
2398_GNLY - Granulysin	2398_GNLY - Granulysin	25	709	1	1900	3462	1977	4579	4733	3518	1740	1837	1450	709	2217
3123_STK17B - Serine/threonine-protein kinase 17B	3123_STK17B - Serine/threonine-protein kinase 17B	25	710	1	3756	3890	4288	4424	3644	2493	4542	3621	4230	3587	710
1851_Neck average buckling ratio (GEE, female, adjussted for multivariable)	1851_Neck average buckling ratio (GEE, female, adjussted for multivariable)	25	711	1	711	3670	4166	4717	1333	1323	1651	2093	4189	4097	2150
1077_Attention deficit hyperactivity disorder	1077_Attention deficit hyperactivity disorder	25	711	1	944	3646	711	1767	3154	3207	1778	3605	4402	2388	3085
1883_Shaft cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	1883_Shaft cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	25	711	1	1918	2174	4111	3157	711	1381	1471	1453	4188	4133	1469
3386_Work/job satisfaction	3386_Work/job satisfaction	25	711	1	4215	4309	3426	1632	4005	711	3050	1500	2194	4181	3481
3929_QT interval	3929_QT interval	25	711	1	3850	1136	3343	4500	4481	1881	2078	4538	711	1900	3001
2588_CLEC7A - C-type lectin domain family 7 member A	2588_CLEC7A - C-type lectin domain family 7 member A	25	712	1	712	2016	2082	4327	2158	1778	4231	3207	2972	986	4499
3508_Non-butter spread type details: Other low or reduced fat spread	3508_Non-butter spread type details: Other low or reduced fat spread	25	712	1	1285	3900	3225	4144	712	4224	4287	2797	3720	1318	810
1058_Amyotrophic lateral sclerosis	1058_Amyotrophic lateral sclerosis	25	712	1	2500	4537	1373	3364	1264	712	3825	4400	3881	1849	1088
1013_Vascular endothelial growth factor	1013_Vascular endothelial growth factor	25	712	1	3800	2614	3353	2373	3380	2220	712	4372	3743	4218	4743
457_Cofactors and vitamins::Vitamin B6 metabolism::pyridoxate	457_Cofactors and vitamins::Vitamin B6 metabolism::pyridoxate	25	712	1	3043	3128	3457	2420	4080	2896	1665	712	747	4392	2432
2393_TMPRSS15 - Enteropeptidase	2393_TMPRSS15 - Enteropeptidase	25	713	1	2107	4645	1162	4549	713	902	3620	4703	3705	3569	3086
1164_Glucose levels 2 h after an oral glucose challenge	1164_Glucose levels 2 h after an oral glucose challenge	25	714	1	1209	714	2679	2960	3976	3157	733	1730	1832	873	3560
4468_Left rostral anterior cingulate	4468_Left rostral anterior cingulate	25	714	1	3925	2580	2868	4742	714	2955	3946	993	1178	2659	1757
2134_MRC1 - Macrophage mannose receptor 1	2134_MRC1 - Macrophage mannose receptor 1	25	714	1	3051	3009	1524	3523	1313	714	2134	1613	1865	1405	3630
1268_Epworth Sleepiness Scale (FBAT)	1268_Epworth Sleepiness Scale (FBAT)	25	714	1	1634	3283	2383	4365	4362	1156	2123	3253	714	3472	1596
3734_Depression - Duration of worst depression	3734_Depression - Duration of worst depression	25	715	1	2900	1396	1253	4280	1181	1644	3772	3933	715	3726	1567
1788_QT interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1788_QT interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	715	1	754	4482	2907	4013	4069	1423	3036	4049	2319	3352	715
2509_CAMK1D - Calcium/calmodulin-dependent protein kinase type 1D	2509_CAMK1D - Calcium/calmodulin-dependent protein kinase type 1D	25	716	1	716	3684	800	2691	930	3235	3142	4046	2146	2315	2328
3370_Duration of other exercises	3370_Duration of other exercises	25	716	1	3917	4350	716	4737	2415	2856	3324	2067	4018	3537	4735
1684_Brain natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	1684_Brain natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	25	716	1	1744	1767	3752	734	2188	2363	1907	716	1174	744	1995
1590_Platelet aggregation to ADP (at exam 5, FBAT, adjusted for age and sex)	1590_Platelet aggregation to ADP (at exam 5, FBAT, adjusted for age and sex)	25	717	1	3103	1312	872	3499	940	717	780	2902	820	2973	3152
2234_MMP17 - Matrix metalloproteinase-17	2234_MMP17 - Matrix metalloproteinase-17	25	717	1	3129	1929	3202	2236	3612	3417	1207	3276	717	936	3707
2619_CDH12 - Cadherin-12	2619_CDH12 - Cadherin-12	25	717	1	3194	3364	4171	1451	4048	1379	4055	2456	3225	2724	717
1182_Sleep duration (male)	1182_Sleep duration (male)	25	718	1	3557	2286	718	3649	1803	3396	1903	4643	2344	1495	4243
2936_ANG - Angiogenin	2936_ANG - Angiogenin	25	718	1	3490	3889	1937	3086	1843	718	3363	2240	3579	3755	4652
27_Neuroticism (NEO-FFI)	27_Neuroticism (NEO-FFI)	25	718	1	4617	1213	1130	914	3674	4389	2502	4310	1366	2827	718
1492_Remnant lipoprotein triglycerides (at exam 4, FBAT, adjusted for age and sex)	1492_Remnant lipoprotein triglycerides (at exam 4, FBAT, adjusted for age and sex)	25	719	1	719	2008	4379	751	2729	4154	3135	3969	1528	2192	813
478_Lipid::Carnitine metabolism::carnitine	478_Lipid::Carnitine metabolism::carnitine	25	719	1	2026	4139	1709	1004	2730	719	3388	2715	773	2368	1136
499_Lipid::Fatty acid, dicarboxylate::dodecanedioate	499_Lipid::Fatty acid, dicarboxylate::dodecanedioate	25	719	1	2165	1150	2998	2590	3274	861	3798	4264	4289	719	4598
3833_Basophil count (two-way meta)	3833_Basophil count (two-way meta)	25	720	1	2159	1731	720	3257	3013	816	2682	1826	3839	2537	3002
2340_CCL18 - C-C motif chemokine 18	2340_CCL18 - C-C motif chemokine 18	25	720	1	4019	1278	1341	4295	720	1516	2689	4239	1460	1314	3813
236_CD123 on pDC	236_CD123 on pDC	25	721	1	4651	1386	4700	3351	1056	3895	2595	1058	721	4074	3010
2730_BPI - Bactericidal permeability-increasing protein	2730_BPI - Bactericidal permeability-increasing protein	25	721	1	2839	3735	3646	4494	3980	3973	3542	3430	4709	721	1700
1178_Insomnia	1178_Insomnia	25	722	1	3084	2621	2223	804	722	3718	4410	976	2086	1008	1644
1211_Type 2 Diabetes	1211_Type 2 Diabetes	25	722	1	4362	4147	3833	4058	1240	722	3988	3759	2020	2987	1997
4283_FVC	4283_FVC	25	723	1	2892	3458	1441	1120	2302	723	4646	3834	4179	2741	2299
4047_Medial collateral ligament injury	4047_Medial collateral ligament injury	25	723	1	2611	2437	4666	1178	951	968	2165	723	1221	4489	2193
3020_PLA2G7 - Platelet-activating factor acetylhydrolase	3020_PLA2G7 - Platelet-activating factor acetylhydrolase	25	723	1	4638	725	3058	1503	4418	4039	2327	2345	3788	723	1871
3656_Alcohol - Alcohol drinker status: Never	3656_Alcohol - Alcohol drinker status: Never	25	724	1	3778	4102	724	1281	3484	4742	1143	4516	3609	4638	3864
1460_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1460_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	724	1	1776	1833	1156	3900	724	3520	1851	1795	4353	3025	846
65_Insulin sensitivity index (adjusted for age, sex. Bmi)	65_Insulin sensitivity index (adjusted for age, sex. Bmi)	25	724	1	1307	1533	1405	1606	2461	724	1968	4616	2035	4613	2493
1783_Artial fibrillation (GEE, adjusted for multivariable)	1783_Artial fibrillation (GEE, adjusted for multivariable)	25	724	1	2969	3251	3588	3325	1932	4351	2992	724	2036	2522	4568
2459_TFPI - Tissue factor pathway inhibitor	2459_TFPI - Tissue factor pathway inhibitor	25	725	1	1704	1708	1157	2276	725	4055	3391	1840	2798	2927	2964
3222_Drive faster than motorway speed limit	3222_Drive faster than motorway speed limit	25	726	1	1698	735	4293	726	4132	776	2442	2119	963	1454	2105
3196_Time employed in main current job	3196_Time employed in main current job	25	726	1	3423	1439	2734	768	726	1256	2116	4293	3285	1031	3819
3138_CCL11 - Eotaxin	3138_CCL11 - Eotaxin	25	727	1	3895	727	955	1414	1078	3016	1921	1651	1967	1034	1289
797_::::X-12729	797_::::X-12729	25	728	1	3981	3802	728	1735	3432	1919	1646	1121	2240	3594	1293
1767_Heart failure (free of MI, GEE, adjusted for multivariable)	1767_Heart failure (free of MI, GEE, adjusted for multivariable)	25	728	1	2120	3851	1198	728	1768	964	3169	2077	2269	4525	2430
1894_Shaft Section Modulus (FBAT, female, adjussted for multivariable)	1894_Shaft Section Modulus (FBAT, female, adjussted for multivariable)	25	729	1	3187	1236	1892	3974	3239	3379	4125	1830	729	1242	2321
2222_CDH5 - Cadherin-5	2222_CDH5 - Cadherin-5	25	730	1	730	4422	2735	3175	1526	3509	1002	4725	3495	2395	3884
1142_Sleep duration	1142_Sleep duration	25	730	1	1162	1428	3819	730	2477	1352	3435	1713	760	2438	3922
413_Amino acid::Urea cycle; arginine-, proline-, metabolism::dimethylarginine (SDMA + ADMA)	413_Amino acid::Urea cycle; arginine-, proline-, metabolism::dimethylarginine (SDMA + ADMA)	25	730	1	3540	3017	2909	3094	3981	4640	2479	730	3384	1332	3021
2113_CST3 - Cystatin-C	2113_CST3 - Cystatin-C	25	731	1	3744	3687	939	731	3765	3769	2130	3485	4040	4429	2666
98_Height SDS	98_Height SDS	25	731	1	1890	3160	783	1874	4553	731	1274	3699	4423	4654	2363
826_::::X-13658	826_::::X-13658	25	732	1	732	3154	1529	2773	3966	2858	3546	4734	4682	3477	2447
187_Waist-hip ratio (male, adjusted for BMI)	187_Waist-hip ratio (male, adjusted for BMI)	25	732	1	2706	3637	1411	912	732	1613	4320	1801	1535	934	4673
3028_ADSL - Adenylosuccinate lyase	3028_ADSL - Adenylosuccinate lyase	25	732	1	3798	1412	2757	4449	2646	2796	3074	732	1838	3802	2921
4585_Right lateral occipital	4585_Right lateral occipital	25	732	1	2409	1249	2095	1463	1975	3180	2702	1510	732	983	4439
687_::::X-10810	687_::::X-10810	25	733	1	1666	733	2436	3641	4240	4419	1814	2788	1684	4302	2372
972_Triglycerides in chylomicrons and extremely large VLDL	972_Triglycerides in chylomicrons and extremely large VLDL	25	733	1	1878	1132	1551	4238	733	2508	2824	1567	2079	3192	3093
1722_Serum calcium (at exam 2, FBAT, adjusted for age and sex)	1722_Serum calcium (at exam 2, FBAT, adjusted for age and sex)	25	734	1	4164	1887	734	3645	2926	851	2146	3603	4096	1826	4175
1502_Triglycerides (at exam 3, FBAT, adjusted for age and sex)	1502_Triglycerides (at exam 3, FBAT, adjusted for age and sex)	25	734	1	2428	2764	4438	3847	734	2032	1956	3158	4236	3715	2507
4672_Body of corpus callosum axial diusivities	4672_Body of corpus callosum axial diusivities	25	734	1	2740	3195	1123	1181	1323	3466	2373	734	1252	4297	1965
3211_Frequency of stair climbing in last 4 weeks	3211_Frequency of stair climbing in last 4 weeks	25	735	1	4679	3962	735	2218	2505	2096	4518	1875	1541	984	2325
833_Peptide::Dipeptide::X-14189--leucylalanine	833_Peptide::Dipeptide::X-14189--leucylalanine	25	736	1	3296	1560	736	4434	4039	2947	1612	3977	1218	785	4317
4352_Male pattern baldness (BOLT LMM non-infinitesimal mixed model)	4352_Male pattern baldness (BOLT LMM non-infinitesimal mixed model)	25	736	1	977	4666	2094	736	4485	1713	1623	2529	1755	3481	3671
1797_RR interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1797_RR interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	736	1	2813	1784	1018	2838	736	4372	1186	1725	1377	1089	4209
1011_Tumor necrosis factor beta	1011_Tumor necrosis factor beta	25	736	1	3909	1064	2694	4575	4479	2344	736	2829	4197	3686	1679
2571_VIP - Vasoactive Intestinal Peptide	2571_VIP - Vasoactive Intestinal Peptide	25	737	1	1435	737	3119	1283	3715	1602	2155	2635	943	740	3100
2625_MSR1 - Macrophage scavenger receptor types I and II	2625_MSR1 - Macrophage scavenger receptor types I and II	25	737	1	1599	3897	4425	4071	737	1974	1517	3876	3072	4668	3605
2888_KIRREL3 - Kin of IRRE-like protein 3	2888_KIRREL3 - Kin of IRRE-like protein 3	25	738	1	2843	3969	1985	738	4320	3381	4066	4246	1408	3224	3375
876_Total cholesterol in HDL	876_Total cholesterol in HDL	25	739	1	2656	4051	1479	4033	3899	3144	4119	4135	739	4487	4118
4418_Mumps seropositivity	4418_Mumps seropositivity	25	740	1	2989	1847	4273	2098	4020	3312	740	3713	3045	3876	1415
3470_Impedance measures - Trunk fat-free mass	3470_Impedance measures - Trunk fat-free mass	25	741	1	1430	3699	2114	3601	4131	3455	2074	3709	1581	741	1812
565_Lipid::Monoacylglycerol::1-stearoylglycerol (1-monostearin)	565_Lipid::Monoacylglycerol::1-stearoylglycerol (1-monostearin)	25	742	1	2683	2027	4520	3851	742	1259	3673	3289	4394	3322	2395
941_Total lipids in small VLDL	941_Total lipids in small VLDL	25	742	1	3180	3671	1574	3544	4306	1341	2805	4266	742	3943	2160
4096_Open-angle glaucoma	4096_Open-angle glaucoma	25	743	1	743	3787	3307	2725	3598	4290	3695	4300	4108	4547	3865
1323_Fasting plasma glucose (at exam 5, GEE, adjusted for age, sex and BMI)	1323_Fasting plasma glucose (at exam 5, GEE, adjusted for age, sex and BMI)	24	743	1	3650	1872	4154	2219	1044	743	2425	1460	1844	1687	3532
2568_CCL17 - C-C motif chemokine 17	2568_CCL17 - C-C motif chemokine 17	25	744	1	2227	744	3823	1343	2040	839	3654	1138	4354	1911	4313
2586_CHIT1 - Chitotriosidase-1	2586_CHIT1 - Chitotriosidase-1	25	744	1	1987	3125	744	2438	3809	4243	2713	1686	2585	3042	4261
2090_EFNB3 - Ephrin-B3	2090_EFNB3 - Ephrin-B3	25	744	1	2452	3529	2903	744	3367	4520	4452	1609	3577	2141	3509
3187_Standing height	3187_Standing height	25	745	1	4024	4453	3570	2470	3810	3521	4185	745	1471	1777	2750
443_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::lactate	443_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::lactate	25	745	1	3135	4480	2037	3482	4688	4146	1773	1545	4665	3434	745
1031_Neck Width (GEE, adjusted for multivariable)	1031_Neck Width (GEE, adjusted for multivariable)	25	746	1	3773	3587	1453	1830	4220	4164	746	2402	4259	4673	1129
793_::::X-12717	793_::::X-12717	25	746	1	2096	2451	1609	2766	2713	2890	1045	746	2249	4529	2838
4413_Total IgE levels	4413_Total IgE levels	25	746	1	3986	2912	3887	1868	2920	4513	3913	2955	2208	3904	746
3198_Frequency of travelling from home to job workplace	3198_Frequency of travelling from home to job workplace	25	747	1	2767	4114	747	2528	3077	988	4662	4147	1022	1870	4236
4491_Right pars opercularis	4491_Right pars opercularis	25	748	1	3854	4595	1769	1602	748	3004	2124	2501	3939	2474	4084
4172_Social support - Leisure/social activities: Pub or social club	4172_Social support - Leisure/social activities: Pub or social club	25	748	1	3979	4715	4476	1539	4147	2886	1178	2960	3728	3313	748
1348_Plasma Apolipoprotein B level (FBAT, multivariate adjusted)	1348_Plasma Apolipoprotein B level (FBAT, multivariate adjusted)	25	749	1	3360	904	749	2188	2387	1654	4702	4117	3037	1953	2107
682_::::X-10395	682_::::X-10395	25	749	1	1603	3580	1834	749	3748	3833	4010	2630	3976	3680	4506
1084_Hemoglobin A1C level	1084_Hemoglobin A1C level	25	749	1	3982	1320	1756	2689	2360	1065	749	4527	3733	1115	4668
4209_Chronic kidney disease	4209_Chronic kidney disease	25	749	1	1385	4608	1309	3691	3541	3544	1974	4446	1664	3487	749
680_::::X-09789	680_::::X-09789	25	750	1	3894	3082	3899	1474	2830	750	4637	1540	2439	4719	3901
350_gdT:%CM (1)	350_gdT:%CM (1)	25	750	1	3593	1265	4601	4122	2740	1035	1588	2587	1330	2719	750
2093_CCL5 - C-C motif chemokine 5	2093_CCL5 - C-C motif chemokine 5	25	751	1	2934	4391	801	2615	3399	3502	751	2274	2392	1128	1359
1514_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	1514_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	25	752	1	1344	752	4304	1206	4591	3916	1861	3513	2857	761	1347
692_::::X-11315	692_::::X-11315	25	752	1	1764	3150	2007	1053	752	4500	4739	1910	990	2100	3244
366_Amino acid::Alanine and aspartate metabolism::aspartate	366_Amino acid::Alanine and aspartate metabolism::aspartate	25	752	1	1006	1398	4143	3383	2758	3650	3351	3012	752	1521	4539
3993_Irritability (IRR)	3993_Irritability (IRR)	25	753	1	753	1585	2179	3269	2624	2729	4208	1571	1432	2309	3951
440_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,6-anhydroglucose	440_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,6-anhydroglucose	25	753	1	2591	1971	3160	4247	3174	1618	4725	4003	753	3951	4560
1293_Diabetes incidence (GEE, adjusted for age and sex)	1293_Diabetes incidence (GEE, adjusted for age and sex)	25	753	1	3629	3102	3812	3737	2495	1579	2257	4717	2484	1821	753
2748_NTF3 - Neurotrophin-3	2748_NTF3 - Neurotrophin-3	25	756	1	3994	2138	3246	2149	756	961	3018	981	3570	4615	2351
2838_ENTPD3 - Ectonucleoside triphosphate diphosphohydrolase 3	2838_ENTPD3 - Ectonucleoside triphosphate diphosphohydrolase 3	25	756	1	2970	3878	1625	1192	3671	3578	4058	756	888	4173	3257
3575_Pain type(s) experienced in last month: Knee pain	3575_Pain type(s) experienced in last month: Knee pain	25	756	1	2830	2522	3482	4604	1362	3388	3167	1708	756	2215	2482
1131_Ratio of visceral-tosubcutaneous adipose tissue volume (female)	1131_Ratio of visceral-tosubcutaneous adipose tissue volume (female)	25	757	1	2851	4658	1293	4188	3831	1068	2190	757	2147	1812	3798
1739_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for age and sex)	1739_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for age and sex)	25	757	1	2558	953	2433	3759	1597	3848	1339	3646	757	977	2434
2440_FCGR2A FCGR2B - Low affinity immunoglobulin gamma Fc region receptor II-a/b	2440_FCGR2A FCGR2B - Low affinity immunoglobulin gamma Fc region receptor II-a/b	25	758	1	3860	2957	758	3895	4637	1636	4333	2675	2646	962	4513
2840_FCRL3 - Fc receptor-like protein 3	2840_FCRL3 - Fc receptor-like protein 3	25	758	1	3190	1275	2530	4027	3624	4613	1192	758	4647	2164	3675
1597_Platelet aggregation to collagen (at exam 5, GEE, adjusted for multivariable)	1597_Platelet aggregation to collagen (at exam 5, GEE, adjusted for multivariable)	25	758	1	1124	2037	4687	4739	991	1787	4506	2371	1917	758	4739
2044_Severe gingival inflammation	2044_Severe gingival inflammation	25	759	1	1545	759	2012	1550	2595	4568	2921	761	848	1378	1083
2395_WFIKKN1 - WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1	2395_WFIKKN1 - WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1	25	759	1	4397	2139	759	2917	3552	3080	4199	3377	908	3304	1240
4612_Right basal forebrain	4612_Right basal forebrain	25	759	1	2471	3595	3896	3982	4243	3795	3634	759	4537	3555	3415
4291_Asthma	4291_Asthma	25	760	1	2028	2566	4000	3574	4213	760	1015	3725	975	4484	1822
108_Coronary artery disease	108_Coronary artery disease	25	761	1	4011	1432	3717	3164	2558	761	2390	2028	2353	866	2835
3676_Diagnoses - main ICD10: M16 Osteoarthritis of hip	3676_Diagnoses - main ICD10: M16 Osteoarthritis of hip	25	761	1	796	4594	3232	1918	4721	2200	2796	3466	761	1854	4329
2991_ERP29 - Endoplasmic reticulum resident protein 29	2991_ERP29 - Endoplasmic reticulum resident protein 29	25	761	1	2607	4070	2144	2170	2760	2086	2374	2627	4584	3918	761
2390_F7 - Coagulation Factor VII	2390_F7 - Coagulation Factor VII	25	762	1	762	4734	3698	3038	3699	1283	2668	3730	3109	2019	2594
1782_Artial fibrillation (FBAT, adjusted for multivariable)	1782_Artial fibrillation (FBAT, adjusted for multivariable)	25	762	1	3488	1113	762	3405	2325	1025	1676	4167	4311	1315	2196
2351_TNFSF13B - Tumor necrosis factor ligand superfamily member 13B	2351_TNFSF13B - Tumor necrosis factor ligand superfamily member 13B	25	763	1	4365	4310	763	1740	2297	4092	2723	1821	1297	3483	2481
3478_Own or rent accommodation lived in: Rent - from local authority, local council, housing association	3478_Own or rent accommodation lived in: Rent - from local authority, local council, housing association	25	763	1	3362	3631	3027	763	2213	4629	3547	4679	3035	2126	4292
425_Amino acid::Valine, leucine and isoleucine metabolism::alpha-hydroxyisovalerate	425_Amino acid::Valine, leucine and isoleucine metabolism::alpha-hydroxyisovalerate	25	763	1	2998	4253	4127	1489	4058	763	2830	1527	3421	3179	4336
266_DPT:%Exhausted	266_DPT:%Exhausted	25	763	1	1415	1033	1527	2491	2573	1063	2771	2667	3664	2419	763
2943_WNT7A - Protein Wnt-7a	2943_WNT7A - Protein Wnt-7a	25	764	1	4536	764	851	3141	3812	3566	1156	1151	2844	2482	879
3717_Diagnoses - secondary ICD10: Z96 Presence of other functional implants	3717_Diagnoses - secondary ICD10: Z96 Presence of other functional implants	25	764	1	3063	2906	764	3577	2340	4366	4220	3396	2671	2656	2937
2184_ULBP3 - NKG2D ligand 3	2184_ULBP3 - NKG2D ligand 3	25	764	1	1196	2586	4033	2895	3291	764	4475	1954	4233	4561	1108
373_Amino acid::Cysteine, methionine, SAM, taurine metabolism::methionine	373_Amino acid::Cysteine, methionine, SAM, taurine metabolism::methionine	25	765	1	3873	2695	765	2478	3799	1424	2334	3856	3860	1130	1112
455_Cofactors and vitamins::Tocopherol metabolism::alpha-tocopherol	455_Cofactors and vitamins::Tocopherol metabolism::alpha-tocopherol	25	765	1	3631	3937	1580	1164	765	4528	4219	4556	3918	4137	3477
2613_CD84 - SLAM family member 5	2613_CD84 - SLAM family member 5	25	765	1	2572	4095	4256	2881	3008	2679	1361	1269	765	4049	4573
4320_Positive affect (univariate)	4320_Positive affect (univariate)	25	767	1	4300	1369	860	767	4552	3690	4086	3637	2909	1107	2487
2465_AURKB - Aurora kinase B	2465_AURKB - Aurora kinase B	25	767	1	1791	4183	4411	1392	1463	2868	767	1457	4336	2514	4052
2236_FRZB - Secreted frizzled-related protein 3	2236_FRZB - Secreted frizzled-related protein 3	25	768	1	768	3369	4539	2530	2712	2033	1209	1145	1778	4281	4470
2245_CHEK1 - Serine/threonine-protein kinase Chk1	2245_CHEK1 - Serine/threonine-protein kinase Chk1	25	768	1	4050	2975	3645	4103	2771	768	2594	1816	4732	2835	1278
3810_Eosinphil count	3810_Eosinphil count	25	768	1	805	2364	2547	2025	2681	3779	3922	768	3828	4002	2679
4592_Right pars opercularis	4592_Right pars opercularis	25	768	1	1923	1945	4207	1592	4390	4544	4122	3690	768	3678	1209
3664_External causes: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	3664_External causes: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	25	769	1	769	1357	3803	1525	3540	2804	1781	3563	1834	803	4176
3702_Diagnoses - secondary ICD10: R10 Abdominal and pelvic pain	3702_Diagnoses - secondary ICD10: R10 Abdominal and pelvic pain	25	770	1	1719	770	2132	3754	2323	1227	1253	4340	2662	841	1915
2661_ESM1 - Endothelial cell-specific molecule 1	2661_ESM1 - Endothelial cell-specific molecule 1	25	770	1	3056	3935	4145	1858	3723	770	3208	3005	4533	4432	3672
2660_DMP1 - Dentin matrix acidic phosphoprotein 1	2660_DMP1 - Dentin matrix acidic phosphoprotein 1	25	770	1	1373	3903	4332	2156	2392	1870	1025	770	3078	2301	2014
353_IgE+B:%27+	353_IgE+B:%27+	25	770	1	2929	4669	1303	4655	3511	3575	4062	3582	1930	3707	770
4564_Left pericalcarine	4564_Left pericalcarine	25	771	1	4064	771	3871	1721	1289	1962	1888	4593	1140	1995	3300
2495_PLK1 - Serine/threonine-protein kinase PLK1	2495_PLK1 - Serine/threonine-protein kinase PLK1	25	771	1	4266	4396	3927	3674	2074	995	4249	2651	4235	1215	771
2399_HAPLN1 - Hyaluronan and proteoglycan link protein 1	2399_HAPLN1 - Hyaluronan and proteoglycan link protein 1	25	772	1	2557	1504	4083	4631	1664	772	2010	2405	2399	1515	1497
2784_LIN7B - Protein lin-7 homolog B	2784_LIN7B - Protein lin-7 homolog B	25	772	1	2050	3180	949	1446	4572	3415	2068	772	880	1879	1225
1139_Body Mass Index (Dominance deviation model)	1139_Body Mass Index (Dominance deviation model)	25	772	1	4323	1544	2427	2837	3947	3262	939	1590	851	772	4280
2911_PDIA3 - Protein disulfide-isomerase A3	2911_PDIA3 - Protein disulfide-isomerase A3	25	773	1	1138	2553	1994	773	4163	1187	1823	1175	1660	2779	4275
2812_CST2 - Cystatin-SA	2812_CST2 - Cystatin-SA	25	773	1	4717	3472	2648	3718	3394	2074	3162	773	1173	4335	2435
2626_MFRP - Membrane frizzled-related protein	2626_MFRP - Membrane frizzled-related protein	25	773	1	4026	2150	2651	2871	1830	937	3240	2907	1468	3187	773
2844_LRRTM3 - Leucine-rich repeat transmembrane neuronal protein 3	2844_LRRTM3 - Leucine-rich repeat transmembrane neuronal protein 3	25	774	1	774	855	4554	3207	3874	1534	838	3339	1303	1464	4374
2647_MMP10 - Stromelysin-2	2647_MMP10 - Stromelysin-2	25	774	1	1625	4706	774	4192	2138	1648	4280	3492	4330	2929	3340
4665_Superior fronto-occipital fasciculus fractional anisotropy	4665_Superior fronto-occipital fasciculus fractional anisotropy	25	774	1	2360	3308	3194	1478	774	1798	1596	4462	3156	2810	4501
3350_Bilateral oophorectomy (both ovaries removed) (female)	3350_Bilateral oophorectomy (both ovaries removed) (female)	25	774	1	2919	1057	1396	2661	2130	774	3332	4474	1170	2610	1593
2445_GPC2 - Glypican-2	2445_GPC2 - Glypican-2	25	774	1	2847	3508	2644	3586	4174	3475	774	3297	3445	1916	4488
973_Beta nerve growth factor	973_Beta nerve growth factor	25	774	1	973	2741	2553	2159	1779	4447	4033	4371	1235	774	1473
4593_Right pars orbitalis	4593_Right pars orbitalis	25	775	1	3844	775	3314	2457	4336	3786	1016	4513	1283	4021	3987
3002_HNRNPK - Heterogeneous nuclear ribonucleoprotein K	3002_HNRNPK - Heterogeneous nuclear ribonucleoprotein K	25	775	1	3014	2942	1974	1135	3585	3341	3622	3229	775	1948	4405
3445_Impedance measures - Body Mass Index (BMI)	3445_Impedance measures - Body Mass Index (BMI)	25	776	2	1273	2032	957	776	4184	1338	2467	4235	4329	1276	3897
2979_ATP5B - ATP synthase subunit beta, mitochondrial	2979_ATP5B - ATP synthase subunit beta, mitochondrial	25	776	1	4336	2179	2581	2179	3160	2888	2916	4337	776	1883	3929
1158_Fasting glucose interaction (adjusted for BMI)	1158_Fasting glucose interaction (adjusted for BMI)	25	777	1	777	3289	1811	2186	1227	2726	1385	1081	1076	1501	3174
1274_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	1274_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	25	777	1	3087	3876	2201	4577	1421	777	2993	3366	4284	3377	2436
223_Mature B:%Memory	223_Mature B:%Memory	25	777	1	3976	3483	4231	1851	4166	3436	777	1503	3611	3872	1246
3329_Cancer (diagnosed by doctor)	3329_Cancer (diagnosed by doctor)	25	778	1	3453	2089	1349	2531	778	4322	2973	4598	2936	3365	4672
2095_TNFRSF11B - Tumor necrosis factor receptor superfamily member 11B	2095_TNFRSF11B - Tumor necrosis factor receptor superfamily member 11B	25	778	1	3609	2279	3940	1766	1647	1360	778	2048	935	1999	1904
708_::::X-11452	708_::::X-11452	25	778	1	1269	2897	1336	3220	1973	4529	1937	3720	778	1701	2730
1043_Shaft Width (GEE, adjusted for multivariable)	1043_Shaft Width (GEE, adjusted for multivariable)	25	779	1	3058	3561	1864	779	1512	1204	3684	2671	2784	3699	1767
4435_Influenza A IgG levels	4435_Influenza A IgG levels	25	779	1	808	2456	1230	4531	2238	3856	779	2457	3551	1517	3833
4639_Right hippocampus	4639_Right hippocampus	25	779	1	4168	2471	1806	906	2399	2047	4484	779	3771	3901	2038
638_Xenobiotics::Sugar, sugar substitute, starch::erythritol	638_Xenobiotics::Sugar, sugar substitute, starch::erythritol	25	779	1	3717	3066	2096	4338	1448	4652	1358	3101	779	2845	2637
2638_PYY - Peptide YY	2638_PYY - Peptide YY	25	779	1	2365	1021	1037	2209	3739	1396	1614	1085	1108	779	4588
4434_Measles IgG levels	4434_Measles IgG levels	25	780	1	780	1273	2902	2152	4421	2370	3730	2628	1764	1024	3688
418_Amino acid::Urea cycle; arginine-, proline-, metabolism::trans-4-hydroxyproline	418_Amino acid::Urea cycle; arginine-, proline-, metabolism::trans-4-hydroxyproline	25	780	1	1194	780	3974	3778	2790	3384	2918	2999	2151	894	3631
118_Extreme Height	118_Extreme Height	25	780	1	1944	3039	4734	2377	2421	2860	2822	2380	3307	780	1551
1037_Neck-Shaft Angle (GEE, adjusted for age and sex)	1037_Neck-Shaft Angle (GEE, adjusted for age and sex)	25	781	1	4400	4099	2886	4715	3149	781	2852	4127	1644	2241	1284
4002_Guilty feelings (GUILT)	4002_Guilty feelings (GUILT)	25	781	1	4421	3513	1176	2558	1520	4614	781	3964	3232	4521	2899
4076_Body Mass Index (female)	4076_Body Mass Index (female)	25	781	1	3291	823	3087	1485	4395	4305	1373	1934	3015	781	2763
2418_SFRP1 - Secreted frizzled-related protein 1	2418_SFRP1 - Secreted frizzled-related protein 1	25	782	1	782	3693	1173	3418	4530	4265	2350	2275	3024	2668	3978
3557_Medication for pain relief, constipation, heartburn: Aspirin	3557_Medication for pain relief, constipation, heartburn: Aspirin	25	782	1	3064	2672	782	3044	916	4565	4147	4367	4613	3942	3334
4747_Posterior corona radiata radial diusivities	4747_Posterior corona radiata radial diusivities	25	782	1	3934	1990	3141	782	3919	2791	1079	2299	3304	4488	3414
2292_TNFSF15 - Tumor necrosis factor ligand superfamily member 15	2292_TNFSF15 - Tumor necrosis factor ligand superfamily member 15	25	782	1	3316	4433	4627	4463	3600	782	3207	1502	2871	1490	804
1943_White matter hyperintensity volume (GEE, adjusted for multivariable with APOE)	1943_White matter hyperintensity volume (GEE, adjusted for multivariable with APOE)	25	782	1	4227	2392	1601	1889	1233	1048	2768	3554	782	3922	3209
1167_HOMA-B	1167_HOMA-B	25	783	1	2258	783	3050	3874	938	2371	3508	2878	4512	875	2823
3080_NRXN1 - Neurexin-1-beta	3080_NRXN1 - Neurexin-1-beta	25	784	1	3690	3536	2634	3414	3669	1936	784	1792	1745	4334	4724
1532_Ankle-brachial index (at exam 6, FBAT, adjusted for multivariable)	1532_Ankle-brachial index (at exam 6, FBAT, adjusted for multivariable)	25	784	1	1678	2932	3696	1932	4349	3849	3784	2946	4373	1372	784
996_Interleukin-9	996_Interleukin-9	25	785	1	3175	785	2854	2568	2568	1008	1127	2967	1638	3023	4049
3783_Depression - Waking too early	3783_Depression - Waking too early	25	785	1	2903	1940	4402	3208	785	3393	4371	2793	2931	955	3866
3457_Impedance measures - Leg fat mass (left)	3457_Impedance measures - Leg fat mass (left)	25	785	1	1150	4163	1530	1070	3472	785	3307	3628	4199	2172	818
2837_ENPP7 - Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	2837_ENPP7 - Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	25	785	1	2506	2876	1142	3757	2155	3874	2211	785	3461	3144	1689
2232_XRCC6 - X-ray repair cross-complementing protein 6	2232_XRCC6 - X-ray repair cross-complementing protein 6	25	786	1	1905	3348	1061	786	3103	3318	2894	2330	2257	4132	2765
2000_Weight	2000_Weight	25	786	1	3339	4430	1686	3833	2262	3125	3488	786	4062	3575	4297
2471_CA7 - Carbonic anhydrase 7	2471_CA7 - Carbonic anhydrase 7	25	786	1	3808	4131	1995	2487	2159	2752	2846	1476	3848	3984	786
308_CD4nv:%Th0	308_CD4nv:%Th0	25	787	1	1477	3234	1735	787	3210	4213	2754	2144	3244	4354	3454
2957_CCL16 - C-C motif chemokine 16	2957_CCL16 - C-C motif chemokine 16	25	787	1	2922	2218	4087	2630	1795	1029	4714	3537	2457	1809	787
4136_Hemoglobin	4136_Hemoglobin	25	788	1	1705	4083	788	1987	3891	3089	3487	1207	4300	1864	3772
139_Waist-hip ratio (female)	139_Waist-hip ratio (female)	25	788	1	1437	2105	2380	4214	2501	788	972	2499	2661	4603	3394
4158_Generalised epilepsy	4158_Generalised epilepsy	25	788	1	2212	3361	3873	4444	3369	2627	788	3452	3781	975	2401
3272_Handedness (chirality/laterality)	3272_Handedness (chirality/laterality)	25	789	1	4191	2639	2529	789	2900	3533	4550	1930	1139	2854	3040
2659_CST5 - Cystatin-D	2659_CST5 - Cystatin-D	25	789	1	3351	3832	3968	3760	2877	1686	2548	3223	789	4591	2118
1093_Glioma	1093_Glioma	25	790	1	2636	4010	4740	4242	1999	3288	3414	790	4123	4043	3990
4389_Bust size	4389_Bust size	25	790	1	2571	2458	1094	4049	3216	1290	3299	2545	1913	790	4691
4016_Central corneal thickness	4016_Central corneal thickness	25	791	1	4429	791	1653	4389	1249	3494	1988	4075	2872	3459	3330
816_::::X-13215	816_::::X-13215	25	791	1	1713	1379	1802	1160	4520	2076	1635	791	871	1541	2780
4250_L5 timing	4250_L5 timing	25	792	1	2407	3902	1038	4567	3691	1766	3534	792	3145	2790	819
2640_SST - Somatostatin-28	2640_SST - Somatostatin-28	25	792	1	3137	4364	1579	3008	4017	4045	3314	1013	3640	4423	792
2714_LMNB1 - Lamin-B1	2714_LMNB1 - Lamin-B1	25	793	1	4208	793	3208	2648	2235	3416	2447	3440	1122	1874	4065
1155_Insulin sensitivity index	1155_Insulin sensitivity index	25	794	1	2960	4250	4220	3434	794	3137	4674	3322	3370	4740	4338
2696_RPS7 - 40S ribosomal protein S7	2696_RPS7 - 40S ribosomal protein S7	25	794	1	2269	2600	3963	3944	1947	794	3209	4346	1634	2639	1290
2301_CXCL5 - C-X-C motif chemokine 5	2301_CXCL5 - C-X-C motif chemokine 5	25	794	1	3015	4598	4583	3493	4367	957	1478	794	4031	1721	1249
1968_MMSE score (at age 65, FBAT, adjusted for birth-cohort)	1968_MMSE score (at age 65, FBAT, adjusted for birth-cohort)	25	795	1	3193	3481	3145	4412	1409	4270	4509	795	2868	1761	1980
2905_LTA - Lymphotoxin-alpha	2905_LTA - Lymphotoxin-alpha	25	796	1	859	1259	865	4343	796	4194	2891	3792	4034	834	1765
2287_CFP - Properdin	2287_CFP - Properdin	25	797	1	2921	4527	4019	1938	1150	797	4496	4534	4541	1615	2041
1284_Visceral fat by CT (FBAT, adjusted for age and sex)	1284_Visceral fat by CT (FBAT, adjusted for age and sex)	25	798	1	4456	2152	798	1211	1086	1248	2252	4406	3594	2870	1235
302_CD4mem:R6+	302_CD4mem:R6+	25	798	1	1948	3211	942	3052	798	4442	975	3317	1225	2915	1412
4478_Right cuneus	4478_Right cuneus	25	798	1	4391	3705	1902	1289	1314	2253	900	900	2526	3550	798
1381_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	1381_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	25	799	1	2482	4713	2440	2640	2027	799	3070	2115	3506	4455	1202
3928_Total-body less head BMD and total body lean mass (bivariate meta-analysis)	3928_Total-body less head BMD and total body lean mass (bivariate meta-analysis)	25	799	1	1996	894	3066	4173	2378	4476	799	2890	2130	2607	1830
763_::::X-12216	763_::::X-12216	25	800	1	800	1106	1912	3473	4419	3397	1955	1294	3529	4724	870
2654_CDH2 - Cadherin-2	2654_CDH2 - Cadherin-2	25	800	1	3906	2760	3829	1377	1549	2922	4271	3825	4121	800	1495
129_Hip circumference (female)	129_Hip circumference (female)	25	802	1	802	4723	2272	2002	2050	3220	4065	3008	3633	4459	3145
3295_Guilty feelings	3295_Guilty feelings	25	803	1	2616	1590	2464	2372	803	2090	2389	2718	4558	2337	998
688_::::X-11204	688_::::X-11204	25	803	1	4136	2765	2385	3451	4043	803	4640	3703	3242	3063	4233
4699_Fornix (column and body of fornix) mean diusivities	4699_Fornix (column and body of fornix) mean diusivities	25	803	1	806	2691	3380	1162	3203	2625	3810	1564	803	4143	4167
1932_Parietal brain volume (FBAT, adjusted for age and sex)	1932_Parietal brain volume (FBAT, adjusted for age and sex)	25	804	1	804	2255	4459	4704	1209	3247	2054	4393	3731	2780	1344
3423_Trail making test - Duration to complete alphanumeric path (trail #2)	3423_Trail making test - Duration to complete alphanumeric path (trail #2)	25	804	1	3521	3300	3978	1882	2299	804	4734	1216	2025	4382	1124
1289_Waist circumference by CT (GEE, adjusted for age and sex)	1289_Waist circumference by CT (GEE, adjusted for age and sex)	25	806	1	1927	3389	806	3930	2598	1751	1124	4566	4559	1848	2407
1488_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for multivariable)	1488_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for multivariable)	25	806	1	827	4362	3643	2926	806	1553	3493	3361	1044	2250	1095
1170_Leptin (adjusted for BMI)	1170_Leptin (adjusted for BMI)	25	806	1	3046	1977	2791	1495	1807	806	4016	3616	4118	2191	3840
1728_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for multivariable)	1728_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for multivariable)	25	807	1	2494	2223	807	1806	1433	4145	1366	3086	2803	4073	4451
1956_Wide Range Achievement Test (FBAT, adjusted for multivariable)	1956_Wide Range Achievement Test (FBAT, adjusted for multivariable)	25	807	1	900	1978	4009	3006	2204	2645	4440	3217	807	3175	1926
3300_Frequency of tiredness / lethargy in last 2 weeks	3300_Frequency of tiredness / lethargy in last 2 weeks	25	808	1	2142	808	4221	4592	1368	1953	2364	2162	4015	2547	2806
4414_Total IgA levels	4414_Total IgA levels	25	808	1	3916	4090	2066	808	2566	3621	4207	4029	4196	3833	1784
3424_Symbol digit substitution test - Number of symbol digit matches made correctly	3424_Symbol digit substitution test - Number of symbol digit matches made correctly	25	808	1	3776	3820	3730	2376	3938	3787	2430	808	4514	3910	3722
3298_Frequency of unenthusiasm / disinterest in last 2 weeks	3298_Frequency of unenthusiasm / disinterest in last 2 weeks	25	808	1	4683	2477	1374	2739	4363	3030	3276	2957	3789	1859	808
4117_Total bilirubin	4117_Total bilirubin	25	809	1	809	1477	4479	4084	3933	1442	3260	1909	2904	4503	3313
442_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glycerate	442_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glycerate	25	809	1	2753	3429	1840	1555	1847	809	4228	3740	3691	1673	1324
4354_Infantile hypertrophic pyloric stenosis	4354_Infantile hypertrophic pyloric stenosis	25	809	1	906	1944	2873	3862	2789	1452	1749	2754	2924	809	3673
739_::::X-11850	739_::::X-11850	25	809	1	1869	2769	1165	3987	3634	3524	3380	2188	3622	2355	809
2265_CCL14 - C-C motif chemokine 14	2265_CCL14 - C-C motif chemokine 14	25	810	1	1839	810	4431	3660	999	1444	1597	2725	970	1925	1416
3081_NRXN3 - Neurexin-3-beta	3081_NRXN3 - Neurexin-3-beta	25	811	1	820	4381	4254	3701	1225	4394	4576	1562	1249	2975	811
1792_RR interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1792_RR interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	812	1	1661	2917	1206	4053	812	2132	2849	2074	1641	1120	1892
376_Amino acid::Glutamate metabolism::pyroglutamine*	376_Amino acid::Glutamate metabolism::pyroglutamine*	25	812	1	1728	1734	1979	4617	3233	2754	812	3442	1534	2057	4218
102_Late pubertal growth (female)	102_Late pubertal growth (female)	25	813	1	4544	1413	2746	2918	1371	813	2349	4467	1049	1298	2719
1016_Femoral BMD (FBAT, adjusted for multivariable)	1016_Femoral BMD (FBAT, adjusted for multivariable)	25	813	1	2369	4612	2260	1238	3592	3908	2725	1735	4345	813	1059
560_Lipid::Medium chain fatty acid::pelargonate (9:0)	560_Lipid::Medium chain fatty acid::pelargonate (9:0)	25	814	1	1497	4561	3659	4234	3834	3898	2200	2637	3208	3280	814
1246_Mean FEV1/FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	1246_Mean FEV1/FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	25	815	1	2478	4746	4299	2687	1003	815	1433	1266	3437	3106	2571
36_Loneliness (multivariate)	36_Loneliness (multivariate)	25	815	1	1067	1251	2122	2193	3489	3059	1227	2511	1161	815	4221
109_Coronary artery disease	109_Coronary artery disease	25	816	1	4688	1597	3133	816	3740	2529	1093	2032	1260	2521	2644
2109_ANGPT2 - Angiopoietin-2	2109_ANGPT2 - Angiopoietin-2	25	816	1	1916	4135	4404	4406	2422	3380	816	2526	3283	2244	3124
2767_EIF4EBP2 - Eukaryotic translation initiation factor 4E-binding protein 2	2767_EIF4EBP2 - Eukaryotic translation initiation factor 4E-binding protein 2	25	816	1	3007	3285	4330	2535	2043	4004	1031	816	1038	4581	1860
237_CD32 on pDC	237_CD32 on pDC	25	816	1	3518	859	4084	3069	3295	2586	2342	3863	816	895	3468
515_Lipid::Long chain fatty acid::10-nonadecenoate (19:1n9)	515_Lipid::Long chain fatty acid::10-nonadecenoate (19:1n9)	25	817	1	817	2339	1120	3003	4140	3366	3662	3847	2102	3066	2106
1029_Neck Width (GEE, adjusted for age and sex)	1029_Neck Width (GEE, adjusted for age and sex)	25	817	1	4728	817	1251	1561	4117	1328	4441	3155	3233	1909	3582
3507_Non-butter spread type details: Polyunsaturated/sunflower oil based spread (eg: Flora)	3507_Non-butter spread type details: Polyunsaturated/sunflower oil based spread (eg: Flora)	25	817	1	3578	3422	1275	3565	817	3476	1000	2995	4155	2201	2479
4009_Osteoarthritis of hip or knee (hospital diagnosed)	4009_Osteoarthritis of hip or knee (hospital diagnosed)	25	817	1	4014	1968	1073	4710	3018	817	2453	1950	945	4293	2643
220_T:%Vd1	220_T:%Vd1	25	818	1	3584	3712	4507	3801	3408	818	1640	980	4687	4101	1025
2480_DKK4 - Dickkopf-related protein 4	2480_DKK4 - Dickkopf-related protein 4	25	818	1	1480	4490	2068	1849	3470	3468	818	914	2058	3073	3393
222_B:%Mature	222_B:%Mature	25	818	1	1879	2547	1074	1324	4374	1095	1812	818	4122	2173	3729
3632_Illnesses of father: Chronic bronchitis/emphysema	3632_Illnesses of father: Chronic bronchitis/emphysema	25	819	1	4356	819	2184	2043	3855	4380	1765	4392	3452	2300	3292
378_Amino acid::Glutathione metabolism::cysteine-glutathione disulfide	378_Amino acid::Glutathione metabolism::cysteine-glutathione disulfide	25	819	1	3968	4015	4492	819	2182	2099	3998	4659	4158	1247	2963
1918_Total cerebral brain volume (FBAT, adjusted for multivariable)	1918_Total cerebral brain volume (FBAT, adjusted for multivariable)	25	819	1	4178	1134	4413	4141	819	2844	1348	3075	3684	2852	1649
3611_Treatment/medication code: lisinopril	3611_Treatment/medication code: lisinopril	25	819	1	3624	2084	896	2354	2725	819	3902	4563	1878	3400	956
4557_Left medial orbitofrontal	4557_Left medial orbitofrontal	25	819	1	3589	1937	3263	3387	1861	2065	819	4722	3440	863	3036
853_Albumin	853_Albumin	25	820	1	2260	820	2054	3550	1622	3597	1774	1514	4479	2506	997
965_Total lipids in very small VLDL	965_Total lipids in very small VLDL	25	820	1	4079	2058	4230	4694	820	1082	3712	1762	1429	4139	4010
1049_Parkinson disease of sibling pairs (tier 1)	1049_Parkinson disease of sibling pairs (tier 1)	25	820	1	3975	3896	2151	2010	1619	820	1702	2936	3257	4513	1954
743_::::X-11876	743_::::X-11876	25	820	1	3171	3256	1499	935	4566	1995	820	2206	2183	2273	3525
38_Verbal-numerical reasoning	38_Verbal-numerical reasoning	25	821	1	821	3403	3382	1264	987	2746	1068	3528	1668	1783	1421
1353_Plasma Apolipoprotein C3 level (GEE, multivariate adjusted)	1353_Plasma Apolipoprotein C3 level (GEE, multivariate adjusted)	25	821	1	2592	4348	3018	3888	3150	821	4386	4008	4556	2339	1927
4596_Right postcentral	4596_Right postcentral	25	821	1	3264	3034	2762	2171	1102	4299	1044	3742	821	3647	4347
248_CD337 on NK early	248_CD337 on NK early	25	821	1	4297	1532	2072	2910	1065	2327	4634	3308	2521	821	2346
4454_Left lateral orbitofrontal	4454_Left lateral orbitofrontal	25	822	1	822	3329	2134	1715	2779	1218	4732	3068	3165	3303	2204
2208_CCL8 - C-C motif chemokine 8	2208_CCL8 - C-C motif chemokine 8	25	823	1	823	1158	4060	2485	2014	3077	2493	3953	2198	2291	4266
554_Lipid::Medium chain fatty acid::5-dodecenoate (12:1n7)	554_Lipid::Medium chain fatty acid::5-dodecenoate (12:1n7)	25	823	1	1583	1102	4604	4254	3287	3746	3292	1892	823	2423	4168
1914_Parietal brain volume (FBAT, adjusted for multivariable)	1914_Parietal brain volume (FBAT, adjusted for multivariable)	25	824	1	824	3650	3422	4362	2911	4526	3170	4265	4483	3968	2358
504_Lipid::Fatty acid, monohydroxy::2-hydroxypalmitate	504_Lipid::Fatty acid, monohydroxy::2-hydroxypalmitate	25	825	1	1876	1350	2044	4088	825	3843	4043	3902	3316	1588	2923
4567_Left precentral	4567_Left precentral	25	826	1	2778	2640	1234	3027	2376	2182	2151	3007	826	4172	3586
3440_Impedance measures - Weight	3440_Impedance measures - Weight	25	827	1	3892	2591	4024	827	3852	3248	2396	4370	4384	3773	3434
3443_Impedance measures - Whole body fat-free mass	3443_Impedance measures - Whole body fat-free mass	25	827	2	1977	4510	3331	2148	3525	2721	1989	3519	1146	827	2203
1844_Neck Section Modulus (FBAT, male, adjusted for multivariable)	1844_Neck Section Modulus (FBAT, male, adjusted for multivariable)	25	827	1	2561	2166	1387	4251	2661	4108	3179	4312	4642	4671	827
2150_CKM - Creatine kinase M-type	2150_CKM - Creatine kinase M-type	25	828	1	3602	2156	3868	2110	828	1041	3706	2681	1281	880	4393
1986_Age at natural menopause (FBAT)	1986_Age at natural menopause (FBAT)	25	829	1	870	2723	4347	1024	829	1782	1293	4033	3572	968	4409
2868_NCAM1 - Neural cell adhesion molecule 1, 120 kDa isoform	2868_NCAM1 - Neural cell adhesion molecule 1, 120 kDa isoform	25	830	1	2294	4289	4390	3855	830	1182	3555	3426	1771	3953	2374
2968_SHBG - Sex hormone-binding globulin	2968_SHBG - Sex hormone-binding globulin	25	830	1	2949	4682	1616	3057	3526	4669	2157	3188	830	2143	4128
4698_External capsule mean diusivities	4698_External capsule mean diusivities	25	831	1	2136	2228	3617	2646	831	2046	3760	3042	1550	1484	1323
3001_GSTA3 - Glutathione S-transferase A3	3001_GSTA3 - Glutathione S-transferase A3	25	831	1	3587	4296	1199	1653	3584	3992	2875	831	3063	4720	1305
4524_Left pallidum	4524_Left pallidum	25	831	1	1461	2482	4175	4501	2993	2406	4218	1040	831	3744	2997
579_Lipid::Sterol, Steroid::lathosterol	579_Lipid::Sterol, Steroid::lathosterol	25	834	1	1870	834	3603	3698	1874	4111	1810	2805	907	1807	3134
3590_Medication for cholesterol, blood pressure or diabetes: Cholesterol lowering medication	3590_Medication for cholesterol, blood pressure or diabetes: Cholesterol lowering medication	25	834	1	4547	2676	2263	3907	834	877	3489	3882	1348	2276	4505
3405_Fluid intelligence test - FI7 : synonym	3405_Fluid intelligence test - FI7 : synonym	25	835	1	835	1078	2172	2965	3861	2110	3342	3036	1538	3661	1852
597_Peptide::Dipeptide::pyroglutamylglycine	597_Peptide::Dipeptide::pyroglutamylglycine	25	835	1	4493	3837	979	3662	835	3428	2209	3335	977	3505	1975
733_::::X-11818	733_::::X-11818	25	835	1	3903	1046	1955	2748	1773	3337	4502	1235	4662	2236	835
123_Overweight	123_Overweight	25	837	1	837	3362	2538	4627	4718	3724	2279	1635	3388	2559	1876
3474_Type of accommodation lived in: A house or bungalow	3474_Type of accommodation lived in: A house or bungalow	25	837	1	2524	2720	1739	2091	1239	2671	1301	837	1367	3250	2465
1524_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	1524_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	25	837	1	2335	1908	2890	2394	2609	1924	4602	1652	3592	837	1906
1124_Subcutaneous adipose tissue attenuation (male)	1124_Subcutaneous adipose tissue attenuation (male)	25	838	1	838	1053	1923	2427	1725	3842	4225	2505	1698	900	4503
3963_Gestational weight gain (offspring, total)	3963_Gestational weight gain (offspring, total)	25	838	1	1263	4117	1916	838	1599	4259	1105	3732	1491	4649	2389
7_Anxiety disorder (factor score)	7_Anxiety disorder (factor score)	25	840	1	840	2763	3576	3831	4477	2018	4329	1618	1072	4299	1691
2305_CXCL3 CXCL2 - Gro-beta/gamma	2305_CXCL3 CXCL2 - Gro-beta/gamma	25	840	1	3199	1561	3163	1838	2512	1472	840	4297	3263	1337	4028
4032_Alcohol dependency (unrelated individuals)	4032_Alcohol dependency (unrelated individuals)	25	841	1	841	1924	1751	1734	3493	2761	3526	4619	3076	2119	876
1344_Plasma Apolipoprotein A-I level (FBAT, multivariate adjusted)	1344_Plasma Apolipoprotein A-I level (FBAT, multivariate adjusted)	25	842	1	3110	842	2985	1010	2859	3595	1171	1445	1947	2879	2491
1528_Remnant lipoprotein cholesterol (at exam 4, FBAT)	1528_Remnant lipoprotein cholesterol (at exam 4, FBAT)	25	842	1	2985	3716	1689	2024	2937	842	4323	3190	3673	3579	3604
3697_Diagnoses - secondary ICD10: K29 Gastritis and duodenitis	3697_Diagnoses - secondary ICD10: K29 Gastritis and duodenitis	25	842	1	2180	4126	2314	2046	3386	2662	2580	842	3641	2922	2940
2797_PEBP1 - Phosphatidylethanolamine-binding protein 1	2797_PEBP1 - Phosphatidylethanolamine-binding protein 1	25	843	1	2093	1060	1554	3197	3964	843	3815	1869	4487	4187	1400
1207_Longevity (>= 85 yrs vs < 65 yrs)	1207_Longevity (>= 85 yrs vs < 65 yrs)	25	844	1	844	4302	3003	2618	2543	2984	3105	2571	4377	3938	3857
863_Double bonds in fatty acids	863_Double bonds in fatty acids	25	844	1	3261	3615	2194	844	2481	2591	3062	4499	2216	1594	4715
2835_CHST6 - Carbohydrate sulfotransferase 6	2835_CHST6 - Carbohydrate sulfotransferase 6	25	844	1	1797	4413	3679	3468	2562	4080	3407	844	2814	2940	4301
2114_TYRO3 - Tyrosine-protein kinase receptor TYRO3	2114_TYRO3 - Tyrosine-protein kinase receptor TYRO3	25	844	1	2772	1745	4148	4216	1120	3894	1453	1924	844	3921	3158
3353_Number of cigarettes previously smoked daily	3353_Number of cigarettes previously smoked daily	25	845	1	4670	3915	2176	4620	845	2829	1276	1838	3822	3257	3076
3909_Vertical cup-disc ratio	3909_Vertical cup-disc ratio	25	846	1	846	3390	1669	2078	4093	900	4693	1039	3727	2714	1438
1558_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1558_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	846	1	3183	3788	3291	1809	846	4448	2741	3920	3625	2811	2173
2013_Response following treatment of MDD subjects	2013_Response following treatment of MDD subjects	25	847	1	3667	1071	858	3399	1623	847	3044	3913	1889	1006	1632
3347_Age started oral contraceptive pill (female)	3347_Age started oral contraceptive pill (female)	25	849	1	1790	4639	2539	4274	2173	849	3608	4120	3796	1843	1462
799_::::X-12740	799_::::X-12740	25	849	1	4390	1004	2264	1720	4562	4728	3834	3499	4513	849	4097
4408_Vaginal discharge: Itching	4408_Vaginal discharge: Itching	25	850	1	964	4377	3565	850	1726	3904	4006	3631	3882	2998	3610
3767_Depression - Recent lack of interenst of pleasure in doing things	3767_Depression - Recent lack of interenst of pleasure in doing things	25	850	1	925	1574	3839	1772	3556	2190	850	1341	2456	969	2387
3016_NAMPT - Nicotinamide phosphoribosyltransferase	3016_NAMPT - Nicotinamide phosphoribosyltransferase	25	851	1	1485	895	2120	929	2659	3429	851	2727	1774	1244	2698
144_Body Mass Index (male)	144_Body Mass Index (male)	25	851	1	857	1192	3436	1706	2013	1781	2073	4736	2023	2853	851
2967_MMP13 - Collagenase 3	2967_MMP13 - Collagenase 3	25	852	1	1145	2604	4444	3089	1857	852	2568	3931	1756	3573	1657
1881_Shaft cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	1881_Shaft cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	25	853	1	3754	3590	2447	3526	2786	853	2402	3658	3934	3380	3482
984_Interleukin-16	984_Interleukin-16	25	853	1	3569	1270	4006	3233	4071	4082	1874	4414	2250	853	3318
3889_Monocyte count (three-way meta)	3889_Monocyte count (three-way meta)	25	856	1	3610	4031	3192	4537	856	2167	3069	3753	2614	1303	983
4482_Right inferior temporal	4482_Right inferior temporal	25	858	1	4036	2376	2485	1637	2344	858	3188	3504	1244	3601	1856
2485_IL17RD - Interleukin-17 receptor D	2485_IL17RD - Interleukin-17 receptor D	25	858	1	4594	1578	3694	4118	2489	2102	858	3729	3220	3098	1228
3399_Tinnitus	3399_Tinnitus	25	858	1	2714	3044	977	1685	2367	1459	3453	2194	858	4374	1720
2650_STX1A - Syntaxin-1A	2650_STX1A - Syntaxin-1A	25	859	1	4289	1998	1804	2518	3024	859	2538	2614	3295	4369	1960
3475_Type of accommodation lived in: A flat, maisonette or apartment	3475_Type of accommodation lived in: A flat, maisonette or apartment	25	860	1	2006	3212	4040	3294	860	2199	1698	3873	2811	3811	3765
4473_Left supramarginal	4473_Left supramarginal	25	860	1	4139	3192	4131	2787	1730	3911	3051	1733	860	4226	3307
4521_Left thalamus proper	4521_Left thalamus proper	25	861	1	2373	4185	2398	1523	1202	2954	1418	4064	2508	1707	861
526_Lipid::Long chain fatty acid::palmitoleate (16:1n7)	526_Lipid::Long chain fatty acid::palmitoleate (16:1n7)	25	862	1	1739	4055	3703	3837	1453	862	3103	1969	890	3839	2091
2450_LRIG3 - Leucine-rich repeats and immunoglobulin-like domains protein 3	2450_LRIG3 - Leucine-rich repeats and immunoglobulin-like domains protein 3	25	863	1	863	3005	3781	2957	2332	1076	4023	2984	1747	3566	1396
1572_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable\)	1572_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable\)	25	863	1	2534	4165	1710	863	1587	4473	4284	3245	3714	3215	2746
410_Amino acid::Tryptophan metabolism::tryptophan betaine	410_Amino acid::Tryptophan metabolism::tryptophan betaine	25	863	1	1399	864	2565	1337	4078	4090	1518	4490	863	1589	4455
2070_C5 - Complement C5	2070_C5 - Complement C5	25	864	1	2342	4048	4255	864	3854	4216	4405	4211	3201	4624	4356
3560_Medication for pain relief, constipation, heartburn: Omeprazole (e.g. Zanprol)	3560_Medication for pain relief, constipation, heartburn: Omeprazole (e.g. Zanprol)	25	864	1	4385	3287	4388	3013	864	2243	3721	2642	1264	4461	3703
4145_Pulse pressure	4145_Pulse pressure	25	864	1	4378	2934	1471	2761	4583	2335	1902	2830	864	2387	1090
593_Peptide::Dipeptide::glycylvaline	593_Peptide::Dipeptide::glycylvaline	25	865	1	4001	1812	4342	2623	1332	865	2842	4014	4167	4233	4263
2112_CRLF1 CLCF1 - Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex	2112_CRLF1 CLCF1 - Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex	25	866	1	866	3065	2478	3795	2167	1501	3702	1481	1931	2567	4319
489_Lipid::Essential fatty acid::docosapentaenoate (n3 DPA; 22:5n3)	489_Lipid::Essential fatty acid::docosapentaenoate (n3 DPA; 22:5n3)	25	866	1	2204	4298	866	3474	1755	1783	1599	3474	2894	1106	2509
2356_GDF9 - Growth/differentiation factor 9	2356_GDF9 - Growth/differentiation factor 9	25	866	1	3911	3588	1677	866	2941	4378	2657	3706	2322	3235	4226
4020_Freckles	4020_Freckles	25	867	1	2597	867	1250	3658	2125	1411	3658	3896	2158	1133	4029
2819_DAPK2 - Death-associated protein kinase 2	2819_DAPK2 - Death-associated protein kinase 2	25	868	1	868	4246	2169	2583	2312	2548	2462	4187	4632	3417	1564
955_Cholesterol esters in very large HDL	955_Cholesterol esters in very large HDL	25	868	1	3262	3680	3725	1246	3745	4677	4636	2326	868	2959	4716
3905_Intraocular pressure	3905_Intraocular pressure	25	869	1	2907	3905	2050	869	1635	1569	1516	3330	3383	3348	3382
241_CD161 on CD4mem	241_CD161 on CD4mem	25	869	1	3560	4372	3837	3497	869	3957	3227	2376	4443	3171	3921
3396_Other sociodemographic factors - Private healthcare	3396_Other sociodemographic factors - Private healthcare	25	869	1	923	1791	2479	1943	2264	2906	875	3988	2629	2979	869
804_::::X-12798	804_::::X-12798	25	870	1	2304	3797	4152	2864	4666	3840	2267	3829	870	3516	2334
4298_Thin vs extreme obese	4298_Thin vs extreme obese	25	871	1	3654	1290	871	4479	2938	949	3470	3670	3593	1694	2244
254_CD3 on DN T	254_CD3 on DN T	25	871	1	2493	1947	2052	1288	2931	3707	871	3762	1277	3939	3236
2826_FGF8 - Fibroblast growth factor 8 isoform A	2826_FGF8 - Fibroblast growth factor 8 isoform A	25	871	1	2104	4507	4367	1946	3075	1234	3084	2947	1830	2772	871
582_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::xanthine	582_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::xanthine	25	872	1	3324	4157	4643	872	1992	2238	1363	1421	4263	2111	3439
3408_Average weekly intake of other alcoholic drinks	3408_Average weekly intake of other alcoholic drinks	25	872	1	4629	3790	2279	1887	872	3558	4701	3393	4364	2105	3118
4152_Relative wall thickness	4152_Relative wall thickness	25	872	1	4038	4582	1092	2262	1826	4136	3055	2541	2346	872	2733
4384_Epithelial ovarian cancer (low-grade serous and borderline serous)	4384_Epithelial ovarian cancer (low-grade serous and borderline serous)	25	873	1	2520	3810	873	4685	1816	2913	2302	2665	2866	3798	3226
2720_PGAM1 - Phosphoglycerate mutase 1	2720_PGAM1 - Phosphoglycerate mutase 1	25	873	1	3596	2407	2141	873	3653	2583	4632	3862	3958	2259	3358
2993_FABP5 - Fatty acid-binding protein, epidermal	2993_FABP5 - Fatty acid-binding protein, epidermal	25	873	1	3067	2994	3532	2475	873	4358	2634	2331	2107	3694	873
1984_Age at natural menopause (FBAT, adjusted for multivariable)	1984_Age at natural menopause (FBAT, adjusted for multivariable)	25	874	1	874	1769	3231	2572	4675	3593	2182	2315	2564	1297	3103
4088_Paternal history of Alzheimer's disease	4088_Paternal history of Alzheimer's disease	25	875	1	875	3215	2850	4638	3730	886	4659	2874	2777	1835	1280
3740_Depression - Depression possibly related to stressful or traumatic event	3740_Depression - Depression possibly related to stressful or traumatic event	25	875	1	2719	875	2795	4450	4185	2619	4007	2493	1396	3362	2078
3657_Alcohol - Alcohol drinker status: Previous vs Current	3657_Alcohol - Alcohol drinker status: Previous vs Current	25	875	1	4658	3023	875	2063	4437	3873	2241	3139	4654	3998	4634
4545_Total brain volume	4545_Total brain volume	25	875	1	933	1032	4216	2447	3085	875	2193	4093	2192	954	4695
1503_Triglycerides (at exam 3, GEE, adjusted for age and sex)	1503_Triglycerides (at exam 3, GEE, adjusted for age and sex)	25	876	1	1935	3749	876	4517	2622	3211	3108	1458	4719	3665	2391
272_CD4:%RTE	272_CD4:%RTE	25	876	1	2760	3497	2708	1757	3391	876	2449	3629	1614	2422	1079
3228_Sleep duration	3228_Sleep duration	25	878	1	4512	984	2801	2039	1812	2839	878	2126	1783	1752	935
369_Amino acid::Creatine metabolism::creatine	369_Amino acid::Creatine metabolism::creatine	25	878	1	1405	2211	4209	1252	4491	1971	3674	2127	878	4430	3114
3276_Facial ageing	3276_Facial ageing	25	879	1	3220	3043	3533	3501	879	1074	1132	1538	1981	3146	2438
4630_Left vessel	4630_Left vessel	25	879	1	4244	2884	4536	3349	3058	879	3418	2752	1749	3201	2784
2322_CTLA4 - Cytotoxic T-lymphocyte protein 4	2322_CTLA4 - Cytotoxic T-lymphocyte protein 4	25	880	1	3391	2285	3834	3338	880	2568	4100	2323	1815	4466	2007
2578_ARSA - Arylsulfatase A	2578_ARSA - Arylsulfatase A	25	880	1	1392	1633	4217	1055	3586	4115	880	1706	4074	1369	2851
2251_MAP2K1 - Dual specificity mitogen-activated protein kinase kinase 1	2251_MAP2K1 - Dual specificity mitogen-activated protein kinase kinase 1	25	881	1	1811	2145	3625	3945	2793	4069	3153	2604	881	2439	1426
3087_RTN4 - Reticulon-4	3087_RTN4 - Reticulon-4	25	881	1	4630	2845	2147	3054	2186	2736	2104	4114	3638	881	4459
1303_Fasting insulin (at exam 5, GEE, adjusted for age and sex)	1303_Fasting insulin (at exam 5, GEE, adjusted for age and sex)	25	882	1	882	2872	1813	3441	3095	3371	4067	1385	4067	4574	3142
3585_Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	3585_Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	25	882	1	4045	2571	2429	882	4528	3878	957	2750	4321	1982	2275
594_Peptide::Dipeptide::leucylleucine	594_Peptide::Dipeptide::leucylleucine	25	882	1	3012	4291	3295	1142	882	3589	1149	3091	1879	2825	1138
2804_SPON1 - Spondin-1	2804_SPON1 - Spondin-1	25	883	1	3688	2890	2390	883	1731	3472	2783	4350	3178	3259	2149
1236_Usual weekday sleep duration (FBAT, adjusted for age, sex and BMI)	1236_Usual weekday sleep duration (FBAT, adjusted for age, sex and BMI)	25	883	1	935	2205	3322	4159	4716	1183	1265	2383	1592	1509	883
1189_Aortic-valve calcification	1189_Aortic-valve calcification	25	884	1	884	4204	3023	1222	2219	2571	2419	1957	1899	3919	4061
914_Concentration of medium HDL particles	914_Concentration of medium HDL particles	25	884	1	4088	3763	3585	3152	2059	2461	956	884	1149	3439	3009
4655_Fornix (column and body of fornix) fractional anisotropy	4655_Fornix (column and body of fornix) fractional anisotropy	25	885	1	2184	3583	2683	1901	1254	3430	885	4512	4087	4286	4654
3764_Depression - Recent poor appetite or overeting	3764_Depression - Recent poor appetite or overeting	25	886	1	4375	886	1117	2484	3985	4516	2569	2538	3877	4268	3661
533_Lipid::Lysolipid::1-docosahexaenoylglycerophosphocholine*	533_Lipid::Lysolipid::1-docosahexaenoylglycerophosphocholine*	25	886	1	2899	3179	1035	4181	2746	3665	3850	886	3659	4544	3968
4599_Right precuneus	4599_Right precuneus	25	886	1	2618	1316	4187	3106	1467	3120	2526	3573	4582	886	2590
3451_Impedance measures - Impedance of arm (left)	3451_Impedance measures - Impedance of arm (left)	25	887	1	893	2214	3914	3500	4492	887	4118	3313	2613	1680	2791
2517_EPHA3 - Ephrin type-A receptor 3	2517_EPHA3 - Ephrin type-A receptor 3	25	887	1	3111	2190	2301	933	3086	1383	929	887	3922	1861	2048
181_Waist-hip ratio (male)	181_Waist-hip ratio (male)	25	887	1	1854	2132	3392	4705	4684	4298	1077	3226	887	1259	3028
1607_Viscosity I (at exam 5, GEE, adjusted for age and sex)	1607_Viscosity I (at exam 5, GEE, adjusted for age and sex)	25	887	1	3978	3120	1115	1680	1548	2599	3282	4641	1609	887	2518
4654_External capsule fractional anisotropy	4654_External capsule fractional anisotropy	25	888	1	3435	1851	4708	3587	888	2769	1591	1565	1115	1071	2672
3378_Number of pregnancy terminations (female)	3378_Number of pregnancy terminations (female)	25	888	1	1907	4563	3689	3720	2047	2222	4573	2648	4498	1502	888
3057_IL20RA - Interleukin-20 receptor subunit alpha	3057_IL20RA - Interleukin-20 receptor subunit alpha	25	890	1	3621	3242	2343	890	893	3966	3404	1760	3846	1942	2426
3653_Illnesses of siblings: Severe depression	3653_Illnesses of siblings: Severe depression	25	890	1	4351	3863	2475	3060	3054	2084	2370	890	1505	4585	4625
552_Lipid::Lysolipid::2-stearoylglycerophosphocholine*	552_Lipid::Lysolipid::2-stearoylglycerophosphocholine*	25	891	1	2945	1632	1928	4218	891	2636	1910	3014	1335	992	2414
4555_Left lateral orbitofrontal	4555_Left lateral orbitofrontal	25	891	1	2991	1142	3147	4125	4201	3171	3720	891	2879	995	4211
2602_PRSS27 - Serine protease 27	2602_PRSS27 - Serine protease 27	25	892	1	2894	1513	4664	1249	1070	3485	2650	892	3695	2369	4019
1852_Neck average buckling ratio (FBAT, male, adjussted for multivariable)	1852_Neck average buckling ratio (FBAT, male, adjussted for multivariable)	25	893	1	1588	1621	893	1762	2794	4741	2399	2063	2444	1127	2368
3505_Non-butter spread type details: Soft (tub) margarine	3505_Non-butter spread type details: Soft (tub) margarine	25	893	1	3950	3250	3386	893	3607	2482	2492	3055	2966	1353	2116
557_Lipid::Medium chain fatty acid::caprylate (8:0)	557_Lipid::Medium chain fatty acid::caprylate (8:0)	25	894	1	4570	1599	3506	894	2880	1514	3931	2108	2731	2898	1502
1866_Neck-Shaft Angle (FBAT, female, adjussted for multivariable)	1866_Neck-Shaft Angle (FBAT, female, adjussted for multivariable)	25	894	1	4022	4034	1436	3320	1119	4637	2911	894	4044	2635	2010
1790_QT interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1790_QT interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	896	1	3759	2323	2926	896	1321	2383	2726	4080	2913	3859	3870
3641_Illnesses of mother: Bowel cancer	3641_Illnesses of mother: Bowel cancer	25	897	1	3344	1594	4439	4545	3504	2119	3058	897	1619	4121	4632
3670_Diagnoses - main ICD10: K29 Gastritis and duodenitis	3670_Diagnoses - main ICD10: K29 Gastritis and duodenitis	25	897	1	1252	1025	2786	4574	3309	926	2474	3521	897	1898	2820
1038_Neck-Shaft Angle (FBAT, adjusted for multivariable)	1038_Neck-Shaft Angle (FBAT, adjusted for multivariable)	25	898	1	898	2386	2495	3898	4510	3104	1521	3526	1462	1028	3023
1541_White matter hyperintensity volume (GEE, adjusted for multivariable)	1541_White matter hyperintensity volume (GEE, adjusted for multivariable)	25	898	1	3687	3165	2248	2999	898	2188	3427	3476	2271	3502	4331
1632_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for multivariable)	1632_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for multivariable)	25	899	1	2792	899	4192	4189	2032	3372	1939	3059	2503	2932	2624
1069_Diabetic Nephropathy in Type 1 Diabetes	1069_Diabetic Nephropathy in Type 1 Diabetes	25	899	1	3174	2521	4704	2579	4155	3121	4656	4521	3028	899	4631
640_Xenobiotics::Xanthine metabolism::1,3,7-trimethylurate	640_Xenobiotics::Xanthine metabolism::1,3,7-trimethylurate	25	899	1	2309	2065	4705	3611	3650	2812	4099	3622	3144	3129	899
2402_KLK12 - Kallikrein-12	2402_KLK12 - Kallikrein-12	25	900	1	4373	2537	2895	1948	900	1997	4394	3835	4393	3820	3743
3452_Impedance measures - Leg fat percentage (right)	3452_Impedance measures - Leg fat percentage (right)	25	901	1	901	1521	2199	1747	4217	1232	3181	4341	4019	2169	4339
1490_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for age and sex)	1490_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for age and sex)	25	902	1	902	4233	4198	2942	2452	2187	3995	3580	937	2362	1771
760_::::X-12189	760_::::X-12189	25	902	1	1139	4292	4422	4721	4736	3320	4743	3356	2316	3167	902
2407_LYVE1 - Lymphatic vessel endothelial hyaluronic acid receptor 1	2407_LYVE1 - Lymphatic vessel endothelial hyaluronic acid receptor 1	25	903	1	1312	2908	4373	1542	2397	3017	2301	1851	3490	903	2676
1551_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1551_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	903	1	4312	4113	2536	4020	3987	4471	4302	1299	3331	1753	903
3710_Diagnoses - secondary ICD10: Z85 Personal history of malignant neoplasm	3710_Diagnoses - secondary ICD10: Z85 Personal history of malignant neoplasm	25	904	1	3660	2567	1376	3015	3249	904	3394	3465	4432	3172	1633
1225_Mean Thalamus	1225_Mean Thalamus	25	904	1	4451	2457	4265	4330	1531	3879	3483	904	4392	1947	991
2545_DUSP3 - Dual specificity protein phosphatase 3	2545_DUSP3 - Dual specificity protein phosphatase 3	25	905	1	1129	1554	4380	3530	3906	2408	2671	4106	2383	1036	905
584_Nucleotide::Purine metabolism, guanine containing::7-methylguanine	584_Nucleotide::Purine metabolism, guanine containing::7-methylguanine	25	906	1	4235	3184	3848	4683	2838	3626	906	1182	4561	2889	2071
1019_Lumbar Spine BMD (GEE, adjusted for multivariable)	1019_Lumbar Spine BMD (GEE, adjusted for multivariable)	25	906	1	2051	3317	3738	1387	1184	4311	1761	906	2245	3906	3004
4307_Osteoarthritis	4307_Osteoarthritis	25	906	1	1574	4369	3591	1694	2749	3055	3274	4254	1328	1679	906
307_CD4mem:%cFTH (3)	307_CD4mem:%cFTH (3)	25	907	1	2505	2705	4466	4524	2869	2874	1661	4277	3380	907	1063
4355_IL-1beta in gingival crevicular	4355_IL-1beta in gingival crevicular	25	907	1	3405	4718	4711	2490	3271	1512	2949	1841	2559	3688	907
4026_Childhood idiopathic nephrotic syndrome	4026_Childhood idiopathic nephrotic syndrome	25	908	1	908	1147	1444	4198	1229	1799	4529	2786	1162	3556	2009
4254_Sleep duration (SD)	4254_Sleep duration (SD)	25	908	1	3980	3912	3374	2204	3621	2620	2478	3039	3271	908	4642
2430_FCER2 - Low affinity immunoglobulin epsilon Fc receptor	2430_FCER2 - Low affinity immunoglobulin epsilon Fc receptor	25	909	1	909	917	4126	3512	3112	3663	1771	1090	1683	2228	4177
954_Total cholesterol in very large HDL	954_Total cholesterol in very large HDL	25	909	1	3016	4341	4026	909	2541	3607	3424	2123	954	2976	3421
2971_EREG - Epiregulin	2971_EREG - Epiregulin	25	909	1	3268	1419	3973	1778	3544	909	3848	2013	3722	1973	1972
3897_Plateletcrit (three-way meta)	3897_Plateletcrit (three-way meta)	25	909	1	2263	3641	947	3746	4090	4688	2751	2795	1675	926	909
3306_Ever had same-sex intercourse	3306_Ever had same-sex intercourse	25	910	1	910	2661	3169	3033	2649	1761	3879	4613	1970	1439	1943
4393_Menstrual fever	4393_Menstrual fever	25	910	1	4639	3209	910	1537	4181	4109	1772	1475	2282	2684	1199
4385_Epithelial ovarian cancer (Mucinous invasive and borderline mucinous)	4385_Epithelial ovarian cancer (Mucinous invasive and borderline mucinous)	25	910	1	3524	1821	4308	3902	910	1748	2643	1593	1991	1039	1726
3450_Impedance measures - Impedance of arm (right)	3450_Impedance measures - Impedance of arm (right)	25	910	1	1235	3000	3303	3521	2707	910	3564	2914	2268	2931	2849
3245_Non-oily fish intake	3245_Non-oily fish intake	25	911	1	2315	911	4224	3350	2478	1276	1376	2015	3576	4014	2967
627_Xenobiotics::Drug::p-acetamidophenylglucuronide	627_Xenobiotics::Drug::p-acetamidophenylglucuronide	25	911	1	3622	971	4543	1643	911	3306	3925	3414	1479	3896	2272
3397_Shortness of breath walking on level ground	3397_Shortness of breath walking on level ground	25	912	1	2619	2370	4688	3324	3770	912	2955	1296	3581	2084	2421
689_::::X-11247	689_::::X-11247	25	913	1	1917	913	2525	4569	1956	3478	3907	1418	4691	991	2425
1989_Age at death (GEE, adjusted for multivariable)	1989_Age at death (GEE, adjusted for multivariable)	25	913	1	1755	1323	3933	1316	956	913	2299	1000	1413	2523	1342
1738_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for age and sex)	1738_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for age and sex)	25	913	1	1058	2433	4594	1361	3721	948	3093	3487	1906	913	3841
4029_Alcohol dependency (random effect model for unrelated genotyped individuals)	4029_Alcohol dependency (random effect model for unrelated genotyped individuals)	25	914	1	1175	3047	4110	4386	914	4678	3745	2366	1588	2611	3279
711_::::X-11478	711_::::X-11478	25	914	1	1095	1519	1886	1310	2525	2198	4303	2489	3287	914	1894
4627_Left amygdala	4627_Left amygdala	25	915	1	3467	4623	4573	1896	915	3649	3814	4588	1494	2051	3518
3708_Diagnoses - secondary ICD10: Z80 Family history of primary malignant neoplasm	3708_Diagnoses - secondary ICD10: Z80 Family history of primary malignant neoplasm	25	917	1	917	4382	3789	1547	4515	4230	4009	1250	3624	1929	4223
2376_ADAMTS5 - A disintegrin and metalloproteinase with thrombospondin motifs 5	2376_ADAMTS5 - A disintegrin and metalloproteinase with thrombospondin motifs 5	25	917	1	3494	2861	2533	1711	2066	1270	1658	4486	4638	2761	917
257_CD8:%Senescent	257_CD8:%Senescent	25	918	1	2817	3482	918	3182	3267	4295	4232	4068	4522	1894	4689
3537_Attendance/disability/mobility allowance: Disability living allowance	3537_Attendance/disability/mobility allowance: Disability living allowance	25	919	1	3009	1653	3801	919	1541	2567	1369	4517	1784	3760	4650
158_Hip circumference (male)	158_Hip circumference (male)	25	919	1	4063	2678	3099	2554	919	1955	3800	4223	941	1257	2011
375_Amino acid::Glutamate metabolism::glutamine	375_Amino acid::Glutamate metabolism::glutamine	25	919	1	2752	3666	3440	2259	2940	919	2414	1937	4293	1113	4737
3153_HNRNPA2B1 - Heterogeneous nuclear ribonucleoproteins A2/B1	3153_HNRNPA2B1 - Heterogeneous nuclear ribonucleoproteins A2/B1	25	919	1	4587	4357	2751	3506	4118	1412	3687	3248	2374	4341	919
657_::::X-03094	657_::::X-03094	25	920	1	3672	1260	920	4595	3835	1284	2145	936	2656	2545	3918
1971_MMSE score (at exam 7, GEE, adjusted for age)	1971_MMSE score (at exam 7, GEE, adjusted for age)	25	921	1	3197	1751	921	1686	1643	3832	4735	3294	2160	1088	1591
377_Amino acid::Glutathione metabolism::5-oxoproline	377_Amino acid::Glutathione metabolism::5-oxoproline	25	921	1	2853	3617	2645	921	4191	4736	1896	3535	4220	3592	996
1580_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	1580_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	25	921	1	4474	4355	4172	4637	921	3346	4551	4263	3449	3045	3844
227_mDC:%CD1c-	227_mDC:%CD1c-	25	921	1	1035	2866	4318	3128	3072	921	3481	3952	3020	3767	4719
124_Body Mass Index (male)	124_Body Mass Index (male)	25	921	1	2962	4488	1024	1937	3547	1203	4393	4153	4717	921	3732
2259_YES1 - Tyrosine-protein kinase Yes	2259_YES1 - Tyrosine-protein kinase Yes	25	921	1	3515	2925	2778	4544	4386	3630	4269	2471	2527	4183	921
3148_CPE - Carboxypeptidase E	3148_CPE - Carboxypeptidase E	25	922	1	2153	2495	922	2239	3700	963	2285	1432	1700	1270	2567
4587_Right lingual	4587_Right lingual	25	922	1	4198	4161	3529	1472	4519	1366	3854	3211	922	2442	3567
4611_Left basal forebrain	4611_Left basal forebrain	25	923	1	1173	1511	1745	1565	2635	4214	923	1031	1071	3593	3465
1493_Remnant lipoprotein triglycerides (at exam 4, GEE, adjusted for age and sex)	1493_Remnant lipoprotein triglycerides (at exam 4, GEE, adjusted for age and sex)	25	924	1	924	3701	3912	3244	2296	1132	4670	2116	3089	2046	4581
1697_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for multivariable)	1697_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for multivariable)	25	924	1	4041	4551	924	3934	950	1127	3573	1977	2985	4715	1216
73_Total cholesterol	73_Total cholesterol	25	924	1	4115	3719	2442	2624	924	1407	3548	2136	4597	3978	4094
3976_Total body BMD (15 or younger)	3976_Total body BMD (15 or younger)	25	926	1	2977	2395	4035	4153	3506	3704	926	4098	2441	2944	3012
3359_Age high blood pressure diagnosed	3359_Age high blood pressure diagnosed	25	926	1	4652	2444	1154	1109	4114	3581	3882	926	1418	1606	1258
1036_Neck-Shaft Angle (FBAT, adjusted for age and sex)	1036_Neck-Shaft Angle (FBAT, adjusted for age and sex)	25	927	1	927	3394	2347	2690	3675	4281	2194	1711	1692	2205	2965
3712_Diagnoses - secondary ICD10: Z87 Personal history of other diseases and conditions	3712_Diagnoses - secondary ICD10: Z87 Personal history of other diseases and conditions	25	927	1	3390	964	3791	2223	3550	4052	927	3484	1205	4185	4384
3112_KIF23 - Kinesin-like protein KIF23	3112_KIF23 - Kinesin-like protein KIF23	25	928	1	928	3849	1744	2980	1961	1943	4283	2301	2561	4022	2789
3801_Hematocrit	3801_Hematocrit	25	931	1	3096	1353	931	2674	1451	3968	1715	2368	3785	3122	3607
1296_Adiponectin (FBAT, adjusted for age and sex)	1296_Adiponectin (FBAT, adjusted for age and sex)	25	931	1	2712	1027	1623	931	4212	3691	1261	2808	3442	1125	1918
1750_Cystatin C (at exam 7, FBAT, adjusted for age and sex)	1750_Cystatin C (at exam 7, FBAT, adjusted for age and sex)	25	933	1	3999	3992	933	2350	1993	3340	1123	3208	1130	3359	986
4372_Free thyroxine (FT4)	4372_Free thyroxine (FT4)	25	933	1	4408	1233	4483	1546	1325	933	1111	2043	3238	4127	2145
3201_Job involves heavy manual or physical work	3201_Job involves heavy manual or physical work	25	933	1	2804	3764	3704	2671	2139	3887	4131	3654	933	1427	1115
3600_Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	3600_Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	25	934	1	4359	1388	934	2729	2259	4171	936	2167	1025	3845	3042
2243_ARG1 - Arginase-1	2243_ARG1 - Arginase-1	25	934	1	3659	2295	1726	1905	3784	4166	1003	934	1112	1869	3127
4233_Antimigraine preparations	4233_Antimigraine preparations	25	935	1	4410	3312	4586	3132	3083	935	4277	3003	2017	4652	4589
3142_F2 - Prothrombin	3142_F2 - Prothrombin	25	935	1	3444	1491	2908	3018	1156	4510	4221	935	4684	1736	4003
3144_ANXA6 - Annexin A6	3144_ANXA6 - Annexin A6	25	936	1	4169	936	2608	3773	2733	3184	3530	4351	4020	1645	2486
2676_MAPK8 - Mitogen-activated protein kinase 8	2676_MAPK8 - Mitogen-activated protein kinase 8	25	936	1	1335	2694	3954	936	985	4676	3408	952	4619	1233	3954
3267_Alcohol usually taken with meals	3267_Alcohol usually taken with meals	25	937	1	1845	3053	2405	937	4428	4663	3696	3786	4388	971	3071
661_::::X-04498	661_::::X-04498	25	937	1	1355	3230	1439	2040	3319	3203	3951	1273	2699	937	4318
4448_Left entorhinal	4448_Left entorhinal	25	938	1	2562	938	3230	4209	1051	1098	2943	3558	1640	3976	3708
2848_RASA1 - Ras GTPase-activating protein 1	2848_RASA1 - Ras GTPase-activating protein 1	25	938	1	4423	2967	1020	938	2975	4193	3630	4583	2329	1691	3251
2080_PLA2G5 - Calcium-dependent phospholipase A2	2080_PLA2G5 - Calcium-dependent phospholipase A2	25	939	1	939	3908	1973	2399	2279	3818	4011	3912	3963	2410	4008
707_Lipid::Sterol/Steroid::X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	707_Lipid::Sterol/Steroid::X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	25	939	1	2156	3156	2051	2082	4256	1343	3849	4140	1721	2660	939
4387_Epithelial ovarian cancer (Clear cell)	4387_Epithelial ovarian cancer (Clear cell)	25	940	1	4597	2851	3120	2659	1682	1199	940	3453	1322	1882	1397
4719_Corticospinal tract mode of anisotropy	4719_Corticospinal tract mode of anisotropy	25	941	1	941	2739	3750	3285	3676	3639	2005	4492	3277	2076	3696
2554_FGF17 - Fibroblast growth factor 17	2554_FGF17 - Fibroblast growth factor 17	25	943	1	1911	4045	3065	943	1257	1083	4679	4573	2112	3651	1357
282_CD4:%Eff(127-PD1-)	282_CD4:%Eff(127-PD1-)	25	943	1	2209	4575	3509	2670	1298	943	2710	1373	2553	3209	2706
4085_Type 2 Diabetes	4085_Type 2 Diabetes	25	944	1	2383	944	2800	1491	1429	3139	3790	4636	966	1712	1722
2085_TIMP3 - Metalloproteinase inhibitor 3	2085_TIMP3 - Metalloproteinase inhibitor 3	25	944	1	4399	2417	4227	944	2386	1772	1790	2068	2420	2498	2619
1816_Femoral Neck BMD (FBAT, male, adjusted for multivariable)	1816_Femoral Neck BMD (FBAT, male, adjusted for multivariable)	25	944	1	3375	2492	3487	1603	3223	2792	4601	2546	944	3970	1091
1527_Remnant lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	1527_Remnant lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	25	945	1	945	4158	3084	3498	2346	1003	3484	4502	3204	4259	1937
782_Amino acid::Amino fatty acid::X-12510--2-aminooctanoic acid	782_Amino acid::Amino fatty acid::X-12510--2-aminooctanoic acid	25	945	1	2885	2300	1947	945	2420	3864	2728	4209	3401	2404	4678
2227_SPINT1 - Kunitz-type protease inhibitor 1	2227_SPINT1 - Kunitz-type protease inhibitor 1	25	945	1	4467	1909	2601	2307	3130	4268	945	3559	2750	4179	3635
3428_Fluid intelligence test - FI5 : family relationship calculation	3428_Fluid intelligence test - FI5 : family relationship calculation	25	946	1	1997	1235	4047	1290	3043	946	1245	3517	1114	1547	1000
4463_Left pericalcarine	4463_Left pericalcarine	25	947	1	3543	2888	4739	4148	4006	1055	3298	1751	2238	3510	947
1426_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1426_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	948	1	3996	3607	1767	2710	948	2884	4430	3030	2628	2980	2059
901_Total lipids in large VLDL	901_Total lipids in large VLDL	25	948	1	3142	3307	1270	2503	2462	1306	2187	2990	948	1816	3572
1601_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for multivariable)	1601_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for multivariable)	25	949	1	1710	4128	3097	949	4601	3352	3212	4464	2511	2312	3686
3910_Vertical cup-disc ratio	3910_Vertical cup-disc ratio	25	949	1	2769	2397	3349	1261	949	2722	2059	1283	1707	1605	1345
4716_Body of corpus callosum mode of anisotropy	4716_Body of corpus callosum mode of anisotropy	25	949	1	2642	4219	1827	2035	2780	967	983	949	3052	4427	2747
44_Household income	44_Household income	25	950	1	3225	2257	2718	2627	2657	1954	1281	2130	4193	1617	950
3987_Heart rate recovery at 30 secnds	3987_Heart rate recovery at 30 secnds	25	951	1	951	4605	1818	1011	3014	4382	2848	3017	1689	3662	3019
4406_Menstrual quality of life impact: Sleepiness	4406_Menstrual quality of life impact: Sleepiness	25	952	1	3623	3988	2803	3775	952	4078	4247	4670	4661	3404	2143
92_Birth weight	92_Birth weight	25	952	1	1021	2337	1620	1379	2504	952	4340	4720	1810	1514	1542
691_::::X-11299	691_::::X-11299	25	952	1	3987	1088	4482	4640	2326	3909	952	1155	4701	4186	3267
1406_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for multivariable)	1406_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for multivariable)	25	953	1	4071	2076	1970	4606	4508	1856	953	1542	4589	4260	1684
4107_Albumin/globulin ratio	4107_Albumin/globulin ratio	25	954	1	3244	2950	2970	1936	3741	954	4481	4649	4283	3285	4523
4488_Right middle temporal	4488_Right middle temporal	25	955	1	1708	4514	3330	955	2854	3677	4359	2567	3003	1635	3549
922_Cholesterol esters in medium VLDL	922_Cholesterol esters in medium VLDL	25	956	1	4557	3985	1458	4042	2432	956	3475	4540	1031	4605	4316
2673_MAPKAPK5 - MAP kinase-activated protein kinase 5	2673_MAPKAPK5 - MAP kinase-activated protein kinase 5	25	957	1	3354	957	2067	3229	2774	2080	2135	4608	2702	2324	4388
1705_Follicle stimulating hormone (at exam 3, GEE, adjusted for multivariable)	1705_Follicle stimulating hormone (at exam 3, GEE, adjusted for multivariable)	25	958	1	2392	3887	4351	1574	3487	2659	958	2931	2512	2130	1056
1253_Percent predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	1253_Percent predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	25	958	1	1770	2840	2395	1112	4268	3656	1890	1716	4156	2137	958
224_B Mem:%IgA	224_B Mem:%IgA	25	960	1	1550	960	3338	2901	2959	3979	2214	3316	3937	4027	4358
4690_Uncinate fasciculus axial diusivities	4690_Uncinate fasciculus axial diusivities	25	960	1	3819	1534	3536	1579	960	2606	1886	2548	2153	4336	2837
3489_Cereal type: Biscuit cereal (e.g. Weetabix)	3489_Cereal type: Biscuit cereal (e.g. Weetabix)	25	960	1	1213	4062	3207	1166	3416	1478	4406	4674	3192	3311	960
1340_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age, sex and BMI)	1340_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age, sex and BMI)	25	961	1	3735	4740	3468	1465	1825	1432	3586	3809	961	2297	2793
5_Bipolar disorder	5_Bipolar disorder	25	962	1	2784	1942	3176	1712	4692	962	1881	3468	1481	3992	4557
2429_CD109 - CD109 antigen	2429_CD109 - CD109 antigen	25	962	1	4230	1904	4638	4190	1584	4397	4404	962	3878	3169	1782
1463_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1463_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	965	1	4021	2164	1056	4349	965	2649	2975	4039	4272	1724	2606
2361_F10 - Coagulation factor Xa	2361_F10 - Coagulation factor Xa	25	965	1	1070	1372	2690	3191	1480	2592	1743	3037	965	4405	3805
2014_Response following 8-week treatment of MDD subjects	2014_Response following 8-week treatment of MDD subjects	25	966	1	1225	2768	2350	4081	966	3930	2736	2539	4187	4625	3988
2163_PF4 - Platelet factor 4	2163_PF4 - Platelet factor 4	25	966	1	4714	1151	2635	3552	2997	3407	4389	4065	3851	966	3618
3547_Mouth/teeth dental problems: Loose teeth	3547_Mouth/teeth dental problems: Loose teeth	25	967	1	1806	3351	967	1154	4393	4673	4142	2608	3807	2556	2678
3982_Schizophrenia	3982_Schizophrenia	25	967	1	3134	4618	2439	967	1706	3759	4229	2666	4501	3965	1404
2129_IL12RB1 - Interleukin-12 receptor subunit beta-1	2129_IL12RB1 - Interleukin-12 receptor subunit beta-1	25	967	1	1817	1550	3656	2493	3039	4480	4724	2221	2045	967	2562
3875_Eosinophil percentage of white cells (three-way meta)	3875_Eosinophil percentage of white cells (three-way meta)	25	970	1	1476	4379	970	4661	4704	1666	3065	1776	2299	4494	3685
3714_Diagnoses - secondary ICD10: Z90 Acquired absence of organs, not elsewhere classified	3714_Diagnoses - secondary ICD10: Z90 Acquired absence of organs, not elsewhere classified	25	970	1	3398	1685	4356	970	2766	3764	4446	3776	4234	4493	4352
1756_Cancer (FBAT, adjusted for multivariable)	1756_Cancer (FBAT, adjusted for multivariable)	25	971	1	4626	4127	971	2780	3389	3072	4667	3400	2615	1772	2238
4150_Left ventricular mass	4150_Left ventricular mass	25	971	1	2035	1462	3110	3956	3527	3149	971	1732	4606	4696	3783
738_::::X-11849	738_::::X-11849	25	973	1	2649	3244	973	3733	2548	2000	1406	2751	2573	3213	2134
987_Interleukin-1-beta	987_Interleukin-1-beta	25	973	1	3677	3608	1215	973	1312	4680	1630	4398	1990	2287	1947
614_Xenobiotics::Benzoate metabolism::4-hydroxyhippurate	614_Xenobiotics::Benzoate metabolism::4-hydroxyhippurate	25	973	1	4352	1385	1844	2933	973	2134	2881	4309	4210	2341	3701
2181_SIGLEC7 - Sialic acid-binding Ig-like lectin 7	2181_SIGLEC7 - Sialic acid-binding Ig-like lectin 7	25	973	1	1325	1000	4389	3609	3477	2899	1561	4614	1872	973	3249
2820_DYRK3 - Dual specificity tyrosine-phosphorylation-regulated kinase 3	2820_DYRK3 - Dual specificity tyrosine-phosphorylation-regulated kinase 3	25	974	1	1605	4169	3157	4530	3161	2685	2413	974	2081	4231	2220
164_Hip circumference (male, adjusted for BMI)	164_Hip circumference (male, adjusted for BMI)	25	974	1	3722	3531	2788	3436	2706	1918	4653	3800	2606	1912	974
1650_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for age and sex)	1650_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for age and sex)	25	975	1	975	3883	4716	2622	3462	1571	2362	3865	2502	2769	4619
505_Lipid::Fatty acid, monohydroxy::2-hydroxystearate	505_Lipid::Fatty acid, monohydroxy::2-hydroxystearate	25	975	1	2654	2416	4077	4039	975	4403	2272	1181	1230	3489	4151
3219_Time spent watching television (TV)	3219_Time spent watching television (TV)	25	975	1	2594	3469	4512	3715	1863	1437	3512	2556	1530	1918	975
249_CD27 on CD4 T	249_CD27 on CD4 T	25	976	1	1241	1559	4003	976	1626	2266	1460	3957	4471	2393	4592
3659_Cancer register - Type of cancer: ICD10: C50 Malignant neoplasm of breast	3659_Cancer register - Type of cancer: ICD10: C50 Malignant neoplasm of breast	25	976	1	1922	1498	1299	3823	2625	976	1021	1229	2684	2043	4575
1903_Frontal lobe volume (GEE, adjusted for multivariable)	1903_Frontal lobe volume (GEE, adjusted for multivariable)	25	976	1	3725	4073	1610	3742	3070	4717	976	1715	2376	2784	2836
363_Mono:%11c-16-274+	363_Mono:%11c-16-274+	25	976	1	3365	2655	3127	4346	2928	2413	4401	3640	2173	3323	976
1270_Epworth Sleepiness Scale (FBAT, adjusted for age, sex and BMI)	1270_Epworth Sleepiness Scale (FBAT, adjusted for age, sex and BMI)	25	977	1	3989	4499	2445	2550	1398	977	1107	2429	2185	1499	1296
4422_Herpes simplex virus 2 seropositivity	4422_Herpes simplex virus 2 seropositivity	25	977	1	3828	2256	4631	2922	1348	4252	977	4020	4318	1143	3649
841_::::X-14588	841_::::X-14588	25	978	1	2078	2711	4214	978	2744	1595	4462	3985	1547	1800	3581
2304_CXCL1 - Growth-regulated alpha protein	2304_CXCL1 - Growth-regulated alpha protein	25	978	1	3416	1927	4717	3184	3128	3058	2286	3656	978	2266	3503
1965_MMSE score (at exam 5, GEE, adjusted for age)	1965_MMSE score (at exam 5, GEE, adjusted for age)	25	980	1	4185	4096	1555	2765	980	1554	1793	1854	3338	2968	2151
2853_TGM3 - Protein-glutamine gamma-glutamyltransferase E	2853_TGM3 - Protein-glutamine gamma-glutamyltransferase E	25	981	1	981	1133	2789	2645	2549	4538	2339	4360	4482	2777	4627
3394_Ever unenthusiastic/disinterested for a whole week	3394_Ever unenthusiastic/disinterested for a whole week	25	982	1	1048	1366	2149	1496	4697	3032	3840	3307	2645	982	2882
2293_ACVRL1 - Serine/threonine-protein kinase receptor R3	2293_ACVRL1 - Serine/threonine-protein kinase receptor R3	25	983	1	3769	1222	1472	2647	1306	4318	2353	983	3830	1569	4694
1525_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	1525_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	25	984	1	3929	3669	2975	2840	984	2861	1843	3325	4094	4256	1581
3596_Mineral and other dietary supplements: Iron	3596_Mineral and other dietary supplements: Iron	25	985	1	3311	2226	3239	1784	2282	985	4165	2092	4227	4368	3046
4583_Right inferior temporal	4583_Right inferior temporal	25	985	1	3647	1762	1699	1703	1662	1054	3311	3237	985	3262	1764
3345_Ever had stillbirth, spontaneous miscarriage or termination (female)	3345_Ever had stillbirth, spontaneous miscarriage or termination (female)	25	985	1	3299	4305	3653	4499	2140	2295	2587	4687	2959	1677	985
3158_NLGN4X - Neuroligin-4, X-linked	3158_NLGN4X - Neuroligin-4, X-linked	25	986	1	2756	1789	3595	2441	2328	986	3218	3790	1338	4707	4516
3800_Total blood hemoglobin	3800_Total blood hemoglobin	25	987	1	4703	1896	1771	3953	2916	3991	1543	987	1760	4742	3895
1501_Triglycerides (at exam 2, GEE, adjusted for age and sex)	1501_Triglycerides (at exam 2, GEE, adjusted for age and sex)	25	987	1	4017	2267	3672	1251	2425	3164	3528	3747	2988	2092	987
1954_Similarities raw score (FBAT, adjusted for multivariable)	1954_Similarities raw score (FBAT, adjusted for multivariable)	25	988	1	2627	2310	988	2581	4346	4679	3376	3867	3510	2138	2767
521_Lipid::Long chain fatty acid::myristate (14:0)	521_Lipid::Long chain fatty acid::myristate (14:0)	25	989	1	989	3405	4092	1857	1557	1158	1648	1497	1304	3930	2273
4472_Left superior temporal	4472_Left superior temporal	25	989	1	3585	1657	3017	989	2553	2072	4567	1610	4657	2338	3420
4035_Alcohol dependency (unrelated individuals)	4035_Alcohol dependency (unrelated individuals)	25	989	1	1245	3163	3786	3699	2640	3590	4396	989	3947	3482	3078
3642_Illnesses of mother: Breast cancer	3642_Illnesses of mother: Breast cancer	25	989	1	3335	4203	2430	4057	1422	2189	3246	1672	989	3070	1524
228_Lymph:%DP T	228_Lymph:%DP T	25	990	1	1675	2976	990	3813	4149	4648	2392	3433	2864	2690	3746
783_::::X-12524	783_::::X-12524	25	990	1	1279	4449	1790	3575	4722	3669	2834	3641	4703	2584	990
2917_GSN - Gelsolin	2917_GSN - Gelsolin	25	991	1	991	4023	1503	4514	1750	3537	1766	2463	3367	2480	3906
1663_Alanine transaminase (at exam 2, GEE, adjusted for age and sex)	1663_Alanine transaminase (at exam 2, GEE, adjusted for age and sex)	25	991	1	4112	4738	1894	991	2016	4593	1330	3334	4403	3864	1007
4200_Height	4200_Height	25	993	1	3251	993	2819	3505	1484	3619	2602	1364	2577	3606	3546
4619_Left inferior lateral ventricle	4619_Left inferior lateral ventricle	25	993	1	1794	2352	1889	993	1095	4498	1653	2110	4496	4208	3757
1754_Cancer (FBAT, adjusted for age and sex)	1754_Cancer (FBAT, adjusted for age and sex)	25	994	1	4104	3827	994	4329	4707	3487	1850	4333	1296	4094	2384
2574_DDC - Aromatic-L-amino-acid decarboxylase	2574_DDC - Aromatic-L-amino-acid decarboxylase	25	994	1	2563	4635	3261	4410	2516	2820	4005	994	4041	2234	4477
368_Amino acid::Butanoate metabolism::2-aminobutyrate	368_Amino acid::Butanoate metabolism::2-aminobutyrate	25	995	1	4693	995	3511	3529	2308	2338	1934	3456	4049	3935	1802
2973_AGR2 - Anterior gradient protein 2 homolog	2973_AGR2 - Anterior gradient protein 2 homolog	25	995	1	3865	3448	2060	995	1563	3774	3947	3486	3448	3136	2745
18_Former versus current smokers	18_Former versus current smokers	25	995	1	1688	3253	3502	4730	995	1430	2551	2304	4103	3211	3193
4724_Inferior fronto-occipital fasciculus mode of anisotropy	4724_Inferior fronto-occipital fasciculus mode of anisotropy	25	995	1	1062	1655	4069	3107	4652	1477	2469	4696	995	1220	2446
3419_Pairs matching test - Number of correct matches in round	3419_Pairs matching test - Number of correct matches in round	25	996	1	3861	1696	3916	996	1586	1743	2122	2843	2381	1359	3960
3200_Job involves mainly walking or standing	3200_Job involves mainly walking or standing	25	996	1	4246	3838	3612	1556	996	2492	3354	3610	2514	2035	2423
3563_Vitamin and mineral supplements: Vitamin C	3563_Vitamin and mineral supplements: Vitamin C	25	996	1	1898	2366	1237	2891	1033	996	2576	3606	2547	1321	4707
3887_Mean corpuscular hemoglobin (three-way meta)	3887_Mean corpuscular hemoglobin (three-way meta)	25	996	1	2434	1787	1882	4322	3501	4359	2838	996	1628	1235	3202
138_Waist-hip ratio (male)	138_Waist-hip ratio (male)	25	997	1	2798	1665	3882	3569	997	4179	1682	2963	4126	1877	4639
960_Triglycerides in very large HDL	960_Triglycerides in very large HDL	25	997	1	3760	4722	2407	4684	2886	4410	1952	4053	997	4575	4171
460_Energy::Krebs cycle::malate	460_Energy::Krebs cycle::malate	25	998	1	2966	3692	4292	998	2401	4344	2996	3793	3112	4396	1996
809_::::X-12847	809_::::X-12847	25	998	1	2302	3618	2423	2634	1384	3119	3551	998	1726	4255	2916
3453_Impedance measures - Leg fat mass (right)	3453_Impedance measures - Leg fat mass (right)	25	999	1	999	4187	1538	1535	4394	1205	4216	2019	3540	1984	1229
1761_Breast cancer (GEE, adjusted for age and BMI)	1761_Breast cancer (GEE, adjusted for age and BMI)	25	999	1	2421	3535	4731	4394	3490	1651	4240	1265	3889	999	2382
2338_MB - Myoglobin	2338_MB - Myoglobin	25	1000	1	3969	4211	1377	1000	3900	1334	4068	3373	2997	1485	1595
2239_TIE1 - Tyrosine-protein kinase receptor Tie-1, soluble	2239_TIE1 - Tyrosine-protein kinase receptor Tie-1, soluble	25	1001	1	1001	4179	1656	2938	4634	4402	1807	2561	3903	2038	3966
681_::::X-10346	681_::::X-10346	25	1002	1	2476	1002	2236	2055	3186	2336	3535	1807	1791	2183	3660
4257_Facial attractiveness (male-coder)	4257_Facial attractiveness (male-coder)	25	1003	1	1379	3030	3211	3227	2012	4684	3657	2046	1512	3562	1003
2932_BMPR1A - Bone morphogenetic protein receptor type-1A	2932_BMPR1A - Bone morphogenetic protein receptor type-1A	25	1005	1	1005	1993	1805	2264	1854	4209	2603	3744	2335	3920	2247
2092_CCL21 - C-C motif chemokine 21	2092_CCL21 - C-C motif chemokine 21	25	1005	1	2729	2313	1794	2850	2402	1625	1005	1148	4056	1686	1810
4181_High cholesterol lipoprotein	4181_High cholesterol lipoprotein	25	1006	1	4341	3954	3907	1006	3062	2841	1562	1878	2692	1197	1409
1730_Chronic kidney disease (at exam 7, FBAT, adjusted for age and sex)	1730_Chronic kidney disease (at exam 7, FBAT, adjusted for age and sex)	25	1008	1	1888	1008	1797	4720	4028	2276	1236	3119	2070	1544	2954
964_Triglycerides in very large VLDL	964_Triglycerides in very large VLDL	25	1008	1	1860	1295	1752	2756	1008	1213	2803	1352	1621	2640	3611
1798_High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1798_High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	1009	1	3636	4110	1009	2714	3692	4023	4731	2769	3173	4098	2651
2121_TACSTD2 - Tumor-associated calcium signal transducer 2	2121_TACSTD2 - Tumor-associated calcium signal transducer 2	25	1009	1	1525	2381	2284	1009	4382	2375	1164	1566	2612	4280	4534
4466_Left precentral	4466_Left precentral	25	1009	1	1117	3172	3771	3920	4204	2512	3537	4168	1009	3856	3786
476_Lipid::Carnitine metabolism::3-dehydrocarnitine*	476_Lipid::Carnitine metabolism::3-dehydrocarnitine*	25	1010	1	1491	2478	1010	4302	3376	4010	2761	3832	3620	2352	1612
1880_Shaft cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	1880_Shaft cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	25	1010	1	2916	2411	4045	3243	1010	3060	3106	1912	2427	2675	2685
4034_Alcohol dependency (discovery)	4034_Alcohol dependency (discovery)	25	1011	1	1182	1011	3153	2481	3106	3353	1598	2288	2304	1343	3246
1526_Remnant lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	1526_Remnant lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	1011	1	2406	2284	2972	1709	1011	4554	4289	2507	3569	4688	1410
3704_Diagnoses - secondary ICD10: Z37 Outcome of delivery	3704_Diagnoses - secondary ICD10: Z37 Outcome of delivery	25	1012	1	1012	2870	1997	4611	4337	4249	3906	3878	1359	2872	3892
2204_IL22 - Interleukin-22	2204_IL22 - Interleukin-22	25	1012	1	3496	2533	3150	1263	2018	2580	1895	2449	1012	3774	3296
2922_COL8A1 - Collagen alpha-1(VIII) chain	2922_COL8A1 - Collagen alpha-1(VIII) chain	25	1013	1	1013	3979	2157	3635	1565	2797	3443	2447	4397	2302	2122
999_Monocyte specific chemokine 3 (CCL7)	999_Monocyte specific chemokine 3 (CCL7)	25	1013	1	2886	1797	1800	2523	1013	2725	2540	3899	2610	2039	2073
2148_DCN - Decorin	2148_DCN - Decorin	25	1015	1	3117	1015	4509	2241	1701	3241	2265	4271	2825	3812	2599
1496_Triglycerides (at exam 1, FBAT, adjusted for multivariable)	1496_Triglycerides (at exam 1, FBAT, adjusted for multivariable)	25	1015	1	4327	4397	1015	4202	2221	1539	3983	1268	4002	3854	1315
2135_CSF1R - Macrophage colony-stimulating factor 1 receptor	2135_CSF1R - Macrophage colony-stimulating factor 1 receptor	25	1015	1	2605	1928	2131	1015	3822	4597	2243	4334	4518	2029	3676
4025_Excessive sweating	4025_Excessive sweating	25	1015	1	2512	2680	3397	2935	1015	3652	1662	3051	1753	2505	3506
2972_RPSA - 40S ribosomal protein SA	2972_RPSA - 40S ribosomal protein SA	25	1015	1	3326	3662	3236	4541	3415	2465	1477	1015	3679	2647	4146
3951_Amyotrophic lateral sclerosis (LMM)	3951_Amyotrophic lateral sclerosis (LMM)	25	1015	1	2637	4384	1878	2921	3749	4718	4241	3469	1015	1339	4675
4444_Cytomegalovirus IgG levels	4444_Cytomegalovirus IgG levels	25	1015	1	1377	1049	4065	3829	3042	1653	3449	1483	1650	1015	2539
1154_Insulin at 30 min	1154_Insulin at 30 min	25	1016	1	1016	1562	2164	3226	1831	3622	2201	4032	3444	4412	1836
3164_BRF1 - Transcription factor IIIB 90 kDa subunit	3164_BRF1 - Transcription factor IIIB 90 kDa subunit	25	1016	1	2306	2342	1016	1872	4150	4271	3003	4331	3774	2226	2833
1160_Fasting insulin main effect (adjusted for BMI)	1160_Fasting insulin main effect (adjusted for BMI)	25	1017	1	2145	1897	1221	1017	2690	1701	3934	4303	2039	1150	3062
513_Lipid::Ketone bodies::3-hydroxybutyrate (BHBA)	513_Lipid::Ketone bodies::3-hydroxybutyrate (BHBA)	25	1018	1	1018	4590	3233	3952	1762	1468	1106	1894	3332	3344	1829
3446_Impedance measures - Basal metabolic rate	3446_Impedance measures - Basal metabolic rate	25	1018	1	1602	2094	2369	2202	3709	3683	1018	1536	3303	2452	2309
2708_DYNLL1 - Dynein light chain 1, cytoplasmic	2708_DYNLL1 - Dynein light chain 1, cytoplasmic	25	1019	1	2622	3564	1019	2954	2909	1804	2050	2198	2510	2475	2896
3129_MAP3K7 TAB1 - Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion	3129_MAP3K7 TAB1 - Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion	25	1019	1	2538	2974	2946	3751	3385	1019	3350	2367	2728	1178	1739
210_Insomnia	210_Insomnia	25	1019	1	3119	4659	3462	4357	4657	3079	2020	1019	4033	3261	3423
1362_Total cholesterol (at exam 3, FBAT, adjusted for age and sex)	1362_Total cholesterol (at exam 3, FBAT, adjusted for age and sex)	25	1020	1	3620	1194	2327	1691	4626	1020	2853	4274	2949	1082	1109
861_Citrate	861_Citrate	25	1021	1	3495	3048	2183	1940	3002	1021	2133	2872	1537	2738	3416
1177_Excessive daytime sleepness (female)	1177_Excessive daytime sleepness (female)	25	1021	1	2291	3359	2974	3883	4516	4464	4514	1021	3657	4425	2713
1863_Neck cross-sectional moment of inertia (GEE, female, adjussted for age)	1863_Neck cross-sectional moment of inertia (GEE, female, adjussted for age)	25	1021	1	2453	2933	2700	4525	4223	2660	3583	2373	3116	4577	1021
2464_SERPINC1 - Antithrombin-III	2464_SERPINC1 - Antithrombin-III	25	1022	1	1805	3507	1468	1584	1022	3186	4720	4289	3629	2257	4199
28_Extraversion (NEO-FFI)	28_Extraversion (NEO-FFI)	25	1022	1	2877	3678	3048	3959	4641	1022	1927	2503	3759	4265	1660
516_Lipid::Long chain fatty acid::adrenate (22:4n6)	516_Lipid::Long chain fatty acid::adrenate (22:4n6)	25	1022	1	4153	3073	1893	2984	2575	3387	4555	2227	4186	4522	1022
3624_Treatment/medication code: glucosamine product	3624_Treatment/medication code: glucosamine product	25	1023	1	1736	2937	4247	1023	3782	2027	1960	1083	3899	2557	3281
4526_Left amygdala	4526_Left amygdala	25	1023	1	4273	3795	3476	1302	3355	3554	1023	3100	1420	4580	4185
4286_FEV1	4286_FEV1	25	1024	1	3732	1024	1659	3686	2237	3332	3600	3013	4176	3349	4600
3369_Frequency of other exercises in last 4 weeks	3369_Frequency of other exercises in last 4 weeks	25	1024	1	3755	2856	2938	3890	2372	1024	3728	2901	4268	4410	2190
4501_Right superior frontal	4501_Right superior frontal	25	1025	1	4107	3773	1762	4363	1025	4250	2509	2403	2557	3847	1311
2601_LY86 - Lymphocyte antigen 86	2601_LY86 - Lymphocyte antigen 86	25	1026	1	1203	2438	4623	2529	1081	4727	1608	4618	4006	1026	3846
2191_FAM107A - Protein FAM107A	2191_FAM107A - Protein FAM107A	25	1027	1	3148	3728	1027	4698	2680	3535	1570	1693	1099	2843	1929
112_Body Mass Index	112_Body Mass Index	25	1027	1	3170	4739	2720	2635	1027	1146	1550	3674	2634	1667	3286
2982_CA1 - Carbonic anhydrase 1	2982_CA1 - Carbonic anhydrase 1	25	1027	1	1207	2421	4109	3865	2361	1027	2164	2988	2579	4239	1145
2811_AMN - Protein amnionless	2811_AMN - Protein amnionless	25	1027	1	4078	3331	3971	2363	4632	1405	2463	1027	2122	2367	2729
2798_P4HB - Protein disulfide-isomerase	2798_P4HB - Protein disulfide-isomerase	25	1027	1	2298	1176	3387	1638	3344	2122	1346	2977	1027	3036	1285
162_Hip circumference (adjusted for BMI)	162_Hip circumference (adjusted for BMI)	25	1027	2	3532	3336	2667	4194	2669	3773	3529	2885	3390	4449	1027
1920_Frontal lobe volume (FBAT, adjusted for age and sex)	1920_Frontal lobe volume (FBAT, adjusted for age and sex)	24	1028	1	2105	2782	1028	2676	3565	3815	3617	4244	2133	4653	2022
321_CD8mem:%R6+PD1+161-	321_CD8mem:%R6+PD1+161-	25	1029	1	4056	4634	4134	2856	1029	2728	4435	3457	3398	3290	3295
3282_Number of full brothers	3282_Number of full brothers	25	1029	1	1218	4349	2170	4536	2458	4241	1908	1029	1622	1903	4343
4483_Right isthmus cingulate	4483_Right isthmus cingulate	25	1029	1	2845	1589	1216	2334	2227	2799	2537	4193	4431	1148	1029
2987_DBNL - Drebrin-like protein	2987_DBNL - Drebrin-like protein	25	1030	1	3962	3729	4645	2683	1030	3202	1103	2201	2395	2358	2792
721_::::X-11540	721_::::X-11540	25	1031	1	1031	2717	2550	4229	3061	3300	2136	4101	4076	2770	1907
3939_Body Mass Index	3939_Body Mass Index	25	1033	1	1033	3467	2042	1848	1550	1642	2400	1958	2253	2009	2468
3873_Sum eosinophil basophil count (three-way meta)	3873_Sum eosinophil basophil count (three-way meta)	25	1033	1	4623	2907	1456	1033	3231	4533	4433	2782	4678	1675	1076
829_::::X-13859	829_::::X-13859	25	1033	1	1807	3782	4694	1190	1605	3039	1268	2867	4212	1899	1033
3179_SRC - Proto-oncogene tyrosine-protein kinase Src	3179_SRC - Proto-oncogene tyrosine-protein kinase Src	25	1034	1	1034	1221	2561	4693	2451	2048	3014	4071	2159	3993	1343
2906_EPB41 - Protein 4.1	2906_EPB41 - Protein 4.1	25	1034	1	3450	4168	1289	3206	1555	1706	3731	2157	1179	3786	1034
3758_Anxiety - Recent easy annoyance or irritability	3758_Anxiety - Recent easy annoyance or irritability	25	1035	1	2118	2755	4511	1035	1297	1277	3614	2986	2241	4474	4677
1936_Total cerebral brain volume (FBAT, adjusted for age and sex)	1936_Total cerebral brain volume (FBAT, adjusted for age and sex)	25	1035	1	4444	2543	3592	3976	1035	1742	1189	4638	3373	3824	1992
3853_Monocyte count (two-way meta)	3853_Monocyte count (two-way meta)	25	1035	1	4135	4546	2686	3899	1568	1942	1694	2709	2022	1035	1210
1255_Percent predicted FVC for latest exam (GEE, adjusted for multiple covariates)	1255_Percent predicted FVC for latest exam (GEE, adjusted for multiple covariates)	25	1036	1	3313	1668	1258	1513	3934	4435	3220	1036	1457	2159	1626
3203_Age completed full time education	3203_Age completed full time education	25	1036	1	4449	3978	4465	2608	3378	4572	2108	3441	1036	2023	2640
4561_Left pars opercularis	4561_Left pars opercularis	25	1037	1	1502	3233	1170	4288	2998	2966	3101	3669	1047	1037	2141
3618_Treatment/medication code: aspirin	3618_Treatment/medication code: aspirin	25	1039	1	1323	1902	1039	2913	4373	2223	4622	3242	3151	1857	4306
2401_IDS - Iduronate 2-sulfatase	2401_IDS - Iduronate 2-sulfatase	25	1039	1	1740	1826	2702	4738	1039	2914	2712	3653	3615	3750	1840
4407_Menstrual quality of life impact: Stiff neck	4407_Menstrual quality of life impact: Stiff neck	25	1040	1	4069	2918	1040	4337	3297	3361	3064	3783	3457	2679	1556
3436_Weight	3436_Weight	25	1041	1	2087	1137	3012	1041	3742	2117	1759	3914	4473	3882	2257
1899_Troch Neck BMD (GEE, female, adjussted for multivariable)	1899_Troch Neck BMD (GEE, female, adjussted for multivariable)	25	1041	1	3441	4080	3952	2587	1041	3400	2140	3915	4184	4325	1046
2570_CGA TSHB - Thyroid Stimulating Hormone	2570_CGA TSHB - Thyroid Stimulating Hormone	25	1041	1	3116	4170	2599	3438	4037	1438	1818	1041	3780	2360	4308
4375_Hyperthyroidism	4375_Hyperthyroidism	25	1042	1	1042	1163	1359	3422	3259	3534	1683	2537	2619	3996	1148
2642_BMP6 - Bone morphogenetic protein 6	2642_BMP6 - Bone morphogenetic protein 6	25	1042	1	2253	1042	2936	1783	1194	4269	1443	1548	3825	1862	3997
3484_Spread type: Butter/spreadable butter	3484_Spread type: Butter/spreadable butter	25	1042	1	4053	2780	4061	1802	1991	3816	1042	1634	2500	1126	1815
4188_Fasting insulin	4188_Fasting insulin	25	1043	1	1043	4318	4460	1630	4216	4379	4478	3436	2325	3841	4159
3603_Non-cancer illness code, self-reported: migraine	3603_Non-cancer illness code, self-reported: migraine	25	1043	1	2948	1330	1357	3637	1879	3841	1043	1908	2717	1553	3909
1499_Triglycerides (at exam 1, GEE, adjusted for age and sex)	1499_Triglycerides (at exam 1, GEE, adjusted for age and sex)	25	1044	1	4125	1848	1044	4423	3638	1684	2381	4418	4523	3157	1792
3169_TNFRSF11A - Tumor necrosis factor receptor superfamily member 11A	3169_TNFRSF11A - Tumor necrosis factor receptor superfamily member 11A	25	1044	1	2580	2612	3282	4370	3694	4087	2303	2297	4730	1044	1555
2075_CTSG - Cathepsin G	2075_CTSG - Cathepsin G	25	1045	1	4620	3259	4178	4746	4486	1045	3615	2973	3441	4479	3426
650_::::X-01911	650_::::X-01911	25	1046	1	1436	3346	1819	2222	1046	1230	4187	4363	3381	1575	1987
3014_SOD2 - Superoxide dismutase [Mn], mitochondrial	3014_SOD2 - Superoxide dismutase [Mn], mitochondrial	25	1046	1	2758	4393	1935	4149	2405	2034	1046	1605	3538	3038	1754
125_Body Mass Index (female)	125_Body Mass Index (female)	25	1047	1	2391	1047	4524	2472	3336	3451	4153	2944	2065	1746	1337
1765_Heart failure (free of MI, GEE, adjusted for age and sex)	1765_Heart failure (free of MI, GEE, adjusted for age and sex)	25	1048	1	1442	2617	1048	3786	3222	2696	3822	4484	2419	4330	1386
1927_Lateral ventricular volume (GEE, adjusted for age and sex)	1927_Lateral ventricular volume (GEE, adjusted for age and sex)	25	1048	1	1555	3698	2687	4171	2233	2326	3755	4203	2906	2260	1048
4447_Left cuneus	4447_Left cuneus	25	1049	1	1049	3478	3342	1399	3821	2605	4722	3220	3472	1923	2394
1351_Plasma Apolipoprotein B level (GEE, adjusted for age and sex)	1351_Plasma Apolipoprotein B level (GEE, adjusted for age and sex)	25	1049	1	3002	4132	3986	3237	1539	1049	2421	1257	3787	3091	2385
4083_Type 2 Diabetes	4083_Type 2 Diabetes	25	1050	1	1050	2719	3537	3753	1892	2836	3507	4165	4110	3339	3745
2281_PLA2G10 - Group 10 secretory phospholipase A2	2281_PLA2G10 - Group 10 secretory phospholipase A2	25	1050	1	4582	3457	1050	3861	2976	4425	2639	2693	2880	2214	4246
1652_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for multivariable)	1652_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for multivariable)	25	1052	1	1052	4116	3601	3871	1855	1952	2527	4231	4246	3408	4420
1678_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	1678_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	25	1052	1	4252	3152	3445	4000	1140	3736	4710	3818	2214	4701	1052
1186_Triglycerides cholesterol	1186_Triglycerides cholesterol	25	1054	1	3131	1054	4334	4236	1069	2437	3158	1901	2442	1636	1889
157_Hip circumference (male)	157_Hip circumference (male)	25	1055	1	4746	2227	2904	2580	1926	3156	4182	3645	1055	1524	1824
629_Xenobiotics::Drug::salicyluric glucuronide*	629_Xenobiotics::Drug::salicyluric glucuronide*	25	1055	1	4653	2106	4412	2542	3559	3499	2938	1943	3761	1204	1055
3506_Non-butter spread type details: Olive oil based spread (eg: Bertolli)	3506_Non-butter spread type details: Olive oil based spread (eg: Bertolli)	25	1056	1	1056	4390	2154	2538	3751	3363	4050	4170	2708	4225	4103
3132_BCAR3 - Breast cancer anti-estrogen resistance protein 3	3132_BCAR3 - Breast cancer anti-estrogen resistance protein 3	25	1056	1	4641	3816	4226	2235	3581	1056	1887	4047	2404	3217	4326
147_Body Mass Index (male > 50 yrs)	147_Body Mass Index (male > 50 yrs)	25	1057	1	1701	2484	3031	1057	4571	1186	2406	2307	3471	3683	2460
3120_PRKAA2 PRKAB2 PRKAG1 - AMP Kinase (alpha2beta2gamma1)	3120_PRKAA2 PRKAB2 PRKAG1 - AMP Kinase (alpha2beta2gamma1)	25	1057	1	2324	4506	2322	3258	4482	2030	1057	1774	4400	3810	2843
3269_Breastfed as a baby	3269_Breastfed as a baby	25	1058	1	4086	1522	4151	2297	2345	2031	2821	1710	1058	1979	4165
477_Lipid::Carnitine metabolism::acetylcarnitine	477_Lipid::Carnitine metabolism::acetylcarnitine	25	1058	1	3447	3041	2661	4332	2644	2624	4082	3548	3329	1058	2714
4277_Meconium ileus in cystic fibrosis	4277_Meconium ileus in cystic fibrosis	25	1059	1	1850	1059	3515	3738	4517	1851	3315	4457	1706	4584	2914
352_NKT:%TM	352_NKT:%TM	25	1059	1	3138	4547	1059	3188	2083	2818	4150	4413	3697	1880	4450
4546_Left caudal anterior cingulate	4546_Left caudal anterior cingulate	25	1059	1	4055	4212	1750	4008	3286	3230	3007	4695	4611	1059	4198
1088_Neuroblastoma	1088_Neuroblastoma	25	1060	1	2734	4452	1060	1799	1820	3559	3999	3717	4463	2918	4369
2327_CD209 - CD209 antigen	2327_CD209 - CD209 antigen	25	1060	1	2514	2220	1640	3798	3190	1060	1104	3766	2471	2623	4556
1696_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for multivariable)	1696_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for multivariable)	25	1060	1	2871	3516	4229	2879	3115	2560	1060	2352	4038	3165	1291
2589_CNDP1 - Beta-Ala-His dipeptidase	2589_CNDP1 - Beta-Ala-His dipeptidase	25	1061	1	2185	1656	3640	2332	1061	3456	2775	4226	3909	3589	1708
25_Internalizing	25_Internalizing	25	1062	1	3811	2260	3563	2015	1413	1062	2398	1245	2974	1551	1776
4411_Total IgG levels	4411_Total IgG levels	25	1064	1	1809	1430	1064	2629	3236	1734	3733	2585	4148	2413	4024
247_CD56 on 2+NK eff	247_CD56 on 2+NK eff	25	1064	1	1534	1646	1266	1064	2222	2490	1305	2690	3385	3602	1867
3782_Depression - Sleeping too much	3782_Depression - Sleeping too much	25	1064	1	3948	2902	4005	1350	3613	3945	3553	1064	1305	3853	2664
817_::::X-13429	817_::::X-13429	25	1065	1	1065	4475	1320	2118	4642	3493	3807	3801	3468	3857	1201
1000_Macrophage colony-stimulating factor	1000_Macrophage colony-stimulating factor	25	1066	1	2786	2896	4282	2746	1066	4707	3415	4177	2243	2644	1609
4648_Anterior limb of internal capsule fractional anisotropy	4648_Anterior limb of internal capsule fractional anisotropy	25	1066	1	1102	2528	3957	1886	2947	3693	4638	2590	1908	1066	4414
1108_Subcutaneous adipose tissue volume	1108_Subcutaneous adipose tissue volume	25	1067	1	2943	4112	4375	2986	1067	1463	4242	2078	1658	3866	2563
2872_PRSS22 - Brain-specific serine protease 4	2872_PRSS22 - Brain-specific serine protease 4	25	1067	1	3565	3473	4456	3326	2532	4724	1137	1883	1067	2689	3831
2884_GPR114 - Probable G-protein coupled receptor 114	2884_GPR114 - Probable G-protein coupled receptor 114	25	1067	1	3492	2186	2671	1843	3518	2817	3205	2050	1993	1067	1893
3738_Depression - Lifetime number of depressed periods	3738_Depression - Lifetime number of depressed periods	25	1067	1	3252	2354	2770	3181	4272	3302	3304	3378	4697	2321	1067
3784_Depression - Weight change during worst episode of depression	3784_Depression - Weight change during worst episode of depression	25	1068	1	4211	1068	3623	2786	1423	3236	2839	4568	3804	3069	3406
2288_PROC - Vitamin K-dependent protein C	2288_PROC - Vitamin K-dependent protein C	25	1069	1	3145	2823	3836	1069	3685	4155	2433	3133	2881	4447	2437
3084_RELT - Tumor necrosis factor receptor superfamily member 19L	3084_RELT - Tumor necrosis factor receptor superfamily member 19L	25	1069	1	4263	3413	1506	3287	2105	1069	4074	1578	4509	1086	2627
2306_HIST1H1C - Histone H1.2	2306_HIST1H1C - Histone H1.2	25	1069	1	3675	2283	1631	4464	3301	3143	1909	1069	2084	4422	2542
2731_C6 - Complement component C6	2731_C6 - Complement component C6	25	1070	1	4010	1070	2838	4492	1581	1617	4683	3066	3319	1188	4643
2977_ARPP19 - cAMP-regulated phosphoprotein 19	2977_ARPP19 - cAMP-regulated phosphoprotein 19	25	1070	1	1107	2490	1070	3391	3941	2486	4557	1436	3481	3638	3867
4474_Left transverse temporal	4474_Left transverse temporal	25	1070	1	1422	3122	4303	4180	4458	1070	4374	3842	2934	1214	2528
646_Xenobiotics::Xanthine metabolism::caffeine	646_Xenobiotics::Xanthine metabolism::caffeine	25	1071	1	2887	3951	3692	1071	1744	3061	4034	4537	4238	2794	2301
3769_Anxiety - Recent restlessness	3769_Anxiety - Recent restlessness	25	1073	1	3790	4677	2286	1794	3872	3043	2899	1073	3944	3559	2891
3750_Traumatic events - Felt irritable or had angry outbursts in past month	3750_Traumatic events - Felt irritable or had angry outbursts in past month	25	1075	1	3715	2071	3538	2476	4670	1633	1075	2925	4494	3979	4617
225_B Mem:%IgE	225_B Mem:%IgE	25	1075	1	3461	3718	4562	3518	2953	1133	2095	1075	4516	3695	4036
2235_TNFSF4 - Tumor necrosis factor ligand superfamily member 4	2235_TNFSF4 - Tumor necrosis factor ligand superfamily member 4	25	1076	1	1076	3963	4470	2238	4333	2405	3509	2660	4316	1457	1732
913_Total lipids in medium HDL	913_Total lipids in medium HDL	25	1076	1	2560	4192	4114	2543	2025	1340	2181	1076	2090	2496	4567
2193_FGF19 - Fibroblast growth factor 19	2193_FGF19 - Fibroblast growth factor 19	25	1077	1	4396	1077	4743	3567	1513	2737	2245	3054	2903	3530	1794
507_Lipid::Glycerolipid metabolism::glycerol	507_Lipid::Glycerolipid metabolism::glycerol	25	1077	1	2963	4338	3189	3996	4467	3788	3857	3624	1077	4511	2631
1005_Platelet derived growth factor BB	1005_Platelet derived growth factor BB	25	1077	1	3340	3295	4531	2607	2775	1484	4104	4283	4093	4180	1077
2349_KLRK1 - NKG2-D type II integral membrane protein	2349_KLRK1 - NKG2-D type II integral membrane protein	25	1079	1	2930	1152	4103	1079	2816	4514	2818	4450	1729	2753	2464
4248_Parkinson's disease age at onset	4248_Parkinson's disease age at onset	25	1079	1	1982	3895	4159	3805	1545	1079	4486	2822	3087	4034	3245
4416_Toxoplasmosis seropositivity	4416_Toxoplasmosis seropositivity	25	1079	1	3599	4471	3627	2367	1528	3469	2742	1079	4598	3959	2661
2072_BDNF - Brain-derived neurotrophic factor	2072_BDNF - Brain-derived neurotrophic factor	25	1080	1	2671	4180	3660	2598	1080	3365	3004	4281	4614	4667	2084
2242_AIF1 - Allograft inflammatory factor 1	2242_AIF1 - Allograft inflammatory factor 1	25	1080	1	4509	2716	1111	1813	3829	3227	2127	3929	2287	1080	1607
2833_BCL2L1 - Bcl-2-like protein 1	2833_BCL2L1 - Bcl-2-like protein 1	25	1081	1	2781	1580	3917	2143	4178	4405	4285	4728	1081	1446	3619
4750_Retrolenticular part of internal capsule radial diusivities	4750_Retrolenticular part of internal capsule radial diusivities	25	1083	1	3548	2344	2880	3924	1083	4343	1439	2653	3989	2363	3486
345_NKearly:%337+	345_NKearly:%337+	25	1083	1	2481	3207	4089	3954	2924	4704	1083	3148	2232	3164	1468
4246_Right handed	4246_Right handed	25	1083	1	2034	2384	4464	3456	1287	4560	3187	2702	1607	1083	2966
1417_High-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	1417_High-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	25	1084	1	1798	3170	1353	3167	1084	1225	2114	4630	4097	2860	1162
4245_Left handed	4245_Left handed	25	1086	1	1086	3110	4208	2351	2846	3401	3697	3328	1390	1450	1571
1780_Artial fibrillation (FBAT, adjusted for age and sex)	1780_Artial fibrillation (FBAT, adjusted for age and sex)	25	1086	1	2216	2781	1421	3884	1656	2517	2236	4062	3654	2426	1086
1174_Extreme chronotype	1174_Extreme chronotype	25	1087	1	2393	2006	4371	3894	3135	1769	1087	2065	2588	2941	1599
414_Amino acid::Urea cycle; arginine-, proline-, metabolism::homocitrulline	414_Amino acid::Urea cycle; arginine-, proline-, metabolism::homocitrulline	25	1088	1	4117	2311	3826	3623	2341	1583	1858	1088	1646	2308	2635
1533_Ankle-brachial index (at exam 6, GEE, adjusted for multivariable)	1533_Ankle-brachial index (at exam 6, GEE, adjusted for multivariable)	25	1089	1	1454	2001	3310	3997	2247	2650	1196	2209	1485	1470	1089
3562_Vitamin and mineral supplements: Vitamin B	3562_Vitamin and mineral supplements: Vitamin B	25	1090	1	1090	3579	3369	1198	2615	1825	1576	2758	2485	4421	3347
1304_Fasting insulin (at exam 7, FBAT, adjusted for age and sex)	1304_Fasting insulin (at exam 7, FBAT, adjusted for age and sex)	25	1092	1	2010	2913	2984	2211	4709	3287	3520	4531	1092	3135	1944
1848_Neck Section Modulus (FBAT, male, adjusted for age)	1848_Neck Section Modulus (FBAT, male, adjusted for age)	25	1093	1	3841	1093	2461	2274	4700	2782	4051	1818	4085	3803	3993
4439_Hepatitis B HBs antigen IgG levels	4439_Hepatitis B HBs antigen IgG levels	25	1093	1	2395	4423	1093	4204	2015	2256	3258	3117	1415	3850	3218
1145_Insulin secretion rate (adjusted for BMI)	1145_Insulin secretion rate (adjusted for BMI)	25	1093	1	2491	3932	4281	3332	1899	1767	4565	1455	1637	1093	4251
2128_IL10RB - Interleukin-10 receptor subunit beta	2128_IL10RB - Interleukin-10 receptor subunit beta	25	1093	1	3367	1485	2659	3889	3020	4291	2320	4219	3488	1592	1093
3352_Age started smoking in former smokers	3352_Age started smoking in former smokers	25	1094	1	3502	4283	1329	1094	1205	4355	2284	3110	1704	3696	1351
784_::::X-12544	784_::::X-12544	25	1094	1	3970	2157	3357	3358	2450	2289	1445	1094	2838	4040	4742
3908_Vertical cup-disc ratio	3908_Vertical cup-disc ratio	25	1095	1	2333	1095	2046	2650	4542	3051	1742	4433	1290	4274	1203
670_::::X-06307	670_::::X-06307	25	1096	1	2210	1179	1578	4273	4137	2275	4026	4660	2826	1096	2207
2424_ANGPTL3 - Angiopoietin-related protein 3	2424_ANGPTL3 - Angiopoietin-related protein 3	25	1097	1	3501	2004	3016	1209	1811	4126	4663	2815	3647	1097	3446
3830_Amyotrophic lateral sclerosis (meta-analysis)	3830_Amyotrophic lateral sclerosis (meta-analysis)	25	1097	1	2457	4263	1558	3344	1705	1862	3039	1981	3819	1702	1097
2152_EGFR - Epidermal growth factor receptor	2152_EGFR - Epidermal growth factor receptor	25	1098	1	4156	1250	2032	3464	1552	3594	2417	1098	4578	2176	2740
4732_Superior longitudinal fasciculus mode of anisotropy	4732_Superior longitudinal fasciculus mode of anisotropy	25	1098	1	3394	3222	2376	2577	4408	1791	3163	4201	2878	1098	3116
1907_Hippocampal volume (GEE, adjusted for multivariable)	1907_Hippocampal volume (GEE, adjusted for multivariable)	25	1099	1	1158	4637	1099	3549	4417	1515	3837	2953	3842	3318	4023
4495_Right postcentral	4495_Right postcentral	25	1100	1	1100	2713	1791	3551	2864	2368	3385	2453	1472	3361	2707
2320_TGFBR3 - Transforming growth factor beta receptor type 3	2320_TGFBR3 - Transforming growth factor beta receptor type 3	25	1100	1	4277	3970	4074	3935	1941	1100	3471	4022	3596	3002	3706
3115_PCSK9 - Proprotein convertase subtilisin/kexin type 9	3115_PCSK9 - Proprotein convertase subtilisin/kexin type 9	25	1103	1	2771	1103	1981	2260	2983	3793	3718	3213	4457	1530	3336
4484_Right lateral occipital	4484_Right lateral occipital	25	1103	1	3319	4445	1983	4163	2639	3129	3938	3707	1103	2342	4423
871_Glucose	871_Glucose	25	1105	1	3582	2399	4691	3676	1105	4206	3543	4270	4109	1292	2694
6_Anxiety disorder (case/control)	6_Anxiety disorder (case/control)	25	1106	1	1106	2146	3156	4458	2128	4646	2088	4000	3281	1411	3448
1636_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for multivariable)	1636_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for multivariable)	25	1106	1	2993	3720	1106	4345	3816	1846	3253	3578	3399	4254	2110
4547_Left caudal middle frontal	4547_Left caudal middle frontal	25	1107	1	2581	2235	1180	1107	2653	3865	4275	4603	4198	4537	2639
977_Granulocyte colony-stimulating factor	977_Granulocyte colony-stimulating factor	25	1107	1	1973	2973	3383	1741	2411	1107	3887	2697	3499	4064	1554
1214_Alcohol consumption (male)	1214_Alcohol consumption (male)	25	1108	1	2437	3700	4188	2893	1108	2588	4013	2490	1254	2805	2716
2739_IGHE IGK@ IGL@ - Immunoglobulin E	2739_IGHE IGK@ IGL@ - Immunoglobulin E	25	1110	1	4202	1110	3221	3475	3229	3172	2560	3693	4572	1722	3709
4733_Sagittal stratum mode of anisotropy	4733_Sagittal stratum mode of anisotropy	25	1110	1	4695	4366	2794	1110	3435	4284	4424	3131	3782	3131	3366
3351_Had other major operations	3351_Had other major operations	25	1111	1	2086	4054	3204	1471	4206	2011	3063	1111	3702	2754	1358
1900_Troch Neck BMD (FBAT, male, adjussted for multivariable)	1900_Troch Neck BMD (FBAT, male, adjussted for multivariable)	25	1111	1	3805	2242	3020	2849	1989	2997	1399	1543	1111	2365	3000
4157_Focal Epilepsy	4157_Focal Epilepsy	25	1112	1	2522	3387	1784	4497	1870	1112	3364	2911	3801	4031	1480
420_Amino acid::Valine, leucine and isoleucine metabolism::2-hydroxyisobutyrate	420_Amino acid::Valine, leucine and isoleucine metabolism::2-hydroxyisobutyrate	25	1113	1	4042	3758	3898	1933	1113	2511	1634	1922	3533	4348	4493
3927_Total-body lean mass	3927_Total-body lean mass	25	1114	1	1378	1991	2767	3353	2519	3672	1114	3029	1988	4514	3380
2463_ACY1 - Aminoacylase-1	2463_ACY1 - Aminoacylase-1	25	1116	1	4321	2664	2615	1484	3171	1502	4677	2205	2110	2742	1116
654_::::X-03003	654_::::X-03003	25	1117	1	4357	2615	3901	2366	2879	4360	1117	3387	3478	3613	4561
4056_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	4056_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	25	1118	1	1118	2779	3055	3640	3329	3231	1983	2356	1816	2279	3715
3707_Diagnoses - secondary ICD10: Z72 Problems related to lifestyle	3707_Diagnoses - secondary ICD10: Z72 Problems related to lifestyle	25	1120	1	1904	2123	2711	3444	1778	2173	1120	3758	1548	3604	1940
2405_KREMEN2 - Kremen protein 2	2405_KREMEN2 - Kremen protein 2	25	1121	1	2130	3725	3226	1121	3318	4570	4222	1785	1948	2875	2919
3204_Number of days/week walked 10+ minutes	3204_Number of days/week walked 10+ minutes	25	1121	1	3736	1529	1424	2446	2434	2287	2488	3667	1121	3577	4372
2879_DNAJC19 - Mitochondrial import inner membrane translocase subunit TIM14	2879_DNAJC19 - Mitochondrial import inner membrane translocase subunit TIM14	25	1121	1	3758	2177	2678	3113	1437	4675	3421	4691	3027	1121	1166
3548_Mouth/teeth dental problems: Toothache	3548_Mouth/teeth dental problems: Toothache	25	1123	1	1123	1411	3564	3487	4186	4288	1270	3161	3278	1505	1546
701_::::X-11437	701_::::X-11437	25	1123	1	2485	2926	1344	4667	4603	1123	3969	4510	4308	1158	3458
4602_Right superior frontal	4602_Right superior frontal	25	1123	1	1697	1962	1323	4583	3695	2394	2574	1123	2965	4361	3090
1386_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	1386_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	25	1123	1	4187	3543	2503	1175	1403	4119	3464	3995	1123	4571	2174
4706_Retrolenticular part of internal capsule mean diusivities	4706_Retrolenticular part of internal capsule mean diusivities	25	1123	1	2207	3867	4699	4269	1419	1582	2758	4108	3137	1123	2535
11_Schizophrenia	11_Schizophrenia	25	1124	2	3457	2977	2241	1124	4274	2515	3272	1689	3824	4495	2764
1834_Neck width (FBAT, female, adjusted for multivariable)	1834_Neck width (FBAT, female, adjusted for multivariable)	25	1124	1	1134	4231	2391	4521	1352	1124	4345	2306	3036	3523	2766
690_::::X-11261	690_::::X-11261	25	1124	1	2288	3098	2513	1385	2703	4600	4004	4669	4474	1124	3151
1677_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for multivariable)	1677_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for multivariable)	25	1125	1	3130	3449	4370	3466	1125	3495	3265	2646	3894	4020	4335
1623_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for age and sex)	1623_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for age and sex)	25	1125	1	2826	4646	3500	1127	2841	1136	2879	2364	3207	3242	1125
4513_CSF	4513_CSF	25	1128	1	2345	1128	1277	3590	1856	1712	4015	4475	2362	1284	2342
3075_RTN4R - Reticulon-4 receptor	3075_RTN4R - Reticulon-4 receptor	25	1128	1	2317	3601	3483	1128	2177	4065	3648	3209	3985	3934	3343
1459_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1459_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	1129	1	4222	1129	4397	1340	2917	1489	1730	1524	2388	3388	1643
4743_Fornix (column and body of fornix) radial diusivities	4743_Fornix (column and body of fornix) radial diusivities	25	1132	1	1132	1728	3043	2169	4171	2116	4027	1820	1258	3461	4696
456_Cofactors and vitamins::Tocopherol metabolism::gamma-tocopherol	456_Cofactors and vitamins::Tocopherol metabolism::gamma-tocopherol	25	1133	1	1133	4316	4634	1969	3781	1770	3937	4604	3494	3197	1271
3918_High-density lipoprotein cholesterol	3918_High-density lipoprotein cholesterol	25	1133	1	3066	2903	2566	1133	3719	4546	1244	4365	1974	2796	2632
666_::::X-06126	666_::::X-06126	25	1133	1	2018	2054	2881	1974	1133	4275	1870	2204	2109	2579	2339
4477_Right caudal middle frontal	4477_Right caudal middle frontal	25	1133	1	4089	3465	3700	1676	2732	1336	4625	4589	1414	1287	1133
1573_Mean abdominal aortic calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	1573_Mean abdominal aortic calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	25	1134	1	3105	2673	3070	1411	1134	4530	2129	1685	4548	3964	2290
21_Age of smoking initiation	21_Age of smoking initiation	25	1135	1	3037	3613	1135	1977	2863	4730	2119	1758	1927	3927	1718
66_Insulin sensitivity index (combined influence of the genotype effect adjusted for BMI and the interaction effect between the genotype and BMI on ISI)	66_Insulin sensitivity index (combined influence of the genotype effect adjusted for BMI and the interaction effect between the genotype and BMI on ISI)	25	1135	1	4472	4667	3178	2185	3883	1250	4438	4361	1135	2329	2867
1870_Shaft average buckling ratio (FBAT, female, adjussted for multivariable)	1870_Shaft average buckling ratio (FBAT, female, adjussted for multivariable)	25	1135	1	2155	3141	1222	4379	3909	4263	4395	2886	4125	1135	1697
1476_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	1476_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	25	1136	1	2004	3853	2605	3546	1136	1678	3034	4724	3130	1804	1834
3949_MYCN amplification neuroblastoma	3949_MYCN amplification neuroblastoma	25	1136	1	4522	3950	4070	4172	3348	2514	2781	1136	2597	3861	2955
735_::::X-11843	735_::::X-11843	25	1137	1	1651	3294	2725	4564	1430	4653	3127	2552	2977	4639	1137
354_IgE+B:%27+20-38+	354_IgE+B:%27+20-38+	25	1139	1	2429	4462	1139	4666	1432	2154	1495	3840	3227	3284	2738
3543_Eye problems/disorders: Cataract	3543_Eye problems/disorders: Cataract	25	1140	1	1140	1246	4011	4184	1517	4030	2002	1980	1877	3643	4089
4415_Varicella Zoster Virus seropositivity	4415_Varicella Zoster Virus seropositivity	25	1141	1	1141	2155	3126	2575	4056	2528	2900	4505	3174	1927	2625
1114_Visceral sdipose tissue volume (adjusted for BMI)	1114_Visceral sdipose tissue volume (adjusted for BMI)	25	1142	1	2058	4378	3388	2303	3454	1142	3197	2079	2251	3514	1878
1849_Neck Section Modulus (GEE, male, adjusted for age)	1849_Neck Section Modulus (GEE, male, adjusted for age)	25	1142	1	3932	2595	4322	2279	2601	2699	1142	2322	4250	1430	2761
3466_Impedance measures - Arm fat-free mass (left)	3466_Impedance measures - Arm fat-free mass (left)	25	1142	2	1474	4518	1722	3284	2868	4264	2729	4549	1142	1394	2417
1119_Pericardial adipose tissue volume (female)	1119_Pericardial adipose tissue volume (female)	25	1143	1	1143	2814	2983	4664	1918	3777	4069	4656	1973	3279	4658
3152_DLL1 - Delta-like protein 1	3152_DLL1 - Delta-like protein 1	25	1143	1	1346	2557	2425	4485	4265	2827	2588	2018	1143	4686	4533
2226_CX3CL1 - Fractalkine	2226_CX3CL1 - Fractalkine	25	1144	1	3991	2200	4354	2044	1900	1557	1925	1868	3347	2208	1144
1302_Fasting insulin (at exam 5, FBAT, adjusted for age and sex)	1302_Fasting insulin (at exam 5, FBAT, adjusted for age and sex)	25	1145	1	3384	3055	4251	3370	2161	4521	3964	4288	3121	1145	1220
4498_Right precuneus	4498_Right precuneus	25	1146	1	3638	2972	3274	3761	2674	1374	1146	2632	3114	2681	3177
4517_Left lateral ventricle	4517_Left lateral ventricle	25	1147	1	1147	2078	1572	3425	3755	2778	2557	3057	2422	3320	3054
2658_CST4 - Cystatin-S	2658_CST4 - Cystatin-S	25	1147	1	3334	3223	2867	1147	4672	4715	4155	4704	1674	3722	4661
2231_KLK8 - Kallikrein-8	2231_KLK8 - Kallikrein-8	25	1147	1	3040	1329	2754	2117	4190	1147	2024	2470	1219	2561	2585
1732_Chronic kidney disease (at exam 7, FBAT, adjusted for multivariable)	1732_Chronic kidney disease (at exam 7, FBAT, adjusted for multivariable)	25	1147	1	1249	1669	1713	4277	2390	1275	1147	3833	3362	1147	3514
756_Nucleotide::NAD metabolism::X-12095--N1-methyl-3-pyridone-4-carboxamide	756_Nucleotide::NAD metabolism::X-12095--N1-methyl-3-pyridone-4-carboxamide	25	1147	1	4103	3855	3770	3639	4130	2414	3645	1147	4285	4102	3187
2830_SLPI - Antileukoproteinase	2830_SLPI - Antileukoproteinase	25	1147	1	4736	1334	3911	2563	2533	1721	2148	1939	1147	2833	4396
2468_CAMK2A - Calcium/calmodulin-dependent protein kinase type II subunit alpha	2468_CAMK2A - Calcium/calmodulin-dependent protein kinase type II subunit alpha	25	1148	1	1640	1148	2840	3519	4296	2421	2203	3967	3688	3486	2762
309_CD4nv:%Th2	309_CD4nv:%Th2	25	1148	1	3177	3682	2989	1148	2506	3005	4465	1311	4297	4039	3905
3907_Intraocular pressure	3907_Intraocular pressure	25	1149	1	3692	3274	2988	2421	2811	1560	1322	1316	2584	2350	1149
2782_IL1RL1 - Interleukin-1 receptor-like 1	2782_IL1RL1 - Interleukin-1 receptor-like 1	25	1151	1	3267	4701	1803	1518	3686	1151	4175	3886	2730	3104	1450
4049_Achilles tendon injury	4049_Achilles tendon injury	25	1151	1	1243	2748	3485	2272	1210	4581	2678	2055	1151	1922	1950
3027_PSME1 - Proteasome activator complex subunit 1	3027_PSME1 - Proteasome activator complex subunit 1	25	1152	1	2449	1921	3103	2750	3431	3021	1152	3617	1919	2578	3887
2621_COLEC12 - Collectin-12	2621_COLEC12 - Collectin-12	25	1152	1	1725	1891	1895	3424	4035	4674	1675	2492	4644	1152	1487
182_Waist-hip ratio (male)	182_Waist-hip ratio (male)	25	1153	1	1153	2843	3988	4334	2891	4723	1219	3212	1387	2892	1383
3053_TNFRSF18 - Tumor necrosis factor receptor superfamily member 18	3053_TNFRSF18 - Tumor necrosis factor receptor superfamily member 18	25	1153	1	3590	1382	3477	3835	1917	4685	1153	1629	1379	1745	4307
2686_DYNLRB1 - Dynein light chain roadblock-type 1	2686_DYNLRB1 - Dynein light chain roadblock-type 1	25	1155	1	1999	2745	1248	2540	1529	1155	2356	2594	2369	1867	2008
2556_IFNA2 - Interferon alpha-2	2556_IFNA2 - Interferon alpha-2	25	1155	1	3605	3960	2551	2036	1986	4444	4466	3857	1975	1155	2356
2886_HDGFRP2 - Hepatoma-derived growth factor-related protein 2	2886_HDGFRP2 - Hepatoma-derived growth factor-related protein 2	25	1155	1	3386	3879	3475	4101	1377	2476	4212	3374	1770	3054	1155
1129_Ratio of visceral-tosubcutaneous adipose tissue volume	1129_Ratio of visceral-tosubcutaneous adipose tissue volume	25	1158	1	1856	3468	1158	3298	2252	1159	1943	2916	2292	2958	3161
1517_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	1517_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	25	1158	1	3646	1706	1586	3964	2273	2883	1158	3122	2948	2982	1873
2873_BST1 - ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2	2873_BST1 - ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2	25	1159	1	1159	3714	2545	2682	2456	2849	4419	2525	4059	2903	2347
951_Urea	951_Urea	25	1160	1	3673	4249	4393	2133	3970	4552	2998	3757	3180	1160	3388
4674_Cingulum (hippocampus) axial diusivities	4674_Cingulum (hippocampus) axial diusivities	25	1161	1	1202	1161	4313	1298	3830	2942	2287	4519	2397	2920	3473
494_Lipid::Fatty acid metabolism (also BCAA metabolism)::butyrylcarnitine	494_Lipid::Fatty acid metabolism (also BCAA metabolism)::butyrylcarnitine	25	1161	1	4075	2882	3491	4252	4046	3096	1302	1161	3415	4059	4730
1039_Neck-Shaft Angle (GEE, adjusted for multivariable)	1039_Neck-Shaft Angle (GEE, adjusted for multivariable)	25	1161	1	4554	2464	4120	3610	3303	1726	4146	4103	1503	4582	1161
3089_ICAM5 - Intercellular adhesion molecule 5	3089_ICAM5 - Intercellular adhesion molecule 5	25	1162	1	3643	1612	1862	4418	1162	2964	4437	4524	4489	2370	4529
801_::::X-12771	801_::::X-12771	25	1163	1	1614	3510	1163	4162	3134	2924	2769	3132	4605	3347	2815
3098_TNFRSF12A - Tumor necrosis factor receptor superfamily member 12A	3098_TNFRSF12A - Tumor necrosis factor receptor superfamily member 12A	25	1163	1	3218	3754	2591	1163	2737	3001	2344	3590	3907	3969	4337
2083_APCS - Serum amyloid P-component	2083_APCS - Serum amyloid P-component	25	1163	1	3514	2758	4263	3984	1163	3116	4042	1844	4383	2831	4733
2909_IL3 - Interleukin-3	2909_IL3 - Interleukin-3	25	1163	1	1669	2099	4585	4082	4088	3053	3565	2139	4626	1163	2159
912_Free cholesterol in medium HDL	912_Free cholesterol in medium HDL	25	1164	1	4579	1440	3474	1369	3546	1451	1783	3318	3067	1164	3771
396_Amino acid::Phenylalanine & tyrosine metabolism::phenol sulfate	396_Amino acid::Phenylalanine & tyrosine metabolism::phenol sulfate	25	1166	1	1166	3846	1918	2033	3999	4323	2484	2659	2436	1494	3455
1179_Insomnia (male)	1179_Insomnia (male)	25	1166	1	4705	3776	4547	4109	2832	1166	4198	2841	4280	3195	3511
1921_Frontal lobe volume (GEE, adjusted for age and sex)	1921_Frontal lobe volume (GEE, adjusted for age and sex)	25	1167	1	2988	3050	1570	4130	3166	3008	1167	1348	1871	2608	3634
4666_Superior longitudinal fasciculus fractional anisotropy	4666_Superior longitudinal fasciculus fractional anisotropy	25	1167	1	2799	2756	4327	1840	1302	3175	4741	3354	3949	4546	1167
1959_MMSE score (at exam 5, GEE, adjusted for multivariable)	1959_MMSE score (at exam 5, GEE, adjusted for multivariable)	25	1168	1	4232	3757	1593	3860	1168	2434	1713	4448	3966	4110	3186
2899_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 27	2899_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 27	25	1168	1	3342	1804	3433	3820	4227	3006	3752	1168	3730	3097	2726
2178_NCR2 - Natural cytotoxicity triggering receptor 2	2178_NCR2 - Natural cytotoxicity triggering receptor 2	25	1169	1	2854	1169	1646	3873	4685	2623	4159	2161	1896	3768	3563
2829_MST1 - Hepatocyte growth factor-like protein	2829_MST1 - Hepatocyte growth factor-like protein	25	1169	1	3005	2611	2403	2392	3728	2701	2013	2355	1169	3184	4047
648_Xenobiotics::Xanthine metabolism::theobromine	648_Xenobiotics::Xanthine metabolism::theobromine	25	1172	1	1320	2203	1172	1173	1608	4387	2558	4460	1353	2432	4361
1957_Wide Range Achievement Test (GEE, adjusted for multivariable)	1957_Wide Range Achievement Test (GEE, adjusted for multivariable)	25	1174	1	1596	2325	1174	4017	2991	4712	4098	2268	4130	1623	1336
2154_HSPD1 - 60 kDa heat shock protein, mitochondrial	2154_HSPD1 - 60 kDa heat shock protein, mitochondrial	25	1174	1	1527	3166	3976	4364	1174	2531	1911	4030	3941	3156	4072
2633_IFNGR1 - Interferon gamma receptor 1	2633_IFNGR1 - Interferon gamma receptor 1	25	1175	1	2933	3012	3639	1336	3351	4548	4541	1592	1175	1334	3791
426_Amino acid::Valine, leucine and isoleucine metabolism::beta-hydroxyisovalerate	426_Amino acid::Valine, leucine and isoleucine metabolism::beta-hydroxyisovalerate	25	1176	1	2828	4698	3754	4291	1554	1828	3750	1176	1829	3436	2781
4191_QT interval	4191_QT interval	25	1177	1	1177	4244	3292	2398	4643	2193	3157	1896	2242	2789	3713
725_Cofactors and vitamins::Ascorbate and aldarate metabolism::X-11593--O-methylascorbate*	725_Cofactors and vitamins::Ascorbate and aldarate metabolism::X-11593--O-methylascorbate*	25	1177	1	4369	3322	4041	4011	1177	2350	1384	1300	2952	4702	1441
4460_Left pars opercularis	4460_Left pars opercularis	25	1179	1	1936	3817	1179	3985	2358	2610	4400	3185	3764	4131	3243
2806_LCORL - Ligand-dependent nuclear receptor corepressor-like protein	2806_LCORL - Ligand-dependent nuclear receptor corepressor-like protein	25	1180	1	3552	2316	2913	1180	3842	4457	3331	2544	4239	1391	3044
2746_XCL1 - Lymphotactin	2746_XCL1 - Lymphotactin	25	1180	1	3704	3203	1361	2249	4074	4211	2092	3928	3115	1180	3633
3733_Depression - Thoughts of death during worst depression	3733_Depression - Thoughts of death during worst depression	25	1183	1	1363	2374	1264	2253	2110	2929	4383	3233	2204	1183	3278
1842_Neck Section Modulus (FBAT, female, adjusted for multivariable)	1842_Neck Section Modulus (FBAT, female, adjusted for multivariable)	25	1184	1	1184	2210	3718	3910	4348	3583	2143	2384	3322	3783	1714
2657_CKB - Creatine kinase B-type	2657_CKB - Creatine kinase B-type	25	1184	1	1757	1557	2978	1184	1185	2379	4064	3981	3256	3513	1615
2674_MAPKAPK3 - MAP kinase-activated protein kinase 3	2674_MAPKAPK3 - MAP kinase-activated protein kinase 3	25	1185	1	2810	3069	3036	2066	2664	1575	1185	2668	2049	3544	2494
335_NKeff:%314-158a+	335_NKeff:%314-158a+	25	1185	1	4201	1591	4102	2085	3081	3855	3729	1185	3378	1193	2146
1540_White matter hyperintensity volume (FBAT, adjusted for multivariable)	1540_White matter hyperintensity volume (FBAT, adjusted for multivariable)	25	1186	1	3310	2117	1186	4165	4742	1597	4105	1223	2808	3753	2097
2786_MDM2 - E3 ubiquitin-protein ligase Mdm2	2786_MDM2 - E3 ubiquitin-protein ligase Mdm2	25	1186	1	3566	1431	4652	4341	2809	3519	4341	2421	2252	1186	3176
2692_PRDX1 - Peroxiredoxin-1	2692_PRDX1 - Peroxiredoxin-1	25	1187	1	3653	3024	4745	1670	4676	4492	4665	4493	1187	3435	2427
4458_Left parahippocampal	4458_Left parahippocampal	25	1190	1	4511	2809	3152	2880	3757	2367	3965	2091	3858	2364	1190
2041_Attention function - Hit reaction time - Child	2041_Attention function - Hit reaction time - Child	25	1191	1	1837	1324	2994	2754	1763	1984	2094	1191	1890	3330	3180
59_Childhood IQ	59_Childhood IQ	25	1191	1	4492	1844	4279	2621	4026	2774	3262	3348	1191	4100	3830
2437_CST7 - Cystatin-F	2437_CST7 - Cystatin-F	25	1192	1	2162	1303	1568	4051	2853	4016	1212	4575	3164	4357	1192
700_Amino acid::Phenylalanine & tyrosine metabolism::X-11423--O-sulfo-L-tyrosine	700_Amino acid::Phenylalanine & tyrosine metabolism::X-11423--O-sulfo-L-tyrosine	25	1194	1	1943	3639	1194	4436	3038	3378	3560	1660	3050	3079	3595
2158_MIA - Melanoma-derived growth regulatory protein	2158_MIA - Melanoma-derived growth regulatory protein	25	1194	1	1875	1946	3129	1194	4609	1474	4152	2694	3243	2897	3782
2680_PTK6 - Protein-tyrosine kinase 6	2680_PTK6 - Protein-tyrosine kinase 6	25	1194	1	4526	4235	3352	1723	1836	1967	3656	1194	2940	4305	4109
3022_PRDX5 - Peroxiredoxin-5, mitochondrial	3022_PRDX5 - Peroxiredoxin-5, mitochondrial	25	1196	1	3438	4172	2710	2522	2720	1196	4367	2918	4594	3871	2094
4093_Verbal-numerical reasoning	4093_Verbal-numerical reasoning	25	1197	1	1197	2852	2057	2651	3677	2290	2654	2379	1724	4069	2895
3121_PDE2A - cGMP-dependent 3',5'-cyclic phosphodiesterase	3121_PDE2A - cGMP-dependent 3',5'-cyclic phosphodiesterase	25	1197	1	3189	2626	2142	4235	1197	2195	1531	1642	2333	1607	1503
370_Amino acid::Creatine metabolism::creatinine	370_Amino acid::Creatine metabolism::creatinine	25	1197	1	1957	2893	2202	4588	2187	3897	3966	4349	1197	2901	2439
3283_Number of full sisters	3283_Number of full sisters	25	1198	1	3387	3487	4020	2250	3807	3742	3954	1198	2890	4728	3195
529_Lipid::Long chain fatty acid::stearidonate (18:4n3)	529_Lipid::Long chain fatty acid::stearidonate (18:4n3)	25	1199	1	2802	1199	3814	3123	1933	1999	4717	1973	4287	4498	2668
1361_Total cholesterol (at exam 2, GEE, adjusted for age and sex)	1361_Total cholesterol (at exam 2, GEE, adjusted for age and sex)	25	1199	1	4133	3785	3172	1199	1475	2263	1378	1646	3868	4035	1759
4493_Right pars triangularis	4493_Right pars triangularis	25	1199	1	2259	4322	3686	4540	1199	2104	4697	4653	4596	2406	4108
1416_High-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	1416_High-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	25	1199	1	1431	2042	2437	4506	2686	3242	1199	3326	3302	4665	1870
3513_Gas or solid-fuel cooking/heating: A gas hob or gas cooker	3513_Gas or solid-fuel cooking/heating: A gas hob or gas cooker	25	1199	1	2878	2651	2306	3186	4372	4681	3527	1199	2382	2914	4015
3127_PDE4D - cAMP-specific 3',5'-cyclic phosphodiesterase 4D	3127_PDE4D - cAMP-specific 3',5'-cyclic phosphodiesterase 4D	25	1199	1	2789	2796	1728	3459	1604	2231	3457	2073	4552	1199	1371
3876_Eosinophil percentage of granulocytes (three-way meta)	3876_Eosinophil percentage of granulocytes (three-way meta)	25	1200	1	1200	4668	1420	2620	3951	3274	3349	2564	3073	2583	4648
1071_Diabetic Nephropathy in Type 1 Diabetes	1071_Diabetic Nephropathy in Type 1 Diabetes	25	1200	1	1831	1582	1678	1200	3492	2214	2465	3597	4084	4620	2133
103_Late pubertal growth (male)	103_Late pubertal growth (male)	25	1201	1	3594	1892	1823	1201	2839	1702	3816	4327	2534	2165	4397
329_CD4Nv:%TFH (3)	329_CD4Nv:%TFH (3)	25	1201	1	4575	4731	3956	4094	2660	4218	3679	2249	4305	1201	2857
3091_SLAMF6 - SLAM family member 6	3091_SLAMF6 - SLAM family member 6	25	1202	1	3303	1543	2891	1202	4065	1784	1727	2847	1841	2123	3803
2726_DDR1 - Epithelial discoidin domain-containing receptor 1	2726_DDR1 - Epithelial discoidin domain-containing receptor 1	25	1202	1	2891	2574	2742	3315	1479	3459	4544	1202	2616	3622	2758
3847_Immature fraction of reticulocytes (two-way meta)	3847_Immature fraction of reticulocytes (two-way meta)	25	1203	1	2695	3016	3105	3669	3767	1759	4063	1203	2722	4191	4140
342_NKearly:%337+335+R7-	342_NKearly:%337+335+R7-	25	1203	1	1547	2443	3025	1731	4597	2989	3150	2523	1203	3163	3848
4401_Menstruation quality of life impact: Headache	4401_Menstruation quality of life impact: Headache	25	1204	1	3420	1204	4584	1846	4702	3678	3776	4709	1833	3504	1932
4012_Probable major dpressive disorder	4012_Probable major dpressive disorder	25	1204	1	2849	3542	4394	1934	1787	2144	2026	1204	4486	3196	3173
77_Adiponectin level	77_Adiponectin level	25	1204	1	2990	3737	4674	3127	3010	4632	2473	4615	1204	3794	2520
3107_PSME3 - Proteasome activator complex subunit 3	3107_PSME3 - Proteasome activator complex subunit 3	25	1205	1	3348	2815	1433	1306	1334	1780	1205	2956	3077	3600	3451
2637_PTH - Parathyroid hormone	2637_PTH - Parathyroid hormone	25	1208	1	3741	4280	4237	1208	2529	3858	2799	3295	1694	3133	4595
434_Carbohydrate::Aminosugars metabolism::erythronate*	434_Carbohydrate::Aminosugars metabolism::erythronate*	25	1208	1	3541	3993	4610	3528	3228	3150	3073	1208	3268	3952	4132
667_::::X-06226	667_::::X-06226	25	1210	1	2841	1676	4258	1210	3268	4131	3796	3598	2951	2990	4375
4737_Average across all tracts radial diusivities	4737_Average across all tracts radial diusivities	25	1210	1	2691	2577	3498	1681	2048	3445	2490	1692	2217	1210	4662
1188_Tetralogy of Fallot	1188_Tetralogy of Fallot	25	1211	1	3472	1931	1211	4070	4289	1606	2542	1426	2293	3387	2600
2983_CA2 - Carbonic anhydrase 2	2983_CA2 - Carbonic anhydrase 2	25	1211	1	1284	4380	1613	4556	1211	3780	3817	2521	1657	4313	4461
3674_Diagnoses - main ICD10: K62 Other diseases of anus and rectum	3674_Diagnoses - main ICD10: K62 Other diseases of anus and rectum	25	1212	1	3694	1704	3497	2288	1717	1510	2763	1212	3718	3928	1475
4456_Left medial orbitofrontal	4456_Left medial orbitofrontal	25	1212	1	1221	1970	3492	1508	1691	1228	1777	1595	3231	1212	3441
1431_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1431_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	1212	1	2272	2742	3831	1437	1930	1837	3196	3038	4628	3571	1212
997_Interferon gamma-induced protein 10 (CXCL10)	997_Interferon gamma-induced protein 10 (CXCL10)	25	1213	1	3323	2596	4632	2931	2191	4582	3288	2678	4734	1213	4122
778_::::X-12443	778_::::X-12443	25	1214	1	3597	4056	2115	1214	3195	4245	1462	1839	3400	2729	3995
4341_Moderate intesity	4341_Moderate intesity	25	1214	1	2833	4009	4565	2041	4252	2601	4596	1516	1214	1407	4105
395_Amino acid::Phenylalanine & tyrosine metabolism::p-cresol sulfate	395_Amino acid::Phenylalanine & tyrosine metabolism::p-cresol sulfate	25	1216	1	1216	2718	4617	3745	2515	3439	2610	3124	3792	4409	3748
2704_ARID3A - AT-rich interactive domain-containing protein 3A	2704_ARID3A - AT-rich interactive domain-containing protein 3A	25	1217	1	1785	4189	2450	1217	2721	1406	2185	2959	3746	1956	4026
275_CD8:%CM	275_CD8:%CM	25	1217	1	4237	4640	2853	2370	1624	3850	3405	2994	2667	1217	2318
3334_Duration of heavy DIY	3334_Duration of heavy DIY	25	1219	1	1219	2036	2707	2863	2837	2012	1254	3197	4462	1478	4443
2758_TGFB2 - Transforming growth factor beta-2	2758_TGFB2 - Transforming growth factor beta-2	25	1219	1	3158	4196	2375	2166	1269	3403	4527	1219	2093	4090	3183
1645_Osteoprotegerin (at exam 7, GEE, adjusted for multivariable	1645_Osteoprotegerin (at exam 7, GEE, adjusted for multivariable	25	1220	1	3782	2644	1220	2467	2808	2779	2644	1224	2182	3658	4092
2553_EPO - Erythropoietin	2553_EPO - Erythropoietin	25	1221	1	4452	2857	3633	4415	1729	1221	3090	3994	4740	3099	1608
2069_FLT4 - Vascular endothelial growth factor receptor 3	2069_FLT4 - Vascular endothelial growth factor receptor 3	25	1222	1	1352	2508	3990	1303	4605	2396	1417	1944	1222	3236	1655
2566_CXCL12 - Stromal cell-derived factor 1	2566_CXCL12 - Stromal cell-derived factor 1	25	1223	1	3985	4285	3606	3336	4472	4607	2288	3109	1223	2170	3442
3403_Fluid intelligence test - FI5 : family relationship calculation	3403_Fluid intelligence test - FI5 : family relationship calculation	25	1223	1	2942	1244	3762	2309	1866	2497	1226	3691	2264	1223	4486
2108_TNFSF9 - Tumor necrosis factor ligand superfamily member 9	2108_TNFSF9 - Tumor necrosis factor ligand superfamily member 9	25	1224	1	4485	4138	3140	4326	4279	1224	2242	3079	3735	4188	3557
3064_JAG2 - Protein jagged-2	3064_JAG2 - Protein jagged-2	25	1228	1	1228	3576	4158	1979	2743	2365	4409	4321	2711	3511	3788
2264_CD22 - B-cell receptor CD22	2264_CD22 - B-cell receptor CD22	25	1229	1	3100	1229	2252	3225	3569	3539	3273	1602	2914	3887	1586
3346_Ever taken oral contraceptive pill (female)	3346_Ever taken oral contraceptive pill (female)	25	1231	1	2679	2939	3420	1231	2861	3653	4103	4451	3252	3546	3091
2489_PAK3 - Serine/threonine-protein kinase PAK 3	2489_PAK3 - Serine/threonine-protein kinase PAK 3	25	1234	1	2080	4084	1898	3395	1234	1528	4700	2738	4313	3288	2258
4445_Left caudal anterior cingulate	4445_Left caudal anterior cingulate	25	1234	1	3881	4505	4268	1852	3153	1604	2170	2764	1234	2597	4448
1588_Factor VII (at exam 5, FBAT, adjusted for multivariable)	1588_Factor VII (at exam 5, FBAT, adjusted for multivariable)	25	1235	1	4442	4653	1235	4372	4152	2767	1382	3723	3371	1520	2316
3970_GLP-1 stimulated insulin secretion	3970_GLP-1 stimulated insulin secretion	25	1235	1	3797	3365	3745	1235	2098	4226	2547	3425	3980	3141	2498
371_Amino acid::Cysteine, methionine, SAM, taurine metabolism::2-hydroxybutyrate (AHB)	371_Amino acid::Cysteine, methionine, SAM, taurine metabolism::2-hydroxybutyrate (AHB)	25	1235	1	3317	2734	4239	2561	3353	1741	1235	1240	2284	2060	1905
470_Lipid::Bile acid metabolism::taurochenodeoxycholate	470_Lipid::Bile acid metabolism::taurochenodeoxycholate	25	1237	1	4690	4091	4101	2368	3785	1237	3154	1687	4174	1278	4133
4405_Menstrual quality of life impact: Pressure in the breasts	4405_Menstrual quality of life impact: Pressure in the breasts	25	1238	1	1238	4606	3918	4630	1819	1658	4274	1871	3663	2459	2065
1644_Osteoprotegerin (at exam 7, FBAT, adjusted for multivariable)	1644_Osteoprotegerin (at exam 7, FBAT, adjusted for multivariable)	25	1238	1	2473	4314	4345	3214	3720	3259	3980	4296	3219	2698	1238
982_Interleukin-12p70	982_Interleukin-12p70	25	1239	1	1239	4553	3486	2964	3773	2051	3297	2789	1495	1600	2278
278_CD8:%Act(25+38+)	278_CD8:%Act(25+38+)	25	1241	1	2956	4140	4423	2026	2851	3093	2946	4045	3259	3007	1241
2097_CFI - Complement factor I	2097_CFI - Complement factor I	25	1243	1	2710	3975	2793	3887	2603	1243	2533	3649	3632	3684	4157
3843_Hematocrit (two-way meta)	3843_Hematocrit (two-way meta)	25	1243	1	1685	2960	2190	3245	4415	1496	2572	2740	1243	3369	4385
2238_SPINT2 - Kunitz-type protease inhibitor 2	2238_SPINT2 - Kunitz-type protease inhibitor 2	25	1244	1	1244	4178	3038	3470	3040	1788	2892	1391	3558	3208	4415
3861_Plateletcrit (two-way meta)	3861_Plateletcrit (two-way meta)	25	1245	1	4033	3238	2161	3112	2314	3824	4552	4227	4404	2345	1245
4284_FEV1/FVC ratio	4284_FEV1/FVC ratio	25	1247	1	1247	1853	4603	4736	3313	1657	1377	1459	3223	4722	2866
4261_Facial attractiveness (male-coder, female samples)	4261_Facial attractiveness (male-coder, female samples)	25	1248	1	4348	1478	2950	2173	1248	2675	4420	3773	4470	2471	4136
3869_Basophil count (three-way meta)	3869_Basophil count (three-way meta)	25	1249	1	4553	1404	3820	3317	3756	1632	1249	2417	4367	3357	1677
3213_Duration walking for pleasure	3213_Duration walking for pleasure	25	1250	1	1843	4629	4651	1305	4319	3706	4073	3408	3217	4395	1250
2600_LGMN - Legumain	2600_LGMN - Legumain	25	1251	1	1251	3379	4213	2988	3330	3550	2858	4228	2057	4717	2317
673_::::X-07765	673_::::X-07765	25	1253	1	1253	1558	1905	1958	2095	1966	1780	2025	4530	4485	2377
834_Peptide::Dipeptide::X-14205--alpha-glutamyltyrosine	834_Peptide::Dipeptide::X-14205--alpha-glutamyltyrosine	25	1254	1	4138	2798	2469	4614	2053	1866	3989	2700	3864	1665	1254
774_::::X-12428	774_::::X-12428	25	1256	1	4090	3480	4048	1256	2354	3732	2924	1606	3080	3194	2913
3331_Other serious medical condition/disability (diagnosed by doctor)	3331_Other serious medical condition/disability (diagnosed by doctor)	25	1258	1	2660	1775	3890	2991	1572	3044	1258	4578	3885	2180	2875
850_Acetoacetate	850_Acetoacetate	25	1259	1	1382	2899	1259	3109	4399	4633	1796	3992	4083	1632	3387
2068_TGFB1 - Transforming growth factor beta-1	2068_TGFB1 - Transforming growth factor beta-1	25	1259	1	2356	2387	2386	4342	1259	1752	2813	2286	2920	2330	1922
1336_HOMA-IR (at exam 5, FBAT, adjusted for age, sex and BMI)	1336_HOMA-IR (at exam 5, FBAT, adjusted for age, sex and BMI)	25	1260	1	2271	1586	3626	1260	1833	2967	4096	4102	3505	3907	1969
776_Lipid::Eicosanoid::X-12441--12-hydroxyeicosatetraenoate (12-HETE)	776_Lipid::Eicosanoid::X-12441--12-hydroxyeicosatetraenoate (12-HETE)	25	1263	1	4660	4337	3414	3630	1263	3705	3040	1603	2898	2149	2390
488_Lipid::Essential fatty acid::docosahexaenoate (DHA; 22:6n3)	488_Lipid::Essential fatty acid::docosahexaenoate (DHA; 22:6n3)	25	1265	1	1265	2159	4568	4197	4038	3409	4326	3172	2721	2937	3535
2247_NR3C1 - Glucocorticoid receptor	2247_NR3C1 - Glucocorticoid receptor	25	1266	1	4432	3191	2563	2950	3955	1266	4593	3750	4510	3848	2670
1789_QT interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1789_QT interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	1267	1	3972	2952	1267	2009	4290	2472	1703	3081	2982	2646	2343
1727_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for age and sex)	1727_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for age and sex)	25	1268	1	3930	2497	2833	2463	2446	1435	1526	4174	2950	1268	3614
2330_CGA FSHB - Follicle stimulating hormone	2330_CGA FSHB - Follicle stimulating hormone	25	1269	1	3572	2181	1269	1587	3648	1317	4738	2192	4077	4629	2799
4006_Osteoarthritis (hospital diagnosed)	4006_Osteoarthritis (hospital diagnosed)	25	1269	1	3301	2194	1956	1536	3597	4580	4325	1978	1874	3433	1269
303_CD4mem:%Th1* (4)	303_CD4mem:%Th1* (4)	25	1271	1	1271	4005	3746	3372	4361	3191	3753	4536	3146	1307	2931
2690_MDH1 - Malate dehydrogenase, cytoplasmic	2690_MDH1 - Malate dehydrogenase, cytoplasmic	25	1273	1	3765	3574	3363	4360	1273	2760	1997	2595	4705	3379	2634
2206_CCL4L1 - C-C motif chemokine 4-like	2206_CCL4L1 - C-C motif chemokine 4-like	25	1273	1	2193	2507	3780	3423	3046	1486	1273	2332	4739	4516	1334
2693_ACP1 - Low molecular weight phosphotyrosine protein phosphatase	2693_ACP1 - Low molecular weight phosphotyrosine protein phosphatase	25	1276	1	3271	4017	1276	2383	2485	3029	3485	1612	3528	4578	4555
348_CD8:%R5+	348_CD8:%R5+	25	1276	1	3212	3723	4549	4284	3266	1996	2235	3376	1276	2563	3616
2620_PPP3R1 - Calcineurin subunit B type 1	2620_PPP3R1 - Calcineurin subunit B type 1	25	1279	1	2467	4374	4639	1279	3005	1605	3671	2599	1680	2189	4247
2828_IFNL2 - Interferon lambda-2	2828_IFNL2 - Interferon lambda-2	25	1279	1	4678	2733	3572	4256	1279	1507	3401	3089	3335	3161	2453
200_Microalbuminuria	200_Microalbuminuria	25	1279	1	1316	2331	4667	3919	1562	1910	1409	1968	3760	1832	1279
2403_KLK13 - Kallikrein-13	2403_KLK13 - Kallikrein-13	25	1282	1	3377	1282	1652	1850	1859	3460	2483	3575	2472	2517	4158
2220_AGRP - Agouti-related protein	2220_AGRP - Agouti-related protein	25	1284	1	4228	2689	4096	1284	2011	2828	2942	4391	4573	1985	2338
1992_Survival past average life expectancy (FBAT, adjusted for multivariable)	1992_Survival past average life expectancy (FBAT, adjusted for multivariable)	25	1287	1	3454	2788	1730	4642	3777	1287	3924	2296	4100	4048	1574
3473_Reported occurrences of cancer	3473_Reported occurrences of cancer	25	1287	1	4003	2501	3678	4456	3281	2541	1287	2684	1605	1531	2223
976_Basic fibroblast growth factor	976_Basic fibroblast growth factor	25	1288	1	1472	1637	3542	2858	4222	1288	2759	3594	2460	3364	3102
492_Lipid::Essential fatty acid::linolenate [alpha or gamma; (18:3n3 or 6)]	492_Lipid::Essential fatty acid::linolenate [alpha or gamma; (18:3n3 or 6)]	25	1288	1	4318	4194	2128	2306	4258	2941	2099	3661	1288	3159	3916
4396_Menstruation quality of life impact: Agressiveness	4396_Menstruation quality of life impact: Agressiveness	25	1289	1	2629	4665	4541	3067	2894	1289	3445	1559	2891	4601	3638
22_Clozapine-Induced Agranulocytosis/Granulocytopenia	22_Clozapine-Induced Agranulocytosis/Granulocytopenia	25	1291	1	1426	3539	2875	2610	2407	3772	2264	1291	2917	2588	2099
716_::::X-11521	716_::::X-11521	25	1292	1	4295	1292	2629	1760	2263	3694	3095	3514	2132	2166	3513
3779_Traumatic events - Witnessed sudden violent death	3779_Traumatic events - Witnessed sudden violent death	25	1292	1	2441	2019	4457	1292	4060	4616	2545	2455	3707	2106	4110
3519_Current employment status: In paid employment or self-employed	3519_Current employment status: In paid employment or self-employed	25	1293	1	4668	1293	3203	3764	2093	4099	4014	2023	4580	3519	2690
2472_CDK2 CCNA2 - Cyclin-dependent kinase 2:Cyclin-A2 complex	2472_CDK2 CCNA2 - Cyclin-dependent kinase 2:Cyclin-A2 complex	25	1297	1	1297	4122	3254	3680	1617	2103	4658	1468	3979	1327	1838
1553_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1553_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	1298	1	3598	4573	2474	2816	2933	4048	3963	1673	4211	2349	1298
3594_Mineral and other dietary supplements: Calcium	3594_Mineral and other dietary supplements: Calcium	25	1300	1	1300	2970	4516	3868	4322	2159	4375	2629	1572	4104	2604
2431_CD48 - CD48 antigen	2431_CD48 - CD48 antigen	25	1300	1	2397	1300	3535	3264	3972	1816	2055	4373	3541	3028	1895
4125_Fibrinogen	4125_Fibrinogen	25	1300	1	3203	4053	1561	4014	4344	1989	3104	1361	1300	3635	3262
1539_White matter hyperintensity volume (GEE, adjusted for age and sex)	1539_White matter hyperintensity volume (GEE, adjusted for age and sex)	25	1301	1	4366	2930	1931	2089	1301	2045	3518	1936	2281	2470	3863
3574_Pain type(s) experienced in last month: Hip pain	3574_Pain type(s) experienced in last month: Hip pain	25	1301	1	3093	1360	1370	2790	2565	1301	1473	2365	2123	4352	4398
3412_Sitting height	3412_Sitting height	25	1301	1	2951	3842	3356	2711	4332	1694	1316	1301	4519	3865	2444
911_Cholesterol esters in medium HDL	911_Cholesterol esters in medium HDL	25	1302	1	1302	4684	2775	1873	3136	1589	4412	3999	2639	1960	3332
2374_TNFRSF1B - Tumor necrosis factor receptor superfamily member 1B	2374_TNFRSF1B - Tumor necrosis factor receptor superfamily member 1B	25	1303	1	4140	2817	2393	1332	1303	3036	3893	2601	2048	1910	4674
1671_Bilirubin (at exam 2, GEE, adjusted for age and sex)	1671_Bilirubin (at exam 2, GEE, adjusted for age and sex)	25	1303	1	2588	3402	1963	4307	3285	1555	1731	2917	2297	2850	1303
235_CD123 on mDC	235_CD123 on mDC	25	1304	1	1966	3706	2517	2160	4238	3025	1304	1765	4369	3116	3437
4537_Right pallidum	4537_Right pallidum	25	1305	1	3182	2265	4504	3620	1305	3712	3757	2825	1924	3420	3702
3682_Diagnoses - main ICD10: R10 Abdominal and pelvic pain	3682_Diagnoses - main ICD10: R10 Abdominal and pelvic pain	25	1308	1	2940	2141	2724	3183	2063	2673	1308	1712	2348	2677	3449
35_Loneliness (linear)	35_Loneliness (linear)	25	1308	1	2923	3309	4277	2230	2948	1777	2929	4532	2981	1308	2262
1859_Neck cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	1859_Neck cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	25	1310	1	3807	4596	1753	2741	1338	2088	1310	1529	4205	2913	3175
2186_AZU1 - Azurocidin	2186_AZU1 - Azurocidin	25	1311	1	1311	1642	3794	2747	3113	4470	4000	3077	3667	2592	2269
3948_1p deletion neuroblastoma	3948_1p deletion neuroblastoma	25	1313	1	1313	3818	1612	3579	3212	3324	4117	3099	3708	2758	2636
403_Amino acid::Tryptophan metabolism::C-glycosyltryptophan*	403_Amino acid::Tryptophan metabolism::C-glycosyltryptophan*	25	1313	1	2910	2523	2516	4043	4162	4608	1969	1313	1849	2328	1799
4278_FEV1	4278_FEV1	25	1316	1	3302	2878	1316	3032	4298	4140	1981	4328	3737	4572	1661
1592_Log ADP platelet aggregation (at exam 5, FBAT, adjusted for multivariable)	1592_Log ADP platelet aggregation (at exam 5, FBAT, adjusted for multivariable)	25	1316	1	3389	3991	2910	3723	1792	1316	3025	2950	3216	3788	3308
2636_NPPB - Brain natriuretic peptide 32	2636_NPPB - Brain natriuretic peptide 32	25	1317	1	1317	1925	3904	3955	3097	2160	2141	3885	1508	1461	4357
619_Xenobiotics::Chemical::glycerol 2-phosphate	619_Xenobiotics::Chemical::glycerol 2-phosphate	25	1317	1	3914	2108	1775	3502	4359	3546	1317	2922	1349	3940	2970
4078_Waist-hip ratio (male)	4078_Waist-hip ratio (male)	25	1317	1	1887	1778	1884	4686	1943	3625	2937	1317	3834	2331	2185
163_Hip circumference (male, adjusted for BMI)	163_Hip circumference (male, adjusted for BMI)	25	1317	1	2987	3235	2368	4140	1939	2757	4258	3777	1949	2129	1317
3100_UNC5D - Netrin receptor UNC5D	3100_UNC5D - Netrin receptor UNC5D	25	1319	1	3834	2980	2787	2389	1952	1603	1319	3926	3460	1543	3877
509_Lipid::Glycerolipid metabolism::glycerophosphorylcholine (GPC)	509_Lipid::Glycerolipid metabolism::glycerophosphorylcholine (GPC)	25	1322	1	1465	1333	4091	2246	2281	3019	4368	1322	4066	3499	4082
2889_KYNU - Kynureninase	2889_KYNU - Kynureninase	25	1325	1	4490	2447	2449	3028	3346	2279	2520	4526	1847	1325	2757
3894_Neutrophil percentage of granulocytes (three-way meta)	3894_Neutrophil percentage of granulocytes (three-way meta)	25	1329	1	1329	4529	2836	3678	3141	4239	2802	1655	2682	3150	4025
2433_CFC1 - Cryptic protein	2433_CFC1 - Cryptic protein	25	1329	1	2873	3775	2228	2020	1464	4505	3525	1489	1533	1738	1329
1057_Major depressive disorder	1057_Major depressive disorder	25	1330	1	3737	4465	1330	3143	2973	4443	1704	4233	2458	3355	4244
2916_FAM107B - Protein FAM107B	2916_FAM107B - Protein FAM107B	25	1330	1	3167	4687	2441	1330	3193	3135	3232	3129	4351	3554	4095
2357_IGHM IGJ IGK@ IGL@ - Immunoglobulin M	2357_IGHM IGJ IGK@ IGL@ - Immunoglobulin M	25	1330	1	2192	2541	2939	2129	2666	3766	1524	1330	1603	2248	4373
1272_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI and usual sleep duration)	1272_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI and usual sleep duration)	25	1331	1	4738	3089	2899	4419	1331	1988	4130	3657	4444	1561	2871
2980_C1QBP - Complement component 1 Q subcomponent-binding protein, mitochondrial	2980_C1QBP - Complement component 1 Q subcomponent-binding protein, mitochondrial	25	1332	1	3693	1639	4383	3115	1382	3811	2180	3547	4571	2864	1332
2666_FGR - Tyrosine-protein kinase Fgr	2666_FGR - Tyrosine-protein kinase Fgr	25	1335	1	3184	1335	2026	2305	2356	2304	3233	2273	2908	1637	4077
3981_25-Hydroxyvitamin D level	3981_25-Hydroxyvitamin D level	25	1337	1	2020	3881	4540	2721	3858	2602	1337	3118	1386	4655	2330
805_::::X-12816	805_::::X-12816	25	1338	1	1338	4040	4633	3607	4521	2454	3191	2132	3006	1370	3155
4342_Moderate intesity (conditioning sex and BMI)	4342_Moderate intesity (conditioning sex and BMI)	25	1338	1	3025	3968	4010	4503	2154	4127	4594	2972	2605	1338	2297
3071_SCARB2 - Lysosome membrane protein 2	3071_SCARB2 - Lysosome membrane protein 2	25	1338	1	2147	4272	3080	3017	2292	2208	3390	1506	3965	1455	1338
2585_CTSE - Cathepsin E	2585_CTSE - Cathepsin E	25	1340	1	3966	1384	4326	2217	1340	4208	2684	1779	2360	3340	4463
1221_Mean Caudate	1221_Mean Caudate	25	1340	1	3825	2915	2016	3250	1896	1441	1340	3542	4050	1872	1361
3492_Coffee type: Decaffeinated coffee (any type)	3492_Coffee type: Decaffeinated coffee (any type)	25	1342	1	4464	4688	3268	1342	4546	3952	3768	2090	3879	1395	4341
675_::::X-08766	675_::::X-08766	25	1343	1	1693	2606	3448	4350	3189	2456	4337	1343	2196	4211	2616
3485_Bread type: White	3485_Bread type: White	25	1343	1	4534	4441	3001	3946	2801	2227	3873	2836	1343	4518	3258
527_Lipid::Long chain fatty acid::pentadecanoate (15:0)	527_Lipid::Long chain fatty acid::pentadecanoate (15:0)	25	1344	1	4302	4133	4219	1344	1444	2479	2549	2002	4312	3599	1933
1731_Chronic kidney disease (at exam 7, GEE, adjusted for age and sex)	1731_Chronic kidney disease (at exam 7, GEE, adjusted for age and sex)	25	1344	1	3553	2131	4331	2883	2865	1344	2705	2016	3160	3785	3543
1135_Eczema	1135_Eczema	25	1345	1	2385	3490	1345	4442	1498	1506	3021	3329	4381	3312	1428
299_CD4mem:%Th1* (2)	299_CD4mem:%Th1* (2)	25	1345	1	4186	2104	2884	1345	2396	1384	1375	3481	4723	2548	3469
553_Lipid::Medium chain fatty acid::10-undecenoate (11:1n1)	553_Lipid::Medium chain fatty acid::10-undecenoate (11:1n1)	25	1347	1	1772	2679	3577	2668	1347	3342	2872	3870	3042	1768	3845
2146_NTRK3 - NT-3 growth factor receptor	2146_NTRK3 - NT-3 growth factor receptor	25	1347	1	1813	1733	1562	1879	2435	4307	3152	3262	3543	1347	3290
4027_Alcohol dependency (full discovery samples)	4027_Alcohol dependency (full discovery samples)	25	1348	1	1749	4019	3553	1348	4427	2904	4531	3903	4621	3567	2912
1104_Low-density lipoprotein - Birth cohorts	1104_Low-density lipoprotein - Birth cohorts	25	1348	1	1483	2871	2020	1534	1612	1348	1350	1533	3588	2857	4512
2244_C5 - C5a anaphylatoxin	2244_C5 - C5a anaphylatoxin	25	1350	1	1615	4057	1986	3594	3476	4523	2638	1350	1735	1975	1826
3705_Diagnoses - secondary ICD10: Z51 Encounter for other aftercare	3705_Diagnoses - secondary ICD10: Z51 Encounter for other aftercare	25	1352	1	2435	1464	1352	3313	2829	2391	4364	3411	4389	1957	2337
1495_Remnant lipoprotein triglycerides (at exam 4, GEE)	1495_Remnant lipoprotein triglycerides (at exam 4, GEE)	25	1352	1	3123	2269	4316	1597	3918	1565	1897	1413	1352	3784	2164
2546_XPNPEP1 - Xaa-Pro aminopeptidase 1	2546_XPNPEP1 - Xaa-Pro aminopeptidase 1	25	1353	1	1667	1377	3061	3004	1353	4257	2645	2282	3975	2851	2972
4744_Fornix (cres) / Stria terminalis radial diusivities	4744_Fornix (cres) / Stria terminalis radial diusivities	25	1354	1	1859	4205	2524	1892	3640	1354	2435	3803	2747	4158	3742
2271_SERPINE1 - Plasminogen activator inhibitor 1	2271_SERPINE1 - Plasminogen activator inhibitor 1	25	1354	1	4454	3310	4706	3617	4487	3152	4698	3023	4601	1384	1354
4196_Hypertension	4196_Hypertension	25	1356	1	4291	3286	4071	2784	3815	2916	1649	3454	2101	3228	1356
840_::::X-14541	840_::::X-14541	25	1357	1	2665	4674	4307	1357	2134	1888	1992	1382	2620	1527	2894
2123_HMOX2 - Heme oxygenase 2	2123_HMOX2 - Heme oxygenase 2	25	1357	1	1899	3135	3768	1959	1357	4703	2388	4353	1536	3572	3170
3318_Weight change compared with 1 year ago	3318_Weight change compared with 1 year ago	25	1358	1	4551	1829	3298	2588	2987	1358	2583	1534	4206	3003	3528
1555_Mean common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1555_Mean common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	1359	1	2347	4450	4049	3437	1359	3661	2947	4180	2425	3181	4325
2851_SPHK2 - Sphingosine kinase 2	2851_SPHK2 - Sphingosine kinase 2	25	1360	1	2092	3548	1360	3093	3863	4408	4558	1379	4738	3447	4086
4618_Left lateral ventricle	4618_Left lateral ventricle	25	1362	1	1532	1362	1688	1929	3514	2257	1707	2570	3074	2734	3309
1945_Total cerebral brain volume (GEE, adjusted for multivariable with APOE)	1945_Total cerebral brain volume (GEE, adjusted for multivariable with APOE)	25	1365	1	1585	3922	2963	2471	1660	1365	1464	2723	2164	1643	3213
311_CD4nv:%R6+R4-	311_CD4nv:%R6+R4-	25	1367	1	4326	3299	1606	1367	1948	2501	4539	3684	4231	2449	4621
4294_Chronotype	4294_Chronotype	25	1367	1	3652	3026	1909	2267	4690	1367	2976	2010	4708	3899	3011
1059_Diabetic Nephropathy in Type 1 Diabetes	1059_Diabetic Nephropathy in Type 1 Diabetes	25	1368	1	1368	4067	3710	4502	3710	2302	3357	1541	3826	3247	4546
3362_Mother's age at death	3362_Mother's age at death	25	1368	1	4389	2836	2388	1368	3856	4412	3080	3236	4159	3130	2499
1196_Asthma (female)	1196_Asthma (female)	25	1368	1	4361	4038	4222	1964	1417	1368	2171	1836	2652	1935	2157
983_Interleukin-13	983_Interleukin-13	25	1368	1	2279	3382	4029	1985	2963	2158	3251	4409	3929	2752	1368
2364_ULBP1 - NKG2D ligand 1	2364_ULBP1 - NKG2D ligand 1	25	1370	1	3008	2291	3571	2282	3205	2590	1370	2378	1371	2420	2069
3004_HRG - Histidine-rich glycoprotein	3004_HRG - Histidine-rich glycoprotein	25	1371	1	3285	1614	3599	1371	2254	2378	3059	3602	1864	2957	3493
4067_Cognitive performance	4067_Cognitive performance	25	1371	1	2904	3280	3085	3570	4049	1371	3716	4501	1443	4385	3505
343_NKearly:%337+158b+	343_NKearly:%337+158b+	25	1375	1	4106	3596	3582	2087	2604	1375	3373	2104	4554	4706	1801
1995_Survival past average life expectancy (GEE, adjusted for birth-cohort)	1995_Survival past average life expectancy (GEE, adjusted for birth-cohort)	25	1386	1	2717	3139	1721	3793	2209	4746	2970	2817	4478	1386	1514
4219_Vasodilators used in cardiac diseases	4219_Vasodilators used in cardiac diseases	25	1387	1	2808	1387	4363	3582	3001	1810	2409	2229	3432	4589	2855
4404_Menstrual quality of life impact: Nervousness	4404_Menstrual quality of life impact: Nervousness	25	1387	1	4256	2953	3937	4373	4192	2507	3704	1387	4549	2669	3682
1637_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for multivariable)	1637_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for multivariable)	25	1389	1	2634	2153	1389	1586	2518	2697	3799	3527	3835	1747	1866
424_Amino acid::Valine, leucine and isoleucine metabolism::4-methyl-2-oxopentanoate	424_Amino acid::Valine, leucine and isoleucine metabolism::4-methyl-2-oxopentanoate	25	1390	1	4744	1390	2680	3966	2087	3255	2661	2631	2279	4075	3263
3189_Number of self-reported cancers	3189_Number of self-reported cancers	25	1390	1	4148	4012	1729	1447	2871	4139	4712	1857	3741	3900	1390
2145_TNFRSF1A - Tumor necrosis factor receptor superfamily member 1A	2145_TNFRSF1A - Tumor necrosis factor receptor superfamily member 1A	25	1391	1	4180	4068	3395	2507	4525	1391	3668	3053	4447	3422	3190
2985_BIRC3 - Baculoviral IAP repeat-containing protein 3	2985_BIRC3 - Baculoviral IAP repeat-containing protein 3	25	1392	1	3305	2440	1392	2742	1668	2948	4177	4377	3176	2435	3627
259_CD8:%TM-like	259_CD8:%TM-like	25	1392	1	3586	3987	3166	1947	4032	4490	4467	1392	3983	3021	1862
2543_NTRK1 - High affinity nerve growth factor receptor	2543_NTRK1 - High affinity nerve growth factor receptor	25	1393	1	4513	4257	4348	4217	1959	3562	1393	2983	1617	3823	4224
2230_KLK4 - Kallikrein-4	2230_KLK4 - Kallikrein-4	25	1393	1	2647	3750	2594	1434	1912	3240	2174	3472	2499	1393	2547
3957_Antisocial behavior	3957_Antisocial behavior	25	1395	1	2519	3726	3451	3724	1395	2215	3549	4570	1728	3828	2659
2316_NCR3 - Natural cytotoxicity triggering receptor 3	2316_NCR3 - Natural cytotoxicity triggering receptor 3	25	1398	1	3538	3603	4136	3633	4331	2755	4526	2655	4344	4278	1398
4430_Varicella Zoster Virus IgG levels	4430_Varicella Zoster Virus IgG levels	25	1399	1	4192	1508	2381	4445	1399	4626	3607	4081	4714	4693	3858
4603_Right superior parietal	4603_Right superior parietal	25	1400	1	4311	2357	3144	2819	3561	1400	4176	3586	3991	3728	4124
2308_IL1R1 - Interleukin-1 receptor type 1	2308_IL1R1 - Interleukin-1 receptor type 1	25	1401	1	3882	2789	2063	1808	2538	1696	1401	3719	1995	4457	2796
3523_Current employment status: Doing unpaid or voluntary work	3523_Current employment status: Doing unpaid or voluntary work	25	1402	1	1729	3249	3929	1402	3853	2168	4059	3529	3070	4288	2306
3675_Diagnoses - main ICD10: K80 Cholelithiasis	3675_Diagnoses - main ICD10: K80 Cholelithiasis	25	1403	1	1403	3591	4358	3790	2141	2352	3609	2762	2887	2636	4519
356_IgG+B:%20+24+27+	356_IgG+B:%20+24+27+	25	1403	1	2896	3493	3228	1403	2710	3598	4304	2385	3261	4306	4610
3015_MSN - Moesin	3015_MSN - Moesin	25	1403	1	4196	2761	3014	3043	4514	4468	1841	1403	1885	2436	4248
1487_Mean triglycerides from exam 1-7 (GEE, adjusted for age and sex)	1487_Mean triglycerides from exam 1-7 (GEE, adjusted for age and sex)	25	1404	1	1423	4143	3647	1966	2490	1807	2229	2342	1404	3022	3925
1120_Pericardial adipose tissue volume (adjusted for height and weight)	1120_Pericardial adipose tissue volume (adjusted for height and weight)	25	1405	1	4537	3371	3240	4380	4315	1745	1405	4149	4036	2006	4389
3612_Treatment/medication code: ramipril	3612_Treatment/medication code: ramipril	25	1409	1	1409	4320	2239	4096	2935	4021	4690	3880	2393	3351	2379
20_Number of cigarettes smoked per day	20_Number of cigarettes smoked per day	25	1410	1	1802	2581	3195	3001	1712	2310	1410	4110	4391	4371	2710
1878_Shaft cross-sectional moment of inertia (FBAT, adjussted for multivariable)	1878_Shaft cross-sectional moment of inertia (FBAT, adjussted for multivariable)	25	1411	1	1411	3823	1426	3584	4667	4643	3754	2156	1580	2551	1959
3181_SPOCK1 - Testican-1	3181_SPOCK1 - Testican-1	25	1418	1	2190	1722	2719	4095	2536	1418	3250	2859	1914	4065	4630
1106_Triglycerides - Birth cohorts	1106_Triglycerides - Birth cohorts	25	1420	1	3075	2818	3806	4132	3187	1420	4093	2298	4736	2063	4732
1408_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for age and sex)	1408_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	1422	1	4671	4252	1540	1942	1850	3054	4288	1422	1509	4079	1664
1338_HOMA-IR (at exam 7, FBAT, adjusted for age, sex and BMI)	1338_HOMA-IR (at exam 7, FBAT, adjusted for age, sex and BMI)	25	1422	1	3792	1967	2810	2183	2930	4040	1830	1433	1422	3633	3806
4646_Total brain volume	4646_Total brain volume	25	1425	1	1425	1664	4505	3653	4466	1922	4538	4077	2104	1483	4565
2870_CLEC11A - Stem Cell Growth Factor-alpha	2870_CLEC11A - Stem Cell Growth Factor-alpha	25	1425	1	2590	2579	2589	1425	4638	4413	3473	3416	3675	3503	4228
3785_Intelligence	3785_Intelligence	25	1425	1	1451	2948	2953	3130	2908	1556	3333	3812	2884	1425	1874
1176_Excessive daytime sleepness (male)	1176_Excessive daytime sleepness (male)	25	1426	1	2805	1426	4128	2070	1888	2429	4091	2877	1951	2786	3130
3950_Amyotrophic lateral sclerosis (logistic)	3950_Amyotrophic lateral sclerosis (logistic)	25	1426	1	3931	2996	2482	1733	3488	4665	3602	2915	1426	2581	4293
393_Amino acid::Phenylalanine & tyrosine metabolism::3-methoxytyrosine	393_Amino acid::Phenylalanine & tyrosine metabolism::3-methoxytyrosine	25	1427	1	4367	4531	2138	1869	4402	2556	1427	3592	3898	2799	3656
1746_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for multivariable)	1746_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for multivariable)	25	1428	1	4666	3270	2338	2409	2770	1948	1428	3968	2809	3170	2735
1133_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, male)	1133_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, male)	25	1428	1	2349	1910	4253	4491	3123	4525	4505	1428	4585	2880	4362
726_Amino acid::Cysteine, methionine, SAM, taurine metabolism::X-11786--methylcysteine	726_Amino acid::Cysteine, methionine, SAM, taurine metabolism::X-11786--methylcysteine	25	1431	1	2167	2003	2508	3448	4070	3531	4294	1431	3509	3455	2442
2062_CCL27 - C-C motif chemokine 27	2062_CCL27 - C-C motif chemokine 27	25	1435	1	4009	2333	2498	2602	1435	2297	3361	2054	4634	4642	1768
2261_C7 - Complement component C7	2261_C7 - Complement component C7	25	1435	1	3607	1493	3720	4339	4248	4696	1435	3739	4695	4116	1680
656_::::X-03088	656_::::X-03088	25	1436	1	2141	2603	1814	1436	2524	4631	3855	2572	4449	3649	2610
450_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,Z or Z,E)*	450_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,Z or Z,E)*	25	1436	1	2496	3378	3455	1566	2487	4620	1436	3971	4645	4114	3881
2173_IL37 - Interleukin-37	2173_IL37 - Interleukin-37	25	1436	1	3940	4176	2528	4143	4259	1564	2664	1874	2592	1436	3734
2342_RETN - Resistin	2342_RETN - Resistin	25	1438	1	1438	3277	3552	2753	2084	2969	2618	4639	4055	2003	3747
1243_Mean FEV1 from exam 3 and 5 (GEE, adjusted for multiple covariates)	1243_Mean FEV1 from exam 3 and 5 (GEE, adjusted for multiple covariates)	25	1439	1	3699	3385	4305	1439	4434	4441	4189	2746	3030	2801	2254
1654_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for age and sex)	1654_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for age and sex)	25	1439	1	4463	3130	4519	4068	2782	3807	3826	3950	1439	4364	1476
631_Xenobiotics::Food component, Plant::homostachydrine*	631_Xenobiotics::Food component, Plant::homostachydrine*	25	1442	1	3234	1494	4244	1442	3968	3132	3832	2313	1560	4416	3838
2004_Primary biliary cirrhosis	2004_Primary biliary cirrhosis	25	1443	1	1841	2315	3748	1951	3257	1596	3711	4522	3260	1443	3577
3447_Impedance measures - Impedance of whole body	3447_Impedance measures - Impedance of whole body	25	1445	1	1445	2064	2951	2944	4297	2225	3870	2679	2659	4323	2280
1578_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	1578_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	25	1447	1	4505	4428	3756	2180	1447	2226	3926	3864	2644	4298	2005
2215_APOB - Apolipoprotein B	2215_APOB - Apolipoprotein B	25	1447	1	2214	2435	3034	3784	4545	1447	3202	3114	3984	2848	1518
3718_Amount of alcohol drunk on a typical drinking day	3718_Amount of alcohol drunk on a typical drinking day	25	1448	1	1448	4222	4494	2547	2514	2712	4654	2052	2327	1884	4001
3157_MIF - Macrophage migration inhibitory factor	3157_MIF - Macrophage migration inhibitory factor	25	1448	1	4409	2519	3580	4316	3825	3540	1622	1482	1448	4216	3098
429_Amino acid::Valine, leucine and isoleucine metabolism::isoleucine	429_Amino acid::Valine, leucine and isoleucine metabolism::isoleucine	25	1450	1	2693	3427	2040	1450	2454	4009	4524	3858	3100	2820	4615
1331_Insulin sensitivity (GEE, adjusted for age, sex and BMI)	1331_Insulin sensitivity (GEE, adjusted for age, sex and BMI)	25	1450	1	2955	3686	2418	3689	1450	2478	1595	4252	2131	2490	3431
1657_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for multivariable)	1657_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for multivariable)	25	1452	1	1452	3177	3857	1459	3735	4064	3043	2006	2779	2434	2470
821_::::X-13496	821_::::X-13496	25	1453	1	4059	4101	3223	3768	3090	4465	3956	2223	4080	4383	1453
3839_Eosinophil percentage of white cells (two-way meta)	3839_Eosinophil percentage of white cells (two-way meta)	25	1456	1	1456	3266	2198	3730	4052	3174	2931	2086	4248	3639	4651
437_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannitol	437_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannitol	25	1456	1	4731	1456	3788	4382	3563	1757	1624	3419	4415	3877	4083
3175_IL17RC - Interleukin-17 receptor C	3175_IL17RC - Interleukin-17 receptor C	25	1457	1	1457	3733	2862	2157	2528	3474	2857	4423	2748	4349	4064
3021_PARK7 - Protein DJ-1	3021_PARK7 - Protein DJ-1	25	1459	1	2650	4214	1459	1906	2060	4469	3835	2349	3038	4443	2647
1222_Mean Hippocampus	1222_Mean Hippocampus	25	1462	1	2172	2558	3860	2783	4343	1731	3245	1986	3068	1462	3253
2324_FGF2 - Fibroblast growth factor 2	2324_FGF2 - Fibroblast growth factor 2	25	1465	1	2221	4118	2549	3818	1465	3941	3141	2241	3150	3536	3705
1744_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for age and sex)	1744_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for age and sex)	25	1465	1	3957	4446	2345	3134	2593	1465	2906	3461	2473	2224	1999
37_Loneliness (case/control)	37_Loneliness (case/control)	25	1466	1	3571	2168	2519	3821	1466	4641	2592	3227	3601	1628	4267
3239_Exposure to tobacco smoke outside home	3239_Exposure to tobacco smoke outside home	25	1468	1	1468	3386	3739	4067	3601	2973	3847	2566	4119	4391	3215
4638_Right pallidum	4638_Right pallidum	25	1469	1	3136	3606	3321	4261	2147	2574	4733	1469	2631	3491	4150
2684_AIP - AH receptor-interacting protein	2684_AIP - AH receptor-interacting protein	25	1470	1	1470	4417	3512	2258	1501	1762	1472	2208	4355	4713	1541
64_Insulin sensitivity index (adjusted for age, sex)	64_Insulin sensitivity index (adjusted for age, sex)	25	1473	1	3700	3769	1473	2287	4699	2411	2532	3113	4032	3305	2968
3209_Duration of vigorous activity	3209_Duration of vigorous activity	25	1474	1	3801	4315	1474	4468	4475	2982	4504	2824	3590	2817	4006
2623_IGF2R - Cation-independent mannose-6-phosphate receptor	2623_IGF2R - Cation-independent mannose-6-phosphate receptor	25	1476	1	3029	3085	1476	1804	4412	4165	2619	3635	2850	3331	2502
2106_VEGFA - Vascular endothelial growth factor A	2106_VEGFA - Vascular endothelial growth factor A	25	1479	1	1919	1874	2372	2361	1720	3708	1479	3892	3674	2747	2881
294_CD4mem:%Th1* (1)	294_CD4mem:%Th1* (1)	25	1481	1	1481	4496	3173	4176	2912	3292	1942	3277	4175	3222	4584
233_Lymph:%T	233_Lymph:%T	25	1484	1	2031	3611	3054	3101	3055	4485	1484	2399	3915	4249	4253
2408_MATN3 - Matrilin-3	2408_MATN3 - Matrilin-3	25	1485	1	1960	3663	3393	2785	1485	3465	4362	3321	2117	1599	3141
4192_QRS interval	4192_QRS interval	25	1486	1	3019	3404	3004	1705	4444	2651	2204	2047	1723	1486	4050
2653_ANGPTL4 - Angiopoietin-related protein 4	2653_ANGPTL4 - Angiopoietin-related protein 4	25	1487	1	2774	3040	2944	3409	3848	1487	3846	2757	4437	4533	1917
4695_Cingulum (cingulate gyrus) mean diusivities	4695_Cingulum (cingulate gyrus) mean diusivities	25	1488	1	1488	4321	3209	2693	3633	4289	3672	3593	1654	1797	4330
1320_Adiponectin (FBAT, adjusted for age, sex and BMI)	1320_Adiponectin (FBAT, adjusted for age, sex and BMI)	25	1490	1	1925	4418	1490	4708	1774	2400	3669	3630	4358	2256	2013
331_NKeff:%Act(314+)	331_NKeff:%Act(314+)	25	1490	1	2088	3998	4075	4429	3084	4432	4423	1490	3895	2945	3677
472_Lipid::Bile acid metabolism::taurodeoxycholate	472_Lipid::Bile acid metabolism::taurodeoxycholate	25	1492	1	2027	3284	4132	2731	4493	4421	4730	4663	1492	2157	3125
704_::::X-11441	704_::::X-11441	25	1493	1	1493	4288	4240	3116	2929	4591	3279	4105	3482	4201	3270
3150_CPNE1 - Copine-1	3150_CPNE1 - Copine-1	25	1493	1	4422	3584	1493	3602	3315	1815	4372	3120	2763	2710	2818
1498_Triglycerides (at exam 1, FBAT, adjusted for age and sex)	1498_Triglycerides (at exam 1, FBAT, adjusted for age and sex)	25	1494	1	2541	3877	4359	2342	3445	1855	3598	1494	4319	4661	3624
1141_Chronotype	1141_Chronotype	25	1498	1	1895	4007	1498	1695	4075	2062	3027	2120	2738	2599	1803
290_CD4:%Act(DR+)	290_CD4:%Act(DR+)	25	1506	1	3101	2848	3712	3293	2117	4144	1506	2657	4390	1567	3214
3360_Hearing aid user	3360_Hearing aid user	25	1507	1	2196	1894	2443	2638	2118	3547	1507	2094	2854	3332	1625
1706_Luteinizing hormone (at exam 3, FBAT, adjusted for age and sex)	1706_Luteinizing hormone (at exam 3, FBAT, adjusted for age and sex)	25	1508	1	3038	2213	3367	3393	3409	1508	2868	1993	1687	2151	2768
540_Lipid::Lysolipid::1-oleoylglycerophosphocholine	540_Lipid::Lysolipid::1-oleoylglycerophosphocholine	25	1511	1	2529	4077	4086	3310	2896	1794	3575	4642	2359	1511	3700
2841_GREM1 - Gremlin-1	2841_GREM1 - Gremlin-1	25	1512	1	1687	2171	2771	3828	2097	3506	3759	4042	3587	3445	1512
2073_FGFR1 - Fibroblast growth factor receptor 1	2073_FGFR1 - Fibroblast growth factor receptor 1	25	1513	1	3154	2028	2830	3443	2388	1612	2835	2480	1513	2240	1737
1241_Rate of decline of FEV1 (GEE, adjusted for multiple covariates)	1241_Rate of decline of FEV1 (GEE, adjusted for multiple covariates)	25	1519	1	1866	3923	1519	3419	2274	1883	1973	2152	2078	3903	2500
3711_Diagnoses - secondary ICD10: Z86 Personal history of certain other diseases	3711_Diagnoses - secondary ICD10: Z86 Personal history of certain other diseases	25	1519	1	3400	3412	3874	4333	1519	2403	4474	4732	4039	2993	4004
1299_Fasting plasma glucose (at exam 5, GEE, adjusted for age and sex)	1299_Fasting plasma glucose (at exam 5, GEE, adjusted for age and sex)	24	1519	1	1786	3792	1675	4135	1658	1519	4070	2794	4332	2041	2319
3766_Depression - Recent thoughts of suicide or self-harm	3766_Depression - Recent thoughts of suicide or self-harm	25	1520	1	4519	2683	1920	2411	3101	2430	3479	3973	2725	1651	1520
2799_PSMA2 - Proteasome subunit alpha type-2	2799_PSMA2 - Proteasome subunit alpha type-2	25	1523	1	1523	2833	2227	3010	1915	3035	2491	4737	2258	2303	4288
2012_Remission following 8-week treatment of MDD subjects	2012_Remission following 8-week treatment of MDD subjects	25	1526	1	3500	2858	3199	1526	4630	4008	2843	3084	1568	1856	2478
4594_Right pars triangularis	4594_Right pars triangularis	25	1526	1	4499	3109	1816	4113	4311	1526	3079	4124	4743	3584	3094
1665_Alanine transaminase (at exam 2, GEE, adjusted for multivariable)	1665_Alanine transaminase (at exam 2, GEE, adjusted for multivariable)	25	1528	1	2643	3828	4538	1771	4294	2402	1528	3286	1781	4504	2939
3770_Depression - Trouble falling or staying asleep. or sleeping too much	3770_Depression - Trouble falling or staying asleep. or sleeping too much	25	1529	1	2757	1620	3345	4089	3260	3158	4379	2245	1529	2218	3690
3752_Traumatic events - Felt distant from other people in past month	3752_Traumatic events - Felt distant from other people in past month	25	1529	1	4507	4744	2824	3296	2642	3040	1795	2341	2923	3470	1529
3964_Gestational weight gain (offspring, early)	3964_Gestational weight gain (offspring, early)	25	1531	1	4706	4516	4406	3841	3704	3239	3186	1531	2144	2951	3460
3802_Mean erythrocyte cell volume	3802_Mean erythrocyte cell volume	25	1532	1	4607	4522	1532	3885	4613	2026	4278	2985	3298	3679	3088
644_Xenobiotics::Xanthine metabolism::3-methylxanthine	644_Xenobiotics::Xanthine metabolism::3-methylxanthine	25	1532	1	2870	2021	4016	3583	3468	1677	3247	4555	1532	2163	3328
1349_Plasma Apolipoprotein B level (GEE, multivariate adjusted)	1349_Plasma Apolipoprotein B level (GEE, multivariate adjusted)	25	1534	1	4346	3632	3683	4495	1534	1590	3221	4090	3968	3889	3744
3092_SCARF1 - Scavenger receptor class F member 1	3092_SCARF1 - Scavenger receptor class F member 1	25	1534	1	2737	3042	2379	4712	2632	1874	3981	4410	2449	1534	2232
2779_HSPA8 - Heat shock cognate 71 kDa protein	2779_HSPA8 - Heat shock cognate 71 kDa protein	25	1536	1	4121	2373	1536	4121	4540	3668	1583	2428	3981	1810	1603
4420_Influenza A seropositivity	4420_Influenza A seropositivity	25	1536	1	2052	2441	4325	3281	3973	1536	3217	4217	4063	3017	4126
2439_DLL4 - Delta-like protein 4	2439_DLL4 - Delta-like protein 4	25	1536	1	3209	1686	4051	1984	4703	3710	2611	1748	1670	1536	4327
1183_Sleep duration (female)	1183_Sleep duration (female)	25	1537	1	3371	3052	1837	2927	2106	2494	1537	3216	2663	2177	4070
3226_Difference in mobile phone use compared to two years previously	3226_Difference in mobile phone use compared to two years previously	25	1543	1	4516	3504	4443	2805	1543	4714	3936	2033	1941	2971	3574
4647_Anterior corona radiata fractional anisotropy	4647_Anterior corona radiata fractional anisotropy	25	1545	1	4184	3569	4297	4036	3177	1709	1545	3438	3656	2760	3704
4238_Antiglaucoma preparations and miotics	4238_Antiglaucoma preparations and miotics	25	1546	1	2565	1546	3749	2749	4168	1610	2597	3993	3473	4644	4188
518_Lipid::Long chain fatty acid::dihomo-linoleate (20:2n6)	518_Lipid::Long chain fatty acid::dihomo-linoleate (20:2n6)	25	1547	1	1556	1648	1547	3058	1802	2952	3140	4420	3602	1994	4179
2101_CCL2 - C-C motif chemokine 2	2101_CCL2 - C-C motif chemokine 2	25	1548	1	1548	2627	1773	2430	3567	3699	3833	4292	4372	2904	2827
57_Educational attainment	57_Educational attainment	25	1549	1	1549	4220	2814	3692	3491	3301	3762	2171	3630	3287	2842
1461_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1461_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	1550	1	3297	4557	1550	2099	3125	1887	3943	2707	3134	3401	2476
3109_CSNK2A1 CSNK2B - Casein kinase II 2-alpha:2-beta heterotetramer	3109_CSNK2A1 CSNK2B - Casein kinase II 2-alpha:2-beta heterotetramer	25	1551	1	1558	2110	2506	1551	3208	3081	1657	1812	2678	2377	2129
3777_Traumatic events - Diagnosed with life-threatening illness	3777_Traumatic events - Diagnosed with life-threatening illness	25	1553	1	4340	4308	3463	4467	3507	1879	4149	2581	1553	3733	2284
4043_Height	4043_Height	25	1553	1	2017	4156	4472	2743	3015	2533	3987	2747	3527	2124	1553
1953_Boston Naming Test score without cues (GEE, adjusted for multivariable)	1953_Boston Naming Test score without cues (GEE, adjusted for multivariable)	25	1561	1	2463	2712	3695	3711	4614	2616	2896	3678	2136	1771	1561
1545_White matter hyperintensity volume (GEE, adjusted for multivariable)	1545_White matter hyperintensity volume (GEE, adjusted for multivariable)	25	1562	1	3191	2951	1588	3771	1665	1562	4310	4407	1955	2455	3593
2256_TBP - TATA-box-binding protein	2256_TBP - TATA-box-binding protein	25	1562	1	2895	3742	2584	4659	3269	4462	4126	4624	1562	2800	2250
1543_White matter hyperintensity volume (GEE, adjusted for age and sex)	1543_White matter hyperintensity volume (GEE, adjusted for age and sex)	25	1564	1	3478	3031	1736	3507	1564	2179	3190	3822	4659	4083	3265
1279_Sabuctaneous fat by CT (GEE, adjusted for age, sex, smoking and menopause)	1279_Sabuctaneous fat by CT (GEE, adjusted for age, sex, smoking and menopause)	25	1566	1	3186	1566	4176	4019	3963	2537	3290	4544	2542	3068	3198
3780_Depression - Did your sleep change?	3780_Depression - Did your sleep change?	25	1567	1	3706	1661	3600	3213	2107	2489	2536	2586	1567	3973	4381
4756_Uncinate fasciculus radial diusivities	4756_Uncinate fasciculus radial diusivities	25	1569	1	1658	4586	4676	4527	2019	2558	3386	2753	4676	4309	1569
238_CD27 on IgA+B	238_CD27 on IgA+B	25	1572	1	1754	3112	1657	3794	2234	4393	1572	1636	4166	3114	2519
1161_Fasting insulin interaction (adjusted for BMI)	1161_Fasting insulin interaction (adjusted for BMI)	25	1573	1	4682	3061	2593	3388	1573	4667	4238	2398	2462	4476	3926
3154_TNFRSF14 - Tumor necrosis factor receptor superfamily member 14	3154_TNFRSF14 - Tumor necrosis factor receptor superfamily member 14	25	1575	1	1575	4146	4468	1701	2714	2063	4080	3908	1901	3471	2348
454_Cofactors and vitamins::Pantothenate and CoA metabolism::pantothenate	454_Cofactors and vitamins::Pantothenate and CoA metabolism::pantothenate	25	1579	1	1840	2778	2717	4317	1579	3928	3214	3978	3635	1819	4526
2421_CCDC80 - Coiled-coil domain-containing protein 80	2421_CCDC80 - Coiled-coil domain-containing protein 80	25	1579	1	3407	3298	3220	2569	2133	2274	1579	2673	2052	4283	1598
3771_Depression - Recent changes in speed/amount of moving or speaking	3771_Depression - Recent changes in speed/amount of moving or speaking	25	1582	1	2111	2128	2722	4673	4737	4054	3429	1582	3687	4010	4190
128_Hip circumference (male)	128_Hip circumference (male)	25	1584	1	4114	3063	3808	4062	4608	3556	2393	3028	1854	2836	1584
612_Xenobiotics::Benzoate metabolism::2-hydroxyhippurate (salicylurate)	612_Xenobiotics::Benzoate metabolism::2-hydroxyhippurate (salicylurate)	25	1591	1	1591	4120	2927	4376	4406	3266	4193	4698	2493	4296	4191
330_CD4mem:%R6+	330_CD4mem:%R6+	25	1594	1	3683	3628	1594	2018	3997	1670	2316	4744	3265	4692	3128
757_Amino acid::Tryptophan metabolism::X-12100--hydroxytryptophan*	757_Amino acid::Tryptophan metabolism::X-12100--hydroxytryptophan*	25	1599	1	2946	2280	1641	4602	3159	1675	3423	1599	2786	1803	3212
473_Lipid::Bile acid metabolism::taurolithocholate 3-sulfate	473_Lipid::Bile acid metabolism::taurolithocholate 3-sulfate	25	1604	1	1931	3938	2340	1604	3912	3658	3734	1984	3305	1690	3874
2960_IGHD  IGK@ IGL@ - Immunoglobulin D	2960_IGHD  IGK@ IGL@ - Immunoglobulin D	25	1606	1	1743	1606	3897	4231	3578	4449	2859	3498	4741	2101	4197
4402_Menstruation quality of life impact: Joint pina	4402_Menstruation quality of life impact: Joint pina	25	1606	1	3561	3084	4031	3638	1606	3360	3751	2039	2961	3966	3452
3431_Fluid intelligence test - Fluid intelligence score	3431_Fluid intelligence test - Fluid intelligence score	25	1606	1	4035	4115	4324	2452	2445	2410	2427	2854	2026	3000	1606
1418_High-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	1418_High-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	25	1608	1	4419	1699	4485	2172	2180	4706	2743	3174	4608	1608	1749
1112_Visceral sdipose tissue volume (male)	1112_Visceral sdipose tissue volume (male)	25	1611	1	4571	3176	4724	3618	3988	4160	3701	1611	4416	3306	2673
4176_Type 2 Diabetes	4176_Type 2 Diabetes	25	1612	1	3397	4152	2688	2841	3828	4002	3066	4592	4745	1612	3642
427_Amino acid::Valine, leucine and isoleucine metabolism::hydroxyisovaleroyl carnitine	427_Amino acid::Valine, leucine and isoleucine metabolism::hydroxyisovaleroyl carnitine	25	1613	1	3329	1613	4346	2644	3631	3162	3569	2605	3661	3234	3939
3975_Total body BMD (15-30 years old)	3975_Total body BMD (15-30 years old)	25	1616	1	1939	4583	3052	1755	3762	4588	3419	3662	1616	3166	3946
4373_Free thyroxine (FT4, male)	4373_Free thyroxine (FT4, male)	25	1617	1	4343	2468	4418	1854	1964	2718	1933	1617	2749	3712	4703
563_Lipid::Monoacylglycerol::1-oleoylglycerol (1-monoolein)	563_Lipid::Monoacylglycerol::1-oleoylglycerol (1-monoolein)	25	1620	1	4558	3534	4642	3892	2300	1620	2962	2579	2762	2400	2546
1076_Pancreatic cancer	1076_Pancreatic cancer	25	1621	1	4618	4585	4262	1829	2442	1621	2669	2705	4567	1787	1778
755_::::X-12094	755_::::X-12094	25	1622	1	1622	3020	4553	4366	4387	3261	2352	4430	3328	2196	2932
1277_Sabuctaneous fat by CT (GEE, adjusted for age and sex)	1277_Sabuctaneous fat by CT (GEE, adjusted for age and sex)	25	1623	1	4631	1737	2460	2011	3643	2347	4666	3306	1623	2707	3182
2486_KLK7 - Kallikrein-7	2486_KLK7 - Kallikrein-7	25	1630	1	1630	4339	4068	3217	2017	3423	2090	2409	4617	3490	4467
1523_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	1523_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	25	1632	1	2151	4502	4452	4513	1632	2265	3804	2062	4542	3642	3304
2918_SERPINA6 - Corticosteroid-binding globulin	2918_SERPINA6 - Corticosteroid-binding globulin	25	1633	1	1672	3455	3139	1633	2550	4709	2596	3451	2901	1693	2907
3093_SCARF2 - Scavenger receptor class F member 2	3093_SCARF2 - Scavenger receptor class F member 2	25	1633	1	3073	3665	3184	4253	1633	2593	4266	1781	2334	3173	2101
3636_Illnesses of father: Severe depression	3636_Illnesses of father: Severe depression	25	1637	1	2121	2485	1637	2595	3766	1985	4543	3290	3246	3277	3207
3703_Diagnoses - secondary ICD10: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	3703_Diagnoses - secondary ICD10: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	25	1637	1	2776	2261	3587	2717	2052	3273	4053	1637	3762	4562	3089
2538_SELE - E-Selectin	2538_SELE - E-Selectin	25	1639	1	2547	3930	2732	3849	4622	1639	2439	1752	2969	3605	4521
2651_TEK - Angiopoietin-1 receptor, soluble	2651_TEK - Angiopoietin-1 receptor, soluble	25	1642	1	3292	4087	4355	2214	1642	3405	2021	3579	1761	4144	2711
1557_Mean common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1557_Mean common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	1647	1	1647	3848	3946	2474	1786	2305	2952	2020	1751	1951	2335
498_Lipid::Fatty acid, dicarboxylate::3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF)	498_Lipid::Fatty acid, dicarboxylate::3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF)	25	1647	1	2283	2082	1969	3177	3805	2938	1647	3531	1895	4277	2897
3262_Average weekly red wine intake	3262_Average weekly red wine intake	25	1655	1	3017	2232	4665	1716	4301	2376	1917	3180	1655	4684	3714
337_NKeff:%Kir+ (2)	337_NKeff:%Kir+ (2)	25	1659	1	2030	4142	3060	3126	3837	3549	2909	3388	1659	3084	3194
3790_Daytime sleepiness / dozing	3790_Daytime sleepiness / dozing	25	1661	1	3795	4589	1661	4265	4668	3632	3646	2372	4672	2544	4045
3165_LEPR - Leptin receptor	3165_LEPR - Leptin receptor	25	1662	1	2150	1662	3861	4671	4285	3986	3148	2732	4274	3796	4655
878_Histidine	878_Histidine	25	1665	1	2631	3028	4403	4147	2977	3576	2341	2823	4467	4599	1665
3067_KIR3DL2 - Killer cell immunoglobulin-like receptor 3DL2	3067_KIR3DL2 - Killer cell immunoglobulin-like receptor 3DL2	25	1671	1	2745	3205	2323	4369	4159	1671	2608	3070	3522	2723	2237
3066_KIR2DL4 - Killer cell immunoglobulin-like receptor 2DL4	3066_KIR2DL4 - Killer cell immunoglobulin-like receptor 2DL4	25	1671	1	3738	4576	4618	1822	4581	3070	2086	1671	4679	3981	3629
1239_Rate of decline FEF25-75 (GEE, adjusted for multiple covariates)	1239_Rate of decline FEF25-75 (GEE, adjusted for multiple covariates)	25	1672	1	4109	4148	4119	3682	1672	3760	4087	2876	3299	4015	1916
2744_IL7 - Interleukin-7	2744_IL7 - Interleukin-7	25	1673	1	1673	1732	2074	3625	2572	2218	3915	4553	3605	3112	2614
3837_Sum eosinophil basophil count (two-way meta)	3837_Sum eosinophil basophil count (two-way meta)	25	1684	1	2918	3263	3994	1684	3628	4451	4097	2075	3883	2960	3096
4062_Urinary albumin-to-creatinine ratio	4062_Urinary albumin-to-creatinine ratio	25	1688	1	2705	3974	2639	1688	1960	3796	3700	1697	2885	3005	4554
3643_Illnesses of mother: Chronic bronchitis/emphysema	3643_Illnesses of mother: Chronic bronchitis/emphysema	25	1688	1	2785	4375	4436	3494	1688	4204	2434	4631	3767	2034	3979
3131_ABL2 - Abelson tyrosine-protein kinase 2	3131_ABL2 - Abelson tyrosine-protein kinase 2	25	1693	1	4082	2722	4653	4669	2658	4553	2867	3479	2478	2264	1693
2930_GPC3 - Glypican-3	2930_GPC3 - Glypican-3	25	1694	1	3775	4111	2682	3664	1694	4205	4516	3024	3712	3884	1981
4432_Rubella IgG levels	4432_Rubella IgG levels	25	1697	1	3960	3208	3186	1697	4586	1740	3536	1848	1763	2466	2215
3321_Ever had bowel cancer screening	3321_Ever had bowel cancer screening	25	1698	1	2438	4282	3622	1698	3850	2280	4301	4119	1823	3582	2687
60_Educational attainment	60_Educational attainment	25	1706	1	2194	3158	1706	2280	4693	4137	2003	3975	2014	4666	3221
484_Lipid::Carnitine metabolism::oleoylcarnitine	484_Lipid::Carnitine metabolism::oleoylcarnitine	25	1707	1	4281	2083	2165	1707	1714	2595	2864	2445	3241	2265	4583
2852_CHST15 - Carbohydrate sulfotransferase 15	2852_CHST15 - Carbohydrate sulfotransferase 15	25	1707	1	4161	3933	4570	4426	1707	2815	4171	2741	2980	4377	2314
773_::::X-12407	773_::::X-12407	25	1712	1	2657	4353	2952	3927	3029	4005	2950	2197	1712	4420	2466
4549_Left entorhinal	4549_Left entorhinal	25	1716	1	1716	3116	4204	3392	1840	1895	4545	4146	2675	4326	3575
2958_CGA CGB - Human Chorionic Gonadotropin	2958_CGA CGB - Human Chorionic Gonadotropin	25	1718	1	1718	1906	4195	3508	4665	3045	2343	2474	2907	3423	2367
729_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::X-11793--oxidized bilirubin*	729_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::X-11793--oxidized bilirubin*	25	1718	1	2007	1765	3923	3748	4055	1718	1831	4084	3917	3517	3911
2086_TNFSF12 - Tumor necrosis factor ligand superfamily member 12	2086_TNFSF12 - Tumor necrosis factor ligand superfamily member 12	25	1724	1	1724	4024	4042	4384	3604	3333	3375	4123	2095	4542	2854
4106_Non-albumin protein	4106_Non-albumin protein	25	1725	1	3857	3438	4149	4658	3110	2693	3783	3947	1725	2888	4201
4040_Schizophrenia/Bipolar disorder	4040_Schizophrenia/Bipolar disorder	25	1729	1	3229	3734	2205	3967	3589	1729	1768	2626	2497	4109	3669
1901_Troch Neck BMD (GEE, male, adjussted for multivariable)	1901_Troch Neck BMD (GEE, male, adjussted for multivariable)	25	1737	1	3041	3958	2885	4515	1737	3799	2779	4605	2875	3191	2083
2396_CNDP2 - Cytosolic non-specific dipeptidase	2396_CNDP2 - Cytosolic non-specific dipeptidase	25	1738	1	3018	3377	1738	3532	4277	2864	4427	2358	3837	4378	3349
761_::::X-12206	761_::::X-12206	25	1738	1	2240	4202	2127	3685	3629	3623	1738	4332	4072	3024	4570
2169_CNTFR - Ciliary neurotrophic factor receptor subunit alpha	2169_CNTFR - Ciliary neurotrophic factor receptor subunit alpha	25	1739	1	3886	3339	3713	1816	3776	1739	4037	1864	2759	2744	2089
3700_Diagnoses - secondary ICD10: M13 Other arthritis	3700_Diagnoses - secondary ICD10: M13 Other arthritis	25	1741	1	1741	4726	2317	3085	3663	1843	3437	3650	2470	3031	4232
2681_RGMA - Repulsive guidance molecule A	2681_RGMA - Repulsive guidance molecule A	25	1746	1	1748	1746	2900	4551	4288	3271	4415	2163	4081	2815	2153
3052_EPHB6 - Ephrin type-B receptor 6	3052_EPHB6 - Ephrin type-B receptor 6	25	1748	1	2205	3164	3424	3839	4353	4420	3802	4586	4009	1748	2872
3778_Traumatic events - Victim of physically violent crime	3778_Traumatic events - Victim of physically violent crime	25	1752	1	2286	3774	1873	4258	1752	3965	1961	3698	4341	3754	4618
1313_HOMA-IR (at exam 5, GEE, adjusted for age and sex)	1313_HOMA-IR (at exam 5, GEE, adjusted for age and sex)	25	1753	1	2425	4333	2129	3029	2406	4598	1753	2107	2677	3219	2553
857_Ratio of bisLallylic bonds to total fatty acids in lipids	857_Ratio of bisLallylic bonds to total fatty acids in lipids	25	1758	1	2469	2784	1758	2012	2754	3484	2383	3838	4454	2935	3512
1048_Type 2 Diabetes	1048_Type 2 Diabetes	25	1763	1	4619	4269	3428	1763	3119	2838	4079	3511	4718	2082	2433
439_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,5-anhydroglucitol (1,5-AG)	439_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,5-anhydroglucitol (1,5-AG)	25	1768	1	3684	3966	2311	3030	4371	3141	3660	1768	3224	4419	2708
705_::::X-11442	705_::::X-11442	25	1771	1	1771	4216	4058	3020	2205	3257	2407	2832	3135	4005	4058
2268_CCL23 - C-C motif chemokine 23	2268_CCL23 - C-C motif chemokine 23	25	1777	1	3163	2895	2116	2845	4068	3752	4611	4548	4225	3186	1777
3145_CD86 - T-lymphocyte activation antigen CD86	3145_CD86 - T-lymphocyte activation antigen CD86	25	1787	1	3804	4325	4661	3857	3053	3648	2604	4338	4418	3714	1787
1152_Incremental insulin 30 min	1152_Incremental insulin 30 min	25	1788	1	2596	3435	4310	2949	2119	2038	2784	1788	2205	2446	3606
512_Lipid::Inositol metabolism::scyllo-inositol	512_Lipid::Inositol metabolism::scyllo-inositol	25	1789	1	3890	3051	2196	3088	4575	3884	3808	2547	2495	2871	1789
3046_CD55 - Complement decay-accelerating factor	3046_CD55 - Complement decay-accelerating factor	25	1795	1	1795	2382	3707	3697	4490	3448	2142	3518	2067	2298	1920
1556_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1556_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	1796	1	2076	3323	4021	3712	3290	2535	3558	4491	2440	3521	1796
4486_Right lingual	4486_Right lingual	25	1801	1	2265	3955	3787	2718	4278	1801	3200	3683	3061	3053	3105
4133_Monocyte count	4133_Monocyte count	25	1808	1	2834	3217	2015	2177	2588	1830	3478	3697	1808	1888	3659
116_Variability of Height	116_Variability of Height	25	1813	1	3150	2379	2488	3053	4694	4034	2514	1813	4459	4303	2826
810_::::X-12850	810_::::X-12850	25	1830	1	1830	2940	2249	3842	4706	2710	3383	4116	3179	4682	3835
3342_Birth weight of first child (female)	3342_Birth weight of first child (female)	25	1833	1	2353	4155	2878	2344	3357	2219	2850	3991	4105	1833	4187
4487_Right medial orbitofrontal	4487_Right medial orbitofrontal	25	1841	1	2170	3756	1841	3732	3167	3326	3094	4577	3360	4555	4007
3953_Amyotrophic lateral sclerosis (LMM)	3953_Amyotrophic lateral sclerosis (LMM)	25	1845	1	2372	2594	2293	3734	3031	3042	1845	3202	4058	2075	3319
430_Amino acid::Valine, leucine and isoleucine metabolism::isovalerylcarnitine	430_Amino acid::Valine, leucine and isoleucine metabolism::isovalerylcarnitine	25	1846	1	1846	4700	2730	3914	3893	4733	2711	3088	2385	2465	2179
1101_Glucose - Birth cohorts	1101_Glucose - Birth cohorts	25	1851	1	3439	3046	3402	2424	1851	3222	2832	2522	3491	2450	3779
412_Amino acid::Urea cycle; arginine-, proline-, metabolism::citrulline	412_Amino acid::Urea cycle; arginine-, proline-, metabolism::citrulline	25	1852	1	1852	3094	3075	2823	4375	2334	4536	3032	4165	3995	3122
696_::::X-11374	696_::::X-11374	25	1852	1	3382	3004	3437	3758	1852	1896	4418	3767	4460	2319	4332
2652_ADAM9 - Disintegrin and metalloproteinase domain-containing protein 9	2652_ADAM9 - Disintegrin and metalloproteinase domain-containing protein 9	25	1854	1	2430	2806	3346	4167	3345	3728	1854	4287	2865	3421	2019
3048_DSG2 - Desmoglein-2	3048_DSG2 - Desmoglein-2	25	1855	1	1855	4432	3384	4347	4556	3228	2338	4542	3000	3253	2613
1216_Alcohol consumption (dichotomous)	1216_Alcohol consumption (dichotomous)	25	1855	1	3745	2347	2776	3327	3197	3615	4513	2853	1977	1855	3140
2685_PPIA - Peptidyl-prolyl cis-trans isomerase A	2685_PPIA - Peptidyl-prolyl cis-trans isomerase A	25	1857	1	1857	2556	2069	2594	1924	3489	2885	2801	1873	3393	2252
3173_ALCAM - CD166 antigen	3173_ALCAM - CD166 antigen	25	1880	1	1880	3856	4556	4613	3337	2292	3341	3663	3893	3709	3199
4296_Thinness	4296_Thinness	25	1889	1	1889	4457	4414	2703	2570	4167	4708	2649	3752	4156	3410
3538_Attendance/disability/mobility allowance: Blue badge	3538_Attendance/disability/mobility allowance: Blue badge	25	1891	1	1891	4705	4315	3371	4533	4007	3566	4652	3603	4224	4582
2185_INHBA - Inhibin beta A chain	2185_INHBA - Inhibin beta A chain	25	1901	1	4118	2389	4271	2330	3555	1901	2206	3515	4120	3243	4194
4333_Polycystic ovary syndrome	4333_Polycystic ovary syndrome	25	1903	1	2243	4328	1903	3491	2121	4368	2521	3626	2841	2156	2400
645_Xenobiotics::Xanthine metabolism::7-methylxanthine	645_Xenobiotics::Xanthine metabolism::7-methylxanthine	25	1905	1	3544	3983	3631	4374	4568	4058	1905	3784	4641	2683	1978
3838_Eosinophil count (two-way meta)	3838_Eosinophil count (two-way meta)	25	1907	1	1985	3296	3920	3299	3868	3940	3829	1907	3751	3484	4074
1812_Biologic age by osseographic scoring system (FBAT, adjusted for multivariable)	1812_Biologic age by osseographic scoring system (FBAT, adjusted for multivariable)	25	1909	1	2624	3872	2843	1909	2990	3331	4215	3599	1953	3645	3711
1602_tPA (at exam 5, FBAT, adjusted for age and sex)	1602_tPA (at exam 5, FBAT, adjusted for age and sex)	25	1912	1	3274	2578	4090	4593	4067	3265	3031	4399	3157	2441	1912
3223_Length of mobile phone use	3223_Length of mobile phone use	25	1913	1	2602	3193	4210	3510	1913	4563	3746	4092	3952	4257	2028
1691_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for age and sex)	1691_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for age and sex)	25	1915	1	4675	3292	3320	1915	3122	3674	4116	3228	2900	3105	2053
1785_PR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1785_PR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	1925	1	4098	2475	3214	2516	2157	2318	3377	2588	3710	4569	1925
4190_Type 2 Diabetes	4190_Type 2 Diabetes	25	1927	1	4624	3117	1927	2911	2324	3638	2420	4637	3325	3804	4354
1999_Hip circumference	1999_Hip circumference	25	1929	1	1929	3174	2329	3380	2183	2055	4045	2182	3800	4284	4048
2290_CLEC11A - Stem Cell Growth Factor-beta	2290_CLEC11A - Stem Cell Growth Factor-beta	25	1932	1	3464	3314	4658	3276	2978	3662	2368	1932	2843	3689	3515
3525_Transport type for commuting to job workplace: Walk	3525_Transport type for commuting to job workplace: Walk	25	1933	1	3298	2935	1933	3110	2584	3635	3320	2713	2578	2381	4644
4578_Right caudal middle frontal	4578_Right caudal middle frontal	25	1938	1	1938	3570	2573	3104	2136	3761	4322	4472	3280	4012	3037
2656_CA3 - Carbonic anhydrase 3	2656_CA3 - Carbonic anhydrase 3	25	1946	1	3161	3159	4027	4321	3882	1946	3026	3779	2572	3075	2984
2895_SH2D1A - SH2 domain-containing protein 1A	2895_SH2D1A - SH2 domain-containing protein 1A	25	1951	1	2721	3418	3354	4457	1951	3182	3568	1959	4622	3873	4093
1531_Ankle-brachial index (at exam 6, GEE, adjusted for age and sex)	1531_Ankle-brachial index (at exam 6, GEE, adjusted for age and sex)	25	1952	1	4460	2327	2463	1952	3104	4472	4259	3050	3698	3418	3418
3610_Treatment/medication code: multivitamins	3610_Treatment/medication code: multivitamins	25	1958	1	2879	3577	3076	2835	3099	1958	2804	3571	3703	3043	2860
234_Lymph:%NK	234_Lymph:%NK	25	1963	1	3106	3558	3217	2336	2122	4276	3880	1963	2726	3199	3815
2988_DPT - Dermatopontin	2988_DPT - Dermatopontin	25	1970	1	2211	3319	2811	3845	2958	4436	3395	4692	3104	1970	4142
3899_Platelet count (three-way meta)	3899_Platelet count (three-way meta)	25	1981	1	3657	3054	2782	4156	3407	3290	2345	4280	2617	1981	3519
385_Amino acid::Guanidino and acetamido metabolism::4-acetamidobutanoate	385_Amino acid::Guanidino and acetamido metabolism::4-acetamidobutanoate	25	1982	1	2108	2813	1982	4663	2971	4618	2636	2412	2978	4526	3068
3479_Own or rent accommodation lived in: Rent - from private landlord or letting agency	3479_Own or rent accommodation lived in: Rent - from private landlord or letting agency	25	1994	1	4498	2901	2673	3799	2678	3580	2554	3712	4546	4169	1994
4588_Right medial orbitofrontal	4588_Right medial orbitofrontal	25	2000	1	3059	3654	3776	3314	2113	3715	3694	2427	2576	2000	4299
1726_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for age and sex)	1726_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for age and sex)	25	2001	1	3767	3556	2321	2715	3642	2001	2788	4308	3153	4327	2235
620_Xenobiotics::Drug::2-hydroxyacetaminophen sulfate*	620_Xenobiotics::Drug::2-hydroxyacetaminophen sulfate*	25	2005	1	4590	2793	2005	2483	3202	4657	4227	3755	3485	3563	4401
3732_Depression - Fraction of day affected during worst episode of depression	3732_Depression - Fraction of day affected during worst episode of depression	25	2005	1	2375	4487	3083	2005	4061	2513	3641	3163	2727	2142	3095
1001_Macrophage migration inhibitory factor (glycosylation-inhibiting factor)	1001_Macrophage migration inhibitory factor (glycosylation-inhibiting factor)	25	2006	1	3840	4093	3399	4409	2006	2680	2328	4182	3374	2037	3070
4589_Right middle temporal	4589_Right middle temporal	25	2028	1	2063	2885	3499	3170	3199	3536	3125	4257	2028	3495	3030
4330_Postburn scar pliability	4330_Postburn scar pliability	25	2029	1	3870	3971	4446	4055	4464	2029	4607	2253	3254	4373	2804
824_::::X-13553	824_::::X-13553	25	2031	1	3353	2060	2846	2031	3880	4534	2102	3633	2716	2431	2633
2801_RBM39 - RNA-binding protein 39	2801_RBM39 - RNA-binding protein 39	25	2035	1	3651	2035	3728	4432	4003	3260	3523	3116	4503	3220	2536
3047_TNFRSF6B - Tumor necrosis factor receptor superfamily member 6B	3047_TNFRSF6B - Tumor necrosis factor receptor superfamily member 6B	25	2043	1	4293	4287	2218	2716	3459	2043	2989	3482	4099	3118	2295
2257_TOP1 - DNA topoisomerase 1	2257_TOP1 - DNA topoisomerase 1	25	2051	1	3816	3575	2270	2051	3180	4176	2167	4240	2821	3267	3962
3874_Eosinophil count (three-way meta)	3874_Eosinophil count (three-way meta)	25	2059	1	3459	3108	2887	2649	3033	4595	4342	2059	3812	2962	2090
1012_TNF-related apoptosis inducing ligand	1012_TNF-related apoptosis inducing ligand	25	2074	1	2128	2074	4410	4651	4086	3863	4291	2895	4576	4236	3860
2665_FGFR3 - Fibroblast growth factor receptor 3	2665_FGFR3 - Fibroblast growth factor receptor 3	25	2076	1	4134	4572	3309	2167	4228	2143	3975	2290	2076	3777	3983
229_mDC:%CD1c+	229_mDC:%CD1c+	25	2092	1	3237	4584	2925	4375	2092	2786	3838	2906	4656	3913	2593
588_Nucleotide::Purine metabolism, urate metabolism::urate	588_Nucleotide::Purine metabolism, urate metabolism::urate	25	2102	1	3431	4354	4250	2102	4645	4686	3991	3004	3892	4463	2935
1137_Father's age at death	1137_Father's age at death	25	2105	1	3483	4650	2914	4245	2590	4086	2105	3140	2753	2763	4270
2291_VCAM1 - Vascular cell adhesion protein 1	2291_VCAM1 - Vascular cell adhesion protein 1	25	2113	1	2113	4535	4167	4133	3885	4159	4135	2215	3264	4467	3371
765_::::X-12230	765_::::X-12230	25	2137	1	3000	4694	3895	3787	2276	4175	2137	2685	4296	3176	3985
1676_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for multivariable)	1676_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for multivariable)	25	2148	1	4667	4218	2829	2963	2148	3327	3996	3877	3552	2919	4156
4116_Phosphorus	4116_Phosphorus	25	2152	1	2152	3495	3285	4648	4629	3385	4691	4010	4327	4264	3750
625_Xenobiotics::Drug::ibuprofen	625_Xenobiotics::Drug::ibuprofen	25	2154	1	2213	2730	2569	3843	4555	4708	4560	4256	2839	2970	2154
2529_SERPINA4 - Kallistatin	2529_SERPINA4 - Kallistatin	25	2171	1	4301	4151	2415	3572	2251	3959	4648	4188	3998	4060	2171
296_CD4mem:%preTh17 (1)	296_CD4mem:%preTh17 (1)	25	2189	1	2800	4243	3333	3576	2546	3323	2564	4746	2417	3337	2189
3432_Symbol digit substitution test - Number of symbol digit matches attempted	3432_Symbol digit substitution test - Number of symbol digit matches attempted	25	2210	1	2414	3062	3629	3322	4057	3695	4273	2210	4141	3932	3172
3122_PPIF - Peptidyl-prolyl cis-trans isomerase F, mitochondrial	3122_PPIF - Peptidyl-prolyl cis-trans isomerase F, mitochondrial	25	2224	1	4424	4532	3802	4723	2224	4338	2797	4272	4064	2856	4685
419_Amino acid::Urea cycle; arginine-, proline-, metabolism::urea	419_Amino acid::Urea cycle; arginine-, proline-, metabolism::urea	25	2225	1	3469	3498	4462	2225	2870	4309	4534	3538	3901	3399	2839
2452_LY9 - T-lymphocyte surface antigen Ly-9	2452_LY9 - T-lymphocyte surface antigen Ly-9	25	2228	1	4435	4330	4270	3249	4225	4043	2228	3854	2336	2519	4154
1126_Visceral adipose tissue sttenutation	1126_Visceral adipose tissue sttenutation	25	2239	1	3463	4197	2784	2245	3185	2239	4032	3225	2653	3403	4435
1055_Inflammatory Bowel Disease	1055_Inflammatory Bowel Disease	25	2246	1	3859	4633	4079	3782	2382	3877	2310	4069	4666	2278	2246
3309_Wears glasses or contact lenses	3309_Wears glasses or contact lenses	25	2272	1	2703	2629	2377	3155	2275	4026	3845	3874	2272	3283	4471
2249_HDAC8 - Histone deacetylase 8	2249_HDAC8 - Histone deacetylase 8	25	2293	1	2293	4181	3610	2308	2569	3960	3238	4262	4620	2346	3289
2736_FST - Follistatin	2736_FST - Follistatin	25	2304	1	4032	3869	4690	3657	2304	3853	3402	3716	2486	3795	2926
2160_OSM - Oncostatin-M	2160_OSM - Oncostatin-M	25	2310	1	3912	2751	4117	3161	2600	2991	4018	4463	2862	3299	2310
1902_Frontal lobe volume (FBAT, adjusted for multivariable)	1902_Frontal lobe volume (FBAT, adjusted for multivariable)	25	2339	1	3711	2757	2458	3356	3940	3660	2880	2339	2833	3008	2807
2510_CAMK2D - Calcium/calmodulin-dependent protein kinase type II subunit delta	2510_CAMK2D - Calcium/calmodulin-dependent protein kinase type II subunit delta	25	2443	1	4604	3373	3484	3597	2559	3251	4363	3404	2443	4609	2701
2055_Remission after 12 weeks of antidepressant treatment in MDD	2055_Remission after 12 weeks of antidepressant treatment in MDD	25	2445	1	4417	3893	4513	3488	4538	2445	3993	3734	3816	2629	3576
3980_Offspring birthweight (maternal)	3980_Offspring birthweight (maternal)	25	2452	1	4149	2452	4177	2824	3840	4101	2854	4476	2568	4450	4120
3863_Platelet count (two-way meta)	3863_Platelet count (two-way meta)	25	2461	1	4306	3633	3673	4223	2834	3803	2461	3503	2930	2500	3101
2161_PECAM1 - Platelet endothelial cell adhesion molecule	2161_PECAM1 - Platelet endothelial cell adhesion molecule	25	2537	1	3740	3291	4670	4447	3645	4117	3928	2542	4257	3251	2537
2200_IGFBP1 - Insulin-like growth factor-binding protein 1	2200_IGFBP1 - Insulin-like growth factor-binding protein 1	25	2545	1	2545	4464	2736	3585	4370	3050	3878	3444	4262	3829	3325
562_Lipid::Monoacylglycerol::1-linoleoylglycerol (1-monolinolein)	562_Lipid::Monoacylglycerol::1-linoleoylglycerol (1-monolinolein)	25	2546	1	4431	3891	2546	4603	4153	4384	4432	3721	4715	2739	4039
2608_OPCML - Opioid-binding protein/cell adhesion molecule	2608_OPCML - Opioid-binding protein/cell adhesion molecule	25	2573	1	4176	3845	4595	4560	4588	2702	3901	4591	3724	2573	2618
1052_Ischemic stroke	1052_Ischemic stroke	25	2574	1	3872	4702	2574	4026	2956	3944	3439	3659	4144	3325	3222
566_Lipid::Short chain fatty acid::valerate	566_Lipid::Short chain fatty acid::valerate	25	2575	1	2587	2575	3784	3365	4383	4138	3892	2674	4538	3980	2715
3390_Financial situation satisfaction	3390_Financial situation satisfaction	25	2585	1	2585	3155	2826	4074	3929	3166	2887	4740	3676	3623	4603
2579_BSG - Basigin	2579_BSG - Basigin	25	2773	1	3061	3673	3262	3306	3009	4594	2773	2777	3716	4052	2832
4243_Rapid automised naming of objects	4243_Rapid automised naming of objects	25	2786	1	4379	3368	4337	3538	4355	4256	3192	3151	4375	4650	2786
1082_Hemoglobin A1C level in conventional treatment group	1082_Hemoglobin A1C level in conventional treatment group	25	2831	1	3853	2900	3466	4692	2831	3237	2951	4633	3311	3449	4509
